data_6q2z_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6q2z _Structure_validation_residue.Date_analyzed 2019-06-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 . . . . . 0 CA--C 1.517 -0.318 0 CA-C-O 121.216 0.531 . . . . 1.0 110.915 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 33.5 mmtp -140.13 98.31 3.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.65 172.33 3.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.627 -0.715 . . . . 1.0 109.904 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.478 ' HA ' ' HB2' ' B' ' 255' ' ' ALA . 52.3 p-80 -169.48 146.5 3.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.01 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.2 m-85 -85.0 145.57 27.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.592 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.98 124.26 20.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.346 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 118' ' ' TRP . 62.6 t -96.48 133.78 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.449 -0.342 . . . . 1.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -142.95 179.72 6.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.027 0.205 . . . . 1.0 110.776 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.6 t -101.75 138.05 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.426 0.632 . . . . 1.0 112.485 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.71 178.15 8.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.379 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.51 -15.32 63.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 1.0 111.209 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.77 19.21 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.593 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 71.27 36.12 1.42 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.93 0.769 . . . . 1.0 110.927 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 10.5 mmtt -110.88 150.53 29.04 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.261 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -93.95 119.28 32.63 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.915 -1.038 . . . . 1.0 110.499 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -132.05 -179.95 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.418 ' HB3' HG21 ' A' ' 108' ' ' VAL . 51.2 p-90 -152.84 162.48 41.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.354 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -146.54 143.25 28.77 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.171 0.919 . . . . 1.0 109.882 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.568 ' HG ' HD11 ' A' ' 128' ' ' LEU . 33.1 tp -95.08 130.57 41.73 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.79 131.61 70.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.266 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.584 ' CB ' HD22 ' A' ' 126' ' ' ASN . 5.2 t-80 -81.4 172.93 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 23.8 t70 -58.5 -27.46 64.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.27 0.557 . . . . 1.0 110.873 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.62 -32.85 70.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.772 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.88 12.76 21.71 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.9 -1.045 . . . . 1.0 112.626 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.584 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.42 146.98 24.29 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.423 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 51.1 mm -79.42 114.53 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.568 HD11 ' HG ' ' A' ' 120' ' ' LEU . 15.6 mt -87.94 -43.24 11.91 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.415 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.27 162.98 40.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.952 -1.022 . . . . 1.0 111.051 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -135.94 155.41 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.047 -1.094 . . . . 1.0 108.047 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 133' ' ' GLU . 53.3 p -55.88 -38.74 70.55 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.332 0.395 . . . . 1.0 111.968 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.19 -33.96 2.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 131' ' ' SER . 47.2 mt-10 -87.97 -178.68 6.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.934 -0.633 . . . . 1.0 111.118 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.65 114.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.094 -1.203 . . . . 1.0 110.094 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.49 169.68 17.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.616 0.208 . . . . 1.0 110.45 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.54 10.03 14.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.9 m -122.41 131.33 53.83 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.631 0.729 . . . . 1.0 112.234 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -67.39 -32.25 73.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.527 -1.215 . . . . 1.0 109.734 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.7 tt0 -60.93 -46.79 89.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.229 -0.896 . . . . 1.0 109.915 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.29 -38.74 80.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.462 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.245 0.545 . . . . 1.0 109.918 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.498 ' HA ' HD11 ' A' ' 145' ' ' ILE . 45.8 mtmt -64.82 -33.36 75.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -64.86 -32.29 73.92 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.444 -0.502 . . . . 1.0 109.974 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -40.84 94.41 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.732 -0.747 . . . . 1.0 111.257 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' A' ' 142' ' ' LYS . 71.9 mt -59.83 -51.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 1.0 110.613 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.19 -35.66 81.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.806 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.5 m -66.74 -34.99 79.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.003 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.71 -35.17 43.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.712 -177.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -68.92 -15.44 63.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.742 0.782 . . . . 1.0 110.238 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -99.39 -2.72 35.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.431 -1.259 . . . . 1.0 112.591 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -136.91 -39.12 0.62 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.944 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB3' HG23 ' A' ' 148' ' ' VAL . . . -57.16 -51.6 80.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 55.7 Cg_endo -66.41 -7.77 18.68 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.243 1.296 . . . . 1.0 113.229 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -116.56 -24.62 7.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.056 0.455 . . . . 1.0 111.644 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.05 136.88 57.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.946 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -92.07 137.84 32.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 1.0 110.724 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -88.99 131.51 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.378 0.609 . . . . 1.0 112.587 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 114.832 -1.076 . . . . 1.0 108.46 177.405 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.449 0.642 . . . . 1.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.475 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 72.8 mmtt -136.89 97.39 3.51 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.906 -1.516 . . . . 1.0 106.906 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.96 174.23 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.614 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.464 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 41.0 p-80 -170.95 148.16 2.77 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.273 0.358 . . . . 1.0 110.519 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.524 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 50.2 m-85 -85.61 149.56 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.734 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -141.99 118.39 10.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.721 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' B' ' 218' ' ' TRP . 75.9 t -93.48 132.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -143.16 -177.88 5.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.3 t -102.64 137.46 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 1.0 112.284 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.32 179.4 6.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.552 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.33 -14.61 62.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.049 0.452 . . . . 1.0 110.575 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.12 15.88 24.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.503 -0.772 . . . . 1.0 111.758 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 70.42 41.71 0.97 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.482 0.713 . . . . 1.0 110.611 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 9.2 mmtt -115.13 152.03 33.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.71 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.97 118.76 31.07 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.391 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -134.68 179.37 6.34 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.119 -0.946 . . . . 1.0 109.046 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.446 ' HB3' HG22 ' B' ' 208' ' ' VAL . 50.6 p-90 -154.28 161.46 41.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.516 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -147.31 142.85 27.59 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.885 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.552 ' HG ' HD11 ' B' ' 228' ' ' LEU . 33.8 tp -94.16 131.98 39.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 t -128.68 131.43 68.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.268 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.536 ' CB ' HD22 ' B' ' 226' ' ' ASN . 9.5 t-80 -78.01 170.7 16.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 20.8 t70 -57.19 -27.7 62.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.373 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.81 -33.77 62.27 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.19 13.33 10.93 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 114.999 -1.0 . . . . 1.0 113.459 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.536 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.2 OUTLIER -87.96 144.57 26.47 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.904 -0.174 . . . . 1.0 111.256 178.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.36 123.36 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.815 0.697 . . . . 1.0 109.262 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.552 HD11 ' HG ' ' B' ' 220' ' ' LEU . 14.0 mt -99.35 -42.11 7.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.322 0.582 . . . . 1.0 109.796 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -153.01 164.3 38.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.895 -1.048 . . . . 1.0 111.625 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -139.61 153.49 47.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 1.0 108.897 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 11.9 p -51.58 -35.43 41.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.49 -46.6 3.51 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.119 -0.792 . . . . 1.0 111.119 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.7 mt-10 -107.43 173.99 6.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.955 -0.623 . . . . 1.0 111.73 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -133.65 145.62 17.65 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.965 -1.254 . . . . 1.0 109.965 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -142.48 171.95 13.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.359 0.579 . . . . 1.0 110.788 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.69 10.28 41.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.306 0.484 . . . . 1.0 112.306 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 9.5 m -136.69 134.8 37.61 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.357 0.598 . . . . 1.0 111.484 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -63.98 -35.41 80.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.3 tt0 -57.74 -48.32 79.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.607 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -61.88 -38.14 87.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.351 0.407 . . . . 1.0 110.847 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.46 -49.56 76.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 1.0 109.698 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' B' ' 245' ' ' ILE . 43.9 mtmt -64.8 -33.81 76.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.369 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.9 mm-40 -63.42 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.32 -0.552 . . . . 1.0 109.744 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.26 89.44 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' B' ' 242' ' ' LYS . 73.9 mt -60.88 -50.5 80.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.697 0.76 . . . . 1.0 110.374 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.36 -33.83 76.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.652 -0.704 . . . . 1.0 111.23 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 m -65.05 -38.69 91.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.175 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' B' ' 252' ' ' ALA . 1.1 p -73.92 -40.61 52.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.094 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.09 -15.25 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.177 0.513 . . . . 1.0 111.907 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -101.31 -1.47 33.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.825 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -135.82 -37.39 0.74 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.84 0.352 . . . . 1.0 111.942 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' B' ' 248' ' ' VAL . . . -55.47 -50.67 85.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 112.898 0.703 . . . . 1.0 112.898 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.6 Cg_endo -65.46 -10.4 26.07 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 120.764 0.976 . . . . 1.0 113.503 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.07 -20.39 8.71 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 105' ' ' HIS . . . -66.02 135.34 54.53 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.86 -0.609 . . . . 1.0 112.27 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.89 139.52 30.67 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.764 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -91.7 128.31 43.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . 0.421 HD13 ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -124.4 146.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.283 -1.326 . . . . 1.0 110.174 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -91.26 114.66 27.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.926 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.077 -0.963 . . . . 1.0 111.19 -178.123 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 121.253 0.549 . . . . 1.0 111.5 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -136.98 97.7 3.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.055 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.44 171.14 3.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.076 -0.965 . . . . 1.0 109.504 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.437 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 44.2 p-80 -169.22 148.32 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -85.32 147.74 26.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.388 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.59 116.92 11.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 118' ' ' TRP . 97.0 t -92.47 133.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.579 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -142.71 179.25 7.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 1.0 110.707 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.3 t -103.36 134.41 44.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.939 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.7 -179.95 7.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.762 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.09 -12.97 62.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.776 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -115.24 26.88 9.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.257 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 65.58 30.48 10.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.404 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 71.9 mmtt -95.66 156.24 16.41 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.9 117.2 33.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.3 mtm105 -132.91 178.0 7.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.437 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.9 p-90 -150.53 163.27 38.86 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.931 0.396 . . . . 1.0 111.417 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -147.73 143.37 27.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.826 -1.079 . . . . 1.0 109.304 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.59 ' HG ' HD13 ' A' ' 128' ' ' LEU . 34.7 tp -91.61 131.66 36.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.6 t -128.29 130.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.43 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.569 ' CB ' HD22 ' A' ' 126' ' ' ASN . 1.9 t-80 -79.08 170.95 15.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -55.73 -31.8 62.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.884 0.373 . . . . 1.0 111.187 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.3 -34.16 77.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.478 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.41 9.36 19.73 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.907 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.569 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.47 142.74 27.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.0 mm -77.09 118.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.634 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.59 HD13 ' HG ' ' A' ' 120' ' ' LEU . 15.2 mt -92.19 -42.42 9.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.217 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.0 164.77 36.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.654 -1.157 . . . . 1.0 111.255 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -137.32 154.02 50.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.844 . . . . 1.0 108.862 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 p -53.32 -35.01 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 1.0 112.343 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.0 -42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.566 -0.614 . . . . 1.0 111.566 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -102.79 -177.52 3.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.204 0.526 . . . . 1.0 111.556 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.9 126.31 1.8 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.4 173.1 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.136 0.468 . . . . 1.0 111.121 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.99 9.79 31.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.585 0.957 . . . . 1.0 113.585 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -122.64 130.55 53.1 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.427 0.632 . . . . 1.0 111.341 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.84 -38.31 88.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.5 tt0 -61.42 -41.39 97.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.081 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -60.06 -42.75 95.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.897 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.94 81.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.259 0.552 . . . . 1.0 110.196 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HA ' HD11 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.24 -33.8 76.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.388 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -65.22 -31.45 72.62 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.921 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.98 -38.85 95.97 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.461 HG23 HG22 ' B' ' 257' ' ' VAL . 64.5 mt -61.28 -51.06 77.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.365 0.602 . . . . 1.0 110.304 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -63.41 -32.89 74.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.989 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -64.2 -39.68 94.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.336 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.549 HG23 ' HB1' ' A' ' 152' ' ' ALA . 1.6 p -75.04 -38.28 42.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 C-N-CA 119.906 -0.718 . . . . 1.0 109.887 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -64.6 -13.83 55.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.145 0.498 . . . . 1.0 111.211 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -4.58 40.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.721 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 22.1 m-80 -137.03 -37.93 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.757 0.651 . . . . 1.0 112.757 -174.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.549 ' HB1' HG23 ' A' ' 148' ' ' VAL . . . -53.69 -50.01 85.82 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.1 Cg_endo -65.88 -14.12 43.09 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 120.882 1.055 . . . . 1.0 113.633 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.48 -27.46 8.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -61.32 135.51 57.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.555 0.946 . . . . 1.0 113.555 -176.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -90.98 139.21 30.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.06 -1.427 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.22 133.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.214 0.531 . . . . 1.0 111.983 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.356 178.83 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 12.8 p-10 . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.848 0.832 . . . . 1.0 112.622 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -143.74 98.94 3.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.899 -1.5 . . . . 1.0 107.447 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.33 173.58 2.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.789 -1.096 . . . . 1.0 109.223 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.468 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 54.1 p-80 -169.5 148.78 3.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 49.5 m-85 -85.42 145.41 27.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.143 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -139.0 120.73 15.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.511 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.431 HG21 ' HG2' ' B' ' 242' ' ' LYS . 72.4 t -92.48 132.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.889 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.39 -176.02 4.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.078 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.8 t -107.33 139.69 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 1.0 112.579 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -81.85 -179.75 7.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.144 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.9 0.381 . . . . 1.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.24 24.05 13.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.17 41.36 8.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.344 0.592 . . . . 1.0 111.09 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.4 mmtt -103.61 155.82 18.26 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.447 -0.797 . . . . 1.0 108.901 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.49 123.01 41.19 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.043 0.449 . . . . 1.0 110.308 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -137.51 -178.83 5.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.058 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.411 ' HB3' HG23 ' B' ' 208' ' ' VAL . 58.2 p-90 -155.37 162.59 40.77 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.413 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' B' ' 219' ' ' ARG . 13.5 mtp180 -146.63 146.78 30.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.041 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.579 ' HG ' HD13 ' B' ' 228' ' ' LEU . 32.9 tp -97.03 130.2 44.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.73 130.18 71.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.444 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.497 ' CB ' HD22 ' B' ' 226' ' ' ASN . 1.9 t-80 -81.37 175.3 10.68 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.75 -35.56 63.88 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.347 0.404 . . . . 1.0 111.859 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -67.91 -33.26 74.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.285 0.564 . . . . 1.0 110.298 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.49 10.93 20.84 Favored Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 114.894 -1.048 . . . . 1.0 112.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.497 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.11 143.25 28.14 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 1.0 112.057 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.78 120.35 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.263 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.579 HD13 ' HG ' ' B' ' 220' ' ' LEU . 13.3 mt -97.39 -42.61 7.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.519 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -153.7 165.42 36.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.363 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.69 159.72 41.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 57.4 p -55.75 -33.81 64.64 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.151 0.5 . . . . 1.0 111.427 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.63 -51.19 3.58 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -100.99 177.79 4.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.979 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.95 139.5 9.67 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -137.49 172.46 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.544 0.672 . . . . 1.0 111.489 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.15 10.9 36.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.0 113.129 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 7.0 m -136.7 135.93 38.58 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.079 0.466 . . . . 1.0 110.926 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -64.53 -38.18 90.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.6 tt0 -57.24 -45.14 84.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.838 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -62.78 -40.75 98.29 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.906 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.63 79.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.558 0.694 . . . . 1.0 109.772 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.435 ' HA ' HD11 ' B' ' 245' ' ' ILE . 44.0 mtmt -65.02 -35.36 80.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.532 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.0 mm-40 -63.37 -28.02 69.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 176.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.75 -42.08 95.42 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.451 ' O ' HG11 ' B' ' 248' ' ' VAL . 62.1 mt -61.83 -44.93 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.931 -0.634 . . . . 1.0 110.021 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.06 -39.74 93.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.208 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -67.68 -34.08 76.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.957 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.511 HG23 ' HB1' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.59 -39.27 53.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.03 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -68.43 -12.25 60.9 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.306 0.574 . . . . 1.0 111.078 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -101.22 -3.12 29.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 1.0 111.09 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -136.42 -40.09 0.65 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.511 ' HB1' HG23 ' B' ' 248' ' ' VAL . . . -55.35 -49.67 91.12 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 46.7 Cg_endo -66.48 -9.12 22.96 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 120.916 1.077 . . . . 1.0 113.456 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.61 -13.91 8.27 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -69.27 137.74 53.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.464 0.649 . . . . 1.0 112.13 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -91.14 144.01 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.997 -1.001 . . . . 1.0 111.495 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 145' ' ' ILE . 43.7 t -85.76 123.49 39.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.226 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.7 mt -115.53 138.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -89.65 100.51 13.3 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.492 -0.766 . . . . 1.0 110.965 -176.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-O 121.42 0.629 . . . . 1.0 111.806 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 35.2 mmtp -142.37 96.39 2.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.24 174.67 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.164 -177.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.487 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 53.3 p-80 -168.94 147.3 3.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.694 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 47.1 m-85 -85.04 148.82 25.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.71 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.06 120.44 13.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.766 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 118' ' ' TRP . 83.6 t -94.76 137.95 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.937 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.39 -178.63 6.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.437 -0.208 . . . . 1.0 110.437 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 8.2 t -103.98 136.75 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.186 0.517 . . . . 1.0 112.363 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.24 -179.68 7.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.086 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.48 -15.19 63.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.075 0.398 . . . . 1.0 112.075 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.81 22.59 15.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.677 0.275 . . . . 1.0 111.396 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.87 40.3 1.32 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.695 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 2.5 mmtp -111.79 149.88 31.1 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.286 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -94.19 120.67 34.78 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.62 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -133.91 -179.4 5.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.818 -1.083 . . . . 1.0 108.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.445 ' HB3' HG23 ' A' ' 108' ' ' VAL . 56.5 p-90 -153.25 162.94 40.75 Favored 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 120.55 -0.46 . . . . 1.0 111.428 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.488 HH21 HG13 ' A' ' 127' ' ' ILE . 41.9 mtp180 -148.23 141.17 24.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.397 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.573 ' HG ' HD13 ' A' ' 128' ' ' LEU . 36.0 tp -90.97 135.15 33.93 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.09 130.25 69.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.084 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.539 ' CB ' HD22 ' A' ' 126' ' ' ASN . 3.5 t-80 -77.49 171.84 14.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.6 t70 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.247 0.546 . . . . 1.0 110.356 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -33.57 75.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.169 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.89 8.18 24.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.289 -0.869 . . . . 1.0 112.884 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.539 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.83 145.26 26.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.715 0.265 . . . . 1.0 111.715 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.488 HG13 HH21 ' A' ' 119' ' ' ARG . 51.0 mm -76.81 119.74 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.809 0.693 . . . . 1.0 110.017 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.573 HD13 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -94.86 -43.75 8.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.104 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.01 168.91 21.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.663 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -143.83 155.86 44.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.272 -0.876 . . . . 1.0 108.671 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.3 p -58.16 -32.96 68.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.189 0.519 . . . . 1.0 111.191 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.89 -47.24 3.52 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -109.25 170.66 7.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.734 -0.733 . . . . 1.0 111.549 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.34 16.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.267 -0.878 . . . . 1.0 110.934 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -141.46 165.92 26.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.848 0.324 . . . . 1.0 110.45 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.43 10.27 30.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 p -127.38 129.23 47.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.453 0.644 . . . . 1.0 112.188 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -66.84 -37.05 83.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.456 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 10.0 tt0 -58.81 -43.17 90.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.135 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tppt? -60.07 -41.89 93.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.785 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.16 -50.29 69.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.293 0.568 . . . . 1.0 109.906 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.488 ' HA ' HD13 ' A' ' 145' ' ' ILE . 49.1 mtmt -65.45 -33.08 75.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.563 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.3 mm-40 -66.73 -31.02 71.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.128 176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.66 -38.26 93.08 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.488 HD13 ' HA ' ' A' ' 142' ' ' LYS . 71.7 mt -61.47 -50.32 80.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.307 0.575 . . . . 1.0 110.652 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -62.8 -33.79 75.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.181 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 52.5 m -65.28 -37.45 87.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.753 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -74.49 -33.88 34.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 120.411 -0.516 . . . . 1.0 109.866 -177.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -69.35 -13.21 62.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.657 0.741 . . . . 1.0 110.634 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -101.21 -2.92 30.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.764 -1.107 . . . . 1.0 112.325 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.19 -39.5 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.745 0.307 . . . . 1.0 111.737 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.491 ' HB2' HG23 ' A' ' 148' ' ' VAL . . . -57.13 -51.32 82.57 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 32.0 Cg_endo -60.71 -12.26 20.86 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.364 1.376 . . . . 1.0 113.515 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -123.79 -7.46 7.9 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -73.48 134.3 43.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.704 0.764 . . . . 1.0 112.23 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.03 135.82 33.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.621 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -88.05 134.13 28.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.445 0.641 . . . . 1.0 112.124 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 11.0 mt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 114.711 -1.131 . . . . 1.0 109.327 178.281 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 CA--C 1.513 -0.479 0 CA-C-O 121.838 0.828 . . . . 1.0 112.592 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 23.6 mmtp -140.14 97.26 3.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.926 -1.488 . . . . 1.0 107.699 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.63 172.2 3.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.899 . . . . 1.0 109.831 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 45.3 p-80 -169.22 148.09 3.89 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.781 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 53.2 m-85 -85.35 148.55 25.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.921 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -140.33 117.01 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.43 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.8 t -92.95 129.79 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.91 -0.586 . . . . 1.0 109.662 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -141.34 -179.19 5.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.788 0.328 . . . . 1.0 110.589 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.9 t -102.23 136.34 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 1.0 112.149 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 16.0 t70 -78.72 179.92 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.013 -0.994 . . . . 1.0 109.752 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.417 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -67.9 -18.01 64.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.238 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.54 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.236 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 63.53 39.37 9.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.431 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 31.7 mmtp -103.48 156.34 17.84 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.71 118.5 34.39 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -134.29 179.57 6.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.308 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.404 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.1 p-90 -154.0 161.37 42.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.945 0.402 . . . . 1.0 111.172 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -147.07 141.11 26.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.047 -0.979 . . . . 1.0 109.89 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.566 ' HG ' HD13 ' B' ' 228' ' ' LEU . 31.9 tp -91.39 131.1 37.1 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.01 130.93 71.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.174 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.504 ' CB ' HD22 ' B' ' 226' ' ' ASN . 6.3 t-80 -77.16 173.19 12.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . 0.551 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.0 t70 -56.56 -34.39 67.05 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.368 0.418 . . . . 1.0 111.063 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . 0.406 ' HB2' ' OD1' ' B' ' 226' ' ' ASN . 1.4 m-20 -68.65 -34.62 76.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.019 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.79 13.93 9.87 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.378 -0.828 . . . . 1.0 113.514 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.504 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.2 OUTLIER -87.63 147.33 25.32 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.98 -0.129 . . . . 1.0 111.112 178.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.53 119.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.588 0.555 . . . . 1.0 110.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.566 HD13 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -93.69 -43.35 8.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.555 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.42 165.07 35.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.297 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.0 157.16 46.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.053 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 12.9 p -54.67 -32.99 60.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.8 -43.77 3.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.87 170.02 8.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.17 0.51 . . . . 1.0 111.553 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -122.87 124.78 5.77 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.338 -1.505 . . . . 1.0 109.338 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -110.8 172.45 6.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.993 0.396 . . . . 1.0 111.372 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -105.54 10.85 32.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.874 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 3.3 p -143.94 130.88 20.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.629 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.03 -44.41 97.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.087 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.2 tt0 -54.04 -40.49 67.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.261 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.559 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.3 OUTLIER -61.62 -42.8 99.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.323 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.29 92.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.305 0.574 . . . . 1.0 109.817 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.439 ' HA ' HD13 ' B' ' 245' ' ' ILE . 46.3 mtmt -64.04 -35.52 80.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.13 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.2 mm-40 -65.4 -31.39 72.47 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.045 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.48 94.7 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.511 -0.852 . . . . 1.0 110.979 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.501 ' O ' HG12 ' B' ' 248' ' ' VAL . 70.6 mt -61.16 -52.3 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.365 0.602 . . . . 1.0 110.606 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -63.35 -34.85 78.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.646 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.7 m -66.15 -35.85 81.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.754 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.5 OUTLIER -73.33 -41.06 57.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -65.06 -13.48 58.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.801 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -102.74 -2.92 27.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.261 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 17.8 m-80 -137.01 -38.31 0.63 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.223 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' B' ' 248' ' ' VAL . . . -55.58 -50.77 85.06 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.696 0.628 . . . . 1.0 112.696 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.9 Cg_endo -63.92 -10.65 23.61 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.037 1.158 . . . . 1.0 113.266 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.99 -17.04 11.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.978 0.418 . . . . 1.0 111.464 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -69.73 136.92 51.54 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.18 0.807 . . . . 1.0 113.18 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -90.25 137.58 32.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.966 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -88.72 132.27 34.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.253 0.549 . . . . 1.0 112.416 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -121.58 142.72 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.526 -1.215 . . . . 1.0 108.407 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -93.51 106.9 18.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.825 -176.633 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 . . . . . 0 CA--C 1.517 -0.326 0 CA-C-O 122.108 0.956 . . . . 1.0 113.081 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 72.3 mmtt -135.02 97.61 3.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.387 -1.733 . . . . 1.0 107.183 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.49 170.81 3.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -170.75 150.78 3.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.413 -0.217 . . . . 1.0 110.413 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.403 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 69.7 m-85 -88.57 150.85 22.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.267 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -143.19 123.35 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.717 . . . . 1.0 110.636 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.7 t -96.96 134.06 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.909 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -146.32 -177.55 5.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 1.0 110.869 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -96.82 138.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.362 0.601 . . . . 1.0 112.552 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 112' ' ' ALA . 22.8 t70 -82.12 179.67 7.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.772 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.455 ' H ' ' CG ' ' A' ' 111' ' ' ASP . . . -70.08 -13.61 62.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.289 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.82 26.33 10.44 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.871 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 59.54 43.61 15.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.402 0.62 . . . . 1.0 111.004 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.8 mmtp -101.72 178.32 4.66 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -118.57 103.37 9.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.517 ' CD ' ' HA2' ' A' ' 134' ' ' GLY . 12.7 mmm180 -122.28 178.63 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.46 ' HB3' HG22 ' A' ' 108' ' ' VAL . 60.2 p-90 -151.6 163.81 38.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.735 0.302 . . . . 1.0 111.355 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -148.4 149.64 32.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.658 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' HD13 ' A' ' 128' ' ' LEU . 33.7 tp -96.94 133.29 41.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 177.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -131.31 131.43 63.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.141 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.598 ' CB ' HD22 ' A' ' 126' ' ' ASN . 4.1 t-80 -76.89 168.2 20.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.413 -1.329 . . . . 1.0 107.413 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 22.8 t70 -61.36 -22.39 64.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.852 0.358 . . . . 1.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -35.04 72.12 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.511 0.672 . . . . 1.0 109.513 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.9 11.39 11.17 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 114.8 -1.091 . . . . 1.0 113.199 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.598 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -91.01 143.93 26.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.718 -0.283 . . . . 1.0 111.673 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.32 126.58 36.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 O-C-N 123.96 0.787 . . . . 1.0 110.133 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.558 HD13 ' HG ' ' A' ' 120' ' ' LEU . 13.4 mt -105.12 -39.62 6.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 1.0 110.071 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.03 166.81 31.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.775 -1.102 . . . . 1.0 111.277 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -139.6 156.0 47.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.341 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.494 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 83.1 p -56.64 -42.74 79.39 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.99 -41.88 3.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.903 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.511 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 35.7 mt-10 -83.95 -168.48 2.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.118 0.485 . . . . 1.0 110.17 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.517 ' HA2' ' CD ' ' A' ' 117' ' ' ARG . . . -168.65 119.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 1.0 111.706 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -141.3 169.01 18.42 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.76 35.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -116.62 131.85 56.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.409 0.624 . . . . 1.0 111.456 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -65.12 -36.11 83.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.792 -1.095 . . . . 1.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.8 tt0 -61.24 -45.59 93.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.394 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.6 -38.14 80.44 Favored 'General case' 0 CA--C 1.52 -0.176 0 O-C-N 123.208 0.317 . . . . 1.0 110.638 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.59 -52.33 65.85 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.538 0.685 . . . . 1.0 109.649 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -64.12 -36.23 83.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.623 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.5 mm-40 -65.47 -27.03 68.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -41.75 94.05 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 148' ' ' VAL . 47.8 mt -63.4 -40.96 91.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.186 -0.507 . . . . 1.0 110.162 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.76 -43.01 99.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.073 0.463 . . . . 1.0 110.075 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 m -63.27 -35.58 80.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.641 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.537 HG21 ' HB1' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -74.63 -42.55 48.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 119.832 -0.747 . . . . 1.0 110.239 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -67.19 -14.08 62.57 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.958 -0.464 . . . . 1.0 111.775 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -104.32 -1.88 26.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.016 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.7 m-80 -133.04 -39.33 0.95 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.908 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.537 ' HB1' HG21 ' A' ' 148' ' ' VAL . . . -56.32 -50.26 88.61 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 52.8 Cg_endo -67.24 -7.83 20.12 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.181 1.254 . . . . 1.0 113.344 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.21 -29.97 6.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.248 0.547 . . . . 1.0 111.727 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' B' ' 205' ' ' HIS . . . -62.41 136.81 58.08 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.238 -0.892 . . . . 1.0 113.361 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -96.89 141.92 29.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.149 -1.387 . . . . 1.0 111.024 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.51 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.31 135.26 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.986 0.736 . . . . 1.0 112.986 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.0 mt . . . . . 0 N--CA 1.45 -0.458 0 CA-C-N 114.88 -1.054 . . . . 1.0 109.272 176.958 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.415 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.7 p-10 . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.831 0.824 . . . . 1.0 112.905 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -140.04 96.87 3.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.436 -1.69 . . . . 1.0 106.436 173.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.41 174.02 2.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.238 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 40.4 p-80 -168.83 149.22 4.42 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.143 0.277 . . . . 1.0 110.607 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.7 m-85 -85.75 152.89 22.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.69 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -141.27 117.05 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.535 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' B' ' 218' ' ' TRP . 82.7 t -95.01 130.92 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.87 178.86 7.22 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.188 0.305 . . . . 1.0 110.39 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.1 t -101.58 136.77 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.256 0.55 . . . . 1.0 112.067 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -82.91 178.61 8.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.466 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.7 64.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.114 0.483 . . . . 1.0 110.956 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.22 21.54 16.95 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.563 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 64.23 36.28 9.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.414 -0.812 . . . . 1.0 111.187 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 32.2 mmtp -99.21 157.48 16.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.21 112.86 26.06 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.4 HH12 ' CG ' ' B' ' 230' ' ' ASP . 11.1 mtm105 -127.44 176.8 7.18 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' B' ' 231' ' ' SER . 49.4 p-90 -149.12 161.84 41.16 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.735 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -145.72 143.47 29.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.163 -0.926 . . . . 1.0 109.649 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.557 ' HG ' HD13 ' B' ' 228' ' ' LEU . 36.3 tp -93.54 134.09 36.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.17 133.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.505 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.54 ' CB ' HD22 ' B' ' 226' ' ' ASN . 4.4 t-80 -80.35 172.36 13.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.56 -31.77 66.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 1.0 111.1 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -32.86 74.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.897 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.5 10.65 21.3 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.722 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.54 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.57 145.1 25.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -73.42 130.17 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.789 0.681 . . . . 1.0 109.199 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.557 HD13 ' HG ' ' B' ' 220' ' ' LEU . 13.8 mt -107.44 -41.9 4.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.347 0.594 . . . . 1.0 110.033 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.84 166.61 30.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.962 -1.017 . . . . 1.0 111.376 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . 0.4 ' CG ' HH12 ' B' ' 217' ' ' ARG . 7.0 t70 -139.23 154.29 47.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.851 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.485 ' C ' ' H ' ' B' ' 233' ' ' GLU . 24.8 p -54.22 -39.61 66.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 78.65 -26.92 2.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 1.0 111.149 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' B' ' 231' ' ' SER . 48.8 mt-10 -87.2 -175.84 5.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.59 0.71 . . . . 1.0 111.502 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -170.09 102.17 0.18 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -129.71 169.75 14.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.356 -0.238 . . . . 1.0 110.356 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.07 37.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -121.81 131.17 53.91 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.615 0.721 . . . . 1.0 111.365 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -65.2 -34.67 78.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.583 -1.189 . . . . 1.0 110.421 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.4 tt0 -58.57 -46.45 86.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.461 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -60.01 -40.29 88.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.52 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.81 68.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.015 0.436 . . . . 1.0 110.3 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.44 ' HA ' HD11 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.23 -35.88 82.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.676 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.4 mm-40 -65.7 -31.02 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.536 -0.466 . . . . 1.0 109.995 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.35 95.04 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.496 ' O ' HG13 ' B' ' 248' ' ' VAL . 73.5 mt -60.8 -53.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 1.0 110.687 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.11 -32.79 74.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.645 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -67.19 -38.11 84.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.635 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.496 HG13 ' O ' ' B' ' 245' ' ' ILE . 1.4 p -73.05 -36.03 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 119.843 -0.743 . . . . 1.0 109.08 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.24 -12.62 57.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.98 0.419 . . . . 1.0 111.304 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -104.44 -2.25 25.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.723 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -131.32 -37.5 1.24 Allowed 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 111.944 0.35 . . . . 1.0 111.944 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.465 ' HB3' HG21 ' B' ' 248' ' ' VAL . . . -56.65 -51.5 80.77 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 112.504 0.557 . . . . 1.0 112.504 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.66 -12.51 36.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.268 1.312 . . . . 1.0 113.2 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.35 -29.6 9.18 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.205 0.526 . . . . 1.0 111.437 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . . . . . . . . . . . -63.24 137.89 58.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.16 -0.927 . . . . 1.0 112.939 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -97.72 149.41 22.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.148 -1.387 . . . . 1.0 111.557 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.437 HG22 HG21 ' A' ' 145' ' ' ILE . 46.1 t -86.62 131.58 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.029 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.13 138.31 54.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -90.67 101.55 14.3 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.499 -0.763 . . . . 1.0 111.387 -176.886 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 . . . . . 0 CA--C 1.517 -0.31 0 CA-C-O 121.784 0.802 . . . . 1.0 112.439 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 14.2 mmtp -134.53 96.92 3.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.965 -1.471 . . . . 1.0 107.656 173.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.06 166.62 3.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.408 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.431 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.3 p-80 -168.83 146.87 3.93 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.025 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.23 147.98 26.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.543 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -139.46 117.11 11.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.464 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 118' ' ' TRP . 93.9 t -94.61 134.27 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.942 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -146.29 -179.17 6.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.594 0.235 . . . . 1.0 110.639 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.1 t -101.39 134.97 40.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.175 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.58 178.94 8.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.4 52.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.829 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.1 21.64 13.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.856 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.05 33.36 1.63 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.807 0.843 . . . . 1.0 111.306 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.5 mttt -108.68 150.78 27.08 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.583 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -94.56 116.05 28.31 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.833 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.464 HH12 ' CG ' ' A' ' 130' ' ' ASP . 16.7 mtm105 -133.55 177.73 7.48 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.441 ' HB3' HG23 ' A' ' 108' ' ' VAL . 53.9 p-90 -150.19 161.09 43.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.782 0.325 . . . . 1.0 111.108 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -145.95 142.19 28.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.096 -0.956 . . . . 1.0 109.543 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.575 ' HG ' HD13 ' A' ' 128' ' ' LEU . 34.9 tp -91.88 132.69 36.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.38 132.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.533 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.496 ' CB ' HD22 ' A' ' 126' ' ' ASN . 1.7 t-80 -81.06 173.03 12.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 13.2 t70 -58.62 -31.99 68.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 1.0 110.691 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -63.68 -34.42 77.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.832 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 9.37 25.47 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.664 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.496 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.23 143.34 27.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.185 . . . . 1.0 111.496 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.81 123.73 31.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.895 0.747 . . . . 1.0 109.353 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.575 HD13 ' HG ' ' A' ' 120' ' ' LEU . 14.8 mt -98.37 -41.88 7.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.354 0.597 . . . . 1.0 109.91 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.73 169.09 22.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.677 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.464 ' CG ' HH12 ' A' ' 117' ' ' ARG . 7.6 t70 -142.4 154.36 44.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.867 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.6 p -57.09 -35.07 68.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.903 0.382 . . . . 1.0 111.679 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.69 -44.96 3.38 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -94.66 177.54 5.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 1.0 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -150.45 127.04 2.28 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.858 -1.065 . . . . 1.0 110.454 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -141.97 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.792 0.296 . . . . 1.0 110.46 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.05 10.22 27.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.501 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -124.06 130.56 52.76 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.633 0.73 . . . . 1.0 111.715 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 138' ' ' LYS . 7.9 ptpp? -65.95 -34.38 77.98 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.919 -1.037 . . . . 1.0 110.297 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.6 tt0 -58.37 -46.64 85.94 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.453 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -59.52 -38.63 81.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.422 -0.214 . . . . 1.0 110.422 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -52.94 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.225 0.536 . . . . 1.0 110.135 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.463 ' HA ' HD12 ' A' ' 145' ' ' ILE . 46.5 mtmt -64.99 -35.97 82.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.033 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.2 mm-40 -65.32 -30.7 71.57 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.468 -0.493 . . . . 1.0 109.787 177.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.86 -38.73 94.59 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 148' ' ' VAL . 75.4 mt -60.52 -53.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.402 0.62 . . . . 1.0 110.531 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -62.53 -33.27 74.58 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.5 m -67.36 -38.17 84.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.636 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -73.17 -33.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.247 -0.581 . . . . 1.0 109.61 -177.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.58 -14.62 62.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.539 0.685 . . . . 1.0 110.396 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -100.49 -1.89 34.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.723 -1.126 . . . . 1.0 112.037 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -134.34 -40.89 0.81 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.263 0.468 . . . . 1.0 112.263 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -57.33 -52.06 77.08 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 113.041 0.756 . . . . 1.0 113.041 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.9 -12.75 35.91 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 120.883 1.055 . . . . 1.0 113.294 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.47 -29.4 8.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.07 0.462 . . . . 1.0 111.149 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -62.14 136.45 57.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.949 -1.023 . . . . 1.0 113.347 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -99.12 144.06 28.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.131 -1.395 . . . . 1.0 110.534 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.05 137.16 21.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.668 177.377 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 . . . . . 0 CA--C 1.518 -0.285 0 CA-C-O 121.758 0.79 . . . . 1.0 111.991 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 18.1 mmtp -138.97 96.49 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.117 -1.401 . . . . 1.0 108.087 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.16 170.84 3.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.589 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.449 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 34.2 p-80 -170.26 148.08 3.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.391 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.483 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.5 m-85 -84.63 152.59 23.72 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.131 0.269 . . . . 1.0 110.696 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -141.52 120.45 12.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.419 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' B' ' 218' ' ' TRP . 89.1 t -96.29 135.17 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.061 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.82 178.66 8.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.136 0.273 . . . . 1.0 110.779 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -98.39 135.49 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.671 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 23.4 t70 -81.3 177.87 8.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.911 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.451 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.2 -13.73 62.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.967 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.73 19.02 19.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.619 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 69.4 38.84 1.73 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.511 -0.768 . . . . 1.0 111.008 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.8 mmtt -109.13 155.9 20.47 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.397 -0.819 . . . . 1.0 110.261 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -99.28 102.65 14.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.845 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.498 HH21 ' HB2' ' B' ' 231' ' ' SER . 12.1 mmm180 -122.52 177.43 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.171 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.442 ' HB3' HG23 ' B' ' 208' ' ' VAL . 55.7 p-90 -150.7 161.12 43.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.768 0.318 . . . . 1.0 111.486 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 28.3 mtp180 -147.49 145.87 29.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.469 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.576 ' HG ' HD13 ' B' ' 228' ' ' LEU . 33.4 tp -94.22 134.95 36.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.14 132.94 64.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.792 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.526 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.1 t-80 -81.93 173.85 11.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.5 t70 -55.02 -32.18 61.64 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.353 0.408 . . . . 1.0 111.887 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -71.21 -34.29 70.71 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.419 0.628 . . . . 1.0 110.335 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.49 13.19 11.96 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.162 -0.926 . . . . 1.0 112.655 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.526 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.99 143.49 26.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 178.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.21 121.66 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.903 0.752 . . . . 1.0 109.717 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.576 HD13 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -96.88 -40.67 8.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.545 -0.752 . . . . 1.0 109.629 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -152.68 164.54 37.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.771 -1.104 . . . . 1.0 111.425 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -137.54 156.99 47.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.984 -1.007 . . . . 1.0 109.262 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.498 ' HB2' HH21 ' B' ' 217' ' ' ARG . 79.3 p -58.06 -45.99 86.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.73 2.89 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.806 -0.712 . . . . 1.0 112.989 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . 0.488 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 42.0 mt-10 -84.97 -168.9 2.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.072 0.463 . . . . 1.0 110.294 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.496 ' HA2' ' CD ' ' B' ' 217' ' ' ARG . . . -170.17 124.55 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.871 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -146.73 170.06 17.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.35 9.97 39.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.416 0.447 . . . . 1.0 112.007 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.0 m -111.94 130.21 55.92 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.393 0.616 . . . . 1.0 111.312 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -66.17 -35.95 81.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.175 -0.92 . . . . 1.0 110.89 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.412 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.3 tt0 -59.59 -46.84 87.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.459 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -59.91 -38.33 81.98 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.584 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.73 -53.11 62.08 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.563 0.697 . . . . 1.0 110.319 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.432 ' HA ' HD11 ' B' ' 245' ' ' ILE . 44.9 mtmt -64.46 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.4 mm-40 -66.04 -30.26 70.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.16 95.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.425 -0.893 . . . . 1.0 110.971 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.503 ' O ' HG12 ' B' ' 248' ' ' VAL . 69.7 mt -60.47 -52.86 56.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 1.0 110.562 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.66 -35.96 81.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.253 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.3 m -66.94 -35.62 80.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.905 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.503 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.5 OUTLIER -72.61 -38.79 59.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.565 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -65.56 -17.88 64.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.766 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' B' ' 250' ' ' ARG . 30.9 ttp-105 -100.9 -1.66 34.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.607 -0.724 . . . . 1.0 111.123 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -132.71 -40.58 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' B' ' 248' ' ' VAL . . . -57.17 -49.69 92.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 112.902 0.705 . . . . 1.0 112.902 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 55.9 Cg_endo -66.36 -5.75 13.38 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.029 1.153 . . . . 1.0 113.423 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.79 -11.06 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 1.0 111.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -71.95 137.02 47.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.213 0.53 . . . . 1.0 112.05 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.3 140.34 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.228 -0.896 . . . . 1.0 110.25 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -91.53 129.87 41.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.632 0.729 . . . . 1.0 112.468 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.04 140.2 37.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.54 -1.209 . . . . 1.0 109.054 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -89.06 102.66 15.31 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.458 -0.782 . . . . 1.0 111.447 -177.24 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.435 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 13.6 p-10 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.689 0.757 . . . . 1.0 112.514 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 23.9 mmtp -138.7 98.36 3.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.738 -1.574 . . . . 1.0 108.273 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.47 167.35 3.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.116 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.476 ' HA ' ' HB2' ' B' ' 255' ' ' ALA . 51.6 p-80 -167.87 147.11 4.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 52.2 m-85 -87.17 148.21 25.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.078 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -143.02 120.67 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.72 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.426 HG21 ' HG2' ' A' ' 142' ' ' LYS . 92.2 t -96.02 130.94 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.716 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.09 179.3 6.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.69 0.281 . . . . 1.0 110.644 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -103.28 136.81 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.191 0.519 . . . . 1.0 111.99 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.49 -175.28 5.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.286 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.2 -10.24 56.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.04 33.18 5.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.718 0.294 . . . . 1.0 111.523 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.5 35.13 17.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 mmtp -96.86 154.28 17.39 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.94 114.95 29.47 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.961 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 mtm105 -131.67 175.41 9.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.269 -0.878 . . . . 1.0 108.853 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.42 ' CD1' ' HB3' ' A' ' 131' ' ' SER . 55.1 p-90 -151.07 162.45 40.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.656 0.265 . . . . 1.0 111.361 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -147.54 144.91 28.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.252 -0.885 . . . . 1.0 110.068 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.556 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.0 tp -97.29 134.15 40.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 t -127.31 132.56 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 1.0 110.736 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.49 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.6 t-80 -84.56 177.39 8.1 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.818 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 17.9 t70 -52.04 -43.98 64.01 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.805 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -63.13 -33.45 75.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.407 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.79 11.66 22.41 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.312 -0.858 . . . . 1.0 112.331 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.49 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.13 144.19 27.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.78 -0.21 . . . . 1.0 111.371 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.467 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 50.2 mm -74.46 120.43 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.556 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.6 mt -93.06 -42.76 9.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.067 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.66 166.33 29.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.655 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.37 155.72 45.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.041 -0.981 . . . . 1.0 108.558 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.42 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 13.6 p -53.33 -31.78 45.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.994 0.426 . . . . 1.0 111.698 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.55 -41.36 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HB2' ' HH ' ' A' ' 135' ' ' TYR . 50.2 mm-40 -114.53 173.44 6.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.466 0.651 . . . . 1.0 111.933 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.7 132.71 8.82 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 109.947 -1.261 . . . . 1.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.465 ' HH ' ' HB2' ' A' ' 133' ' ' GLU . 18.0 m-85 -122.28 167.21 13.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.114 0.457 . . . . 1.0 110.241 -176.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -102.57 9.77 39.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.47 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -139.11 133.61 31.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.5 -38.43 91.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 1.0 110.401 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.4 tt0 -58.46 -43.04 88.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.897 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.524 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.89 -41.06 95.28 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.116 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.014 0.435 . . . . 1.0 110.029 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HA ' HD13 ' A' ' 145' ' ' ILE . 42.6 mtmt -64.48 -37.04 86.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.2 mm-40 -63.58 -26.57 68.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.488 -0.56 . . . . 1.0 109.488 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.94 -41.74 93.14 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.473 ' O ' HG12 ' A' ' 148' ' ' VAL . 67.9 mt -60.98 -41.38 88.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.469 0.652 . . . . 1.0 109.771 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.95 -43.05 93.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.237 0.541 . . . . 1.0 110.166 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 m -63.49 -35.4 80.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.514 -0.767 . . . . 1.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.539 HG21 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.84 -41.86 53.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 120.165 -0.614 . . . . 1.0 109.841 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -66.72 -12.22 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.15 -0.344 . . . . 1.0 111.49 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -104.76 -2.78 24.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.205 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -132.94 -39.58 0.95 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.923 0.392 . . . . 1.0 111.884 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -55.38 -50.33 87.36 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.692 -0.685 . . . . 1.0 112.456 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.6 Cg_endo -65.13 -9.34 21.41 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.387 1.391 . . . . 1.0 113.241 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -115.03 -23.34 9.1 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.284 0.475 . . . . 1.0 112.284 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' B' ' 205' ' ' HIS . . . -67.83 138.26 55.96 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -93.18 151.25 19.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.683 -1.144 . . . . 1.0 111.761 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.433 HG21 HG23 ' B' ' 245' ' ' ILE . 44.0 t -86.48 132.27 32.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.799 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 175.405 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.66 0.743 . . . . 1.0 112.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 30.2 mmtp -138.55 98.5 3.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.174 -1.376 . . . . 1.0 107.659 172.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.47 168.12 3.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.592 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 46.7 p-80 -167.94 149.11 5.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.198 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -85.83 148.22 25.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.985 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -139.2 119.83 14.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.519 HG21 ' HG2' ' B' ' 242' ' ' LYS . 90.3 t -92.83 132.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.787 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -142.62 -178.37 5.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.3 t -104.6 139.77 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 13.7 t70 -81.85 -178.45 6.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.042 -0.981 . . . . 1.0 110.208 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.446 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.62 -20.15 64.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.043 0.449 . . . . 1.0 111.351 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.85 24.23 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.703 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 60.95 40.15 15.79 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.901 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -100.25 156.48 17.2 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' B' ' 238' ' ' LYS . 89.6 m-85 -98.48 115.86 29.47 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.702 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -133.91 178.57 6.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' B' ' 231' ' ' SER . 53.4 p-90 -151.3 163.68 38.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.908 -0.317 . . . . 1.0 111.508 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -146.06 146.41 30.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.887 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.551 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -96.13 133.16 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.46 130.96 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.544 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.562 ' CB ' HD22 ' B' ' 226' ' ' ASN . 1.9 t-80 -80.75 172.64 13.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 19.4 t70 -54.94 -36.81 65.67 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.191 0.307 . . . . 1.0 111.63 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.02 -34.64 78.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.269 0.557 . . . . 1.0 110.396 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 111.75 15.08 10.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.423 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.562 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -90.99 142.33 27.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mm -75.83 119.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.933 0.771 . . . . 1.0 109.981 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.551 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -94.87 -43.38 8.22 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.468 -0.787 . . . . 1.0 109.739 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -149.72 170.03 19.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.494 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.72 157.31 44.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.981 -1.009 . . . . 1.0 108.538 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 77.4 p -59.09 -37.15 76.45 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.187 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.55 -45.7 3.48 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 33.3 mm-40 -94.88 166.41 11.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.418 0.628 . . . . 1.0 111.502 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.19 126.86 4.94 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.08 166.62 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.873 0.337 . . . . 1.0 111.453 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.4 10.26 40.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.502 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.1 m -141.32 135.15 30.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.908 0.385 . . . . 1.0 110.663 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' B' ' 216' ' ' TYR . 16.6 ptpt -61.91 -41.95 98.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.485 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.4 tt0 -55.9 -45.22 78.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.565 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -62.42 -41.72 98.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.039 -177.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.06 87.46 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.356 0.598 . . . . 1.0 110.378 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.519 ' HG2' HG21 ' B' ' 208' ' ' VAL . 49.6 mtmt -63.12 -35.61 80.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.142 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.8 mm-40 -65.92 -26.82 67.77 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.74 96.02 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.461 ' O ' HG13 ' B' ' 248' ' ' VAL . 58.5 mt -59.72 -45.51 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 121.409 0.623 . . . . 1.0 110.034 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.51 -39.43 93.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.126 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.9 m -66.34 -35.57 80.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.671 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -72.93 -40.48 59.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.599 -177.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -65.86 -12.41 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.436 . . . . 1.0 111.331 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -104.94 -3.14 23.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.696 -0.684 . . . . 1.0 111.004 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 17.6 m-80 -130.83 -40.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.99 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.491 ' HB3' HG21 ' B' ' 248' ' ' VAL . . . -55.6 -51.22 81.89 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.616 -0.72 . . . . 1.0 112.516 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.5 Cg_endo -65.91 -11.84 32.69 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 120.987 1.125 . . . . 1.0 113.219 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -113.01 -15.49 12.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.954 0.407 . . . . 1.0 112.04 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 105' ' ' HIS . . . -74.95 137.88 41.93 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.022 0.749 . . . . 1.0 113.022 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.66 138.29 31.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.647 -1.161 . . . . 1.0 110.722 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.23 129.87 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.622 0.725 . . . . 1.0 112.339 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -116.1 142.21 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.033 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.93 104.87 17.39 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.607 -0.711 . . . . 1.0 110.819 -178.412 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.427 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 14.9 p-10 . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.77 0.795 . . . . 1.0 112.55 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.435 ' HD2' ' HB2' ' A' ' 123' ' ' ASP . 28.2 mmtt -141.9 94.53 2.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 1.0 107.82 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.48 174.39 1.92 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.237 -177.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.441 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 40.1 p-80 -170.56 148.79 3.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.388 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -86.84 150.17 24.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.587 0.232 . . . . 1.0 110.681 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.51 120.12 12.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.788 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 118' ' ' TRP . 86.8 t -94.67 132.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.532 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -142.91 179.06 7.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.047 0.217 . . . . 1.0 110.576 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -99.87 133.24 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.98 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.83 178.78 8.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.866 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.25 -7.64 43.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.514 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.09 20.01 14.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.172 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 71.11 36.18 1.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.625 0.77 . . . . 1.0 111.062 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.4 mttt -110.92 151.19 28.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.624 -175.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.12 112.95 25.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.716 -1.129 . . . . 1.0 109.53 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -130.8 179.25 6.08 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.472 ' HB3' HG23 ' A' ' 108' ' ' VAL . 56.0 p-90 -150.68 163.7 37.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.714 -0.395 . . . . 1.0 111.522 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -147.91 146.3 28.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.78 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.554 ' HG ' HD13 ' A' ' 128' ' ' LEU . 32.1 tp -96.31 130.65 43.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.17 131.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.967 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.544 ' CB ' HD22 ' A' ' 126' ' ' ASN . 3.0 t-80 -78.0 172.17 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.435 ' HB2' ' HD2' ' A' ' 103' ' ' LYS . 11.5 t70 -57.89 -31.45 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.14 0.495 . . . . 1.0 110.637 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.31 -33.62 75.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.028 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.23 9.86 21.24 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.073 -0.967 . . . . 1.0 112.978 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.544 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.49 144.94 26.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.642 0.258 . . . . 1.0 111.467 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.8 mm -75.39 122.08 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.028 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.554 HD13 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -97.92 -42.53 7.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 1.0 109.374 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.05 165.71 32.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.156 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -141.39 155.09 45.94 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.2 p -55.79 -32.83 63.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.03 0.443 . . . . 1.0 111.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.18 -41.39 3.03 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.928 -0.636 . . . . 1.0 112.084 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -133.03 147.77 19.08 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -141.79 174.29 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.415 0.607 . . . . 1.0 110.99 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.27 10.16 41.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.616 0.599 . . . . 1.0 112.616 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -133.16 131.56 40.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.746 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -64.03 -36.15 83.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.355 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.8 tt0 -58.33 -45.21 88.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.762 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -59.91 -40.83 90.17 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.957 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.97 79.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 1.0 109.901 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.46 ' HA ' HD11 ' A' ' 145' ' ' ILE . 43.2 mtmt -64.29 -37.11 86.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.659 -0.701 . . . . 1.0 111.032 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.9 mm-40 -63.87 -29.68 70.84 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.41 97.98 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.479 ' O ' HG11 ' A' ' 148' ' ' VAL . 57.0 mt -63.98 -45.55 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.887 -0.657 . . . . 1.0 110.298 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.25 -38.28 88.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.137 0.494 . . . . 1.0 110.055 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.4 m -65.9 -36.27 82.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.638 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.529 HG22 ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.1 -42.21 51.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.343 -177.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -66.22 -11.89 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 112.018 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -104.46 -2.84 24.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.079 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -133.45 -37.88 0.94 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.997 -176.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.529 ' HB1' HG22 ' A' ' 148' ' ' VAL . . . -57.21 -50.01 90.62 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.2 Cg_endo -63.48 -15.24 47.32 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.254 1.303 . . . . 1.0 113.185 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -109.93 -26.37 9.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.281 0.562 . . . . 1.0 111.362 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -62.26 136.43 57.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.008 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -96.61 141.68 29.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.18 -1.373 . . . . 1.0 111.117 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.487 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -89.84 135.01 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.333 0.587 . . . . 1.0 112.478 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.453 -0.323 0 CA-C-N 114.937 -1.029 . . . . 1.0 109.266 177.758 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 121.526 0.679 . . . . 1.0 112.219 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 70.9 mmtt -136.59 95.52 3.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.92 171.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.19 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 53.2 p-80 -170.92 148.61 2.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.159 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.2 m-85 -86.41 149.67 24.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.721 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -142.07 119.03 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.332 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' B' ' 218' ' ' TRP . 71.2 t -94.31 132.88 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -145.68 -178.68 6.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.126 0.266 . . . . 1.0 110.647 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -100.89 138.29 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.309 0.576 . . . . 1.0 112.129 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.46 179.7 7.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.098 -0.956 . . . . 1.0 109.664 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.13 -9.3 58.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.181 0.515 . . . . 1.0 111.004 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.69 20.43 15.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.462 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 70.04 36.84 1.83 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.634 0.774 . . . . 1.0 111.534 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.0 mttt -112.74 149.69 32.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.289 0.566 . . . . 1.0 111.332 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -89.97 119.6 30.47 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.715 -1.129 . . . . 1.0 109.978 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.29 -179.0 5.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.977 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.44 ' HB3' HG23 ' B' ' 208' ' ' VAL . 57.1 p-90 -154.31 161.55 41.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.257 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -146.79 141.86 27.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.813 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.556 ' HG ' HD13 ' B' ' 228' ' ' LEU . 31.9 tp -93.46 130.77 39.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.59 131.48 70.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.044 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.528 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.6 t-80 -81.2 173.0 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 10.8 t70 -54.67 -36.98 65.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.035 0.445 . . . . 1.0 111.222 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.21 -33.78 76.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.219 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.84 12.13 19.24 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 115.087 -0.961 . . . . 1.0 112.659 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.528 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.32 144.06 26.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.819 0.303 . . . . 1.0 111.819 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.5 mm -75.97 116.63 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.007 0.817 . . . . 1.0 109.69 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.556 HD13 ' HG ' ' B' ' 220' ' ' LEU . 18.3 mt -90.57 -44.7 9.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.405 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.47 160.75 43.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.301 -1.318 . . . . 1.0 111.027 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.8 156.34 49.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.406 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 16.7 p -52.27 -35.63 50.64 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.378 0.424 . . . . 1.0 111.977 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.58 -46.09 3.53 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -99.32 179.51 4.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.915 -0.643 . . . . 1.0 110.792 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -146.0 137.78 7.12 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.83 171.28 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.68 0.74 . . . . 1.0 111.795 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.36 10.07 39.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.387 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 12.2 m -135.75 134.41 39.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.55 0.69 . . . . 1.0 111.276 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -64.51 -35.66 81.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.915 -1.039 . . . . 1.0 110.462 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.7 tt0 -56.12 -47.64 77.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.292 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -61.42 -40.48 94.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.804 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.54 80.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 1.0 109.768 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.452 ' HA ' HD13 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.14 -35.62 81.36 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.411 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.6 mm-40 -64.85 -29.09 70.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.48 -40.95 96.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.954 -1.258 . . . . 1.0 109.954 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' B' ' 242' ' ' LYS . 59.8 mt -62.78 -43.29 98.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.15 -0.525 . . . . 1.0 110.231 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.61 -43.56 98.5 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.648 -0.421 . . . . 1.0 109.921 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.6 m -63.63 -35.21 79.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.83 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.513 HG22 ' HB1' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -75.06 -41.8 45.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 119.697 -0.801 . . . . 1.0 109.49 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -67.2 -11.62 57.86 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.051 -0.406 . . . . 1.0 111.352 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -103.12 -3.12 26.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.319 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 10.7 m-80 -135.48 -37.45 0.76 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.968 0.358 . . . . 1.0 111.968 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.513 ' HB1' HG22 ' B' ' 248' ' ' VAL . . . -56.22 -49.87 90.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 1.0 112.478 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.4 Cg_endo -63.69 -9.53 18.82 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.642 1.562 . . . . 1.0 113.904 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -123.24 -11.57 7.95 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -70.61 138.93 51.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.27 0.557 . . . . 1.0 111.841 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.01 148.65 22.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.012 -0.994 . . . . 1.0 112.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 145' ' ' ILE . 44.1 t -84.45 131.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.619 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.1 mt -124.26 139.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -87.66 101.89 14.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.265 -0.874 . . . . 1.0 111.349 -177.157 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 . . . . . 0 CA--C 1.512 -0.486 0 CA-C-O 121.054 0.454 . . . . 1.0 110.478 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -143.05 95.35 2.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.21 -1.404 . . . . 1.0 107.21 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.64 178.96 1.49 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.327 -0.851 . . . . 1.0 109.735 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.41 ' HA ' ' HB2' ' B' ' 255' ' ' ALA . 50.8 p-80 -169.52 147.72 3.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.808 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 48.7 m-85 -87.44 147.95 25.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.848 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -140.64 118.95 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.77 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 118' ' ' TRP . 81.7 t -94.23 135.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.549 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -144.86 -179.6 6.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.469 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -104.28 138.83 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.287 0.565 . . . . 1.0 111.989 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 179.85 7.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.947 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.12 46.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.577 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.23 24.37 10.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.486 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.25 33.17 2.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.654 0.782 . . . . 1.0 111.613 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.2 mttt -107.48 147.17 30.83 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.426 0.631 . . . . 1.0 111.123 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -93.46 118.89 31.88 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.028 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -131.87 179.79 5.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.162 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.46 ' HB3' HG22 ' A' ' 108' ' ' VAL . 58.2 p-90 -154.52 162.24 41.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.212 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.418 HH21 HG13 ' A' ' 127' ' ' ILE . 50.5 mtp180 -147.18 142.45 27.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.515 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.5 tp -91.48 133.21 35.69 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.67 128.57 69.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.103 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.544 ' CB ' HD22 ' A' ' 126' ' ' ASN . 3.0 t-80 -77.31 172.91 12.55 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.37 -28.17 58.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.598 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.02 -34.67 66.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.71 . . . . 1.0 109.898 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.39 10.1 15.95 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.579 -1.191 . . . . 1.0 112.709 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.544 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.53 142.84 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.748 0.277 . . . . 1.0 111.748 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.418 HG13 HH21 ' A' ' 119' ' ' ARG . 50.6 mm -74.45 119.79 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.92 0.763 . . . . 1.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.558 HD12 ' HG ' ' A' ' 120' ' ' LEU . 14.1 mt -96.88 -43.65 7.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.96 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.45 168.57 23.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.061 -0.972 . . . . 1.0 111.593 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.77 157.99 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.1 p -57.61 -32.26 67.04 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.296 0.57 . . . . 1.0 111.292 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.17 -50.05 3.83 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.458 ' HG2' ' HB ' ' B' ' 227' ' ' ILE . 69.4 mm-40 -100.81 178.96 4.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.446 -0.877 . . . . 1.0 111.424 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.06 137.53 7.97 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.49 166.47 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.096 0.448 . . . . 1.0 111.378 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.95 11.19 25.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.864 0.691 . . . . 1.0 112.864 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -127.97 131.06 49.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.399 0.618 . . . . 1.0 111.044 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.18 -38.23 90.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.882 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.5 tt0 -63.28 -43.16 98.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 1.0 110.027 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.559 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -57.77 -41.34 81.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.895 -178.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.13 74.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.369 0.604 . . . . 1.0 110.318 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.452 ' HA ' HD13 ' A' ' 145' ' ' ILE . 44.4 mtmt -64.16 -34.15 77.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.392 -0.822 . . . . 1.0 111.205 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.9 mm-40 -64.8 -30.96 71.99 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.121 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.79 -39.15 93.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.557 -0.83 . . . . 1.0 111.136 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.522 ' O ' HG11 ' A' ' 148' ' ' VAL . 76.8 mt -59.34 -51.47 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.635 0.731 . . . . 1.0 110.49 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -64.6 -35.05 79.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.016 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -66.37 -37.97 86.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.711 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 145' ' ' ILE . 1.4 p -73.08 -37.46 53.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.132 -0.627 . . . . 1.0 109.618 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.13 -16.33 61.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.538 0.57 . . . . 1.0 112.538 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -104.46 -5.84 21.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.929 0.395 . . . . 1.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -121.69 -37.66 2.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.8 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.496 ' HB1' HG22 ' A' ' 148' ' ' VAL . . . -56.11 -51.03 83.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.829 -0.623 . . . . 1.0 112.602 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.07 -7.82 20.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.154 1.236 . . . . 1.0 113.385 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.81 -21.14 10.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.157 0.504 . . . . 1.0 111.425 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.443 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -70.01 138.69 52.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.649 0.738 . . . . 1.0 112.952 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.37 136.73 36.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.265 -1.334 . . . . 1.0 110.801 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.82 135.29 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 112.45 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 114.796 -1.093 . . . . 1.0 109.799 -179.38 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 121.404 0.621 . . . . 1.0 111.795 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.17 95.62 2.83 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.38 175.37 2.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.138 -0.937 . . . . 1.0 109.526 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.443 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.3 p-80 -170.27 146.38 2.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.101 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.489 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 55.0 m-85 -85.61 147.62 26.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.653 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -141.3 121.9 14.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.546 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.4 t -93.36 131.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -140.99 -179.88 6.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.213 0.321 . . . . 1.0 110.808 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 1.4 t -102.08 139.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.334 0.588 . . . . 1.0 111.694 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 15.1 t70 -80.64 -176.47 5.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.637 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.44 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -69.25 -16.94 63.7 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.976 -0.453 . . . . 1.0 110.874 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.06 17.08 22.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.603 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . 0.43 ' HA ' HG12 ' B' ' 210' ' ' VAL . 30.1 t70 68.64 44.02 1.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.481 1.134 . . . . 1.0 110.374 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.1 mmtt -112.97 150.86 31.29 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.323 -177.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -91.12 117.82 29.92 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.843 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -133.8 179.18 6.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.631 -1.168 . . . . 1.0 108.368 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.434 ' HB3' HG22 ' B' ' 208' ' ' VAL . 55.3 p-90 -153.33 161.39 42.4 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.702 0.287 . . . . 1.0 111.052 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . 0.404 HH21 HG13 ' B' ' 227' ' ' ILE . 28.3 mtp180 -147.28 143.26 27.96 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.897 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.543 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -93.5 132.55 37.67 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 177.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.86 129.9 72.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.415 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.54 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.0 t-80 -80.77 172.85 13.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.15 -29.53 63.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 1.0 111.587 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -68.11 -33.51 74.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.511 0.672 . . . . 1.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.99 10.56 22.38 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.799 -1.091 . . . . 1.0 112.145 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.54 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.97 142.73 27.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.651 0.241 . . . . 1.0 111.651 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . 0.458 ' HB ' ' HG2' ' A' ' 133' ' ' GLU . 51.2 mm -76.25 118.85 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 123.783 0.677 . . . . 1.0 109.495 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.543 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -93.18 -43.28 8.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.205 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -148.33 164.76 33.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.389 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -141.52 159.03 43.07 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.635 0.774 . . . . 1.0 109.278 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 58.5 p -57.64 -33.62 68.47 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.942 0.401 . . . . 1.0 111.666 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.4 -47.21 3.05 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -104.7 171.87 7.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.615 -0.792 . . . . 1.0 111.205 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -135.4 138.29 9.86 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.94 172.44 12.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.012 0.406 . . . . 1.0 110.883 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.83 10.53 38.66 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.7 m -131.68 131.42 43.11 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.455 0.645 . . . . 1.0 111.608 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -65.07 -35.23 80.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.191 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.0 tt0 -56.61 -46.48 80.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.819 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.551 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.96 -42.05 97.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.536 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.9 79.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.441 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.464 ' HA ' HD13 ' B' ' 245' ' ' ILE . 44.0 mtmt -64.05 -36.69 84.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.426 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 30.0 mm-40 -63.87 -32.93 74.62 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.763 -0.375 . . . . 1.0 109.99 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.88 94.13 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.532 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.465 ' O ' HG11 ' B' ' 248' ' ' VAL . 72.7 mt -60.31 -51.57 71.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.542 0.686 . . . . 1.0 110.498 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.97 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.9 m -65.72 -37.6 86.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.366 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -72.9 -40.1 59.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.648 -177.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -64.03 -15.17 58.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -101.32 -10.45 20.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.042 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.68 -37.57 2.47 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.518 ' HB3' HG22 ' B' ' 248' ' ' VAL . . . -55.12 -51.9 75.7 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 43.0 Cg_endo -65.4 -10.64 26.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.19 1.26 . . . . 1.0 113.56 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.19 -13.9 11.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.702 0.287 . . . . 1.0 111.766 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 105' ' ' HIS . . . -72.95 138.68 46.27 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.62 134.05 34.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.557 -1.201 . . . . 1.0 111.188 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -87.24 131.46 35.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.354 0.597 . . . . 1.0 111.977 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.9 mt -118.74 143.76 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.934 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -90.28 104.21 16.81 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.183 -177.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -138.22 93.46 2.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -176.91 179.69 1.02 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.567 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.437 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 47.8 p-80 -170.1 144.54 2.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 1.0 109.963 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.1 m-85 -84.71 149.3 25.88 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.161 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.69 118.77 11.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.451 HG22 ' HB3' ' A' ' 118' ' ' TRP . 79.3 t -94.57 133.17 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.711 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -142.99 179.64 6.91 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.393 0.433 . . . . 1.0 110.603 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -101.68 135.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.736 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.26 179.46 7.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.353 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.57 39.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.622 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -117.7 20.19 13.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.134 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 69.46 37.13 2.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.203 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.8 mmtt -109.2 150.73 27.48 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.071 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 93.1 m-85 -93.05 112.39 24.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.65 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -129.33 178.62 6.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.451 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.8 p-90 -151.73 163.38 39.27 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 120.854 -0.338 . . . . 1.0 111.437 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -148.4 141.62 25.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.5 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.573 ' HG ' HD13 ' A' ' 128' ' ' LEU . 35.4 tp -93.75 134.45 36.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.73 131.03 68.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.598 ' CB ' HD22 ' A' ' 126' ' ' ASN . 6.0 t-80 -77.23 171.2 15.22 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -18.08 52.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.146 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -34.11 35.22 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.635 0.731 . . . . 1.0 109.638 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.32 9.29 15.45 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.871 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.598 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.55 145.15 25.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.338 0.113 . . . . 1.0 110.944 178.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.477 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.4 mm -79.33 118.96 27.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.573 HD13 ' HG ' ' A' ' 120' ' ' LEU . 16.3 mt -90.78 -42.2 10.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.555 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.31 163.31 39.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.973 -1.012 . . . . 1.0 111.883 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.78 152.83 49.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.192 -0.913 . . . . 1.0 108.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 85.7 p -55.54 -34.04 64.36 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.982 0.42 . . . . 1.0 111.486 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.3 -45.92 3.45 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 47.1 mt-10 -109.27 168.59 9.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.799 -0.7 . . . . 1.0 111.562 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.24 145.84 16.34 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.174 -1.17 . . . . 1.0 110.174 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.56 165.59 25.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.245 0.522 . . . . 1.0 111.046 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.26 9.85 32.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.59 -0.732 . . . . 1.0 112.51 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 m -136.38 133.73 37.07 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.076 0.465 . . . . 1.0 110.775 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.439 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 6.8 ptpp? -63.87 -36.53 84.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.6 tt0 -56.89 -46.05 82.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.673 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.05 -39.19 91.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.8 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.29 72.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.313 0.578 . . . . 1.0 109.898 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.507 ' HA ' HD13 ' A' ' 145' ' ' ILE . 44.5 mtmt -65.28 -33.28 75.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.308 -0.86 . . . . 1.0 111.072 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.1 mm-40 -65.44 -31.84 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.178 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.98 95.15 Favored Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.507 HD13 ' HA ' ' A' ' 142' ' ' LYS . 73.2 mt -60.66 -51.28 74.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.813 -0.694 . . . . 1.0 110.428 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.83 -33.03 74.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.468 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.6 m -68.06 -35.69 78.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.786 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -72.61 -39.7 61.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -178.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.65 -16.12 63.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.326 0.584 . . . . 1.0 111.148 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -99.68 -1.43 37.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.799 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -137.24 -42.42 0.56 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.711 0.634 . . . . 1.0 112.711 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.481 ' HB3' HG23 ' A' ' 148' ' ' VAL . . . -54.69 -50.7 84.2 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 113.356 0.873 . . . . 1.0 113.356 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 42.5 Cg_endo -64.69 -9.41 20.74 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.248 1.299 . . . . 1.0 113.061 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.5 -12.22 8.59 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.861 0.362 . . . . 1.0 111.831 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -73.34 136.04 44.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.065 0.459 . . . . 1.0 111.443 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -96.44 145.12 25.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.511 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -90.88 129.5 41.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.84 0.828 . . . . 1.0 112.514 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.3 mt . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 114.282 -1.326 . . . . 1.0 109.888 -179.899 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 121.373 0.606 . . . . 1.0 112.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -132.83 97.81 4.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.18 166.99 4.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.109 -1.405 . . . . 1.0 108.402 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 40.5 p-80 -168.69 149.52 4.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.5 m-85 -85.28 149.93 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.393 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -141.83 120.14 12.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.211 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.88 135.75 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.439 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -149.49 179.55 7.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.658 0.266 . . . . 1.0 110.724 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -101.77 140.13 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 16.1 t70 -83.47 -178.8 7.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.018 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.483 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -71.01 -11.52 61.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.352 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.15 26.08 10.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.038 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 62.84 39.48 10.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.058 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 71.8 mmtt -103.8 156.03 18.14 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.33 117.96 32.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -134.16 -179.23 5.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.78 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -154.08 162.43 41.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.503 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -147.41 141.67 26.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.2 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.566 ' HG ' HD13 ' B' ' 228' ' ' LEU . 31.2 tp -93.75 131.2 39.33 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.33 132.17 65.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.412 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.57 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.2 t-80 -80.89 170.34 16.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.77 -27.1 64.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.069 0.462 . . . . 1.0 110.895 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -66.97 -33.24 75.13 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.503 0.668 . . . . 1.0 109.977 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.99 9.84 25.47 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.695 -1.139 . . . . 1.0 112.261 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.57 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.99 143.81 27.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.395 0.141 . . . . 1.0 111.02 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . 0.421 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.5 mm -80.27 117.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.566 HD13 ' HG ' ' B' ' 220' ' ' LEU . 15.8 mt -89.7 -41.25 12.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.746 . . . . 1.0 109.276 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -154.26 164.7 38.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.585 -1.189 . . . . 1.0 111.743 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -138.6 159.11 42.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.858 -1.064 . . . . 1.0 108.328 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 63.2 p -55.55 -30.78 61.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.149 0.5 . . . . 1.0 111.185 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.99 -40.12 3.04 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.1 mt-10 -116.42 169.45 9.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.118 -0.541 . . . . 1.0 111.107 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -128.86 132.82 7.36 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.38 172.78 9.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.94 0.37 . . . . 1.0 111.808 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.63 9.8 41.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -136.02 131.95 35.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.957 0.408 . . . . 1.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -63.81 -36.47 84.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.694 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.6 tt0 -57.57 -42.59 83.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.281 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.68 -40.69 95.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.469 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.41 86.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.315 0.578 . . . . 1.0 109.975 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.443 ' HA ' HD11 ' B' ' 245' ' ' ILE . 46.7 mtmt -64.05 -35.25 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.264 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.8 mm-40 -65.27 -34.3 78.01 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.67 98.02 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.505 ' O ' HG12 ' B' ' 248' ' ' VAL . 65.9 mt -60.75 -52.24 63.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.39 0.614 . . . . 1.0 110.706 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.19 -36.66 84.78 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.167 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.2 m -64.16 -36.52 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.881 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.505 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.8 OUTLIER -73.4 -40.18 55.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 -178.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.99 -15.59 62.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.739 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -100.54 -2.95 31.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.918 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -135.66 -37.73 0.75 Allowed 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.501 ' HB3' HG23 ' B' ' 248' ' ' VAL . . . -55.18 -50.21 87.86 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 54.0 Cg_endo -65.96 -8.9 21.29 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.026 1.15 . . . . 1.0 113.797 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.53 -19.21 8.88 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -66.48 136.99 56.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.447 0.641 . . . . 1.0 112.619 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -92.88 135.9 33.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.819 -1.082 . . . . 1.0 111.286 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.532 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -85.23 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.635 0.731 . . . . 1.0 112.185 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.6 mt -116.38 140.7 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.489 -1.232 . . . . 1.0 109.366 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -86.62 107.34 18.12 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.285 -0.864 . . . . 1.0 111.182 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 . . . . . 0 CA--C 1.509 -0.597 0 CA-C-O 121.398 0.618 . . . . 1.0 111.76 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 99.35 5.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 172.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.41 163.7 3.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.472 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.0 p-80 -167.25 148.89 5.8 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.919 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.6 m-85 -87.93 148.47 24.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.719 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -141.21 119.27 11.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.387 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.484 HG23 ' HG2' ' A' ' 142' ' ' LYS . 77.2 t -89.89 131.45 37.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -140.33 -179.65 6.12 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.059 0.224 . . . . 1.0 110.537 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.6 t -102.28 137.9 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.245 0.545 . . . . 1.0 112.341 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.84 179.8 7.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.193 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 -19.65 65.33 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.919 0.39 . . . . 1.0 110.765 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.02 21.08 17.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.72 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 69.83 37.13 1.87 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.66 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.0 mttt -110.72 150.54 28.92 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.981 -176.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -93.04 121.06 34.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.835 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 55.7 mtp180 -134.27 -176.78 4.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.661 -1.154 . . . . 1.0 108.109 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.411 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.8 p-90 -151.89 165.6 34.05 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.912 -0.715 . . . . 1.0 112.337 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -144.48 140.38 28.88 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.423 -1.262 . . . . 1.0 111.234 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.565 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.9 tp -100.85 132.06 46.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.32 132.6 69.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.512 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.456 ' HB2' HD22 ' A' ' 128' ' ' LEU . 2.4 t-80 -83.07 177.64 8.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 1.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.5 -44.47 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.06 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -67.42 -33.65 75.61 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.308 -177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.52 10.48 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.546 -0.752 . . . . 1.0 113.468 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.45 147.77 25.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.606 0.224 . . . . 1.0 111.606 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.3 mm -74.14 119.77 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.796 0.685 . . . . 1.0 109.57 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.8 mt -94.94 -43.86 7.98 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.271 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.71 166.85 30.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.923 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -139.35 160.36 40.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.026 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 68.0 p -58.74 -38.49 78.52 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.34 -42.28 3.08 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -91.47 173.49 7.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.719 -0.74 . . . . 1.0 110.776 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.47 125.7 1.66 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.85 171.21 14.74 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 120.431 0.157 . . . . 1.0 110.609 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.24 9.54 28.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.0 p -121.53 129.57 52.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.538 0.685 . . . . 1.0 112.551 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -64.94 -42.84 94.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.893 . . . . 1.0 111.173 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.1 tt0 -55.15 -45.0 75.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.459 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.528 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -56.98 -42.77 80.83 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.81 76.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.016 0.436 . . . . 1.0 110.402 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.484 ' HG2' HG23 ' A' ' 108' ' ' VAL . 45.3 mtmt -62.98 -38.65 91.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -63.46 -26.28 68.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.72 -43.85 93.44 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.093 -1.203 . . . . 1.0 110.093 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.475 ' O ' HG12 ' A' ' 148' ' ' VAL . 59.7 mt -62.18 -45.09 99.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.564 0.697 . . . . 1.0 110.169 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -62.74 -39.9 95.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -67.87 -34.71 77.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.57 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.489 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -72.93 -40.38 59.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.264 -177.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.89 -12.57 59.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.132 0.491 . . . . 1.0 111.651 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -103.4 -2.53 26.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.475 -0.784 . . . . 1.0 111.154 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.58 -39.14 1.14 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.887 -177.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.489 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.64 -50.09 88.96 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.388 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.6 Cg_endo -64.44 -16.57 55.85 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.163 1.242 . . . . 1.0 113.095 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -106.84 -23.9 12.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.498 . . . . 1.0 111.33 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.28 135.55 55.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.452 -0.794 . . . . 1.0 112.874 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -96.56 148.75 22.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.558 -1.201 . . . . 1.0 111.792 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.425 HG21 HG21 ' B' ' 245' ' ' ILE . 40.1 t -85.27 131.38 34.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 1.0 112.061 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 175.667 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.411 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 6.4 p-10 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.705 0.764 . . . . 1.0 111.98 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.468 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 13.1 mmmm -142.27 99.67 3.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.068 -1.424 . . . . 1.0 107.592 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.36 169.94 4.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.124 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.418 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 50.2 p-80 -169.53 150.11 4.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -87.72 150.33 23.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.336 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.52 118.01 10.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.383 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' B' ' 218' ' ' TRP . 94.0 t -95.42 133.42 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.84 175.57 9.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.2 t -100.66 135.97 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.283 0.563 . . . . 1.0 111.536 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 23.8 t70 -82.11 178.29 8.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.997 -1.001 . . . . 1.0 110.101 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.429 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -69.91 -10.62 59.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.185 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.93 19.69 17.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.357 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 70.17 36.1 1.96 Allowed 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.165 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.6 mttt -110.05 144.76 38.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.459 -176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.63 111.72 23.41 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.972 -1.467 . . . . 1.0 109.345 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -128.74 175.37 8.66 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.473 ' HB3' HG22 ' B' ' 208' ' ' VAL . 53.5 p-90 -153.4 162.15 41.57 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.014 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -144.17 151.35 39.4 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.456 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -98.58 131.2 44.98 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 13.7 t -128.55 133.56 66.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.361 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.533 ' CB ' HD22 ' B' ' 226' ' ' ASN . 3.0 t-80 -82.2 173.25 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . 0.468 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 16.5 t70 -58.02 -27.42 63.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.196 0.522 . . . . 1.0 110.963 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.12 -33.28 67.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.514 0.673 . . . . 1.0 110.165 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.42 10.28 22.09 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.848 -1.069 . . . . 1.0 112.772 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.533 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.64 142.96 27.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.671 0.272 . . . . 1.0 111.566 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.4 mm -74.75 123.57 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.583 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -100.56 -42.96 6.35 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.045 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -147.71 167.38 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.801 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 231' ' ' SER . 15.2 t0 -141.81 153.24 44.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.034 -0.985 . . . . 1.0 108.459 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.412 ' N ' ' OD1' ' B' ' 230' ' ' ASP . 55.0 p -58.35 -40.31 81.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 1.0 112.098 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.97 -41.12 3.03 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.21 177.25 6.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.185 -0.508 . . . . 1.0 110.667 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -167.86 114.59 0.58 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -142.37 166.04 25.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.564 0.221 . . . . 1.0 110.493 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.96 6.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.117 0.784 . . . . 1.0 113.117 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 13.2 p -112.12 127.36 55.9 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.694 0.759 . . . . 1.0 111.994 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -68.37 -40.77 81.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.112 -0.949 . . . . 1.0 110.952 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.2 tt0 -56.43 -46.12 80.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.297 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.573 ' HB2' ' HZ3' ' B' ' 240' ' ' LYS . 0.2 OUTLIER -57.86 -42.95 85.57 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.296 0.372 . . . . 1.0 110.972 -178.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.39 70.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 1.0 110.646 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -63.3 -38.01 89.47 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.24 -0.891 . . . . 1.0 111.222 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.8 mm-40 -63.4 -28.03 69.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.76 -43.45 97.71 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.485 ' O ' HG12 ' B' ' 248' ' ' VAL . 48.7 mt -63.48 -46.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.435 0.636 . . . . 1.0 110.698 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.36 -38.24 88.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.23 0.538 . . . . 1.0 110.213 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -35.25 78.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.572 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.2 -41.48 58.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.535 -177.163 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -65.85 -15.13 62.63 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 1.0 112.121 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -104.74 -2.34 25.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.866 0.365 . . . . 1.0 111.315 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -127.8 -37.44 1.94 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.415 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.505 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -55.11 -51.09 82.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.893 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.0 Cg_endo -66.43 -12.29 35.08 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.168 1.245 . . . . 1.0 113.462 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.15 -27.48 10.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.576 0.703 . . . . 1.0 111.577 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.38 136.87 57.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.977 1.103 . . . . 1.0 113.977 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.65 139.08 30.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -88.79 131.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.38 0.61 . . . . 1.0 111.816 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.57 144.44 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.873 -1.058 . . . . 1.0 109.004 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -88.59 102.32 14.83 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.115 -0.945 . . . . 1.0 111.236 -177.295 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 9.9 p-10 . . . . . 0 CA--C 1.509 -0.611 0 CA-C-O 121.408 0.623 . . . . 1.0 112.007 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -124.87 100.59 6.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.014 -1.476 . . . . 1.0 107.014 172.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -172.3 165.42 5.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.455 -1.248 . . . . 1.0 108.163 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 50.4 p-80 -167.81 150.21 5.69 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.56 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 57.1 m-85 -86.38 148.53 25.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.734 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.6 121.97 14.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.868 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.506 HG23 ' HG2' ' A' ' 142' ' ' LYS . 92.1 t -95.05 135.98 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.9 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.17 178.08 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.714 0.293 . . . . 1.0 110.543 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 2.9 t -101.22 133.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.343 0.592 . . . . 1.0 110.898 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.67 178.78 7.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.711 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -12.7 61.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.174 0.511 . . . . 1.0 110.929 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.39 18.75 19.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.346 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 71.1 35.2 1.67 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.794 0.838 . . . . 1.0 111.567 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.6 mttt -109.72 148.58 31.15 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.254 -175.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.32 112.21 24.07 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.329 -1.305 . . . . 1.0 109.383 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -132.95 178.31 6.98 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.401 -0.962 . . . . 1.0 108.401 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.481 ' CD1' ' HB3' ' A' ' 131' ' ' SER . 53.3 p-90 -150.09 164.0 36.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.813 0.34 . . . . 1.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -146.83 147.22 30.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.127 -0.942 . . . . 1.0 109.805 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.7 tp -96.65 134.69 39.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.1 t -128.06 131.07 69.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.448 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.541 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.0 t-80 -79.59 173.87 12.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.85 -39.39 68.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.279 0.562 . . . . 1.0 110.455 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -33.44 74.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.046 -0.979 . . . . 1.0 110.642 -177.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.34 9.75 23.14 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.837 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.541 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.45 144.69 26.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.689 0.255 . . . . 1.0 111.689 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.2 119.49 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.762 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.558 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.5 mt -94.93 -43.92 7.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.639 0.733 . . . . 1.0 109.9 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.39 166.74 28.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.635 -1.166 . . . . 1.0 111.367 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -141.17 153.5 45.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.951 -1.022 . . . . 1.0 108.464 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.481 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 15.8 p -53.37 -36.57 61.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.006 0.372 . . . . 1.0 112.006 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.69 -45.92 3.56 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.526 -0.63 . . . . 1.0 111.526 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -93.49 174.4 7.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.285 0.564 . . . . 1.0 111.507 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.53 136.92 8.68 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.94 165.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 117.627 0.714 . . . . 1.0 111.094 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.09 10.98 37.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.218 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 m -139.64 137.28 35.14 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.483 0.659 . . . . 1.0 111.543 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -63.22 -39.58 95.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.861 -1.063 . . . . 1.0 111.047 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.3 tt0 -58.31 -47.02 85.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.268 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.9 -44.57 86.87 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.61 0.569 . . . . 1.0 110.976 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.29 83.36 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.266 0.555 . . . . 1.0 110.612 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.506 ' HG2' HG23 ' A' ' 108' ' ' VAL . 44.5 mtmt -64.56 -35.32 80.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.383 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -64.78 -27.92 69.22 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.88 91.97 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 148' ' ' VAL . 63.5 mt -61.43 -43.04 96.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 1.0 110.338 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.83 -40.07 94.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.5 m -63.54 -36.36 83.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.599 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.498 HG22 ' HB1' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.53 -42.78 55.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 C-N-CA 119.826 -0.75 . . . . 1.0 109.529 -178.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.17 -11.77 51.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -102.54 -2.31 28.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 1.0 110.664 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 23.9 m-80 -135.52 -37.77 0.76 Allowed 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.787 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HB1' HG22 ' A' ' 148' ' ' VAL . . . -55.49 -49.7 91.08 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 44.4 Cg_endo -67.0 -11.96 34.27 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.322 1.348 . . . . 1.0 112.855 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -110.64 -19.8 12.75 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.065 0.46 . . . . 1.0 111.408 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -70.83 134.71 47.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.896 0.855 . . . . 1.0 113.153 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -94.53 142.25 27.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.22 -1.355 . . . . 1.0 110.317 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.528 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -90.67 134.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.237 0.541 . . . . 1.0 112.088 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt . . . . . 0 N--CA 1.45 -0.443 0 CA-C-N 114.902 -1.045 . . . . 1.0 109.192 177.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.415 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 9.3 p-10 . . . . . 0 CA--C 1.515 -0.374 0 CA-C-O 121.475 0.655 . . . . 1.0 112.189 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' B' ' 223' ' ' ASP . 0.0 OUTLIER -126.17 101.16 6.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 172.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.17 159.3 3.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.136 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.46 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 44.9 p-80 -166.95 150.81 6.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.744 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.6 m-85 -86.34 150.19 24.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.693 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -142.49 118.21 10.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.615 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' B' ' 218' ' ' TRP . 97.2 t -95.09 132.8 38.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.127 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.74 177.66 8.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.2 t -100.03 136.36 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.483 0.659 . . . . 1.0 112.346 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.7 -179.78 7.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.802 -1.09 . . . . 1.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.515 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.45 20.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.917 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 71.13 34.67 1.77 Allowed 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.498 0.719 . . . . 1.0 110.901 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.9 mttt -108.64 147.94 31.12 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.56 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -94.17 109.11 20.92 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.409 -1.269 . . . . 1.0 109.822 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -122.02 176.13 5.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.461 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.1 p-90 -150.62 162.76 40.04 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.28 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -147.28 146.71 29.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.197 -0.91 . . . . 1.0 110.247 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.564 ' HG ' HD12 ' B' ' 228' ' ' LEU . 35.0 tp -99.31 132.58 44.54 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 4.2 t -126.64 133.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.077 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.489 ' HB2' HD23 ' B' ' 228' ' ' LEU . 1.6 t-80 -86.09 176.55 7.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.389 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' B' ' 203' ' ' LYS . 43.2 t0 -52.61 -43.37 65.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.176 -0.92 . . . . 1.0 110.847 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.05 -33.6 75.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.617 -0.72 . . . . 1.0 110.47 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.45 12.34 19.63 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.493 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.477 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.43 144.84 27.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.59 0.218 . . . . 1.0 111.59 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.99 116.94 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.564 HD12 ' HG ' ' B' ' 220' ' ' LEU . 17.7 mt -89.19 -43.23 11.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.742 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.07 164.92 35.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 1.0 111.471 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -139.48 156.82 46.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.379 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 13.6 p -53.89 -35.08 61.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.78 -47.04 3.37 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -104.93 177.59 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.921 -0.64 . . . . 1.0 111.796 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -137.2 135.24 7.52 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.899 -1.28 . . . . 1.0 109.899 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -133.1 165.48 24.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.385 0.592 . . . . 1.0 111.78 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.62 10.9 26.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.9 m -138.48 135.83 35.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.46 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -64.14 -38.18 90.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.703 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.4 tt0 -59.84 -43.01 94.81 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.194 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -61.57 -40.64 95.46 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.793 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.33 87.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.307 0.575 . . . . 1.0 109.854 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.454 ' HA ' HD11 ' B' ' 245' ' ' ILE . 41.0 mtmt -64.79 -35.3 80.66 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.914 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.0 mm-40 -62.18 -29.05 70.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.705 -0.48 . . . . 1.0 109.705 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.95 -42.81 94.6 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.493 ' O ' HG11 ' B' ' 248' ' ' VAL . 57.3 mt -63.67 -44.16 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.235 0.54 . . . . 1.0 110.186 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -62.27 -40.88 97.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.974 0.416 . . . . 1.0 110.295 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.55 -35.0 79.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.504 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.534 HG22 ' HB1' ' B' ' 252' ' ' ALA . 0.3 OUTLIER -74.13 -41.96 51.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.478 -177.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.62 -11.76 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.816 -0.552 . . . . 1.0 111.832 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -104.79 -5.71 20.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.24 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 10.1 m-80 -130.08 -39.4 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.026 0.38 . . . . 1.0 112.026 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.534 ' HB1' HG22 ' B' ' 248' ' ' VAL . . . -55.74 -50.04 89.35 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 28.7 Cg_endo -62.03 -16.74 51.99 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.336 1.357 . . . . 1.0 113.187 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.64 -29.36 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.272 0.558 . . . . 1.0 111.899 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -59.11 135.92 57.79 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.644 0.979 . . . . 1.0 113.644 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -93.7 141.08 28.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.802 -1.545 . . . . 1.0 110.252 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.56 133.41 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.498 0.666 . . . . 1.0 112.233 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -119.41 146.76 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.691 -1.14 . . . . 1.0 109.034 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.95 104.1 16.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.088 -0.958 . . . . 1.0 111.873 -176.348 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 16.4 p-10 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.373 0.606 . . . . 1.0 112.34 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -131.87 97.22 4.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.98 168.24 4.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.055 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.459 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 31.8 p-80 -171.45 151.21 2.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.301 -0.259 . . . . 1.0 110.301 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -88.5 150.38 23.14 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.062 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.83 119.64 12.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.26 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 118' ' ' TRP . 73.4 t -93.97 131.69 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.975 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.43 179.78 6.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.772 0.32 . . . . 1.0 110.823 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.7 t -102.21 137.83 28.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.239 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.54 -179.97 7.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.939 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.17 -12.36 61.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.429 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.22 20.03 16.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.767 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 71.33 35.18 1.59 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.562 0.745 . . . . 1.0 111.249 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 9.5 mmtt -108.71 153.31 23.63 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.203 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -96.6 118.3 32.8 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.643 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.0 mtm105 -133.51 -179.99 5.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.437 ' CZ2' ' HA ' ' A' ' 131' ' ' SER . 51.7 p-90 -150.09 170.58 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.377 0.608 . . . . 1.0 112.366 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -148.41 141.88 25.33 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.448 -1.251 . . . . 1.0 110.63 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' HD11 ' A' ' 128' ' ' LEU . 33.6 tp -102.15 129.8 48.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 174.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.52 134.65 61.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 121.08 -0.248 . . . . 1.0 110.726 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.568 ' CB ' HD22 ' A' ' 126' ' ' ASN . 1.7 t-80 -83.04 172.25 12.93 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 177.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -57.14 -30.55 64.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.958 0.409 . . . . 1.0 111.843 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -68.26 -33.6 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.3 0.571 . . . . 1.0 110.037 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.76 11.76 16.09 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.069 -0.969 . . . . 1.0 112.347 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.568 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.94 142.02 27.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.841 -0.18 . . . . 1.0 111.086 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.53 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.6 mm -77.58 118.19 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.921 0.763 . . . . 1.0 109.711 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.558 HD11 ' HG ' ' A' ' 120' ' ' LEU . 17.2 mt -89.83 -40.06 12.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.413 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.16 164.52 37.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.781 -1.1 . . . . 1.0 111.917 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.53 154.27 49.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.826 -1.079 . . . . 1.0 108.723 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 118' ' ' TRP . 77.6 p -55.59 -41.47 73.44 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.13 -35.52 2.77 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.441 -0.664 . . . . 1.0 111.441 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -94.71 174.92 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.19 0.519 . . . . 1.0 111.132 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.54 124.12 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.739 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -146.03 179.44 7.48 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.56 9.42 41.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.768 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.6 m -117.59 128.86 55.35 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.675 0.75 . . . . 1.0 111.664 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -69.52 -32.07 70.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.573 -1.194 . . . . 1.0 110.214 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.3 tt0 -63.06 -44.83 94.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.112 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -60.87 -37.07 80.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.681 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.83 75.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.194 0.521 . . . . 1.0 109.962 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.436 ' HA ' HD11 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.97 -36.96 86.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.3 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.6 mm-40 -61.65 -27.44 68.68 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.14 -43.62 89.46 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.07 -1.212 . . . . 1.0 110.07 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 148' ' ' VAL . 54.4 mt -63.29 -44.48 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.318 0.58 . . . . 1.0 109.97 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.09 -43.78 98.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.354 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.0 m -64.09 -34.93 79.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.745 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -73.5 -43.25 55.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 C-N-CA 119.897 -0.721 . . . . 1.0 109.653 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -67.6 -11.92 59.22 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.042 -0.411 . . . . 1.0 111.729 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -104.11 -2.35 25.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.807 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.1 m-80 -137.04 -37.2 0.65 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.514 ' HB3' HG21 ' A' ' 148' ' ' VAL . . . -54.89 -50.14 87.85 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -64.89 -11.12 28.0 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.329 1.353 . . . . 1.0 113.226 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.88 -22.42 11.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.065 0.459 . . . . 1.0 111.394 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -67.84 137.77 55.58 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.269 0.84 . . . . 1.0 113.269 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -100.11 154.21 18.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.3 -1.318 . . . . 1.0 111.489 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.405 HG22 HG21 ' B' ' 245' ' ' ILE . 36.1 t -87.61 133.45 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.995 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 176.54 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.408 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.5 p-10 . . . . . 0 CA--C 1.514 -0.427 0 CA-C-O 121.685 0.755 . . . . 1.0 112.878 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -135.75 97.76 3.74 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.571 -1.649 . . . . 1.0 106.971 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.31 167.46 4.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.322 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.445 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 44.3 p-80 -169.32 149.63 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.738 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -85.9 151.17 23.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -140.93 120.68 13.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.568 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' B' ' 218' ' ' TRP . 81.0 t -94.33 133.35 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.654 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -140.18 -178.79 5.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.101 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.9 t -108.36 138.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.333 0.494 . . . . 1.0 112.333 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.8 178.57 8.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.748 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.23 -18.86 65.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.735 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.89 23.09 14.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.112 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 62.64 40.87 9.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.854 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.2 mmtt -102.1 158.66 16.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -102.47 118.48 36.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -132.03 179.08 6.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' B' ' 231' ' ' SER . 52.5 p-90 -149.0 171.05 16.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.588 0.709 . . . . 1.0 112.317 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -147.43 142.49 27.07 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.205 -1.361 . . . . 1.0 110.649 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.567 ' HG ' HD11 ' B' ' 228' ' ' LEU . 36.0 tp -100.46 129.39 46.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.56 135.0 61.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.363 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.576 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.5 t-80 -81.73 168.59 17.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.46 -17.73 55.78 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.947 0.403 . . . . 1.0 111.419 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -74.25 -33.9 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.546 0.689 . . . . 1.0 109.488 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.59 10.91 15.89 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 114.41 -1.268 . . . . 1.0 112.596 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.576 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -90.54 143.26 26.92 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.265 0.226 . . . . 1.0 111.481 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.81 127.01 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 123.675 0.609 . . . . 1.0 109.513 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.567 HD11 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -103.81 -40.75 6.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.231 0.539 . . . . 1.0 109.99 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.86 164.86 36.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.908 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' B' ' 231' ' ' SER . 10.2 t0 -139.22 151.88 46.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.829 -1.078 . . . . 1.0 108.186 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.44 ' N ' ' OD1' ' B' ' 230' ' ' ASP . 11.9 p -51.51 -36.47 44.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.864 0.32 . . . . 1.0 111.864 176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.62 -45.32 3.34 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.355 -0.698 . . . . 1.0 111.355 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . 0.53 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 89.0 mt-10 -113.26 171.26 7.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.559 . . . . 1.0 111.011 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.99 141.3 9.55 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.05 174.27 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.603 0.24 . . . . 1.0 110.458 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -86.17 10.83 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 -176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.3 m -128.61 131.17 48.1 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 121.74 -0.6 . . . . 1.0 111.336 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' B' ' 242' ' ' LYS . 20.3 ptmt -66.51 -34.87 78.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.627 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.8 tt0 -57.16 -43.99 83.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.905 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.544 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.4 OUTLIER -60.49 -40.88 92.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.22 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.25 78.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.217 0.532 . . . . 1.0 110.376 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' B' ' 238' ' ' LYS . 44.9 mtmt -63.0 -41.11 99.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.91 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.5 mm-40 -64.79 -26.22 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.134 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.27 -42.56 96.15 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.029 -1.228 . . . . 1.0 110.029 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.486 ' O ' HG12 ' B' ' 248' ' ' VAL . 57.5 mt -62.23 -46.16 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 1.0 110.161 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.41 -40.3 96.06 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.201 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.02 -34.18 77.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.662 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.01 -43.03 52.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.888 -177.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -65.95 -12.01 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 1.0 111.848 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -102.63 -3.09 27.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.786 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 13.5 m-80 -135.65 -36.36 0.78 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -176.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.492 ' HB3' HG23 ' B' ' 248' ' ' VAL . . . -56.16 -50.41 87.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.538 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.4 Cg_endo -63.47 -14.12 40.4 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.444 1.43 . . . . 1.0 113.254 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.45 -21.49 12.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.88 0.371 . . . . 1.0 111.906 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.51 138.18 57.9 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.131 0.789 . . . . 1.0 113.131 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -97.05 150.38 20.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.328 -1.305 . . . . 1.0 112.053 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.424 HG22 HG23 ' A' ' 145' ' ' ILE . 36.2 t -85.53 133.93 28.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.258 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.44 143.95 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.78 102.4 13.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.595 -0.717 . . . . 1.0 110.892 -178.14 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 17.7 p-10 . . . . . 0 CA--C 1.511 -0.535 0 CA-C-O 121.468 0.651 . . . . 1.0 112.744 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.5 mptt -121.63 97.4 5.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.03 167.48 4.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.451 -1.249 . . . . 1.0 108.426 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.441 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 52.3 p-80 -168.88 148.37 4.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.929 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.9 m-85 -86.27 149.09 25.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.868 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -142.56 121.43 12.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.759 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 118' ' ' TRP . 85.5 t -97.09 136.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -147.25 -179.26 6.71 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.245 0.341 . . . . 1.0 110.593 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -105.82 138.5 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.394 0.616 . . . . 1.0 112.082 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.23 178.54 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.744 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.21 63.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.046 0.45 . . . . 1.0 111.162 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.71 22.22 16.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.444 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 70.62 33.18 2.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.687 0.795 . . . . 1.0 111.236 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.4 mttt -107.42 146.56 31.53 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.517 0.675 . . . . 1.0 111.941 -175.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -92.9 115.76 28.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.198 -1.364 . . . . 1.0 109.802 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -128.99 179.36 5.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.203 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.461 ' HB3' HG21 ' A' ' 108' ' ' VAL . 54.9 p-90 -154.5 165.49 36.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.1 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 16.4 mtt180 -149.09 150.63 33.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 124.016 0.823 . . . . 1.0 110.497 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' HD13 ' A' ' 128' ' ' LEU . 32.0 tp -99.83 132.02 45.44 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.86 129.72 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.554 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.57 ' CB ' HD22 ' A' ' 126' ' ' ASN . 3.0 t-80 -78.23 172.62 13.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.03 -32.39 66.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.15 0.5 . . . . 1.0 110.959 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -65.29 -33.73 76.67 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.203 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.66 14.22 16.39 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.078 -0.965 . . . . 1.0 112.384 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.57 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.34 143.6 26.6 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 178.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mm -74.96 118.64 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 123.926 0.766 . . . . 1.0 109.566 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.558 HD13 ' HG ' ' A' ' 120' ' ' LEU . 17.3 mt -93.87 -43.41 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.384 0.612 . . . . 1.0 109.799 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.21 163.74 37.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.367 177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -139.07 156.86 46.86 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.8 p -53.74 -31.5 48.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.931 0.396 . . . . 1.0 111.401 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.06 -38.26 2.98 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 49.9 mt-10 -118.3 171.39 8.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.048 -0.576 . . . . 1.0 110.951 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.42 138.66 10.49 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -133.43 169.43 16.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.32 0.56 . . . . 1.0 111.982 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.01 10.72 30.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -142.5 139.22 31.42 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.815 -0.553 . . . . 1.0 111.9 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.64 -37.48 87.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.461 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.9 tt0 -59.03 -46.67 87.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.544 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -59.12 -41.59 88.55 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.614 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.11 75.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.09 0.471 . . . . 1.0 109.861 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.468 ' HA ' HD11 ' A' ' 145' ' ' ILE . 43.9 mtmt -64.21 -34.73 78.76 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.344 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.0 mm-40 -63.69 -27.13 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.76 -42.38 87.02 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 142' ' ' LYS . 66.5 mt -62.2 -44.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.414 0.626 . . . . 1.0 109.637 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -61.52 -44.77 96.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.239 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.8 m -63.56 -34.83 78.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.751 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -74.55 -41.61 48.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 C-N-CA 119.878 -0.729 . . . . 1.0 109.684 -177.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.36 -12.1 54.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.753 0.311 . . . . 1.0 111.657 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -104.63 -2.8 24.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.591 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -132.02 -40.58 1.04 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.835 0.35 . . . . 1.0 111.502 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' A' ' 148' ' ' VAL . . . -55.15 -51.48 79.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.617 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -63.54 -9.0 16.52 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.508 1.472 . . . . 1.0 113.98 -177.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.58 -22.19 7.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.918 0.39 . . . . 1.0 111.939 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 136.52 57.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.777 0.799 . . . . 1.0 113.038 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.93 138.78 31.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.438 -1.255 . . . . 1.0 110.581 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.527 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.69 130.65 38.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.711 . . . . 1.0 112.699 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 114.369 -1.287 . . . . 1.0 108.568 177.496 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 CA--C 1.514 -0.423 0 CA-C-O 121.022 0.439 . . . . 1.0 110.787 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 73.3 mmtt -137.73 95.77 3.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.609 -1.256 . . . . 1.0 107.609 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.91 173.03 2.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.094 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.487 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.6 p-80 -170.7 147.59 2.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.583 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.527 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 57.6 m-85 -85.16 147.61 26.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.654 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.37 119.55 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.08 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' B' ' 218' ' ' TRP . 75.4 t -92.14 133.93 31.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.151 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -145.66 -176.43 5.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.619 0.247 . . . . 1.0 110.4 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.8 t -101.99 139.42 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.909 0.707 . . . . 1.0 112.909 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 17.4 t70 -81.22 -178.65 7.01 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.309 -0.86 . . . . 1.0 109.548 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.424 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -70.82 -16.96 62.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.154 0.502 . . . . 1.0 110.673 178.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.37 19.33 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.712 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.67 39.99 1.44 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.425 0.69 . . . . 1.0 110.956 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -113.76 151.86 31.38 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.791 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -91.99 118.87 31.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.158 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -130.69 -178.67 4.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.808 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.424 ' HB3' HG23 ' B' ' 208' ' ' VAL . 56.8 p-90 -155.43 164.44 38.71 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.345 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -149.66 148.31 29.13 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.216 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.562 ' HG ' HD13 ' B' ' 228' ' ' LEU . 31.9 tp -97.15 130.16 44.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.28 130.59 71.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.252 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.571 ' CB ' HD22 ' B' ' 226' ' ' ASN . 3.8 t-80 -78.94 169.31 18.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 29.0 t70 -58.36 -26.47 63.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.266 0.555 . . . . 1.0 110.954 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.4 -33.07 70.95 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.941 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.48 11.52 19.44 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.125 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.571 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.55 144.21 26.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.807 -0.231 . . . . 1.0 111.385 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . 0.474 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.9 mm -78.24 116.72 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 1.0 109.472 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.562 HD13 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -90.25 -42.58 10.92 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.547 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -150.35 164.27 36.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.608 -1.178 . . . . 1.0 111.374 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.34 155.33 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 65.6 p -54.72 -33.26 60.84 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.066 0.46 . . . . 1.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.69 3.51 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.53 -0.628 . . . . 1.0 111.53 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -122.72 166.94 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.175 0.512 . . . . 1.0 111.572 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -118.73 139.78 14.72 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.651 -1.38 . . . . 1.0 109.651 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -127.47 171.02 11.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.623 0.711 . . . . 1.0 111.545 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -100.73 9.69 42.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 1.0 112.28 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.7 m -143.78 137.21 27.9 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.68 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -62.88 -38.42 90.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.78 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.3 tt0 -60.98 -40.71 94.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.211 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -61.05 -41.51 96.74 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.647 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.28 89.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.973 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.499 ' HA ' HD11 ' B' ' 245' ' ' ILE . 45.0 mtmt -64.91 -34.99 79.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.228 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.3 mm-40 -62.62 -30.98 71.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.15 -41.28 95.03 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.048 -1.221 . . . . 1.0 110.048 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' B' ' 242' ' ' LYS . 66.6 mt -63.36 -43.08 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.976 -0.612 . . . . 1.0 110.582 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -63.99 -41.3 97.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.04 0.448 . . . . 1.0 110.232 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -64.03 -37.08 86.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.522 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -74.06 -41.46 52.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 C-N-CA 120.22 -0.592 . . . . 1.0 110.755 -176.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.53 -16.35 63.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -105.82 -3.23 22.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 1.0 111.353 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 15.2 m-80 -123.32 -38.88 2.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.986 0.422 . . . . 1.0 111.082 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.511 ' HB3' HG21 ' B' ' 248' ' ' VAL . . . -56.51 -50.87 85.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.495 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.5 Cg_endo -63.59 -12.75 32.66 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.53 1.486 . . . . 1.0 113.528 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.56 -19.47 10.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -64.57 136.77 57.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.866 0.841 . . . . 1.0 112.593 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -91.83 135.76 33.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.022 -1.445 . . . . 1.0 110.573 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.51 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -88.54 129.85 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.601 0.715 . . . . 1.0 112.298 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.9 mt -115.1 140.59 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.406 -1.27 . . . . 1.0 109.27 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -90.31 106.55 18.57 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.674 -0.862 . . . . 1.0 108.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.337 -0.839 . . . . 1.0 111.213 -177.399 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 21.4 p-10 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.333 0.587 . . . . 1.0 112.066 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -134.37 96.64 3.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.55 171.13 3.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.856 -1.065 . . . . 1.0 109.401 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.467 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 48.4 p-80 -170.53 148.36 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.1 m-85 -84.83 149.94 25.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.38 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.35 118.73 12.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.559 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 118' ' ' TRP . 68.2 t -90.95 133.39 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.878 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -142.6 177.43 8.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.412 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.36 137.47 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.334 0.587 . . . . 1.0 111.969 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.57 177.76 8.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.96 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.87 -12.25 61.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.237 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.97 24.28 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.669 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 69.35 35.19 2.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 1.0 111.674 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -110.68 147.53 34.15 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.457 0.646 . . . . 1.0 111.4 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.6 120.98 32.13 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.431 -1.259 . . . . 1.0 110.467 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -136.32 -179.7 5.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.572 -1.194 . . . . 1.0 108.675 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 131' ' ' SER . 56.3 p-90 -151.7 162.9 40.24 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.683 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.513 HH11 HG23 ' A' ' 127' ' ' ILE . 21.6 mmt180 -143.48 142.82 31.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.298 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.571 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.5 tp -99.97 129.99 46.1 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -127.79 132.36 68.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.483 -0.192 . . . . 1.0 110.483 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.0 t-80 -83.34 174.35 10.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.4 -39.18 67.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.0 111.476 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -60.32 -33.96 73.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.513 0.673 . . . . 1.0 110.26 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.54 12.17 21.8 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.873 -1.058 . . . . 1.0 112.096 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.529 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.77 142.57 28.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.63 0.252 . . . . 1.0 111.376 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.513 HG23 HH11 ' A' ' 119' ' ' ARG . 50.9 mm -76.26 116.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.194 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.571 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.1 mt -88.38 -42.74 11.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.634 0.731 . . . . 1.0 109.917 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.65 166.43 30.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.756 -1.111 . . . . 1.0 111.237 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -140.34 155.41 46.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.87 -1.059 . . . . 1.0 110.13 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 18.9 p -54.5 -36.03 63.75 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.601 0.563 . . . . 1.0 111.605 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.38 -50.67 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.65 178.61 4.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.709 -0.746 . . . . 1.0 111.618 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -145.67 140.62 9.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -141.37 167.47 22.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.531 0.165 . . . . 1.0 110.66 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.4 9.9 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 p -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.601 0.715 . . . . 1.0 111.862 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -64.94 -41.52 95.44 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.595 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -59.83 -37.78 80.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.621 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -62.0 -43.35 99.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.241 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.95 83.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.26 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.486 ' HA ' HD13 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.66 -34.43 78.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.169 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -62.99 -30.29 71.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.34 -40.35 94.57 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.42 -1.072 . . . . 1.0 110.42 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 142' ' ' LYS . 58.3 mt -62.73 -42.26 95.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.085 0.469 . . . . 1.0 110.081 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.09 -43.75 97.63 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.155 0.502 . . . . 1.0 109.885 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -61.25 -36.16 79.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -75.22 -42.4 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 119.536 -0.866 . . . . 1.0 110.169 -177.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.6 mtpt -66.86 -15.65 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 1.0 112.399 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -105.43 -2.26 23.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.366 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.62 -37.53 1.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.693 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB3' HG21 ' A' ' 148' ' ' VAL . . . -57.34 -51.35 82.33 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.499 0.555 . . . . 1.0 112.499 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 57.8 Cg_endo -66.56 -4.81 11.55 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.261 1.308 . . . . 1.0 113.208 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.18 -23.41 6.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.593 0.59 . . . . 1.0 112.593 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' B' ' 205' ' ' HIS . . . -66.69 139.12 57.83 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.472 0.916 . . . . 1.0 113.472 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.78 135.42 33.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.488 -1.233 . . . . 1.0 111.189 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.497 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -88.04 131.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.335 0.588 . . . . 1.0 112.075 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.6 mt . . . . . 0 N--CA 1.449 -0.476 0 CA-C-N 114.93 -1.032 . . . . 1.0 108.92 178.204 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.419 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 14.4 p-10 . . . . . 0 CA--C 1.512 -0.507 0 CA-C-O 121.363 0.601 . . . . 1.0 112.588 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.405 ' HD2' ' C ' ' B' ' 202' ' ' ASN . 12.0 mptt -127.78 96.46 4.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 174.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.95 171.4 3.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.417 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 52.6 p-80 -169.32 147.26 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.213 -0.195 . . . . 1.0 110.59 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.497 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 52.1 m-85 -86.67 146.72 26.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.144 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -141.75 122.0 13.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.752 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.0 t -93.24 135.68 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.09 -178.62 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.355 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.1 t -106.15 139.65 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.22 179.12 7.8 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.47 -0.787 . . . . 1.0 109.51 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.38 -17.58 64.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.893 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.8 19.16 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.118 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 69.78 35.37 2.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.041 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.1 mmtt -108.57 149.16 29.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.407 -175.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.38 119.67 32.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.53 -1.214 . . . . 1.0 110.254 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -132.32 -178.1 4.76 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.706 -1.134 . . . . 1.0 108.972 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.454 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.0 p-90 -155.7 168.22 27.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.742 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -150.44 154.13 37.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.849 -1.069 . . . . 1.0 110.613 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -104.36 132.62 50.41 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.3 t -126.25 132.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.259 -0.275 . . . . 1.0 110.259 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.483 ' CB ' HD22 ' B' ' 226' ' ' ASN . 0.6 OUTLIER -85.26 174.49 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.256 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -52.5 -33.88 46.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.833 -0.621 . . . . 1.0 112.249 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -70.81 -33.29 70.55 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.322 0.582 . . . . 1.0 110.179 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.92 10.34 21.09 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.074 -0.967 . . . . 1.0 112.38 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.483 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -85.69 144.51 27.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.35 118.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 O-C-N 123.926 0.766 . . . . 1.0 109.38 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.575 HD12 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -93.42 -43.52 8.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.608 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.67 40.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.195 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -136.85 155.11 50.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.435 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.3 p -51.86 -37.03 50.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.905 0.383 . . . . 1.0 111.817 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.18 -46.44 3.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . 0.444 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 7.8 mm-40 -98.15 -179.75 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.127 -0.537 . . . . 1.0 111.399 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -150.0 133.86 4.57 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -138.85 170.01 16.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.089 0.444 . . . . 1.0 110.962 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -92.27 9.46 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 6.5 p -126.96 129.05 47.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.594 0.711 . . . . 1.0 112.1 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.21 -41.17 94.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.8 tt0 -58.4 -41.14 84.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.342 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -60.59 -41.95 95.76 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.918 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.18 79.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.43 0.633 . . . . 1.0 109.511 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.483 ' HA ' HD13 ' B' ' 245' ' ' ILE . 47.2 mtmt -65.78 -33.68 76.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.265 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.1 mm-40 -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -68.15 -39.64 88.36 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.502 ' O ' HG12 ' B' ' 248' ' ' VAL . 72.9 mt -61.58 -52.43 61.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.519 0.676 . . . . 1.0 110.59 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -61.87 -35.57 78.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.02 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.2 m -67.95 -36.29 79.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.846 177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.502 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.5 OUTLIER -71.54 -37.16 62.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -177.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -66.41 -15.46 63.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.938 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 41.2 ttt85 -105.04 -2.9 23.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.074 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . 0.426 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 16.1 m-80 -127.08 -41.17 1.8 Allowed 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.639 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.486 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -56.82 -50.51 87.64 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.768 -0.651 . . . . 1.0 112.431 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.6 Cg_endo -62.84 -15.15 45.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 121.162 1.241 . . . . 1.0 113.712 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.5 -18.3 11.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.823 0.344 . . . . 1.0 111.923 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -67.6 135.25 52.61 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.641 0.734 . . . . 1.0 112.791 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -93.56 140.28 29.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.213 -1.358 . . . . 1.0 110.592 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -87.27 136.36 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.369 0.604 . . . . 1.0 112.205 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.8 mt -124.58 148.72 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.658 -1.156 . . . . 1.0 109.761 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.9 106.37 17.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.577 -0.725 . . . . 1.0 111.296 -177.858 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.428 ' C ' ' HD2' ' A' ' 103' ' ' LYS . 10.7 p-10 . . . . . 0 CA--C 1.508 -0.664 0 CA-C-O 121.351 0.595 . . . . 1.0 112.151 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.2 mptt -122.71 97.91 5.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.72 169.34 4.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.685 -1.143 . . . . 1.0 108.954 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.465 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 51.9 p-80 -169.14 148.94 4.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.59 146.9 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.66 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.36 116.8 11.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.939 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 118' ' ' TRP . 70.2 t -90.97 132.12 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.526 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -140.5 -179.08 5.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.383 -0.228 . . . . 1.0 110.383 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.2 t -103.53 136.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.586 . . . . 1.0 112.388 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.11 177.55 8.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 1.0 108.957 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.29 62.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 1.0 111.006 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.55 19.16 20.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.102 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.6 39.99 1.96 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.672 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 13.2 mmtt -111.76 152.45 27.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.283 -176.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.44 118.63 31.55 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.727 -1.124 . . . . 1.0 110.067 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -132.06 -179.26 5.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.442 ' HB3' HG23 ' A' ' 108' ' ' VAL . 60.5 p-90 -155.77 167.41 30.48 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.082 0.468 . . . . 1.0 111.926 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -151.64 149.87 29.62 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.334 -1.303 . . . . 1.0 110.63 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.536 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.4 tp -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 t -126.59 131.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.561 -0.291 . . . . 1.0 110.549 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.554 ' CB ' HD22 ' A' ' 126' ' ' ASN . 1.9 t-80 -81.65 172.08 13.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.84 -27.36 63.13 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.323 0.582 . . . . 1.0 110.792 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -33.64 73.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.955 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.12 11.7 23.53 Favored Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.109 -0.95 . . . . 1.0 112.318 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.554 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.09 144.68 25.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.101 0.408 . . . . 1.0 112.101 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.41 117.4 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.944 0.777 . . . . 1.0 109.137 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.536 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.0 mt -90.57 -43.96 9.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.6 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.48 158.48 44.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.692 -1.14 . . . . 1.0 111.02 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.64 154.99 51.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 16.3 p -52.9 -33.16 49.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.406 0.442 . . . . 1.0 112.159 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.35 -48.04 3.73 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -104.07 -175.38 2.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.913 -0.644 . . . . 1.0 111.406 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -149.25 137.77 6.48 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -144.34 168.47 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.96 0.38 . . . . 1.0 111.06 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.06 10.29 32.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.226 0.824 . . . . 1.0 113.226 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -125.83 132.53 52.21 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 111.076 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -64.77 -38.55 91.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.879 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.9 tt0 -61.17 -41.23 96.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.988 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.57 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.64 -41.21 94.47 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.555 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.985 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.487 ' HA ' HD13 ' A' ' 145' ' ' ILE . 48.3 mtmt -63.63 -36.41 83.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.632 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.0 mm-40 -65.1 -25.49 67.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.2 -40.95 92.48 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 142' ' ' LYS . 67.7 mt -62.43 -44.53 99.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.8 -0.7 . . . . 1.0 109.766 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.55 -40.16 95.95 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.809 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -63.17 -35.39 80.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.007 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.534 HG23 ' HB1' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -73.68 -40.86 54.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 119.581 -0.848 . . . . 1.0 109.371 -178.286 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -68.06 -11.92 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.251 0.548 . . . . 1.0 110.768 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -97.73 -6.87 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.259 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -138.91 -37.51 0.52 Allowed 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB1' HG23 ' A' ' 148' ' ' VAL . . . -53.84 -50.68 82.47 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 56.8 Cg_endo -67.36 -6.21 15.82 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 121.307 1.338 . . . . 1.0 113.473 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.88 -26.96 5.9 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.247 0.546 . . . . 1.0 111.684 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -64.98 136.44 56.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.424 -0.807 . . . . 1.0 112.502 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.35 139.4 34.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.566 -1.197 . . . . 1.0 110.975 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -86.72 139.92 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.542 0.686 . . . . 1.0 112.584 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.7 mt . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.013 177.291 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 CA--C 1.517 -0.296 0 CA-C-O 121.52 0.676 . . . . 1.0 112.252 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -144.94 97.12 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.17 -1.418 . . . . 1.0 107.17 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.98 177.41 1.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.958 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 52.8 p-80 -169.2 148.12 3.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.831 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.489 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 60.8 m-85 -86.16 150.12 24.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.836 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.16 117.59 10.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' B' ' 218' ' ' TRP . 88.9 t -93.5 134.53 30.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.958 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -145.75 179.76 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.312 . . . . 1.0 110.968 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 1.3 t -97.44 135.94 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.37 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 9.3 t70 -84.53 -179.11 7.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.055 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.425 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.05 -6.91 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.972 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.79 18.42 11.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.531 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 35.1 t70 69.83 43.69 0.92 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.47 1.128 . . . . 1.0 110.359 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.7 mmtt -113.51 150.23 33.21 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.749 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.06 116.32 28.71 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.799 -1.091 . . . . 1.0 109.988 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -134.03 178.29 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.432 ' HB3' HG23 ' B' ' 208' ' ' VAL . 51.1 p-90 -151.27 164.01 37.59 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.742 -0.383 . . . . 1.0 111.391 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' B' ' 219' ' ' ARG . 4.5 mtp-105 -146.63 145.76 30.17 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.913 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.562 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.5 tp -96.61 130.66 43.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 t -126.13 130.77 72.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.027 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.443 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.1 t-80 -81.83 175.47 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.62 -36.81 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.414 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -67.13 -34.58 77.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.563 0.697 . . . . 1.0 110.503 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.63 12.33 17.02 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 114.97 -1.014 . . . . 1.0 112.203 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.443 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.06 143.33 27.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.056 0.391 . . . . 1.0 112.056 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.17 120.15 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 124.053 0.845 . . . . 1.0 109.911 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.562 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.9 mt -96.49 -43.96 7.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.703 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -150.46 162.3 40.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.489 -1.232 . . . . 1.0 111.135 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -137.65 152.93 49.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.972 -1.013 . . . . 1.0 108.442 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 79.8 p -55.25 -36.43 66.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.013 0.435 . . . . 1.0 111.416 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.25 -48.1 3.57 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -98.01 171.76 8.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.78 -0.71 . . . . 1.0 111.563 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.11 135.82 6.23 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.349 -1.101 . . . . 1.0 110.349 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -141.86 178.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.066 0.433 . . . . 1.0 110.405 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -99.27 9.8 42.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.192 0.812 . . . . 1.0 113.192 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -125.86 131.83 52.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.2 0.524 . . . . 1.0 111.544 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.58 -39.13 93.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.164 -0.926 . . . . 1.0 110.448 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.5 tt0 -60.29 -43.82 95.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.224 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -59.52 -41.43 89.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.618 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.49 -51.08 71.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.064 0.459 . . . . 1.0 110.318 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.7 mtmt -63.59 -33.37 75.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.3 mm-40 -65.55 -30.38 71.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.425 -0.51 . . . . 1.0 109.72 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.14 96.42 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.497 ' O ' HG13 ' B' ' 248' ' ' VAL . 75.6 mt -61.62 -53.42 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.588 0.709 . . . . 1.0 110.535 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -61.37 -34.8 75.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.591 -0.731 . . . . 1.0 111.034 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.5 m -66.82 -37.64 84.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.389 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.497 HG13 ' O ' ' B' ' 245' ' ' ILE . 0.4 OUTLIER -70.72 -40.59 77.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.984 -0.687 . . . . 1.0 109.247 -177.637 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.72 -17.26 62.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -104.07 -2.77 25.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.967 0.413 . . . . 1.0 111.033 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.82 -41.77 1.63 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.608 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.483 ' HB3' HG23 ' B' ' 248' ' ' VAL . . . -55.87 -50.68 85.81 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.503 -0.771 . . . . 1.0 112.852 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.3 Cg_endo -63.14 -15.14 46.16 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.232 1.288 . . . . 1.0 113.379 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.52 -19.94 11.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.925 0.393 . . . . 1.0 111.906 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -67.84 136.23 53.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.786 0.803 . . . . 1.0 112.507 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.81 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.125 -1.398 . . . . 1.0 110.988 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.0 OUTLIER -88.86 130.07 38.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.613 0.721 . . . . 1.0 112.621 179.084 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.3 mt -116.41 142.58 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.468 -1.242 . . . . 1.0 108.864 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -90.17 101.91 14.63 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.869 -0.586 . . . . 1.0 111.21 -177.137 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 121.711 0.767 . . . . 1.0 112.033 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -137.58 98.43 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.136 -1.393 . . . . 1.0 107.319 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.17 172.8 3.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.425 -0.807 . . . . 1.0 109.392 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.425 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 31.6 p-80 -172.02 149.41 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.154 0.283 . . . . 1.0 110.238 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.506 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 66.1 m-85 -86.11 153.63 21.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.483 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -141.66 117.68 10.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.4 t -93.84 129.54 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -143.63 179.3 7.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.804 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -98.82 134.8 36.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.809 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.13 178.54 8.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.173 -0.922 . . . . 1.0 109.53 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.35 -16.83 64.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.165 0.507 . . . . 1.0 110.629 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.05 20.25 18.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.738 -0.664 . . . . 1.0 111.708 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 71.3 35.53 1.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.453 0.701 . . . . 1.0 111.398 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.2 mttt -109.61 150.27 28.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.159 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.06 109.38 20.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.006 -0.997 . . . . 1.0 109.264 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -126.15 176.91 6.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.43 ' CE2' ' HA ' ' A' ' 131' ' ' SER . 49.8 p-90 -147.3 162.45 38.93 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.365 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.49 HH21 HG13 ' A' ' 127' ' ' ILE . 14.7 mmm-85 -144.5 142.18 30.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.157 -0.929 . . . . 1.0 109.635 -177.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.568 ' HG ' HD13 ' A' ' 128' ' ' LEU . 33.9 tp -98.79 131.61 44.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.238 -1.023 . . . . 1.0 108.238 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -130.78 132.97 63.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.542 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.52 ' CB ' HD22 ' A' ' 126' ' ' ASN . 4.8 t-80 -81.81 174.71 11.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -56.11 -36.58 68.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.285 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -64.88 -33.45 76.04 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.551 0.691 . . . . 1.0 109.699 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 11.57 21.35 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 114.688 -1.142 . . . . 1.0 112.398 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.52 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -85.97 141.31 29.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.721 0.296 . . . . 1.0 111.587 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.49 HG13 HH21 ' A' ' 119' ' ' ARG . 47.6 mm -74.66 122.1 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.299 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.568 HD13 ' HG ' ' A' ' 120' ' ' LEU . 13.9 mt -98.17 -41.42 7.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.881 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.19 169.24 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.26 -0.882 . . . . 1.0 111.935 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -141.97 153.49 44.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.698 -1.137 . . . . 1.0 108.325 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.43 ' HA ' ' CE2' ' A' ' 118' ' ' TRP . 77.3 p -53.49 -34.49 58.25 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.005 0.431 . . . . 1.0 111.597 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.88 -40.45 3.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.652 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 93.9 mt-10 -110.82 174.85 5.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.307 -0.446 . . . . 1.0 110.78 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.85 136.67 6.74 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.311 -0.715 . . . . 1.0 111.311 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -144.54 177.53 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.733 0.266 . . . . 1.0 110.968 -177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.36 9.67 42.32 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.773 0.657 . . . . 1.0 112.773 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 m -122.03 131.34 53.94 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.561 0.696 . . . . 1.0 111.451 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.96 -36.23 83.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.835 -1.075 . . . . 1.0 110.82 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.9 tt0 -63.31 -42.19 98.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.146 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -57.99 -41.26 82.64 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.689 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.2 70.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.194 0.521 . . . . 1.0 110.089 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.445 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.5 -36.77 85.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.682 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -64.0 -28.07 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.64 -41.91 95.73 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.469 ' O ' HG11 ' A' ' 148' ' ' VAL . 62.3 mt -63.48 -45.68 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.837 -0.682 . . . . 1.0 110.466 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.63 -40.43 94.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.871 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.4 m -66.8 -33.73 76.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.817 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.527 HG23 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.69 -40.39 54.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.037 -0.665 . . . . 1.0 109.948 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -68.17 -11.8 59.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 111.153 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.39 -8.61 26.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.289 -0.868 . . . . 1.0 109.691 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -134.39 -39.14 0.83 Allowed 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 113.482 0.919 . . . . 1.0 113.482 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 148' ' ' VAL . . . -54.31 -49.18 91.92 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.837 0.68 . . . . 1.0 112.837 -177.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 53.7 Cg_endo -66.69 -7.06 17.01 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.32 1.347 . . . . 1.0 113.153 -177.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -122.44 -13.6 8.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.473 0.545 . . . . 1.0 112.473 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.27 135.21 44.43 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.748 0.785 . . . . 1.0 112.869 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -93.57 138.73 31.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.352 -1.295 . . . . 1.0 110.36 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.1 p -88.01 133.89 29.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 112.348 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.275 177.907 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.454 0.645 . . . . 1.0 112.319 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -133.47 98.92 4.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.392 -1.336 . . . . 1.0 107.392 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.4 170.23 3.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.75 -1.114 . . . . 1.0 108.694 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.448 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 47.7 p-80 -170.96 149.94 3.04 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.08 0.237 . . . . 1.0 110.497 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 54.9 m-85 -85.73 149.38 25.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.8 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -140.48 120.29 13.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' B' ' 218' ' ' TRP . 71.5 t -95.5 135.07 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.204 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -146.04 175.78 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 1.0 110.734 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 5.3 t -99.9 133.45 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 1.0 111.965 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.65 179.79 7.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.81 -1.086 . . . . 1.0 109.5 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.02 -17.96 64.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.95 0.405 . . . . 1.0 111.325 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.55 21.8 16.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.909 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 70.46 36.15 1.79 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 111.121 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -109.91 143.93 39.12 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.794 . . . . 1.0 111.185 -176.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.77 106.09 18.12 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.222 -1.354 . . . . 1.0 109.567 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -118.3 178.04 4.59 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.458 ' HB3' HG21 ' B' ' 208' ' ' VAL . 52.4 p-90 -147.8 167.33 25.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.459 0.647 . . . . 1.0 111.979 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -146.25 146.5 30.78 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.422 -1.263 . . . . 1.0 110.432 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.557 ' HG ' HD13 ' B' ' 228' ' ' LEU . 33.7 tp -105.53 130.69 53.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 174.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.06 132.96 66.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.919 -175.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.529 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.5 t-80 -82.93 173.76 11.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.292 -0.632 . . . . 1.0 109.292 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.87 -36.87 68.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.08 0.467 . . . . 1.0 110.698 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -63.2 -32.96 74.49 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.296 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.22 11.22 24.36 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 114.769 -1.105 . . . . 1.0 112.45 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.529 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.57 143.2 27.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.789 -0.206 . . . . 1.0 111.359 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . 0.434 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.37 116.39 22.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.53 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.557 HD13 ' HG ' ' B' ' 220' ' ' LEU . 17.0 mt -88.73 -42.8 11.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.019 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -149.52 168.31 23.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.054 -0.975 . . . . 1.0 111.625 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -141.67 156.3 45.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.09 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 66.0 p -54.37 -35.14 62.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.0 0.37 . . . . 1.0 112.0 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.74 -33.68 3.47 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.045 -0.598 . . . . 1.0 111.761 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -122.89 178.57 4.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 1.0 111.174 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -143.01 137.43 7.67 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.337 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -140.01 166.71 23.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.814 -0.439 . . . . 1.0 109.814 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.02 29.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.8 m -126.26 131.84 51.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.325 0.583 . . . . 1.0 111.347 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.17 -35.93 81.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.034 -0.985 . . . . 1.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.5 tt0 -57.86 -47.22 83.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.251 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -59.9 -40.43 88.76 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.124 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.52 74.57 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.587 0.708 . . . . 1.0 109.533 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.45 ' HA ' HD13 ' B' ' 245' ' ' ILE . 49.3 mtmt -64.38 -35.54 81.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.528 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.2 mm-40 -64.22 -31.24 72.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.79 -41.11 95.86 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.458 ' O ' HG11 ' B' ' 248' ' ' VAL . 65.6 mt -62.4 -43.86 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.064 -0.568 . . . . 1.0 110.278 177.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.9 -41.58 99.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.193 0.52 . . . . 1.0 110.141 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.7 m -64.38 -34.36 77.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.981 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.48 -41.33 49.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.968 -177.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -66.89 -11.86 57.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.035 0.445 . . . . 1.0 111.798 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -2.92 31.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.905 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -135.36 -42.74 0.7 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.77 0.656 . . . . 1.0 112.77 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.498 ' HB2' HG23 ' B' ' 248' ' ' VAL . . . -53.64 -48.34 93.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.1 Cg_endo -64.23 -10.6 24.18 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.036 1.158 . . . . 1.0 113.079 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.49 -22.12 7.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.373 0.508 . . . . 1.0 112.373 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -65.95 134.88 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.654 0.74 . . . . 1.0 112.736 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.47 142.08 29.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.423 -1.262 . . . . 1.0 110.691 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -89.13 134.18 29.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.8 mt -112.23 139.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.662 -1.154 . . . . 1.0 108.695 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.0 100.24 12.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.311 -0.852 . . . . 1.0 110.984 -177.783 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 . . . . . 0 CA--C 1.511 -0.538 0 CA-C-O 121.223 0.535 . . . . 1.0 111.905 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -123.34 95.11 4.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.76 174.86 2.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.03 -0.987 . . . . 1.0 108.979 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -170.29 147.88 3.15 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.573 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -86.15 150.18 24.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.258 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -141.46 121.46 13.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.413 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.427 HG23 ' HB3' ' A' ' 118' ' ' TRP . 85.3 t -93.67 133.87 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.068 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.77 178.49 7.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.633 0.254 . . . . 1.0 110.414 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -100.53 136.79 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.772 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 112' ' ' ALA . 11.6 t70 -83.03 -178.97 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.326 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.446 ' H ' ' CG ' ' A' ' 111' ' ' ASP . . . -69.31 -13.01 62.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.651 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.14 19.58 17.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.962 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 71.0 38.25 1.14 Allowed 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.275 -0.875 . . . . 1.0 111.182 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 3.1 mmtp -108.91 153.29 23.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.804 -1.089 . . . . 1.0 111.219 -175.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -95.01 118.14 31.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.232 -0.895 . . . . 1.0 109.666 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -133.59 -179.03 5.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.107 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.427 ' HB3' HG23 ' A' ' 108' ' ' VAL . 58.7 p-90 -151.31 162.1 41.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.884 0.373 . . . . 1.0 111.455 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.434 HH21 HG13 ' A' ' 127' ' ' ILE . 36.3 mmm-85 -144.37 139.91 28.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.725 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.55 ' HG ' HD13 ' A' ' 128' ' ' LEU . 33.4 tp -96.94 131.44 43.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 176.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.0 t -131.07 132.34 63.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.054 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.495 ' CB ' HD22 ' A' ' 126' ' ' ASN . 4.4 t-80 -78.31 172.9 12.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.95 -30.93 66.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.207 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -33.68 67.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.94 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.03 13.84 10.59 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.244 -0.889 . . . . 1.0 113.836 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.495 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -87.85 143.68 27.0 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.075 0.15 . . . . 1.0 110.717 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.434 HG13 HH21 ' A' ' 119' ' ' ARG . 44.6 mm -76.36 115.13 17.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.55 HD13 ' HG ' ' A' ' 120' ' ' LEU . 17.1 mt -88.4 -42.25 12.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.789 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.05 170.53 20.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.283 -0.871 . . . . 1.0 111.582 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.962 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -53.52 -36.43 61.77 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.416 0.447 . . . . 1.0 111.896 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.76 -43.54 3.25 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.529 -0.628 . . . . 1.0 111.529 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 89.2 mt-10 -108.88 179.93 4.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.293 -0.454 . . . . 1.0 110.826 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.86 134.54 4.51 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -142.88 170.94 14.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 117.077 0.439 . . . . 1.0 110.637 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.06 24.65 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 m -118.63 131.11 56.18 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.362 0.601 . . . . 1.0 111.478 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -65.87 -33.67 76.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.803 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.0 tt0 -61.33 -48.48 81.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.971 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -56.82 -40.49 76.13 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.982 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.18 -53.38 58.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.239 0.543 . . . . 1.0 110.217 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.436 ' HA ' HD13 ' A' ' 145' ' ' ILE . 41.7 mtmt -63.82 -36.72 84.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.238 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.8 mm-40 -63.79 -28.8 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 1.0 110.021 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.51 96.74 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.477 ' O ' HG13 ' A' ' 148' ' ' VAL . 40.4 mt -64.11 -44.6 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.208 0.528 . . . . 1.0 110.133 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -60.34 -43.99 95.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.401 . . . . 1.0 110.149 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.4 m -64.37 -33.82 76.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.724 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.489 HG21 ' HB1' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -74.43 -41.86 49.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.151 -0.62 . . . . 1.0 109.822 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -68.74 -11.57 60.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.085 0.469 . . . . 1.0 111.588 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -101.25 -3.14 29.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.928 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -138.07 -38.63 0.56 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.489 ' HB1' HG21 ' A' ' 148' ' ' VAL . . . -55.42 -49.92 89.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.57 -9.52 25.67 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 120.906 1.071 . . . . 1.0 112.95 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -109.8 -28.68 8.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.445 0.641 . . . . 1.0 110.927 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -62.08 135.8 57.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.873 -1.058 . . . . 1.0 113.671 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -96.59 140.65 30.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.064 -1.426 . . . . 1.0 110.716 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.58 133.11 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.352 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.3 mt . . . . . 0 N--CA 1.45 -0.473 0 CA-C-N 114.766 -1.106 . . . . 1.0 108.933 177.071 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.339 0.59 . . . . 1.0 111.512 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.45 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 32.4 mmtp -136.98 97.88 3.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.31 169.19 3.87 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.86 -1.064 . . . . 1.0 109.183 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 55.8 p-80 -171.34 149.1 2.7 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.517 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 61.8 m-85 -85.34 148.06 26.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.299 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -139.57 118.83 12.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.482 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' B' ' 218' ' ' TRP . 82.3 t -93.92 133.23 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.677 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -145.36 -178.4 6.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.648 0.261 . . . . 1.0 110.555 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.8 t -99.8 137.43 27.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.623 . . . . 1.0 112.238 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 17.9 t70 -83.07 179.78 7.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.565 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.437 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.31 -16.36 63.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.473 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.49 19.84 18.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.182 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 69.28 41.26 1.37 Allowed 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.857 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 3.2 mmtp -110.95 156.51 21.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.266 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -99.82 117.03 33.27 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.854 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 20.6 mtp-105 -132.42 179.11 6.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' B' ' 231' ' ' SER . 56.7 p-90 -151.72 163.66 38.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.079 0.466 . . . . 1.0 111.649 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -147.29 145.96 29.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.05 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.558 ' HG ' HD13 ' B' ' 228' ' ' LEU . 34.0 tp -96.28 131.85 42.36 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.19 133.79 62.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.738 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.559 ' CB ' HD22 ' B' ' 226' ' ' ASN . 5.5 t-80 -79.77 171.31 15.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 36.6 t70 -62.54 -22.18 66.12 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.152 0.501 . . . . 1.0 110.851 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.34 -33.21 67.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.521 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.85 11.26 19.4 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 114.791 -1.095 . . . . 1.0 112.86 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.559 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.27 142.92 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.655 0.264 . . . . 1.0 111.572 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.55 116.81 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.491 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.558 HD13 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -89.58 -42.53 11.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.734 . . . . 1.0 109.638 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.18 164.97 35.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.845 -1.071 . . . . 1.0 111.597 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -140.67 153.37 45.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.238 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.6 p -52.88 -36.9 59.87 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.03 -47.31 3.51 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -96.74 -172.86 2.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.265 -0.468 . . . . 1.0 111.25 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -159.05 133.86 3.55 Favored Glycine 0 N--CA 1.454 -0.16 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -145.07 169.85 17.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.93 0.365 . . . . 1.0 110.338 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.38 9.11 41.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.708 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 m -116.0 129.53 56.41 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.425 0.631 . . . . 1.0 110.928 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -66.97 -34.5 77.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.951 -1.022 . . . . 1.0 110.364 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.3 tt0 -61.12 -46.12 91.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.255 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.66 -40.55 83.82 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.788 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.11 70.62 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.482 0.658 . . . . 1.0 110.127 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.454 ' HA ' HD13 ' B' ' 245' ' ' ILE . 47.4 mtmt -64.6 -37.0 86.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.91 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -64.05 -29.58 70.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -64.97 -41.37 97.37 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.462 -1.055 . . . . 1.0 110.462 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.463 ' O ' HG13 ' B' ' 248' ' ' VAL . 56.8 mt -62.48 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 1.0 110.193 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -63.06 -40.11 96.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.3 m -65.62 -35.39 80.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.633 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.495 HG21 ' HB1' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -75.3 -39.96 42.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.069 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 63.8 mtpt -66.79 -12.51 59.14 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.987 0.365 . . . . 1.0 111.987 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -100.27 -12.12 19.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.843 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -120.97 -40.14 2.65 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.103 -0.499 . . . . 1.0 112.18 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.495 ' HB1' HG21 ' B' ' 248' ' ' VAL . . . -55.0 -48.94 94.78 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.5 Cg_endo -66.87 -11.69 33.09 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.276 1.317 . . . . 1.0 113.399 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -116.0 -16.76 11.05 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . . . . . . . . . . . -69.22 139.05 54.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.805 0.669 . . . . 1.0 112.805 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -94.88 147.41 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.666 -1.152 . . . . 1.0 111.99 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.443 HG21 HG21 ' A' ' 145' ' ' ILE . 40.9 t -84.39 130.45 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.438 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.2 mt -128.85 142.47 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.541 -0.541 . . . . 1.0 109.541 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.9 113.17 22.46 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.203 -0.903 . . . . 1.0 110.843 -177.838 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 CA--C 1.519 -0.246 0 CA-C-O 120.973 0.416 . . . . 1.0 109.942 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 38.7 mmtm -145.28 96.36 2.82 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 173.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.13 176.44 1.73 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.01 -0.996 . . . . 1.0 109.533 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.9 p-80 -170.23 145.42 2.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.439 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.1 m-85 -85.51 147.61 26.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.146 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.68 119.97 13.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.592 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 118' ' ' TRP . 86.1 t -95.21 132.27 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.164 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -143.14 178.08 7.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.1 t -97.82 134.18 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.215 0.531 . . . . 1.0 111.562 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 112' ' ' ALA . 13.2 t70 -79.22 -180.0 7.06 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 1.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.403 ' H ' ' CG ' ' A' ' 111' ' ' ASP . . . -68.51 -15.3 63.49 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.942 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.63 21.47 16.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.713 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 69.75 35.85 2.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.626 0.77 . . . . 1.0 111.506 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -110.84 149.55 30.42 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.881 -176.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -91.63 112.0 23.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.801 -1.09 . . . . 1.0 109.537 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.478 HH12 ' CG ' ' A' ' 130' ' ' ASP . 19.2 mtm105 -126.8 179.92 5.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.437 ' HB3' HG21 ' A' ' 108' ' ' VAL . 55.8 p-90 -152.1 162.11 41.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.187 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 42.6 mtp180 -148.23 143.66 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.146 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 128' ' ' LEU . 34.7 tp -93.62 134.39 35.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.3 131.02 71.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.896 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.545 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.9 t-80 -78.97 171.74 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 12.0 t70 -56.0 -33.59 65.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.003 0.43 . . . . 1.0 111.216 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -34.34 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.13 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.36 10.92 14.2 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.124 -0.944 . . . . 1.0 113.09 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.545 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.22 145.84 24.71 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.52 0.192 . . . . 1.0 111.52 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.5 123.55 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 123.778 0.674 . . . . 1.0 109.926 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.55 HD11 ' HG ' ' A' ' 120' ' ' LEU . 15.1 mt -98.07 -43.47 7.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.067 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.7 164.58 33.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.983 -1.008 . . . . 1.0 111.336 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 117' ' ' ARG . 6.8 t70 -139.7 152.82 46.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.246 -0.888 . . . . 1.0 108.86 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.7 p -56.32 -38.41 71.26 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.31 0.485 . . . . 1.0 112.31 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.43 -42.66 3.17 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -94.52 172.14 8.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.152 -0.524 . . . . 1.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.63 124.67 1.52 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -142.05 171.05 14.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.714 0.257 . . . . 1.0 110.742 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.43 10.24 20.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.265 0.839 . . . . 1.0 113.265 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 m -120.0 130.71 54.86 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.529 0.68 . . . . 1.0 111.636 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.52 -35.41 80.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.485 -1.234 . . . . 1.0 110.333 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.5 tt0 -62.02 -45.96 91.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.484 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -59.9 -39.15 84.4 Favored 'General case' 0 CA--C 1.521 -0.163 0 O-C-N 123.2 0.313 . . . . 1.0 110.883 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.48 69.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.604 0.716 . . . . 1.0 109.786 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.476 ' HA ' HD13 ' A' ' 145' ' ' ILE . 45.0 mtmt -64.91 -33.77 76.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.561 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -65.64 -32.36 73.88 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 1.0 110.03 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.5 -39.87 97.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.501 ' O ' HG11 ' A' ' 148' ' ' VAL . 67.4 mt -60.24 -51.49 72.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.529 0.681 . . . . 1.0 110.758 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.83 -33.03 75.04 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.5 m -66.03 -37.64 86.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.535 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.501 HG11 ' O ' ' A' ' 145' ' ' ILE . 1.1 p -74.42 -40.0 48.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 120.399 -0.521 . . . . 1.0 109.846 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.61 -15.77 61.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.958 0.408 . . . . 1.0 111.871 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -100.1 -2.48 34.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.916 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 11.8 m-80 -133.74 -37.08 0.93 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.903 -177.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 148' ' ' VAL . . . -55.85 -50.47 86.97 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.365 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.7 Cg_endo -64.44 -12.07 31.44 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 121.29 1.327 . . . . 1.0 113.419 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.13 -18.58 9.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.179 0.437 . . . . 1.0 112.179 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -66.03 135.71 55.04 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.484 0.659 . . . . 1.0 112.337 -177.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.78 132.39 34.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.585 -1.189 . . . . 1.0 110.919 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.41 130.79 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.462 0.648 . . . . 1.0 111.698 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.474 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . 0.419 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 21.1 p-10 . . . . . 0 CA--C 1.516 -0.362 0 CA-C-O 121.515 0.674 . . . . 1.0 112.323 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -138.92 96.32 3.1 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.093 -1.817 . . . . 1.0 106.093 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.81 175.69 2.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.638 -1.165 . . . . 1.0 108.612 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 52.5 p-80 -170.04 146.99 3.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.054 -0.259 . . . . 1.0 110.575 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 46.8 m-85 -87.11 146.69 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.479 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.65 121.4 13.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.856 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' B' ' 218' ' ' TRP . 96.3 t -94.27 133.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.767 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -144.48 -179.55 6.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.572 0.225 . . . . 1.0 110.582 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.7 t -96.14 133.48 37.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.138 -0.483 . . . . 1.0 112.232 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 41.4 t0 -81.74 178.34 8.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.928 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.421 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -70.37 -6.92 38.89 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.314 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.28 17.91 16.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.995 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 69.57 39.19 1.6 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.94 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 13.2 mmtt -111.04 156.88 20.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.121 -0.945 . . . . 1.0 111.217 -175.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.448 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 70.6 m-85 -98.74 102.53 14.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.799 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.504 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 14.9 mmm180 -121.5 179.82 4.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.416 ' HB3' HG21 ' B' ' 208' ' ' VAL . 51.5 p-90 -150.94 160.48 43.89 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.802 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -145.95 146.35 31.01 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.091 -0.959 . . . . 1.0 109.666 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.559 ' HG ' HD11 ' B' ' 228' ' ' LEU . 32.1 tp -95.78 132.63 40.81 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 t -127.41 130.12 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.354 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.478 ' CB ' HD22 ' B' ' 226' ' ' ASN . 1.9 t-80 -82.51 173.66 11.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.26 -36.34 63.51 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.38 0.425 . . . . 1.0 111.913 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -65.08 -31.12 72.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.22 0.533 . . . . 1.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.31 13.86 21.77 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.375 -0.829 . . . . 1.0 112.41 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.478 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.41 142.08 27.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 111.789 0.292 . . . . 1.0 111.789 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.53 121.73 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.882 0.739 . . . . 1.0 109.564 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.559 HD11 ' HG ' ' B' ' 220' ' ' LEU . 14.5 mt -96.92 -43.8 7.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.228 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -150.83 163.88 37.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.419 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.38 160.07 40.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.383 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.46 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 83.6 p -60.24 -40.71 91.22 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.52 -48.38 2.59 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.285 -0.483 . . . . 1.0 112.669 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -94.75 -169.78 2.09 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.231 0.612 . . . . 1.0 110.936 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.504 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -156.75 136.43 4.95 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.715 -0.755 . . . . 1.0 113.289 176.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -143.92 168.66 19.43 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.396 -0.594 . . . . 1.0 109.396 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.49 11.43 36.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -127.0 135.02 50.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.207 -0.597 . . . . 1.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.14 -39.6 93.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.148 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.0 tt0 -57.65 -45.72 85.15 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.287 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -60.94 -39.53 89.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.787 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.2 -49.7 76.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.472 0.653 . . . . 1.0 110.231 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.523 ' HA ' HD13 ' B' ' 245' ' ' ILE . 45.2 mtmt -64.81 -32.8 74.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.112 -0.949 . . . . 1.0 111.47 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.8 mm-40 -63.6 -33.02 74.69 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.588 -0.445 . . . . 1.0 109.916 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.78 95.31 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.523 HD13 ' HA ' ' B' ' 242' ' ' LYS . 75.9 mt -60.73 -52.36 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.664 0.745 . . . . 1.0 110.258 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.29 -33.97 77.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.264 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.4 m -67.61 -35.9 79.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.511 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.505 HG11 ' O ' ' B' ' 245' ' ' ILE . 0.8 OUTLIER -72.49 -40.47 63.53 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.373 -177.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.59 -15.45 61.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.121 -0.49 . . . . 1.0 112.187 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -103.35 -2.75 26.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.866 0.365 . . . . 1.0 111.3 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 28.6 m-80 -130.46 -38.37 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 111.452 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.474 ' HB3' HG23 ' B' ' 248' ' ' VAL . . . -55.86 -50.49 86.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.681 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.5 Cg_endo -63.24 -10.98 23.1 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.273 1.315 . . . . 1.0 113.663 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.11 -15.92 9.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.963 0.411 . . . . 1.0 111.938 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.22 138.65 57.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.68 0.752 . . . . 1.0 112.633 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -89.21 141.68 28.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.938 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.412 HG22 HG23 ' A' ' 145' ' ' ILE . 60.6 t -83.74 128.66 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.432 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 12.3 mt -121.71 138.14 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -91.74 100.87 13.5 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.303 -0.856 . . . . 1.0 111.675 -176.699 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 122.321 1.058 . . . . 1.0 113.579 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 28.8 mmtp -138.25 98.19 3.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.987 -1.915 . . . . 1.0 107.461 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.1 169.89 3.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.455 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.6 p-80 -168.22 150.34 5.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.233 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 63.7 m-85 -86.73 148.95 25.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.906 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.27 123.83 14.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.785 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 118' ' ' TRP . 91.1 t -94.75 134.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 O-C-N 123.585 0.553 . . . . 1.0 110.475 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -142.78 178.61 7.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.608 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -100.67 140.24 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.478 0.656 . . . . 1.0 112.689 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.83 177.87 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.416 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.57 -14.36 62.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.362 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.01 17.89 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.11 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 70.82 34.77 1.91 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.377 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -109.7 152.99 24.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.507 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.72 112.11 23.9 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.016 -0.993 . . . . 1.0 110.612 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -123.18 179.28 4.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 131' ' ' SER . 57.6 p-90 -153.02 168.47 25.74 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.366 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -150.76 152.28 33.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.508 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.557 ' HG ' HD13 ' A' ' 128' ' ' LEU . 32.9 tp -99.84 131.23 45.94 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -126.54 130.48 71.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.289 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.555 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.4 t-80 -79.67 172.35 13.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 32.2 t70 -57.22 -30.98 65.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 1.0 111.342 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.66 -33.37 74.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.504 0.669 . . . . 1.0 110.07 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.38 11.74 19.06 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 114.982 -1.008 . . . . 1.0 112.789 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.555 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.59 143.51 26.9 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.67 119.07 22.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.802 0.689 . . . . 1.0 109.744 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.557 HD13 ' HG ' ' A' ' 120' ' ' LEU . 15.0 mt -94.41 -43.31 8.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.63 0.729 . . . . 1.0 109.608 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.73 166.61 27.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.641 -1.163 . . . . 1.0 111.201 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -140.14 158.19 44.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 53.9 p -57.44 -35.23 69.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.448 . . . . 1.0 111.452 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.7 -48.62 3.54 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -102.87 171.8 7.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.374 -0.913 . . . . 1.0 111.648 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.04 139.06 9.29 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.236 -1.145 . . . . 1.0 110.236 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -141.53 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.175 0.488 . . . . 1.0 110.852 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.57 9.98 27.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -125.82 130.53 51.59 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.727 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.104 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.449 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 10.0 tt0 -59.41 -42.14 91.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.962 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.537 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.4 OUTLIER -62.62 -39.78 94.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.005 -179.053 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.33 87.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.962 0.411 . . . . 1.0 109.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.437 ' HZ1' ' CB ' ' A' ' 142' ' ' LYS . 7.3 mtmp? -63.86 -43.19 96.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.117 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 32.8 mm-40 -60.01 -27.05 66.56 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.69 -46.32 90.22 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 148' ' ' VAL . 61.1 mt -62.51 -48.82 86.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.946 0.879 . . . . 1.0 109.938 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.53 -40.04 90.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.287 -0.869 . . . . 1.0 110.857 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -69.93 -34.55 73.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.213 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -70.5 -39.13 75.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 C-N-CA 120.08 -0.648 . . . . 1.0 110.033 -176.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.79 -12.98 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.975 -0.453 . . . . 1.0 111.516 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -104.69 -3.1 24.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.656 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -129.87 -42.76 1.25 Allowed 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.305 -0.407 . . . . 1.0 112.068 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.524 ' HB3' HG21 ' A' ' 148' ' ' VAL . . . -55.06 -50.94 83.58 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.9 Cg_endo -64.48 -13.15 36.9 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.129 1.219 . . . . 1.0 112.952 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.2 -27.56 9.5 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.324 0.583 . . . . 1.0 111.23 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 134.83 55.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.071 -0.968 . . . . 1.0 113.207 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.25 141.02 31.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.982 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -86.99 135.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.679 . . . . 1.0 112.344 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 114.7 -1.136 . . . . 1.0 109.241 178.777 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.931 0.872 . . . . 1.0 112.805 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 22.7 mmtp -141.74 97.6 3.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.68 -1.6 . . . . 1.0 108.142 173.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.65 170.75 3.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.147 -0.933 . . . . 1.0 109.679 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.412 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 55.1 p-80 -170.01 147.79 3.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.0 m-85 -85.62 150.71 24.44 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.332 0.395 . . . . 1.0 110.383 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -143.09 124.3 14.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.862 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -95.08 133.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.937 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.8 -178.21 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.663 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -110.89 137.72 42.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.358 0.503 . . . . 1.0 112.358 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 25.4 t70 -83.25 -178.77 7.2 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.583 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.478 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.63 -17.92 64.2 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.954 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.85 25.62 11.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 62.07 38.96 13.57 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.859 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -97.44 155.53 16.88 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.453 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 73.4 m-85 -109.05 102.92 11.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.311 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.496 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -122.54 -178.56 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -176.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -151.29 162.83 40.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.768 0.318 . . . . 1.0 111.384 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -147.56 146.71 29.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.549 ' HG ' HD13 ' B' ' 228' ' ' LEU . 35.2 tp -93.86 132.68 38.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.92 129.88 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.66 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.538 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.4 t-80 -80.04 174.54 11.49 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 26.7 t70 -55.93 -34.34 65.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.018 0.437 . . . . 1.0 111.46 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.96 -33.65 76.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.646 0.736 . . . . 1.0 110.324 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.01 10.7 22.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.967 -1.015 . . . . 1.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.538 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.02 143.49 27.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.593 0.235 . . . . 1.0 111.626 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -76.29 119.81 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.665 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.549 HD13 ' HG ' ' B' ' 220' ' ' LEU . 15.5 mt -94.19 -44.14 8.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.987 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -147.79 160.78 42.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.711 -1.131 . . . . 1.0 111.02 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.07 158.83 43.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.468 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 71.7 p -57.63 -37.37 73.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.49 0.552 . . . . 1.0 112.49 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.51 -50.56 3.55 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 121.184 0.325 . . . . 1.0 112.691 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -89.86 -168.67 2.2 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.409 0.684 . . . . 1.0 110.863 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -158.98 134.4 3.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.55 -0.833 . . . . 1.0 113.4 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.46 173.73 11.37 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.56 12.31 35.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.2 m -131.03 135.69 47.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.934 -0.706 . . . . 1.0 111.842 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.84 -39.65 95.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.032 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.6 tt0 -56.52 -44.01 80.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.494 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.32 -39.22 86.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.72 87.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.491 ' HA ' HD11 ' B' ' 245' ' ' ILE . 6.9 mtmp? -64.98 -37.78 88.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.765 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.46 -41.2 77.99 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.475 -0.869 . . . . 1.0 111.006 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' B' ' 242' ' ' LYS . 72.6 mt -60.19 -48.59 87.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.9 0.857 . . . . 1.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.49 -35.95 82.14 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.756 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.9 m -67.07 -37.1 83.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.402 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.521 HG21 ' HB1' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -72.55 -41.66 63.63 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.593 -177.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.24 -13.63 60.66 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.125 -0.359 . . . . 1.0 111.585 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -103.73 -2.64 26.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.839 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -130.85 -40.46 1.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.993 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' B' ' 248' ' ' VAL . . . -55.34 -50.53 86.16 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.6 Cg_endo -64.92 -16.6 56.21 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.208 1.272 . . . . 1.0 112.905 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.69 -29.8 11.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.588 0.709 . . . . 1.0 111.146 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -63.92 141.05 58.91 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.201 1.186 . . . . 1.0 114.201 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -103.47 146.38 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.096 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.4 p -93.27 132.05 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -120.64 150.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.187 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -85.02 108.16 17.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.328 -177.715 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.165 0.507 . . . . 1.0 111.877 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 47.5 mmtm -134.49 95.98 3.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -176.39 179.19 1.23 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.107 -0.952 . . . . 1.0 109.085 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.426 ' HA ' ' HB2' ' B' ' 255' ' ' ALA . 24.7 p-80 -171.69 147.9 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.383 0.427 . . . . 1.0 110.066 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 59.1 m-85 -85.47 152.05 23.49 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.832 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -140.62 120.22 13.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 118' ' ' TRP . 99.0 t -97.6 134.67 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.516 0.51 . . . . 1.0 109.738 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.37 178.28 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 110.611 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -99.39 134.12 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.455 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.55 179.85 7.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.02 62.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.478 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.76 19.2 18.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 70.91 36.42 1.49 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.742 0.651 . . . . 1.0 110.739 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.1 mmtt -109.3 150.51 27.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.289 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.07 111.72 23.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.369 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 mtm105 -128.76 179.13 5.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.436 ' HB3' HG23 ' A' ' 108' ' ' VAL . 57.6 p-90 -150.63 166.5 30.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 1.0 111.977 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -146.82 149.24 32.93 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.868 -1.06 . . . . 1.0 110.213 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.559 ' HG ' HD11 ' A' ' 128' ' ' LEU . 34.1 tp -100.56 133.17 45.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.58 130.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.048 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.533 ' CB ' HD22 ' A' ' 126' ' ' ASN . 3.3 t-80 -76.47 170.45 16.36 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.1 t70 -60.55 -24.18 65.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.116 0.484 . . . . 1.0 110.663 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -34.3 69.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.783 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 8.97 17.34 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.036 -0.983 . . . . 1.0 113.386 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.533 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.62 143.36 26.87 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.1 0.408 . . . . 1.0 112.1 -179.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.6 mm -73.83 118.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.811 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.559 HD11 ' HG ' ' A' ' 120' ' ' LEU . 17.4 mt -94.13 -44.12 8.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.491 0.662 . . . . 1.0 109.818 -178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.56 165.1 34.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.285 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.6 154.4 47.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 20.7 p -51.86 -40.75 61.09 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.389 0.514 . . . . 1.0 112.389 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 -46.46 3.01 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -93.97 -178.84 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 1.0 110.597 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.74 127.63 2.14 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.253 -1.139 . . . . 1.0 110.253 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -139.8 173.23 11.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.311 0.556 . . . . 1.0 110.075 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.87 9.53 42.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.23 131.33 56.38 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.198 -0.601 . . . . 1.0 110.949 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.11 -38.4 90.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.819 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.4 tt0 -63.33 -42.81 99.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.149 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.489 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -58.07 -42.77 86.26 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.985 -177.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.11 75.24 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.17 0.509 . . . . 1.0 110.524 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HA ' HD13 ' A' ' 145' ' ' ILE . 45.2 mtmt -63.8 -35.22 79.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.736 -0.666 . . . . 1.0 111.165 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.0 mm-40 -65.09 -26.83 68.39 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.19 97.13 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.04 -1.224 . . . . 1.0 110.04 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 148' ' ' VAL . 55.8 mt -63.11 -45.15 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.194 0.521 . . . . 1.0 109.99 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.12 -38.28 88.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.093 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.8 m -65.3 -36.17 83.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.565 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.525 HG22 ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.88 -42.37 46.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.474 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.99 -15.32 62.91 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.287 0.477 . . . . 1.0 112.287 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -103.61 -2.04 27.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.536 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -131.87 -40.07 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.574 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.525 ' HB1' HG22 ' A' ' 148' ' ' VAL . . . -56.51 -50.41 87.9 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.89 -0.596 . . . . 1.0 112.606 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 33.7 Cg_endo -63.4 -12.8 32.43 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.096 1.198 . . . . 1.0 113.162 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.97 -26.26 8.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.999 0.428 . . . . 1.0 111.574 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' B' ' 205' ' ' HIS . . . -62.4 137.99 58.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.698 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -94.75 149.48 21.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.186 -1.37 . . . . 1.0 111.976 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.415 HG22 HG22 ' B' ' 245' ' ' ILE . 43.9 t -86.17 131.67 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.537 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--N 1.329 -0.324 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 176.108 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 121.266 0.555 . . . . 1.0 111.525 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -138.43 97.03 3.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.06 171.58 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.522 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' HIS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 52.9 p-80 -170.21 148.54 3.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.91 177.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.8 m-85 -87.05 148.82 25.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -141.72 122.38 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.788 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' B' ' 218' ' ' TRP . 97.7 t -96.6 133.96 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.623 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -145.15 -178.66 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.0 110.749 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.6 t -100.33 135.74 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.064 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 30.1 t0 -83.02 178.02 8.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.444 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' ALA . . . . . 0.406 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.56 -9.98 52.91 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.256 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.85 20.14 15.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.503 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 69.59 38.13 1.79 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.115 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.9 mmtt -108.16 151.67 25.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.539 -176.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' TYR . . . . . 0.43 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 81.9 m-85 -98.25 102.7 14.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.162 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' ARG . . . . . 0.504 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -120.26 179.37 4.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.365 0.415 . . . . 1.0 109.975 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' TRP . . . . . 0.466 ' HB3' HG21 ' B' ' 208' ' ' VAL . 56.0 p-90 -151.12 163.24 39.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.696 0.284 . . . . 1.0 111.62 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 36.3 mtp85 -148.25 145.0 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.99 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' LEU . . . . . 0.582 ' HG ' HD11 ' B' ' 228' ' ' LEU . 36.7 tp -97.62 135.01 40.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' HIS . . . . . 0.47 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.3 t-80 -84.78 177.23 8.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.645 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.01 -38.01 67.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.342 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -66.63 -33.12 74.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.572 0.701 . . . . 1.0 109.941 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 107.98 12.61 21.84 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.279 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.47 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.15 142.76 28.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.524 0.202 . . . . 1.0 111.334 179.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.5 mm -74.6 117.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' LEU . . . . . 0.582 HD11 ' HG ' ' B' ' 220' ' ' LEU . 21.3 mt -89.38 -43.16 11.1 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.076 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.63 159.51 44.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.533 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -134.66 155.49 50.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' SER . . . . . 0.488 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 79.5 p -55.79 -40.53 72.79 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.731 0.641 . . . . 1.0 112.731 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.68 -52.52 3.0 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.269 -0.491 . . . . 1.0 112.692 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.01 -169.31 2.52 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.347 0.659 . . . . 1.0 110.707 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.504 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -160.06 132.24 2.91 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.926 -0.654 . . . . 1.0 112.675 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.36 170.6 15.39 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 116.72 0.26 . . . . 1.0 110.423 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.73 10.48 38.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.673 0.99 . . . . 1.0 113.673 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.5 m -122.07 132.08 54.31 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.035 -0.666 . . . . 1.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.37 -35.82 82.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.372 -0.831 . . . . 1.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.1 tt0 -60.08 -47.23 86.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.739 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -61.52 -36.02 79.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.03 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.74 -49.87 75.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.406 0.622 . . . . 1.0 109.602 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' LYS . . . . . 0.46 ' HA ' HD13 ' B' ' 245' ' ' ILE . 45.2 mtmt -65.47 -35.85 82.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.925 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.5 mm-40 -63.51 -29.65 70.88 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.67 96.77 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' ILE . . . . . 0.475 ' O ' HG13 ' B' ' 248' ' ' VAL . 53.1 mt -63.13 -45.61 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.054 -0.573 . . . . 1.0 109.925 177.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.81 -39.07 90.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.183 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 m -66.39 -34.86 78.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.677 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' VAL . . . . . 0.506 HG22 ' HB1' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -74.95 -43.21 45.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 120.27 -0.572 . . . . 1.0 110.289 -177.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -66.08 -11.96 52.22 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.104 -0.373 . . . . 1.0 111.946 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -100.72 -3.25 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -135.9 -36.97 0.74 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.828 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 252' ' ' ALA . . . . . 0.506 ' HB1' HG22 ' B' ' 248' ' ' VAL . . . -54.52 -49.87 88.56 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.833 -0.622 . . . . 1.0 112.659 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 253' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.1 Cg_endo -63.81 -11.52 27.2 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.691 1.594 . . . . 1.0 113.8 -177.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.93 -14.48 8.46 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 255' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 105' ' ' HIS . . . -68.04 137.16 54.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.444 0.64 . . . . 1.0 112.266 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -93.81 147.85 22.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.864 -1.062 . . . . 1.0 111.942 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 145' ' ' ILE . 40.8 t -84.61 132.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.281 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.1 134.22 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -87.13 100.48 12.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.466 -0.778 . . . . 1.0 110.97 -177.294 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.835 0.35 . . . . 1.0 110.566 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -123.88 174.33 7.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.216 0.531 . . . . 1.0 110.915 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 33.5 mmtp -140.13 98.31 3.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.65 172.33 3.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.627 -0.715 . . . . 1.0 109.904 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.478 ' HA ' ' HB2' ' B' ' 255' ' ' ALA . 52.3 p-80 -169.48 146.5 3.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.01 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.2 m-85 -85.0 145.57 27.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.592 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.98 124.26 20.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.346 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 118' ' ' TRP . 62.6 t -96.48 133.78 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.449 -0.342 . . . . 1.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -142.95 179.72 6.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.027 0.205 . . . . 1.0 110.776 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.6 t -101.75 138.05 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.426 0.632 . . . . 1.0 112.485 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.71 178.15 8.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.379 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.51 -15.32 63.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 1.0 111.209 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.77 19.21 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.593 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 71.27 36.12 1.42 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.93 0.769 . . . . 1.0 110.927 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 10.5 mmtt -110.88 150.53 29.04 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.261 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -93.95 119.28 32.63 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.915 -1.038 . . . . 1.0 110.499 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -132.05 -179.95 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.418 ' HB3' HG21 ' A' ' 108' ' ' VAL . 51.2 p-90 -152.84 162.48 41.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.354 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -146.54 143.25 28.77 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.171 0.919 . . . . 1.0 109.882 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.568 ' HG ' HD11 ' A' ' 128' ' ' LEU . 33.1 tp -95.08 130.57 41.73 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.79 131.61 70.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.266 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.584 ' CB ' HD22 ' A' ' 126' ' ' ASN . 5.2 t-80 -81.4 172.93 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 23.8 t70 -58.5 -27.46 64.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.27 0.557 . . . . 1.0 110.873 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.62 -32.85 70.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.772 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.88 12.76 21.71 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.9 -1.045 . . . . 1.0 112.626 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.584 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.42 146.98 24.29 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.423 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 51.1 mm -79.42 114.53 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.568 HD11 ' HG ' ' A' ' 120' ' ' LEU . 15.6 mt -87.94 -43.24 11.91 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.415 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.27 162.98 40.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.952 -1.022 . . . . 1.0 111.051 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -135.94 155.41 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.047 -1.094 . . . . 1.0 108.047 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 133' ' ' GLU . 53.3 p -55.88 -38.74 70.55 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.332 0.395 . . . . 1.0 111.968 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.19 -33.96 2.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 131' ' ' SER . 47.2 mt-10 -87.97 -178.68 6.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.934 -0.633 . . . . 1.0 111.118 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.65 114.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.094 -1.203 . . . . 1.0 110.094 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.49 169.68 17.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.616 0.208 . . . . 1.0 110.45 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.54 10.03 14.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.9 m -122.41 131.33 53.83 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.631 0.729 . . . . 1.0 112.234 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -67.39 -32.25 73.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.527 -1.215 . . . . 1.0 109.734 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.7 tt0 -60.93 -46.79 89.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.229 -0.896 . . . . 1.0 109.915 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.29 -38.74 80.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.462 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.245 0.545 . . . . 1.0 109.918 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.498 ' HA ' HD11 ' A' ' 145' ' ' ILE . 45.8 mtmt -64.82 -33.36 75.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -64.86 -32.29 73.92 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.444 -0.502 . . . . 1.0 109.974 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -40.84 94.41 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.732 -0.747 . . . . 1.0 111.257 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' A' ' 142' ' ' LYS . 71.9 mt -59.83 -51.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 1.0 110.613 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.19 -35.66 81.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.806 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.5 m -66.74 -34.99 79.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.003 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.71 -35.17 43.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.712 -177.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -68.92 -15.44 63.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.742 0.782 . . . . 1.0 110.238 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -99.39 -2.72 35.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.431 -1.259 . . . . 1.0 112.591 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -136.91 -39.12 0.62 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.944 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB3' HG23 ' A' ' 148' ' ' VAL . . . -57.16 -51.6 80.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.403 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 55.7 Cg_endo -66.41 -7.77 18.68 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.243 1.296 . . . . 1.0 113.229 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -116.56 -24.62 7.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.056 0.455 . . . . 1.0 111.644 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.05 136.88 57.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.946 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -92.07 137.84 32.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 1.0 110.724 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -88.99 131.51 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.378 0.609 . . . . 1.0 112.587 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.4 mt -114.29 137.95 45.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.832 -1.076 . . . . 1.0 108.46 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -91.54 101.56 14.21 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.539 -0.744 . . . . 1.0 110.866 -177.829 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.87 0.367 . . . . 1.0 110.538 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -92.87 172.21 8.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.449 0.642 . . . . 1.0 111.163 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.475 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 72.8 mmtt -136.89 97.39 3.51 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.906 -1.516 . . . . 1.0 106.906 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.96 174.23 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.614 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.464 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 41.0 p-80 -170.95 148.16 2.77 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.273 0.358 . . . . 1.0 110.519 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.524 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 50.2 m-85 -85.61 149.56 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.734 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -141.99 118.39 10.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.721 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' B' ' 218' ' ' TRP . 75.9 t -93.48 132.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -143.16 -177.88 5.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.3 t -102.64 137.46 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 1.0 112.284 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.32 179.4 6.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.552 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.33 -14.61 62.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.049 0.452 . . . . 1.0 110.575 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.12 15.88 24.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.503 -0.772 . . . . 1.0 111.758 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 70.42 41.71 0.97 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.482 0.713 . . . . 1.0 110.611 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 9.2 mmtt -115.13 152.03 33.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.71 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.97 118.76 31.07 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.391 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -134.68 179.37 6.34 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.119 -0.946 . . . . 1.0 109.046 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.446 ' HB3' HG22 ' B' ' 208' ' ' VAL . 50.6 p-90 -154.28 161.46 41.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.516 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -147.31 142.85 27.59 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.885 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.552 ' HG ' HD11 ' B' ' 228' ' ' LEU . 33.8 tp -94.16 131.98 39.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 t -128.68 131.43 68.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.268 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.536 ' CB ' HD22 ' B' ' 226' ' ' ASN . 9.5 t-80 -78.01 170.7 16.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 20.8 t70 -57.19 -27.7 62.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.373 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.81 -33.77 62.27 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.19 13.33 10.93 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 114.999 -1.0 . . . . 1.0 113.459 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.536 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.2 OUTLIER -87.96 144.57 26.47 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.904 -0.174 . . . . 1.0 111.256 178.514 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.36 123.36 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.815 0.697 . . . . 1.0 109.262 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.552 HD11 ' HG ' ' B' ' 220' ' ' LEU . 14.0 mt -99.35 -42.11 7.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.322 0.582 . . . . 1.0 109.796 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -153.01 164.3 38.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.895 -1.048 . . . . 1.0 111.625 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -139.61 153.49 47.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 1.0 108.897 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.403 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 11.9 p -51.58 -35.43 41.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.49 -46.6 3.51 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.119 -0.792 . . . . 1.0 111.119 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . 0.423 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.7 mt-10 -107.43 173.99 6.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.955 -0.623 . . . . 1.0 111.73 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -133.65 145.62 17.65 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.965 -1.254 . . . . 1.0 109.965 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -142.48 171.95 13.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.359 0.579 . . . . 1.0 110.788 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.69 10.28 41.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.306 0.484 . . . . 1.0 112.306 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 9.5 m -136.69 134.8 37.61 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.357 0.598 . . . . 1.0 111.484 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -63.98 -35.41 80.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.433 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.3 tt0 -57.74 -48.32 79.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.607 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -61.88 -38.14 87.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.351 0.407 . . . . 1.0 110.847 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.46 -49.56 76.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 1.0 109.698 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' B' ' 245' ' ' ILE . 43.9 mtmt -64.8 -33.81 76.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.369 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.9 mm-40 -63.42 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.32 -0.552 . . . . 1.0 109.744 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.26 89.44 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' B' ' 242' ' ' LYS . 73.9 mt -60.88 -50.5 80.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.697 0.76 . . . . 1.0 110.374 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.36 -33.83 76.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.652 -0.704 . . . . 1.0 111.23 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 m -65.05 -38.69 91.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.175 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' B' ' 252' ' ' ALA . 1.1 p -73.92 -40.61 52.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.094 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.09 -15.25 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.177 0.513 . . . . 1.0 111.907 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -101.31 -1.47 33.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.825 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -135.82 -37.39 0.74 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.84 0.352 . . . . 1.0 111.942 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.509 ' HB2' HG23 ' B' ' 248' ' ' VAL . . . -55.47 -50.67 85.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 112.898 0.703 . . . . 1.0 112.898 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.6 Cg_endo -65.46 -10.4 26.07 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 120.764 0.976 . . . . 1.0 113.503 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.07 -20.39 8.71 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 105' ' ' HIS . . . -66.02 135.34 54.53 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.86 -0.609 . . . . 1.0 112.27 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.89 139.52 30.67 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.764 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -91.7 128.31 43.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . 0.421 HD13 ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -124.4 146.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.283 -1.326 . . . . 1.0 110.174 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -91.26 114.66 27.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.926 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.077 -0.963 . . . . 1.0 111.19 -178.123 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.014 0.435 . . . . 1.0 109.925 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -116.6 176.24 5.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.253 0.549 . . . . 1.0 111.5 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -136.98 97.7 3.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.055 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.44 171.14 3.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.076 -0.965 . . . . 1.0 109.504 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.437 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 44.2 p-80 -169.22 148.32 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -85.32 147.74 26.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.388 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.59 116.92 11.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 118' ' ' TRP . 97.0 t -92.47 133.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.579 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -142.71 179.25 7.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 1.0 110.707 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.3 t -103.36 134.41 44.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.939 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.7 -179.95 7.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.762 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.09 -12.97 62.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.776 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -115.24 26.88 9.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.257 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 65.58 30.48 10.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.404 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 71.9 mmtt -95.66 156.24 16.41 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.9 117.2 33.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.3 mtm105 -132.91 178.0 7.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.437 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.9 p-90 -150.53 163.27 38.86 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.931 0.396 . . . . 1.0 111.417 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.7 mtp180 -147.73 143.37 27.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.826 -1.079 . . . . 1.0 109.304 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.59 ' HG ' HD13 ' A' ' 128' ' ' LEU . 34.7 tp -91.61 131.66 36.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.6 t -128.29 130.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.43 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.569 ' CB ' HD22 ' A' ' 126' ' ' ASN . 1.9 t-80 -79.08 170.95 15.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -55.73 -31.8 62.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.884 0.373 . . . . 1.0 111.187 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.3 -34.16 77.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.478 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.41 9.36 19.73 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.907 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.569 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.47 142.74 27.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.0 mm -77.09 118.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.634 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.59 HD13 ' HG ' ' A' ' 120' ' ' LEU . 15.2 mt -92.19 -42.42 9.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.217 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.0 164.77 36.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.654 -1.157 . . . . 1.0 111.255 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -137.32 154.02 50.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.844 . . . . 1.0 108.862 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 p -53.32 -35.01 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 1.0 112.343 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.0 -42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.566 -0.614 . . . . 1.0 111.566 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -102.79 -177.52 3.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.204 0.526 . . . . 1.0 111.556 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.9 126.31 1.8 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.4 173.1 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.136 0.468 . . . . 1.0 111.121 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.99 9.79 31.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.585 0.957 . . . . 1.0 113.585 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -122.64 130.55 53.1 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.427 0.632 . . . . 1.0 111.341 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.84 -38.31 88.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.5 tt0 -61.42 -41.39 97.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.081 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -60.06 -42.75 95.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.897 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.94 81.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.259 0.552 . . . . 1.0 110.196 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.443 ' HA ' HD11 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.24 -33.8 76.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.388 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -65.22 -31.45 72.62 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.921 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.98 -38.85 95.97 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.461 HG23 HG22 ' B' ' 257' ' ' VAL . 64.5 mt -61.28 -51.06 77.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.365 0.602 . . . . 1.0 110.304 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -63.41 -32.89 74.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.989 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -64.2 -39.68 94.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.336 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.549 HG23 ' HB1' ' A' ' 152' ' ' ALA . 1.6 p -75.04 -38.28 42.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 C-N-CA 119.906 -0.718 . . . . 1.0 109.887 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -64.6 -13.83 55.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.145 0.498 . . . . 1.0 111.211 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -4.58 40.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.721 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.412 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 22.1 m-80 -137.03 -37.93 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.757 0.651 . . . . 1.0 112.757 -174.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.549 ' HB1' HG23 ' A' ' 148' ' ' VAL . . . -53.69 -50.01 85.82 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.1 Cg_endo -65.88 -14.12 43.09 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 120.882 1.055 . . . . 1.0 113.633 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.48 -27.46 8.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -61.32 135.51 57.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.555 0.946 . . . . 1.0 113.555 -176.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -90.98 139.21 30.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.06 -1.427 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.22 133.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.214 0.531 . . . . 1.0 111.983 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt -124.57 146.61 29.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.356 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -88.78 107.78 19.15 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.266 -0.873 . . . . 1.0 111.063 -177.623 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.668 0.27 . . . . 1.0 110.653 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 12.8 p-10 -107.45 178.98 4.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.848 0.832 . . . . 1.0 112.622 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -143.74 98.94 3.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.899 -1.5 . . . . 1.0 107.447 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.33 173.58 2.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.789 -1.096 . . . . 1.0 109.223 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.468 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 54.1 p-80 -169.5 148.78 3.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 49.5 m-85 -85.42 145.41 27.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.143 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -139.0 120.73 15.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.511 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.431 HG21 ' HG2' ' B' ' 242' ' ' LYS . 72.4 t -92.48 132.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.889 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -140.39 -176.02 4.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.078 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.8 t -107.33 139.69 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 1.0 112.579 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -81.85 -179.75 7.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.144 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.9 0.381 . . . . 1.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.24 24.05 13.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.17 41.36 8.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.344 0.592 . . . . 1.0 111.09 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.4 mmtt -103.61 155.82 18.26 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.447 -0.797 . . . . 1.0 108.901 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.49 123.01 41.19 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.043 0.449 . . . . 1.0 110.308 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -137.51 -178.83 5.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.058 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.411 ' HB3' HG23 ' B' ' 208' ' ' VAL . 58.2 p-90 -155.37 162.59 40.77 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.413 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' B' ' 219' ' ' ARG . 13.5 mtp180 -146.63 146.78 30.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.041 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.579 ' HG ' HD13 ' B' ' 228' ' ' LEU . 32.9 tp -97.03 130.2 44.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.73 130.18 71.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.444 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.497 ' CB ' HD22 ' B' ' 226' ' ' ASN . 1.9 t-80 -81.37 175.3 10.68 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.75 -35.56 63.88 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.347 0.404 . . . . 1.0 111.859 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -67.91 -33.26 74.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.285 0.564 . . . . 1.0 110.298 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.49 10.93 20.84 Favored Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 114.894 -1.048 . . . . 1.0 112.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.497 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.11 143.25 28.14 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 1.0 112.057 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.78 120.35 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.263 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.579 HD13 ' HG ' ' B' ' 220' ' ' LEU . 13.3 mt -97.39 -42.61 7.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.519 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -153.7 165.42 36.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.363 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.69 159.72 41.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 57.4 p -55.75 -33.81 64.64 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.151 0.5 . . . . 1.0 111.427 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.63 -51.19 3.58 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -100.99 177.79 4.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.979 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.95 139.5 9.67 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -137.49 172.46 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.544 0.672 . . . . 1.0 111.489 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.15 10.9 36.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.0 113.129 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 7.0 m -136.7 135.93 38.58 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.079 0.466 . . . . 1.0 110.926 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -64.53 -38.18 90.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.6 tt0 -57.24 -45.14 84.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.838 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -62.78 -40.75 98.29 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.906 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.63 79.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.558 0.694 . . . . 1.0 109.772 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.435 ' HA ' HD11 ' B' ' 245' ' ' ILE . 44.0 mtmt -65.02 -35.36 80.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.532 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.0 mm-40 -63.37 -28.02 69.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 176.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.75 -42.08 95.42 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.451 ' O ' HG11 ' B' ' 248' ' ' VAL . 62.1 mt -61.83 -44.93 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.931 -0.634 . . . . 1.0 110.021 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.06 -39.74 93.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.208 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -67.68 -34.08 76.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.957 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.511 HG23 ' HB1' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.59 -39.27 53.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.03 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -68.43 -12.25 60.9 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.306 0.574 . . . . 1.0 111.078 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -101.22 -3.12 29.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 1.0 111.09 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -136.42 -40.09 0.65 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.511 ' HB1' HG23 ' B' ' 248' ' ' VAL . . . -55.35 -49.67 91.12 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 46.7 Cg_endo -66.48 -9.12 22.96 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 120.916 1.077 . . . . 1.0 113.456 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.61 -13.91 8.27 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -69.27 137.74 53.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.464 0.649 . . . . 1.0 112.13 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -91.14 144.01 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.997 -1.001 . . . . 1.0 111.495 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.461 HG22 HG23 ' A' ' 145' ' ' ILE . 43.7 t -85.76 123.49 39.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.226 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.7 mt -115.53 138.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -89.65 100.51 13.3 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.492 -0.766 . . . . 1.0 110.965 -176.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -90.64 168.21 11.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.42 0.629 . . . . 1.0 111.806 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 35.2 mmtp -142.37 96.39 2.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.24 174.67 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.164 -177.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.487 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 53.3 p-80 -168.94 147.3 3.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.694 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 47.1 m-85 -85.04 148.82 25.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.71 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.06 120.44 13.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.766 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 118' ' ' TRP . 83.6 t -94.76 137.95 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.937 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.39 -178.63 6.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.437 -0.208 . . . . 1.0 110.437 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 8.2 t -103.98 136.75 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.186 0.517 . . . . 1.0 112.363 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.24 -179.68 7.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.086 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.48 -15.19 63.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.075 0.398 . . . . 1.0 112.075 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.81 22.59 15.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.677 0.275 . . . . 1.0 111.396 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.87 40.3 1.32 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.695 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 2.5 mmtp -111.79 149.88 31.1 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.286 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -94.19 120.67 34.78 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.62 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -133.91 -179.4 5.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.818 -1.083 . . . . 1.0 108.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.445 ' HB3' HG23 ' A' ' 108' ' ' VAL . 56.5 p-90 -153.25 162.94 40.75 Favored 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 120.55 -0.46 . . . . 1.0 111.428 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.488 HH21 HG13 ' A' ' 127' ' ' ILE . 41.9 mtp180 -148.23 141.17 24.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.397 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.573 ' HG ' HD13 ' A' ' 128' ' ' LEU . 36.0 tp -90.97 135.15 33.93 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.09 130.25 69.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.084 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.539 ' CB ' HD22 ' A' ' 126' ' ' ASN . 3.5 t-80 -77.49 171.84 14.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.6 t70 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.247 0.546 . . . . 1.0 110.356 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -33.57 75.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.169 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.89 8.18 24.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.289 -0.869 . . . . 1.0 112.884 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.539 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.83 145.26 26.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.715 0.265 . . . . 1.0 111.715 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.488 HG13 HH21 ' A' ' 119' ' ' ARG . 51.0 mm -76.81 119.74 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.809 0.693 . . . . 1.0 110.017 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.573 HD13 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -94.86 -43.75 8.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.104 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.01 168.91 21.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.663 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -143.83 155.86 44.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.272 -0.876 . . . . 1.0 108.671 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.3 p -58.16 -32.96 68.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.189 0.519 . . . . 1.0 111.191 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.89 -47.24 3.52 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -109.25 170.66 7.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.734 -0.733 . . . . 1.0 111.549 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.34 16.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.267 -0.878 . . . . 1.0 110.934 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -141.46 165.92 26.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.848 0.324 . . . . 1.0 110.45 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.43 10.27 30.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 p -127.38 129.23 47.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.453 0.644 . . . . 1.0 112.188 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -66.84 -37.05 83.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.456 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.415 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 10.0 tt0 -58.81 -43.17 90.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.135 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tppt? -60.07 -41.89 93.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.785 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.16 -50.29 69.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.293 0.568 . . . . 1.0 109.906 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.488 ' HA ' HD13 ' A' ' 145' ' ' ILE . 49.1 mtmt -65.45 -33.08 75.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.563 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.3 mm-40 -66.73 -31.02 71.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.128 176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.66 -38.26 93.08 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.488 HD13 ' HA ' ' A' ' 142' ' ' LYS . 71.7 mt -61.47 -50.32 80.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.307 0.575 . . . . 1.0 110.652 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -62.8 -33.79 75.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.181 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 52.5 m -65.28 -37.45 87.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.753 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -74.49 -33.88 34.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 120.411 -0.516 . . . . 1.0 109.866 -177.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -69.35 -13.21 62.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.657 0.741 . . . . 1.0 110.634 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -101.21 -2.92 30.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.764 -1.107 . . . . 1.0 112.325 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.19 -39.5 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.745 0.307 . . . . 1.0 111.737 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.491 ' HB2' HG23 ' A' ' 148' ' ' VAL . . . -57.13 -51.32 82.57 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 32.0 Cg_endo -60.71 -12.26 20.86 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.364 1.376 . . . . 1.0 113.515 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -123.79 -7.46 7.9 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -73.48 134.3 43.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.704 0.764 . . . . 1.0 112.23 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.03 135.82 33.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.621 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -88.05 134.13 28.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.445 0.641 . . . . 1.0 112.124 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.05 143.91 28.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.711 -1.131 . . . . 1.0 109.327 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.18 105.15 17.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.61 -0.709 . . . . 1.0 110.514 -178.371 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 14.4 ptm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 111.475 0.176 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -128.35 171.92 11.57 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.838 0.828 . . . . 1.0 112.592 -176.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 23.6 mmtp -140.14 97.26 3.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.926 -1.488 . . . . 1.0 107.699 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.63 172.2 3.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.899 . . . . 1.0 109.831 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 45.3 p-80 -169.22 148.09 3.89 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.781 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 53.2 m-85 -85.35 148.55 25.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.921 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -140.33 117.01 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.43 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.8 t -92.95 129.79 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.91 -0.586 . . . . 1.0 109.662 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -141.34 -179.19 5.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.788 0.328 . . . . 1.0 110.589 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.9 t -102.23 136.34 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 1.0 112.149 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 16.0 t70 -78.72 179.92 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.013 -0.994 . . . . 1.0 109.752 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.417 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -67.9 -18.01 64.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.238 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.54 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.236 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 63.53 39.37 9.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.431 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 31.7 mmtp -103.48 156.34 17.84 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.71 118.5 34.39 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -134.29 179.57 6.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.308 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.404 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.1 p-90 -154.0 161.37 42.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.945 0.402 . . . . 1.0 111.172 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 38.0 mtp180 -147.07 141.11 26.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.047 -0.979 . . . . 1.0 109.89 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.566 ' HG ' HD13 ' B' ' 228' ' ' LEU . 31.9 tp -91.39 131.1 37.1 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.01 130.93 71.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.174 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.504 ' CB ' HD22 ' B' ' 226' ' ' ASN . 6.3 t-80 -77.16 173.19 12.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.551 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.0 t70 -56.56 -34.39 67.05 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.368 0.418 . . . . 1.0 111.063 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . 0.406 ' HB2' ' OD1' ' B' ' 226' ' ' ASN . 1.4 m-20 -68.65 -34.62 76.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.019 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.79 13.93 9.87 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.378 -0.828 . . . . 1.0 113.514 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.504 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.2 OUTLIER -87.63 147.33 25.32 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.98 -0.129 . . . . 1.0 111.112 178.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.53 119.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.588 0.555 . . . . 1.0 110.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.566 HD13 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -93.69 -43.35 8.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.555 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.42 165.07 35.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.297 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.0 157.16 46.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.053 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 12.9 p -54.67 -32.99 60.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.8 -43.77 3.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.87 170.02 8.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.17 0.51 . . . . 1.0 111.553 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -122.87 124.78 5.77 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.338 -1.505 . . . . 1.0 109.338 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -110.8 172.45 6.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.993 0.396 . . . . 1.0 111.372 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -105.54 10.85 32.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.874 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 3.3 p -143.94 130.88 20.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.629 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.03 -44.41 97.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.087 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.2 tt0 -54.04 -40.49 67.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.261 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.559 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.3 OUTLIER -61.62 -42.8 99.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.323 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.29 92.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.305 0.574 . . . . 1.0 109.817 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.439 ' HA ' HD13 ' B' ' 245' ' ' ILE . 46.3 mtmt -64.04 -35.52 80.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.13 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.2 mm-40 -65.4 -31.39 72.47 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.045 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.48 94.7 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.511 -0.852 . . . . 1.0 110.979 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.501 ' O ' HG12 ' B' ' 248' ' ' VAL . 70.6 mt -61.16 -52.3 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.365 0.602 . . . . 1.0 110.606 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -63.35 -34.85 78.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.646 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.7 m -66.15 -35.85 81.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.754 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.501 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.5 OUTLIER -73.33 -41.06 57.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -65.06 -13.48 58.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.801 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -102.74 -2.92 27.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.261 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 17.8 m-80 -137.01 -38.31 0.63 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.223 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' B' ' 248' ' ' VAL . . . -55.58 -50.77 85.06 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.696 0.628 . . . . 1.0 112.696 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.9 Cg_endo -63.92 -10.65 23.61 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.037 1.158 . . . . 1.0 113.266 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.99 -17.04 11.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.978 0.418 . . . . 1.0 111.464 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -69.73 136.92 51.54 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.18 0.807 . . . . 1.0 113.18 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -90.25 137.58 32.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.966 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -88.72 132.27 34.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.253 0.549 . . . . 1.0 112.416 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -121.58 142.72 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.526 -1.215 . . . . 1.0 108.407 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -93.51 106.9 18.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.825 -176.633 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 54.7 ttp . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.869 0.366 . . . . 1.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -137.87 -174.17 3.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.108 0.956 . . . . 1.0 113.081 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 72.3 mmtt -135.02 97.61 3.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.387 -1.733 . . . . 1.0 107.183 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.49 170.81 3.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -170.75 150.78 3.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.413 -0.217 . . . . 1.0 110.413 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.403 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 69.7 m-85 -88.57 150.85 22.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.267 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -143.19 123.35 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.717 . . . . 1.0 110.636 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.7 t -96.96 134.06 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.909 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -146.32 -177.55 5.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 1.0 110.869 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -96.82 138.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.362 0.601 . . . . 1.0 112.552 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 112' ' ' ALA . 22.8 t70 -82.12 179.67 7.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.772 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.455 ' H ' ' CG ' ' A' ' 111' ' ' ASP . . . -70.08 -13.61 62.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.289 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.82 26.33 10.44 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.871 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 59.54 43.61 15.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.402 0.62 . . . . 1.0 111.004 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.8 mmtp -101.72 178.32 4.66 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -118.57 103.37 9.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.517 ' CD ' ' HA2' ' A' ' 134' ' ' GLY . 12.7 mmm180 -122.28 178.63 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.46 ' HB3' HG22 ' A' ' 108' ' ' VAL . 60.2 p-90 -151.6 163.81 38.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.735 0.302 . . . . 1.0 111.355 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -148.4 149.64 32.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.658 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' HD13 ' A' ' 128' ' ' LEU . 33.7 tp -96.94 133.29 41.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 177.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -131.31 131.43 63.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.141 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.598 ' CB ' HD22 ' A' ' 126' ' ' ASN . 4.1 t-80 -76.89 168.2 20.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.413 -1.329 . . . . 1.0 107.413 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 22.8 t70 -61.36 -22.39 64.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.852 0.358 . . . . 1.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -35.04 72.12 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.511 0.672 . . . . 1.0 109.513 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.9 11.39 11.17 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 114.8 -1.091 . . . . 1.0 113.199 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.598 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -91.01 143.93 26.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.718 -0.283 . . . . 1.0 111.673 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.32 126.58 36.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 O-C-N 123.96 0.787 . . . . 1.0 110.133 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.558 HD13 ' HG ' ' A' ' 120' ' ' LEU . 13.4 mt -105.12 -39.62 6.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 1.0 110.071 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.03 166.81 31.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.775 -1.102 . . . . 1.0 111.277 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -139.6 156.0 47.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.341 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.494 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 83.1 p -56.64 -42.74 79.39 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.99 -41.88 3.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.903 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.511 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 35.7 mt-10 -83.95 -168.48 2.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.118 0.485 . . . . 1.0 110.17 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.517 ' HA2' ' CD ' ' A' ' 117' ' ' ARG . . . -168.65 119.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 1.0 111.706 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -141.3 169.01 18.42 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.76 35.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -116.62 131.85 56.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.409 0.624 . . . . 1.0 111.456 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -65.12 -36.11 83.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.792 -1.095 . . . . 1.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.8 tt0 -61.24 -45.59 93.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.394 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.6 -38.14 80.44 Favored 'General case' 0 CA--C 1.52 -0.176 0 O-C-N 123.208 0.317 . . . . 1.0 110.638 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.59 -52.33 65.85 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.538 0.685 . . . . 1.0 109.649 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -64.12 -36.23 83.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.623 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.5 mm-40 -65.47 -27.03 68.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -41.75 94.05 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 148' ' ' VAL . 47.8 mt -63.4 -40.96 91.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.186 -0.507 . . . . 1.0 110.162 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.76 -43.01 99.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.073 0.463 . . . . 1.0 110.075 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 m -63.27 -35.58 80.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.641 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.537 HG21 ' HB1' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -74.63 -42.55 48.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 119.832 -0.747 . . . . 1.0 110.239 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -67.19 -14.08 62.57 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.958 -0.464 . . . . 1.0 111.775 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -104.32 -1.88 26.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.016 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.7 m-80 -133.04 -39.33 0.95 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.908 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.537 ' HB1' HG21 ' A' ' 148' ' ' VAL . . . -56.32 -50.26 88.61 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 52.8 Cg_endo -67.24 -7.83 20.12 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.181 1.254 . . . . 1.0 113.344 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.21 -29.97 6.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.248 0.547 . . . . 1.0 111.727 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' B' ' 205' ' ' HIS . . . -62.41 136.81 58.08 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.238 -0.892 . . . . 1.0 113.361 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -96.89 141.92 29.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.149 -1.387 . . . . 1.0 111.024 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.51 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.31 135.26 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.986 0.736 . . . . 1.0 112.986 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.0 mt -115.61 139.88 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 114.88 -1.054 . . . . 1.0 109.272 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -87.4 103.47 15.53 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.502 -0.761 . . . . 1.0 110.971 -178.729 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 50.9 ttp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.733 0.301 . . . . 1.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.415 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.7 p-10 -128.38 -175.55 3.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.831 0.824 . . . . 1.0 112.905 -174.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -140.04 96.87 3.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.436 -1.69 . . . . 1.0 106.436 173.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.41 174.02 2.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.238 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 40.4 p-80 -168.83 149.22 4.42 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.143 0.277 . . . . 1.0 110.607 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.7 m-85 -85.75 152.89 22.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.69 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -141.27 117.05 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.535 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' B' ' 218' ' ' TRP . 82.7 t -95.01 130.92 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.87 178.86 7.22 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.188 0.305 . . . . 1.0 110.39 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.1 t -101.58 136.77 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.256 0.55 . . . . 1.0 112.067 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -82.91 178.61 8.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.466 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.7 64.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.114 0.483 . . . . 1.0 110.956 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.22 21.54 16.95 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.563 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 64.23 36.28 9.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.414 -0.812 . . . . 1.0 111.187 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 32.2 mmtp -99.21 157.48 16.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.21 112.86 26.06 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.4 HH12 ' CG ' ' B' ' 230' ' ' ASP . 11.1 mtm105 -127.44 176.8 7.18 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' B' ' 231' ' ' SER . 49.4 p-90 -149.12 161.84 41.16 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.735 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -145.72 143.47 29.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.163 -0.926 . . . . 1.0 109.649 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.557 ' HG ' HD13 ' B' ' 228' ' ' LEU . 36.3 tp -93.54 134.09 36.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.17 133.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.505 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.54 ' CB ' HD22 ' B' ' 226' ' ' ASN . 4.4 t-80 -80.35 172.36 13.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.56 -31.77 66.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 1.0 111.1 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -32.86 74.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.897 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.5 10.65 21.3 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.722 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.54 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.57 145.1 25.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -73.42 130.17 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.789 0.681 . . . . 1.0 109.199 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.557 HD13 ' HG ' ' B' ' 220' ' ' LEU . 13.8 mt -107.44 -41.9 4.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.347 0.594 . . . . 1.0 110.033 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.84 166.61 30.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.962 -1.017 . . . . 1.0 111.376 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . 0.4 ' CG ' HH12 ' B' ' 217' ' ' ARG . 7.0 t70 -139.23 154.29 47.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.851 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.485 ' C ' ' H ' ' B' ' 233' ' ' GLU . 24.8 p -54.22 -39.61 66.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 78.65 -26.92 2.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 1.0 111.149 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' B' ' 231' ' ' SER . 48.8 mt-10 -87.2 -175.84 5.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.59 0.71 . . . . 1.0 111.502 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -170.09 102.17 0.18 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -129.71 169.75 14.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.356 -0.238 . . . . 1.0 110.356 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.07 37.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -121.81 131.17 53.91 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.615 0.721 . . . . 1.0 111.365 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -65.2 -34.67 78.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.583 -1.189 . . . . 1.0 110.421 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.4 tt0 -58.57 -46.45 86.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.461 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -60.01 -40.29 88.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.52 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.81 68.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.015 0.436 . . . . 1.0 110.3 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.44 ' HA ' HD11 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.23 -35.88 82.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.676 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.4 mm-40 -65.7 -31.02 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.536 -0.466 . . . . 1.0 109.995 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.35 95.04 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.496 ' O ' HG13 ' B' ' 248' ' ' VAL . 73.5 mt -60.8 -53.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 1.0 110.687 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.11 -32.79 74.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.645 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -67.19 -38.11 84.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.635 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.496 HG13 ' O ' ' B' ' 245' ' ' ILE . 1.4 p -73.05 -36.03 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 119.843 -0.743 . . . . 1.0 109.08 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.24 -12.62 57.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.98 0.419 . . . . 1.0 111.304 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -104.44 -2.25 25.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.723 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -131.32 -37.5 1.24 Allowed 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 111.944 0.35 . . . . 1.0 111.944 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.465 ' HB3' HG21 ' B' ' 248' ' ' VAL . . . -56.65 -51.5 80.77 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 112.504 0.557 . . . . 1.0 112.504 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.66 -12.51 36.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.268 1.312 . . . . 1.0 113.2 -177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.35 -29.6 9.18 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.205 0.526 . . . . 1.0 111.437 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . . . . . . . . . . . -63.24 137.89 58.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.16 -0.927 . . . . 1.0 112.939 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -97.72 149.41 22.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.148 -1.387 . . . . 1.0 111.557 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.437 HG22 HG21 ' A' ' 145' ' ' ILE . 46.1 t -86.62 131.58 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.029 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.13 138.31 54.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -90.67 101.55 14.3 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.499 -0.763 . . . . 1.0 111.387 -176.886 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 112.033 0.383 . . . . 1.0 112.033 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -133.83 175.83 9.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.784 0.802 . . . . 1.0 112.439 -175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 14.2 mmtp -134.53 96.92 3.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.965 -1.471 . . . . 1.0 107.656 173.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.06 166.62 3.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.408 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.431 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.3 p-80 -168.83 146.87 3.93 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.025 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.496 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.23 147.98 26.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.543 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -139.46 117.11 11.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.464 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.441 HG23 ' HB3' ' A' ' 118' ' ' TRP . 93.9 t -94.61 134.27 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.942 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -146.29 -179.17 6.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.594 0.235 . . . . 1.0 110.639 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.1 t -101.39 134.97 40.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.175 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.58 178.94 8.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.4 52.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.829 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.1 21.64 13.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.856 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.05 33.36 1.63 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.807 0.843 . . . . 1.0 111.306 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.5 mttt -108.68 150.78 27.08 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.583 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -94.56 116.05 28.31 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.833 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.464 HH12 ' CG ' ' A' ' 130' ' ' ASP . 16.7 mtm105 -133.55 177.73 7.48 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.441 ' HB3' HG23 ' A' ' 108' ' ' VAL . 53.9 p-90 -150.19 161.09 43.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.782 0.325 . . . . 1.0 111.108 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -145.95 142.19 28.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.096 -0.956 . . . . 1.0 109.543 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.575 ' HG ' HD13 ' A' ' 128' ' ' LEU . 34.9 tp -91.88 132.69 36.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.38 132.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.533 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.496 ' CB ' HD22 ' A' ' 126' ' ' ASN . 1.7 t-80 -81.06 173.03 12.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.528 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 13.2 t70 -58.62 -31.99 68.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 1.0 110.691 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -63.68 -34.42 77.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.832 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 9.37 25.47 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.664 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.496 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.23 143.34 27.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.185 . . . . 1.0 111.496 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.81 123.73 31.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.895 0.747 . . . . 1.0 109.353 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.575 HD13 ' HG ' ' A' ' 120' ' ' LEU . 14.8 mt -98.37 -41.88 7.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.354 0.597 . . . . 1.0 109.91 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.73 169.09 22.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.677 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.464 ' CG ' HH12 ' A' ' 117' ' ' ARG . 7.6 t70 -142.4 154.36 44.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.867 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.6 p -57.09 -35.07 68.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.903 0.382 . . . . 1.0 111.679 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.69 -44.96 3.38 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -94.66 177.54 5.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 1.0 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -150.45 127.04 2.28 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.858 -1.065 . . . . 1.0 110.454 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -141.97 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.792 0.296 . . . . 1.0 110.46 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.05 10.22 27.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.501 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -124.06 130.56 52.76 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.633 0.73 . . . . 1.0 111.715 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 138' ' ' LYS . 7.9 ptpp? -65.95 -34.38 77.98 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.919 -1.037 . . . . 1.0 110.297 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.6 tt0 -58.37 -46.64 85.94 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.453 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -59.52 -38.63 81.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.422 -0.214 . . . . 1.0 110.422 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -52.94 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.225 0.536 . . . . 1.0 110.135 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.463 ' HA ' HD12 ' A' ' 145' ' ' ILE . 46.5 mtmt -64.99 -35.97 82.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.033 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.2 mm-40 -65.32 -30.7 71.57 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.468 -0.493 . . . . 1.0 109.787 177.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.86 -38.73 94.59 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.493 ' O ' HG12 ' A' ' 148' ' ' VAL . 75.4 mt -60.52 -53.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.402 0.62 . . . . 1.0 110.531 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -62.53 -33.27 74.58 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.5 m -67.36 -38.17 84.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.636 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -73.17 -33.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.247 -0.581 . . . . 1.0 109.61 -177.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.58 -14.62 62.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.539 0.685 . . . . 1.0 110.396 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -100.49 -1.89 34.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.723 -1.126 . . . . 1.0 112.037 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -134.34 -40.89 0.81 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.263 0.468 . . . . 1.0 112.263 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -57.33 -52.06 77.08 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 113.041 0.756 . . . . 1.0 113.041 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.9 -12.75 35.91 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 120.883 1.055 . . . . 1.0 113.294 -176.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.47 -29.4 8.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.07 0.462 . . . . 1.0 111.149 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.449 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -62.14 136.45 57.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.949 -1.023 . . . . 1.0 113.347 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -99.12 144.06 28.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.131 -1.395 . . . . 1.0 110.534 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.05 137.16 21.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.1 mt -119.69 144.89 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.668 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -89.08 105.02 17.51 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.614 -0.708 . . . . 1.0 111.292 -177.736 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.708 0.29 . . . . 1.0 111.3 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -111.88 179.35 4.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.758 0.79 . . . . 1.0 111.991 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.538 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 18.1 mmtp -138.97 96.49 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.117 -1.401 . . . . 1.0 108.087 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.16 170.84 3.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.589 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.449 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 34.2 p-80 -170.26 148.08 3.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.391 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.483 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.5 m-85 -84.63 152.59 23.72 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.131 0.269 . . . . 1.0 110.696 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -141.52 120.45 12.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.419 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' B' ' 218' ' ' TRP . 89.1 t -96.29 135.17 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.061 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.82 178.66 8.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.136 0.273 . . . . 1.0 110.779 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -98.39 135.49 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.671 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.451 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 23.4 t70 -81.3 177.87 8.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.911 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.451 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.2 -13.73 62.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.967 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.73 19.02 19.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.619 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 69.4 38.84 1.73 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.511 -0.768 . . . . 1.0 111.008 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.8 mmtt -109.13 155.9 20.47 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.397 -0.819 . . . . 1.0 110.261 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -99.28 102.65 14.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.845 -177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.498 HH21 ' HB2' ' B' ' 231' ' ' SER . 12.1 mmm180 -122.52 177.43 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.171 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.442 ' HB3' HG23 ' B' ' 208' ' ' VAL . 55.7 p-90 -150.7 161.12 43.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.768 0.318 . . . . 1.0 111.486 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 28.3 mtp180 -147.49 145.87 29.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.469 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.576 ' HG ' HD13 ' B' ' 228' ' ' LEU . 33.4 tp -94.22 134.95 36.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.14 132.94 64.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.792 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.526 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.1 t-80 -81.93 173.85 11.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.538 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.5 t70 -55.02 -32.18 61.64 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.353 0.408 . . . . 1.0 111.887 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -71.21 -34.29 70.71 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.419 0.628 . . . . 1.0 110.335 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.49 13.19 11.96 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.162 -0.926 . . . . 1.0 112.655 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.526 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.99 143.49 26.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 178.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.21 121.66 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.903 0.752 . . . . 1.0 109.717 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.576 HD13 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -96.88 -40.67 8.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.545 -0.752 . . . . 1.0 109.629 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -152.68 164.54 37.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.771 -1.104 . . . . 1.0 111.425 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -137.54 156.99 47.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.984 -1.007 . . . . 1.0 109.262 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.498 ' HB2' HH21 ' B' ' 217' ' ' ARG . 79.3 p -58.06 -45.99 86.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.73 2.89 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.806 -0.712 . . . . 1.0 112.989 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . 0.488 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 42.0 mt-10 -84.97 -168.9 2.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.072 0.463 . . . . 1.0 110.294 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.496 ' HA2' ' CD ' ' B' ' 217' ' ' ARG . . . -170.17 124.55 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.871 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -146.73 170.06 17.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.35 9.97 39.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.416 0.447 . . . . 1.0 112.007 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.0 m -111.94 130.21 55.92 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.393 0.616 . . . . 1.0 111.312 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -66.17 -35.95 81.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.175 -0.92 . . . . 1.0 110.89 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.412 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.3 tt0 -59.59 -46.84 87.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.459 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -59.91 -38.33 81.98 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.584 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.73 -53.11 62.08 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.563 0.697 . . . . 1.0 110.319 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.432 ' HA ' HD11 ' B' ' 245' ' ' ILE . 44.9 mtmt -64.46 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.4 mm-40 -66.04 -30.26 70.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.16 95.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.425 -0.893 . . . . 1.0 110.971 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.503 ' O ' HG12 ' B' ' 248' ' ' VAL . 69.7 mt -60.47 -52.86 56.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 1.0 110.562 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.66 -35.96 81.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.253 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.3 m -66.94 -35.62 80.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.905 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.503 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.5 OUTLIER -72.61 -38.79 59.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.565 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -65.56 -17.88 64.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.766 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' B' ' 250' ' ' ARG . 30.9 ttp-105 -100.9 -1.66 34.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.607 -0.724 . . . . 1.0 111.123 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -132.71 -40.58 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.475 ' HB1' HG21 ' B' ' 248' ' ' VAL . . . -57.17 -49.69 92.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 112.902 0.705 . . . . 1.0 112.902 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 55.9 Cg_endo -66.36 -5.75 13.38 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.029 1.153 . . . . 1.0 113.423 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.79 -11.06 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 1.0 111.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -71.95 137.02 47.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.213 0.53 . . . . 1.0 112.05 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.3 140.34 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.228 -0.896 . . . . 1.0 110.25 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.496 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -91.53 129.87 41.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.632 0.729 . . . . 1.0 112.468 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.04 140.2 37.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.54 -1.209 . . . . 1.0 109.054 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -89.06 102.66 15.31 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.458 -0.782 . . . . 1.0 111.447 -177.24 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.0 ttp . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.246 0.546 . . . . 1.0 110.86 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.435 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 13.6 p-10 -102.3 -177.56 3.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.432 -0.804 . . . . 1.0 112.514 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 23.9 mmtp -138.7 98.36 3.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.738 -1.574 . . . . 1.0 108.273 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.47 167.35 3.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.116 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.476 ' HA ' ' HB2' ' B' ' 255' ' ' ALA . 51.6 p-80 -167.87 147.11 4.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 52.2 m-85 -87.17 148.21 25.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.078 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -143.02 120.67 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.72 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.426 HG21 ' HG2' ' A' ' 142' ' ' LYS . 92.2 t -96.02 130.94 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.716 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.09 179.3 6.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.69 0.281 . . . . 1.0 110.644 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -103.28 136.81 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.191 0.519 . . . . 1.0 111.99 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.49 -175.28 5.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.286 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.2 -10.24 56.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.04 33.18 5.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.718 0.294 . . . . 1.0 111.523 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.5 35.13 17.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 mmtp -96.86 154.28 17.39 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.94 114.95 29.47 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.961 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 mtm105 -131.67 175.41 9.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.269 -0.878 . . . . 1.0 108.853 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.42 ' CD1' ' HB3' ' A' ' 131' ' ' SER . 55.1 p-90 -151.07 162.45 40.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.656 0.265 . . . . 1.0 111.361 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -147.54 144.91 28.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.252 -0.885 . . . . 1.0 110.068 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.556 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.0 tp -97.29 134.15 40.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 t -127.31 132.56 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 1.0 110.736 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.49 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.6 t-80 -84.56 177.39 8.1 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.818 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.495 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 17.9 t70 -52.04 -43.98 64.01 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.805 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -63.13 -33.45 75.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.407 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.79 11.66 22.41 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.312 -0.858 . . . . 1.0 112.331 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.49 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.13 144.19 27.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.78 -0.21 . . . . 1.0 111.371 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.467 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 50.2 mm -74.46 120.43 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.556 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.6 mt -93.06 -42.76 9.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.067 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.66 166.33 29.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.655 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.37 155.72 45.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.041 -0.981 . . . . 1.0 108.558 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.42 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 13.6 p -53.33 -31.78 45.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.994 0.426 . . . . 1.0 111.698 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.55 -41.36 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.465 ' HB2' ' HH ' ' A' ' 135' ' ' TYR . 50.2 mm-40 -114.53 173.44 6.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.466 0.651 . . . . 1.0 111.933 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.7 132.71 8.82 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 109.947 -1.261 . . . . 1.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.465 ' HH ' ' HB2' ' A' ' 133' ' ' GLU . 18.0 m-85 -122.28 167.21 13.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.114 0.457 . . . . 1.0 110.241 -176.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -102.57 9.77 39.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.47 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -139.11 133.61 31.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.5 -38.43 91.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 1.0 110.401 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.4 tt0 -58.46 -43.04 88.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.897 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.524 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.89 -41.06 95.28 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.116 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.014 0.435 . . . . 1.0 110.029 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.448 ' HA ' HD13 ' A' ' 145' ' ' ILE . 42.6 mtmt -64.48 -37.04 86.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.2 mm-40 -63.58 -26.57 68.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.488 -0.56 . . . . 1.0 109.488 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.94 -41.74 93.14 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.473 ' O ' HG12 ' A' ' 148' ' ' VAL . 67.9 mt -60.98 -41.38 88.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.469 0.652 . . . . 1.0 109.771 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.95 -43.05 93.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.237 0.541 . . . . 1.0 110.166 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 m -63.49 -35.4 80.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.514 -0.767 . . . . 1.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.539 HG21 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.84 -41.86 53.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 120.165 -0.614 . . . . 1.0 109.841 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -66.72 -12.22 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.15 -0.344 . . . . 1.0 111.49 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -104.76 -2.78 24.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.205 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -132.94 -39.58 0.95 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.923 0.392 . . . . 1.0 111.884 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -55.38 -50.33 87.36 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.692 -0.685 . . . . 1.0 112.456 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.6 Cg_endo -65.13 -9.34 21.41 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.387 1.391 . . . . 1.0 113.241 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -115.03 -23.34 9.1 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.284 0.475 . . . . 1.0 112.284 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.474 ' HB2' ' HA ' ' B' ' 205' ' ' HIS . . . -67.83 138.26 55.96 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -93.18 151.25 19.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.683 -1.144 . . . . 1.0 111.761 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.433 HG21 HG23 ' B' ' 245' ' ' ILE . 44.0 t -86.48 132.27 32.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.799 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.97 140.19 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -87.8 108.37 19.11 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.595 -0.717 . . . . 1.0 111.228 -177.427 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 60.8 ttp . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.962 0.411 . . . . 1.0 110.954 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -102.3 179.74 4.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.66 0.743 . . . . 1.0 112.412 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 30.2 mmtp -138.55 98.5 3.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.174 -1.376 . . . . 1.0 107.659 172.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.47 168.12 3.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.592 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 46.7 p-80 -167.94 149.11 5.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.198 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -85.83 148.22 25.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.985 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -139.2 119.83 14.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.519 HG21 ' HG2' ' B' ' 242' ' ' LYS . 90.3 t -92.83 132.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.787 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -142.62 -178.37 5.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.3 t -104.6 139.77 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 13.7 t70 -81.85 -178.45 6.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.042 -0.981 . . . . 1.0 110.208 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.446 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.62 -20.15 64.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.043 0.449 . . . . 1.0 111.351 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.85 24.23 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.703 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 60.95 40.15 15.79 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.901 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -100.25 156.48 17.2 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' B' ' 238' ' ' LYS . 89.6 m-85 -98.48 115.86 29.47 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.702 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -133.91 178.57 6.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.418 ' CD1' ' HB3' ' B' ' 231' ' ' SER . 53.4 p-90 -151.3 163.68 38.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.908 -0.317 . . . . 1.0 111.508 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -146.06 146.41 30.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.887 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.551 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -96.13 133.16 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.46 130.96 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.544 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.562 ' CB ' HD22 ' B' ' 226' ' ' ASN . 1.9 t-80 -80.75 172.64 13.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.431 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 19.4 t70 -54.94 -36.81 65.67 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.191 0.307 . . . . 1.0 111.63 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.02 -34.64 78.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.269 0.557 . . . . 1.0 110.396 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 111.75 15.08 10.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.423 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.562 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -90.99 142.33 27.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mm -75.83 119.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.933 0.771 . . . . 1.0 109.981 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.551 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -94.87 -43.38 8.22 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.468 -0.787 . . . . 1.0 109.739 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -149.72 170.03 19.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.494 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.72 157.31 44.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.981 -1.009 . . . . 1.0 108.538 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 77.4 p -59.09 -37.15 76.45 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.187 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.55 -45.7 3.48 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . 0.467 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 33.3 mm-40 -94.88 166.41 11.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.418 0.628 . . . . 1.0 111.502 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.19 126.86 4.94 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.08 166.62 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.873 0.337 . . . . 1.0 111.453 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.4 10.26 40.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.502 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.1 m -141.32 135.15 30.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.908 0.385 . . . . 1.0 110.663 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . 0.442 ' HB3' ' CE2' ' B' ' 216' ' ' TYR . 16.6 ptpt -61.91 -41.95 98.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.485 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.4 tt0 -55.9 -45.22 78.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.565 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -62.42 -41.72 98.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.039 -177.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.06 87.46 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.356 0.598 . . . . 1.0 110.378 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.519 ' HG2' HG21 ' B' ' 208' ' ' VAL . 49.6 mtmt -63.12 -35.61 80.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.142 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.8 mm-40 -65.92 -26.82 67.77 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.74 96.02 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.461 ' O ' HG13 ' B' ' 248' ' ' VAL . 58.5 mt -59.72 -45.51 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 121.409 0.623 . . . . 1.0 110.034 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.51 -39.43 93.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.126 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.9 m -66.34 -35.57 80.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.671 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.491 HG21 ' HB3' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -72.93 -40.48 59.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.599 -177.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -65.86 -12.41 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.436 . . . . 1.0 111.331 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -104.94 -3.14 23.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.696 -0.684 . . . . 1.0 111.004 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 17.6 m-80 -130.83 -40.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.99 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.491 ' HB3' HG21 ' B' ' 248' ' ' VAL . . . -55.6 -51.22 81.89 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.616 -0.72 . . . . 1.0 112.516 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.5 Cg_endo -65.91 -11.84 32.69 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 120.987 1.125 . . . . 1.0 113.219 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -113.01 -15.49 12.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.954 0.407 . . . . 1.0 112.04 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.476 ' HB2' ' HA ' ' A' ' 105' ' ' HIS . . . -74.95 137.88 41.93 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.022 0.749 . . . . 1.0 113.022 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.66 138.29 31.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.647 -1.161 . . . . 1.0 110.722 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.23 129.87 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.622 0.725 . . . . 1.0 112.339 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -116.1 142.21 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.033 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.93 104.87 17.39 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.607 -0.711 . . . . 1.0 110.819 -178.412 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.876 0.37 . . . . 1.0 111.302 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.427 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 14.9 p-10 -100.95 173.96 6.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.77 0.795 . . . . 1.0 112.55 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.435 ' HD2' ' HB2' ' A' ' 123' ' ' ASP . 28.2 mmtt -141.9 94.53 2.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 1.0 107.82 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.48 174.39 1.92 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.237 -177.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.441 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 40.1 p-80 -170.56 148.79 3.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.388 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -86.84 150.17 24.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.587 0.232 . . . . 1.0 110.681 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.51 120.12 12.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.788 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 118' ' ' TRP . 86.8 t -94.67 132.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.532 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -142.91 179.06 7.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.047 0.217 . . . . 1.0 110.576 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -99.87 133.24 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.98 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.83 178.78 8.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.866 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.25 -7.64 43.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.514 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.09 20.01 14.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.172 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 71.11 36.18 1.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.625 0.77 . . . . 1.0 111.062 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.4 mttt -110.92 151.19 28.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.624 -175.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.12 112.95 25.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.716 -1.129 . . . . 1.0 109.53 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -130.8 179.25 6.08 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.472 ' HB3' HG23 ' A' ' 108' ' ' VAL . 56.0 p-90 -150.68 163.7 37.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.714 -0.395 . . . . 1.0 111.522 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -147.91 146.3 28.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.78 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.554 ' HG ' HD13 ' A' ' 128' ' ' LEU . 32.1 tp -96.31 130.65 43.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.17 131.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.967 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.544 ' CB ' HD22 ' A' ' 126' ' ' ASN . 3.0 t-80 -78.0 172.17 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.435 ' HB2' ' HD2' ' A' ' 103' ' ' LYS . 11.5 t70 -57.89 -31.45 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.14 0.495 . . . . 1.0 110.637 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.31 -33.62 75.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.028 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.23 9.86 21.24 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.073 -0.967 . . . . 1.0 112.978 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.544 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.49 144.94 26.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.642 0.258 . . . . 1.0 111.467 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.8 mm -75.39 122.08 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.028 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.554 HD13 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -97.92 -42.53 7.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 1.0 109.374 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.05 165.71 32.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.156 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -141.39 155.09 45.94 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 71.2 p -55.79 -32.83 63.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.03 0.443 . . . . 1.0 111.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.18 -41.39 3.03 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.928 -0.636 . . . . 1.0 112.084 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -133.03 147.77 19.08 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -141.79 174.29 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.415 0.607 . . . . 1.0 110.99 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.27 10.16 41.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.616 0.599 . . . . 1.0 112.616 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -133.16 131.56 40.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.746 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -64.03 -36.15 83.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.355 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.8 tt0 -58.33 -45.21 88.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.762 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -59.91 -40.83 90.17 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.957 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.97 79.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 1.0 109.901 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.46 ' HA ' HD11 ' A' ' 145' ' ' ILE . 43.2 mtmt -64.29 -37.11 86.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.659 -0.701 . . . . 1.0 111.032 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.9 mm-40 -63.87 -29.68 70.84 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.41 97.98 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.479 ' O ' HG11 ' A' ' 148' ' ' VAL . 57.0 mt -63.98 -45.55 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.887 -0.657 . . . . 1.0 110.298 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.25 -38.28 88.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.137 0.494 . . . . 1.0 110.055 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.4 m -65.9 -36.27 82.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.638 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.529 HG22 ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.1 -42.21 51.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.343 -177.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -66.22 -11.89 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 112.018 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -104.46 -2.84 24.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.079 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -133.45 -37.88 0.94 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.997 -176.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.529 ' HB1' HG22 ' A' ' 148' ' ' VAL . . . -57.21 -50.01 90.62 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.2 Cg_endo -63.48 -15.24 47.32 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.254 1.303 . . . . 1.0 113.185 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -109.93 -26.37 9.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.281 0.562 . . . . 1.0 111.362 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -62.26 136.43 57.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.008 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -96.61 141.68 29.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.18 -1.373 . . . . 1.0 111.117 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.487 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -89.84 135.01 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.333 0.587 . . . . 1.0 112.478 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.0 mt -119.69 143.2 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.937 -1.029 . . . . 1.0 109.266 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -88.57 107.1 18.72 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 119.177 -0.44 . . . . 1.0 110.461 -179.466 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 43.2 ttp . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 121.042 0.448 . . . . 1.0 110.63 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -63.51 171.91 2.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.555 -0.748 . . . . 1.0 112.219 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 70.9 mmtt -136.59 95.52 3.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.92 171.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.19 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 53.2 p-80 -170.92 148.61 2.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.159 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.2 m-85 -86.41 149.67 24.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.721 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -142.07 119.03 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.332 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' B' ' 218' ' ' TRP . 71.2 t -94.31 132.88 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -145.68 -178.68 6.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.126 0.266 . . . . 1.0 110.647 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -100.89 138.29 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.309 0.576 . . . . 1.0 112.129 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.46 179.7 7.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.098 -0.956 . . . . 1.0 109.664 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.13 -9.3 58.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.181 0.515 . . . . 1.0 111.004 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.69 20.43 15.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.462 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 70.04 36.84 1.83 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.634 0.774 . . . . 1.0 111.534 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.0 mttt -112.74 149.69 32.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.289 0.566 . . . . 1.0 111.332 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -89.97 119.6 30.47 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.715 -1.129 . . . . 1.0 109.978 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.29 -179.0 5.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.977 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.44 ' HB3' HG23 ' B' ' 208' ' ' VAL . 57.1 p-90 -154.31 161.55 41.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.257 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -146.79 141.86 27.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.813 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.556 ' HG ' HD13 ' B' ' 228' ' ' LEU . 31.9 tp -93.46 130.77 39.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.59 131.48 70.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.044 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.528 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.6 t-80 -81.2 173.0 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 10.8 t70 -54.67 -36.98 65.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.035 0.445 . . . . 1.0 111.222 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.21 -33.78 76.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.219 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.84 12.13 19.24 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 115.087 -0.961 . . . . 1.0 112.659 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.528 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.32 144.06 26.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.819 0.303 . . . . 1.0 111.819 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.5 mm -75.97 116.63 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.007 0.817 . . . . 1.0 109.69 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.556 HD13 ' HG ' ' B' ' 220' ' ' LEU . 18.3 mt -90.57 -44.7 9.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.405 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.47 160.75 43.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.301 -1.318 . . . . 1.0 111.027 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.8 156.34 49.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.406 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 16.7 p -52.27 -35.63 50.64 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.378 0.424 . . . . 1.0 111.977 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.58 -46.09 3.53 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -99.32 179.51 4.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.915 -0.643 . . . . 1.0 110.792 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -146.0 137.78 7.12 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.83 171.28 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.68 0.74 . . . . 1.0 111.795 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.36 10.07 39.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.387 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 12.2 m -135.75 134.41 39.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.55 0.69 . . . . 1.0 111.276 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -64.51 -35.66 81.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.915 -1.039 . . . . 1.0 110.462 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.7 tt0 -56.12 -47.64 77.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.292 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -61.42 -40.48 94.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.804 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.54 80.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 1.0 109.768 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.452 ' HA ' HD13 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.14 -35.62 81.36 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.411 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.6 mm-40 -64.85 -29.09 70.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.48 -40.95 96.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.954 -1.258 . . . . 1.0 109.954 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' B' ' 242' ' ' LYS . 59.8 mt -62.78 -43.29 98.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.15 -0.525 . . . . 1.0 110.231 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.61 -43.56 98.5 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.648 -0.421 . . . . 1.0 109.921 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.6 m -63.63 -35.21 79.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.83 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.513 HG22 ' HB1' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -75.06 -41.8 45.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 119.697 -0.801 . . . . 1.0 109.49 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -67.2 -11.62 57.86 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.051 -0.406 . . . . 1.0 111.352 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -103.12 -3.12 26.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.319 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 10.7 m-80 -135.48 -37.45 0.76 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.968 0.358 . . . . 1.0 111.968 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.513 ' HB1' HG22 ' B' ' 248' ' ' VAL . . . -56.22 -49.87 90.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 1.0 112.478 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.4 Cg_endo -63.69 -9.53 18.82 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.642 1.562 . . . . 1.0 113.904 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -123.24 -11.57 7.95 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -70.61 138.93 51.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.27 0.557 . . . . 1.0 111.841 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.01 148.65 22.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.012 -0.994 . . . . 1.0 112.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 145' ' ' ILE . 44.1 t -84.45 131.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.619 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.1 mt -124.26 139.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -87.66 101.89 14.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.265 -0.874 . . . . 1.0 111.349 -177.157 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.428 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.2 tmt? . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 119.847 -0.121 . . . . 1.0 110.876 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 101' ' ' MET . 14.9 p-10 172.07 172.27 0.1 Allowed 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 124.082 0.864 . . . . 1.0 110.478 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -143.05 95.35 2.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.21 -1.404 . . . . 1.0 107.21 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.64 178.96 1.49 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.327 -0.851 . . . . 1.0 109.735 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.41 ' HA ' ' HB2' ' B' ' 255' ' ' ALA . 50.8 p-80 -169.52 147.72 3.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.808 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 48.7 m-85 -87.44 147.95 25.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.848 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -140.64 118.95 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.77 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 118' ' ' TRP . 81.7 t -94.23 135.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.549 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -144.86 -179.6 6.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.469 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -104.28 138.83 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.287 0.565 . . . . 1.0 111.989 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 179.85 7.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.947 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.12 46.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.577 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.23 24.37 10.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.486 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.25 33.17 2.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.654 0.782 . . . . 1.0 111.613 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.2 mttt -107.48 147.17 30.83 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.426 0.631 . . . . 1.0 111.123 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -93.46 118.89 31.88 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.028 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -131.87 179.79 5.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.162 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.46 ' HB3' HG22 ' A' ' 108' ' ' VAL . 58.2 p-90 -154.52 162.24 41.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.212 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.418 HH21 HG13 ' A' ' 127' ' ' ILE . 50.5 mtp180 -147.18 142.45 27.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.515 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.5 tp -91.48 133.21 35.69 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.67 128.57 69.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.103 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.544 ' CB ' HD22 ' A' ' 126' ' ' ASN . 3.0 t-80 -77.31 172.91 12.55 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.37 -28.17 58.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.598 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.02 -34.67 66.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.71 . . . . 1.0 109.898 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.39 10.1 15.95 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.579 -1.191 . . . . 1.0 112.709 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.544 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.53 142.84 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.748 0.277 . . . . 1.0 111.748 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.418 HG13 HH21 ' A' ' 119' ' ' ARG . 50.6 mm -74.45 119.79 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.92 0.763 . . . . 1.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.558 HD12 ' HG ' ' A' ' 120' ' ' LEU . 14.1 mt -96.88 -43.65 7.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.96 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.45 168.57 23.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.061 -0.972 . . . . 1.0 111.593 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.77 157.99 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.1 p -57.61 -32.26 67.04 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.296 0.57 . . . . 1.0 111.292 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.17 -50.05 3.83 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.458 ' HG2' ' HB ' ' B' ' 227' ' ' ILE . 69.4 mm-40 -100.81 178.96 4.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.446 -0.877 . . . . 1.0 111.424 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.06 137.53 7.97 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.49 166.47 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.096 0.448 . . . . 1.0 111.378 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.95 11.19 25.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.864 0.691 . . . . 1.0 112.864 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -127.97 131.06 49.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.399 0.618 . . . . 1.0 111.044 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.18 -38.23 90.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.882 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.5 tt0 -63.28 -43.16 98.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 1.0 110.027 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.559 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -57.77 -41.34 81.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.895 -178.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.13 74.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.369 0.604 . . . . 1.0 110.318 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.452 ' HA ' HD13 ' A' ' 145' ' ' ILE . 44.4 mtmt -64.16 -34.15 77.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.392 -0.822 . . . . 1.0 111.205 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.9 mm-40 -64.8 -30.96 71.99 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.121 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.79 -39.15 93.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.557 -0.83 . . . . 1.0 111.136 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.522 ' O ' HG11 ' A' ' 148' ' ' VAL . 76.8 mt -59.34 -51.47 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.635 0.731 . . . . 1.0 110.49 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -64.6 -35.05 79.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.016 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -66.37 -37.97 86.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.711 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.522 HG11 ' O ' ' A' ' 145' ' ' ILE . 1.4 p -73.08 -37.46 53.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.132 -0.627 . . . . 1.0 109.618 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.13 -16.33 61.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.538 0.57 . . . . 1.0 112.538 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -104.46 -5.84 21.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.929 0.395 . . . . 1.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -121.69 -37.66 2.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.8 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.496 ' HB1' HG22 ' A' ' 148' ' ' VAL . . . -56.11 -51.03 83.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.829 -0.623 . . . . 1.0 112.602 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.07 -7.82 20.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.154 1.236 . . . . 1.0 113.385 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.81 -21.14 10.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.157 0.504 . . . . 1.0 111.425 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.443 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -70.01 138.69 52.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.649 0.738 . . . . 1.0 112.952 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.37 136.73 36.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.265 -1.334 . . . . 1.0 110.801 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.82 135.29 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 112.45 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mt -130.47 153.28 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.796 -1.093 . . . . 1.0 109.799 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -84.33 117.71 23.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' B' ' 207' ' ' GLU . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.448 -0.787 . . . . 1.0 111.106 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ttp . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -173.79 172.85 3.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.404 0.621 . . . . 1.0 111.795 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.17 95.62 2.83 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.38 175.37 2.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.138 -0.937 . . . . 1.0 109.526 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.443 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.3 p-80 -170.27 146.38 2.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.101 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.489 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 55.0 m-85 -85.61 147.62 26.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.653 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 160' ' ' ALA . 40.1 mt-10 -141.3 121.9 14.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.546 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.434 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.4 t -93.36 131.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -140.99 -179.88 6.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.213 0.321 . . . . 1.0 110.808 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 1.4 t -102.08 139.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.334 0.588 . . . . 1.0 111.694 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.44 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 15.1 t70 -80.64 -176.47 5.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.637 178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.44 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -69.25 -16.94 63.7 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.976 -0.453 . . . . 1.0 110.874 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.06 17.08 22.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.603 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . 0.43 ' HA ' HG12 ' B' ' 210' ' ' VAL . 30.1 t70 68.64 44.02 1.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.481 1.134 . . . . 1.0 110.374 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.1 mmtt -112.97 150.86 31.29 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.323 -177.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -91.12 117.82 29.92 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.843 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -133.8 179.18 6.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.631 -1.168 . . . . 1.0 108.368 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.434 ' HB3' HG22 ' B' ' 208' ' ' VAL . 55.3 p-90 -153.33 161.39 42.4 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.702 0.287 . . . . 1.0 111.052 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.404 HH21 HG13 ' B' ' 227' ' ' ILE . 28.3 mtp180 -147.28 143.26 27.96 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.897 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.543 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -93.5 132.55 37.67 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 177.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.86 129.9 72.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.415 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.54 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.0 t-80 -80.77 172.85 13.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.15 -29.53 63.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 1.0 111.587 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -68.11 -33.51 74.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.511 0.672 . . . . 1.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.99 10.56 22.38 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.799 -1.091 . . . . 1.0 112.145 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.54 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.97 142.73 27.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.651 0.241 . . . . 1.0 111.651 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . 0.458 ' HB ' ' HG2' ' A' ' 133' ' ' GLU . 51.2 mm -76.25 118.85 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 123.783 0.677 . . . . 1.0 109.495 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.543 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -93.18 -43.28 8.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.205 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -148.33 164.76 33.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.389 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -141.52 159.03 43.07 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.635 0.774 . . . . 1.0 109.278 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 58.5 p -57.64 -33.62 68.47 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.942 0.401 . . . . 1.0 111.666 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.4 -47.21 3.05 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -104.7 171.87 7.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.615 -0.792 . . . . 1.0 111.205 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -135.4 138.29 9.86 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.94 172.44 12.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.012 0.406 . . . . 1.0 110.883 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.83 10.53 38.66 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.7 m -131.68 131.42 43.11 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.455 0.645 . . . . 1.0 111.608 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -65.07 -35.23 80.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.191 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.0 tt0 -56.61 -46.48 80.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.819 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.551 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.96 -42.05 97.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.536 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.9 79.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.441 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.464 ' HA ' HD13 ' B' ' 245' ' ' ILE . 44.0 mtmt -64.05 -36.69 84.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.426 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 30.0 mm-40 -63.87 -32.93 74.62 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.763 -0.375 . . . . 1.0 109.99 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.88 94.13 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.532 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.465 ' O ' HG11 ' B' ' 248' ' ' VAL . 72.7 mt -60.31 -51.57 71.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.542 0.686 . . . . 1.0 110.498 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.97 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.9 m -65.72 -37.6 86.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.366 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -72.9 -40.1 59.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.648 -177.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -64.03 -15.17 58.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -101.32 -10.45 20.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.042 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.68 -37.57 2.47 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.518 ' HB3' HG22 ' B' ' 248' ' ' VAL . . . -55.12 -51.9 75.7 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 43.0 Cg_endo -65.4 -10.64 26.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.19 1.26 . . . . 1.0 113.56 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.19 -13.9 11.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.702 0.287 . . . . 1.0 111.766 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 105' ' ' HIS . . . -72.95 138.68 46.27 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.62 134.05 34.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.557 -1.201 . . . . 1.0 111.188 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -87.24 131.46 35.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.354 0.597 . . . . 1.0 111.977 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.9 mt -118.74 143.76 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.934 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -90.28 104.21 16.81 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.183 -177.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.409 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 111.372 0.138 . . . . 1.0 111.372 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 101' ' ' MET . 23.6 p-10 170.47 171.71 0.06 Allowed 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 124.451 1.094 . . . . 1.0 109.744 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -138.22 93.46 2.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -176.91 179.69 1.02 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.567 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.437 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 47.8 p-80 -170.1 144.54 2.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 1.0 109.963 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.1 m-85 -84.71 149.3 25.88 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.161 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.69 118.77 11.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.451 HG22 ' HB3' ' A' ' 118' ' ' TRP . 79.3 t -94.57 133.17 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.711 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -142.99 179.64 6.91 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.393 0.433 . . . . 1.0 110.603 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -101.68 135.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.736 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.26 179.46 7.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.353 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.57 39.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.622 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -117.7 20.19 13.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.134 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 69.46 37.13 2.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.203 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.8 mmtt -109.2 150.73 27.48 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.071 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 93.1 m-85 -93.05 112.39 24.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.65 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -129.33 178.62 6.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.451 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.8 p-90 -151.73 163.38 39.27 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 120.854 -0.338 . . . . 1.0 111.437 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 49.4 mtp180 -148.4 141.62 25.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.5 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.573 ' HG ' HD13 ' A' ' 128' ' ' LEU . 35.4 tp -93.75 134.45 36.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.73 131.03 68.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.598 ' CB ' HD22 ' A' ' 126' ' ' ASN . 6.0 t-80 -77.23 171.2 15.22 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -18.08 52.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.146 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -34.11 35.22 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.635 0.731 . . . . 1.0 109.638 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.32 9.29 15.45 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.871 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.598 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.55 145.15 25.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.338 0.113 . . . . 1.0 110.944 178.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.477 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.4 mm -79.33 118.96 27.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.573 HD13 ' HG ' ' A' ' 120' ' ' LEU . 16.3 mt -90.78 -42.2 10.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.555 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.31 163.31 39.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.973 -1.012 . . . . 1.0 111.883 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.78 152.83 49.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.192 -0.913 . . . . 1.0 108.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 85.7 p -55.54 -34.04 64.36 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.982 0.42 . . . . 1.0 111.486 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.3 -45.92 3.45 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 47.1 mt-10 -109.27 168.59 9.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.799 -0.7 . . . . 1.0 111.562 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.24 145.84 16.34 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.174 -1.17 . . . . 1.0 110.174 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.56 165.59 25.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.245 0.522 . . . . 1.0 111.046 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.26 9.85 32.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.59 -0.732 . . . . 1.0 112.51 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 m -136.38 133.73 37.07 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.076 0.465 . . . . 1.0 110.775 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.439 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 6.8 ptpp? -63.87 -36.53 84.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.6 tt0 -56.89 -46.05 82.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.673 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.05 -39.19 91.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.8 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.29 72.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.313 0.578 . . . . 1.0 109.898 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.507 ' HA ' HD13 ' A' ' 145' ' ' ILE . 44.5 mtmt -65.28 -33.28 75.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.308 -0.86 . . . . 1.0 111.072 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.1 mm-40 -65.44 -31.84 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.178 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.98 95.15 Favored Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.507 HD13 ' HA ' ' A' ' 142' ' ' LYS . 73.2 mt -60.66 -51.28 74.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.813 -0.694 . . . . 1.0 110.428 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.83 -33.03 74.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.468 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.6 m -68.06 -35.69 78.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.786 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -72.61 -39.7 61.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -178.365 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.65 -16.12 63.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.326 0.584 . . . . 1.0 111.148 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -99.68 -1.43 37.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.799 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -137.24 -42.42 0.56 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.711 0.634 . . . . 1.0 112.711 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.481 ' HB3' HG23 ' A' ' 148' ' ' VAL . . . -54.69 -50.7 84.2 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 113.356 0.873 . . . . 1.0 113.356 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 42.5 Cg_endo -64.69 -9.41 20.74 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.248 1.299 . . . . 1.0 113.061 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.5 -12.22 8.59 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.861 0.362 . . . . 1.0 111.831 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -73.34 136.04 44.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.065 0.459 . . . . 1.0 111.443 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -96.44 145.12 25.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.511 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -90.88 129.5 41.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.84 0.828 . . . . 1.0 112.514 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.3 mt -116.47 149.46 18.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.282 -1.326 . . . . 1.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -85.41 111.72 20.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.59 -0.892 . . . . 1.0 108.59 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.72 -0.657 . . . . 1.0 110.783 -178.766 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.987 0.423 . . . . 1.0 109.978 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -122.85 171.63 9.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.373 0.606 . . . . 1.0 112.029 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -132.83 97.81 4.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.18 166.99 4.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.109 -1.405 . . . . 1.0 108.402 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 40.5 p-80 -168.69 149.52 4.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.5 m-85 -85.28 149.93 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.393 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -141.83 120.14 12.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.211 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 55.3 t -92.88 135.75 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.439 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -149.49 179.55 7.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.658 0.266 . . . . 1.0 110.724 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -101.77 140.13 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.483 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 16.1 t70 -83.47 -178.8 7.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.018 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.483 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -71.01 -11.52 61.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.352 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.15 26.08 10.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.038 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 62.84 39.48 10.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.058 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 71.8 mmtt -103.8 156.03 18.14 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.33 117.96 32.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -134.16 -179.23 5.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.78 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . . . . . . . . . 54.4 p-90 -154.08 162.43 41.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.503 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 40.4 mtp180 -147.41 141.67 26.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.2 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.566 ' HG ' HD13 ' B' ' 228' ' ' LEU . 31.2 tp -93.75 131.2 39.33 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.33 132.17 65.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.412 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.57 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.2 t-80 -80.89 170.34 16.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.77 -27.1 64.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.069 0.462 . . . . 1.0 110.895 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -66.97 -33.24 75.13 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.503 0.668 . . . . 1.0 109.977 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.99 9.84 25.47 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.695 -1.139 . . . . 1.0 112.261 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.57 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.99 143.81 27.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.395 0.141 . . . . 1.0 111.02 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . 0.421 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.5 mm -80.27 117.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.566 HD13 ' HG ' ' B' ' 220' ' ' LEU . 15.8 mt -89.7 -41.25 12.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.746 . . . . 1.0 109.276 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -154.26 164.7 38.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.585 -1.189 . . . . 1.0 111.743 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -138.6 159.11 42.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.858 -1.064 . . . . 1.0 108.328 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 63.2 p -55.55 -30.78 61.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.149 0.5 . . . . 1.0 111.185 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.99 -40.12 3.04 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.1 mt-10 -116.42 169.45 9.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.118 -0.541 . . . . 1.0 111.107 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -128.86 132.82 7.36 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.38 172.78 9.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.94 0.37 . . . . 1.0 111.808 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.63 9.8 41.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -136.02 131.95 35.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.957 0.408 . . . . 1.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -63.81 -36.47 84.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.694 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.6 tt0 -57.57 -42.59 83.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.281 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.68 -40.69 95.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.469 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.41 86.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.315 0.578 . . . . 1.0 109.975 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.443 ' HA ' HD11 ' B' ' 245' ' ' ILE . 46.7 mtmt -64.05 -35.25 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.264 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.8 mm-40 -65.27 -34.3 78.01 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.67 98.02 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.505 ' O ' HG12 ' B' ' 248' ' ' VAL . 65.9 mt -60.75 -52.24 63.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.39 0.614 . . . . 1.0 110.706 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.19 -36.66 84.78 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.167 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.2 m -64.16 -36.52 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.881 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.505 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.8 OUTLIER -73.4 -40.18 55.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 -178.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.99 -15.59 62.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.739 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -100.54 -2.95 31.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.918 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -135.66 -37.73 0.75 Allowed 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.501 ' HB3' HG23 ' B' ' 248' ' ' VAL . . . -55.18 -50.21 87.86 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 54.0 Cg_endo -65.96 -8.9 21.29 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.026 1.15 . . . . 1.0 113.797 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.53 -19.21 8.88 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.437 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -66.48 136.99 56.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.447 0.641 . . . . 1.0 112.619 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -92.88 135.9 33.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.819 -1.082 . . . . 1.0 111.286 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.532 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -85.23 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.635 0.731 . . . . 1.0 112.185 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.6 mt -116.38 140.7 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.489 -1.232 . . . . 1.0 109.366 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -86.62 107.34 18.12 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.285 -0.864 . . . . 1.0 111.182 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.038 0.447 . . . . 1.0 111.511 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -103.42 -179.8 4.05 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.631 -0.713 . . . . 1.0 111.76 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 99.35 5.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 172.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.41 163.7 3.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.472 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.0 p-80 -167.25 148.89 5.8 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.919 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.6 m-85 -87.93 148.47 24.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.719 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -141.21 119.27 11.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.387 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.484 HG23 ' HG2' ' A' ' 142' ' ' LYS . 77.2 t -89.89 131.45 37.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -140.33 -179.65 6.12 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.059 0.224 . . . . 1.0 110.537 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.6 t -102.28 137.9 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.245 0.545 . . . . 1.0 112.341 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.84 179.8 7.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.193 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 -19.65 65.33 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.919 0.39 . . . . 1.0 110.765 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.02 21.08 17.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.72 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 69.83 37.13 1.87 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.66 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.0 mttt -110.72 150.54 28.92 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.981 -176.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -93.04 121.06 34.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.835 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 55.7 mtp180 -134.27 -176.78 4.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.661 -1.154 . . . . 1.0 108.109 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.411 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.8 p-90 -151.89 165.6 34.05 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.912 -0.715 . . . . 1.0 112.337 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -144.48 140.38 28.88 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.423 -1.262 . . . . 1.0 111.234 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.565 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.9 tp -100.85 132.06 46.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.32 132.6 69.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.512 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.456 ' HB2' HD22 ' A' ' 128' ' ' LEU . 2.4 t-80 -83.07 177.64 8.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 1.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -51.5 -44.47 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.06 176.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -67.42 -33.65 75.61 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.308 -177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.52 10.48 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.546 -0.752 . . . . 1.0 113.468 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.45 147.77 25.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.606 0.224 . . . . 1.0 111.606 177.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.3 mm -74.14 119.77 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.796 0.685 . . . . 1.0 109.57 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.565 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.8 mt -94.94 -43.86 7.98 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.271 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.71 166.85 30.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.923 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -139.35 160.36 40.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.026 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 68.0 p -58.74 -38.49 78.52 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.34 -42.28 3.08 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -91.47 173.49 7.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.719 -0.74 . . . . 1.0 110.776 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.47 125.7 1.66 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.85 171.21 14.74 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 120.431 0.157 . . . . 1.0 110.609 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.24 9.54 28.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.0 p -121.53 129.57 52.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.538 0.685 . . . . 1.0 112.551 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -64.94 -42.84 94.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.893 . . . . 1.0 111.173 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.1 tt0 -55.15 -45.0 75.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.459 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.528 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -56.98 -42.77 80.83 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.81 76.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.016 0.436 . . . . 1.0 110.402 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.484 ' HG2' HG23 ' A' ' 108' ' ' VAL . 45.3 mtmt -62.98 -38.65 91.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -63.46 -26.28 68.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.72 -43.85 93.44 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.093 -1.203 . . . . 1.0 110.093 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.475 ' O ' HG12 ' A' ' 148' ' ' VAL . 59.7 mt -62.18 -45.09 99.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.564 0.697 . . . . 1.0 110.169 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -62.74 -39.9 95.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -67.87 -34.71 77.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.57 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.489 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -72.93 -40.38 59.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.264 -177.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.89 -12.57 59.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.132 0.491 . . . . 1.0 111.651 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -103.4 -2.53 26.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.475 -0.784 . . . . 1.0 111.154 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.411 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.58 -39.14 1.14 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.887 -177.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.489 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.64 -50.09 88.96 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.388 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.6 Cg_endo -64.44 -16.57 55.85 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.163 1.242 . . . . 1.0 113.095 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -106.84 -23.9 12.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.498 . . . . 1.0 111.33 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.418 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.28 135.55 55.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.452 -0.794 . . . . 1.0 112.874 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -96.56 148.75 22.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.558 -1.201 . . . . 1.0 111.792 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.425 HG21 HG21 ' B' ' 245' ' ' ILE . 40.1 t -85.27 131.38 34.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 1.0 112.061 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt -123.38 133.95 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -87.21 103.5 15.48 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.103 -0.951 . . . . 1.0 111.199 -177.166 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 48.7 ttp . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.81 0.338 . . . . 1.0 110.697 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.411 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 6.4 p-10 -125.37 177.23 6.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.705 0.764 . . . . 1.0 111.98 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.468 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 13.1 mmmm -142.27 99.67 3.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.068 -1.424 . . . . 1.0 107.592 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.36 169.94 4.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.124 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.418 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 50.2 p-80 -169.53 150.11 4.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -87.72 150.33 23.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.336 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.52 118.01 10.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.383 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' B' ' 218' ' ' TRP . 94.0 t -95.42 133.42 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.84 175.57 9.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.2 t -100.66 135.97 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.283 0.563 . . . . 1.0 111.536 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 23.8 t70 -82.11 178.29 8.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.997 -1.001 . . . . 1.0 110.101 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.429 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -69.91 -10.62 59.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.185 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.93 19.69 17.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.357 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 70.17 36.1 1.96 Allowed 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.165 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.6 mttt -110.05 144.76 38.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.459 -176.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.63 111.72 23.41 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.972 -1.467 . . . . 1.0 109.345 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -128.74 175.37 8.66 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.473 ' HB3' HG22 ' B' ' 208' ' ' VAL . 53.5 p-90 -153.4 162.15 41.57 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.014 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -144.17 151.35 39.4 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.456 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.569 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -98.58 131.2 44.98 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 13.7 t -128.55 133.56 66.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.361 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.533 ' CB ' HD22 ' B' ' 226' ' ' ASN . 3.0 t-80 -82.2 173.25 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.468 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 16.5 t70 -58.02 -27.42 63.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.196 0.522 . . . . 1.0 110.963 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.12 -33.28 67.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.514 0.673 . . . . 1.0 110.165 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.42 10.28 22.09 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.848 -1.069 . . . . 1.0 112.772 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.533 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.64 142.96 27.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.671 0.272 . . . . 1.0 111.566 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.4 mm -74.75 123.57 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.583 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -100.56 -42.96 6.35 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.045 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -147.71 167.38 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.801 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 231' ' ' SER . 15.2 t0 -141.81 153.24 44.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.034 -0.985 . . . . 1.0 108.459 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.412 ' N ' ' OD1' ' B' ' 230' ' ' ASP . 55.0 p -58.35 -40.31 81.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 1.0 112.098 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.97 -41.12 3.03 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.21 177.25 6.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.185 -0.508 . . . . 1.0 110.667 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -167.86 114.59 0.58 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -142.37 166.04 25.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.564 0.221 . . . . 1.0 110.493 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.96 6.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.117 0.784 . . . . 1.0 113.117 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 13.2 p -112.12 127.36 55.9 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.694 0.759 . . . . 1.0 111.994 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -68.37 -40.77 81.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.112 -0.949 . . . . 1.0 110.952 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.2 tt0 -56.43 -46.12 80.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.297 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.573 ' HB2' ' HZ3' ' B' ' 240' ' ' LYS . 0.2 OUTLIER -57.86 -42.95 85.57 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.296 0.372 . . . . 1.0 110.972 -178.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.39 70.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 1.0 110.646 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -63.3 -38.01 89.47 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.24 -0.891 . . . . 1.0 111.222 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.8 mm-40 -63.4 -28.03 69.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.76 -43.45 97.71 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.485 ' O ' HG12 ' B' ' 248' ' ' VAL . 48.7 mt -63.48 -46.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.435 0.636 . . . . 1.0 110.698 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.36 -38.24 88.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.23 0.538 . . . . 1.0 110.213 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -35.25 78.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.572 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.2 -41.48 58.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.535 -177.163 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -65.85 -15.13 62.63 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 1.0 112.121 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -104.74 -2.34 25.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.866 0.365 . . . . 1.0 111.315 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -127.8 -37.44 1.94 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.415 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.505 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -55.11 -51.09 82.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.893 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.0 Cg_endo -66.43 -12.29 35.08 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.168 1.245 . . . . 1.0 113.462 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.15 -27.48 10.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.576 0.703 . . . . 1.0 111.577 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.472 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.38 136.87 57.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.977 1.103 . . . . 1.0 113.977 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.65 139.08 30.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -88.79 131.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.38 0.61 . . . . 1.0 111.816 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.57 144.44 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.873 -1.058 . . . . 1.0 109.004 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -88.59 102.32 14.83 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.115 -0.945 . . . . 1.0 111.236 -177.295 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.822 0.344 . . . . 1.0 110.121 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.423 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 9.9 p-10 -89.79 161.38 16.05 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.408 0.623 . . . . 1.0 112.007 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.4 ' N ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -124.87 100.59 6.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.014 -1.476 . . . . 1.0 107.014 172.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -172.3 165.42 5.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.455 -1.248 . . . . 1.0 108.163 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 50.4 p-80 -167.81 150.21 5.69 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.56 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.484 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 57.1 m-85 -86.38 148.53 25.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.734 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.6 121.97 14.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.868 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.506 HG23 ' HG2' ' A' ' 142' ' ' LYS . 92.1 t -95.05 135.98 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.9 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.17 178.08 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.714 0.293 . . . . 1.0 110.543 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 2.9 t -101.22 133.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.343 0.592 . . . . 1.0 110.898 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.67 178.78 7.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.711 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -12.7 61.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.174 0.511 . . . . 1.0 110.929 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.39 18.75 19.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.346 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 71.1 35.2 1.67 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.794 0.838 . . . . 1.0 111.567 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.6 mttt -109.72 148.58 31.15 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.254 -175.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.32 112.21 24.07 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.329 -1.305 . . . . 1.0 109.383 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -132.95 178.31 6.98 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.401 -0.962 . . . . 1.0 108.401 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.481 ' CD1' ' HB3' ' A' ' 131' ' ' SER . 53.3 p-90 -150.09 164.0 36.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.813 0.34 . . . . 1.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -146.83 147.22 30.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.127 -0.942 . . . . 1.0 109.805 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.7 tp -96.65 134.69 39.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.1 t -128.06 131.07 69.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.448 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.541 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.0 t-80 -79.59 173.87 12.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.85 -39.39 68.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.279 0.562 . . . . 1.0 110.455 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -33.44 74.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.046 -0.979 . . . . 1.0 110.642 -177.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.34 9.75 23.14 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.837 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.541 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.45 144.69 26.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.689 0.255 . . . . 1.0 111.689 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.2 119.49 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.762 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.558 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.5 mt -94.93 -43.92 7.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.639 0.733 . . . . 1.0 109.9 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.39 166.74 28.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.635 -1.166 . . . . 1.0 111.367 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -141.17 153.5 45.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.951 -1.022 . . . . 1.0 108.464 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.481 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 15.8 p -53.37 -36.57 61.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.006 0.372 . . . . 1.0 112.006 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.69 -45.92 3.56 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.526 -0.63 . . . . 1.0 111.526 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -93.49 174.4 7.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.285 0.564 . . . . 1.0 111.507 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.53 136.92 8.68 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.94 165.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 117.627 0.714 . . . . 1.0 111.094 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.09 10.98 37.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.218 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 m -139.64 137.28 35.14 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.483 0.659 . . . . 1.0 111.543 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -63.22 -39.58 95.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.861 -1.063 . . . . 1.0 111.047 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.3 tt0 -58.31 -47.02 85.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.268 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.9 -44.57 86.87 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.61 0.569 . . . . 1.0 110.976 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.29 83.36 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.266 0.555 . . . . 1.0 110.612 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.506 ' HG2' HG23 ' A' ' 108' ' ' VAL . 44.5 mtmt -64.56 -35.32 80.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.383 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -64.78 -27.92 69.22 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.88 91.97 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.472 ' O ' HG13 ' A' ' 148' ' ' VAL . 63.5 mt -61.43 -43.04 96.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 1.0 110.338 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.83 -40.07 94.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.5 m -63.54 -36.36 83.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.599 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.498 HG22 ' HB1' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.53 -42.78 55.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 C-N-CA 119.826 -0.75 . . . . 1.0 109.529 -178.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.17 -11.77 51.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -102.54 -2.31 28.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 1.0 110.664 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 23.9 m-80 -135.52 -37.77 0.76 Allowed 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.787 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HB1' HG22 ' A' ' 148' ' ' VAL . . . -55.49 -49.7 91.08 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 44.4 Cg_endo -67.0 -11.96 34.27 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.322 1.348 . . . . 1.0 112.855 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -110.64 -19.8 12.75 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.065 0.46 . . . . 1.0 111.408 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -70.83 134.71 47.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.896 0.855 . . . . 1.0 113.153 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -94.53 142.25 27.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.22 -1.355 . . . . 1.0 110.317 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.528 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -90.67 134.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.237 0.541 . . . . 1.0 112.088 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt -119.01 142.63 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 114.902 -1.045 . . . . 1.0 109.192 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.14 104.19 16.46 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.387 -0.816 . . . . 1.0 110.965 -177.757 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.704 0.288 . . . . 1.0 110.245 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.415 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 9.3 p-10 -121.04 160.84 22.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.475 0.655 . . . . 1.0 112.189 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.46 ' HB2' ' HB2' ' B' ' 223' ' ' ASP . 0.0 OUTLIER -126.17 101.16 6.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 172.532 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.17 159.3 3.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.136 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.46 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 44.9 p-80 -166.95 150.81 6.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.744 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.6 m-85 -86.34 150.19 24.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.693 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -142.49 118.21 10.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.615 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' B' ' 218' ' ' TRP . 97.2 t -95.09 132.8 38.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.127 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.74 177.66 8.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.2 t -100.03 136.36 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.483 0.659 . . . . 1.0 112.346 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.7 -179.78 7.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.802 -1.09 . . . . 1.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.515 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.45 20.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.917 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 71.13 34.67 1.77 Allowed 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.498 0.719 . . . . 1.0 110.901 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.9 mttt -108.64 147.94 31.12 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.56 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -94.17 109.11 20.92 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.409 -1.269 . . . . 1.0 109.822 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -122.02 176.13 5.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.461 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.1 p-90 -150.62 162.76 40.04 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.28 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -147.28 146.71 29.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.197 -0.91 . . . . 1.0 110.247 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.564 ' HG ' HD12 ' B' ' 228' ' ' LEU . 35.0 tp -99.31 132.58 44.54 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 4.2 t -126.64 133.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.077 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.489 ' HB2' HD23 ' B' ' 228' ' ' LEU . 1.6 t-80 -86.09 176.55 7.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.389 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' B' ' 203' ' ' LYS . 43.2 t0 -52.61 -43.37 65.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.176 -0.92 . . . . 1.0 110.847 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.05 -33.6 75.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.617 -0.72 . . . . 1.0 110.47 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.45 12.34 19.63 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.493 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.477 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.43 144.84 27.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.59 0.218 . . . . 1.0 111.59 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.99 116.94 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.564 HD12 ' HG ' ' B' ' 220' ' ' LEU . 17.7 mt -89.19 -43.23 11.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.742 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.07 164.92 35.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 1.0 111.471 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -139.48 156.82 46.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.379 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.436 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 13.6 p -53.89 -35.08 61.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.78 -47.04 3.37 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -104.93 177.59 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.921 -0.64 . . . . 1.0 111.796 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -137.2 135.24 7.52 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.899 -1.28 . . . . 1.0 109.899 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -133.1 165.48 24.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.385 0.592 . . . . 1.0 111.78 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.62 10.9 26.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.9 m -138.48 135.83 35.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.46 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -64.14 -38.18 90.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.703 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.4 tt0 -59.84 -43.01 94.81 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.194 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -61.57 -40.64 95.46 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.793 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.33 87.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.307 0.575 . . . . 1.0 109.854 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.454 ' HA ' HD11 ' B' ' 245' ' ' ILE . 41.0 mtmt -64.79 -35.3 80.66 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.914 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.0 mm-40 -62.18 -29.05 70.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.705 -0.48 . . . . 1.0 109.705 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.95 -42.81 94.6 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.493 ' O ' HG11 ' B' ' 248' ' ' VAL . 57.3 mt -63.67 -44.16 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.235 0.54 . . . . 1.0 110.186 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -62.27 -40.88 97.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.974 0.416 . . . . 1.0 110.295 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.55 -35.0 79.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.504 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.534 HG22 ' HB1' ' B' ' 252' ' ' ALA . 0.3 OUTLIER -74.13 -41.96 51.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.478 -177.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.62 -11.76 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.816 -0.552 . . . . 1.0 111.832 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -104.79 -5.71 20.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.24 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 10.1 m-80 -130.08 -39.4 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.026 0.38 . . . . 1.0 112.026 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.534 ' HB1' HG22 ' B' ' 248' ' ' VAL . . . -55.74 -50.04 89.35 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 28.7 Cg_endo -62.03 -16.74 51.99 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.336 1.357 . . . . 1.0 113.187 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.64 -29.36 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.272 0.558 . . . . 1.0 111.899 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -59.11 135.92 57.79 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.644 0.979 . . . . 1.0 113.644 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -93.7 141.08 28.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.802 -1.545 . . . . 1.0 110.252 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.56 133.41 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.498 0.666 . . . . 1.0 112.233 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -119.41 146.76 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.691 -1.14 . . . . 1.0 109.034 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.95 104.1 16.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.088 -0.958 . . . . 1.0 111.873 -176.348 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.6 ttt . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.936 0.398 . . . . 1.0 111.695 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 16.4 p-10 -88.94 168.75 12.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.373 0.606 . . . . 1.0 112.34 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -131.87 97.22 4.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.98 168.24 4.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.055 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.459 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 31.8 p-80 -171.45 151.21 2.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.301 -0.259 . . . . 1.0 110.301 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -88.5 150.38 23.14 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.062 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.83 119.64 12.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.26 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' A' ' 118' ' ' TRP . 73.4 t -93.97 131.69 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.975 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.43 179.78 6.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.772 0.32 . . . . 1.0 110.823 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.7 t -102.21 137.83 28.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.239 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.54 -179.97 7.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.939 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.17 -12.36 61.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.429 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.22 20.03 16.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.767 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 71.33 35.18 1.59 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.562 0.745 . . . . 1.0 111.249 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 9.5 mmtt -108.71 153.31 23.63 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.203 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -96.6 118.3 32.8 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.643 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.0 mtm105 -133.51 -179.99 5.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.437 ' CZ2' ' HA ' ' A' ' 131' ' ' SER . 51.7 p-90 -150.09 170.58 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.377 0.608 . . . . 1.0 112.366 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -148.41 141.88 25.33 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.448 -1.251 . . . . 1.0 110.63 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' HD11 ' A' ' 128' ' ' LEU . 33.6 tp -102.15 129.8 48.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 174.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.52 134.65 61.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 121.08 -0.248 . . . . 1.0 110.726 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.568 ' CB ' HD22 ' A' ' 126' ' ' ASN . 1.7 t-80 -83.04 172.25 12.93 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 177.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -57.14 -30.55 64.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.958 0.409 . . . . 1.0 111.843 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -68.26 -33.6 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.3 0.571 . . . . 1.0 110.037 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.76 11.76 16.09 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.069 -0.969 . . . . 1.0 112.347 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.568 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.94 142.02 27.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.841 -0.18 . . . . 1.0 111.086 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.53 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.6 mm -77.58 118.19 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.921 0.763 . . . . 1.0 109.711 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.558 HD11 ' HG ' ' A' ' 120' ' ' LEU . 17.2 mt -89.83 -40.06 12.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.413 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.16 164.52 37.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.781 -1.1 . . . . 1.0 111.917 177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.53 154.27 49.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.826 -1.079 . . . . 1.0 108.723 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 118' ' ' TRP . 77.6 p -55.59 -41.47 73.44 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.13 -35.52 2.77 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.441 -0.664 . . . . 1.0 111.441 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -94.71 174.92 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.19 0.519 . . . . 1.0 111.132 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.54 124.12 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.739 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -146.03 179.44 7.48 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.56 9.42 41.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.768 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.6 m -117.59 128.86 55.35 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.675 0.75 . . . . 1.0 111.664 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -69.52 -32.07 70.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.573 -1.194 . . . . 1.0 110.214 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.3 tt0 -63.06 -44.83 94.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.112 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -60.87 -37.07 80.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.681 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.83 75.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.194 0.521 . . . . 1.0 109.962 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.436 ' HA ' HD11 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.97 -36.96 86.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.3 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.6 mm-40 -61.65 -27.44 68.68 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.14 -43.62 89.46 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.07 -1.212 . . . . 1.0 110.07 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.468 ' O ' HG12 ' A' ' 148' ' ' VAL . 54.4 mt -63.29 -44.48 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.318 0.58 . . . . 1.0 109.97 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.09 -43.78 98.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.354 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.0 m -64.09 -34.93 79.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.745 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -73.5 -43.25 55.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 C-N-CA 119.897 -0.721 . . . . 1.0 109.653 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -67.6 -11.92 59.22 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.042 -0.411 . . . . 1.0 111.729 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -104.11 -2.35 25.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.807 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.1 m-80 -137.04 -37.2 0.65 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.514 ' HB3' HG21 ' A' ' 148' ' ' VAL . . . -54.89 -50.14 87.85 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -64.89 -11.12 28.0 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.329 1.353 . . . . 1.0 113.226 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.88 -22.42 11.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.065 0.459 . . . . 1.0 111.394 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -67.84 137.77 55.58 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.269 0.84 . . . . 1.0 113.269 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -100.11 154.21 18.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.3 -1.318 . . . . 1.0 111.489 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.405 HG22 HG21 ' B' ' 245' ' ' ILE . 36.1 t -87.61 133.45 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.995 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt -131.65 145.75 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -83.23 118.61 23.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.543 -0.742 . . . . 1.0 110.95 -179.694 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.305 0.097 . . . . 1.0 111.12 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.408 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.5 p-10 -143.6 -174.87 4.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.685 0.755 . . . . 1.0 112.878 -174.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -135.75 97.76 3.74 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.571 -1.649 . . . . 1.0 106.971 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.31 167.46 4.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.322 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.445 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 44.3 p-80 -169.32 149.63 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.738 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -85.9 151.17 23.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -140.93 120.68 13.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.568 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' B' ' 218' ' ' TRP . 81.0 t -94.33 133.35 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.654 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -140.18 -178.79 5.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.101 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.9 t -108.36 138.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.333 0.494 . . . . 1.0 112.333 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.8 178.57 8.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.748 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.23 -18.86 65.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.735 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.89 23.09 14.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.112 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 62.64 40.87 9.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.854 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.2 mmtt -102.1 158.66 16.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -102.47 118.48 36.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -132.03 179.08 6.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.428 ' CD1' ' HB3' ' B' ' 231' ' ' SER . 52.5 p-90 -149.0 171.05 16.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.588 0.709 . . . . 1.0 112.317 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -147.43 142.49 27.07 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.205 -1.361 . . . . 1.0 110.649 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.567 ' HG ' HD11 ' B' ' 228' ' ' LEU . 36.0 tp -100.46 129.39 46.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.56 135.0 61.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.363 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.576 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.5 t-80 -81.73 168.59 17.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.46 -17.73 55.78 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.947 0.403 . . . . 1.0 111.419 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -74.25 -33.9 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.546 0.689 . . . . 1.0 109.488 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.59 10.91 15.89 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 114.41 -1.268 . . . . 1.0 112.596 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.576 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -90.54 143.26 26.92 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.265 0.226 . . . . 1.0 111.481 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.81 127.01 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 123.675 0.609 . . . . 1.0 109.513 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.567 HD11 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -103.81 -40.75 6.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.231 0.539 . . . . 1.0 109.99 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.86 164.86 36.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.908 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' B' ' 231' ' ' SER . 10.2 t0 -139.22 151.88 46.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.829 -1.078 . . . . 1.0 108.186 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.44 ' N ' ' OD1' ' B' ' 230' ' ' ASP . 11.9 p -51.51 -36.47 44.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.864 0.32 . . . . 1.0 111.864 176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.62 -45.32 3.34 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.355 -0.698 . . . . 1.0 111.355 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . 0.53 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 89.0 mt-10 -113.26 171.26 7.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.559 . . . . 1.0 111.011 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.99 141.3 9.55 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.05 174.27 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.603 0.24 . . . . 1.0 110.458 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -86.17 10.83 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 -176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.3 m -128.61 131.17 48.1 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 121.74 -0.6 . . . . 1.0 111.336 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' B' ' 242' ' ' LYS . 20.3 ptmt -66.51 -34.87 78.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.627 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.8 tt0 -57.16 -43.99 83.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.905 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.544 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.4 OUTLIER -60.49 -40.88 92.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.22 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.25 78.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.217 0.532 . . . . 1.0 110.376 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' B' ' 238' ' ' LYS . 44.9 mtmt -63.0 -41.11 99.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.91 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.5 mm-40 -64.79 -26.22 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.134 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.27 -42.56 96.15 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.029 -1.228 . . . . 1.0 110.029 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.486 ' O ' HG12 ' B' ' 248' ' ' VAL . 57.5 mt -62.23 -46.16 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 1.0 110.161 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.41 -40.3 96.06 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.201 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.02 -34.18 77.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.662 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.01 -43.03 52.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.888 -177.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -65.95 -12.01 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 1.0 111.848 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -102.63 -3.09 27.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.786 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 13.5 m-80 -135.65 -36.36 0.78 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -176.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.492 ' HB3' HG23 ' B' ' 248' ' ' VAL . . . -56.16 -50.41 87.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.538 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.4 Cg_endo -63.47 -14.12 40.4 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.444 1.43 . . . . 1.0 113.254 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.45 -21.49 12.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.88 0.371 . . . . 1.0 111.906 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.51 138.18 57.9 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.131 0.789 . . . . 1.0 113.131 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -97.05 150.38 20.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.328 -1.305 . . . . 1.0 112.053 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.424 HG22 HG23 ' A' ' 145' ' ' ILE . 36.2 t -85.53 133.93 28.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.258 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.44 143.95 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.78 102.4 13.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.595 -0.717 . . . . 1.0 110.892 -178.14 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.459 0.647 . . . . 1.0 110.792 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.415 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 17.7 p-10 -69.99 167.52 17.35 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.659 -1.155 . . . . 1.0 112.744 -176.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.5 mptt -121.63 97.4 5.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.03 167.48 4.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.451 -1.249 . . . . 1.0 108.426 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.441 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 52.3 p-80 -168.88 148.37 4.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.929 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.51 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.9 m-85 -86.27 149.09 25.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.868 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -142.56 121.43 12.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.759 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 118' ' ' TRP . 85.5 t -97.09 136.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -147.25 -179.26 6.71 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.245 0.341 . . . . 1.0 110.593 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -105.82 138.5 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.394 0.616 . . . . 1.0 112.082 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.23 178.54 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.744 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.21 63.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.046 0.45 . . . . 1.0 111.162 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.71 22.22 16.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.444 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 70.62 33.18 2.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.687 0.795 . . . . 1.0 111.236 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.4 mttt -107.42 146.56 31.53 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.517 0.675 . . . . 1.0 111.941 -175.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -92.9 115.76 28.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.198 -1.364 . . . . 1.0 109.802 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -128.99 179.36 5.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.203 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.461 ' HB3' HG21 ' A' ' 108' ' ' VAL . 54.9 p-90 -154.5 165.49 36.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.1 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 16.4 mtt180 -149.09 150.63 33.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 124.016 0.823 . . . . 1.0 110.497 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.558 ' HG ' HD13 ' A' ' 128' ' ' LEU . 32.0 tp -99.83 132.02 45.44 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.86 129.72 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.554 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.57 ' CB ' HD22 ' A' ' 126' ' ' ASN . 3.0 t-80 -78.23 172.62 13.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.03 -32.39 66.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.15 0.5 . . . . 1.0 110.959 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -65.29 -33.73 76.67 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.203 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.66 14.22 16.39 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.078 -0.965 . . . . 1.0 112.384 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.57 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.34 143.6 26.6 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 178.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mm -74.96 118.64 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 123.926 0.766 . . . . 1.0 109.566 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.558 HD13 ' HG ' ' A' ' 120' ' ' LEU . 17.3 mt -93.87 -43.41 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.384 0.612 . . . . 1.0 109.799 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.21 163.74 37.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.367 177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -139.07 156.86 46.86 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.8 p -53.74 -31.5 48.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.931 0.396 . . . . 1.0 111.401 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.06 -38.26 2.98 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.474 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 49.9 mt-10 -118.3 171.39 8.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.048 -0.576 . . . . 1.0 110.951 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.42 138.66 10.49 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -133.43 169.43 16.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.32 0.56 . . . . 1.0 111.982 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.01 10.72 30.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -142.5 139.22 31.42 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.815 -0.553 . . . . 1.0 111.9 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.64 -37.48 87.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.461 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.9 tt0 -59.03 -46.67 87.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.544 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -59.12 -41.59 88.55 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.614 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.11 75.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.09 0.471 . . . . 1.0 109.861 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.468 ' HA ' HD11 ' A' ' 145' ' ' ILE . 43.9 mtmt -64.21 -34.73 78.76 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.344 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.0 mm-40 -63.69 -27.13 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.76 -42.38 87.02 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 142' ' ' LYS . 66.5 mt -62.2 -44.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.414 0.626 . . . . 1.0 109.637 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -61.52 -44.77 96.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.239 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.8 m -63.56 -34.83 78.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.751 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.519 HG22 ' HB3' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -74.55 -41.61 48.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 C-N-CA 119.878 -0.729 . . . . 1.0 109.684 -177.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.36 -12.1 54.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.753 0.311 . . . . 1.0 111.657 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -104.63 -2.8 24.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.591 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -132.02 -40.58 1.04 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.835 0.35 . . . . 1.0 111.502 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.519 ' HB3' HG22 ' A' ' 148' ' ' VAL . . . -55.15 -51.48 79.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.617 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -63.54 -9.0 16.52 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.508 1.472 . . . . 1.0 113.98 -177.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.58 -22.19 7.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.918 0.39 . . . . 1.0 111.939 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 136.52 57.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.777 0.799 . . . . 1.0 113.038 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.93 138.78 31.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.438 -1.255 . . . . 1.0 110.581 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.527 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.69 130.65 38.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.711 . . . . 1.0 112.699 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.8 mt -115.47 140.22 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.369 -1.287 . . . . 1.0 108.568 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -92.61 102.05 14.48 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.059 -0.973 . . . . 1.0 111.148 -177.064 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -109.7 171.37 7.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.022 0.439 . . . . 1.0 110.787 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.436 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 73.3 mmtt -137.73 95.77 3.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.609 -1.256 . . . . 1.0 107.609 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.91 173.03 2.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.094 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.487 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.6 p-80 -170.7 147.59 2.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.583 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.527 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 57.6 m-85 -85.16 147.61 26.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.654 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.37 119.55 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.08 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' B' ' 218' ' ' TRP . 75.4 t -92.14 133.93 31.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.151 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -145.66 -176.43 5.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.619 0.247 . . . . 1.0 110.4 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.8 t -101.99 139.42 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.909 0.707 . . . . 1.0 112.909 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 17.4 t70 -81.22 -178.65 7.01 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.309 -0.86 . . . . 1.0 109.548 178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.424 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -70.82 -16.96 62.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.154 0.502 . . . . 1.0 110.673 178.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.37 19.33 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.712 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.67 39.99 1.44 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.425 0.69 . . . . 1.0 110.956 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -113.76 151.86 31.38 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.791 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -91.99 118.87 31.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.158 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -130.69 -178.67 4.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.808 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.424 ' HB3' HG23 ' B' ' 208' ' ' VAL . 56.8 p-90 -155.43 164.44 38.71 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.345 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -149.66 148.31 29.13 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.216 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.562 ' HG ' HD13 ' B' ' 228' ' ' LEU . 31.9 tp -97.15 130.16 44.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.28 130.59 71.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.252 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.571 ' CB ' HD22 ' B' ' 226' ' ' ASN . 3.8 t-80 -78.94 169.31 18.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 29.0 t70 -58.36 -26.47 63.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.266 0.555 . . . . 1.0 110.954 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.4 -33.07 70.95 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.941 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.48 11.52 19.44 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.125 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.571 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.55 144.21 26.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.807 -0.231 . . . . 1.0 111.385 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . 0.474 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.9 mm -78.24 116.72 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 1.0 109.472 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.562 HD13 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -90.25 -42.58 10.92 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.547 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -150.35 164.27 36.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.608 -1.178 . . . . 1.0 111.374 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.34 155.33 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 65.6 p -54.72 -33.26 60.84 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.066 0.46 . . . . 1.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.69 3.51 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.53 -0.628 . . . . 1.0 111.53 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -122.72 166.94 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.175 0.512 . . . . 1.0 111.572 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -118.73 139.78 14.72 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.651 -1.38 . . . . 1.0 109.651 177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -127.47 171.02 11.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.623 0.711 . . . . 1.0 111.545 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -100.73 9.69 42.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 1.0 112.28 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.7 m -143.78 137.21 27.9 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.68 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -62.88 -38.42 90.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.78 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.3 tt0 -60.98 -40.71 94.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.211 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -61.05 -41.51 96.74 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.647 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.28 89.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.973 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.499 ' HA ' HD11 ' B' ' 245' ' ' ILE . 45.0 mtmt -64.91 -34.99 79.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.228 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.3 mm-40 -62.62 -30.98 71.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.15 -41.28 95.03 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.048 -1.221 . . . . 1.0 110.048 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.499 HD11 ' HA ' ' B' ' 242' ' ' LYS . 66.6 mt -63.36 -43.08 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.976 -0.612 . . . . 1.0 110.582 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -63.99 -41.3 97.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.04 0.448 . . . . 1.0 110.232 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -64.03 -37.08 86.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.522 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -74.06 -41.46 52.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 C-N-CA 120.22 -0.592 . . . . 1.0 110.755 -176.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.53 -16.35 63.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -105.82 -3.23 22.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 1.0 111.353 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . 0.415 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 15.2 m-80 -123.32 -38.88 2.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.986 0.422 . . . . 1.0 111.082 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.511 ' HB3' HG21 ' B' ' 248' ' ' VAL . . . -56.51 -50.87 85.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.495 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.5 Cg_endo -63.59 -12.75 32.66 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.53 1.486 . . . . 1.0 113.528 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.56 -19.47 10.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -64.57 136.77 57.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.866 0.841 . . . . 1.0 112.593 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -91.83 135.76 33.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.022 -1.445 . . . . 1.0 110.573 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.51 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -88.54 129.85 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.601 0.715 . . . . 1.0 112.298 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.9 mt -115.1 140.59 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.406 -1.27 . . . . 1.0 109.27 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -90.31 106.55 18.57 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.674 -0.862 . . . . 1.0 108.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.337 -0.839 . . . . 1.0 111.213 -177.399 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 53.3 ttp . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.372 0.606 . . . . 1.0 110.697 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.426 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 21.4 p-10 -92.63 173.99 7.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.421 -0.809 . . . . 1.0 112.066 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -134.37 96.64 3.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.55 171.13 3.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.856 -1.065 . . . . 1.0 109.401 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.467 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 48.4 p-80 -170.53 148.36 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.1 m-85 -84.83 149.94 25.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.38 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.35 118.73 12.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.559 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 118' ' ' TRP . 68.2 t -90.95 133.39 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.878 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -142.6 177.43 8.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.412 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.4 t -102.36 137.47 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.334 0.587 . . . . 1.0 111.969 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.57 177.76 8.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.96 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.87 -12.25 61.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.237 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.97 24.28 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.669 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 69.35 35.19 2.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 1.0 111.674 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -110.68 147.53 34.15 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.457 0.646 . . . . 1.0 111.4 -176.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.6 120.98 32.13 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.431 -1.259 . . . . 1.0 110.467 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -136.32 -179.7 5.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.572 -1.194 . . . . 1.0 108.675 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 131' ' ' SER . 56.3 p-90 -151.7 162.9 40.24 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.683 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.513 HH11 HG23 ' A' ' 127' ' ' ILE . 21.6 mmt180 -143.48 142.82 31.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.298 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.571 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.5 tp -99.97 129.99 46.1 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -127.79 132.36 68.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.483 -0.192 . . . . 1.0 110.483 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.529 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.0 t-80 -83.34 174.35 10.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.4 -39.18 67.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.0 111.476 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -60.32 -33.96 73.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.513 0.673 . . . . 1.0 110.26 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.54 12.17 21.8 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.873 -1.058 . . . . 1.0 112.096 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.529 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.77 142.57 28.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.63 0.252 . . . . 1.0 111.376 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.513 HG23 HH11 ' A' ' 119' ' ' ARG . 50.9 mm -76.26 116.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.194 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.571 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.1 mt -88.38 -42.74 11.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.634 0.731 . . . . 1.0 109.917 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.65 166.43 30.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.756 -1.111 . . . . 1.0 111.237 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -140.34 155.41 46.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.87 -1.059 . . . . 1.0 110.13 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 18.9 p -54.5 -36.03 63.75 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.601 0.563 . . . . 1.0 111.605 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.38 -50.67 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.65 178.61 4.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.709 -0.746 . . . . 1.0 111.618 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -145.67 140.62 9.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -141.37 167.47 22.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.531 0.165 . . . . 1.0 110.66 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.4 9.9 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 p -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.601 0.715 . . . . 1.0 111.862 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -64.94 -41.52 95.44 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.595 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -59.83 -37.78 80.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.621 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -62.0 -43.35 99.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.241 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.95 83.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.26 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.486 ' HA ' HD13 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.66 -34.43 78.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.169 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -62.99 -30.29 71.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.34 -40.35 94.57 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.42 -1.072 . . . . 1.0 110.42 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 142' ' ' LYS . 58.3 mt -62.73 -42.26 95.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.085 0.469 . . . . 1.0 110.081 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.09 -43.75 97.63 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.155 0.502 . . . . 1.0 109.885 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -61.25 -36.16 79.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.51 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -75.22 -42.4 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 119.536 -0.866 . . . . 1.0 110.169 -177.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.6 mtpt -66.86 -15.65 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 1.0 112.399 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -105.43 -2.26 23.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.366 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.62 -37.53 1.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.693 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB3' HG21 ' A' ' 148' ' ' VAL . . . -57.34 -51.35 82.33 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.499 0.555 . . . . 1.0 112.499 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 57.8 Cg_endo -66.56 -4.81 11.55 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.261 1.308 . . . . 1.0 113.208 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.18 -23.41 6.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.593 0.59 . . . . 1.0 112.593 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' B' ' 205' ' ' HIS . . . -66.69 139.12 57.83 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.472 0.916 . . . . 1.0 113.472 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.78 135.42 33.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.488 -1.233 . . . . 1.0 111.189 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.497 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -88.04 131.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.335 0.588 . . . . 1.0 112.075 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.6 mt -123.84 145.94 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.93 -1.032 . . . . 1.0 108.92 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -88.63 113.44 24.2 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.118 -1.068 . . . . 1.0 108.118 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.126 -0.94 . . . . 1.0 111.271 -177.112 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 53.2 ttp . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.304 0.573 . . . . 1.0 111.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.419 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 14.4 p-10 -81.72 163.74 22.24 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.453 -0.794 . . . . 1.0 112.588 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.405 ' HD2' ' C ' ' B' ' 202' ' ' ASN . 12.0 mptt -127.78 96.46 4.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 174.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.95 171.4 3.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.417 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 52.6 p-80 -169.32 147.26 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.213 -0.195 . . . . 1.0 110.59 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.497 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 52.1 m-85 -86.67 146.72 26.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.144 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -141.75 122.0 13.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.752 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.454 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.0 t -93.24 135.68 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.09 -178.62 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.355 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.1 t -106.15 139.65 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.22 179.12 7.8 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.47 -0.787 . . . . 1.0 109.51 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.38 -17.58 64.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.893 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.8 19.16 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.118 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 69.78 35.37 2.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.041 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.1 mmtt -108.57 149.16 29.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.407 -175.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.38 119.67 32.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.53 -1.214 . . . . 1.0 110.254 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -132.32 -178.1 4.76 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.706 -1.134 . . . . 1.0 108.972 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.454 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.0 p-90 -155.7 168.22 27.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.742 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -150.44 154.13 37.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.849 -1.069 . . . . 1.0 110.613 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.575 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -104.36 132.62 50.41 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.3 t -126.25 132.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.259 -0.275 . . . . 1.0 110.259 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.483 ' CB ' HD22 ' B' ' 226' ' ' ASN . 0.6 OUTLIER -85.26 174.49 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.256 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -52.5 -33.88 46.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.833 -0.621 . . . . 1.0 112.249 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -70.81 -33.29 70.55 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.322 0.582 . . . . 1.0 110.179 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.92 10.34 21.09 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.074 -0.967 . . . . 1.0 112.38 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.483 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -85.69 144.51 27.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.35 118.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 O-C-N 123.926 0.766 . . . . 1.0 109.38 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.575 HD12 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -93.42 -43.52 8.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.608 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.67 40.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.195 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -136.85 155.11 50.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.435 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.3 p -51.86 -37.03 50.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.905 0.383 . . . . 1.0 111.817 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.18 -46.44 3.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . 0.444 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 7.8 mm-40 -98.15 -179.75 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.127 -0.537 . . . . 1.0 111.399 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -150.0 133.86 4.57 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -138.85 170.01 16.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.089 0.444 . . . . 1.0 110.962 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -92.27 9.46 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 6.5 p -126.96 129.05 47.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.594 0.711 . . . . 1.0 112.1 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.21 -41.17 94.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.43 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.8 tt0 -58.4 -41.14 84.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.342 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -60.59 -41.95 95.76 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.918 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.18 79.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.43 0.633 . . . . 1.0 109.511 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.483 ' HA ' HD13 ' B' ' 245' ' ' ILE . 47.2 mtmt -65.78 -33.68 76.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.265 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.1 mm-40 -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -68.15 -39.64 88.36 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.502 ' O ' HG12 ' B' ' 248' ' ' VAL . 72.9 mt -61.58 -52.43 61.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.519 0.676 . . . . 1.0 110.59 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -61.87 -35.57 78.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.02 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.2 m -67.95 -36.29 79.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.846 177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.502 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.5 OUTLIER -71.54 -37.16 62.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -177.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -66.41 -15.46 63.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.938 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 41.2 ttt85 -105.04 -2.9 23.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.074 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . 0.426 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 16.1 m-80 -127.08 -41.17 1.8 Allowed 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.639 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.486 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -56.82 -50.51 87.64 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.768 -0.651 . . . . 1.0 112.431 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.6 Cg_endo -62.84 -15.15 45.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 121.162 1.241 . . . . 1.0 113.712 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.5 -18.3 11.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.823 0.344 . . . . 1.0 111.923 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -67.6 135.25 52.61 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.641 0.734 . . . . 1.0 112.791 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -93.56 140.28 29.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.213 -1.358 . . . . 1.0 110.592 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -87.27 136.36 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.369 0.604 . . . . 1.0 112.205 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.8 mt -124.58 148.72 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.658 -1.156 . . . . 1.0 109.761 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.9 106.37 17.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.577 -0.725 . . . . 1.0 111.296 -177.858 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.406 ' C ' ' SD ' ' A' ' 101' ' ' MET . 1.5 tmt? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.704 0.287 . . . . 1.0 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.428 ' C ' ' HD2' ' A' ' 103' ' ' LYS . 10.7 p-10 -85.79 159.58 19.7 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.351 0.595 . . . . 1.0 112.151 -176.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.2 mptt -122.71 97.91 5.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.72 169.34 4.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.685 -1.143 . . . . 1.0 108.954 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.465 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 51.9 p-80 -169.14 148.94 4.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.59 146.9 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.66 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.36 116.8 11.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.939 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 118' ' ' TRP . 70.2 t -90.97 132.12 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.526 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -140.5 -179.08 5.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.383 -0.228 . . . . 1.0 110.383 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.2 t -103.53 136.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.586 . . . . 1.0 112.388 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.11 177.55 8.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 1.0 108.957 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.29 62.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 1.0 111.006 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.55 19.16 20.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.102 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.6 39.99 1.96 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.672 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 13.2 mmtt -111.76 152.45 27.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.283 -176.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.44 118.63 31.55 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.727 -1.124 . . . . 1.0 110.067 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -132.06 -179.26 5.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.442 ' HB3' HG23 ' A' ' 108' ' ' VAL . 60.5 p-90 -155.77 167.41 30.48 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.082 0.468 . . . . 1.0 111.926 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -151.64 149.87 29.62 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.334 -1.303 . . . . 1.0 110.63 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.536 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.4 tp -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 t -126.59 131.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.561 -0.291 . . . . 1.0 110.549 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.554 ' CB ' HD22 ' A' ' 126' ' ' ASN . 1.9 t-80 -81.65 172.08 13.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -57.84 -27.36 63.13 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.323 0.582 . . . . 1.0 110.792 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -33.64 73.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.955 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.12 11.7 23.53 Favored Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.109 -0.95 . . . . 1.0 112.318 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.554 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.09 144.68 25.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.101 0.408 . . . . 1.0 112.101 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.41 117.4 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.944 0.777 . . . . 1.0 109.137 177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.536 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.0 mt -90.57 -43.96 9.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.6 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.48 158.48 44.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.692 -1.14 . . . . 1.0 111.02 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.64 154.99 51.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.401 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 16.3 p -52.9 -33.16 49.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.406 0.442 . . . . 1.0 112.159 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.35 -48.04 3.73 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -104.07 -175.38 2.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.913 -0.644 . . . . 1.0 111.406 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -149.25 137.77 6.48 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -144.34 168.47 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.96 0.38 . . . . 1.0 111.06 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.06 10.29 32.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.226 0.824 . . . . 1.0 113.226 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -125.83 132.53 52.21 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 111.076 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -64.77 -38.55 91.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.879 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.9 tt0 -61.17 -41.23 96.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.988 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.57 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.64 -41.21 94.47 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.555 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.985 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.487 ' HA ' HD13 ' A' ' 145' ' ' ILE . 48.3 mtmt -63.63 -36.41 83.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.632 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.0 mm-40 -65.1 -25.49 67.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.2 -40.95 92.48 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 142' ' ' LYS . 67.7 mt -62.43 -44.53 99.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.8 -0.7 . . . . 1.0 109.766 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.55 -40.16 95.95 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.809 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -63.17 -35.39 80.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.007 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.534 HG23 ' HB1' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -73.68 -40.86 54.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 119.581 -0.848 . . . . 1.0 109.371 -178.286 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -68.06 -11.92 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.251 0.548 . . . . 1.0 110.768 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -97.73 -6.87 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.259 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -138.91 -37.51 0.52 Allowed 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB1' HG23 ' A' ' 148' ' ' VAL . . . -53.84 -50.68 82.47 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 56.8 Cg_endo -67.36 -6.21 15.82 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 121.307 1.338 . . . . 1.0 113.473 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.88 -26.96 5.9 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.247 0.546 . . . . 1.0 111.684 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -64.98 136.44 56.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.424 -0.807 . . . . 1.0 112.502 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.35 139.4 34.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.566 -1.197 . . . . 1.0 110.975 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.489 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -86.72 139.92 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.542 0.686 . . . . 1.0 112.584 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.7 mt -123.82 142.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.013 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -88.9 101.48 14.1 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.562 -0.732 . . . . 1.0 111.294 -177.582 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.515 0.198 . . . . 1.0 110.608 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -112.89 171.19 7.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.52 0.676 . . . . 1.0 112.252 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -144.94 97.12 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.17 -1.418 . . . . 1.0 107.17 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.98 177.41 1.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.958 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 52.8 p-80 -169.2 148.12 3.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.831 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.489 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 60.8 m-85 -86.16 150.12 24.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.836 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.16 117.59 10.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' B' ' 218' ' ' TRP . 88.9 t -93.5 134.53 30.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.958 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -145.75 179.76 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.312 . . . . 1.0 110.968 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 1.3 t -97.44 135.94 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.37 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.425 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 9.3 t70 -84.53 -179.11 7.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.055 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.425 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.05 -6.91 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.972 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.79 18.42 11.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.531 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 35.1 t70 69.83 43.69 0.92 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.47 1.128 . . . . 1.0 110.359 177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.7 mmtt -113.51 150.23 33.21 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.749 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.06 116.32 28.71 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.799 -1.091 . . . . 1.0 109.988 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -134.03 178.29 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.432 ' HB3' HG23 ' B' ' 208' ' ' VAL . 51.1 p-90 -151.27 164.01 37.59 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.742 -0.383 . . . . 1.0 111.391 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' B' ' 219' ' ' ARG . 4.5 mtp-105 -146.63 145.76 30.17 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.913 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.562 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.5 tp -96.61 130.66 43.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 t -126.13 130.77 72.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.027 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.443 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.1 t-80 -81.83 175.47 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.62 -36.81 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.414 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -67.13 -34.58 77.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.563 0.697 . . . . 1.0 110.503 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.63 12.33 17.02 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 114.97 -1.014 . . . . 1.0 112.203 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.443 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.06 143.33 27.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.056 0.391 . . . . 1.0 112.056 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.17 120.15 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 124.053 0.845 . . . . 1.0 109.911 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.562 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.9 mt -96.49 -43.96 7.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.703 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -150.46 162.3 40.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.489 -1.232 . . . . 1.0 111.135 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -137.65 152.93 49.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.972 -1.013 . . . . 1.0 108.442 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 79.8 p -55.25 -36.43 66.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.013 0.435 . . . . 1.0 111.416 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.25 -48.1 3.57 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -98.01 171.76 8.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.78 -0.71 . . . . 1.0 111.563 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.11 135.82 6.23 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.349 -1.101 . . . . 1.0 110.349 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -141.86 178.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.066 0.433 . . . . 1.0 110.405 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -99.27 9.8 42.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.192 0.812 . . . . 1.0 113.192 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -125.86 131.83 52.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.2 0.524 . . . . 1.0 111.544 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.58 -39.13 93.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.164 -0.926 . . . . 1.0 110.448 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.5 tt0 -60.29 -43.82 95.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.224 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -59.52 -41.43 89.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.618 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.49 -51.08 71.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.064 0.459 . . . . 1.0 110.318 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.7 mtmt -63.59 -33.37 75.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.3 mm-40 -65.55 -30.38 71.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.425 -0.51 . . . . 1.0 109.72 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.14 96.42 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.497 ' O ' HG13 ' B' ' 248' ' ' VAL . 75.6 mt -61.62 -53.42 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.588 0.709 . . . . 1.0 110.535 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -61.37 -34.8 75.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.591 -0.731 . . . . 1.0 111.034 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.5 m -66.82 -37.64 84.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.389 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.497 HG13 ' O ' ' B' ' 245' ' ' ILE . 0.4 OUTLIER -70.72 -40.59 77.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.984 -0.687 . . . . 1.0 109.247 -177.637 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.72 -17.26 62.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -104.07 -2.77 25.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.967 0.413 . . . . 1.0 111.033 -177.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.82 -41.77 1.63 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.608 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.483 ' HB3' HG23 ' B' ' 248' ' ' VAL . . . -55.87 -50.68 85.81 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.503 -0.771 . . . . 1.0 112.852 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.3 Cg_endo -63.14 -15.14 46.16 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.232 1.288 . . . . 1.0 113.379 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.52 -19.94 11.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.925 0.393 . . . . 1.0 111.906 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -67.84 136.23 53.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.786 0.803 . . . . 1.0 112.507 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.81 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.125 -1.398 . . . . 1.0 110.988 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.0 OUTLIER -88.86 130.07 38.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.613 0.721 . . . . 1.0 112.621 179.084 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.3 mt -116.41 142.58 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.468 -1.242 . . . . 1.0 108.864 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -90.17 101.91 14.63 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.869 -0.586 . . . . 1.0 111.21 -177.137 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 48.0 ttp . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 121.166 0.508 . . . . 1.0 110.758 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -103.73 -178.38 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.494 -0.775 . . . . 1.0 112.033 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -137.58 98.43 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.136 -1.393 . . . . 1.0 107.319 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.17 172.8 3.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.425 -0.807 . . . . 1.0 109.392 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.425 ' HA ' ' HB3' ' B' ' 255' ' ' ALA . 31.6 p-80 -172.02 149.41 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.154 0.283 . . . . 1.0 110.238 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.506 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 66.1 m-85 -86.11 153.63 21.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.483 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -141.66 117.68 10.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 79.4 t -93.84 129.54 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -143.63 179.3 7.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.804 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -98.82 134.8 36.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.809 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.13 178.54 8.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.173 -0.922 . . . . 1.0 109.53 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.35 -16.83 64.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.165 0.507 . . . . 1.0 110.629 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.05 20.25 18.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.738 -0.664 . . . . 1.0 111.708 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 71.3 35.53 1.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.453 0.701 . . . . 1.0 111.398 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.2 mttt -109.61 150.27 28.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.159 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.06 109.38 20.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.006 -0.997 . . . . 1.0 109.264 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -126.15 176.91 6.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.43 ' CE2' ' HA ' ' A' ' 131' ' ' SER . 49.8 p-90 -147.3 162.45 38.93 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.365 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.49 HH21 HG13 ' A' ' 127' ' ' ILE . 14.7 mmm-85 -144.5 142.18 30.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.157 -0.929 . . . . 1.0 109.635 -177.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.568 ' HG ' HD13 ' A' ' 128' ' ' LEU . 33.9 tp -98.79 131.61 44.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.238 -1.023 . . . . 1.0 108.238 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -130.78 132.97 63.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.542 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.52 ' CB ' HD22 ' A' ' 126' ' ' ASN . 4.8 t-80 -81.81 174.71 11.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -56.11 -36.58 68.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.285 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -64.88 -33.45 76.04 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.551 0.691 . . . . 1.0 109.699 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 11.57 21.35 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 114.688 -1.142 . . . . 1.0 112.398 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.52 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -85.97 141.31 29.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.721 0.296 . . . . 1.0 111.587 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.49 HG13 HH21 ' A' ' 119' ' ' ARG . 47.6 mm -74.66 122.1 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.299 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.568 HD13 ' HG ' ' A' ' 120' ' ' LEU . 13.9 mt -98.17 -41.42 7.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.881 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.19 169.24 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.26 -0.882 . . . . 1.0 111.935 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -141.97 153.49 44.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.698 -1.137 . . . . 1.0 108.325 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.43 ' HA ' ' CE2' ' A' ' 118' ' ' TRP . 77.3 p -53.49 -34.49 58.25 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.005 0.431 . . . . 1.0 111.597 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.88 -40.45 3.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.652 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 93.9 mt-10 -110.82 174.85 5.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.307 -0.446 . . . . 1.0 110.78 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.85 136.67 6.74 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.311 -0.715 . . . . 1.0 111.311 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -144.54 177.53 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.733 0.266 . . . . 1.0 110.968 -177.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.36 9.67 42.32 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.773 0.657 . . . . 1.0 112.773 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 m -122.03 131.34 53.94 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.561 0.696 . . . . 1.0 111.451 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.96 -36.23 83.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.835 -1.075 . . . . 1.0 110.82 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.9 tt0 -63.31 -42.19 98.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.146 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -57.99 -41.26 82.64 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.689 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.2 70.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.194 0.521 . . . . 1.0 110.089 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.445 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.5 -36.77 85.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.682 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -64.0 -28.07 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.64 -41.91 95.73 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.469 ' O ' HG11 ' A' ' 148' ' ' VAL . 62.3 mt -63.48 -45.68 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.837 -0.682 . . . . 1.0 110.466 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.63 -40.43 94.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.871 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.4 m -66.8 -33.73 76.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.817 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.527 HG23 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.69 -40.39 54.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.037 -0.665 . . . . 1.0 109.948 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -68.17 -11.8 59.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 111.153 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.39 -8.61 26.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.289 -0.868 . . . . 1.0 109.691 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -134.39 -39.14 0.83 Allowed 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 113.482 0.919 . . . . 1.0 113.482 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 148' ' ' VAL . . . -54.31 -49.18 91.92 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.837 0.68 . . . . 1.0 112.837 -177.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 53.7 Cg_endo -66.69 -7.06 17.01 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.32 1.347 . . . . 1.0 113.153 -177.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -122.44 -13.6 8.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.473 0.545 . . . . 1.0 112.473 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.27 135.21 44.43 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.748 0.785 . . . . 1.0 112.869 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -93.57 138.73 31.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.352 -1.295 . . . . 1.0 110.36 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.1 p -88.01 133.89 29.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 112.348 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.1 mt -119.84 143.81 30.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.275 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -87.71 107.14 18.49 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.227 -0.892 . . . . 1.0 110.883 -177.792 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 52.4 ttp . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.18 0.514 . . . . 1.0 110.697 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -102.09 177.19 4.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.642 -0.708 . . . . 1.0 112.319 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -133.47 98.92 4.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.392 -1.336 . . . . 1.0 107.392 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.4 170.23 3.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.75 -1.114 . . . . 1.0 108.694 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.448 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 47.7 p-80 -170.96 149.94 3.04 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.08 0.237 . . . . 1.0 110.497 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 54.9 m-85 -85.73 149.38 25.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.8 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -140.48 120.29 13.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.458 HG21 ' HB3' ' B' ' 218' ' ' TRP . 71.5 t -95.5 135.07 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.204 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -146.04 175.78 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 1.0 110.734 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 5.3 t -99.9 133.45 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 1.0 111.965 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.65 179.79 7.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.81 -1.086 . . . . 1.0 109.5 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.02 -17.96 64.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.95 0.405 . . . . 1.0 111.325 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.55 21.8 16.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.909 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 70.46 36.15 1.79 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 111.121 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -109.91 143.93 39.12 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.794 . . . . 1.0 111.185 -176.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.77 106.09 18.12 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.222 -1.354 . . . . 1.0 109.567 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -118.3 178.04 4.59 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.458 ' HB3' HG21 ' B' ' 208' ' ' VAL . 52.4 p-90 -147.8 167.33 25.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.459 0.647 . . . . 1.0 111.979 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -146.25 146.5 30.78 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.422 -1.263 . . . . 1.0 110.432 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.557 ' HG ' HD13 ' B' ' 228' ' ' LEU . 33.7 tp -105.53 130.69 53.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 174.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.06 132.96 66.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.919 -175.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.529 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.5 t-80 -82.93 173.76 11.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.292 -0.632 . . . . 1.0 109.292 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.87 -36.87 68.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.08 0.467 . . . . 1.0 110.698 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -63.2 -32.96 74.49 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.296 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.22 11.22 24.36 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 114.769 -1.105 . . . . 1.0 112.45 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.529 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.57 143.2 27.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.789 -0.206 . . . . 1.0 111.359 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . 0.434 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.37 116.39 22.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.53 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.557 HD13 ' HG ' ' B' ' 220' ' ' LEU . 17.0 mt -88.73 -42.8 11.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.019 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -149.52 168.31 23.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.054 -0.975 . . . . 1.0 111.625 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -141.67 156.3 45.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.09 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 66.0 p -54.37 -35.14 62.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.0 0.37 . . . . 1.0 112.0 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.74 -33.68 3.47 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.045 -0.598 . . . . 1.0 111.761 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -122.89 178.57 4.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 1.0 111.174 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -143.01 137.43 7.67 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.337 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -140.01 166.71 23.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.814 -0.439 . . . . 1.0 109.814 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.02 29.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.8 m -126.26 131.84 51.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.325 0.583 . . . . 1.0 111.347 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.17 -35.93 81.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.034 -0.985 . . . . 1.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.486 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.5 tt0 -57.86 -47.22 83.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.251 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -59.9 -40.43 88.76 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.124 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.52 74.57 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.587 0.708 . . . . 1.0 109.533 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.45 ' HA ' HD13 ' B' ' 245' ' ' ILE . 49.3 mtmt -64.38 -35.54 81.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.528 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.486 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.2 mm-40 -64.22 -31.24 72.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.79 -41.11 95.86 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.458 ' O ' HG11 ' B' ' 248' ' ' VAL . 65.6 mt -62.4 -43.86 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.064 -0.568 . . . . 1.0 110.278 177.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.9 -41.58 99.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.193 0.52 . . . . 1.0 110.141 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.7 m -64.38 -34.36 77.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.981 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.48 -41.33 49.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.968 -177.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -66.89 -11.86 57.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.035 0.445 . . . . 1.0 111.798 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -2.92 31.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.905 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -135.36 -42.74 0.7 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.77 0.656 . . . . 1.0 112.77 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.498 ' HB2' HG23 ' B' ' 248' ' ' VAL . . . -53.64 -48.34 93.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.1 Cg_endo -64.23 -10.6 24.18 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.036 1.158 . . . . 1.0 113.079 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.49 -22.12 7.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.373 0.508 . . . . 1.0 112.373 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 105' ' ' HIS . . . -65.95 134.88 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.654 0.74 . . . . 1.0 112.736 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.47 142.08 29.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.423 -1.262 . . . . 1.0 110.691 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -89.13 134.18 29.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.8 mt -112.23 139.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.662 -1.154 . . . . 1.0 108.695 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.0 100.24 12.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.311 -0.852 . . . . 1.0 110.984 -177.783 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.8 ppp? . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 112.187 0.44 . . . . 1.0 112.187 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -107.54 170.55 7.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.223 0.535 . . . . 1.0 111.905 -176.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -123.34 95.11 4.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 173.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.76 174.86 2.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.03 -0.987 . . . . 1.0 108.979 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -170.29 147.88 3.15 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.573 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -86.15 150.18 24.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.258 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -141.46 121.46 13.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.413 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.427 HG23 ' HB3' ' A' ' 118' ' ' TRP . 85.3 t -93.67 133.87 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.068 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.77 178.49 7.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.633 0.254 . . . . 1.0 110.414 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -100.53 136.79 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.772 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 112' ' ' ALA . 11.6 t70 -83.03 -178.97 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.326 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.446 ' H ' ' CG ' ' A' ' 111' ' ' ASP . . . -69.31 -13.01 62.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.651 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.14 19.58 17.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.962 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 71.0 38.25 1.14 Allowed 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.275 -0.875 . . . . 1.0 111.182 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 3.1 mmtp -108.91 153.29 23.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.804 -1.089 . . . . 1.0 111.219 -175.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -95.01 118.14 31.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.232 -0.895 . . . . 1.0 109.666 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -133.59 -179.03 5.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.107 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.427 ' HB3' HG23 ' A' ' 108' ' ' VAL . 58.7 p-90 -151.31 162.1 41.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.884 0.373 . . . . 1.0 111.455 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.434 HH21 HG13 ' A' ' 127' ' ' ILE . 36.3 mmm-85 -144.37 139.91 28.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.725 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.55 ' HG ' HD13 ' A' ' 128' ' ' LEU . 33.4 tp -96.94 131.44 43.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 176.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.0 t -131.07 132.34 63.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.054 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.495 ' CB ' HD22 ' A' ' 126' ' ' ASN . 4.4 t-80 -78.31 172.9 12.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -57.95 -30.93 66.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.207 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -33.68 67.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.94 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.03 13.84 10.59 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.244 -0.889 . . . . 1.0 113.836 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.495 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -87.85 143.68 27.0 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.075 0.15 . . . . 1.0 110.717 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.434 HG13 HH21 ' A' ' 119' ' ' ARG . 44.6 mm -76.36 115.13 17.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.55 HD13 ' HG ' ' A' ' 120' ' ' LEU . 17.1 mt -88.4 -42.25 12.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.789 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.05 170.53 20.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.283 -0.871 . . . . 1.0 111.582 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.962 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -53.52 -36.43 61.77 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.416 0.447 . . . . 1.0 111.896 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.76 -43.54 3.25 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.529 -0.628 . . . . 1.0 111.529 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 89.2 mt-10 -108.88 179.93 4.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.293 -0.454 . . . . 1.0 110.826 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.86 134.54 4.51 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -142.88 170.94 14.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 117.077 0.439 . . . . 1.0 110.637 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.06 24.65 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 m -118.63 131.11 56.18 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.362 0.601 . . . . 1.0 111.478 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -65.87 -33.67 76.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.803 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.0 tt0 -61.33 -48.48 81.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.971 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -56.82 -40.49 76.13 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.982 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.18 -53.38 58.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.239 0.543 . . . . 1.0 110.217 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.436 ' HA ' HD13 ' A' ' 145' ' ' ILE . 41.7 mtmt -63.82 -36.72 84.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.238 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.8 mm-40 -63.79 -28.8 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 1.0 110.021 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.51 96.74 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.477 ' O ' HG13 ' A' ' 148' ' ' VAL . 40.4 mt -64.11 -44.6 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.208 0.528 . . . . 1.0 110.133 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -60.34 -43.99 95.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.401 . . . . 1.0 110.149 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.4 m -64.37 -33.82 76.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.724 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.489 HG21 ' HB1' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -74.43 -41.86 49.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.151 -0.62 . . . . 1.0 109.822 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -68.74 -11.57 60.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.085 0.469 . . . . 1.0 111.588 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -101.25 -3.14 29.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.928 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -138.07 -38.63 0.56 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.489 ' HB1' HG21 ' A' ' 148' ' ' VAL . . . -55.42 -49.92 89.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.57 -9.52 25.67 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 120.906 1.071 . . . . 1.0 112.95 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -109.8 -28.68 8.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.445 0.641 . . . . 1.0 110.927 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -62.08 135.8 57.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.873 -1.058 . . . . 1.0 113.671 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -96.59 140.65 30.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.064 -1.426 . . . . 1.0 110.716 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.58 133.11 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.352 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.3 mt -118.21 139.24 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 114.766 -1.106 . . . . 1.0 108.933 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -88.16 106.04 17.92 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.533 -0.746 . . . . 1.0 111.164 -177.349 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.1 ppp? . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 111.602 0.223 . . . . 1.0 111.602 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -94.64 167.24 11.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.339 0.59 . . . . 1.0 111.512 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.45 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 32.4 mmtp -136.98 97.88 3.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.31 169.19 3.87 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.86 -1.064 . . . . 1.0 109.183 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.438 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 55.8 p-80 -171.34 149.1 2.7 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.517 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 61.8 m-85 -85.34 148.06 26.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.299 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -139.57 118.83 12.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.482 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' B' ' 218' ' ' TRP . 82.3 t -93.92 133.23 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.677 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -145.36 -178.4 6.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.648 0.261 . . . . 1.0 110.555 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.8 t -99.8 137.43 27.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.623 . . . . 1.0 112.238 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 17.9 t70 -83.07 179.78 7.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.565 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.437 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.31 -16.36 63.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.473 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.49 19.84 18.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.182 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 69.28 41.26 1.37 Allowed 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.857 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 3.2 mmtp -110.95 156.51 21.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.266 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -99.82 117.03 33.27 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.854 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 20.6 mtp-105 -132.42 179.11 6.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' B' ' 231' ' ' SER . 56.7 p-90 -151.72 163.66 38.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.079 0.466 . . . . 1.0 111.649 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -147.29 145.96 29.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.05 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.558 ' HG ' HD13 ' B' ' 228' ' ' LEU . 34.0 tp -96.28 131.85 42.36 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.19 133.79 62.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.738 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.559 ' CB ' HD22 ' B' ' 226' ' ' ASN . 5.5 t-80 -79.77 171.31 15.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 36.6 t70 -62.54 -22.18 66.12 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.152 0.501 . . . . 1.0 110.851 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.34 -33.21 67.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.521 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.85 11.26 19.4 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 114.791 -1.095 . . . . 1.0 112.86 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.559 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.27 142.92 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.655 0.264 . . . . 1.0 111.572 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.55 116.81 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.491 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.558 HD13 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -89.58 -42.53 11.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.734 . . . . 1.0 109.638 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.18 164.97 35.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.845 -1.071 . . . . 1.0 111.597 177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -140.67 153.37 45.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.238 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.6 p -52.88 -36.9 59.87 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.03 -47.31 3.51 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -96.74 -172.86 2.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.265 -0.468 . . . . 1.0 111.25 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -159.05 133.86 3.55 Favored Glycine 0 N--CA 1.454 -0.16 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -145.07 169.85 17.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.93 0.365 . . . . 1.0 110.338 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.38 9.11 41.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.708 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 m -116.0 129.53 56.41 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.425 0.631 . . . . 1.0 110.928 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -66.97 -34.5 77.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.951 -1.022 . . . . 1.0 110.364 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.3 tt0 -61.12 -46.12 91.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.255 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.66 -40.55 83.82 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.788 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.11 70.62 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.482 0.658 . . . . 1.0 110.127 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.454 ' HA ' HD13 ' B' ' 245' ' ' ILE . 47.4 mtmt -64.6 -37.0 86.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.91 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -64.05 -29.58 70.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -64.97 -41.37 97.37 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.462 -1.055 . . . . 1.0 110.462 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.463 ' O ' HG13 ' B' ' 248' ' ' VAL . 56.8 mt -62.48 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 1.0 110.193 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -63.06 -40.11 96.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.3 m -65.62 -35.39 80.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.633 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.495 HG21 ' HB1' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -75.3 -39.96 42.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.069 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 63.8 mtpt -66.79 -12.51 59.14 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.987 0.365 . . . . 1.0 111.987 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -100.27 -12.12 19.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.843 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -120.97 -40.14 2.65 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.103 -0.499 . . . . 1.0 112.18 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.495 ' HB1' HG21 ' B' ' 248' ' ' VAL . . . -55.0 -48.94 94.78 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.5 Cg_endo -66.87 -11.69 33.09 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.276 1.317 . . . . 1.0 113.399 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -116.0 -16.76 11.05 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . . . . . . . . . . . -69.22 139.05 54.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.805 0.669 . . . . 1.0 112.805 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -94.88 147.41 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.666 -1.152 . . . . 1.0 111.99 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.443 HG21 HG21 ' A' ' 145' ' ' ILE . 40.9 t -84.39 130.45 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.438 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.2 mt -128.85 142.47 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.541 -0.541 . . . . 1.0 109.541 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.9 113.17 22.46 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.203 -0.903 . . . . 1.0 110.843 -177.838 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.419 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.1 tmt? . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.06 -0.019 . . . . 1.0 110.968 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 101' ' ' MET . 12.6 p-10 171.03 168.65 0.08 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.117 0.886 . . . . 1.0 109.942 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 38.7 mmtm -145.28 96.36 2.82 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 173.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.13 176.44 1.73 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.01 -0.996 . . . . 1.0 109.533 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.9 p-80 -170.23 145.42 2.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.439 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.1 m-85 -85.51 147.61 26.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.146 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.68 119.97 13.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.592 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 118' ' ' TRP . 86.1 t -95.21 132.27 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.164 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -143.14 178.08 7.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.1 t -97.82 134.18 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.215 0.531 . . . . 1.0 111.562 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 112' ' ' ALA . 13.2 t70 -79.22 -180.0 7.06 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 1.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.403 ' H ' ' CG ' ' A' ' 111' ' ' ASP . . . -68.51 -15.3 63.49 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.942 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.63 21.47 16.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.713 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 69.75 35.85 2.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.626 0.77 . . . . 1.0 111.506 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -110.84 149.55 30.42 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.881 -176.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -91.63 112.0 23.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.801 -1.09 . . . . 1.0 109.537 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.478 HH12 ' CG ' ' A' ' 130' ' ' ASP . 19.2 mtm105 -126.8 179.92 5.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.437 ' HB3' HG21 ' A' ' 108' ' ' VAL . 55.8 p-90 -152.1 162.11 41.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.187 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 42.6 mtp180 -148.23 143.66 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.146 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 128' ' ' LEU . 34.7 tp -93.62 134.39 35.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.3 131.02 71.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.896 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.545 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.9 t-80 -78.97 171.74 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 12.0 t70 -56.0 -33.59 65.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.003 0.43 . . . . 1.0 111.216 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -34.34 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.13 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.36 10.92 14.2 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.124 -0.944 . . . . 1.0 113.09 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.545 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.22 145.84 24.71 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.52 0.192 . . . . 1.0 111.52 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.5 123.55 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 123.778 0.674 . . . . 1.0 109.926 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.55 HD11 ' HG ' ' A' ' 120' ' ' LEU . 15.1 mt -98.07 -43.47 7.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.067 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.7 164.58 33.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.983 -1.008 . . . . 1.0 111.336 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 117' ' ' ARG . 6.8 t70 -139.7 152.82 46.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.246 -0.888 . . . . 1.0 108.86 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.7 p -56.32 -38.41 71.26 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.31 0.485 . . . . 1.0 112.31 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.43 -42.66 3.17 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -94.52 172.14 8.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.152 -0.524 . . . . 1.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.63 124.67 1.52 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -142.05 171.05 14.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.714 0.257 . . . . 1.0 110.742 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.43 10.24 20.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.265 0.839 . . . . 1.0 113.265 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 m -120.0 130.71 54.86 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.529 0.68 . . . . 1.0 111.636 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.52 -35.41 80.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.485 -1.234 . . . . 1.0 110.333 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.5 tt0 -62.02 -45.96 91.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.484 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -59.9 -39.15 84.4 Favored 'General case' 0 CA--C 1.521 -0.163 0 O-C-N 123.2 0.313 . . . . 1.0 110.883 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.48 69.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.604 0.716 . . . . 1.0 109.786 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.476 ' HA ' HD13 ' A' ' 145' ' ' ILE . 45.0 mtmt -64.91 -33.77 76.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.561 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -65.64 -32.36 73.88 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 1.0 110.03 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.5 -39.87 97.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.501 ' O ' HG11 ' A' ' 148' ' ' VAL . 67.4 mt -60.24 -51.49 72.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.529 0.681 . . . . 1.0 110.758 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.83 -33.03 75.04 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.5 m -66.03 -37.64 86.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.535 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.501 HG11 ' O ' ' A' ' 145' ' ' ILE . 1.1 p -74.42 -40.0 48.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 120.399 -0.521 . . . . 1.0 109.846 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.61 -15.77 61.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.958 0.408 . . . . 1.0 111.871 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -100.1 -2.48 34.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.916 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.419 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 11.8 m-80 -133.74 -37.08 0.93 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.903 -177.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.475 ' HB3' HG23 ' A' ' 148' ' ' VAL . . . -55.85 -50.47 86.97 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.365 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.7 Cg_endo -64.44 -12.07 31.44 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 121.29 1.327 . . . . 1.0 113.419 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.13 -18.58 9.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.179 0.437 . . . . 1.0 112.179 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' B' ' 205' ' ' HIS . . . -66.03 135.71 55.04 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.484 0.659 . . . . 1.0 112.337 -177.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.78 132.39 34.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.585 -1.189 . . . . 1.0 110.919 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.41 130.79 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.462 0.648 . . . . 1.0 111.698 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt -120.32 145.84 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.474 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -89.39 102.39 15.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.606 -0.712 . . . . 1.0 110.549 -177.535 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 29.3 ttp . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.29 -0.263 . . . . 1.0 110.29 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . 0.419 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 21.1 p-10 -178.69 171.85 1.45 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.515 0.674 . . . . 1.0 112.323 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -138.92 96.32 3.1 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.093 -1.817 . . . . 1.0 106.093 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.81 175.69 2.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.638 -1.165 . . . . 1.0 108.612 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 52.5 p-80 -170.04 146.99 3.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.054 -0.259 . . . . 1.0 110.575 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 46.8 m-85 -87.11 146.69 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.479 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.65 121.4 13.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.856 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.416 HG21 ' HB3' ' B' ' 218' ' ' TRP . 96.3 t -94.27 133.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.767 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -144.48 -179.55 6.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.572 0.225 . . . . 1.0 110.582 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.7 t -96.14 133.48 37.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.138 -0.483 . . . . 1.0 112.232 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.421 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 41.4 t0 -81.74 178.34 8.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.928 179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.421 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -70.37 -6.92 38.89 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.314 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.28 17.91 16.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.995 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 69.57 39.19 1.6 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.94 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 13.2 mmtt -111.04 156.88 20.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.121 -0.945 . . . . 1.0 111.217 -175.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.448 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 70.6 m-85 -98.74 102.53 14.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.799 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.504 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 14.9 mmm180 -121.5 179.82 4.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.416 ' HB3' HG21 ' B' ' 208' ' ' VAL . 51.5 p-90 -150.94 160.48 43.89 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.802 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -145.95 146.35 31.01 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.091 -0.959 . . . . 1.0 109.666 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.559 ' HG ' HD11 ' B' ' 228' ' ' LEU . 32.1 tp -95.78 132.63 40.81 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 t -127.41 130.12 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.354 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.478 ' CB ' HD22 ' B' ' 226' ' ' ASN . 1.9 t-80 -82.51 173.66 11.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.26 -36.34 63.51 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.38 0.425 . . . . 1.0 111.913 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -65.08 -31.12 72.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.22 0.533 . . . . 1.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.31 13.86 21.77 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.375 -0.829 . . . . 1.0 112.41 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.478 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.41 142.08 27.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 111.789 0.292 . . . . 1.0 111.789 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.53 121.73 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.882 0.739 . . . . 1.0 109.564 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.559 HD11 ' HG ' ' B' ' 220' ' ' LEU . 14.5 mt -96.92 -43.8 7.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.228 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -150.83 163.88 37.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.419 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.38 160.07 40.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.383 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.46 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 83.6 p -60.24 -40.71 91.22 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.52 -48.38 2.59 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.285 -0.483 . . . . 1.0 112.669 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -94.75 -169.78 2.09 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.231 0.612 . . . . 1.0 110.936 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.504 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -156.75 136.43 4.95 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.715 -0.755 . . . . 1.0 113.289 176.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -143.92 168.66 19.43 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.396 -0.594 . . . . 1.0 109.396 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.49 11.43 36.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -127.0 135.02 50.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.207 -0.597 . . . . 1.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.14 -39.6 93.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.148 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.0 tt0 -57.65 -45.72 85.15 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.287 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -60.94 -39.53 89.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.787 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.2 -49.7 76.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.472 0.653 . . . . 1.0 110.231 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.523 ' HA ' HD13 ' B' ' 245' ' ' ILE . 45.2 mtmt -64.81 -32.8 74.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.112 -0.949 . . . . 1.0 111.47 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.8 mm-40 -63.6 -33.02 74.69 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.588 -0.445 . . . . 1.0 109.916 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.78 95.31 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.523 HD13 ' HA ' ' B' ' 242' ' ' LYS . 75.9 mt -60.73 -52.36 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.664 0.745 . . . . 1.0 110.258 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.29 -33.97 77.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.264 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.4 m -67.61 -35.9 79.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.511 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.505 HG11 ' O ' ' B' ' 245' ' ' ILE . 0.8 OUTLIER -72.49 -40.47 63.53 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.373 -177.676 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.59 -15.45 61.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.121 -0.49 . . . . 1.0 112.187 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -103.35 -2.75 26.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.866 0.365 . . . . 1.0 111.3 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 28.6 m-80 -130.46 -38.37 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 111.452 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.474 ' HB3' HG23 ' B' ' 248' ' ' VAL . . . -55.86 -50.49 86.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.681 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.5 Cg_endo -63.24 -10.98 23.1 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.273 1.315 . . . . 1.0 113.663 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.11 -15.92 9.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.963 0.411 . . . . 1.0 111.938 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.22 138.65 57.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.68 0.752 . . . . 1.0 112.633 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -89.21 141.68 28.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.938 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.412 HG22 HG23 ' A' ' 145' ' ' ILE . 60.6 t -83.74 128.66 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.432 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 12.3 mt -121.71 138.14 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -91.74 100.87 13.5 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.303 -0.856 . . . . 1.0 111.675 -176.699 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 28.9 ttp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.904 0.383 . . . . 1.0 111.455 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -92.94 -174.42 3.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.321 1.058 . . . . 1.0 113.579 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 28.8 mmtp -138.25 98.19 3.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.987 -1.915 . . . . 1.0 107.461 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.1 169.89 3.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.455 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.6 p-80 -168.22 150.34 5.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.233 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 63.7 m-85 -86.73 148.95 25.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.906 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.27 123.83 14.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.785 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 118' ' ' TRP . 91.1 t -94.75 134.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 O-C-N 123.585 0.553 . . . . 1.0 110.475 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -142.78 178.61 7.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.608 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -100.67 140.24 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.478 0.656 . . . . 1.0 112.689 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.83 177.87 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.416 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.57 -14.36 62.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.362 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.01 17.89 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.11 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 70.82 34.77 1.91 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.377 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -109.7 152.99 24.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.507 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.72 112.11 23.9 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.016 -0.993 . . . . 1.0 110.612 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -123.18 179.28 4.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 131' ' ' SER . 57.6 p-90 -153.02 168.47 25.74 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.366 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -150.76 152.28 33.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.508 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.557 ' HG ' HD13 ' A' ' 128' ' ' LEU . 32.9 tp -99.84 131.23 45.94 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -126.54 130.48 71.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.289 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.555 ' CB ' HD22 ' A' ' 126' ' ' ASN . 2.4 t-80 -79.67 172.35 13.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.467 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 32.2 t70 -57.22 -30.98 65.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 1.0 111.342 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.66 -33.37 74.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.504 0.669 . . . . 1.0 110.07 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.38 11.74 19.06 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 114.982 -1.008 . . . . 1.0 112.789 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.555 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.59 143.51 26.9 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.67 119.07 22.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.802 0.689 . . . . 1.0 109.744 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.557 HD13 ' HG ' ' A' ' 120' ' ' LEU . 15.0 mt -94.41 -43.31 8.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.63 0.729 . . . . 1.0 109.608 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.73 166.61 27.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.641 -1.163 . . . . 1.0 111.201 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -140.14 158.19 44.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.425 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 53.9 p -57.44 -35.23 69.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.448 . . . . 1.0 111.452 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.7 -48.62 3.54 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -102.87 171.8 7.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.374 -0.913 . . . . 1.0 111.648 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.04 139.06 9.29 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.236 -1.145 . . . . 1.0 110.236 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -141.53 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.175 0.488 . . . . 1.0 110.852 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.57 9.98 27.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -125.82 130.53 51.59 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.727 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.104 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.449 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 10.0 tt0 -59.41 -42.14 91.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.962 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.537 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.4 OUTLIER -62.62 -39.78 94.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.005 -179.053 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.33 87.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.962 0.411 . . . . 1.0 109.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.437 ' HZ1' ' CB ' ' A' ' 142' ' ' LYS . 7.3 mtmp? -63.86 -43.19 96.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.117 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 32.8 mm-40 -60.01 -27.05 66.56 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.69 -46.32 90.22 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.502 ' O ' HG13 ' A' ' 148' ' ' VAL . 61.1 mt -62.51 -48.82 86.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.946 0.879 . . . . 1.0 109.938 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.53 -40.04 90.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.287 -0.869 . . . . 1.0 110.857 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -69.93 -34.55 73.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.213 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.524 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -70.5 -39.13 75.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 C-N-CA 120.08 -0.648 . . . . 1.0 110.033 -176.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.79 -12.98 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.975 -0.453 . . . . 1.0 111.516 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -104.69 -3.1 24.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.656 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -129.87 -42.76 1.25 Allowed 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.305 -0.407 . . . . 1.0 112.068 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.524 ' HB3' HG21 ' A' ' 148' ' ' VAL . . . -55.06 -50.94 83.58 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.9 Cg_endo -64.48 -13.15 36.9 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.129 1.219 . . . . 1.0 112.952 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.2 -27.56 9.5 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.324 0.583 . . . . 1.0 111.23 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 134.83 55.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.071 -0.968 . . . . 1.0 113.207 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.25 141.02 31.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.982 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -86.99 135.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.679 . . . . 1.0 112.344 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt -124.19 148.87 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.7 -1.136 . . . . 1.0 109.241 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.09 110.67 20.82 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.942 -0.762 . . . . 1.0 108.942 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.321 -0.847 . . . . 1.0 111.357 -177.191 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.933 0.396 . . . . 1.0 111.497 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -95.62 178.78 5.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.931 0.872 . . . . 1.0 112.805 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . 0.488 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 22.7 mmtp -141.74 97.6 3.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.68 -1.6 . . . . 1.0 108.142 173.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.65 170.75 3.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.147 -0.933 . . . . 1.0 109.679 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.412 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 55.1 p-80 -170.01 147.79 3.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.0 m-85 -85.62 150.71 24.44 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.332 0.395 . . . . 1.0 110.383 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -143.09 124.3 14.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.862 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . . . . . . . . . 78.2 t -95.08 133.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.937 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.8 -178.21 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.663 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -110.89 137.72 42.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.358 0.503 . . . . 1.0 112.358 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 25.4 t70 -83.25 -178.77 7.2 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.583 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.478 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.63 -17.92 64.2 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.954 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.85 25.62 11.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 62.07 38.96 13.57 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.859 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -97.44 155.53 16.88 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.453 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 73.4 m-85 -109.05 102.92 11.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.311 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.496 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -122.54 -178.56 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -176.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -151.29 162.83 40.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.768 0.318 . . . . 1.0 111.384 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -147.56 146.71 29.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.549 ' HG ' HD13 ' B' ' 228' ' ' LEU . 35.2 tp -93.86 132.68 38.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.92 129.88 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.66 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.538 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.4 t-80 -80.04 174.54 11.49 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 26.7 t70 -55.93 -34.34 65.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.018 0.437 . . . . 1.0 111.46 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.96 -33.65 76.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.646 0.736 . . . . 1.0 110.324 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.01 10.7 22.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.967 -1.015 . . . . 1.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.538 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.02 143.49 27.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.593 0.235 . . . . 1.0 111.626 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -76.29 119.81 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.665 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.549 HD13 ' HG ' ' B' ' 220' ' ' LEU . 15.5 mt -94.19 -44.14 8.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.987 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -147.79 160.78 42.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.711 -1.131 . . . . 1.0 111.02 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.07 158.83 43.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.468 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 71.7 p -57.63 -37.37 73.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.49 0.552 . . . . 1.0 112.49 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.51 -50.56 3.55 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 121.184 0.325 . . . . 1.0 112.691 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -89.86 -168.67 2.2 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.409 0.684 . . . . 1.0 110.863 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.496 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -158.98 134.4 3.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.55 -0.833 . . . . 1.0 113.4 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.46 173.73 11.37 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.56 12.31 35.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.2 m -131.03 135.69 47.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.934 -0.706 . . . . 1.0 111.842 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.84 -39.65 95.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.032 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.6 tt0 -56.52 -44.01 80.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.494 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . 0.538 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.32 -39.22 86.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.72 87.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.491 ' HA ' HD11 ' B' ' 245' ' ' ILE . 6.9 mtmp? -64.98 -37.78 88.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.765 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.46 -41.2 77.99 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.475 -0.869 . . . . 1.0 111.006 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' B' ' 242' ' ' LYS . 72.6 mt -60.19 -48.59 87.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.9 0.857 . . . . 1.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.49 -35.95 82.14 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.756 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.9 m -67.07 -37.1 83.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.402 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.521 HG21 ' HB1' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -72.55 -41.66 63.63 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.593 -177.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.24 -13.63 60.66 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.125 -0.359 . . . . 1.0 111.585 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -103.73 -2.64 26.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.839 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -130.85 -40.46 1.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.993 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.521 ' HB1' HG21 ' B' ' 248' ' ' VAL . . . -55.34 -50.53 86.16 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.6 Cg_endo -64.92 -16.6 56.21 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.208 1.272 . . . . 1.0 112.905 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.69 -29.8 11.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.588 0.709 . . . . 1.0 111.146 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.455 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -63.92 141.05 58.91 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.201 1.186 . . . . 1.0 114.201 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -103.47 146.38 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.096 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.4 p -93.27 132.05 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -120.64 150.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.187 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -85.02 108.16 17.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.328 -177.715 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.5 tmt? . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.504 0.192 . . . . 1.0 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -70.64 165.87 21.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.165 0.507 . . . . 1.0 111.877 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 47.5 mmtm -134.49 95.98 3.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -176.39 179.19 1.23 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.107 -0.952 . . . . 1.0 109.085 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.426 ' HA ' ' HB2' ' B' ' 255' ' ' ALA . 24.7 p-80 -171.69 147.9 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.383 0.427 . . . . 1.0 110.066 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 59.1 m-85 -85.47 152.05 23.49 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.832 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -140.62 120.22 13.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 118' ' ' TRP . 99.0 t -97.6 134.67 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.516 0.51 . . . . 1.0 109.738 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.37 178.28 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 110.611 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -99.39 134.12 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.455 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.55 179.85 7.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.02 62.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.478 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.76 19.2 18.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 70.91 36.42 1.49 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.742 0.651 . . . . 1.0 110.739 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.1 mmtt -109.3 150.51 27.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.289 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.07 111.72 23.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.369 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 mtm105 -128.76 179.13 5.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.436 ' HB3' HG23 ' A' ' 108' ' ' VAL . 57.6 p-90 -150.63 166.5 30.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 1.0 111.977 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -146.82 149.24 32.93 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.868 -1.06 . . . . 1.0 110.213 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.559 ' HG ' HD11 ' A' ' 128' ' ' LEU . 34.1 tp -100.56 133.17 45.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.58 130.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.048 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.533 ' CB ' HD22 ' A' ' 126' ' ' ASN . 3.3 t-80 -76.47 170.45 16.36 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.1 t70 -60.55 -24.18 65.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.116 0.484 . . . . 1.0 110.663 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -34.3 69.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.783 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 8.97 17.34 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.036 -0.983 . . . . 1.0 113.386 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.533 HD22 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.62 143.36 26.87 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.1 0.408 . . . . 1.0 112.1 -179.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.6 mm -73.83 118.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.811 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.559 HD11 ' HG ' ' A' ' 120' ' ' LEU . 17.4 mt -94.13 -44.12 8.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.491 0.662 . . . . 1.0 109.818 -178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.56 165.1 34.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.285 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.6 154.4 47.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.427 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 20.7 p -51.86 -40.75 61.09 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.389 0.514 . . . . 1.0 112.389 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 -46.46 3.01 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -93.97 -178.84 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 1.0 110.597 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.74 127.63 2.14 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.253 -1.139 . . . . 1.0 110.253 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -139.8 173.23 11.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.311 0.556 . . . . 1.0 110.075 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.87 9.53 42.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.23 131.33 56.38 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.198 -0.601 . . . . 1.0 110.949 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.11 -38.4 90.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.819 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.4 tt0 -63.33 -42.81 99.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.149 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.489 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -58.07 -42.77 86.26 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.985 -177.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.11 75.24 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.17 0.509 . . . . 1.0 110.524 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HA ' HD13 ' A' ' 145' ' ' ILE . 45.2 mtmt -63.8 -35.22 79.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.736 -0.666 . . . . 1.0 111.165 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.0 mm-40 -65.09 -26.83 68.39 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.19 97.13 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.04 -1.224 . . . . 1.0 110.04 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 148' ' ' VAL . 55.8 mt -63.11 -45.15 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.194 0.521 . . . . 1.0 109.99 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.12 -38.28 88.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.093 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.8 m -65.3 -36.17 83.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.565 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.525 HG22 ' HB1' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.88 -42.37 46.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.474 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.99 -15.32 62.91 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.287 0.477 . . . . 1.0 112.287 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -103.61 -2.04 27.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.536 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -131.87 -40.07 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.574 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.525 ' HB1' HG22 ' A' ' 148' ' ' VAL . . . -56.51 -50.41 87.9 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.89 -0.596 . . . . 1.0 112.606 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 33.7 Cg_endo -63.4 -12.8 32.43 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.096 1.198 . . . . 1.0 113.162 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.97 -26.26 8.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.999 0.428 . . . . 1.0 111.574 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' B' ' 205' ' ' HIS . . . -62.4 137.99 58.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.698 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -94.75 149.48 21.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.186 -1.37 . . . . 1.0 111.976 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.415 HG22 HG22 ' B' ' 245' ' ' ILE . 43.9 t -86.17 131.67 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.537 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt -128.48 138.21 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -88.94 109.04 19.9 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.194 -0.907 . . . . 1.0 112.028 -176.44 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.674 0.273 . . . . 1.0 110.416 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -79.3 169.39 18.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 1.0 111.525 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -138.43 97.03 3.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.06 171.58 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.522 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' HIS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 52.9 p-80 -170.21 148.54 3.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.91 177.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.8 m-85 -87.05 148.82 25.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -141.72 122.38 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.788 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' B' ' 218' ' ' TRP . 97.7 t -96.6 133.96 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.623 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -145.15 -178.66 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.0 110.749 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.6 t -100.33 135.74 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.064 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 30.1 t0 -83.02 178.02 8.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.444 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . 0.406 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.56 -9.98 52.91 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.256 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.85 20.14 15.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.503 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 69.59 38.13 1.79 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.115 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.9 mmtt -108.16 151.67 25.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.539 -176.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' TYR . . . . . 0.43 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 81.9 m-85 -98.25 102.7 14.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.162 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . 0.504 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -120.26 179.37 4.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.365 0.415 . . . . 1.0 109.975 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' TRP . . . . . 0.466 ' HB3' HG21 ' B' ' 208' ' ' VAL . 56.0 p-90 -151.12 163.24 39.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.696 0.284 . . . . 1.0 111.62 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 36.3 mtp85 -148.25 145.0 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.99 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' LEU . . . . . 0.582 ' HG ' HD11 ' B' ' 228' ' ' LEU . 36.7 tp -97.62 135.01 40.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' HIS . . . . . 0.47 ' CB ' HD22 ' B' ' 226' ' ' ASN . 2.3 t-80 -84.78 177.23 8.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.645 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.01 -38.01 67.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.342 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -66.63 -33.12 74.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.572 0.701 . . . . 1.0 109.941 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 107.98 12.61 21.84 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.279 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.47 HD22 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.15 142.76 28.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.524 0.202 . . . . 1.0 111.334 179.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.5 mm -74.6 117.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' LEU . . . . . 0.582 HD11 ' HG ' ' B' ' 220' ' ' LEU . 21.3 mt -89.38 -43.16 11.1 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.076 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.63 159.51 44.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.533 177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -134.66 155.49 50.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' SER . . . . . 0.488 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 79.5 p -55.79 -40.53 72.79 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.731 0.641 . . . . 1.0 112.731 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.68 -52.52 3.0 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.269 -0.491 . . . . 1.0 112.692 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.01 -169.31 2.52 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.347 0.659 . . . . 1.0 110.707 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.504 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -160.06 132.24 2.91 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.926 -0.654 . . . . 1.0 112.675 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.36 170.6 15.39 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 116.72 0.26 . . . . 1.0 110.423 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.73 10.48 38.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.673 0.99 . . . . 1.0 113.673 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.5 m -122.07 132.08 54.31 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.035 -0.666 . . . . 1.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.37 -35.82 82.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.372 -0.831 . . . . 1.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.1 tt0 -60.08 -47.23 86.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.739 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -61.52 -36.02 79.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.03 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.74 -49.87 75.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.406 0.622 . . . . 1.0 109.602 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' LYS . . . . . 0.46 ' HA ' HD13 ' B' ' 245' ' ' ILE . 45.2 mtmt -65.47 -35.85 82.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.925 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.5 mm-40 -63.51 -29.65 70.88 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.67 96.77 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' ILE . . . . . 0.475 ' O ' HG13 ' B' ' 248' ' ' VAL . 53.1 mt -63.13 -45.61 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.054 -0.573 . . . . 1.0 109.925 177.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.81 -39.07 90.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.183 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 m -66.39 -34.86 78.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.677 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' VAL . . . . . 0.506 HG22 ' HB1' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -74.95 -43.21 45.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 120.27 -0.572 . . . . 1.0 110.289 -177.46 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -66.08 -11.96 52.22 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.104 -0.373 . . . . 1.0 111.946 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -100.72 -3.25 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -135.9 -36.97 0.74 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.828 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' ALA . . . . . 0.506 ' HB1' HG22 ' B' ' 248' ' ' VAL . . . -54.52 -49.87 88.56 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.833 -0.622 . . . . 1.0 112.659 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.1 Cg_endo -63.81 -11.52 27.2 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.691 1.594 . . . . 1.0 113.8 -177.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.93 -14.48 8.46 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' ALA . . . . . 0.426 ' HB2' ' HA ' ' A' ' 105' ' ' HIS . . . -68.04 137.16 54.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.444 0.64 . . . . 1.0 112.266 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -93.81 147.85 22.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.864 -1.062 . . . . 1.0 111.942 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 145' ' ' ILE . 40.8 t -84.61 132.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.281 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.1 134.22 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -87.13 100.48 12.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.466 -0.778 . . . . 1.0 110.97 -177.294 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.318 0 CA-C-O 121.216 0.531 . . . . 1.0 110.915 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 33.5 mmtp -140.13 98.31 3.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.65 172.33 3.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.627 -0.715 . . . . 1.0 109.904 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.503 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 52.3 p-80 -169.48 146.5 3.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.01 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.2 m-85 -85.0 145.57 27.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.592 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.98 124.26 20.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.346 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' A' ' 118' ' ' TRP . 62.6 t -96.48 133.78 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.449 -0.342 . . . . 1.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -142.95 179.72 6.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.027 0.205 . . . . 1.0 110.776 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.6 t -101.75 138.05 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.426 0.632 . . . . 1.0 112.485 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.71 178.15 8.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.379 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.51 -15.32 63.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 1.0 111.209 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.77 19.21 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.593 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 71.27 36.12 1.42 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.93 0.769 . . . . 1.0 110.927 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 10.5 mmtt -110.88 150.53 29.04 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.261 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -93.95 119.28 32.63 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.915 -1.038 . . . . 1.0 110.499 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -132.05 -179.95 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.49 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.2 p-90 -152.84 162.48 41.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.354 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -146.54 143.25 28.77 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.171 0.919 . . . . 1.0 109.882 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.726 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.1 tp -95.08 130.57 41.73 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.79 131.61 70.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.266 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -81.4 172.93 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 23.8 t70 -58.5 -27.46 64.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.27 0.557 . . . . 1.0 110.873 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.62 -32.85 70.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.772 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.88 12.76 21.71 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.9 -1.045 . . . . 1.0 112.626 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -89.42 146.98 24.29 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 51.1 mm -79.42 114.53 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.726 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.6 mt -87.94 -43.24 11.91 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.415 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -152.27 162.98 40.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.952 -1.022 . . . . 1.0 111.051 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -135.94 155.41 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.047 -1.094 . . . . 1.0 108.047 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 53.3 p -55.88 -38.74 70.55 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.332 0.395 . . . . 1.0 111.968 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.19 -33.96 2.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 131' ' ' SER . 47.2 mt-10 -87.97 -178.68 6.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.934 -0.633 . . . . 1.0 111.118 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.65 114.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.094 -1.203 . . . . 1.0 110.094 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.49 169.68 17.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.616 0.208 . . . . 1.0 110.45 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.54 10.03 14.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.9 m -122.41 131.33 53.83 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.631 0.729 . . . . 1.0 112.234 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -67.39 -32.25 73.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.527 -1.215 . . . . 1.0 109.734 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 53.3 tt0 -60.93 -46.79 89.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.229 -0.896 . . . . 1.0 109.915 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.29 -38.74 80.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.462 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.245 0.545 . . . . 1.0 109.918 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.8 mtmt -64.82 -33.36 75.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -64.86 -32.29 73.92 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.444 -0.502 . . . . 1.0 109.974 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -40.84 94.41 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.732 -0.747 . . . . 1.0 111.257 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 142' ' ' LYS . 71.9 mt -59.83 -51.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 1.0 110.613 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.19 -35.66 81.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.806 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.5 m -66.74 -34.99 79.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.003 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.71 -35.17 43.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.712 -177.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -68.92 -15.44 63.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.742 0.782 . . . . 1.0 110.238 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -99.39 -2.72 35.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.431 -1.259 . . . . 1.0 112.591 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -136.91 -39.12 0.62 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.944 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.16 -51.6 80.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 55.7 Cg_endo -66.41 -7.77 18.68 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.243 1.296 . . . . 1.0 113.229 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -116.56 -24.62 7.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.056 0.455 . . . . 1.0 111.644 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.05 136.88 57.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.946 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -92.07 137.84 32.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 1.0 110.724 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.57 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -88.99 131.51 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.378 0.609 . . . . 1.0 112.587 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 114.832 -1.076 . . . . 1.0 108.46 177.405 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.449 0.642 . . . . 1.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 72.8 mmtt -136.89 97.39 3.51 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.906 -1.516 . . . . 1.0 106.906 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.96 174.23 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.614 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.531 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 41.0 p-80 -170.95 148.16 2.77 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.273 0.358 . . . . 1.0 110.519 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.57 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 50.2 m-85 -85.61 149.56 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.734 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -141.99 118.39 10.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.721 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' B' ' 218' ' ' TRP . 75.9 t -93.48 132.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -143.16 -177.88 5.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.3 t -102.64 137.46 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 1.0 112.284 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.32 179.4 6.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.552 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.33 -14.61 62.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.049 0.452 . . . . 1.0 110.575 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.12 15.88 24.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.503 -0.772 . . . . 1.0 111.758 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' B' ' 210' ' ' VAL . 26.5 m-20 70.42 41.71 0.97 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.482 0.713 . . . . 1.0 110.611 177.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 9.2 mmtt -115.13 152.03 33.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.71 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.97 118.76 31.07 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.391 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -134.68 179.37 6.34 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.119 -0.946 . . . . 1.0 109.046 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.511 ' HB3' HG22 ' B' ' 208' ' ' VAL . 50.6 p-90 -154.28 161.46 41.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.516 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' B' ' 219' ' ' ARG . 9.2 mtp180 -147.31 142.85 27.59 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.885 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.703 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.8 tp -94.16 131.98 39.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 t -128.68 131.43 68.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.268 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -78.01 170.7 16.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 20.8 t70 -57.19 -27.7 62.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.373 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 224' ' ' ASN . . . . . 0.525 ' HB2' ' ND2' ' B' ' 226' ' ' ASN . 0.8 OUTLIER -74.81 -33.77 62.27 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.19 13.33 10.93 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 114.999 -1.0 . . . . 1.0 113.459 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' B' ' 224' ' ' ASN . 0.8 OUTLIER -87.96 144.57 26.47 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.904 -0.174 . . . . 1.0 111.256 178.514 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.36 123.36 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.815 0.697 . . . . 1.0 109.262 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.703 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.0 mt -99.35 -42.11 7.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.322 0.582 . . . . 1.0 109.796 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -153.01 164.3 38.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.895 -1.048 . . . . 1.0 111.625 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -139.61 153.49 47.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 1.0 108.897 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.419 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 11.9 p -51.58 -35.43 41.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.49 -46.6 3.51 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.119 -0.792 . . . . 1.0 111.119 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.7 mt-10 -107.43 173.99 6.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.955 -0.623 . . . . 1.0 111.73 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -133.65 145.62 17.65 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.965 -1.254 . . . . 1.0 109.965 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -142.48 171.95 13.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.359 0.579 . . . . 1.0 110.788 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.69 10.28 41.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.306 0.484 . . . . 1.0 112.306 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 9.5 m -136.69 134.8 37.61 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.357 0.598 . . . . 1.0 111.484 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -63.98 -35.41 80.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 52.9 tt0 -57.74 -48.32 79.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.607 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -61.88 -38.14 87.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.351 0.407 . . . . 1.0 110.847 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.46 -49.56 76.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 1.0 109.698 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' B' ' 245' ' ' ILE . 43.9 mtmt -64.8 -33.81 76.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.369 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.9 mm-40 -63.42 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.32 -0.552 . . . . 1.0 109.744 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.26 89.44 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' B' ' 242' ' ' LYS . 73.9 mt -60.88 -50.5 80.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.697 0.76 . . . . 1.0 110.374 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.36 -33.83 76.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.652 -0.704 . . . . 1.0 111.23 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 m -65.05 -38.69 91.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.175 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' B' ' 252' ' ' ALA . 1.1 p -73.92 -40.61 52.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.094 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.09 -15.25 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.177 0.513 . . . . 1.0 111.907 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -101.31 -1.47 33.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.825 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -135.82 -37.39 0.74 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.84 0.352 . . . . 1.0 111.942 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.47 -50.67 85.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 112.898 0.703 . . . . 1.0 112.898 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.6 Cg_endo -65.46 -10.4 26.07 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 120.764 0.976 . . . . 1.0 113.503 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.07 -20.39 8.71 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -66.02 135.34 54.53 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.86 -0.609 . . . . 1.0 112.27 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.89 139.52 30.67 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.764 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -91.7 128.31 43.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 258' ' ' ILE . . . . . 0.449 HD11 ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -124.4 146.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.283 -1.326 . . . . 1.0 110.174 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -91.26 114.66 27.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.926 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.077 -0.963 . . . . 1.0 111.19 -178.123 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 121.253 0.549 . . . . 1.0 111.5 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 45.1 mmtm -136.98 97.7 3.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.055 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.44 171.14 3.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.076 -0.965 . . . . 1.0 109.504 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 44.2 p-80 -169.22 148.32 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.5 m-85 -85.32 147.74 26.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.388 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.59 116.92 11.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 118' ' ' TRP . 97.0 t -92.47 133.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.579 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -142.71 179.25 7.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 1.0 110.707 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.3 t -103.36 134.41 44.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.939 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.7 -179.95 7.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.762 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.09 -12.97 62.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.776 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -115.24 26.88 9.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.257 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 65.58 30.48 10.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.404 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 71.9 mmtt -95.66 156.24 16.41 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.9 117.2 33.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.3 mtm105 -132.91 178.0 7.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.53 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.9 p-90 -150.53 163.27 38.86 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.931 0.396 . . . . 1.0 111.417 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.417 HH21 HG13 ' A' ' 127' ' ' ILE . 39.7 mtp180 -147.73 143.37 27.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.826 -1.079 . . . . 1.0 109.304 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.768 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.7 tp -91.61 131.66 36.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.6 t -128.29 130.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.43 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -79.08 170.95 15.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 11.7 t70 -55.73 -31.8 62.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.884 0.373 . . . . 1.0 111.187 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -66.3 -34.16 77.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.478 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.41 9.36 19.73 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.907 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -87.47 142.74 27.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.425 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 48.0 mm -77.09 118.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.634 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.768 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.2 mt -92.19 -42.42 9.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.217 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -152.0 164.77 36.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.654 -1.157 . . . . 1.0 111.255 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -137.32 154.02 50.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.844 . . . . 1.0 108.862 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 p -53.32 -35.01 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 1.0 112.343 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.0 -42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.566 -0.614 . . . . 1.0 111.566 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -102.79 -177.52 3.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.204 0.526 . . . . 1.0 111.556 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.9 126.31 1.8 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.4 173.1 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.136 0.468 . . . . 1.0 111.121 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.99 9.79 31.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.585 0.957 . . . . 1.0 113.585 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -122.64 130.55 53.1 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.427 0.632 . . . . 1.0 111.341 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.84 -38.31 88.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 62.0 tt0 -61.42 -41.39 97.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.081 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -60.06 -42.75 95.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.897 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.94 81.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.259 0.552 . . . . 1.0 110.196 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.24 -33.8 76.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.388 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -65.22 -31.45 72.62 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.921 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.98 -38.85 95.97 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.626 HG21 HG22 ' B' ' 257' ' ' VAL . 64.5 mt -61.28 -51.06 77.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.365 0.602 . . . . 1.0 110.304 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -63.41 -32.89 74.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.989 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -64.2 -39.68 94.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.336 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 152' ' ' ALA . 1.6 p -75.04 -38.28 42.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 C-N-CA 119.906 -0.718 . . . . 1.0 109.887 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -64.6 -13.83 55.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.145 0.498 . . . . 1.0 111.211 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -4.58 40.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.721 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 22.1 m-80 -137.03 -37.93 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.757 0.651 . . . . 1.0 112.757 -174.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -53.69 -50.01 85.82 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.1 Cg_endo -65.88 -14.12 43.09 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 120.882 1.055 . . . . 1.0 113.633 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.48 -27.46 8.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.546 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -61.32 135.51 57.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.555 0.946 . . . . 1.0 113.555 -176.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -90.98 139.21 30.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.06 -1.427 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.22 133.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.214 0.531 . . . . 1.0 111.983 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.356 178.83 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 12.8 p-10 . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.848 0.832 . . . . 1.0 112.622 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -143.74 98.94 3.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.899 -1.5 . . . . 1.0 107.447 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.33 173.58 2.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.789 -1.096 . . . . 1.0 109.223 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.546 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 54.1 p-80 -169.5 148.78 3.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.512 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 49.5 m-85 -85.42 145.41 27.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.143 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -139.0 120.73 15.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.511 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' B' ' 218' ' ' TRP . 72.4 t -92.48 132.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.889 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.402 ' CE2' ' HD3' ' B' ' 219' ' ' ARG . 11.3 p90 -140.39 -176.02 4.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.078 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' B' ' 214' ' ' ASP . 4.8 t -107.33 139.69 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 1.0 112.579 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -81.85 -179.75 7.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.144 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.9 0.381 . . . . 1.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.24 24.05 13.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.497 ' HA ' HG13 ' B' ' 210' ' ' VAL . 4.9 m-20 63.17 41.36 8.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.344 0.592 . . . . 1.0 111.09 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.4 mmtt -103.61 155.82 18.26 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.447 -0.797 . . . . 1.0 108.901 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.49 123.01 41.19 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.043 0.449 . . . . 1.0 110.308 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -137.51 -178.83 5.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.058 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.525 ' HB3' HG22 ' B' ' 208' ' ' VAL . 58.2 p-90 -155.37 162.59 40.77 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.413 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' B' ' 219' ' ' ARG . 13.5 mtp180 -146.63 146.78 30.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.041 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.722 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.9 tp -97.03 130.2 44.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.73 130.18 71.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.444 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -81.37 175.3 10.68 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.75 -35.56 63.88 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.347 0.404 . . . . 1.0 111.859 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -67.91 -33.26 74.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.285 0.564 . . . . 1.0 110.298 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.49 10.93 20.84 Favored Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 114.894 -1.048 . . . . 1.0 112.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -86.11 143.25 28.14 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 1.0 112.057 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.78 120.35 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.263 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.722 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.3 mt -97.39 -42.61 7.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.519 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -153.7 165.42 36.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.363 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.69 159.72 41.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 57.4 p -55.75 -33.81 64.64 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.151 0.5 . . . . 1.0 111.427 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.63 -51.19 3.58 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 57.4 mm-40 -100.99 177.79 4.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.979 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.95 139.5 9.67 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -137.49 172.46 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.544 0.672 . . . . 1.0 111.489 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.15 10.9 36.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.0 113.129 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 7.0 m -136.7 135.93 38.58 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.079 0.466 . . . . 1.0 110.926 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -64.53 -38.18 90.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 64.0 tt0 -57.24 -45.14 84.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.838 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -62.78 -40.75 98.29 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.906 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.63 79.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.558 0.694 . . . . 1.0 109.772 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.0 mtmt -65.02 -35.36 80.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.532 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.0 mm-40 -63.37 -28.02 69.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 176.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.75 -42.08 95.42 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' B' ' 242' ' ' LYS . 62.1 mt -61.83 -44.93 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.931 -0.634 . . . . 1.0 110.021 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.06 -39.74 93.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.208 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -67.68 -34.08 76.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.957 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.59 -39.27 53.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.03 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -68.43 -12.25 60.9 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.306 0.574 . . . . 1.0 111.078 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -101.22 -3.12 29.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 1.0 111.09 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -136.42 -40.09 0.65 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.35 -49.67 91.12 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 46.7 Cg_endo -66.48 -9.12 22.96 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 120.916 1.077 . . . . 1.0 113.456 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.61 -13.91 8.27 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -69.27 137.74 53.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.464 0.649 . . . . 1.0 112.13 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -91.14 144.01 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.997 -1.001 . . . . 1.0 111.495 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 145' ' ' ILE . 43.7 t -85.76 123.49 39.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.226 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.7 mt -115.53 138.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -89.65 100.51 13.3 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.492 -0.766 . . . . 1.0 110.965 -176.84 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-O 121.42 0.629 . . . . 1.0 111.806 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 35.2 mmtp -142.37 96.39 2.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.24 174.67 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.164 -177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 53.3 p-80 -168.94 147.3 3.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.694 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.566 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 47.1 m-85 -85.04 148.82 25.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.71 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.06 120.44 13.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.766 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 118' ' ' TRP . 83.6 t -94.76 137.95 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.937 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.39 -178.63 6.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.437 -0.208 . . . . 1.0 110.437 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 8.2 t -103.98 136.75 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.186 0.517 . . . . 1.0 112.363 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.24 -179.68 7.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.086 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.48 -15.19 63.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.075 0.398 . . . . 1.0 112.075 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.81 22.59 15.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.677 0.275 . . . . 1.0 111.396 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.87 40.3 1.32 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.695 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 2.5 mmtp -111.79 149.88 31.1 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.286 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -94.19 120.67 34.78 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.62 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -133.91 -179.4 5.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.818 -1.083 . . . . 1.0 108.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.556 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.5 p-90 -153.25 162.94 40.75 Favored 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 120.55 -0.46 . . . . 1.0 111.428 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.509 HH21 HG13 ' A' ' 127' ' ' ILE . 41.9 mtp180 -148.23 141.17 24.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.397 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.659 ' HG ' HD12 ' A' ' 128' ' ' LEU . 36.0 tp -90.97 135.15 33.93 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.09 130.25 69.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.084 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -77.49 171.84 14.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.6 t70 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.247 0.546 . . . . 1.0 110.356 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -33.57 75.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.169 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.89 8.18 24.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.289 -0.869 . . . . 1.0 112.884 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -87.83 145.26 26.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.715 0.265 . . . . 1.0 111.715 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.509 HG13 HH21 ' A' ' 119' ' ' ARG . 51.0 mm -76.81 119.74 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.809 0.693 . . . . 1.0 110.017 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.659 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -94.86 -43.75 8.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.104 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -148.01 168.91 21.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.663 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -143.83 155.86 44.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.272 -0.876 . . . . 1.0 108.671 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.3 p -58.16 -32.96 68.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.189 0.519 . . . . 1.0 111.191 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.89 -47.24 3.52 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -109.25 170.66 7.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.734 -0.733 . . . . 1.0 111.549 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.34 16.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.267 -0.878 . . . . 1.0 110.934 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -141.46 165.92 26.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.848 0.324 . . . . 1.0 110.45 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.43 10.27 30.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 p -127.38 129.23 47.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.453 0.644 . . . . 1.0 112.188 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -66.84 -37.05 83.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.456 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 64.4 tt0 -58.81 -43.17 90.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.135 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tppt? -60.07 -41.89 93.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.785 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.16 -50.29 69.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.293 0.568 . . . . 1.0 109.906 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.514 ' HA ' HD12 ' A' ' 145' ' ' ILE . 49.1 mtmt -65.45 -33.08 75.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.563 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.3 mm-40 -66.73 -31.02 71.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.128 176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.66 -38.26 93.08 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 142' ' ' LYS . 71.7 mt -61.47 -50.32 80.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.307 0.575 . . . . 1.0 110.652 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -62.8 -33.79 75.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.181 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 52.5 m -65.28 -37.45 87.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.753 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.604 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -74.49 -33.88 34.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 120.411 -0.516 . . . . 1.0 109.866 -177.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -69.35 -13.21 62.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.657 0.741 . . . . 1.0 110.634 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -101.21 -2.92 30.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.764 -1.107 . . . . 1.0 112.325 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.19 -39.5 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.745 0.307 . . . . 1.0 111.737 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.13 -51.32 82.57 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 32.0 Cg_endo -60.71 -12.26 20.86 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.364 1.376 . . . . 1.0 113.515 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -123.79 -7.46 7.9 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.48 134.3 43.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.704 0.764 . . . . 1.0 112.23 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.03 135.82 33.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.621 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -88.05 134.13 28.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.445 0.641 . . . . 1.0 112.124 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 11.0 mt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 114.711 -1.131 . . . . 1.0 109.327 178.281 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 CA--C 1.513 -0.479 0 CA-C-O 121.838 0.828 . . . . 1.0 112.592 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 23.6 mmtp -140.14 97.26 3.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.926 -1.488 . . . . 1.0 107.699 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.63 172.2 3.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.899 . . . . 1.0 109.831 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.474 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 45.3 p-80 -169.22 148.09 3.89 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.781 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 53.2 m-85 -85.35 148.55 25.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.921 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -140.33 117.01 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.43 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.8 t -92.95 129.79 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.91 -0.586 . . . . 1.0 109.662 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -141.34 -179.19 5.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.788 0.328 . . . . 1.0 110.589 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.9 t -102.23 136.34 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 1.0 112.149 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -78.72 179.92 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.013 -0.994 . . . . 1.0 109.752 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.9 -18.01 64.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.238 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.54 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.236 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.447 ' HA ' HG13 ' B' ' 210' ' ' VAL . 11.7 m-20 63.53 39.37 9.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.431 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 31.7 mmtp -103.48 156.34 17.84 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.71 118.5 34.39 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.405 ' HG2' ' HA2' ' B' ' 234' ' ' GLY . 69.4 mtp180 -134.29 179.57 6.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.308 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.529 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.1 p-90 -154.0 161.37 42.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.945 0.402 . . . . 1.0 111.172 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 38.0 mtp180 -147.07 141.11 26.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.047 -0.979 . . . . 1.0 109.89 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.694 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -91.39 131.1 37.1 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.01 130.93 71.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.174 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -77.16 173.19 12.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.598 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.0 t70 -56.56 -34.39 67.05 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.368 0.418 . . . . 1.0 111.063 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 224' ' ' ASN . . . . . 0.566 ' HB2' ' ND2' ' B' ' 226' ' ' ASN . 1.1 m120 -68.65 -34.62 76.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.019 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.79 13.93 9.87 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.378 -0.828 . . . . 1.0 113.514 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.566 ' ND2' ' HB2' ' B' ' 224' ' ' ASN . 0.6 OUTLIER -87.63 147.33 25.32 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.98 -0.129 . . . . 1.0 111.112 178.049 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.53 119.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.588 0.555 . . . . 1.0 110.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.694 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -93.69 -43.35 8.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.555 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.451 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.42 165.07 35.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.297 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.0 157.16 46.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.053 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 12.9 p -54.67 -32.99 60.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.8 -43.77 3.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.87 170.02 8.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.17 0.51 . . . . 1.0 111.553 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' B' ' 217' ' ' ARG . . . -122.87 124.78 5.77 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.338 -1.505 . . . . 1.0 109.338 176.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -110.8 172.45 6.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.993 0.396 . . . . 1.0 111.372 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -105.54 10.85 32.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.874 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 3.3 p -143.94 130.88 20.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.629 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.03 -44.41 97.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.087 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 62.1 tt0 -54.04 -40.49 67.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.261 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.597 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.3 OUTLIER -61.62 -42.8 99.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.323 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.29 92.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.305 0.574 . . . . 1.0 109.817 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.3 mtmt -64.04 -35.52 80.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.13 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.2 mm-40 -65.4 -31.39 72.47 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.045 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.48 94.7 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.511 -0.852 . . . . 1.0 110.979 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.506 ' O ' HG12 ' B' ' 248' ' ' VAL . 70.6 mt -61.16 -52.3 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.365 0.602 . . . . 1.0 110.606 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -63.35 -34.85 78.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.646 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.7 m -66.15 -35.85 81.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.754 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.565 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -73.33 -41.06 57.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -65.06 -13.48 58.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.801 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -102.74 -2.92 27.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.261 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 17.8 m-80 -137.01 -38.31 0.63 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.223 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.565 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.58 -50.77 85.06 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.696 0.628 . . . . 1.0 112.696 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.9 Cg_endo -63.92 -10.65 23.61 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.037 1.158 . . . . 1.0 113.266 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.99 -17.04 11.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.978 0.418 . . . . 1.0 111.464 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -69.73 136.92 51.54 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.18 0.807 . . . . 1.0 113.18 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -90.25 137.58 32.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.966 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.566 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -88.72 132.27 34.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.253 0.549 . . . . 1.0 112.416 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -121.58 142.72 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.526 -1.215 . . . . 1.0 108.407 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -93.51 106.9 18.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.825 -176.633 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.524 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.326 0 CA-C-O 122.108 0.956 . . . . 1.0 113.081 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 72.3 mmtt -135.02 97.61 3.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.387 -1.733 . . . . 1.0 107.183 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.49 170.81 3.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.528 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 45.0 p-80 -170.75 150.78 3.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.413 -0.217 . . . . 1.0 110.413 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.452 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 69.7 m-85 -88.57 150.85 22.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.267 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -143.19 123.35 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.717 . . . . 1.0 110.636 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.7 t -96.96 134.06 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.909 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -146.32 -177.55 5.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 1.0 110.869 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -96.82 138.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.362 0.601 . . . . 1.0 112.552 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.12 179.67 7.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.772 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.61 62.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.289 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.82 26.33 10.44 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.871 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.42 ' HA ' HG13 ' A' ' 110' ' ' VAL . 13.3 m-20 59.54 43.61 15.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.402 0.62 . . . . 1.0 111.004 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.8 mmtp -101.72 178.32 4.66 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -118.57 103.37 9.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.584 ' HD3' ' HA2' ' A' ' 134' ' ' GLY . 12.7 mmm180 -122.28 178.63 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.52 ' HB3' HG22 ' A' ' 108' ' ' VAL . 60.2 p-90 -151.6 163.81 38.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.735 0.302 . . . . 1.0 111.355 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 39.0 mtp180 -148.4 149.64 32.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.658 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.699 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.7 tp -96.94 133.29 41.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 177.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -131.31 131.43 63.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.141 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -76.89 168.2 20.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.413 -1.329 . . . . 1.0 107.413 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.502 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 22.8 t70 -61.36 -22.39 64.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.852 0.358 . . . . 1.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.91 -35.04 72.12 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.511 0.672 . . . . 1.0 109.513 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.9 11.39 11.17 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 114.8 -1.091 . . . . 1.0 113.199 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -91.01 143.93 26.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.718 -0.283 . . . . 1.0 111.673 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.32 126.58 36.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 O-C-N 123.96 0.787 . . . . 1.0 110.133 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.699 HD12 ' HG ' ' A' ' 120' ' ' LEU . 13.4 mt -105.12 -39.62 6.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 1.0 110.071 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.451 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.03 166.81 31.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.775 -1.102 . . . . 1.0 111.277 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -139.6 156.0 47.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.341 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.498 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 83.1 p -56.64 -42.74 79.39 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.99 -41.88 3.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.903 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.529 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 35.7 mt-10 -83.95 -168.48 2.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.118 0.485 . . . . 1.0 110.17 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.584 ' HA2' ' HD3' ' A' ' 117' ' ' ARG . . . -168.65 119.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 1.0 111.706 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -141.3 169.01 18.42 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.76 35.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -116.62 131.85 56.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.409 0.624 . . . . 1.0 111.456 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -65.12 -36.11 83.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.792 -1.095 . . . . 1.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 64.2 tt0 -61.24 -45.59 93.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.394 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.6 -38.14 80.44 Favored 'General case' 0 CA--C 1.52 -0.176 0 O-C-N 123.208 0.317 . . . . 1.0 110.638 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.59 -52.33 65.85 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.538 0.685 . . . . 1.0 109.649 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.429 ' HA ' HD12 ' A' ' 145' ' ' ILE . 48.3 mtmt -64.12 -36.23 83.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.623 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.5 mm-40 -65.47 -27.03 68.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -41.75 94.05 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.552 HG21 HG22 ' B' ' 257' ' ' VAL . 47.8 mt -63.4 -40.96 91.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.186 -0.507 . . . . 1.0 110.162 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.76 -43.01 99.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.073 0.463 . . . . 1.0 110.075 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 m -63.27 -35.58 80.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.641 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -74.63 -42.55 48.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 119.832 -0.747 . . . . 1.0 110.239 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -67.19 -14.08 62.57 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.958 -0.464 . . . . 1.0 111.775 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -104.32 -1.88 26.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.016 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.7 m-80 -133.04 -39.33 0.95 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.908 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.613 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.32 -50.26 88.61 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 52.8 Cg_endo -67.24 -7.83 20.12 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.181 1.254 . . . . 1.0 113.344 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.21 -29.97 6.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.248 0.547 . . . . 1.0 111.727 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.41 136.81 58.08 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.238 -0.892 . . . . 1.0 113.361 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -96.89 141.92 29.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.149 -1.387 . . . . 1.0 111.024 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.31 135.26 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.986 0.736 . . . . 1.0 112.986 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.0 mt . . . . . 0 N--CA 1.45 -0.458 0 CA-C-N 114.88 -1.054 . . . . 1.0 109.272 176.958 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.427 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.7 p-10 . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.831 0.824 . . . . 1.0 112.905 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -140.04 96.87 3.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.436 -1.69 . . . . 1.0 106.436 173.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.41 174.02 2.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.238 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.46 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 40.4 p-80 -168.83 149.22 4.42 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.143 0.277 . . . . 1.0 110.607 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.542 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.7 m-85 -85.75 152.89 22.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.69 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -141.27 117.05 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.535 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' B' ' 218' ' ' TRP . 82.7 t -95.01 130.92 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.87 178.86 7.22 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.188 0.305 . . . . 1.0 110.39 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.1 t -101.58 136.77 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.256 0.55 . . . . 1.0 112.067 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -82.91 178.61 8.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.466 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.7 64.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.114 0.483 . . . . 1.0 110.956 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.22 21.54 16.95 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.563 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.431 ' HA ' HG13 ' B' ' 210' ' ' VAL . 18.5 m-20 64.23 36.28 9.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.414 -0.812 . . . . 1.0 111.187 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 32.2 mmtp -99.21 157.48 16.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.21 112.86 26.06 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.1 mtm105 -127.44 176.8 7.18 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.529 ' HB3' HG22 ' B' ' 208' ' ' VAL . 49.4 p-90 -149.12 161.84 41.16 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.735 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 219' ' ' ARG . 9.2 mtp180 -145.72 143.47 29.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.163 -0.926 . . . . 1.0 109.649 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.682 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.3 tp -93.54 134.09 36.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.17 133.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.505 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.35 172.36 13.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.56 -31.77 66.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 1.0 111.1 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -32.86 74.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.897 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.5 10.65 21.3 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.722 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -88.57 145.1 25.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -73.42 130.17 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.789 0.681 . . . . 1.0 109.199 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.682 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.8 mt -107.44 -41.9 4.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.347 0.594 . . . . 1.0 110.033 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.84 166.61 30.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.962 -1.017 . . . . 1.0 111.376 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -139.23 154.29 47.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.851 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.472 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 24.8 p -54.22 -39.61 66.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 78.65 -26.92 2.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 1.0 111.149 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' B' ' 231' ' ' SER . 48.8 mt-10 -87.2 -175.84 5.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.59 0.71 . . . . 1.0 111.502 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -170.09 102.17 0.18 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -129.71 169.75 14.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.356 -0.238 . . . . 1.0 110.356 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.07 37.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -121.81 131.17 53.91 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.615 0.721 . . . . 1.0 111.365 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -65.2 -34.67 78.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.583 -1.189 . . . . 1.0 110.421 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 62.3 tt0 -58.57 -46.45 86.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.461 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -60.01 -40.29 88.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.52 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.81 68.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.015 0.436 . . . . 1.0 110.3 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.502 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.23 -35.88 82.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.676 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.4 mm-40 -65.7 -31.02 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.536 -0.466 . . . . 1.0 109.995 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.35 95.04 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.509 ' O ' HG12 ' B' ' 248' ' ' VAL . 73.5 mt -60.8 -53.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 1.0 110.687 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.11 -32.79 74.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.645 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -67.19 -38.11 84.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.635 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' B' ' 252' ' ' ALA . 1.4 p -73.05 -36.03 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 119.843 -0.743 . . . . 1.0 109.08 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.24 -12.62 57.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.98 0.419 . . . . 1.0 111.304 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -104.44 -2.25 25.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.723 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -131.32 -37.5 1.24 Allowed 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 111.944 0.35 . . . . 1.0 111.944 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.542 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.65 -51.5 80.77 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 112.504 0.557 . . . . 1.0 112.504 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 50.6 Cg_endo -66.66 -12.51 36.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.268 1.312 . . . . 1.0 113.2 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.35 -29.6 9.18 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.205 0.526 . . . . 1.0 111.437 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -63.24 137.89 58.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.16 -0.927 . . . . 1.0 112.939 -176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -97.72 149.41 22.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.148 -1.387 . . . . 1.0 111.557 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 145' ' ' ILE . 46.1 t -86.62 131.58 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.029 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.13 138.31 54.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -90.67 101.55 14.3 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.499 -0.763 . . . . 1.0 111.387 -176.886 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.449 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.31 0 CA-C-O 121.784 0.802 . . . . 1.0 112.439 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 14.2 mmtp -134.53 96.92 3.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.965 -1.471 . . . . 1.0 107.656 173.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.06 166.62 3.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.408 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.3 p-80 -168.83 146.87 3.93 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.025 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.23 147.98 26.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.543 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -139.46 117.11 11.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.464 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' A' ' 118' ' ' TRP . 93.9 t -94.61 134.27 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.942 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -146.29 -179.17 6.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.594 0.235 . . . . 1.0 110.639 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.1 t -101.39 134.97 40.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.175 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.58 178.94 8.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.4 52.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.829 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.1 21.64 13.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.856 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.05 33.36 1.63 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.807 0.843 . . . . 1.0 111.306 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.5 mttt -108.68 150.78 27.08 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.583 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -94.56 116.05 28.31 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.833 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.471 HH12 ' CG ' ' A' ' 130' ' ' ASP . 16.7 mtm105 -133.55 177.73 7.48 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.568 ' HB3' HG22 ' A' ' 108' ' ' VAL . 53.9 p-90 -150.19 161.09 43.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.782 0.325 . . . . 1.0 111.108 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 20.2 mtp180 -145.95 142.19 28.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.096 -0.956 . . . . 1.0 109.543 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.713 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.9 tp -91.88 132.69 36.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.38 132.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.533 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -81.06 173.03 12.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.57 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 13.2 t70 -58.62 -31.99 68.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 1.0 110.691 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -63.68 -34.42 77.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.832 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 9.37 25.47 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.664 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -87.23 143.34 27.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.185 . . . . 1.0 111.496 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.81 123.73 31.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.895 0.747 . . . . 1.0 109.353 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.713 HD12 ' HG ' ' A' ' 120' ' ' LEU . 14.8 mt -98.37 -41.88 7.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.354 0.597 . . . . 1.0 109.91 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.73 169.09 22.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.677 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CG ' HH12 ' A' ' 117' ' ' ARG . 7.6 t70 -142.4 154.36 44.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.867 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.6 p -57.09 -35.07 68.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.903 0.382 . . . . 1.0 111.679 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.69 -44.96 3.38 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -94.66 177.54 5.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 1.0 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -150.45 127.04 2.28 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.858 -1.065 . . . . 1.0 110.454 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -141.97 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.792 0.296 . . . . 1.0 110.46 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.05 10.22 27.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.501 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -124.06 130.56 52.76 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.633 0.73 . . . . 1.0 111.715 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -65.95 -34.38 77.98 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.919 -1.037 . . . . 1.0 110.297 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 50.9 tt0 -58.37 -46.64 85.94 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.453 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -59.52 -38.63 81.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.422 -0.214 . . . . 1.0 110.422 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -52.94 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.225 0.536 . . . . 1.0 110.135 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 145' ' ' ILE . 46.5 mtmt -64.99 -35.97 82.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.033 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.2 mm-40 -65.32 -30.7 71.57 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.468 -0.493 . . . . 1.0 109.787 177.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.86 -38.73 94.59 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 142' ' ' LYS . 75.4 mt -60.52 -53.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.402 0.62 . . . . 1.0 110.531 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -62.53 -33.27 74.58 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.5 m -67.36 -38.17 84.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.636 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -73.17 -33.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.247 -0.581 . . . . 1.0 109.61 -177.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.58 -14.62 62.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.539 0.685 . . . . 1.0 110.396 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -100.49 -1.89 34.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.723 -1.126 . . . . 1.0 112.037 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -134.34 -40.89 0.81 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.263 0.468 . . . . 1.0 112.263 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.33 -52.06 77.08 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 113.041 0.756 . . . . 1.0 113.041 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 47.8 Cg_endo -64.9 -12.75 35.91 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 120.883 1.055 . . . . 1.0 113.294 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.47 -29.4 8.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.07 0.462 . . . . 1.0 111.149 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.14 136.45 57.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.949 -1.023 . . . . 1.0 113.347 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -99.12 144.06 28.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.131 -1.395 . . . . 1.0 110.534 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.05 137.16 21.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.668 177.377 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.285 0 CA-C-O 121.758 0.79 . . . . 1.0 111.991 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.583 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 18.1 mmtp -138.97 96.49 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.117 -1.401 . . . . 1.0 108.087 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.16 170.84 3.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.589 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.508 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 34.2 p-80 -170.26 148.08 3.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.391 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.509 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.5 m-85 -84.63 152.59 23.72 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.131 0.269 . . . . 1.0 110.696 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -141.52 120.45 12.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.419 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' B' ' 218' ' ' TRP . 89.1 t -96.29 135.17 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.061 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.82 178.66 8.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.136 0.273 . . . . 1.0 110.779 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -98.39 135.49 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.671 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.3 177.87 8.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.911 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.2 -13.73 62.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.967 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.73 19.02 19.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.619 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 69.4 38.84 1.73 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.511 -0.768 . . . . 1.0 111.008 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.8 mmtt -109.13 155.9 20.47 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.397 -0.819 . . . . 1.0 110.261 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.43 ' O ' ' HB2' ' B' ' 241' ' ' ALA . 81.0 m-85 -99.28 102.65 14.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.845 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.577 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 12.1 mmm180 -122.52 177.43 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.171 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.523 ' HB3' HG22 ' B' ' 208' ' ' VAL . 55.7 p-90 -150.7 161.12 43.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.768 0.318 . . . . 1.0 111.486 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 28.3 mtp180 -147.49 145.87 29.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.469 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.688 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.4 tp -94.22 134.95 36.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.14 132.94 64.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.792 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' HIS . . . . . 0.404 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.1 t-80 -81.93 173.85 11.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.5 t70 -55.02 -32.18 61.64 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.353 0.408 . . . . 1.0 111.887 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -71.21 -34.29 70.71 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.419 0.628 . . . . 1.0 110.335 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.49 13.19 11.96 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.162 -0.926 . . . . 1.0 112.655 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -88.99 143.49 26.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.21 121.66 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.903 0.752 . . . . 1.0 109.717 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.688 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -96.88 -40.67 8.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.545 -0.752 . . . . 1.0 109.629 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -152.68 164.54 37.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.771 -1.104 . . . . 1.0 111.425 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -137.54 156.99 47.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.984 -1.007 . . . . 1.0 109.262 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.501 ' HB2' HH21 ' B' ' 217' ' ' ARG . 79.3 p -58.06 -45.99 86.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.73 2.89 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.806 -0.712 . . . . 1.0 112.989 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' GLU . . . . . 0.504 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 42.0 mt-10 -84.97 -168.9 2.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.072 0.463 . . . . 1.0 110.294 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.577 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -170.17 124.55 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.871 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -146.73 170.06 17.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.35 9.97 39.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.416 0.447 . . . . 1.0 112.007 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.0 m -111.94 130.21 55.92 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.393 0.616 . . . . 1.0 111.312 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' B' ' 216' ' ' TYR . 8.4 ptpp? -66.17 -35.95 81.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.175 -0.92 . . . . 1.0 110.89 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 48.3 tt0 -59.59 -46.84 87.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.459 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -59.91 -38.33 81.98 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.584 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 216' ' ' TYR . . . -58.73 -53.11 62.08 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.563 0.697 . . . . 1.0 110.319 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.488 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.9 mtmt -64.46 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.4 mm-40 -66.04 -30.26 70.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.16 95.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.425 -0.893 . . . . 1.0 110.971 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.506 ' O ' HG12 ' B' ' 248' ' ' VAL . 69.7 mt -60.47 -52.86 56.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 1.0 110.562 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.66 -35.96 81.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.253 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.3 m -66.94 -35.62 80.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.905 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -72.61 -38.79 59.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.565 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -65.56 -17.88 64.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.766 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' B' ' 250' ' ' ARG . 30.9 ttp-105 -100.9 -1.66 34.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.607 -0.724 . . . . 1.0 111.123 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -132.71 -40.58 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.557 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -57.17 -49.69 92.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 112.902 0.705 . . . . 1.0 112.902 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 55.9 Cg_endo -66.36 -5.75 13.38 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.029 1.153 . . . . 1.0 113.423 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.79 -11.06 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 1.0 111.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -71.95 137.02 47.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.213 0.53 . . . . 1.0 112.05 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.3 140.34 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.228 -0.896 . . . . 1.0 110.25 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -91.53 129.87 41.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.632 0.729 . . . . 1.0 112.468 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.04 140.2 37.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.54 -1.209 . . . . 1.0 109.054 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -89.06 102.66 15.31 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.458 -0.782 . . . . 1.0 111.447 -177.24 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 13.6 p-10 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.689 0.757 . . . . 1.0 112.514 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 23.9 mmtp -138.7 98.36 3.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.738 -1.574 . . . . 1.0 108.273 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.47 167.35 3.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.116 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.554 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.6 p-80 -167.87 147.11 4.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.547 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 52.2 m-85 -87.17 148.21 25.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.078 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -143.02 120.67 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.72 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.606 HG22 ' HB3' ' A' ' 118' ' ' TRP . 92.2 t -96.02 130.94 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.716 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.09 179.3 6.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.69 0.281 . . . . 1.0 110.644 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -103.28 136.81 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.191 0.519 . . . . 1.0 111.99 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.49 -175.28 5.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.286 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.2 -10.24 56.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.04 33.18 5.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.718 0.294 . . . . 1.0 111.523 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.5 35.13 17.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 mmtp -96.86 154.28 17.39 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.94 114.95 29.47 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.961 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 mtm105 -131.67 175.41 9.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.269 -0.878 . . . . 1.0 108.853 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.606 ' HB3' HG22 ' A' ' 108' ' ' VAL . 55.1 p-90 -151.07 162.45 40.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.656 0.265 . . . . 1.0 111.361 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -147.54 144.91 28.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.252 -0.885 . . . . 1.0 110.068 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.691 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.0 tp -97.29 134.15 40.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 t -127.31 132.56 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 1.0 110.736 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.493 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.6 t-80 -84.56 177.39 8.1 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.818 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 17.9 t70 -52.04 -43.98 64.01 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.805 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -63.13 -33.45 75.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.407 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.79 11.66 22.41 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.312 -0.858 . . . . 1.0 112.331 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -86.13 144.19 27.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.78 -0.21 . . . . 1.0 111.371 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.487 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 50.2 mm -74.46 120.43 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.691 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.6 mt -93.06 -42.76 9.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.067 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.66 166.33 29.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.655 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.37 155.72 45.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.041 -0.981 . . . . 1.0 108.558 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 13.6 p -53.33 -31.78 45.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.994 0.426 . . . . 1.0 111.698 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.55 -41.36 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' HG2' ' HB ' ' B' ' 227' ' ' ILE . 50.2 mm-40 -114.53 173.44 6.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.466 0.651 . . . . 1.0 111.933 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.7 132.71 8.82 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 109.947 -1.261 . . . . 1.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.28 167.21 13.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.114 0.457 . . . . 1.0 110.241 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -102.57 9.77 39.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.47 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -139.11 133.61 31.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.5 -38.43 91.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 1.0 110.401 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 54.0 tt0 -58.46 -43.04 88.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.897 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.89 -41.06 95.28 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.116 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.014 0.435 . . . . 1.0 110.029 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.493 ' HG2' HG21 ' A' ' 108' ' ' VAL . 42.6 mtmt -64.48 -37.04 86.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.2 mm-40 -63.58 -26.57 68.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.488 -0.56 . . . . 1.0 109.488 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.94 -41.74 93.14 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 142' ' ' LYS . 67.9 mt -60.98 -41.38 88.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.469 0.652 . . . . 1.0 109.771 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.95 -43.05 93.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.237 0.541 . . . . 1.0 110.166 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 m -63.49 -35.4 80.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.514 -0.767 . . . . 1.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.606 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.84 -41.86 53.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 120.165 -0.614 . . . . 1.0 109.841 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -66.72 -12.22 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.15 -0.344 . . . . 1.0 111.49 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -104.76 -2.78 24.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.205 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.2 m-80 -132.94 -39.58 0.95 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.923 0.392 . . . . 1.0 111.884 -177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.606 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.38 -50.33 87.36 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.692 -0.685 . . . . 1.0 112.456 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.6 Cg_endo -65.13 -9.34 21.41 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.387 1.391 . . . . 1.0 113.241 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -115.03 -23.34 9.1 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.284 0.475 . . . . 1.0 112.284 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.563 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -67.83 138.26 55.96 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -93.18 151.25 19.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.683 -1.144 . . . . 1.0 111.761 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.499 HG22 HG21 ' B' ' 245' ' ' ILE . 44.0 t -86.48 132.27 32.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.799 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 175.405 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.407 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 14.5 p-10 . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.66 0.743 . . . . 1.0 112.412 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 30.2 mmtp -138.55 98.5 3.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.174 -1.376 . . . . 1.0 107.659 172.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.47 168.12 3.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.592 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.563 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 46.7 p-80 -167.94 149.11 5.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.198 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -85.83 148.22 25.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.985 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -139.2 119.83 14.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.568 HG21 ' HG2' ' B' ' 242' ' ' LYS . 90.3 t -92.83 132.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.787 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -142.62 -178.37 5.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' B' ' 214' ' ' ASP . 3.3 t -104.6 139.77 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -81.85 -178.45 6.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.042 -0.981 . . . . 1.0 110.208 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.62 -20.15 64.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.043 0.449 . . . . 1.0 111.351 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.85 24.23 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.703 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' B' ' 210' ' ' VAL . 12.5 m-20 60.95 40.15 15.79 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.901 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -100.25 156.48 17.2 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' B' ' 238' ' ' LYS . 89.6 m-85 -98.48 115.86 29.47 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.702 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -133.91 178.57 6.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.511 ' HB3' HG22 ' B' ' 208' ' ' VAL . 53.4 p-90 -151.3 163.68 38.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.908 -0.317 . . . . 1.0 111.508 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -146.06 146.41 30.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.887 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.686 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -96.13 133.16 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.46 130.96 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.544 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -80.75 172.64 13.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 19.4 t70 -54.94 -36.81 65.67 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.191 0.307 . . . . 1.0 111.63 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -63.02 -34.64 78.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.269 0.557 . . . . 1.0 110.396 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 111.75 15.08 10.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.423 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -90.99 142.33 27.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 133' ' ' GLU . 50.7 mm -75.83 119.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.933 0.771 . . . . 1.0 109.981 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.686 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -94.87 -43.38 8.22 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.468 -0.787 . . . . 1.0 109.739 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -149.72 170.03 19.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.494 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.72 157.31 44.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.981 -1.009 . . . . 1.0 108.538 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 77.4 p -59.09 -37.15 76.45 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.187 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.55 -45.7 3.48 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' GLU . . . . . 0.487 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 33.3 mm-40 -94.88 166.41 11.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.418 0.628 . . . . 1.0 111.502 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.19 126.86 4.94 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.08 166.62 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.873 0.337 . . . . 1.0 111.453 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.4 10.26 40.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.502 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.1 m -141.32 135.15 30.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.908 0.385 . . . . 1.0 110.663 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' B' ' 216' ' ' TYR . 16.6 ptpt -61.91 -41.95 98.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 48.2 tt0 -55.9 -45.22 78.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.565 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -62.42 -41.72 98.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.039 -177.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.06 87.46 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.356 0.598 . . . . 1.0 110.378 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.568 ' HG2' HG21 ' B' ' 208' ' ' VAL . 49.6 mtmt -63.12 -35.61 80.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.142 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.8 mm-40 -65.92 -26.82 67.77 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.74 96.02 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.499 HG21 HG22 ' A' ' 157' ' ' VAL . 58.5 mt -59.72 -45.51 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 121.409 0.623 . . . . 1.0 110.034 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.51 -39.43 93.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.126 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.9 m -66.34 -35.57 80.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.671 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -72.93 -40.48 59.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.599 -177.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -65.86 -12.41 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.436 . . . . 1.0 111.331 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -104.94 -3.14 23.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.696 -0.684 . . . . 1.0 111.004 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 251' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 17.6 m-80 -130.83 -40.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.99 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.6 -51.22 81.89 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.616 -0.72 . . . . 1.0 112.516 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.5 Cg_endo -65.91 -11.84 32.69 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 120.987 1.125 . . . . 1.0 113.219 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -113.01 -15.49 12.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.954 0.407 . . . . 1.0 112.04 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -74.95 137.88 41.93 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.022 0.749 . . . . 1.0 113.022 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.66 138.29 31.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.647 -1.161 . . . . 1.0 110.722 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.23 129.87 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.622 0.725 . . . . 1.0 112.339 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -116.1 142.21 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.033 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.93 104.87 17.39 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.607 -0.711 . . . . 1.0 110.819 -178.412 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 14.9 p-10 . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.77 0.795 . . . . 1.0 112.55 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 123' ' ' ASP . 28.2 mmtt -141.9 94.53 2.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 1.0 107.82 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.48 174.39 1.92 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.237 -177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.535 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 40.1 p-80 -170.56 148.79 3.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.388 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 67.1 m-85 -86.84 150.17 24.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.587 0.232 . . . . 1.0 110.681 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.51 120.12 12.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.788 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 118' ' ' TRP . 86.8 t -94.67 132.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.532 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -142.91 179.06 7.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.047 0.217 . . . . 1.0 110.576 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -99.87 133.24 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.98 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.83 178.78 8.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.866 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.25 -7.64 43.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.514 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.09 20.01 14.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.172 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 71.11 36.18 1.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.625 0.77 . . . . 1.0 111.062 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.4 mttt -110.92 151.19 28.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.624 -175.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.12 112.95 25.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.716 -1.129 . . . . 1.0 109.53 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -130.8 179.25 6.08 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.535 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.0 p-90 -150.68 163.7 37.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.714 -0.395 . . . . 1.0 111.522 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 25.5 mtp180 -147.91 146.3 28.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.78 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.686 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.1 tp -96.31 130.65 43.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.17 131.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.967 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -78.0 172.17 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' A' ' 103' ' ' LYS . 11.5 t70 -57.89 -31.45 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.14 0.495 . . . . 1.0 110.637 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.31 -33.62 75.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.028 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.23 9.86 21.24 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.073 -0.967 . . . . 1.0 112.978 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -88.49 144.94 26.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.642 0.258 . . . . 1.0 111.467 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.8 mm -75.39 122.08 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.028 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.686 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -97.92 -42.53 7.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 1.0 109.374 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.05 165.71 32.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.156 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -141.39 155.09 45.94 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 71.2 p -55.79 -32.83 63.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.03 0.443 . . . . 1.0 111.471 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.18 -41.39 3.03 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.928 -0.636 . . . . 1.0 112.084 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -133.03 147.77 19.08 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -141.79 174.29 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.415 0.607 . . . . 1.0 110.99 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.27 10.16 41.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.616 0.599 . . . . 1.0 112.616 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -133.16 131.56 40.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.746 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -64.03 -36.15 83.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.355 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 50.3 tt0 -58.33 -45.21 88.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.762 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -59.91 -40.83 90.17 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.957 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.97 79.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 1.0 109.901 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.526 ' HA ' HD12 ' A' ' 145' ' ' ILE . 43.2 mtmt -64.29 -37.11 86.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.659 -0.701 . . . . 1.0 111.032 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.9 mm-40 -63.87 -29.68 70.84 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.41 97.98 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 142' ' ' LYS . 57.0 mt -63.98 -45.55 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.887 -0.657 . . . . 1.0 110.298 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.25 -38.28 88.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.137 0.494 . . . . 1.0 110.055 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.4 m -65.9 -36.27 82.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.638 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.1 -42.21 51.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.343 -177.271 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -66.22 -11.89 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 112.018 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -104.46 -2.84 24.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.079 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' B' ' 204' ' ' ALA . 11.1 m-80 -133.45 -37.88 0.94 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.997 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.21 -50.01 90.62 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.2 Cg_endo -63.48 -15.24 47.32 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.254 1.303 . . . . 1.0 113.185 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -109.93 -26.37 9.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.281 0.562 . . . . 1.0 111.362 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.26 136.43 57.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.008 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -96.61 141.68 29.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.18 -1.373 . . . . 1.0 111.117 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.522 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -89.84 135.01 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.333 0.587 . . . . 1.0 112.478 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.453 -0.323 0 CA-C-N 114.937 -1.029 . . . . 1.0 109.266 177.758 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 121.526 0.679 . . . . 1.0 112.219 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 70.9 mmtt -136.59 95.52 3.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 204' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . . . -175.92 171.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.19 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.504 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.2 p-80 -170.92 148.61 2.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.159 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.2 m-85 -86.41 149.67 24.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.721 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -142.07 119.03 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.332 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.2 t -94.31 132.88 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -145.68 -178.68 6.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.126 0.266 . . . . 1.0 110.647 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -100.89 138.29 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.309 0.576 . . . . 1.0 112.129 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.46 179.7 7.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.098 -0.956 . . . . 1.0 109.664 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.13 -9.3 58.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.181 0.515 . . . . 1.0 111.004 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.69 20.43 15.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.462 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 70.04 36.84 1.83 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.634 0.774 . . . . 1.0 111.534 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.0 mttt -112.74 149.69 32.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.289 0.566 . . . . 1.0 111.332 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -89.97 119.6 30.47 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.715 -1.129 . . . . 1.0 109.978 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.29 -179.0 5.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.977 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.531 ' HB3' HG22 ' B' ' 208' ' ' VAL . 57.1 p-90 -154.31 161.55 41.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.257 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 219' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 27.6 mtp180 -146.79 141.86 27.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.813 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.729 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -93.46 130.77 39.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.59 131.48 70.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.044 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' HIS . . . . . 0.432 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.6 t-80 -81.2 173.0 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 10.8 t70 -54.67 -36.98 65.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.035 0.445 . . . . 1.0 111.222 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.21 -33.78 76.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.219 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.84 12.13 19.24 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 115.087 -0.961 . . . . 1.0 112.659 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -88.32 144.06 26.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.819 0.303 . . . . 1.0 111.819 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.5 mm -75.97 116.63 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.007 0.817 . . . . 1.0 109.69 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.729 HD12 ' HG ' ' B' ' 220' ' ' LEU . 18.3 mt -90.57 -44.7 9.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.405 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.47 160.75 43.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.301 -1.318 . . . . 1.0 111.027 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.8 156.34 49.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 16.7 p -52.27 -35.63 50.64 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.378 0.424 . . . . 1.0 111.977 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.58 -46.09 3.53 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -99.32 179.51 4.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.915 -0.643 . . . . 1.0 110.792 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -146.0 137.78 7.12 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.83 171.28 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.68 0.74 . . . . 1.0 111.795 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.36 10.07 39.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.387 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 12.2 m -135.75 134.41 39.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.55 0.69 . . . . 1.0 111.276 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -64.51 -35.66 81.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.915 -1.039 . . . . 1.0 110.462 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 46.4 tt0 -56.12 -47.64 77.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.292 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -61.42 -40.48 94.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.804 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.54 80.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 1.0 109.768 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.492 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.14 -35.62 81.36 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.411 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.6 mm-40 -64.85 -29.09 70.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.48 -40.95 96.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.954 -1.258 . . . . 1.0 109.954 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' B' ' 242' ' ' LYS . 59.8 mt -62.78 -43.29 98.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.15 -0.525 . . . . 1.0 110.231 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.61 -43.56 98.5 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.648 -0.421 . . . . 1.0 109.921 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.6 m -63.63 -35.21 79.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.83 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -75.06 -41.8 45.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 119.697 -0.801 . . . . 1.0 109.49 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -67.2 -11.62 57.86 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.051 -0.406 . . . . 1.0 111.352 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -103.12 -3.12 26.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.319 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 251' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 10.7 m-80 -135.48 -37.45 0.76 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.968 0.358 . . . . 1.0 111.968 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.22 -49.87 90.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 1.0 112.478 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.4 Cg_endo -63.69 -9.53 18.82 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.642 1.562 . . . . 1.0 113.904 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -123.24 -11.57 7.95 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -70.61 138.93 51.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.27 0.557 . . . . 1.0 111.841 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.01 148.65 22.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.012 -0.994 . . . . 1.0 112.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.521 HG22 HG21 ' A' ' 145' ' ' ILE . 44.1 t -84.45 131.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.619 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.1 mt -124.26 139.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -87.66 101.89 14.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.265 -0.874 . . . . 1.0 111.349 -177.157 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 . . . . . 0 CA--C 1.512 -0.486 0 CA-C-O 121.054 0.454 . . . . 1.0 110.478 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -143.05 95.35 2.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.21 -1.404 . . . . 1.0 107.21 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.64 178.96 1.49 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.327 -0.851 . . . . 1.0 109.735 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.426 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.8 p-80 -169.52 147.72 3.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.808 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 48.7 m-85 -87.44 147.95 25.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.848 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -140.64 118.95 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.77 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 118' ' ' TRP . 81.7 t -94.23 135.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.549 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -144.86 -179.6 6.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.469 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -104.28 138.83 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.287 0.565 . . . . 1.0 111.989 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 179.85 7.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.947 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.12 46.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.577 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.23 24.37 10.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.486 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.25 33.17 2.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.654 0.782 . . . . 1.0 111.613 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.2 mttt -107.48 147.17 30.83 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.426 0.631 . . . . 1.0 111.123 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -93.46 118.89 31.88 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.028 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -131.87 179.79 5.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.162 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.562 ' HB3' HG22 ' A' ' 108' ' ' VAL . 58.2 p-90 -154.52 162.24 41.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.212 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.439 HH21 HG13 ' A' ' 127' ' ' ILE . 50.5 mtp180 -147.18 142.45 27.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.515 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.67 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.5 tp -91.48 133.21 35.69 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.67 128.57 69.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.103 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -77.31 172.91 12.55 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.37 -28.17 58.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.598 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -73.02 -34.67 66.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.71 . . . . 1.0 109.898 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.39 10.1 15.95 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.579 -1.191 . . . . 1.0 112.709 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -86.53 142.84 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.748 0.277 . . . . 1.0 111.748 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.439 HG13 HH21 ' A' ' 119' ' ' ARG . 50.6 mm -74.45 119.79 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.92 0.763 . . . . 1.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.67 HD12 ' HG ' ' A' ' 120' ' ' LEU . 14.1 mt -96.88 -43.65 7.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.96 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.45 168.57 23.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.061 -0.972 . . . . 1.0 111.593 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.77 157.99 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.1 p -57.61 -32.26 67.04 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.296 0.57 . . . . 1.0 111.292 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.17 -50.05 3.83 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.493 ' HG2' ' HB ' ' B' ' 227' ' ' ILE . 69.4 mm-40 -100.81 178.96 4.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.446 -0.877 . . . . 1.0 111.424 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.06 137.53 7.97 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.49 166.47 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.096 0.448 . . . . 1.0 111.378 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.95 11.19 25.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.864 0.691 . . . . 1.0 112.864 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -127.97 131.06 49.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.399 0.618 . . . . 1.0 111.044 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.18 -38.23 90.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.882 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 65.1 tt0 -63.28 -43.16 98.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 1.0 110.027 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.603 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -57.77 -41.34 81.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.895 -178.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.13 74.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.369 0.604 . . . . 1.0 110.318 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.516 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.4 mtmt -64.16 -34.15 77.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.392 -0.822 . . . . 1.0 111.205 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.9 mm-40 -64.8 -30.96 71.99 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.121 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.79 -39.15 93.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.557 -0.83 . . . . 1.0 111.136 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 148' ' ' VAL . 76.8 mt -59.34 -51.47 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.635 0.731 . . . . 1.0 110.49 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -64.6 -35.05 79.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.016 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -66.37 -37.97 86.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.711 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.561 HG22 ' HB2' ' A' ' 152' ' ' ALA . 1.4 p -73.08 -37.46 53.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.132 -0.627 . . . . 1.0 109.618 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.13 -16.33 61.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.538 0.57 . . . . 1.0 112.538 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -104.46 -5.84 21.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.929 0.395 . . . . 1.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -121.69 -37.66 2.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.8 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.561 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.11 -51.03 83.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.829 -0.623 . . . . 1.0 112.602 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 56.0 Cg_endo -68.07 -7.82 20.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.154 1.236 . . . . 1.0 113.385 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.81 -21.14 10.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.157 0.504 . . . . 1.0 111.425 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -70.01 138.69 52.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.649 0.738 . . . . 1.0 112.952 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.37 136.73 36.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.265 -1.334 . . . . 1.0 110.801 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.53 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.82 135.29 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 112.45 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' B' ' 207' ' ' GLU . 6.4 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 114.796 -1.093 . . . . 1.0 109.799 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 121.404 0.621 . . . . 1.0 111.795 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.17 95.62 2.83 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.38 175.37 2.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.138 -0.937 . . . . 1.0 109.526 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.458 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.3 p-80 -170.27 146.38 2.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.101 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.53 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 55.0 m-85 -85.61 147.62 26.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.653 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 207' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 158' ' ' ILE . 40.1 mt-10 -141.3 121.9 14.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.546 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.4 t -93.36 131.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -140.99 -179.88 6.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.213 0.321 . . . . 1.0 110.808 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' B' ' 214' ' ' ASP . 1.4 t -102.08 139.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.334 0.588 . . . . 1.0 111.694 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.64 -176.47 5.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.637 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.94 63.7 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.976 -0.453 . . . . 1.0 110.874 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.06 17.08 22.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.603 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.565 ' HA ' HG13 ' B' ' 210' ' ' VAL . 30.1 t70 68.64 44.02 1.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.481 1.134 . . . . 1.0 110.374 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.1 mmtt -112.97 150.86 31.29 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.323 -177.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -91.12 117.82 29.92 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.843 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -133.8 179.18 6.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.631 -1.168 . . . . 1.0 108.368 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.507 ' HB3' HG22 ' B' ' 208' ' ' VAL . 55.3 p-90 -153.33 161.39 42.4 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.702 0.287 . . . . 1.0 111.052 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 219' ' ' ARG . . . . . 0.427 HH21 HG13 ' B' ' 227' ' ' ILE . 28.3 mtp180 -147.28 143.26 27.96 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.897 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.69 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -93.5 132.55 37.67 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 177.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.86 129.9 72.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.415 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' HIS . . . . . 0.424 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.0 t-80 -80.77 172.85 13.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.15 -29.53 63.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 1.0 111.587 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -68.11 -33.51 74.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.511 0.672 . . . . 1.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.99 10.56 22.38 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.799 -1.091 . . . . 1.0 112.145 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -86.97 142.73 27.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.651 0.241 . . . . 1.0 111.651 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.493 ' HB ' ' HG2' ' A' ' 133' ' ' GLU . 51.2 mm -76.25 118.85 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 123.783 0.677 . . . . 1.0 109.495 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.69 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -93.18 -43.28 8.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.205 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -148.33 164.76 33.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.389 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -141.52 159.03 43.07 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.635 0.774 . . . . 1.0 109.278 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 58.5 p -57.64 -33.62 68.47 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.942 0.401 . . . . 1.0 111.666 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.4 -47.21 3.05 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -104.7 171.87 7.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.615 -0.792 . . . . 1.0 111.205 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -135.4 138.29 9.86 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.94 172.44 12.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.012 0.406 . . . . 1.0 110.883 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.83 10.53 38.66 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.7 m -131.68 131.42 43.11 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.455 0.645 . . . . 1.0 111.608 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -65.07 -35.23 80.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.191 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 60.2 tt0 -56.61 -46.48 80.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.819 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.96 -42.05 97.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.536 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.9 79.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.441 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.0 mtmt -64.05 -36.69 84.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.426 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 30.0 mm-40 -63.87 -32.93 74.62 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.763 -0.375 . . . . 1.0 109.99 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.88 94.13 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.532 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.7 mt -60.31 -51.57 71.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.542 0.686 . . . . 1.0 110.498 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.97 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.9 m -65.72 -37.6 86.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.366 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.572 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -72.9 -40.1 59.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.648 -177.547 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -64.03 -15.17 58.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -101.32 -10.45 20.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.042 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.68 -37.57 2.47 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.572 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.12 -51.9 75.7 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 43.0 Cg_endo -65.4 -10.64 26.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.19 1.26 . . . . 1.0 113.56 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.19 -13.9 11.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.702 0.287 . . . . 1.0 111.766 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.426 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -72.95 138.68 46.27 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.62 134.05 34.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.557 -1.201 . . . . 1.0 111.188 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -87.24 131.46 35.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.354 0.597 . . . . 1.0 111.977 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.9 mt -118.74 143.76 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.934 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -90.28 104.21 16.81 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.183 -177.45 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -138.22 93.46 2.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.91 179.69 1.02 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.567 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.42 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 47.8 p-80 -170.1 144.54 2.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 1.0 109.963 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.583 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.1 m-85 -84.71 149.3 25.88 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.161 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.69 118.77 11.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 118' ' ' TRP . 79.3 t -94.57 133.17 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.711 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -142.99 179.64 6.91 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.393 0.433 . . . . 1.0 110.603 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -101.68 135.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.736 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.26 179.46 7.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.353 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.57 39.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.622 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -117.7 20.19 13.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.134 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 69.46 37.13 2.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.203 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.8 mmtt -109.2 150.73 27.48 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.071 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 93.1 m-85 -93.05 112.39 24.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.65 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -129.33 178.62 6.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.558 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.8 p-90 -151.73 163.38 39.27 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 120.854 -0.338 . . . . 1.0 111.437 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 49.4 mtp180 -148.4 141.62 25.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.5 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.684 ' HG ' HD12 ' A' ' 128' ' ' LEU . 35.4 tp -93.75 134.45 36.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.73 131.03 68.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.418 ' HB2' HD21 ' A' ' 128' ' ' LEU . 6.0 t-80 -77.23 171.2 15.22 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -18.08 52.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.146 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.63 -34.11 35.22 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.635 0.731 . . . . 1.0 109.638 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.32 9.29 15.45 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.871 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -88.55 145.15 25.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.338 0.113 . . . . 1.0 110.944 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.4 mm -79.33 118.96 27.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.684 HD12 ' HG ' ' A' ' 120' ' ' LEU . 16.3 mt -90.78 -42.2 10.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.555 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.31 163.31 39.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.973 -1.012 . . . . 1.0 111.883 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.78 152.83 49.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.192 -0.913 . . . . 1.0 108.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 85.7 p -55.54 -34.04 64.36 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.982 0.42 . . . . 1.0 111.486 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.3 -45.92 3.45 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 47.1 mt-10 -109.27 168.59 9.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.799 -0.7 . . . . 1.0 111.562 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.24 145.84 16.34 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.174 -1.17 . . . . 1.0 110.174 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.56 165.59 25.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.245 0.522 . . . . 1.0 111.046 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.26 9.85 32.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.59 -0.732 . . . . 1.0 112.51 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 m -136.38 133.73 37.07 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.076 0.465 . . . . 1.0 110.775 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 6.8 ptpp? -63.87 -36.53 84.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 55.9 tt0 -56.89 -46.05 82.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.673 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.05 -39.19 91.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.8 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.29 72.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.313 0.578 . . . . 1.0 109.898 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.5 mtmt -65.28 -33.28 75.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.308 -0.86 . . . . 1.0 111.072 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.1 mm-40 -65.44 -31.84 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.178 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.98 95.15 Favored Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 142' ' ' LYS . 73.2 mt -60.66 -51.28 74.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.813 -0.694 . . . . 1.0 110.428 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.83 -33.03 74.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.468 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.6 m -68.06 -35.69 78.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.786 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' B' ' 229' ' ' ALA . 0.4 OUTLIER -72.61 -39.7 61.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -178.365 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.65 -16.12 63.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.326 0.584 . . . . 1.0 111.148 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -99.68 -1.43 37.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.799 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -137.24 -42.42 0.56 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.711 0.634 . . . . 1.0 112.711 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.69 -50.7 84.2 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 113.356 0.873 . . . . 1.0 113.356 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 42.5 Cg_endo -64.69 -9.41 20.74 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.248 1.299 . . . . 1.0 113.061 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.5 -12.22 8.59 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.861 0.362 . . . . 1.0 111.831 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.34 136.04 44.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.065 0.459 . . . . 1.0 111.443 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -96.44 145.12 25.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.511 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -90.88 129.5 41.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.84 0.828 . . . . 1.0 112.514 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.3 mt . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 114.282 -1.326 . . . . 1.0 109.888 -179.899 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.439 ' N ' HD21 ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 121.373 0.606 . . . . 1.0 112.029 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -132.83 97.81 4.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.18 166.99 4.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.109 -1.405 . . . . 1.0 108.402 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.498 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 40.5 p-80 -168.69 149.52 4.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.512 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.5 m-85 -85.28 149.93 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.393 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -141.83 120.14 12.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.211 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' B' ' 218' ' ' TRP . 55.3 t -92.88 135.75 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.439 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -149.49 179.55 7.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.658 0.266 . . . . 1.0 110.724 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -101.77 140.13 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 16.1 t70 -83.47 -178.8 7.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.018 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' ALA . . . . . 0.413 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -71.01 -11.52 61.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.352 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.15 26.08 10.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.038 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 62.84 39.48 10.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.058 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 71.8 mmtt -103.8 156.03 18.14 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.33 117.96 32.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -134.16 -179.23 5.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.78 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.489 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.4 p-90 -154.08 162.43 41.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.503 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 219' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 40.4 mtp180 -147.41 141.67 26.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.2 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.707 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.2 tp -93.75 131.2 39.33 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.33 132.17 65.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.412 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -80.89 170.34 16.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.77 -27.1 64.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.069 0.462 . . . . 1.0 110.895 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -66.97 -33.24 75.13 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.503 0.668 . . . . 1.0 109.977 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.99 9.84 25.47 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.695 -1.139 . . . . 1.0 112.261 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -86.99 143.81 27.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.395 0.141 . . . . 1.0 111.02 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.447 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.5 mm -80.27 117.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.707 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.8 mt -89.7 -41.25 12.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.746 . . . . 1.0 109.276 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -154.26 164.7 38.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.585 -1.189 . . . . 1.0 111.743 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -138.6 159.11 42.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.858 -1.064 . . . . 1.0 108.328 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 63.2 p -55.55 -30.78 61.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.149 0.5 . . . . 1.0 111.185 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.99 -40.12 3.04 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' GLU . . . . . 0.504 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.1 mt-10 -116.42 169.45 9.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.118 -0.541 . . . . 1.0 111.107 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -128.86 132.82 7.36 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.38 172.78 9.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.94 0.37 . . . . 1.0 111.808 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.63 9.8 41.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -136.02 131.95 35.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.957 0.408 . . . . 1.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -63.81 -36.47 84.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.694 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.449 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 57.2 tt0 -57.57 -42.59 83.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.281 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.68 -40.69 95.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.469 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.41 86.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.315 0.578 . . . . 1.0 109.975 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.492 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.7 mtmt -64.05 -35.25 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.264 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.8 mm-40 -65.27 -34.3 78.01 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.67 98.02 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.519 ' O ' HG12 ' B' ' 248' ' ' VAL . 65.9 mt -60.75 -52.24 63.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.39 0.614 . . . . 1.0 110.706 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.19 -36.66 84.78 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.167 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.2 m -64.16 -36.52 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.881 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -73.4 -40.18 55.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 -178.333 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.99 -15.59 62.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.739 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -100.54 -2.95 31.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.918 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 251' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 17.4 m-80 -135.66 -37.73 0.75 Allowed 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.575 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.18 -50.21 87.86 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 54.0 Cg_endo -65.96 -8.9 21.29 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.026 1.15 . . . . 1.0 113.797 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.53 -19.21 8.88 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -66.48 136.99 56.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.447 0.641 . . . . 1.0 112.619 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -92.88 135.9 33.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.819 -1.082 . . . . 1.0 111.286 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.583 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -85.23 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.635 0.731 . . . . 1.0 112.185 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.6 mt -116.38 140.7 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.489 -1.232 . . . . 1.0 109.366 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -86.62 107.34 18.12 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.285 -0.864 . . . . 1.0 111.182 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 . . . . . 0 CA--C 1.509 -0.597 0 CA-C-O 121.398 0.618 . . . . 1.0 111.76 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -125.9 99.35 5.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 172.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.41 163.7 3.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.511 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.0 p-80 -167.25 148.89 5.8 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.919 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.6 m-85 -87.93 148.47 24.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.719 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -141.21 119.27 11.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.387 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 118' ' ' TRP . 77.2 t -89.89 131.45 37.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -140.33 -179.65 6.12 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.059 0.224 . . . . 1.0 110.537 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.6 t -102.28 137.9 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.245 0.545 . . . . 1.0 112.341 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.84 179.8 7.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.193 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 -19.65 65.33 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.919 0.39 . . . . 1.0 110.765 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.02 21.08 17.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.72 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' HA ' HG13 ' A' ' 110' ' ' VAL . 3.6 m-20 69.83 37.13 1.87 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.66 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.0 mttt -110.72 150.54 28.92 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.981 -176.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -93.04 121.06 34.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.835 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 55.7 mtp180 -134.27 -176.78 4.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.661 -1.154 . . . . 1.0 108.109 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.521 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.8 p-90 -151.89 165.6 34.05 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.912 -0.715 . . . . 1.0 112.337 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -144.48 140.38 28.88 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.423 -1.262 . . . . 1.0 111.234 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.724 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.9 tp -100.85 132.06 46.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.32 132.6 69.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.512 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.468 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.4 t-80 -83.07 177.64 8.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 1.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 11.7 t70 -51.5 -44.47 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.06 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.569 ' HB2' ' ND2' ' A' ' 126' ' ' ASN . 1.0 OUTLIER -67.42 -33.65 75.61 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.308 -177.493 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.52 10.48 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.546 -0.752 . . . . 1.0 113.468 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 124' ' ' ASN . 0.5 OUTLIER -86.45 147.77 25.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.606 0.224 . . . . 1.0 111.606 177.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.3 mm -74.14 119.77 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.796 0.685 . . . . 1.0 109.57 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.724 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.8 mt -94.94 -43.86 7.98 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.271 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.423 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.71 166.85 30.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.923 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -139.35 160.36 40.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.026 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.433 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 68.0 p -58.74 -38.49 78.52 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.34 -42.28 3.08 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -91.47 173.49 7.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.719 -0.74 . . . . 1.0 110.776 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.47 125.7 1.66 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.85 171.21 14.74 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 120.431 0.157 . . . . 1.0 110.609 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.24 9.54 28.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.0 p -121.53 129.57 52.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.538 0.685 . . . . 1.0 112.551 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -64.94 -42.84 94.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.893 . . . . 1.0 111.173 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 62.2 tt0 -55.15 -45.0 75.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.459 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.557 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -56.98 -42.77 80.83 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.81 76.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.016 0.436 . . . . 1.0 110.402 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.496 ' HG2' HG21 ' A' ' 108' ' ' VAL . 45.3 mtmt -62.98 -38.65 91.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -63.46 -26.28 68.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.72 -43.85 93.44 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.093 -1.203 . . . . 1.0 110.093 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.486 ' O ' HG12 ' A' ' 148' ' ' VAL . 59.7 mt -62.18 -45.09 99.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.564 0.697 . . . . 1.0 110.169 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -62.74 -39.9 95.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -67.87 -34.71 77.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.57 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -72.93 -40.38 59.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.264 -177.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.89 -12.57 59.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.132 0.491 . . . . 1.0 111.651 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -103.4 -2.53 26.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.475 -0.784 . . . . 1.0 111.154 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.422 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.58 -39.14 1.14 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.887 -177.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.64 -50.09 88.96 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.388 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.6 Cg_endo -64.44 -16.57 55.85 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.163 1.242 . . . . 1.0 113.095 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -106.84 -23.9 12.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.498 . . . . 1.0 111.33 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.28 135.55 55.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.452 -0.794 . . . . 1.0 112.874 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -96.56 148.75 22.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.558 -1.201 . . . . 1.0 111.792 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.574 HG22 HG21 ' B' ' 245' ' ' ILE . 40.1 t -85.27 131.38 34.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 1.0 112.061 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 175.667 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.422 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 6.4 p-10 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.705 0.764 . . . . 1.0 111.98 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 13.1 mmmm -142.27 99.67 3.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.068 -1.424 . . . . 1.0 107.592 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.36 169.94 4.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.124 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.499 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 50.2 p-80 -169.53 150.11 4.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.444 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.8 m-85 -87.72 150.33 23.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.336 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.52 118.01 10.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.383 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' B' ' 218' ' ' TRP . 94.0 t -95.42 133.42 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.84 175.57 9.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.2 t -100.66 135.97 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.283 0.563 . . . . 1.0 111.536 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -82.11 178.29 8.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.997 -1.001 . . . . 1.0 110.101 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.91 -10.62 59.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.185 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.93 19.69 17.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.357 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 70.17 36.1 1.96 Allowed 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.165 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.6 mttt -110.05 144.76 38.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.459 -176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.63 111.72 23.41 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.972 -1.467 . . . . 1.0 109.345 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -128.74 175.37 8.66 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.569 ' HB3' HG22 ' B' ' 208' ' ' VAL . 53.5 p-90 -153.4 162.15 41.57 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.014 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -144.17 151.35 39.4 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.456 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.707 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -98.58 131.2 44.98 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 13.7 t -128.55 133.56 66.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.361 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -82.2 173.25 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 16.5 t70 -58.02 -27.42 63.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.196 0.522 . . . . 1.0 110.963 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -72.12 -33.28 67.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.514 0.673 . . . . 1.0 110.165 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.42 10.28 22.09 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.848 -1.069 . . . . 1.0 112.772 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -87.64 142.96 27.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.671 0.272 . . . . 1.0 111.566 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.4 mm -74.75 123.57 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.583 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.707 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -100.56 -42.96 6.35 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.045 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -147.71 167.38 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.801 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 231' ' ' SER . 15.2 t0 -141.81 153.24 44.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.034 -0.985 . . . . 1.0 108.459 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 55.0 p -58.35 -40.31 81.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 1.0 112.098 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.97 -41.12 3.03 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.21 177.25 6.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.185 -0.508 . . . . 1.0 110.667 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -167.86 114.59 0.58 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -142.37 166.04 25.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.564 0.221 . . . . 1.0 110.493 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.96 6.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.117 0.784 . . . . 1.0 113.117 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 13.2 p -112.12 127.36 55.9 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.694 0.759 . . . . 1.0 111.994 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -68.37 -40.77 81.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.112 -0.949 . . . . 1.0 110.952 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 62.8 tt0 -56.43 -46.12 80.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.297 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -42.95 85.57 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.296 0.372 . . . . 1.0 110.972 -178.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.39 70.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 1.0 110.646 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -63.3 -38.01 89.47 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.24 -0.891 . . . . 1.0 111.222 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.8 mm-40 -63.4 -28.03 69.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.76 -43.45 97.71 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.574 HG21 HG22 ' A' ' 157' ' ' VAL . 48.7 mt -63.48 -46.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.435 0.636 . . . . 1.0 110.698 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.36 -38.24 88.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.23 0.538 . . . . 1.0 110.213 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -35.25 78.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.572 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.2 -41.48 58.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.535 -177.163 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -65.85 -15.13 62.63 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 1.0 112.121 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -104.74 -2.34 25.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.866 0.365 . . . . 1.0 111.315 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -127.8 -37.44 1.94 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.415 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.11 -51.09 82.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.893 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.0 Cg_endo -66.43 -12.29 35.08 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.168 1.245 . . . . 1.0 113.462 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.15 -27.48 10.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.576 0.703 . . . . 1.0 111.577 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.38 136.87 57.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.977 1.103 . . . . 1.0 113.977 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.65 139.08 30.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -88.79 131.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.38 0.61 . . . . 1.0 111.816 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.57 144.44 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.873 -1.058 . . . . 1.0 109.004 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -88.59 102.32 14.83 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.115 -0.945 . . . . 1.0 111.236 -177.295 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.509 -0.611 0 CA-C-O 121.408 0.623 . . . . 1.0 112.007 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 100.59 6.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.014 -1.476 . . . . 1.0 107.014 172.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -172.3 165.42 5.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.455 -1.248 . . . . 1.0 108.163 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.53 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.4 p-80 -167.81 150.21 5.69 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.56 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 57.1 m-85 -86.38 148.53 25.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.734 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.6 121.97 14.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.868 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 118' ' ' TRP . 92.1 t -95.05 135.98 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.9 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.17 178.08 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.714 0.293 . . . . 1.0 110.543 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 2.9 t -101.22 133.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.343 0.592 . . . . 1.0 110.898 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.67 178.78 7.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.711 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -12.7 61.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.174 0.511 . . . . 1.0 110.929 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.39 18.75 19.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.346 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 71.1 35.2 1.67 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.794 0.838 . . . . 1.0 111.567 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.6 mttt -109.72 148.58 31.15 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.254 -175.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.32 112.21 24.07 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.329 -1.305 . . . . 1.0 109.383 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -132.95 178.31 6.98 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.401 -0.962 . . . . 1.0 108.401 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.565 ' HB3' HG22 ' A' ' 108' ' ' VAL . 53.3 p-90 -150.09 164.0 36.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.813 0.34 . . . . 1.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -146.83 147.22 30.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.127 -0.942 . . . . 1.0 109.805 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.689 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.7 tp -96.65 134.69 39.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.1 t -128.06 131.07 69.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.448 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.466 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.0 t-80 -79.59 173.87 12.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.85 -39.39 68.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.279 0.562 . . . . 1.0 110.455 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -33.44 74.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.046 -0.979 . . . . 1.0 110.642 -177.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.34 9.75 23.14 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.837 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -87.45 144.69 26.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.689 0.255 . . . . 1.0 111.689 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.2 119.49 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.762 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.689 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.5 mt -94.93 -43.92 7.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.639 0.733 . . . . 1.0 109.9 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.39 166.74 28.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.635 -1.166 . . . . 1.0 111.367 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -141.17 153.5 45.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.951 -1.022 . . . . 1.0 108.464 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.501 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 15.8 p -53.37 -36.57 61.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.006 0.372 . . . . 1.0 112.006 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.69 -45.92 3.56 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.526 -0.63 . . . . 1.0 111.526 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -93.49 174.4 7.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.285 0.564 . . . . 1.0 111.507 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.53 136.92 8.68 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.94 165.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 117.627 0.714 . . . . 1.0 111.094 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.09 10.98 37.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.218 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 m -139.64 137.28 35.14 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.483 0.659 . . . . 1.0 111.543 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -63.22 -39.58 95.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.861 -1.063 . . . . 1.0 111.047 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 58.3 tt0 -58.31 -47.02 85.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.268 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.9 -44.57 86.87 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.61 0.569 . . . . 1.0 110.976 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.29 83.36 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.266 0.555 . . . . 1.0 110.612 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.539 ' HG2' HG21 ' A' ' 108' ' ' VAL . 44.5 mtmt -64.56 -35.32 80.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.383 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -64.78 -27.92 69.22 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.88 91.97 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 142' ' ' LYS . 63.5 mt -61.43 -43.04 96.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 1.0 110.338 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.83 -40.07 94.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.5 m -63.54 -36.36 83.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.599 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.53 -42.78 55.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 C-N-CA 119.826 -0.75 . . . . 1.0 109.529 -178.116 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.17 -11.77 51.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -102.54 -2.31 28.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 1.0 110.664 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.429 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 23.9 m-80 -135.52 -37.77 0.76 Allowed 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.787 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.504 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.49 -49.7 91.08 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 44.4 Cg_endo -67.0 -11.96 34.27 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.322 1.348 . . . . 1.0 112.855 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -110.64 -19.8 12.75 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.065 0.46 . . . . 1.0 111.408 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.533 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -70.83 134.71 47.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.896 0.855 . . . . 1.0 113.153 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -94.53 142.25 27.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.22 -1.355 . . . . 1.0 110.317 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -90.67 134.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.237 0.541 . . . . 1.0 112.088 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt . . . . . 0 N--CA 1.45 -0.443 0 CA-C-N 114.902 -1.045 . . . . 1.0 109.192 177.992 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.429 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.515 -0.374 0 CA-C-O 121.475 0.655 . . . . 1.0 112.189 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' B' ' 223' ' ' ASP . 0.0 OUTLIER -126.17 101.16 6.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 172.532 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.17 159.3 3.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.136 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.533 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 44.9 p-80 -166.95 150.81 6.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.744 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.574 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.6 m-85 -86.34 150.19 24.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.693 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -142.49 118.21 10.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.615 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' B' ' 218' ' ' TRP . 97.2 t -95.09 132.8 38.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.127 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.74 177.66 8.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.2 t -100.03 136.36 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.483 0.659 . . . . 1.0 112.346 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.7 -179.78 7.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.802 -1.09 . . . . 1.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.515 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.45 20.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.917 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 71.13 34.67 1.77 Allowed 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.498 0.719 . . . . 1.0 110.901 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.9 mttt -108.64 147.94 31.12 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.56 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -94.17 109.11 20.92 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.409 -1.269 . . . . 1.0 109.822 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -122.02 176.13 5.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.575 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.1 p-90 -150.62 162.76 40.04 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.28 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -147.28 146.71 29.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.197 -0.91 . . . . 1.0 110.247 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.741 ' HG ' HD12 ' B' ' 228' ' ' LEU . 35.0 tp -99.31 132.58 44.54 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 4.2 t -126.64 133.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.077 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 222' ' ' HIS . . . . . 0.524 ' HB2' HD21 ' B' ' 228' ' ' LEU . 1.6 t-80 -86.09 176.55 7.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.389 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' B' ' 203' ' ' LYS . 43.2 t0 -52.61 -43.37 65.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.176 -0.92 . . . . 1.0 110.847 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -63.05 -33.6 75.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.617 -0.72 . . . . 1.0 110.47 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.45 12.34 19.63 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.493 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -86.43 144.84 27.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.59 0.218 . . . . 1.0 111.59 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.99 116.94 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.741 HD12 ' HG ' ' B' ' 220' ' ' LEU . 17.7 mt -89.19 -43.23 11.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.742 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.478 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.07 164.92 35.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 1.0 111.471 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -139.48 156.82 46.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.379 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.457 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 13.6 p -53.89 -35.08 61.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.78 -47.04 3.37 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -104.93 177.59 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.921 -0.64 . . . . 1.0 111.796 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -137.2 135.24 7.52 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.899 -1.28 . . . . 1.0 109.899 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -133.1 165.48 24.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.385 0.592 . . . . 1.0 111.78 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.62 10.9 26.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.9 m -138.48 135.83 35.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.46 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -64.14 -38.18 90.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.703 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 62.8 tt0 -59.84 -43.01 94.81 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.194 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -61.57 -40.64 95.46 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.793 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.33 87.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.307 0.575 . . . . 1.0 109.854 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' B' ' 245' ' ' ILE . 41.0 mtmt -64.79 -35.3 80.66 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.914 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.0 mm-40 -62.18 -29.05 70.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.705 -0.48 . . . . 1.0 109.705 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.95 -42.81 94.6 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' B' ' 242' ' ' LYS . 57.3 mt -63.67 -44.16 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.235 0.54 . . . . 1.0 110.186 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -62.27 -40.88 97.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.974 0.416 . . . . 1.0 110.295 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.55 -35.0 79.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.504 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.3 OUTLIER -74.13 -41.96 51.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.478 -177.007 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.62 -11.76 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.816 -0.552 . . . . 1.0 111.832 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -104.79 -5.71 20.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.24 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 251' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 10.1 m-80 -130.08 -39.4 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.026 0.38 . . . . 1.0 112.026 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.574 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.74 -50.04 89.35 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 28.7 Cg_endo -62.03 -16.74 51.99 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.336 1.357 . . . . 1.0 113.187 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.64 -29.36 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.272 0.558 . . . . 1.0 111.899 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -59.11 135.92 57.79 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.644 0.979 . . . . 1.0 113.644 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -93.7 141.08 28.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.802 -1.545 . . . . 1.0 110.252 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.532 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.56 133.41 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.498 0.666 . . . . 1.0 112.233 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -119.41 146.76 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.691 -1.14 . . . . 1.0 109.034 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.95 104.1 16.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.088 -0.958 . . . . 1.0 111.873 -176.348 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 16.4 p-10 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.373 0.606 . . . . 1.0 112.34 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -131.87 97.22 4.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.98 168.24 4.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.055 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.527 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 31.8 p-80 -171.45 151.21 2.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.301 -0.259 . . . . 1.0 110.301 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -88.5 150.38 23.14 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.062 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.83 119.64 12.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.26 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 118' ' ' TRP . 73.4 t -93.97 131.69 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.975 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.43 179.78 6.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.772 0.32 . . . . 1.0 110.823 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.7 t -102.21 137.83 28.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.239 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.54 -179.97 7.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.939 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.17 -12.36 61.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.429 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.22 20.03 16.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.767 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 71.33 35.18 1.59 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.562 0.745 . . . . 1.0 111.249 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 9.5 mmtt -108.71 153.31 23.63 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.203 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -96.6 118.3 32.8 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.643 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.0 mtm105 -133.51 -179.99 5.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.516 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.7 p-90 -150.09 170.58 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.377 0.608 . . . . 1.0 112.366 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -148.41 141.88 25.33 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.448 -1.251 . . . . 1.0 110.63 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.737 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.6 tp -102.15 129.8 48.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 174.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.52 134.65 61.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 121.08 -0.248 . . . . 1.0 110.726 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -83.04 172.25 12.93 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -57.14 -30.55 64.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.958 0.409 . . . . 1.0 111.843 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.26 -33.6 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.3 0.571 . . . . 1.0 110.037 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.76 11.76 16.09 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.069 -0.969 . . . . 1.0 112.347 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -88.94 142.02 27.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.841 -0.18 . . . . 1.0 111.086 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.6 mm -77.58 118.19 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.921 0.763 . . . . 1.0 109.711 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.737 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.2 mt -89.83 -40.06 12.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.413 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.16 164.52 37.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.781 -1.1 . . . . 1.0 111.917 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.53 154.27 49.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.826 -1.079 . . . . 1.0 108.723 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 118' ' ' TRP . 77.6 p -55.59 -41.47 73.44 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.13 -35.52 2.77 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.441 -0.664 . . . . 1.0 111.441 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 49.4 mt-10 -94.71 174.92 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.19 0.519 . . . . 1.0 111.132 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.54 124.12 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.739 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -146.03 179.44 7.48 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.56 9.42 41.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.768 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.6 m -117.59 128.86 55.35 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.675 0.75 . . . . 1.0 111.664 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -69.52 -32.07 70.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.573 -1.194 . . . . 1.0 110.214 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 51.9 tt0 -63.06 -44.83 94.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.112 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 133' ' ' GLU . 27.5 tptp -60.87 -37.07 80.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.681 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.83 75.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.194 0.521 . . . . 1.0 109.962 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.458 ' HA ' HD12 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.97 -36.96 86.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.3 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.6 mm-40 -61.65 -27.44 68.68 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.14 -43.62 89.46 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.07 -1.212 . . . . 1.0 110.07 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.524 HG21 HG22 ' B' ' 257' ' ' VAL . 54.4 mt -63.29 -44.48 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.318 0.58 . . . . 1.0 109.97 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.09 -43.78 98.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.354 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.0 m -64.09 -34.93 79.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.745 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -73.5 -43.25 55.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 C-N-CA 119.897 -0.721 . . . . 1.0 109.653 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -67.6 -11.92 59.22 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.042 -0.411 . . . . 1.0 111.729 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -104.11 -2.35 25.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.807 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.428 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.1 m-80 -137.04 -37.2 0.65 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.89 -50.14 87.85 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -64.89 -11.12 28.0 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.329 1.353 . . . . 1.0 113.226 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.88 -22.42 11.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.065 0.459 . . . . 1.0 111.394 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -67.84 137.77 55.58 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.269 0.84 . . . . 1.0 113.269 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -100.11 154.21 18.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.3 -1.318 . . . . 1.0 111.489 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.516 HG22 HG21 ' B' ' 245' ' ' ILE . 36.1 t -87.61 133.45 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.995 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 176.54 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.53 ' N ' HD21 ' B' ' 202' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.514 -0.427 0 CA-C-O 121.685 0.755 . . . . 1.0 112.878 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -135.75 97.76 3.74 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.571 -1.649 . . . . 1.0 106.971 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.31 167.46 4.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.322 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.469 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 30.1 p80 -169.32 149.63 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.738 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -85.9 151.17 23.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -140.93 120.68 13.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.568 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' B' ' 218' ' ' TRP . 81.0 t -94.33 133.35 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.654 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -140.18 -178.79 5.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.101 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.9 t -108.36 138.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.333 0.494 . . . . 1.0 112.333 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.8 178.57 8.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.748 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.23 -18.86 65.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.735 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.89 23.09 14.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.112 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 62.64 40.87 9.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.854 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.2 mmtt -102.1 158.66 16.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -102.47 118.48 36.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -132.03 179.08 6.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.52 ' HB3' HG22 ' B' ' 208' ' ' VAL . 52.5 p-90 -149.0 171.05 16.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.588 0.709 . . . . 1.0 112.317 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -147.43 142.49 27.07 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.205 -1.361 . . . . 1.0 110.649 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.696 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.0 tp -100.46 129.39 46.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.56 135.0 61.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.363 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -81.73 168.59 17.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.46 -17.73 55.78 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.947 0.403 . . . . 1.0 111.419 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.25 -33.9 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.546 0.689 . . . . 1.0 109.488 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.59 10.91 15.89 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 114.41 -1.268 . . . . 1.0 112.596 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -90.54 143.26 26.92 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.265 0.226 . . . . 1.0 111.481 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.81 127.01 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 123.675 0.609 . . . . 1.0 109.513 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.696 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -103.81 -40.75 6.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.231 0.539 . . . . 1.0 109.99 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.86 164.86 36.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.908 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' B' ' 231' ' ' SER . 10.2 t0 -139.22 151.88 46.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.829 -1.078 . . . . 1.0 108.186 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 11.9 p -51.51 -36.47 44.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.864 0.32 . . . . 1.0 111.864 176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.62 -45.32 3.34 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.355 -0.698 . . . . 1.0 111.355 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' GLU . . . . . 0.553 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 89.0 mt-10 -113.26 171.26 7.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.559 . . . . 1.0 111.011 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.99 141.3 9.55 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.05 174.27 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.603 0.24 . . . . 1.0 110.458 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -86.17 10.83 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 -176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.3 m -128.61 131.17 48.1 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 121.74 -0.6 . . . . 1.0 111.336 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' B' ' 242' ' ' LYS . 20.3 ptmt -66.51 -34.87 78.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.627 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 58.2 tt0 -57.16 -43.99 83.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.905 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.4 OUTLIER -60.49 -40.88 92.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.22 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.25 78.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.217 0.532 . . . . 1.0 110.376 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' B' ' 238' ' ' LYS . 44.9 mtmt -63.0 -41.11 99.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.91 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.5 mm-40 -64.79 -26.22 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.134 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.27 -42.56 96.15 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.029 -1.228 . . . . 1.0 110.029 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.516 HG21 HG22 ' A' ' 157' ' ' VAL . 57.5 mt -62.23 -46.16 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 1.0 110.161 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.41 -40.3 96.06 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.201 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.02 -34.18 77.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.662 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.01 -43.03 52.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.888 -177.579 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -65.95 -12.01 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 1.0 111.848 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -102.63 -3.09 27.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.786 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 251' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 13.5 m-80 -135.65 -36.36 0.78 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -176.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.16 -50.41 87.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.538 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.4 Cg_endo -63.47 -14.12 40.4 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.444 1.43 . . . . 1.0 113.254 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.45 -21.49 12.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.88 0.371 . . . . 1.0 111.906 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.51 138.18 57.9 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.131 0.789 . . . . 1.0 113.131 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -97.05 150.38 20.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.328 -1.305 . . . . 1.0 112.053 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 145' ' ' ILE . 36.2 t -85.53 133.93 28.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.258 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.44 143.95 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.78 102.4 13.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.595 -0.717 . . . . 1.0 110.892 -178.14 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.432 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 17.7 p-10 . . . . . 0 CA--C 1.511 -0.535 0 CA-C-O 121.468 0.651 . . . . 1.0 112.744 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.5 mptt -121.63 97.4 5.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.03 167.48 4.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.451 -1.249 . . . . 1.0 108.426 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.469 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 52.3 p-80 -168.88 148.37 4.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.929 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.563 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.9 m-85 -86.27 149.09 25.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.868 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -142.56 121.43 12.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.759 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.5 t -97.09 136.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -147.25 -179.26 6.71 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.245 0.341 . . . . 1.0 110.593 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -105.82 138.5 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.394 0.616 . . . . 1.0 112.082 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.23 178.54 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.744 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.21 63.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.046 0.45 . . . . 1.0 111.162 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.71 22.22 16.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.444 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 70.62 33.18 2.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.687 0.795 . . . . 1.0 111.236 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.4 mttt -107.42 146.56 31.53 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.517 0.675 . . . . 1.0 111.941 -175.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -92.9 115.76 28.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.198 -1.364 . . . . 1.0 109.802 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -128.99 179.36 5.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.203 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.587 ' HB3' HG22 ' A' ' 108' ' ' VAL . 54.9 p-90 -154.5 165.49 36.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.1 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 16.4 mtt180 -149.09 150.63 33.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 124.016 0.823 . . . . 1.0 110.497 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.712 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.0 tp -99.83 132.02 45.44 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.86 129.72 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.554 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -78.23 172.62 13.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.03 -32.39 66.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.15 0.5 . . . . 1.0 110.959 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.29 -33.73 76.67 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.203 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.66 14.22 16.39 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.078 -0.965 . . . . 1.0 112.384 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -90.34 143.6 26.6 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mm -74.96 118.64 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 123.926 0.766 . . . . 1.0 109.566 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.712 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.3 mt -93.87 -43.41 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.384 0.612 . . . . 1.0 109.799 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.479 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.21 163.74 37.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.367 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -139.07 156.86 46.86 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.8 p -53.74 -31.5 48.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.931 0.396 . . . . 1.0 111.401 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.06 -38.26 2.98 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.502 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 49.9 mt-10 -118.3 171.39 8.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.048 -0.576 . . . . 1.0 110.951 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.42 138.66 10.49 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -133.43 169.43 16.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.32 0.56 . . . . 1.0 111.982 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.01 10.72 30.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -142.5 139.22 31.42 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.815 -0.553 . . . . 1.0 111.9 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.64 -37.48 87.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.461 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.449 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 50.0 tt0 -59.03 -46.67 87.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.544 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -59.12 -41.59 88.55 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.614 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.11 75.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.09 0.471 . . . . 1.0 109.861 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 145' ' ' ILE . 43.9 mtmt -64.21 -34.73 78.76 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.344 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.0 mm-40 -63.69 -27.13 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.76 -42.38 87.02 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 142' ' ' LYS . 66.5 mt -62.2 -44.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.414 0.626 . . . . 1.0 109.637 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -61.52 -44.77 96.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.239 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.8 m -63.56 -34.83 78.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.751 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -74.55 -41.61 48.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 C-N-CA 119.878 -0.729 . . . . 1.0 109.684 -177.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.36 -12.1 54.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.753 0.311 . . . . 1.0 111.657 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -104.63 -2.8 24.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.591 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -132.02 -40.58 1.04 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.835 0.35 . . . . 1.0 111.502 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.15 -51.48 79.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.617 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -63.54 -9.0 16.52 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.508 1.472 . . . . 1.0 113.98 -177.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.58 -22.19 7.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.918 0.39 . . . . 1.0 111.939 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 136.52 57.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.777 0.799 . . . . 1.0 113.038 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.93 138.78 31.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.438 -1.255 . . . . 1.0 110.581 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.567 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.69 130.65 38.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.711 . . . . 1.0 112.699 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 114.369 -1.287 . . . . 1.0 108.568 177.496 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 CA--C 1.514 -0.423 0 CA-C-O 121.022 0.439 . . . . 1.0 110.787 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 73.3 mmtt -137.73 95.77 3.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.609 -1.256 . . . . 1.0 107.609 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.91 173.03 2.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.094 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.496 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.6 p-80 -170.7 147.59 2.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.583 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.567 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 57.6 m-85 -85.16 147.61 26.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.654 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.37 119.55 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.08 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' B' ' 218' ' ' TRP . 75.4 t -92.14 133.93 31.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.151 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -145.66 -176.43 5.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.619 0.247 . . . . 1.0 110.4 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.8 t -101.99 139.42 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.909 0.707 . . . . 1.0 112.909 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -81.22 -178.65 7.01 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.309 -0.86 . . . . 1.0 109.548 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.82 -16.96 62.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.154 0.502 . . . . 1.0 110.673 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.37 19.33 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.712 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.67 39.99 1.44 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.425 0.69 . . . . 1.0 110.956 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -113.76 151.86 31.38 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.791 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -91.99 118.87 31.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.158 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.433 ' HG2' ' HA2' ' B' ' 234' ' ' GLY . 62.1 mtp180 -130.69 -178.67 4.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.808 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.507 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.8 p-90 -155.43 164.44 38.71 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.345 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -149.66 148.31 29.13 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.216 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.695 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -97.15 130.16 44.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.28 130.59 71.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.252 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -78.94 169.31 18.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 29.0 t70 -58.36 -26.47 63.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.266 0.555 . . . . 1.0 110.954 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.4 -33.07 70.95 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.941 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.48 11.52 19.44 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.125 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.55 144.21 26.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.807 -0.231 . . . . 1.0 111.385 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.9 mm -78.24 116.72 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 1.0 109.472 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.695 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -90.25 -42.58 10.92 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.547 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.483 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -150.35 164.27 36.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.608 -1.178 . . . . 1.0 111.374 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.34 155.33 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 65.6 p -54.72 -33.26 60.84 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.066 0.46 . . . . 1.0 111.55 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.69 3.51 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.53 -0.628 . . . . 1.0 111.53 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -122.72 166.94 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.175 0.512 . . . . 1.0 111.572 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' B' ' 217' ' ' ARG . . . -118.73 139.78 14.72 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.651 -1.38 . . . . 1.0 109.651 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -127.47 171.02 11.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.623 0.711 . . . . 1.0 111.545 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -100.73 9.69 42.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 1.0 112.28 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.7 m -143.78 137.21 27.9 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.68 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -62.88 -38.42 90.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.78 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 50.8 tt0 -60.98 -40.71 94.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.211 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -61.05 -41.51 96.74 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.647 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.28 89.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.973 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.572 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.0 mtmt -64.91 -34.99 79.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.228 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.3 mm-40 -62.62 -30.98 71.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.15 -41.28 95.03 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.048 -1.221 . . . . 1.0 110.048 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' B' ' 242' ' ' LYS . 66.6 mt -63.36 -43.08 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.976 -0.612 . . . . 1.0 110.582 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -63.99 -41.3 97.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.04 0.448 . . . . 1.0 110.232 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -64.03 -37.08 86.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.522 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -74.06 -41.46 52.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 C-N-CA 120.22 -0.592 . . . . 1.0 110.755 -176.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.53 -16.35 63.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -105.82 -3.23 22.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 1.0 111.353 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 251' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 15.2 m-80 -123.32 -38.88 2.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.986 0.422 . . . . 1.0 111.082 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.51 -50.87 85.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.495 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.5 Cg_endo -63.59 -12.75 32.66 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.53 1.486 . . . . 1.0 113.528 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.56 -19.47 10.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -64.57 136.77 57.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.866 0.841 . . . . 1.0 112.593 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -91.83 135.76 33.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.022 -1.445 . . . . 1.0 110.573 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.563 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -88.54 129.85 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.601 0.715 . . . . 1.0 112.298 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.9 mt -115.1 140.59 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.406 -1.27 . . . . 1.0 109.27 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -90.31 106.55 18.57 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.674 -0.862 . . . . 1.0 108.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.337 -0.839 . . . . 1.0 111.213 -177.399 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.479 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.333 0.587 . . . . 1.0 112.066 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -134.37 96.64 3.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.55 171.13 3.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.856 -1.065 . . . . 1.0 109.401 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.5 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 48.4 p-80 -170.53 148.36 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.1 m-85 -84.83 149.94 25.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.38 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.35 118.73 12.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.559 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 118' ' ' TRP . 68.2 t -90.95 133.39 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.878 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -142.6 177.43 8.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.412 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.4 t -102.36 137.47 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.334 0.587 . . . . 1.0 111.969 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.57 177.76 8.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.96 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.87 -12.25 61.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.237 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.97 24.28 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.669 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 69.35 35.19 2.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 1.0 111.674 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.7 mttt -110.68 147.53 34.15 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.457 0.646 . . . . 1.0 111.4 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.6 120.98 32.13 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.431 -1.259 . . . . 1.0 110.467 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -136.32 -179.7 5.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.572 -1.194 . . . . 1.0 108.675 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.535 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.3 p-90 -151.7 162.9 40.24 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.683 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.531 HH11 HG21 ' A' ' 127' ' ' ILE . 21.6 mmt180 -143.48 142.82 31.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.298 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.719 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.5 tp -99.97 129.99 46.1 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -127.79 132.36 68.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.483 -0.192 . . . . 1.0 110.483 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.439 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.0 t-80 -83.34 174.35 10.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.4 -39.18 67.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.0 111.476 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -60.32 -33.96 73.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.513 0.673 . . . . 1.0 110.26 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.54 12.17 21.8 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.873 -1.058 . . . . 1.0 112.096 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -86.77 142.57 28.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.63 0.252 . . . . 1.0 111.376 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.531 HG21 HH11 ' A' ' 119' ' ' ARG . 50.9 mm -76.26 116.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.194 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.719 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.1 mt -88.38 -42.74 11.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.634 0.731 . . . . 1.0 109.917 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.65 166.43 30.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.756 -1.111 . . . . 1.0 111.237 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -140.34 155.41 46.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.87 -1.059 . . . . 1.0 110.13 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.447 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 18.9 p -54.5 -36.03 63.75 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.601 0.563 . . . . 1.0 111.605 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.38 -50.67 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.65 178.61 4.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.709 -0.746 . . . . 1.0 111.618 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -145.67 140.62 9.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -141.37 167.47 22.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.531 0.165 . . . . 1.0 110.66 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.4 9.9 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 p -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.601 0.715 . . . . 1.0 111.862 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -64.94 -41.52 95.44 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.595 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.83 -37.78 80.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.621 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -62.0 -43.35 99.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.241 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.95 83.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.26 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.587 ' HA ' HD12 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.66 -34.43 78.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.169 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -62.99 -30.29 71.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.34 -40.35 94.57 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.42 -1.072 . . . . 1.0 110.42 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 142' ' ' LYS . 58.3 mt -62.73 -42.26 95.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.085 0.469 . . . . 1.0 110.081 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.09 -43.75 97.63 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.155 0.502 . . . . 1.0 109.885 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -61.25 -36.16 79.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -75.22 -42.4 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 119.536 -0.866 . . . . 1.0 110.169 -177.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.6 mtpt -66.86 -15.65 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 1.0 112.399 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -105.43 -2.26 23.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.366 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.62 -37.53 1.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.693 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.603 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.34 -51.35 82.33 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.499 0.555 . . . . 1.0 112.499 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 57.8 Cg_endo -66.56 -4.81 11.55 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.261 1.308 . . . . 1.0 113.208 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.18 -23.41 6.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.593 0.59 . . . . 1.0 112.593 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -66.69 139.12 57.83 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.472 0.916 . . . . 1.0 113.472 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.78 135.42 33.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.488 -1.233 . . . . 1.0 111.189 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -88.04 131.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.335 0.588 . . . . 1.0 112.075 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.6 mt . . . . . 0 N--CA 1.449 -0.476 0 CA-C-N 114.93 -1.032 . . . . 1.0 108.92 178.204 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.434 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 14.4 p-10 . . . . . 0 CA--C 1.512 -0.507 0 CA-C-O 121.363 0.601 . . . . 1.0 112.588 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 12.0 mptt -127.78 96.46 4.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 174.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.95 171.4 3.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.417 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.555 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.6 p-80 -169.32 147.26 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.213 -0.195 . . . . 1.0 110.59 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 52.1 m-85 -86.67 146.72 26.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.144 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -141.75 122.0 13.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.752 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.0 t -93.24 135.68 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.09 -178.62 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.355 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.1 t -106.15 139.65 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.22 179.12 7.8 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.47 -0.787 . . . . 1.0 109.51 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.38 -17.58 64.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.893 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.8 19.16 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.118 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 69.78 35.37 2.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.041 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.1 mmtt -108.57 149.16 29.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.407 -175.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.38 119.67 32.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.53 -1.214 . . . . 1.0 110.254 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -132.32 -178.1 4.76 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.706 -1.134 . . . . 1.0 108.972 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.517 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.0 p-90 -155.7 168.22 27.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.742 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 219' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 16.6 mtt180 -150.44 154.13 37.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.849 -1.069 . . . . 1.0 110.613 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.693 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -104.36 132.62 50.41 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.3 t -126.25 132.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.259 -0.275 . . . . 1.0 110.259 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' HIS . . . . . 0.485 ' HB2' HD21 ' B' ' 228' ' ' LEU . 0.6 OUTLIER -85.26 174.49 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.256 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 26.8 t70 -52.5 -33.88 46.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.833 -0.621 . . . . 1.0 112.249 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -70.81 -33.29 70.55 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.322 0.582 . . . . 1.0 110.179 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.92 10.34 21.09 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.074 -0.967 . . . . 1.0 112.38 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -85.69 144.51 27.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.35 118.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 O-C-N 123.926 0.766 . . . . 1.0 109.38 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.693 HD12 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -93.42 -43.52 8.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.608 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.67 40.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.195 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -136.85 155.11 50.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.458 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.3 p -51.86 -37.03 50.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.905 0.383 . . . . 1.0 111.817 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.18 -46.44 3.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' GLU . . . . . 0.462 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 7.8 mm-40 -98.15 -179.75 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.127 -0.537 . . . . 1.0 111.399 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -150.0 133.86 4.57 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -138.85 170.01 16.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.089 0.444 . . . . 1.0 110.962 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -92.27 9.46 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 6.5 p -126.96 129.05 47.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.594 0.711 . . . . 1.0 112.1 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.21 -41.17 94.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 53.5 tt0 -58.4 -41.14 84.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.342 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -60.59 -41.95 95.76 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.918 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.18 79.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.43 0.633 . . . . 1.0 109.511 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.515 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.2 mtmt -65.78 -33.68 76.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.265 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.1 mm-40 -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -68.15 -39.64 88.36 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.9 mt -61.58 -52.43 61.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.519 0.676 . . . . 1.0 110.59 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -61.87 -35.57 78.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.02 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.2 m -67.95 -36.29 79.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.846 177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.514 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.5 OUTLIER -71.54 -37.16 62.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -177.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -66.41 -15.46 63.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.938 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 41.2 ttt85 -105.04 -2.9 23.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.074 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 251' ' ' ASN . . . . . 0.44 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 16.1 m-80 -127.08 -41.17 1.8 Allowed 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.639 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.82 -50.51 87.64 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.768 -0.651 . . . . 1.0 112.431 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.6 Cg_endo -62.84 -15.15 45.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 121.162 1.241 . . . . 1.0 113.712 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.5 -18.3 11.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.823 0.344 . . . . 1.0 111.923 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.6 135.25 52.61 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.641 0.734 . . . . 1.0 112.791 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -93.56 140.28 29.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.213 -1.358 . . . . 1.0 110.592 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -87.27 136.36 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.369 0.604 . . . . 1.0 112.205 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.8 mt -124.58 148.72 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.658 -1.156 . . . . 1.0 109.761 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.9 106.37 17.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.577 -0.725 . . . . 1.0 111.296 -177.858 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' C ' ' HD2' ' A' ' 103' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.508 -0.664 0 CA-C-O 121.351 0.595 . . . . 1.0 112.151 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.2 mptt -122.71 97.91 5.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.72 169.34 4.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.685 -1.143 . . . . 1.0 108.954 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.509 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.9 p-80 -169.14 148.94 4.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.576 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.59 146.9 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.66 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.36 116.8 11.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.939 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 118' ' ' TRP . 70.2 t -90.97 132.12 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.526 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -140.5 -179.08 5.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.383 -0.228 . . . . 1.0 110.383 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.2 t -103.53 136.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.586 . . . . 1.0 112.388 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.11 177.55 8.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 1.0 108.957 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.29 62.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 1.0 111.006 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.55 19.16 20.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.102 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.6 39.99 1.96 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.672 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 13.2 mmtt -111.76 152.45 27.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.283 -176.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.44 118.63 31.55 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.727 -1.124 . . . . 1.0 110.067 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -132.06 -179.26 5.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.527 ' HB3' HG22 ' A' ' 108' ' ' VAL . 60.5 p-90 -155.77 167.41 30.48 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.082 0.468 . . . . 1.0 111.926 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -151.64 149.87 29.62 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.334 -1.303 . . . . 1.0 110.63 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.704 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.4 tp -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 t -126.59 131.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.561 -0.291 . . . . 1.0 110.549 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -81.65 172.08 13.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 26.3 t70 -57.84 -27.36 63.13 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.323 0.582 . . . . 1.0 110.792 177.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.1 -33.64 73.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.955 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.12 11.7 23.53 Favored Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.109 -0.95 . . . . 1.0 112.318 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -90.09 144.68 25.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.101 0.408 . . . . 1.0 112.101 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 50.6 mm -76.41 117.4 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.944 0.777 . . . . 1.0 109.137 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.704 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.0 mt -90.57 -43.96 9.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.6 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.51 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.48 158.48 44.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.692 -1.14 . . . . 1.0 111.02 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.64 154.99 51.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.421 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 16.3 p -52.9 -33.16 49.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.406 0.442 . . . . 1.0 112.159 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.35 -48.04 3.73 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -104.07 -175.38 2.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.913 -0.644 . . . . 1.0 111.406 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -149.25 137.77 6.48 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -144.34 168.47 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.96 0.38 . . . . 1.0 111.06 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.06 10.29 32.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.226 0.824 . . . . 1.0 113.226 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -125.83 132.53 52.21 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 111.076 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -64.77 -38.55 91.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.879 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 64.5 tt0 -61.17 -41.23 96.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.988 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.64 -41.21 94.47 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.555 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.985 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 145' ' ' ILE . 48.3 mtmt -63.63 -36.41 83.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.632 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.0 mm-40 -65.1 -25.49 67.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.2 -40.95 92.48 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 142' ' ' LYS . 67.7 mt -62.43 -44.53 99.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.8 -0.7 . . . . 1.0 109.766 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.55 -40.16 95.95 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.809 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -63.17 -35.39 80.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.007 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -73.68 -40.86 54.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 119.581 -0.848 . . . . 1.0 109.371 -178.286 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -68.06 -11.92 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.251 0.548 . . . . 1.0 110.768 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -97.73 -6.87 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.259 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -138.91 -37.51 0.52 Allowed 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -53.84 -50.68 82.47 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 56.8 Cg_endo -67.36 -6.21 15.82 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 121.307 1.338 . . . . 1.0 113.473 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.88 -26.96 5.9 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.247 0.546 . . . . 1.0 111.684 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -64.98 136.44 56.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.424 -0.807 . . . . 1.0 112.502 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.35 139.4 34.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.566 -1.197 . . . . 1.0 110.975 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.518 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -86.72 139.92 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.542 0.686 . . . . 1.0 112.584 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.7 mt . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.013 177.291 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 CA--C 1.517 -0.296 0 CA-C-O 121.52 0.676 . . . . 1.0 112.252 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -144.94 97.12 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.17 -1.418 . . . . 1.0 107.17 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.98 177.41 1.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.958 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.476 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.8 p-80 -169.2 148.12 3.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.831 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 60.8 m-85 -86.16 150.12 24.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.836 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.16 117.59 10.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' B' ' 218' ' ' TRP . 88.9 t -93.5 134.53 30.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.958 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -145.75 179.76 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.312 . . . . 1.0 110.968 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.467 HG13 ' HA ' ' B' ' 214' ' ' ASP . 1.3 t -97.44 135.94 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.37 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.53 -179.11 7.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.055 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.05 -6.91 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.972 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.79 18.42 11.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.531 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.467 ' HA ' HG13 ' B' ' 210' ' ' VAL . 35.1 t70 69.83 43.69 0.92 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.47 1.128 . . . . 1.0 110.359 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.7 mmtt -113.51 150.23 33.21 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.749 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.06 116.32 28.71 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.799 -1.091 . . . . 1.0 109.988 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -134.03 178.29 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.528 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.1 p-90 -151.27 164.01 37.59 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.742 -0.383 . . . . 1.0 111.391 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 219' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' B' ' 219' ' ' ARG . 4.5 mtp-105 -146.63 145.76 30.17 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.913 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.699 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.5 tp -96.61 130.66 43.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 t -126.13 130.77 72.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.027 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 222' ' ' HIS . . . . . 0.434 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.1 t-80 -81.83 175.47 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.62 -36.81 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.414 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.13 -34.58 77.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.563 0.697 . . . . 1.0 110.503 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.63 12.33 17.02 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 114.97 -1.014 . . . . 1.0 112.203 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -87.06 143.33 27.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.056 0.391 . . . . 1.0 112.056 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.17 120.15 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 124.053 0.845 . . . . 1.0 109.911 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.699 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.9 mt -96.49 -43.96 7.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.703 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -150.46 162.3 40.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.489 -1.232 . . . . 1.0 111.135 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -137.65 152.93 49.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.972 -1.013 . . . . 1.0 108.442 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 79.8 p -55.25 -36.43 66.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.013 0.435 . . . . 1.0 111.416 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.25 -48.1 3.57 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 233' ' ' GLU . . . . . 0.417 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 14.9 mm-40 -98.01 171.76 8.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.78 -0.71 . . . . 1.0 111.563 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.11 135.82 6.23 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.349 -1.101 . . . . 1.0 110.349 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -141.86 178.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.066 0.433 . . . . 1.0 110.405 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -99.27 9.8 42.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.192 0.812 . . . . 1.0 113.192 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -125.86 131.83 52.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.2 0.524 . . . . 1.0 111.544 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.58 -39.13 93.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.164 -0.926 . . . . 1.0 110.448 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 53.8 tt0 -60.29 -43.82 95.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.224 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -59.52 -41.43 89.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.618 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.49 -51.08 71.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.064 0.459 . . . . 1.0 110.318 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.497 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.7 mtmt -63.59 -33.37 75.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.3 mm-40 -65.55 -30.38 71.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.425 -0.51 . . . . 1.0 109.72 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.14 96.42 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.509 ' O ' HG12 ' B' ' 248' ' ' VAL . 75.6 mt -61.62 -53.42 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.588 0.709 . . . . 1.0 110.535 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -61.37 -34.8 75.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.591 -0.731 . . . . 1.0 111.034 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.5 m -66.82 -37.64 84.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.389 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -70.72 -40.59 77.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.984 -0.687 . . . . 1.0 109.247 -177.637 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.72 -17.26 62.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 250' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 250' ' ' ARG . 8.4 ttt180 -104.07 -2.77 25.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.967 0.413 . . . . 1.0 111.033 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.82 -41.77 1.63 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.608 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.514 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.87 -50.68 85.81 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.503 -0.771 . . . . 1.0 112.852 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.3 Cg_endo -63.14 -15.14 46.16 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.232 1.288 . . . . 1.0 113.379 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.52 -19.94 11.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.925 0.393 . . . . 1.0 111.906 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.84 136.23 53.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.786 0.803 . . . . 1.0 112.507 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.81 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.125 -1.398 . . . . 1.0 110.988 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.576 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.0 OUTLIER -88.86 130.07 38.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.613 0.721 . . . . 1.0 112.621 179.084 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.3 mt -116.41 142.58 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.468 -1.242 . . . . 1.0 108.864 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -90.17 101.91 14.63 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.869 -0.586 . . . . 1.0 111.21 -177.137 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.425 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 121.711 0.767 . . . . 1.0 112.033 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 46.8 mmtm -137.58 98.43 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.136 -1.393 . . . . 1.0 107.319 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.17 172.8 3.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.425 -0.807 . . . . 1.0 109.392 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.439 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 31.6 p-80 -172.02 149.41 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.154 0.283 . . . . 1.0 110.238 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 66.1 m-85 -86.11 153.63 21.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.483 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -141.66 117.68 10.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 118' ' ' TRP . 79.4 t -93.84 129.54 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -143.63 179.3 7.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.804 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -98.82 134.8 36.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.809 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.13 178.54 8.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.173 -0.922 . . . . 1.0 109.53 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.35 -16.83 64.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.165 0.507 . . . . 1.0 110.629 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.05 20.25 18.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.738 -0.664 . . . . 1.0 111.708 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 71.3 35.53 1.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.453 0.701 . . . . 1.0 111.398 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.2 mttt -109.61 150.27 28.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.159 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.06 109.38 20.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.006 -0.997 . . . . 1.0 109.264 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -126.15 176.91 6.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.526 ' HB3' HG22 ' A' ' 108' ' ' VAL . 49.8 p-90 -147.3 162.45 38.93 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.365 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.504 HH21 HG13 ' A' ' 127' ' ' ILE . 14.7 mmm-85 -144.5 142.18 30.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.157 -0.929 . . . . 1.0 109.635 -177.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.736 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.9 tp -98.79 131.61 44.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.238 -1.023 . . . . 1.0 108.238 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -130.78 132.97 63.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.542 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -81.81 174.71 11.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.7 t70 -56.11 -36.58 68.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.285 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -64.88 -33.45 76.04 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.551 0.691 . . . . 1.0 109.699 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 11.57 21.35 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 114.688 -1.142 . . . . 1.0 112.398 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -85.97 141.31 29.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.721 0.296 . . . . 1.0 111.587 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.504 HG13 HH21 ' A' ' 119' ' ' ARG . 47.6 mm -74.66 122.1 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.299 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.736 HD12 ' HG ' ' A' ' 120' ' ' LEU . 13.9 mt -98.17 -41.42 7.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.881 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.516 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.19 169.24 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.26 -0.882 . . . . 1.0 111.935 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -141.97 153.49 44.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.698 -1.137 . . . . 1.0 108.325 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.434 ' HA ' ' CE2' ' A' ' 118' ' ' TRP . 77.3 p -53.49 -34.49 58.25 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.005 0.431 . . . . 1.0 111.597 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.88 -40.45 3.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.652 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 93.9 mt-10 -110.82 174.85 5.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.307 -0.446 . . . . 1.0 110.78 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.85 136.67 6.74 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.311 -0.715 . . . . 1.0 111.311 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -144.54 177.53 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.733 0.266 . . . . 1.0 110.968 -177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.36 9.67 42.32 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.773 0.657 . . . . 1.0 112.773 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 m -122.03 131.34 53.94 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.561 0.696 . . . . 1.0 111.451 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.96 -36.23 83.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.835 -1.075 . . . . 1.0 110.82 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 63.1 tt0 -63.31 -42.19 98.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.146 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -57.99 -41.26 82.64 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.689 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.2 70.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.194 0.521 . . . . 1.0 110.089 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.51 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.5 -36.77 85.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.682 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -64.0 -28.07 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.64 -41.91 95.73 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 142' ' ' LYS . 62.3 mt -63.48 -45.68 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.837 -0.682 . . . . 1.0 110.466 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.63 -40.43 94.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.871 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.4 m -66.8 -33.73 76.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.817 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.69 -40.39 54.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.037 -0.665 . . . . 1.0 109.948 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -68.17 -11.8 59.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 111.153 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.39 -8.61 26.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.289 -0.868 . . . . 1.0 109.691 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -134.39 -39.14 0.83 Allowed 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 113.482 0.919 . . . . 1.0 113.482 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.31 -49.18 91.92 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.837 0.68 . . . . 1.0 112.837 -177.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 53.7 Cg_endo -66.69 -7.06 17.01 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.32 1.347 . . . . 1.0 113.153 -177.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -122.44 -13.6 8.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.473 0.545 . . . . 1.0 112.473 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.27 135.21 44.43 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.748 0.785 . . . . 1.0 112.869 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -93.57 138.73 31.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.352 -1.295 . . . . 1.0 110.36 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.1 p -88.01 133.89 29.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 112.348 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.275 177.907 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.47 ' N ' HD21 ' B' ' 202' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.454 0.645 . . . . 1.0 112.319 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -133.47 98.92 4.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.392 -1.336 . . . . 1.0 107.392 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.4 170.23 3.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.75 -1.114 . . . . 1.0 108.694 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.454 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 47.7 p-80 -170.96 149.94 3.04 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.08 0.237 . . . . 1.0 110.497 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 54.9 m-85 -85.73 149.38 25.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.8 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -140.48 120.29 13.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.5 t -95.5 135.07 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.204 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -146.04 175.78 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 1.0 110.734 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 5.3 t -99.9 133.45 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 1.0 111.965 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.65 179.79 7.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.81 -1.086 . . . . 1.0 109.5 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.02 -17.96 64.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.95 0.405 . . . . 1.0 111.325 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.55 21.8 16.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.909 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 70.46 36.15 1.79 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 111.121 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -109.91 143.93 39.12 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.794 . . . . 1.0 111.185 -176.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.77 106.09 18.12 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.222 -1.354 . . . . 1.0 109.567 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -118.3 178.04 4.59 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.537 ' HB3' HG22 ' B' ' 208' ' ' VAL . 52.4 p-90 -147.8 167.33 25.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.459 0.647 . . . . 1.0 111.979 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -146.25 146.5 30.78 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.422 -1.263 . . . . 1.0 110.432 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.75 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.7 tp -105.53 130.69 53.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 174.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.06 132.96 66.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.919 -175.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -82.93 173.76 11.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.292 -0.632 . . . . 1.0 109.292 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.87 -36.87 68.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.08 0.467 . . . . 1.0 110.698 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.2 -32.96 74.49 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.296 -178.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.22 11.22 24.36 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 114.769 -1.105 . . . . 1.0 112.45 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -86.57 143.2 27.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.789 -0.206 . . . . 1.0 111.359 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.462 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.37 116.39 22.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.53 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.75 HD12 ' HG ' ' B' ' 220' ' ' LEU . 17.0 mt -88.73 -42.8 11.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.019 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -149.52 168.31 23.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.054 -0.975 . . . . 1.0 111.625 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -141.67 156.3 45.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.09 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 66.0 p -54.37 -35.14 62.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.0 0.37 . . . . 1.0 112.0 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.74 -33.68 3.47 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.045 -0.598 . . . . 1.0 111.761 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -122.89 178.57 4.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 1.0 111.174 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -143.01 137.43 7.67 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.337 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -140.01 166.71 23.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.814 -0.439 . . . . 1.0 109.814 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.02 29.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.8 m -126.26 131.84 51.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.325 0.583 . . . . 1.0 111.347 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.17 -35.93 81.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.034 -0.985 . . . . 1.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 61.5 tt0 -57.86 -47.22 83.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.251 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -59.9 -40.43 88.76 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.124 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.52 74.57 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.587 0.708 . . . . 1.0 109.533 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.499 ' HA ' HD12 ' B' ' 245' ' ' ILE . 49.3 mtmt -64.38 -35.54 81.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.528 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.2 mm-40 -64.22 -31.24 72.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.79 -41.11 95.86 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' B' ' 242' ' ' LYS . 65.6 mt -62.4 -43.86 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.064 -0.568 . . . . 1.0 110.278 177.282 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.9 -41.58 99.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.193 0.52 . . . . 1.0 110.141 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.7 m -64.38 -34.36 77.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.981 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.48 -41.33 49.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.968 -177.535 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -66.89 -11.86 57.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.035 0.445 . . . . 1.0 111.798 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -2.92 31.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.905 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -135.36 -42.74 0.7 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.77 0.656 . . . . 1.0 112.77 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -53.64 -48.34 93.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.1 Cg_endo -64.23 -10.6 24.18 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.036 1.158 . . . . 1.0 113.079 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.49 -22.12 7.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.373 0.508 . . . . 1.0 112.373 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.95 134.88 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.654 0.74 . . . . 1.0 112.736 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.47 142.08 29.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.423 -1.262 . . . . 1.0 110.691 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -89.13 134.18 29.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.8 mt -112.23 139.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.662 -1.154 . . . . 1.0 108.695 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.0 100.24 12.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.311 -0.852 . . . . 1.0 110.984 -177.783 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.527 HD21 ' N ' ' A' ' 102' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.511 -0.538 0 CA-C-O 121.223 0.535 . . . . 1.0 111.905 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 2.5 mptp? -123.34 95.11 4.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 173.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.76 174.86 2.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.03 -0.987 . . . . 1.0 108.979 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -170.29 147.88 3.15 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.573 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 58.3 m-85 -86.15 150.18 24.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.258 177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -141.46 121.46 13.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.413 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.3 t -93.67 133.87 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.068 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.77 178.49 7.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.633 0.254 . . . . 1.0 110.414 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -100.53 136.79 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.772 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.03 -178.97 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.31 -13.01 62.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.651 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.14 19.58 17.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.962 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 71.0 38.25 1.14 Allowed 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.275 -0.875 . . . . 1.0 111.182 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 3.1 mmtp -108.91 153.29 23.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.804 -1.089 . . . . 1.0 111.219 -175.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -95.01 118.14 31.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.232 -0.895 . . . . 1.0 109.666 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -133.59 -179.03 5.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.107 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.504 ' HB3' HG22 ' A' ' 108' ' ' VAL . 58.7 p-90 -151.31 162.1 41.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.884 0.373 . . . . 1.0 111.455 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.45 HH21 HG13 ' A' ' 127' ' ' ILE . 36.3 mmm-85 -144.37 139.91 28.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.725 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.4 tp -96.94 131.44 43.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 176.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.0 t -131.07 132.34 63.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.054 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -78.31 172.9 12.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 30.3 t70 -57.95 -30.93 66.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.207 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.513 ' HB2' ' ND2' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -72.14 -33.68 67.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.94 -177.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.03 13.84 10.59 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.244 -0.889 . . . . 1.0 113.836 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 124' ' ' ASN . 0.7 OUTLIER -87.85 143.68 27.0 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.075 0.15 . . . . 1.0 110.717 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.45 HG13 HH21 ' A' ' 119' ' ' ARG . 44.6 mm -76.36 115.13 17.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.722 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.1 mt -88.4 -42.25 12.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.789 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.504 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.05 170.53 20.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.283 -0.871 . . . . 1.0 111.582 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.962 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -53.52 -36.43 61.77 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.416 0.447 . . . . 1.0 111.896 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.76 -43.54 3.25 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.529 -0.628 . . . . 1.0 111.529 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 89.2 mt-10 -108.88 179.93 4.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.293 -0.454 . . . . 1.0 110.826 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.86 134.54 4.51 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -142.88 170.94 14.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 117.077 0.439 . . . . 1.0 110.637 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.06 24.65 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 m -118.63 131.11 56.18 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.362 0.601 . . . . 1.0 111.478 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -65.87 -33.67 76.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.803 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 61.7 tt0 -61.33 -48.48 81.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.971 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -56.82 -40.49 76.13 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.982 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.18 -53.38 58.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.239 0.543 . . . . 1.0 110.217 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 145' ' ' ILE . 41.7 mtmt -63.82 -36.72 84.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.238 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.8 mm-40 -63.79 -28.8 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 1.0 110.021 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.51 96.74 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.551 HG21 HG22 ' B' ' 257' ' ' VAL . 40.4 mt -64.11 -44.6 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.208 0.528 . . . . 1.0 110.133 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -60.34 -43.99 95.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.401 . . . . 1.0 110.149 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.4 m -64.37 -33.82 76.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.724 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' B' ' 229' ' ' ALA . 0.3 OUTLIER -74.43 -41.86 49.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.151 -0.62 . . . . 1.0 109.822 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -68.74 -11.57 60.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.085 0.469 . . . . 1.0 111.588 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -101.25 -3.14 29.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.928 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' B' ' 204' ' ' ALA . 23.0 m-80 -138.07 -38.63 0.56 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -176.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.42 -49.92 89.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 54.3 Cg_endo -67.57 -9.52 25.67 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 120.906 1.071 . . . . 1.0 112.95 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -109.8 -28.68 8.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.445 0.641 . . . . 1.0 110.927 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.08 135.8 57.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.873 -1.058 . . . . 1.0 113.671 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -96.59 140.65 30.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.064 -1.426 . . . . 1.0 110.716 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.557 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.58 133.11 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.352 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.3 mt . . . . . 0 N--CA 1.45 -0.473 0 CA-C-N 114.766 -1.106 . . . . 1.0 108.933 177.071 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.339 0.59 . . . . 1.0 111.512 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 32.4 mmtp -136.98 97.88 3.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 204' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . . . -174.31 169.19 3.87 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.86 -1.064 . . . . 1.0 109.183 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.479 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 55.8 p-80 -171.34 149.1 2.7 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 61.8 m-85 -85.34 148.06 26.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.299 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -139.57 118.83 12.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.482 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' B' ' 218' ' ' TRP . 82.3 t -93.92 133.23 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.677 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -145.36 -178.4 6.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.648 0.261 . . . . 1.0 110.555 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.8 t -99.8 137.43 27.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.623 . . . . 1.0 112.238 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.07 179.78 7.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.565 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.31 -16.36 63.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.473 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.49 19.84 18.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.182 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 214' ' ' ASP . . . . . 0.404 ' HA ' HG13 ' B' ' 210' ' ' VAL . 24.4 m-20 69.28 41.26 1.37 Allowed 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.857 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 3.2 mmtp -110.95 156.51 21.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.266 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -99.82 117.03 33.27 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.854 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 20.6 mtp-105 -132.42 179.11 6.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.527 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.7 p-90 -151.72 163.66 38.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.079 0.466 . . . . 1.0 111.649 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -147.29 145.96 29.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.05 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.725 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.0 tp -96.28 131.85 42.36 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.19 133.79 62.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.738 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -79.77 171.31 15.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 36.6 t70 -62.54 -22.18 66.12 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.152 0.501 . . . . 1.0 110.851 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.34 -33.21 67.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.521 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.85 11.26 19.4 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 114.791 -1.095 . . . . 1.0 112.86 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.27 142.92 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.655 0.264 . . . . 1.0 111.572 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.477 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.55 116.81 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.491 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.725 HD12 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -89.58 -42.53 11.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.734 . . . . 1.0 109.638 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.18 164.97 35.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.845 -1.071 . . . . 1.0 111.597 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -140.67 153.37 45.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.238 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.443 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.6 p -52.88 -36.9 59.87 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.03 -47.31 3.51 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -96.74 -172.86 2.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.265 -0.468 . . . . 1.0 111.25 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -159.05 133.86 3.55 Favored Glycine 0 N--CA 1.454 -0.16 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -145.07 169.85 17.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.93 0.365 . . . . 1.0 110.338 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.38 9.11 41.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.708 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 m -116.0 129.53 56.41 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.425 0.631 . . . . 1.0 110.928 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -66.97 -34.5 77.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.951 -1.022 . . . . 1.0 110.364 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 61.8 tt0 -61.12 -46.12 91.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.255 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.66 -40.55 83.82 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.788 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.11 70.62 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.482 0.658 . . . . 1.0 110.127 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.509 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.4 mtmt -64.6 -37.0 86.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.91 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -64.05 -29.58 70.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -64.97 -41.37 97.37 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.462 -1.055 . . . . 1.0 110.462 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' B' ' 242' ' ' LYS . 56.8 mt -62.48 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 1.0 110.193 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -63.06 -40.11 96.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.3 m -65.62 -35.39 80.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.633 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -75.3 -39.96 42.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.069 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 63.8 mtpt -66.79 -12.51 59.14 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.987 0.365 . . . . 1.0 111.987 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -100.27 -12.12 19.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.843 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -120.97 -40.14 2.65 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.103 -0.499 . . . . 1.0 112.18 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.0 -48.94 94.78 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.5 Cg_endo -66.87 -11.69 33.09 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.276 1.317 . . . . 1.0 113.399 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -116.0 -16.76 11.05 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 255' ' ' ALA . . . . . . . . . . . . . . . -69.22 139.05 54.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.805 0.669 . . . . 1.0 112.805 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -94.88 147.41 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.666 -1.152 . . . . 1.0 111.99 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 145' ' ' ILE . 40.9 t -84.39 130.45 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.438 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.2 mt -128.85 142.47 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.541 -0.541 . . . . 1.0 109.541 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.9 113.17 22.46 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.203 -0.903 . . . . 1.0 110.843 -177.838 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 CA--C 1.519 -0.246 0 CA-C-O 120.973 0.416 . . . . 1.0 109.942 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 38.7 mmtm -145.28 96.36 2.82 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 173.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.13 176.44 1.73 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.01 -0.996 . . . . 1.0 109.533 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.504 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.9 p-80 -170.23 145.42 2.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.439 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.1 m-85 -85.51 147.61 26.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.146 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.68 119.97 13.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.592 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 118' ' ' TRP . 86.1 t -95.21 132.27 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.164 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -143.14 178.08 7.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.1 t -97.82 134.18 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.215 0.531 . . . . 1.0 111.562 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.22 -180.0 7.06 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 1.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.51 -15.3 63.49 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.942 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.63 21.47 16.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.713 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 69.75 35.85 2.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.626 0.77 . . . . 1.0 111.506 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -110.84 149.55 30.42 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.881 -176.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -91.63 112.0 23.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.801 -1.09 . . . . 1.0 109.537 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.481 HH12 ' CG ' ' A' ' 130' ' ' ASP . 19.2 mtm105 -126.8 179.92 5.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.541 ' HB3' HG22 ' A' ' 108' ' ' VAL . 55.8 p-90 -152.1 162.11 41.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.187 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 42.6 mtp180 -148.23 143.66 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.146 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.662 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.7 tp -93.62 134.39 35.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.3 131.02 71.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.896 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.473 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.9 t-80 -78.97 171.74 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 12.0 t70 -56.0 -33.59 65.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.003 0.43 . . . . 1.0 111.216 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -34.34 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.13 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.36 10.92 14.2 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.124 -0.944 . . . . 1.0 113.09 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -90.22 145.84 24.71 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.52 0.192 . . . . 1.0 111.52 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.5 123.55 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 123.778 0.674 . . . . 1.0 109.926 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.662 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.1 mt -98.07 -43.47 7.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.067 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -147.7 164.58 33.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.983 -1.008 . . . . 1.0 111.336 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.481 ' CG ' HH12 ' A' ' 117' ' ' ARG . 6.8 t70 -139.7 152.82 46.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.246 -0.888 . . . . 1.0 108.86 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.7 p -56.32 -38.41 71.26 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.31 0.485 . . . . 1.0 112.31 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.43 -42.66 3.17 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -94.52 172.14 8.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.152 -0.524 . . . . 1.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.63 124.67 1.52 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -142.05 171.05 14.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.714 0.257 . . . . 1.0 110.742 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.43 10.24 20.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.265 0.839 . . . . 1.0 113.265 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 m -120.0 130.71 54.86 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.529 0.68 . . . . 1.0 111.636 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.52 -35.41 80.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.485 -1.234 . . . . 1.0 110.333 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 51.2 tt0 -62.02 -45.96 91.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.484 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -59.9 -39.15 84.4 Favored 'General case' 0 CA--C 1.521 -0.163 0 O-C-N 123.2 0.313 . . . . 1.0 110.883 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.48 69.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.604 0.716 . . . . 1.0 109.786 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.0 mtmt -64.91 -33.77 76.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.561 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -65.64 -32.36 73.88 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 1.0 110.03 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.5 -39.87 97.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.552 HG21 HG22 ' B' ' 257' ' ' VAL . 67.4 mt -60.24 -51.49 72.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.529 0.681 . . . . 1.0 110.758 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.83 -33.03 75.04 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.5 m -66.03 -37.64 86.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.535 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' B' ' 229' ' ' ALA . 1.1 p -74.42 -40.0 48.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 120.399 -0.521 . . . . 1.0 109.846 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.61 -15.77 61.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.958 0.408 . . . . 1.0 111.871 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -100.1 -2.48 34.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.916 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 11.8 m-80 -133.74 -37.08 0.93 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.903 -177.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.85 -50.47 86.97 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.365 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.7 Cg_endo -64.44 -12.07 31.44 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 121.29 1.327 . . . . 1.0 113.419 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.13 -18.58 9.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.179 0.437 . . . . 1.0 112.179 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -66.03 135.71 55.04 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.484 0.659 . . . . 1.0 112.337 -177.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.78 132.39 34.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.585 -1.189 . . . . 1.0 110.919 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.41 130.79 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.462 0.648 . . . . 1.0 111.698 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.474 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 202' ' ' ASN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 21.1 p-10 . . . . . 0 CA--C 1.516 -0.362 0 CA-C-O 121.515 0.674 . . . . 1.0 112.323 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -138.92 96.32 3.1 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.093 -1.817 . . . . 1.0 106.093 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.81 175.69 2.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.638 -1.165 . . . . 1.0 108.612 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.47 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.5 p-80 -170.04 146.99 3.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.054 -0.259 . . . . 1.0 110.575 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.538 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 46.8 m-85 -87.11 146.69 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.479 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.65 121.4 13.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.856 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' B' ' 218' ' ' TRP . 96.3 t -94.27 133.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.767 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -144.48 -179.55 6.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.572 0.225 . . . . 1.0 110.582 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.7 t -96.14 133.48 37.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.138 -0.483 . . . . 1.0 112.232 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -81.74 178.34 8.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.928 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.37 -6.92 38.89 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.314 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.28 17.91 16.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.995 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 69.57 39.19 1.6 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.94 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 13.2 mmtt -111.04 156.88 20.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.121 -0.945 . . . . 1.0 111.217 -175.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.464 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 70.6 m-85 -98.74 102.53 14.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.799 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.581 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 14.9 mmm180 -121.5 179.82 4.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.518 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.5 p-90 -150.94 160.48 43.89 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.802 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -145.95 146.35 31.01 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.091 -0.959 . . . . 1.0 109.666 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.705 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.1 tp -95.78 132.63 40.81 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 t -127.41 130.12 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.354 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 222' ' ' HIS . . . . . 0.433 ' HB2' HD21 ' B' ' 228' ' ' LEU . 1.9 t-80 -82.51 173.66 11.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.26 -36.34 63.51 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.38 0.425 . . . . 1.0 111.913 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -65.08 -31.12 72.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.22 0.533 . . . . 1.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.31 13.86 21.77 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.375 -0.829 . . . . 1.0 112.41 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.41 142.08 27.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 111.789 0.292 . . . . 1.0 111.789 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.53 121.73 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.882 0.739 . . . . 1.0 109.564 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.705 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.5 mt -96.92 -43.8 7.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.228 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -150.83 163.88 37.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.419 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.38 160.07 40.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.383 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.468 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 83.6 p -60.24 -40.71 91.22 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.52 -48.38 2.59 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.285 -0.483 . . . . 1.0 112.669 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -94.75 -169.78 2.09 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.231 0.612 . . . . 1.0 110.936 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.581 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -156.75 136.43 4.95 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.715 -0.755 . . . . 1.0 113.289 176.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -143.92 168.66 19.43 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.396 -0.594 . . . . 1.0 109.396 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.49 11.43 36.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -127.0 135.02 50.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.207 -0.597 . . . . 1.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.14 -39.6 93.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.148 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 50.5 tt0 -57.65 -45.72 85.15 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.287 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -60.94 -39.53 89.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.787 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 241' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' B' ' 216' ' ' TYR . . . -58.2 -49.7 76.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.472 0.653 . . . . 1.0 110.231 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.565 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -64.81 -32.8 74.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.112 -0.949 . . . . 1.0 111.47 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.8 mm-40 -63.6 -33.02 74.69 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.588 -0.445 . . . . 1.0 109.916 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.78 95.31 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' B' ' 242' ' ' LYS . 75.9 mt -60.73 -52.36 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.664 0.745 . . . . 1.0 110.258 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.29 -33.97 77.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.264 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.4 m -67.61 -35.9 79.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.511 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -72.49 -40.47 63.53 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.373 -177.676 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.59 -15.45 61.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.121 -0.49 . . . . 1.0 112.187 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -103.35 -2.75 26.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.866 0.365 . . . . 1.0 111.3 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 251' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 28.6 m-80 -130.46 -38.37 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 111.452 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.548 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.86 -50.49 86.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.681 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.5 Cg_endo -63.24 -10.98 23.1 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.273 1.315 . . . . 1.0 113.663 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.11 -15.92 9.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.963 0.411 . . . . 1.0 111.938 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.22 138.65 57.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.68 0.752 . . . . 1.0 112.633 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -89.21 141.68 28.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.938 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 145' ' ' ILE . 60.6 t -83.74 128.66 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.432 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 12.3 mt -121.71 138.14 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -91.74 100.87 13.5 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.303 -0.856 . . . . 1.0 111.675 -176.699 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 122.321 1.058 . . . . 1.0 113.579 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 28.8 mmtp -138.25 98.19 3.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.987 -1.915 . . . . 1.0 107.461 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.1 169.89 3.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.466 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.6 p-80 -168.22 150.34 5.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.233 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 63.7 m-85 -86.73 148.95 25.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.906 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.27 123.83 14.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.785 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 118' ' ' TRP . 91.1 t -94.75 134.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 O-C-N 123.585 0.553 . . . . 1.0 110.475 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -142.78 178.61 7.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.608 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -100.67 140.24 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.478 0.656 . . . . 1.0 112.689 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.83 177.87 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.416 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.57 -14.36 62.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.362 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.01 17.89 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.11 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 70.82 34.77 1.91 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.377 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -109.7 152.99 24.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.507 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.72 112.11 23.9 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.016 -0.993 . . . . 1.0 110.612 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -123.18 179.28 4.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.524 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.6 p-90 -153.02 168.47 25.74 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.366 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 22.6 mtt180 -150.76 152.28 33.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.508 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.681 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.9 tp -99.84 131.23 45.94 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -126.54 130.48 71.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.289 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -79.67 172.35 13.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 32.2 t70 -57.22 -30.98 65.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 1.0 111.342 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -33.37 74.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.504 0.669 . . . . 1.0 110.07 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.38 11.74 19.06 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 114.982 -1.008 . . . . 1.0 112.789 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -88.59 143.51 26.9 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.67 119.07 22.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.802 0.689 . . . . 1.0 109.744 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.681 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.0 mt -94.41 -43.31 8.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.63 0.729 . . . . 1.0 109.608 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.73 166.61 27.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.641 -1.163 . . . . 1.0 111.201 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -140.14 158.19 44.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 53.9 p -57.44 -35.23 69.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.448 . . . . 1.0 111.452 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.7 -48.62 3.54 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -102.87 171.8 7.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.374 -0.913 . . . . 1.0 111.648 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.04 139.06 9.29 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.236 -1.145 . . . . 1.0 110.236 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -141.53 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.175 0.488 . . . . 1.0 110.852 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.57 9.98 27.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -125.82 130.53 51.59 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.727 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 21.2 ptmt -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.104 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 64.1 tt0 -59.41 -42.14 91.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.962 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.4 OUTLIER -62.62 -39.78 94.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.005 -179.053 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.33 87.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.962 0.411 . . . . 1.0 109.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' A' ' 145' ' ' ILE . 7.3 mtmp? -63.86 -43.19 96.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.117 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 13.7 mm100 -60.01 -27.05 66.56 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.69 -46.32 90.22 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 148' ' ' VAL . 61.1 mt -62.51 -48.82 86.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.946 0.879 . . . . 1.0 109.938 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.53 -40.04 90.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.287 -0.869 . . . . 1.0 110.857 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -69.93 -34.55 73.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.213 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -70.5 -39.13 75.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 C-N-CA 120.08 -0.648 . . . . 1.0 110.033 -176.788 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.79 -12.98 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.975 -0.453 . . . . 1.0 111.516 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -104.69 -3.1 24.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.656 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -129.87 -42.76 1.25 Allowed 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.305 -0.407 . . . . 1.0 112.068 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.06 -50.94 83.58 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.9 Cg_endo -64.48 -13.15 36.9 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.129 1.219 . . . . 1.0 112.952 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.2 -27.56 9.5 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.324 0.583 . . . . 1.0 111.23 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 134.83 55.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.071 -0.968 . . . . 1.0 113.207 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.25 141.02 31.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.982 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -86.99 135.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.679 . . . . 1.0 112.344 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 114.7 -1.136 . . . . 1.0 109.241 178.777 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.931 0.872 . . . . 1.0 112.805 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 203' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 22.7 mmtp -141.74 97.6 3.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.68 -1.6 . . . . 1.0 108.142 173.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.65 170.75 3.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.147 -0.933 . . . . 1.0 109.679 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.423 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 55.1 p-80 -170.01 147.79 3.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.0 m-85 -85.62 150.71 24.44 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.332 0.395 . . . . 1.0 110.383 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -143.09 124.3 14.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.862 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.2 t -95.08 133.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.937 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.8 -178.21 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.663 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -110.89 137.72 42.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.358 0.503 . . . . 1.0 112.358 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 25.4 t70 -83.25 -178.77 7.2 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.583 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 212' ' ' ALA . . . . . 0.41 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.63 -17.92 64.2 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.954 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.85 25.62 11.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 62.07 38.96 13.57 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.859 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -97.44 155.53 16.88 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.469 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 73.4 m-85 -109.05 102.92 11.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.311 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.568 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -122.54 -178.56 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -176.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.488 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.8 p-90 -151.29 162.83 40.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.768 0.318 . . . . 1.0 111.384 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -147.56 146.71 29.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.677 ' HG ' HD12 ' B' ' 228' ' ' LEU . 35.2 tp -93.86 132.68 38.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.92 129.88 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.66 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 222' ' ' HIS . . . . . 0.4 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.4 t-80 -80.04 174.54 11.49 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 223' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 26.7 t70 -55.93 -34.34 65.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.018 0.437 . . . . 1.0 111.46 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.96 -33.65 76.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.646 0.736 . . . . 1.0 110.324 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.01 10.7 22.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.967 -1.015 . . . . 1.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -87.02 143.49 27.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.593 0.235 . . . . 1.0 111.626 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -76.29 119.81 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.665 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.677 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.5 mt -94.19 -44.14 8.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.987 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -147.79 160.78 42.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.711 -1.131 . . . . 1.0 111.02 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.07 158.83 43.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.471 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 71.7 p -57.63 -37.37 73.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.49 0.552 . . . . 1.0 112.49 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.51 -50.56 3.55 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 121.184 0.325 . . . . 1.0 112.691 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -89.86 -168.67 2.2 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.409 0.684 . . . . 1.0 110.863 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.568 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -158.98 134.4 3.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.55 -0.833 . . . . 1.0 113.4 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.46 173.73 11.37 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.56 12.31 35.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.2 m -131.03 135.69 47.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.934 -0.706 . . . . 1.0 111.842 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.84 -39.65 95.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.032 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 55.4 tt0 -56.52 -44.01 80.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.494 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 240' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.32 -39.22 86.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.72 87.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.527 ' HA ' HD12 ' B' ' 245' ' ' ILE . 6.9 mtmp? -64.98 -37.78 88.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.765 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.46 -41.2 77.99 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.475 -0.869 . . . . 1.0 111.006 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.6 mt -60.19 -48.59 87.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.9 0.857 . . . . 1.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.49 -35.95 82.14 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.756 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.9 m -67.07 -37.1 83.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.402 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -72.55 -41.66 63.63 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.593 -177.747 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.24 -13.63 60.66 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.125 -0.359 . . . . 1.0 111.585 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -103.73 -2.64 26.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.839 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -130.85 -40.46 1.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.993 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.34 -50.53 86.16 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.6 Cg_endo -64.92 -16.6 56.21 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.208 1.272 . . . . 1.0 112.905 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.69 -29.8 11.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.588 0.709 . . . . 1.0 111.146 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -63.92 141.05 58.91 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.201 1.186 . . . . 1.0 114.201 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -103.47 146.38 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.096 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.4 p -93.27 132.05 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -120.64 150.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.187 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -85.02 108.16 17.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.328 -177.715 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.165 0.507 . . . . 1.0 111.877 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 47.5 mmtm -134.49 95.98 3.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -176.39 179.19 1.23 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.107 -0.952 . . . . 1.0 109.085 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.464 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 24.7 p-80 -171.69 147.9 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.383 0.427 . . . . 1.0 110.066 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 59.1 m-85 -85.47 152.05 23.49 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.832 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -140.62 120.22 13.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 118' ' ' TRP . 99.0 t -97.6 134.67 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.516 0.51 . . . . 1.0 109.738 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.37 178.28 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 110.611 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -99.39 134.12 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.455 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.55 179.85 7.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.02 62.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.478 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.76 19.2 18.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 70.91 36.42 1.49 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.742 0.651 . . . . 1.0 110.739 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.1 mmtt -109.3 150.51 27.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.289 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.07 111.72 23.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.369 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 mtm105 -128.76 179.13 5.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.537 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.6 p-90 -150.63 166.5 30.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 1.0 111.977 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -146.82 149.24 32.93 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.868 -1.06 . . . . 1.0 110.213 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.681 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.1 tp -100.56 133.17 45.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.58 130.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.048 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.424 ' HB2' HD21 ' A' ' 128' ' ' LEU . 3.3 t-80 -76.47 170.45 16.36 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.1 t70 -60.55 -24.18 65.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.116 0.484 . . . . 1.0 110.663 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -34.3 69.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.783 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 8.97 17.34 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.036 -0.983 . . . . 1.0 113.386 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -89.62 143.36 26.87 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.1 0.408 . . . . 1.0 112.1 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.6 mm -73.83 118.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.811 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.681 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.4 mt -94.13 -44.12 8.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.491 0.662 . . . . 1.0 109.818 -178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.56 165.1 34.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.285 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.6 154.4 47.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 20.7 p -51.86 -40.75 61.09 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.389 0.514 . . . . 1.0 112.389 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 -46.46 3.01 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -93.97 -178.84 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 1.0 110.597 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.74 127.63 2.14 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.253 -1.139 . . . . 1.0 110.253 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -139.8 173.23 11.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.311 0.556 . . . . 1.0 110.075 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.87 9.53 42.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.23 131.33 56.38 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.198 -0.601 . . . . 1.0 110.949 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.11 -38.4 90.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.819 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 52.2 tt0 -63.33 -42.81 99.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.149 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.523 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -58.07 -42.77 86.26 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.985 -177.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.11 75.24 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.17 0.509 . . . . 1.0 110.524 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.2 mtmt -63.8 -35.22 79.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.736 -0.666 . . . . 1.0 111.165 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.0 mm-40 -65.09 -26.83 68.39 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.19 97.13 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.04 -1.224 . . . . 1.0 110.04 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.509 HG21 HG22 ' B' ' 257' ' ' VAL . 55.8 mt -63.11 -45.15 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.194 0.521 . . . . 1.0 109.99 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.12 -38.28 88.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.093 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.8 m -65.3 -36.17 83.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.565 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.88 -42.37 46.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.474 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.99 -15.32 62.91 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.287 0.477 . . . . 1.0 112.287 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -103.61 -2.04 27.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.536 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -131.87 -40.07 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.574 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.51 -50.41 87.9 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.89 -0.596 . . . . 1.0 112.606 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 33.7 Cg_endo -63.4 -12.8 32.43 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.096 1.198 . . . . 1.0 113.162 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.97 -26.26 8.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.999 0.428 . . . . 1.0 111.574 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.4 137.99 58.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.698 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -94.75 149.48 21.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.186 -1.37 . . . . 1.0 111.976 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.551 HG22 HG21 ' B' ' 245' ' ' ILE . 43.9 t -86.17 131.67 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.537 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--N 1.329 -0.324 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 176.108 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 121.266 0.555 . . . . 1.0 111.525 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -138.43 97.03 3.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.06 171.58 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.522 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 205' ' ' HIS . . . . . 0.539 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.9 p-80 -170.21 148.54 3.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.91 177.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 206' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.8 m-85 -87.05 148.82 25.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -141.72 122.38 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.788 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 208' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' B' ' 218' ' ' TRP . 97.7 t -96.6 133.96 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.623 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -145.15 -178.66 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.0 110.749 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.6 t -100.33 135.74 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.064 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -83.02 178.02 8.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.444 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.56 -9.98 52.91 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.256 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.85 20.14 15.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.503 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 69.59 38.13 1.79 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.115 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 215' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.9 mmtt -108.16 151.67 25.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.539 -176.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 216' ' ' TYR . . . . . 0.445 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 81.9 m-85 -98.25 102.7 14.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.162 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 217' ' ' ARG . . . . . 0.588 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -120.26 179.37 4.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.365 0.415 . . . . 1.0 109.975 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 218' ' ' TRP . . . . . 0.531 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.0 p-90 -151.12 163.24 39.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.696 0.284 . . . . 1.0 111.62 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 219' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 36.3 mtp85 -148.25 145.0 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.99 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 220' ' ' LEU . . . . . 0.69 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.7 tp -97.62 135.01 40.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' HIS . . . . . 0.483 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.3 t-80 -84.78 177.23 8.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.645 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.01 -38.01 67.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.342 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.63 -33.12 74.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.572 0.701 . . . . 1.0 109.941 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 107.98 12.61 21.84 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.279 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -86.15 142.76 28.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.524 0.202 . . . . 1.0 111.334 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.5 mm -74.6 117.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 228' ' ' LEU . . . . . 0.69 HD12 ' HG ' ' B' ' 220' ' ' LEU . 21.3 mt -89.38 -43.16 11.1 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.076 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 229' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.63 159.51 44.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.533 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -134.66 155.49 50.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 231' ' ' SER . . . . . 0.493 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 79.5 p -55.79 -40.53 72.79 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.731 0.641 . . . . 1.0 112.731 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.68 -52.52 3.0 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.269 -0.491 . . . . 1.0 112.692 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.01 -169.31 2.52 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.347 0.659 . . . . 1.0 110.707 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.588 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -160.06 132.24 2.91 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.926 -0.654 . . . . 1.0 112.675 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.36 170.6 15.39 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 116.72 0.26 . . . . 1.0 110.423 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.73 10.48 38.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.673 0.99 . . . . 1.0 113.673 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.5 m -122.07 132.08 54.31 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.035 -0.666 . . . . 1.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.37 -35.82 82.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.372 -0.831 . . . . 1.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 239' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 52.7 tt0 -60.08 -47.23 86.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.739 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -61.52 -36.02 79.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.03 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.74 -49.87 75.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.406 0.622 . . . . 1.0 109.602 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 242' ' ' LYS . . . . . 0.499 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -65.47 -35.85 82.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.925 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 243' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.5 mm-40 -63.51 -29.65 70.88 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.67 96.77 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 245' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 157' ' ' VAL . 53.1 mt -63.13 -45.61 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.054 -0.573 . . . . 1.0 109.925 177.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.81 -39.07 90.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.183 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 m -66.39 -34.86 78.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.677 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -74.95 -43.21 45.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 120.27 -0.572 . . . . 1.0 110.289 -177.46 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -66.08 -11.96 52.22 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.104 -0.373 . . . . 1.0 111.946 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -100.72 -3.25 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -135.9 -36.97 0.74 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.828 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -54.52 -49.87 88.56 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.833 -0.622 . . . . 1.0 112.659 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 253' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.1 Cg_endo -63.81 -11.52 27.2 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.691 1.594 . . . . 1.0 113.8 -177.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.93 -14.48 8.46 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 255' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -68.04 137.16 54.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.444 0.64 . . . . 1.0 112.266 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -93.81 147.85 22.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.864 -1.062 . . . . 1.0 111.942 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 145' ' ' ILE . 40.8 t -84.61 132.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.281 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.1 134.22 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -87.13 100.48 12.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.466 -0.778 . . . . 1.0 110.97 -177.294 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.835 0.35 . . . . 1.0 110.566 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -123.88 174.33 7.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.216 0.531 . . . . 1.0 110.915 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 33.5 mmtp -140.13 98.31 3.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.65 172.33 3.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.627 -0.715 . . . . 1.0 109.904 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.503 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 52.3 p-80 -169.48 146.5 3.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.01 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.2 m-85 -85.0 145.57 27.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.592 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.98 124.26 20.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.346 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' A' ' 118' ' ' TRP . 62.6 t -96.48 133.78 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.449 -0.342 . . . . 1.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -142.95 179.72 6.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.027 0.205 . . . . 1.0 110.776 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.6 t -101.75 138.05 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.426 0.632 . . . . 1.0 112.485 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.71 178.15 8.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.379 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.51 -15.32 63.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 1.0 111.209 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.77 19.21 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.593 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 71.27 36.12 1.42 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.93 0.769 . . . . 1.0 110.927 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 10.5 mmtt -110.88 150.53 29.04 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.261 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -93.95 119.28 32.63 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.915 -1.038 . . . . 1.0 110.499 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -132.05 -179.95 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.49 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.2 p-90 -152.84 162.48 41.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.354 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -146.54 143.25 28.77 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.171 0.919 . . . . 1.0 109.882 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.726 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.1 tp -95.08 130.57 41.73 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.79 131.61 70.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.266 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -81.4 172.93 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 23.8 t70 -58.5 -27.46 64.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.27 0.557 . . . . 1.0 110.873 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.62 -32.85 70.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.772 -178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.88 12.76 21.71 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.9 -1.045 . . . . 1.0 112.626 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -89.42 146.98 24.29 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 51.1 mm -79.42 114.53 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.726 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.6 mt -87.94 -43.24 11.91 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.415 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -152.27 162.98 40.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.952 -1.022 . . . . 1.0 111.051 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -135.94 155.41 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.047 -1.094 . . . . 1.0 108.047 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 53.3 p -55.88 -38.74 70.55 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.332 0.395 . . . . 1.0 111.968 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.19 -33.96 2.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 131' ' ' SER . 47.2 mt-10 -87.97 -178.68 6.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.934 -0.633 . . . . 1.0 111.118 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.65 114.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.094 -1.203 . . . . 1.0 110.094 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.49 169.68 17.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.616 0.208 . . . . 1.0 110.45 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.54 10.03 14.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.9 m -122.41 131.33 53.83 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.631 0.729 . . . . 1.0 112.234 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -67.39 -32.25 73.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.527 -1.215 . . . . 1.0 109.734 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 53.3 tt0 -60.93 -46.79 89.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.229 -0.896 . . . . 1.0 109.915 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.29 -38.74 80.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.462 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.245 0.545 . . . . 1.0 109.918 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.8 mtmt -64.82 -33.36 75.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -64.86 -32.29 73.92 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.444 -0.502 . . . . 1.0 109.974 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -40.84 94.41 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.732 -0.747 . . . . 1.0 111.257 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 142' ' ' LYS . 71.9 mt -59.83 -51.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 1.0 110.613 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.19 -35.66 81.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.806 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.5 m -66.74 -34.99 79.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.003 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.71 -35.17 43.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.712 -177.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -68.92 -15.44 63.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.742 0.782 . . . . 1.0 110.238 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -99.39 -2.72 35.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.431 -1.259 . . . . 1.0 112.591 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -136.91 -39.12 0.62 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.944 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.16 -51.6 80.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 55.7 Cg_endo -66.41 -7.77 18.68 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.243 1.296 . . . . 1.0 113.229 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -116.56 -24.62 7.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.056 0.455 . . . . 1.0 111.644 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.05 136.88 57.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.946 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -92.07 137.84 32.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 1.0 110.724 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.57 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -88.99 131.51 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.378 0.609 . . . . 1.0 112.587 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.4 mt -114.29 137.95 45.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.832 -1.076 . . . . 1.0 108.46 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -91.54 101.56 14.21 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.539 -0.744 . . . . 1.0 110.866 -177.829 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.87 0.367 . . . . 1.0 110.538 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -92.87 172.21 8.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.449 0.642 . . . . 1.0 111.163 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 72.8 mmtt -136.89 97.39 3.51 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.906 -1.516 . . . . 1.0 106.906 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.96 174.23 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.614 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.531 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 41.0 p-80 -170.95 148.16 2.77 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.273 0.358 . . . . 1.0 110.519 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.57 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 50.2 m-85 -85.61 149.56 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.734 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -141.99 118.39 10.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.721 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' B' ' 218' ' ' TRP . 75.9 t -93.48 132.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -143.16 -177.88 5.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.3 t -102.64 137.46 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 1.0 112.284 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.32 179.4 6.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.552 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.33 -14.61 62.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.049 0.452 . . . . 1.0 110.575 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.12 15.88 24.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.503 -0.772 . . . . 1.0 111.758 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' B' ' 210' ' ' VAL . 26.5 m-20 70.42 41.71 0.97 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.482 0.713 . . . . 1.0 110.611 177.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 9.2 mmtt -115.13 152.03 33.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.71 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.97 118.76 31.07 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.391 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -134.68 179.37 6.34 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.119 -0.946 . . . . 1.0 109.046 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.511 ' HB3' HG22 ' B' ' 208' ' ' VAL . 50.6 p-90 -154.28 161.46 41.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.516 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' B' ' 219' ' ' ARG . 9.2 mtp180 -147.31 142.85 27.59 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.885 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.703 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.8 tp -94.16 131.98 39.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 t -128.68 131.43 68.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.268 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -78.01 170.7 16.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 20.8 t70 -57.19 -27.7 62.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.373 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ASN . . . . . 0.525 ' HB2' ' ND2' ' B' ' 226' ' ' ASN . 0.8 OUTLIER -74.81 -33.77 62.27 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.19 13.33 10.93 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 114.999 -1.0 . . . . 1.0 113.459 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' B' ' 224' ' ' ASN . 0.8 OUTLIER -87.96 144.57 26.47 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.904 -0.174 . . . . 1.0 111.256 178.514 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.36 123.36 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.815 0.697 . . . . 1.0 109.262 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.703 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.0 mt -99.35 -42.11 7.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.322 0.582 . . . . 1.0 109.796 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -153.01 164.3 38.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.895 -1.048 . . . . 1.0 111.625 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -139.61 153.49 47.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 1.0 108.897 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.419 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 11.9 p -51.58 -35.43 41.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.49 -46.6 3.51 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.119 -0.792 . . . . 1.0 111.119 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.7 mt-10 -107.43 173.99 6.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.955 -0.623 . . . . 1.0 111.73 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -133.65 145.62 17.65 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.965 -1.254 . . . . 1.0 109.965 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -142.48 171.95 13.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.359 0.579 . . . . 1.0 110.788 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.69 10.28 41.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.306 0.484 . . . . 1.0 112.306 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 9.5 m -136.69 134.8 37.61 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.357 0.598 . . . . 1.0 111.484 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -63.98 -35.41 80.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 52.9 tt0 -57.74 -48.32 79.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.607 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -61.88 -38.14 87.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.351 0.407 . . . . 1.0 110.847 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.46 -49.56 76.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 1.0 109.698 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' B' ' 245' ' ' ILE . 43.9 mtmt -64.8 -33.81 76.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.369 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.9 mm-40 -63.42 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.32 -0.552 . . . . 1.0 109.744 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.26 89.44 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' B' ' 242' ' ' LYS . 73.9 mt -60.88 -50.5 80.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.697 0.76 . . . . 1.0 110.374 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.36 -33.83 76.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.652 -0.704 . . . . 1.0 111.23 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 m -65.05 -38.69 91.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.175 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' B' ' 252' ' ' ALA . 1.1 p -73.92 -40.61 52.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.094 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.09 -15.25 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.177 0.513 . . . . 1.0 111.907 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -101.31 -1.47 33.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.825 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -135.82 -37.39 0.74 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.84 0.352 . . . . 1.0 111.942 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.47 -50.67 85.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 112.898 0.703 . . . . 1.0 112.898 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.6 Cg_endo -65.46 -10.4 26.07 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 120.764 0.976 . . . . 1.0 113.503 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.07 -20.39 8.71 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -66.02 135.34 54.53 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.86 -0.609 . . . . 1.0 112.27 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.89 139.52 30.67 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.764 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -91.7 128.31 43.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ILE . . . . . 0.449 HD11 ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -124.4 146.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.283 -1.326 . . . . 1.0 110.174 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -91.26 114.66 27.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.926 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.077 -0.963 . . . . 1.0 111.19 -178.123 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.014 0.435 . . . . 1.0 109.925 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -116.6 176.24 5.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.253 0.549 . . . . 1.0 111.5 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 45.1 mmtm -136.98 97.7 3.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.055 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.44 171.14 3.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.076 -0.965 . . . . 1.0 109.504 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 44.2 p-80 -169.22 148.32 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.5 m-85 -85.32 147.74 26.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.388 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.59 116.92 11.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 118' ' ' TRP . 97.0 t -92.47 133.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.579 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -142.71 179.25 7.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 1.0 110.707 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.3 t -103.36 134.41 44.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.939 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.7 -179.95 7.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.762 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.09 -12.97 62.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.776 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -115.24 26.88 9.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.257 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 65.58 30.48 10.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.404 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 71.9 mmtt -95.66 156.24 16.41 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.9 117.2 33.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.3 mtm105 -132.91 178.0 7.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.53 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.9 p-90 -150.53 163.27 38.86 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.931 0.396 . . . . 1.0 111.417 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.417 HH21 HG13 ' A' ' 127' ' ' ILE . 39.7 mtp180 -147.73 143.37 27.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.826 -1.079 . . . . 1.0 109.304 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.768 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.7 tp -91.61 131.66 36.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.6 t -128.29 130.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.43 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -79.08 170.95 15.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 11.7 t70 -55.73 -31.8 62.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.884 0.373 . . . . 1.0 111.187 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -66.3 -34.16 77.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.478 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.41 9.36 19.73 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.907 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -87.47 142.74 27.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.425 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 48.0 mm -77.09 118.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.634 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.768 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.2 mt -92.19 -42.42 9.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.217 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -152.0 164.77 36.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.654 -1.157 . . . . 1.0 111.255 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -137.32 154.02 50.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.844 . . . . 1.0 108.862 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 p -53.32 -35.01 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 1.0 112.343 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.0 -42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.566 -0.614 . . . . 1.0 111.566 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -102.79 -177.52 3.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.204 0.526 . . . . 1.0 111.556 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.9 126.31 1.8 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.4 173.1 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.136 0.468 . . . . 1.0 111.121 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.99 9.79 31.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.585 0.957 . . . . 1.0 113.585 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -122.64 130.55 53.1 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.427 0.632 . . . . 1.0 111.341 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.84 -38.31 88.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 62.0 tt0 -61.42 -41.39 97.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.081 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -60.06 -42.75 95.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.897 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.94 81.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.259 0.552 . . . . 1.0 110.196 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.24 -33.8 76.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.388 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -65.22 -31.45 72.62 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.921 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.98 -38.85 95.97 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.626 HG21 HG22 ' B' ' 257' ' ' VAL . 64.5 mt -61.28 -51.06 77.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.365 0.602 . . . . 1.0 110.304 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -63.41 -32.89 74.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.989 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -64.2 -39.68 94.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.336 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 152' ' ' ALA . 1.6 p -75.04 -38.28 42.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 C-N-CA 119.906 -0.718 . . . . 1.0 109.887 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -64.6 -13.83 55.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.145 0.498 . . . . 1.0 111.211 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -4.58 40.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.721 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 22.1 m-80 -137.03 -37.93 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.757 0.651 . . . . 1.0 112.757 -174.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -53.69 -50.01 85.82 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.1 Cg_endo -65.88 -14.12 43.09 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 120.882 1.055 . . . . 1.0 113.633 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.48 -27.46 8.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.546 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -61.32 135.51 57.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.555 0.946 . . . . 1.0 113.555 -176.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -90.98 139.21 30.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.06 -1.427 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.22 133.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.214 0.531 . . . . 1.0 111.983 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt -124.57 146.61 29.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.356 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -88.78 107.78 19.15 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.266 -0.873 . . . . 1.0 111.063 -177.623 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' B' ' 201' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.668 0.27 . . . . 1.0 110.653 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 12.8 p-10 -107.45 178.98 4.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.848 0.832 . . . . 1.0 112.622 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -143.74 98.94 3.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.899 -1.5 . . . . 1.0 107.447 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.33 173.58 2.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.789 -1.096 . . . . 1.0 109.223 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.546 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 54.1 p-80 -169.5 148.78 3.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.512 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 49.5 m-85 -85.42 145.41 27.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.143 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -139.0 120.73 15.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.511 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' B' ' 218' ' ' TRP . 72.4 t -92.48 132.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.889 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.402 ' CE2' ' HD3' ' B' ' 219' ' ' ARG . 11.3 p90 -140.39 -176.02 4.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.078 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' B' ' 214' ' ' ASP . 4.8 t -107.33 139.69 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 1.0 112.579 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -81.85 -179.75 7.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.144 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.9 0.381 . . . . 1.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.24 24.05 13.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.497 ' HA ' HG13 ' B' ' 210' ' ' VAL . 4.9 m-20 63.17 41.36 8.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.344 0.592 . . . . 1.0 111.09 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.4 mmtt -103.61 155.82 18.26 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.447 -0.797 . . . . 1.0 108.901 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.49 123.01 41.19 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.043 0.449 . . . . 1.0 110.308 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -137.51 -178.83 5.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.058 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.525 ' HB3' HG22 ' B' ' 208' ' ' VAL . 58.2 p-90 -155.37 162.59 40.77 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.413 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' B' ' 219' ' ' ARG . 13.5 mtp180 -146.63 146.78 30.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.041 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.722 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.9 tp -97.03 130.2 44.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.73 130.18 71.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.444 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -81.37 175.3 10.68 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.75 -35.56 63.88 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.347 0.404 . . . . 1.0 111.859 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -67.91 -33.26 74.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.285 0.564 . . . . 1.0 110.298 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.49 10.93 20.84 Favored Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 114.894 -1.048 . . . . 1.0 112.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -86.11 143.25 28.14 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 1.0 112.057 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.78 120.35 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.263 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.722 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.3 mt -97.39 -42.61 7.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.519 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -153.7 165.42 36.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.363 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.69 159.72 41.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 57.4 p -55.75 -33.81 64.64 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.151 0.5 . . . . 1.0 111.427 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.63 -51.19 3.58 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 57.4 mm-40 -100.99 177.79 4.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.979 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.95 139.5 9.67 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -137.49 172.46 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.544 0.672 . . . . 1.0 111.489 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.15 10.9 36.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.0 113.129 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 7.0 m -136.7 135.93 38.58 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.079 0.466 . . . . 1.0 110.926 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -64.53 -38.18 90.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 64.0 tt0 -57.24 -45.14 84.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.838 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -62.78 -40.75 98.29 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.906 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.63 79.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.558 0.694 . . . . 1.0 109.772 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.0 mtmt -65.02 -35.36 80.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.532 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.0 mm-40 -63.37 -28.02 69.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 176.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.75 -42.08 95.42 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' B' ' 242' ' ' LYS . 62.1 mt -61.83 -44.93 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.931 -0.634 . . . . 1.0 110.021 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.06 -39.74 93.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.208 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -67.68 -34.08 76.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.957 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.59 -39.27 53.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.03 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -68.43 -12.25 60.9 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.306 0.574 . . . . 1.0 111.078 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -101.22 -3.12 29.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 1.0 111.09 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -136.42 -40.09 0.65 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.35 -49.67 91.12 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 46.7 Cg_endo -66.48 -9.12 22.96 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 120.916 1.077 . . . . 1.0 113.456 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.61 -13.91 8.27 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -69.27 137.74 53.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.464 0.649 . . . . 1.0 112.13 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -91.14 144.01 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.997 -1.001 . . . . 1.0 111.495 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 145' ' ' ILE . 43.7 t -85.76 123.49 39.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.226 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.7 mt -115.53 138.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -89.65 100.51 13.3 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.492 -0.766 . . . . 1.0 110.965 -176.84 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -90.64 168.21 11.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.42 0.629 . . . . 1.0 111.806 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 35.2 mmtp -142.37 96.39 2.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.24 174.67 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.164 -177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 53.3 p-80 -168.94 147.3 3.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.694 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.566 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 47.1 m-85 -85.04 148.82 25.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.71 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.06 120.44 13.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.766 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 118' ' ' TRP . 83.6 t -94.76 137.95 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.937 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.39 -178.63 6.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.437 -0.208 . . . . 1.0 110.437 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 8.2 t -103.98 136.75 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.186 0.517 . . . . 1.0 112.363 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.24 -179.68 7.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.086 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.48 -15.19 63.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.075 0.398 . . . . 1.0 112.075 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.81 22.59 15.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.677 0.275 . . . . 1.0 111.396 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.87 40.3 1.32 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.695 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 2.5 mmtp -111.79 149.88 31.1 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.286 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -94.19 120.67 34.78 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.62 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -133.91 -179.4 5.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.818 -1.083 . . . . 1.0 108.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.556 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.5 p-90 -153.25 162.94 40.75 Favored 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 120.55 -0.46 . . . . 1.0 111.428 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.509 HH21 HG13 ' A' ' 127' ' ' ILE . 41.9 mtp180 -148.23 141.17 24.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.397 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.659 ' HG ' HD12 ' A' ' 128' ' ' LEU . 36.0 tp -90.97 135.15 33.93 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.09 130.25 69.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.084 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -77.49 171.84 14.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.6 t70 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.247 0.546 . . . . 1.0 110.356 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -33.57 75.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.169 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.89 8.18 24.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.289 -0.869 . . . . 1.0 112.884 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -87.83 145.26 26.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.715 0.265 . . . . 1.0 111.715 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.509 HG13 HH21 ' A' ' 119' ' ' ARG . 51.0 mm -76.81 119.74 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.809 0.693 . . . . 1.0 110.017 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.659 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -94.86 -43.75 8.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.104 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -148.01 168.91 21.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.663 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -143.83 155.86 44.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.272 -0.876 . . . . 1.0 108.671 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.3 p -58.16 -32.96 68.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.189 0.519 . . . . 1.0 111.191 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.89 -47.24 3.52 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -109.25 170.66 7.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.734 -0.733 . . . . 1.0 111.549 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.34 16.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.267 -0.878 . . . . 1.0 110.934 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -141.46 165.92 26.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.848 0.324 . . . . 1.0 110.45 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.43 10.27 30.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 p -127.38 129.23 47.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.453 0.644 . . . . 1.0 112.188 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -66.84 -37.05 83.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.456 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 64.4 tt0 -58.81 -43.17 90.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.135 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tppt? -60.07 -41.89 93.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.785 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.16 -50.29 69.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.293 0.568 . . . . 1.0 109.906 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.514 ' HA ' HD12 ' A' ' 145' ' ' ILE . 49.1 mtmt -65.45 -33.08 75.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.563 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.3 mm-40 -66.73 -31.02 71.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.128 176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.66 -38.26 93.08 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 142' ' ' LYS . 71.7 mt -61.47 -50.32 80.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.307 0.575 . . . . 1.0 110.652 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -62.8 -33.79 75.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.181 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 52.5 m -65.28 -37.45 87.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.753 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.604 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -74.49 -33.88 34.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 120.411 -0.516 . . . . 1.0 109.866 -177.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -69.35 -13.21 62.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.657 0.741 . . . . 1.0 110.634 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -101.21 -2.92 30.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.764 -1.107 . . . . 1.0 112.325 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.19 -39.5 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.745 0.307 . . . . 1.0 111.737 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.13 -51.32 82.57 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 32.0 Cg_endo -60.71 -12.26 20.86 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.364 1.376 . . . . 1.0 113.515 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -123.79 -7.46 7.9 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.48 134.3 43.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.704 0.764 . . . . 1.0 112.23 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.03 135.82 33.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.621 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -88.05 134.13 28.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.445 0.641 . . . . 1.0 112.124 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.05 143.91 28.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.711 -1.131 . . . . 1.0 109.327 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.18 105.15 17.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.61 -0.709 . . . . 1.0 110.514 -178.371 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 14.4 ptm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 111.475 0.176 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -128.35 171.92 11.57 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.838 0.828 . . . . 1.0 112.592 -176.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 23.6 mmtp -140.14 97.26 3.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.926 -1.488 . . . . 1.0 107.699 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.63 172.2 3.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.899 . . . . 1.0 109.831 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.474 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 45.3 p-80 -169.22 148.09 3.89 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.781 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 53.2 m-85 -85.35 148.55 25.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.921 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -140.33 117.01 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.43 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.8 t -92.95 129.79 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.91 -0.586 . . . . 1.0 109.662 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -141.34 -179.19 5.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.788 0.328 . . . . 1.0 110.589 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.9 t -102.23 136.34 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 1.0 112.149 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -78.72 179.92 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.013 -0.994 . . . . 1.0 109.752 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.9 -18.01 64.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.238 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.54 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.236 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.447 ' HA ' HG13 ' B' ' 210' ' ' VAL . 11.7 m-20 63.53 39.37 9.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.431 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 31.7 mmtp -103.48 156.34 17.84 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.71 118.5 34.39 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.405 ' HG2' ' HA2' ' B' ' 234' ' ' GLY . 69.4 mtp180 -134.29 179.57 6.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.308 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.529 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.1 p-90 -154.0 161.37 42.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.945 0.402 . . . . 1.0 111.172 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 38.0 mtp180 -147.07 141.11 26.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.047 -0.979 . . . . 1.0 109.89 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.694 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -91.39 131.1 37.1 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.01 130.93 71.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.174 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -77.16 173.19 12.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 177.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.598 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.0 t70 -56.56 -34.39 67.05 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.368 0.418 . . . . 1.0 111.063 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' ASN . . . . . 0.566 ' HB2' ' ND2' ' B' ' 226' ' ' ASN . 1.1 m120 -68.65 -34.62 76.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.019 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.79 13.93 9.87 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.378 -0.828 . . . . 1.0 113.514 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.566 ' ND2' ' HB2' ' B' ' 224' ' ' ASN . 0.6 OUTLIER -87.63 147.33 25.32 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.98 -0.129 . . . . 1.0 111.112 178.049 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.53 119.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.588 0.555 . . . . 1.0 110.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.694 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -93.69 -43.35 8.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.555 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.451 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.42 165.07 35.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.297 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.0 157.16 46.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.053 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 12.9 p -54.67 -32.99 60.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.8 -43.77 3.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.87 170.02 8.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.17 0.51 . . . . 1.0 111.553 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' B' ' 217' ' ' ARG . . . -122.87 124.78 5.77 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.338 -1.505 . . . . 1.0 109.338 176.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -110.8 172.45 6.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.993 0.396 . . . . 1.0 111.372 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -105.54 10.85 32.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.874 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 3.3 p -143.94 130.88 20.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.629 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.03 -44.41 97.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.087 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 62.1 tt0 -54.04 -40.49 67.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.261 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.597 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.3 OUTLIER -61.62 -42.8 99.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.323 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.29 92.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.305 0.574 . . . . 1.0 109.817 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.3 mtmt -64.04 -35.52 80.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.13 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.2 mm-40 -65.4 -31.39 72.47 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.045 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.48 94.7 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.511 -0.852 . . . . 1.0 110.979 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.506 ' O ' HG12 ' B' ' 248' ' ' VAL . 70.6 mt -61.16 -52.3 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.365 0.602 . . . . 1.0 110.606 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -63.35 -34.85 78.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.646 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.7 m -66.15 -35.85 81.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.754 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.565 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -73.33 -41.06 57.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -65.06 -13.48 58.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.801 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -102.74 -2.92 27.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.261 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 17.8 m-80 -137.01 -38.31 0.63 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.223 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.565 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.58 -50.77 85.06 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.696 0.628 . . . . 1.0 112.696 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.9 Cg_endo -63.92 -10.65 23.61 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.037 1.158 . . . . 1.0 113.266 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.99 -17.04 11.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.978 0.418 . . . . 1.0 111.464 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -69.73 136.92 51.54 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.18 0.807 . . . . 1.0 113.18 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -90.25 137.58 32.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.966 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.566 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -88.72 132.27 34.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.253 0.549 . . . . 1.0 112.416 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -121.58 142.72 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.526 -1.215 . . . . 1.0 108.407 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -93.51 106.9 18.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.825 -176.633 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 54.7 ttp . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.869 0.366 . . . . 1.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -137.87 -174.17 3.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.108 0.956 . . . . 1.0 113.081 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 72.3 mmtt -135.02 97.61 3.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.387 -1.733 . . . . 1.0 107.183 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.49 170.81 3.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.528 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 45.0 p-80 -170.75 150.78 3.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.413 -0.217 . . . . 1.0 110.413 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.452 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 69.7 m-85 -88.57 150.85 22.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.267 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -143.19 123.35 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.717 . . . . 1.0 110.636 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.7 t -96.96 134.06 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.909 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -146.32 -177.55 5.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 1.0 110.869 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -96.82 138.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.362 0.601 . . . . 1.0 112.552 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.12 179.67 7.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.772 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.61 62.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.289 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.82 26.33 10.44 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.871 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.42 ' HA ' HG13 ' A' ' 110' ' ' VAL . 13.3 m-20 59.54 43.61 15.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.402 0.62 . . . . 1.0 111.004 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.8 mmtp -101.72 178.32 4.66 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -118.57 103.37 9.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.584 ' HD3' ' HA2' ' A' ' 134' ' ' GLY . 12.7 mmm180 -122.28 178.63 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.52 ' HB3' HG22 ' A' ' 108' ' ' VAL . 60.2 p-90 -151.6 163.81 38.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.735 0.302 . . . . 1.0 111.355 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 39.0 mtp180 -148.4 149.64 32.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.658 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.699 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.7 tp -96.94 133.29 41.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 177.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -131.31 131.43 63.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.141 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -76.89 168.2 20.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.413 -1.329 . . . . 1.0 107.413 177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.502 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 22.8 t70 -61.36 -22.39 64.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.852 0.358 . . . . 1.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.91 -35.04 72.12 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.511 0.672 . . . . 1.0 109.513 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.9 11.39 11.17 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 114.8 -1.091 . . . . 1.0 113.199 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -91.01 143.93 26.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.718 -0.283 . . . . 1.0 111.673 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.32 126.58 36.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 O-C-N 123.96 0.787 . . . . 1.0 110.133 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.699 HD12 ' HG ' ' A' ' 120' ' ' LEU . 13.4 mt -105.12 -39.62 6.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 1.0 110.071 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.451 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.03 166.81 31.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.775 -1.102 . . . . 1.0 111.277 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -139.6 156.0 47.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.341 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.498 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 83.1 p -56.64 -42.74 79.39 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.99 -41.88 3.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.903 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.529 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 35.7 mt-10 -83.95 -168.48 2.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.118 0.485 . . . . 1.0 110.17 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.584 ' HA2' ' HD3' ' A' ' 117' ' ' ARG . . . -168.65 119.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 1.0 111.706 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -141.3 169.01 18.42 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.76 35.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -116.62 131.85 56.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.409 0.624 . . . . 1.0 111.456 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -65.12 -36.11 83.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.792 -1.095 . . . . 1.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 64.2 tt0 -61.24 -45.59 93.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.394 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.6 -38.14 80.44 Favored 'General case' 0 CA--C 1.52 -0.176 0 O-C-N 123.208 0.317 . . . . 1.0 110.638 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.59 -52.33 65.85 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.538 0.685 . . . . 1.0 109.649 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.429 ' HA ' HD12 ' A' ' 145' ' ' ILE . 48.3 mtmt -64.12 -36.23 83.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.623 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.5 mm-40 -65.47 -27.03 68.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -41.75 94.05 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.552 HG21 HG22 ' B' ' 257' ' ' VAL . 47.8 mt -63.4 -40.96 91.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.186 -0.507 . . . . 1.0 110.162 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.76 -43.01 99.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.073 0.463 . . . . 1.0 110.075 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 m -63.27 -35.58 80.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.641 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -74.63 -42.55 48.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 119.832 -0.747 . . . . 1.0 110.239 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -67.19 -14.08 62.57 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.958 -0.464 . . . . 1.0 111.775 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -104.32 -1.88 26.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.016 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.7 m-80 -133.04 -39.33 0.95 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.908 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.613 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.32 -50.26 88.61 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 52.8 Cg_endo -67.24 -7.83 20.12 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.181 1.254 . . . . 1.0 113.344 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.21 -29.97 6.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.248 0.547 . . . . 1.0 111.727 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.41 136.81 58.08 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.238 -0.892 . . . . 1.0 113.361 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -96.89 141.92 29.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.149 -1.387 . . . . 1.0 111.024 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.31 135.26 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.986 0.736 . . . . 1.0 112.986 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.0 mt -115.61 139.88 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 114.88 -1.054 . . . . 1.0 109.272 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -87.4 103.47 15.53 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.502 -0.761 . . . . 1.0 110.971 -178.729 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 50.9 ttp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.733 0.301 . . . . 1.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.427 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.7 p-10 -128.38 -175.55 3.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.831 0.824 . . . . 1.0 112.905 -174.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -140.04 96.87 3.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.436 -1.69 . . . . 1.0 106.436 173.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.41 174.02 2.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.238 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.46 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 40.4 p-80 -168.83 149.22 4.42 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.143 0.277 . . . . 1.0 110.607 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.542 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.7 m-85 -85.75 152.89 22.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.69 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -141.27 117.05 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.535 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' B' ' 218' ' ' TRP . 82.7 t -95.01 130.92 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.87 178.86 7.22 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.188 0.305 . . . . 1.0 110.39 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.1 t -101.58 136.77 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.256 0.55 . . . . 1.0 112.067 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -82.91 178.61 8.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.466 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.7 64.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.114 0.483 . . . . 1.0 110.956 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.22 21.54 16.95 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.563 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.431 ' HA ' HG13 ' B' ' 210' ' ' VAL . 18.5 m-20 64.23 36.28 9.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.414 -0.812 . . . . 1.0 111.187 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 32.2 mmtp -99.21 157.48 16.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.21 112.86 26.06 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.1 mtm105 -127.44 176.8 7.18 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.529 ' HB3' HG22 ' B' ' 208' ' ' VAL . 49.4 p-90 -149.12 161.84 41.16 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.735 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 219' ' ' ARG . 9.2 mtp180 -145.72 143.47 29.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.163 -0.926 . . . . 1.0 109.649 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.682 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.3 tp -93.54 134.09 36.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.17 133.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.505 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.35 172.36 13.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.56 -31.77 66.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 1.0 111.1 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -32.86 74.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.897 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.5 10.65 21.3 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.722 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -88.57 145.1 25.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -73.42 130.17 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.789 0.681 . . . . 1.0 109.199 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.682 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.8 mt -107.44 -41.9 4.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.347 0.594 . . . . 1.0 110.033 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.84 166.61 30.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.962 -1.017 . . . . 1.0 111.376 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -139.23 154.29 47.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.851 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.472 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 24.8 p -54.22 -39.61 66.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 78.65 -26.92 2.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 1.0 111.149 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' B' ' 231' ' ' SER . 48.8 mt-10 -87.2 -175.84 5.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.59 0.71 . . . . 1.0 111.502 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -170.09 102.17 0.18 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -129.71 169.75 14.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.356 -0.238 . . . . 1.0 110.356 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.07 37.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -121.81 131.17 53.91 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.615 0.721 . . . . 1.0 111.365 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -65.2 -34.67 78.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.583 -1.189 . . . . 1.0 110.421 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 62.3 tt0 -58.57 -46.45 86.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.461 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -60.01 -40.29 88.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.52 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.81 68.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.015 0.436 . . . . 1.0 110.3 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.502 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.23 -35.88 82.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.676 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.4 mm-40 -65.7 -31.02 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.536 -0.466 . . . . 1.0 109.995 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.35 95.04 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.509 ' O ' HG12 ' B' ' 248' ' ' VAL . 73.5 mt -60.8 -53.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 1.0 110.687 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.11 -32.79 74.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.645 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -67.19 -38.11 84.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.635 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' B' ' 252' ' ' ALA . 1.4 p -73.05 -36.03 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 119.843 -0.743 . . . . 1.0 109.08 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.24 -12.62 57.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.98 0.419 . . . . 1.0 111.304 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -104.44 -2.25 25.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.723 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -131.32 -37.5 1.24 Allowed 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 111.944 0.35 . . . . 1.0 111.944 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.542 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.65 -51.5 80.77 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 112.504 0.557 . . . . 1.0 112.504 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 50.6 Cg_endo -66.66 -12.51 36.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.268 1.312 . . . . 1.0 113.2 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.35 -29.6 9.18 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.205 0.526 . . . . 1.0 111.437 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -63.24 137.89 58.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.16 -0.927 . . . . 1.0 112.939 -176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -97.72 149.41 22.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.148 -1.387 . . . . 1.0 111.557 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 145' ' ' ILE . 46.1 t -86.62 131.58 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.029 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.13 138.31 54.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -90.67 101.55 14.3 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.499 -0.763 . . . . 1.0 111.387 -176.886 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 112.033 0.383 . . . . 1.0 112.033 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -133.83 175.83 9.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.784 0.802 . . . . 1.0 112.439 -175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 14.2 mmtp -134.53 96.92 3.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.965 -1.471 . . . . 1.0 107.656 173.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.06 166.62 3.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.408 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.3 p-80 -168.83 146.87 3.93 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.025 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.23 147.98 26.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.543 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -139.46 117.11 11.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.464 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' A' ' 118' ' ' TRP . 93.9 t -94.61 134.27 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.942 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -146.29 -179.17 6.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.594 0.235 . . . . 1.0 110.639 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.1 t -101.39 134.97 40.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.175 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.58 178.94 8.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.4 52.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.829 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.1 21.64 13.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.856 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.05 33.36 1.63 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.807 0.843 . . . . 1.0 111.306 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.5 mttt -108.68 150.78 27.08 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.583 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -94.56 116.05 28.31 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.833 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.471 HH12 ' CG ' ' A' ' 130' ' ' ASP . 16.7 mtm105 -133.55 177.73 7.48 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.568 ' HB3' HG22 ' A' ' 108' ' ' VAL . 53.9 p-90 -150.19 161.09 43.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.782 0.325 . . . . 1.0 111.108 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 20.2 mtp180 -145.95 142.19 28.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.096 -0.956 . . . . 1.0 109.543 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.713 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.9 tp -91.88 132.69 36.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.38 132.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.533 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -81.06 173.03 12.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.57 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 13.2 t70 -58.62 -31.99 68.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 1.0 110.691 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -63.68 -34.42 77.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.832 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 9.37 25.47 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.664 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -87.23 143.34 27.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.185 . . . . 1.0 111.496 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.81 123.73 31.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.895 0.747 . . . . 1.0 109.353 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.713 HD12 ' HG ' ' A' ' 120' ' ' LEU . 14.8 mt -98.37 -41.88 7.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.354 0.597 . . . . 1.0 109.91 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.73 169.09 22.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.677 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CG ' HH12 ' A' ' 117' ' ' ARG . 7.6 t70 -142.4 154.36 44.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.867 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.6 p -57.09 -35.07 68.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.903 0.382 . . . . 1.0 111.679 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.69 -44.96 3.38 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -94.66 177.54 5.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 1.0 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -150.45 127.04 2.28 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.858 -1.065 . . . . 1.0 110.454 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -141.97 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.792 0.296 . . . . 1.0 110.46 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.05 10.22 27.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.501 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -124.06 130.56 52.76 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.633 0.73 . . . . 1.0 111.715 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -65.95 -34.38 77.98 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.919 -1.037 . . . . 1.0 110.297 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 50.9 tt0 -58.37 -46.64 85.94 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.453 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -59.52 -38.63 81.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.422 -0.214 . . . . 1.0 110.422 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -52.94 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.225 0.536 . . . . 1.0 110.135 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 145' ' ' ILE . 46.5 mtmt -64.99 -35.97 82.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.033 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.2 mm-40 -65.32 -30.7 71.57 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.468 -0.493 . . . . 1.0 109.787 177.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.86 -38.73 94.59 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 142' ' ' LYS . 75.4 mt -60.52 -53.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.402 0.62 . . . . 1.0 110.531 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -62.53 -33.27 74.58 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.5 m -67.36 -38.17 84.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.636 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -73.17 -33.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.247 -0.581 . . . . 1.0 109.61 -177.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.58 -14.62 62.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.539 0.685 . . . . 1.0 110.396 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -100.49 -1.89 34.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.723 -1.126 . . . . 1.0 112.037 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -134.34 -40.89 0.81 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.263 0.468 . . . . 1.0 112.263 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.33 -52.06 77.08 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 113.041 0.756 . . . . 1.0 113.041 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 47.8 Cg_endo -64.9 -12.75 35.91 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 120.883 1.055 . . . . 1.0 113.294 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.47 -29.4 8.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.07 0.462 . . . . 1.0 111.149 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.14 136.45 57.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.949 -1.023 . . . . 1.0 113.347 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -99.12 144.06 28.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.131 -1.395 . . . . 1.0 110.534 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.05 137.16 21.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.1 mt -119.69 144.89 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.668 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -89.08 105.02 17.51 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.614 -0.708 . . . . 1.0 111.292 -177.736 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.708 0.29 . . . . 1.0 111.3 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -111.88 179.35 4.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.758 0.79 . . . . 1.0 111.991 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.583 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 18.1 mmtp -138.97 96.49 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.117 -1.401 . . . . 1.0 108.087 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.16 170.84 3.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.589 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.508 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 34.2 p-80 -170.26 148.08 3.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.391 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.509 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.5 m-85 -84.63 152.59 23.72 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.131 0.269 . . . . 1.0 110.696 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -141.52 120.45 12.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.419 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' B' ' 218' ' ' TRP . 89.1 t -96.29 135.17 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.061 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.82 178.66 8.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.136 0.273 . . . . 1.0 110.779 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -98.39 135.49 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.671 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.3 177.87 8.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.911 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.2 -13.73 62.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.967 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.73 19.02 19.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.619 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 69.4 38.84 1.73 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.511 -0.768 . . . . 1.0 111.008 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.8 mmtt -109.13 155.9 20.47 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.397 -0.819 . . . . 1.0 110.261 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.43 ' O ' ' HB2' ' B' ' 241' ' ' ALA . 81.0 m-85 -99.28 102.65 14.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.845 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.577 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 12.1 mmm180 -122.52 177.43 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.171 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.523 ' HB3' HG22 ' B' ' 208' ' ' VAL . 55.7 p-90 -150.7 161.12 43.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.768 0.318 . . . . 1.0 111.486 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 28.3 mtp180 -147.49 145.87 29.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.469 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.688 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.4 tp -94.22 134.95 36.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.14 132.94 64.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.792 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' HIS . . . . . 0.404 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.1 t-80 -81.93 173.85 11.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.5 t70 -55.02 -32.18 61.64 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.353 0.408 . . . . 1.0 111.887 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -71.21 -34.29 70.71 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.419 0.628 . . . . 1.0 110.335 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.49 13.19 11.96 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.162 -0.926 . . . . 1.0 112.655 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -88.99 143.49 26.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.21 121.66 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.903 0.752 . . . . 1.0 109.717 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.688 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -96.88 -40.67 8.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.545 -0.752 . . . . 1.0 109.629 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -152.68 164.54 37.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.771 -1.104 . . . . 1.0 111.425 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -137.54 156.99 47.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.984 -1.007 . . . . 1.0 109.262 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.501 ' HB2' HH21 ' B' ' 217' ' ' ARG . 79.3 p -58.06 -45.99 86.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.73 2.89 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.806 -0.712 . . . . 1.0 112.989 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' GLU . . . . . 0.504 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 42.0 mt-10 -84.97 -168.9 2.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.072 0.463 . . . . 1.0 110.294 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.577 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -170.17 124.55 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.871 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -146.73 170.06 17.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.35 9.97 39.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.416 0.447 . . . . 1.0 112.007 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.0 m -111.94 130.21 55.92 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.393 0.616 . . . . 1.0 111.312 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' B' ' 216' ' ' TYR . 8.4 ptpp? -66.17 -35.95 81.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.175 -0.92 . . . . 1.0 110.89 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 48.3 tt0 -59.59 -46.84 87.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.459 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -59.91 -38.33 81.98 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.584 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 216' ' ' TYR . . . -58.73 -53.11 62.08 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.563 0.697 . . . . 1.0 110.319 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.488 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.9 mtmt -64.46 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.4 mm-40 -66.04 -30.26 70.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.16 95.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.425 -0.893 . . . . 1.0 110.971 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.506 ' O ' HG12 ' B' ' 248' ' ' VAL . 69.7 mt -60.47 -52.86 56.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 1.0 110.562 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.66 -35.96 81.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.253 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.3 m -66.94 -35.62 80.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.905 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -72.61 -38.79 59.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.565 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -65.56 -17.88 64.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.766 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' B' ' 250' ' ' ARG . 30.9 ttp-105 -100.9 -1.66 34.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.607 -0.724 . . . . 1.0 111.123 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -132.71 -40.58 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.557 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -57.17 -49.69 92.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 112.902 0.705 . . . . 1.0 112.902 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 55.9 Cg_endo -66.36 -5.75 13.38 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.029 1.153 . . . . 1.0 113.423 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.79 -11.06 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 1.0 111.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -71.95 137.02 47.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.213 0.53 . . . . 1.0 112.05 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.3 140.34 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.228 -0.896 . . . . 1.0 110.25 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -91.53 129.87 41.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.632 0.729 . . . . 1.0 112.468 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.04 140.2 37.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.54 -1.209 . . . . 1.0 109.054 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -89.06 102.66 15.31 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.458 -0.782 . . . . 1.0 111.447 -177.24 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.0 ttp . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.246 0.546 . . . . 1.0 110.86 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 13.6 p-10 -102.3 -177.56 3.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.432 -0.804 . . . . 1.0 112.514 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 23.9 mmtp -138.7 98.36 3.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.738 -1.574 . . . . 1.0 108.273 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.47 167.35 3.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.116 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.554 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.6 p-80 -167.87 147.11 4.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.547 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 52.2 m-85 -87.17 148.21 25.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.078 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -143.02 120.67 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.72 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.606 HG22 ' HB3' ' A' ' 118' ' ' TRP . 92.2 t -96.02 130.94 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.716 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.09 179.3 6.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.69 0.281 . . . . 1.0 110.644 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -103.28 136.81 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.191 0.519 . . . . 1.0 111.99 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.49 -175.28 5.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.286 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.2 -10.24 56.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.04 33.18 5.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.718 0.294 . . . . 1.0 111.523 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.5 35.13 17.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 mmtp -96.86 154.28 17.39 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.94 114.95 29.47 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.961 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 mtm105 -131.67 175.41 9.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.269 -0.878 . . . . 1.0 108.853 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.606 ' HB3' HG22 ' A' ' 108' ' ' VAL . 55.1 p-90 -151.07 162.45 40.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.656 0.265 . . . . 1.0 111.361 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -147.54 144.91 28.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.252 -0.885 . . . . 1.0 110.068 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.691 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.0 tp -97.29 134.15 40.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 t -127.31 132.56 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 1.0 110.736 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.493 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.6 t-80 -84.56 177.39 8.1 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.818 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 17.9 t70 -52.04 -43.98 64.01 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.805 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -63.13 -33.45 75.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.407 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.79 11.66 22.41 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.312 -0.858 . . . . 1.0 112.331 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -86.13 144.19 27.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.78 -0.21 . . . . 1.0 111.371 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.487 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 50.2 mm -74.46 120.43 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.691 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.6 mt -93.06 -42.76 9.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.067 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.66 166.33 29.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.655 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.37 155.72 45.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.041 -0.981 . . . . 1.0 108.558 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 13.6 p -53.33 -31.78 45.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.994 0.426 . . . . 1.0 111.698 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.55 -41.36 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' HG2' ' HB ' ' B' ' 227' ' ' ILE . 50.2 mm-40 -114.53 173.44 6.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.466 0.651 . . . . 1.0 111.933 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.7 132.71 8.82 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 109.947 -1.261 . . . . 1.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.28 167.21 13.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.114 0.457 . . . . 1.0 110.241 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -102.57 9.77 39.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.47 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -139.11 133.61 31.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.5 -38.43 91.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 1.0 110.401 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 54.0 tt0 -58.46 -43.04 88.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.897 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.89 -41.06 95.28 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.116 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.014 0.435 . . . . 1.0 110.029 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.493 ' HG2' HG21 ' A' ' 108' ' ' VAL . 42.6 mtmt -64.48 -37.04 86.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.2 mm-40 -63.58 -26.57 68.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.488 -0.56 . . . . 1.0 109.488 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.94 -41.74 93.14 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 142' ' ' LYS . 67.9 mt -60.98 -41.38 88.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.469 0.652 . . . . 1.0 109.771 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.95 -43.05 93.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.237 0.541 . . . . 1.0 110.166 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 m -63.49 -35.4 80.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.514 -0.767 . . . . 1.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.606 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.84 -41.86 53.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 120.165 -0.614 . . . . 1.0 109.841 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -66.72 -12.22 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.15 -0.344 . . . . 1.0 111.49 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -104.76 -2.78 24.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.205 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.2 m-80 -132.94 -39.58 0.95 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.923 0.392 . . . . 1.0 111.884 -177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.606 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.38 -50.33 87.36 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.692 -0.685 . . . . 1.0 112.456 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.6 Cg_endo -65.13 -9.34 21.41 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.387 1.391 . . . . 1.0 113.241 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -115.03 -23.34 9.1 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.284 0.475 . . . . 1.0 112.284 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.563 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -67.83 138.26 55.96 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -93.18 151.25 19.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.683 -1.144 . . . . 1.0 111.761 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.499 HG22 HG21 ' B' ' 245' ' ' ILE . 44.0 t -86.48 132.27 32.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.799 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.97 140.19 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -87.8 108.37 19.11 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.595 -0.717 . . . . 1.0 111.228 -177.427 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 60.8 ttp . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.962 0.411 . . . . 1.0 110.954 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.407 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 14.5 p-10 -102.3 179.74 4.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.66 0.743 . . . . 1.0 112.412 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 30.2 mmtp -138.55 98.5 3.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.174 -1.376 . . . . 1.0 107.659 172.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.47 168.12 3.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.592 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.563 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 46.7 p-80 -167.94 149.11 5.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.198 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -85.83 148.22 25.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.985 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -139.2 119.83 14.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.568 HG21 ' HG2' ' B' ' 242' ' ' LYS . 90.3 t -92.83 132.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.787 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -142.62 -178.37 5.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' B' ' 214' ' ' ASP . 3.3 t -104.6 139.77 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -81.85 -178.45 6.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.042 -0.981 . . . . 1.0 110.208 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.62 -20.15 64.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.043 0.449 . . . . 1.0 111.351 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.85 24.23 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.703 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' B' ' 210' ' ' VAL . 12.5 m-20 60.95 40.15 15.79 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.901 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -100.25 156.48 17.2 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' B' ' 238' ' ' LYS . 89.6 m-85 -98.48 115.86 29.47 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.702 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -133.91 178.57 6.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.511 ' HB3' HG22 ' B' ' 208' ' ' VAL . 53.4 p-90 -151.3 163.68 38.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.908 -0.317 . . . . 1.0 111.508 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -146.06 146.41 30.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.887 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.686 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -96.13 133.16 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.46 130.96 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.544 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -80.75 172.64 13.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 19.4 t70 -54.94 -36.81 65.67 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.191 0.307 . . . . 1.0 111.63 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -63.02 -34.64 78.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.269 0.557 . . . . 1.0 110.396 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 111.75 15.08 10.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.423 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -90.99 142.33 27.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 133' ' ' GLU . 50.7 mm -75.83 119.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.933 0.771 . . . . 1.0 109.981 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.686 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -94.87 -43.38 8.22 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.468 -0.787 . . . . 1.0 109.739 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -149.72 170.03 19.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.494 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.72 157.31 44.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.981 -1.009 . . . . 1.0 108.538 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 77.4 p -59.09 -37.15 76.45 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.187 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.55 -45.7 3.48 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' GLU . . . . . 0.487 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 33.3 mm-40 -94.88 166.41 11.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.418 0.628 . . . . 1.0 111.502 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.19 126.86 4.94 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.08 166.62 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.873 0.337 . . . . 1.0 111.453 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.4 10.26 40.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.502 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.1 m -141.32 135.15 30.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.908 0.385 . . . . 1.0 110.663 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' B' ' 216' ' ' TYR . 16.6 ptpt -61.91 -41.95 98.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 48.2 tt0 -55.9 -45.22 78.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.565 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -62.42 -41.72 98.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.039 -177.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.06 87.46 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.356 0.598 . . . . 1.0 110.378 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.568 ' HG2' HG21 ' B' ' 208' ' ' VAL . 49.6 mtmt -63.12 -35.61 80.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.142 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.8 mm-40 -65.92 -26.82 67.77 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.74 96.02 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.499 HG21 HG22 ' A' ' 157' ' ' VAL . 58.5 mt -59.72 -45.51 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 121.409 0.623 . . . . 1.0 110.034 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.51 -39.43 93.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.126 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.9 m -66.34 -35.57 80.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.671 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -72.93 -40.48 59.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.599 -177.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -65.86 -12.41 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.436 . . . . 1.0 111.331 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -104.94 -3.14 23.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.696 -0.684 . . . . 1.0 111.004 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 17.6 m-80 -130.83 -40.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.99 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.6 -51.22 81.89 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.616 -0.72 . . . . 1.0 112.516 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.5 Cg_endo -65.91 -11.84 32.69 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 120.987 1.125 . . . . 1.0 113.219 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -113.01 -15.49 12.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.954 0.407 . . . . 1.0 112.04 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -74.95 137.88 41.93 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.022 0.749 . . . . 1.0 113.022 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.66 138.29 31.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.647 -1.161 . . . . 1.0 110.722 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.23 129.87 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.622 0.725 . . . . 1.0 112.339 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -116.1 142.21 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.033 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.93 104.87 17.39 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.607 -0.711 . . . . 1.0 110.819 -178.412 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.876 0.37 . . . . 1.0 111.302 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 14.9 p-10 -100.95 173.96 6.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.77 0.795 . . . . 1.0 112.55 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 123' ' ' ASP . 28.2 mmtt -141.9 94.53 2.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 1.0 107.82 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.48 174.39 1.92 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.237 -177.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.535 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 40.1 p-80 -170.56 148.79 3.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.388 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 67.1 m-85 -86.84 150.17 24.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.587 0.232 . . . . 1.0 110.681 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.51 120.12 12.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.788 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 118' ' ' TRP . 86.8 t -94.67 132.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.532 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -142.91 179.06 7.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.047 0.217 . . . . 1.0 110.576 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -99.87 133.24 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.98 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.83 178.78 8.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.866 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.25 -7.64 43.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.514 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.09 20.01 14.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.172 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 71.11 36.18 1.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.625 0.77 . . . . 1.0 111.062 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.4 mttt -110.92 151.19 28.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.624 -175.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.12 112.95 25.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.716 -1.129 . . . . 1.0 109.53 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -130.8 179.25 6.08 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.535 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.0 p-90 -150.68 163.7 37.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.714 -0.395 . . . . 1.0 111.522 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 25.5 mtp180 -147.91 146.3 28.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.78 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.686 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.1 tp -96.31 130.65 43.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.17 131.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.967 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -78.0 172.17 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' A' ' 103' ' ' LYS . 11.5 t70 -57.89 -31.45 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.14 0.495 . . . . 1.0 110.637 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -67.31 -33.62 75.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.028 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.23 9.86 21.24 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.073 -0.967 . . . . 1.0 112.978 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -88.49 144.94 26.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.642 0.258 . . . . 1.0 111.467 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.8 mm -75.39 122.08 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.028 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.686 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -97.92 -42.53 7.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 1.0 109.374 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.05 165.71 32.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.156 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -141.39 155.09 45.94 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 71.2 p -55.79 -32.83 63.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.03 0.443 . . . . 1.0 111.471 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.18 -41.39 3.03 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.928 -0.636 . . . . 1.0 112.084 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -133.03 147.77 19.08 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -141.79 174.29 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.415 0.607 . . . . 1.0 110.99 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.27 10.16 41.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.616 0.599 . . . . 1.0 112.616 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -133.16 131.56 40.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.746 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -64.03 -36.15 83.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.355 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 50.3 tt0 -58.33 -45.21 88.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.762 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -59.91 -40.83 90.17 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.957 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.97 79.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 1.0 109.901 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.526 ' HA ' HD12 ' A' ' 145' ' ' ILE . 43.2 mtmt -64.29 -37.11 86.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.659 -0.701 . . . . 1.0 111.032 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.9 mm-40 -63.87 -29.68 70.84 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.41 97.98 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 142' ' ' LYS . 57.0 mt -63.98 -45.55 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.887 -0.657 . . . . 1.0 110.298 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.25 -38.28 88.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.137 0.494 . . . . 1.0 110.055 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.4 m -65.9 -36.27 82.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.638 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.1 -42.21 51.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.343 -177.271 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -66.22 -11.89 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 112.018 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -104.46 -2.84 24.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.079 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' B' ' 204' ' ' ALA . 11.1 m-80 -133.45 -37.88 0.94 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.997 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.21 -50.01 90.62 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.2 Cg_endo -63.48 -15.24 47.32 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.254 1.303 . . . . 1.0 113.185 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -109.93 -26.37 9.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.281 0.562 . . . . 1.0 111.362 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.26 136.43 57.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.008 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -96.61 141.68 29.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.18 -1.373 . . . . 1.0 111.117 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.522 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -89.84 135.01 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.333 0.587 . . . . 1.0 112.478 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.0 mt -119.69 143.2 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.937 -1.029 . . . . 1.0 109.266 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -88.57 107.1 18.72 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 119.177 -0.44 . . . . 1.0 110.461 -179.466 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 43.2 ttp . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 121.042 0.448 . . . . 1.0 110.63 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -63.51 171.91 2.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.555 -0.748 . . . . 1.0 112.219 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 70.9 mmtt -136.59 95.52 3.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 204' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . . . -175.92 171.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.19 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.504 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.2 p-80 -170.92 148.61 2.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.159 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.2 m-85 -86.41 149.67 24.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.721 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -142.07 119.03 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.332 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.2 t -94.31 132.88 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -145.68 -178.68 6.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.126 0.266 . . . . 1.0 110.647 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -100.89 138.29 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.309 0.576 . . . . 1.0 112.129 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.46 179.7 7.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.098 -0.956 . . . . 1.0 109.664 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.13 -9.3 58.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.181 0.515 . . . . 1.0 111.004 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.69 20.43 15.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.462 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 70.04 36.84 1.83 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.634 0.774 . . . . 1.0 111.534 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.0 mttt -112.74 149.69 32.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.289 0.566 . . . . 1.0 111.332 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -89.97 119.6 30.47 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.715 -1.129 . . . . 1.0 109.978 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.29 -179.0 5.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.977 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.531 ' HB3' HG22 ' B' ' 208' ' ' VAL . 57.1 p-90 -154.31 161.55 41.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.257 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 27.6 mtp180 -146.79 141.86 27.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.813 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.729 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -93.46 130.77 39.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.59 131.48 70.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.044 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' HIS . . . . . 0.432 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.6 t-80 -81.2 173.0 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 10.8 t70 -54.67 -36.98 65.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.035 0.445 . . . . 1.0 111.222 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.21 -33.78 76.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.219 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.84 12.13 19.24 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 115.087 -0.961 . . . . 1.0 112.659 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -88.32 144.06 26.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.819 0.303 . . . . 1.0 111.819 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.5 mm -75.97 116.63 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.007 0.817 . . . . 1.0 109.69 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.729 HD12 ' HG ' ' B' ' 220' ' ' LEU . 18.3 mt -90.57 -44.7 9.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.405 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.47 160.75 43.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.301 -1.318 . . . . 1.0 111.027 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.8 156.34 49.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 16.7 p -52.27 -35.63 50.64 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.378 0.424 . . . . 1.0 111.977 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.58 -46.09 3.53 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -99.32 179.51 4.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.915 -0.643 . . . . 1.0 110.792 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -146.0 137.78 7.12 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.83 171.28 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.68 0.74 . . . . 1.0 111.795 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.36 10.07 39.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.387 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 12.2 m -135.75 134.41 39.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.55 0.69 . . . . 1.0 111.276 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -64.51 -35.66 81.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.915 -1.039 . . . . 1.0 110.462 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 46.4 tt0 -56.12 -47.64 77.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.292 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -61.42 -40.48 94.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.804 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.54 80.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 1.0 109.768 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.492 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.14 -35.62 81.36 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.411 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.6 mm-40 -64.85 -29.09 70.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.48 -40.95 96.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.954 -1.258 . . . . 1.0 109.954 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' B' ' 242' ' ' LYS . 59.8 mt -62.78 -43.29 98.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.15 -0.525 . . . . 1.0 110.231 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.61 -43.56 98.5 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.648 -0.421 . . . . 1.0 109.921 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.6 m -63.63 -35.21 79.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.83 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -75.06 -41.8 45.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 119.697 -0.801 . . . . 1.0 109.49 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -67.2 -11.62 57.86 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.051 -0.406 . . . . 1.0 111.352 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -103.12 -3.12 26.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.319 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 10.7 m-80 -135.48 -37.45 0.76 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.968 0.358 . . . . 1.0 111.968 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.22 -49.87 90.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 1.0 112.478 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.4 Cg_endo -63.69 -9.53 18.82 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.642 1.562 . . . . 1.0 113.904 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -123.24 -11.57 7.95 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -70.61 138.93 51.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.27 0.557 . . . . 1.0 111.841 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.01 148.65 22.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.012 -0.994 . . . . 1.0 112.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.521 HG22 HG21 ' A' ' 145' ' ' ILE . 44.1 t -84.45 131.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.619 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.1 mt -124.26 139.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -87.66 101.89 14.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.265 -0.874 . . . . 1.0 111.349 -177.157 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.439 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.2 tmt? . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 119.847 -0.121 . . . . 1.0 110.876 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 101' ' ' MET . 14.9 p-10 172.07 172.27 0.1 Allowed 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 124.082 0.864 . . . . 1.0 110.478 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -143.05 95.35 2.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.21 -1.404 . . . . 1.0 107.21 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.64 178.96 1.49 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.327 -0.851 . . . . 1.0 109.735 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.426 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.8 p-80 -169.52 147.72 3.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.808 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 48.7 m-85 -87.44 147.95 25.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.848 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -140.64 118.95 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.77 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 118' ' ' TRP . 81.7 t -94.23 135.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.549 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -144.86 -179.6 6.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.469 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -104.28 138.83 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.287 0.565 . . . . 1.0 111.989 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 179.85 7.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.947 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.12 46.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.577 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.23 24.37 10.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.486 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.25 33.17 2.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.654 0.782 . . . . 1.0 111.613 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.2 mttt -107.48 147.17 30.83 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.426 0.631 . . . . 1.0 111.123 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -93.46 118.89 31.88 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.028 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -131.87 179.79 5.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.162 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.562 ' HB3' HG22 ' A' ' 108' ' ' VAL . 58.2 p-90 -154.52 162.24 41.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.212 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.439 HH21 HG13 ' A' ' 127' ' ' ILE . 50.5 mtp180 -147.18 142.45 27.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.515 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.67 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.5 tp -91.48 133.21 35.69 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.67 128.57 69.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.103 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -77.31 172.91 12.55 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.37 -28.17 58.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.598 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -73.02 -34.67 66.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.71 . . . . 1.0 109.898 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.39 10.1 15.95 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.579 -1.191 . . . . 1.0 112.709 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -86.53 142.84 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.748 0.277 . . . . 1.0 111.748 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.439 HG13 HH21 ' A' ' 119' ' ' ARG . 50.6 mm -74.45 119.79 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.92 0.763 . . . . 1.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.67 HD12 ' HG ' ' A' ' 120' ' ' LEU . 14.1 mt -96.88 -43.65 7.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.96 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.45 168.57 23.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.061 -0.972 . . . . 1.0 111.593 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.77 157.99 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.1 p -57.61 -32.26 67.04 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.296 0.57 . . . . 1.0 111.292 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.17 -50.05 3.83 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.493 ' HG2' ' HB ' ' B' ' 227' ' ' ILE . 69.4 mm-40 -100.81 178.96 4.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.446 -0.877 . . . . 1.0 111.424 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.06 137.53 7.97 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.49 166.47 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.096 0.448 . . . . 1.0 111.378 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.95 11.19 25.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.864 0.691 . . . . 1.0 112.864 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -127.97 131.06 49.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.399 0.618 . . . . 1.0 111.044 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.18 -38.23 90.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.882 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 65.1 tt0 -63.28 -43.16 98.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 1.0 110.027 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.603 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -57.77 -41.34 81.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.895 -178.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.13 74.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.369 0.604 . . . . 1.0 110.318 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.516 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.4 mtmt -64.16 -34.15 77.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.392 -0.822 . . . . 1.0 111.205 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.9 mm-40 -64.8 -30.96 71.99 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.121 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.79 -39.15 93.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.557 -0.83 . . . . 1.0 111.136 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 148' ' ' VAL . 76.8 mt -59.34 -51.47 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.635 0.731 . . . . 1.0 110.49 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -64.6 -35.05 79.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.016 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -66.37 -37.97 86.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.711 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.561 HG22 ' HB2' ' A' ' 152' ' ' ALA . 1.4 p -73.08 -37.46 53.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.132 -0.627 . . . . 1.0 109.618 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.13 -16.33 61.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.538 0.57 . . . . 1.0 112.538 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -104.46 -5.84 21.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.929 0.395 . . . . 1.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -121.69 -37.66 2.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.8 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.561 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.11 -51.03 83.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.829 -0.623 . . . . 1.0 112.602 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 56.0 Cg_endo -68.07 -7.82 20.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.154 1.236 . . . . 1.0 113.385 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.81 -21.14 10.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.157 0.504 . . . . 1.0 111.425 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -70.01 138.69 52.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.649 0.738 . . . . 1.0 112.952 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.37 136.73 36.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.265 -1.334 . . . . 1.0 110.801 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.53 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.82 135.29 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 112.45 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' B' ' 207' ' ' GLU . 6.4 mt -130.47 153.28 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.796 -1.093 . . . . 1.0 109.799 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -84.33 117.71 23.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' B' ' 207' ' ' GLU . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.448 -0.787 . . . . 1.0 111.106 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ttp . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -173.79 172.85 3.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.404 0.621 . . . . 1.0 111.795 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.17 95.62 2.83 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.38 175.37 2.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.138 -0.937 . . . . 1.0 109.526 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.458 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.3 p-80 -170.27 146.38 2.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.101 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.53 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 55.0 m-85 -85.61 147.62 26.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.653 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 207' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 160' ' ' ALA . 40.1 mt-10 -141.3 121.9 14.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.546 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.4 t -93.36 131.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -140.99 -179.88 6.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.213 0.321 . . . . 1.0 110.808 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' B' ' 214' ' ' ASP . 1.4 t -102.08 139.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.334 0.588 . . . . 1.0 111.694 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.64 -176.47 5.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.637 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.94 63.7 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.976 -0.453 . . . . 1.0 110.874 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.06 17.08 22.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.603 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.565 ' HA ' HG13 ' B' ' 210' ' ' VAL . 30.1 t70 68.64 44.02 1.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.481 1.134 . . . . 1.0 110.374 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.1 mmtt -112.97 150.86 31.29 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.323 -177.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -91.12 117.82 29.92 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.843 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -133.8 179.18 6.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.631 -1.168 . . . . 1.0 108.368 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.507 ' HB3' HG22 ' B' ' 208' ' ' VAL . 55.3 p-90 -153.33 161.39 42.4 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.702 0.287 . . . . 1.0 111.052 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.427 HH21 HG13 ' B' ' 227' ' ' ILE . 28.3 mtp180 -147.28 143.26 27.96 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.897 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.69 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -93.5 132.55 37.67 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 177.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.86 129.9 72.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.415 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' HIS . . . . . 0.424 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.0 t-80 -80.77 172.85 13.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.15 -29.53 63.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 1.0 111.587 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -68.11 -33.51 74.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.511 0.672 . . . . 1.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.99 10.56 22.38 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.799 -1.091 . . . . 1.0 112.145 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -86.97 142.73 27.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.651 0.241 . . . . 1.0 111.651 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.493 ' HB ' ' HG2' ' A' ' 133' ' ' GLU . 51.2 mm -76.25 118.85 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 123.783 0.677 . . . . 1.0 109.495 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.69 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -93.18 -43.28 8.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.205 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -148.33 164.76 33.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.389 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -141.52 159.03 43.07 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.635 0.774 . . . . 1.0 109.278 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 58.5 p -57.64 -33.62 68.47 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.942 0.401 . . . . 1.0 111.666 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.4 -47.21 3.05 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -104.7 171.87 7.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.615 -0.792 . . . . 1.0 111.205 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -135.4 138.29 9.86 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.94 172.44 12.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.012 0.406 . . . . 1.0 110.883 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.83 10.53 38.66 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.7 m -131.68 131.42 43.11 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.455 0.645 . . . . 1.0 111.608 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -65.07 -35.23 80.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.191 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 60.2 tt0 -56.61 -46.48 80.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.819 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.96 -42.05 97.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.536 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.9 79.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.441 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.0 mtmt -64.05 -36.69 84.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.426 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 30.0 mm-40 -63.87 -32.93 74.62 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.763 -0.375 . . . . 1.0 109.99 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.88 94.13 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.532 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.7 mt -60.31 -51.57 71.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.542 0.686 . . . . 1.0 110.498 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.97 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.9 m -65.72 -37.6 86.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.366 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.572 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -72.9 -40.1 59.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.648 -177.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -64.03 -15.17 58.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -101.32 -10.45 20.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.042 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.68 -37.57 2.47 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.572 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.12 -51.9 75.7 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 43.0 Cg_endo -65.4 -10.64 26.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.19 1.26 . . . . 1.0 113.56 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.19 -13.9 11.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.702 0.287 . . . . 1.0 111.766 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.426 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -72.95 138.68 46.27 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.62 134.05 34.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.557 -1.201 . . . . 1.0 111.188 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -87.24 131.46 35.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.354 0.597 . . . . 1.0 111.977 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.9 mt -118.74 143.76 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.934 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -90.28 104.21 16.81 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.183 -177.45 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.419 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 111.372 0.138 . . . . 1.0 111.372 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 101' ' ' MET . 23.6 p-10 170.47 171.71 0.06 Allowed 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 124.451 1.094 . . . . 1.0 109.744 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -138.22 93.46 2.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.91 179.69 1.02 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.567 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.42 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 47.8 p-80 -170.1 144.54 2.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 1.0 109.963 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.583 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.1 m-85 -84.71 149.3 25.88 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.161 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.69 118.77 11.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 118' ' ' TRP . 79.3 t -94.57 133.17 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.711 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -142.99 179.64 6.91 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.393 0.433 . . . . 1.0 110.603 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -101.68 135.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.736 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.26 179.46 7.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.353 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.57 39.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.622 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -117.7 20.19 13.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.134 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 69.46 37.13 2.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.203 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.8 mmtt -109.2 150.73 27.48 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.071 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 93.1 m-85 -93.05 112.39 24.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.65 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -129.33 178.62 6.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.558 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.8 p-90 -151.73 163.38 39.27 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 120.854 -0.338 . . . . 1.0 111.437 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 49.4 mtp180 -148.4 141.62 25.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.5 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.684 ' HG ' HD12 ' A' ' 128' ' ' LEU . 35.4 tp -93.75 134.45 36.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.73 131.03 68.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.418 ' HB2' HD21 ' A' ' 128' ' ' LEU . 6.0 t-80 -77.23 171.2 15.22 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -18.08 52.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.146 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.63 -34.11 35.22 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.635 0.731 . . . . 1.0 109.638 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.32 9.29 15.45 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.871 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -88.55 145.15 25.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.338 0.113 . . . . 1.0 110.944 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.4 mm -79.33 118.96 27.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.684 HD12 ' HG ' ' A' ' 120' ' ' LEU . 16.3 mt -90.78 -42.2 10.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.555 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.31 163.31 39.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.973 -1.012 . . . . 1.0 111.883 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.78 152.83 49.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.192 -0.913 . . . . 1.0 108.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 85.7 p -55.54 -34.04 64.36 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.982 0.42 . . . . 1.0 111.486 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.3 -45.92 3.45 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 47.1 mt-10 -109.27 168.59 9.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.799 -0.7 . . . . 1.0 111.562 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.24 145.84 16.34 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.174 -1.17 . . . . 1.0 110.174 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.56 165.59 25.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.245 0.522 . . . . 1.0 111.046 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.26 9.85 32.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.59 -0.732 . . . . 1.0 112.51 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 m -136.38 133.73 37.07 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.076 0.465 . . . . 1.0 110.775 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 6.8 ptpp? -63.87 -36.53 84.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 55.9 tt0 -56.89 -46.05 82.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.673 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.05 -39.19 91.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.8 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.29 72.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.313 0.578 . . . . 1.0 109.898 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.5 mtmt -65.28 -33.28 75.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.308 -0.86 . . . . 1.0 111.072 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.1 mm-40 -65.44 -31.84 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.178 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.98 95.15 Favored Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 142' ' ' LYS . 73.2 mt -60.66 -51.28 74.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.813 -0.694 . . . . 1.0 110.428 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.83 -33.03 74.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.468 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.6 m -68.06 -35.69 78.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.786 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' B' ' 229' ' ' ALA . 0.4 OUTLIER -72.61 -39.7 61.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -178.365 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.65 -16.12 63.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.326 0.584 . . . . 1.0 111.148 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -99.68 -1.43 37.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.799 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -137.24 -42.42 0.56 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.711 0.634 . . . . 1.0 112.711 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.69 -50.7 84.2 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 113.356 0.873 . . . . 1.0 113.356 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 42.5 Cg_endo -64.69 -9.41 20.74 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.248 1.299 . . . . 1.0 113.061 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.5 -12.22 8.59 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.861 0.362 . . . . 1.0 111.831 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.34 136.04 44.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.065 0.459 . . . . 1.0 111.443 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -96.44 145.12 25.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.511 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -90.88 129.5 41.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.84 0.828 . . . . 1.0 112.514 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.3 mt -116.47 149.46 18.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.282 -1.326 . . . . 1.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -85.41 111.72 20.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.59 -0.892 . . . . 1.0 108.59 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.72 -0.657 . . . . 1.0 110.783 -178.766 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.987 0.423 . . . . 1.0 109.978 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -122.85 171.63 9.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.373 0.606 . . . . 1.0 112.029 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -132.83 97.81 4.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.18 166.99 4.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.109 -1.405 . . . . 1.0 108.402 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.498 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 40.5 p-80 -168.69 149.52 4.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.512 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.5 m-85 -85.28 149.93 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.393 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -141.83 120.14 12.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.211 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' B' ' 218' ' ' TRP . 55.3 t -92.88 135.75 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.439 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -149.49 179.55 7.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.658 0.266 . . . . 1.0 110.724 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -101.77 140.13 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 16.1 t70 -83.47 -178.8 7.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.018 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' ALA . . . . . 0.413 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -71.01 -11.52 61.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.352 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.15 26.08 10.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.038 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 62.84 39.48 10.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.058 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 71.8 mmtt -103.8 156.03 18.14 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.33 117.96 32.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -134.16 -179.23 5.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.78 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.489 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.4 p-90 -154.08 162.43 41.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.503 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 40.4 mtp180 -147.41 141.67 26.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.2 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.707 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.2 tp -93.75 131.2 39.33 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.33 132.17 65.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.412 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -80.89 170.34 16.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.77 -27.1 64.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.069 0.462 . . . . 1.0 110.895 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -66.97 -33.24 75.13 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.503 0.668 . . . . 1.0 109.977 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.99 9.84 25.47 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.695 -1.139 . . . . 1.0 112.261 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -86.99 143.81 27.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.395 0.141 . . . . 1.0 111.02 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.447 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.5 mm -80.27 117.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.707 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.8 mt -89.7 -41.25 12.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.746 . . . . 1.0 109.276 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -154.26 164.7 38.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.585 -1.189 . . . . 1.0 111.743 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -138.6 159.11 42.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.858 -1.064 . . . . 1.0 108.328 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 63.2 p -55.55 -30.78 61.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.149 0.5 . . . . 1.0 111.185 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.99 -40.12 3.04 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' GLU . . . . . 0.504 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.1 mt-10 -116.42 169.45 9.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.118 -0.541 . . . . 1.0 111.107 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -128.86 132.82 7.36 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.38 172.78 9.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.94 0.37 . . . . 1.0 111.808 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.63 9.8 41.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -136.02 131.95 35.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.957 0.408 . . . . 1.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -63.81 -36.47 84.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.694 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.449 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 57.2 tt0 -57.57 -42.59 83.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.281 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.68 -40.69 95.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.469 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.41 86.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.315 0.578 . . . . 1.0 109.975 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.492 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.7 mtmt -64.05 -35.25 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.264 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.8 mm-40 -65.27 -34.3 78.01 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.67 98.02 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.519 ' O ' HG12 ' B' ' 248' ' ' VAL . 65.9 mt -60.75 -52.24 63.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.39 0.614 . . . . 1.0 110.706 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.19 -36.66 84.78 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.167 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.2 m -64.16 -36.52 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.881 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -73.4 -40.18 55.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 -178.333 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.99 -15.59 62.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.739 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -100.54 -2.95 31.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.918 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 17.4 m-80 -135.66 -37.73 0.75 Allowed 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.575 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.18 -50.21 87.86 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 54.0 Cg_endo -65.96 -8.9 21.29 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.026 1.15 . . . . 1.0 113.797 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.53 -19.21 8.88 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -66.48 136.99 56.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.447 0.641 . . . . 1.0 112.619 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -92.88 135.9 33.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.819 -1.082 . . . . 1.0 111.286 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.583 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -85.23 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.635 0.731 . . . . 1.0 112.185 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.6 mt -116.38 140.7 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.489 -1.232 . . . . 1.0 109.366 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -86.62 107.34 18.12 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.285 -0.864 . . . . 1.0 111.182 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.038 0.447 . . . . 1.0 111.511 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -103.42 -179.8 4.05 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.631 -0.713 . . . . 1.0 111.76 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -125.9 99.35 5.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 172.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.41 163.7 3.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.511 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.0 p-80 -167.25 148.89 5.8 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.919 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.6 m-85 -87.93 148.47 24.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.719 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -141.21 119.27 11.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.387 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 118' ' ' TRP . 77.2 t -89.89 131.45 37.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -140.33 -179.65 6.12 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.059 0.224 . . . . 1.0 110.537 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.6 t -102.28 137.9 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.245 0.545 . . . . 1.0 112.341 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.84 179.8 7.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.193 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 -19.65 65.33 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.919 0.39 . . . . 1.0 110.765 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.02 21.08 17.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.72 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' HA ' HG13 ' A' ' 110' ' ' VAL . 3.6 m-20 69.83 37.13 1.87 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.66 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.0 mttt -110.72 150.54 28.92 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.981 -176.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -93.04 121.06 34.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.835 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 55.7 mtp180 -134.27 -176.78 4.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.661 -1.154 . . . . 1.0 108.109 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.521 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.8 p-90 -151.89 165.6 34.05 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.912 -0.715 . . . . 1.0 112.337 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -144.48 140.38 28.88 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.423 -1.262 . . . . 1.0 111.234 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.724 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.9 tp -100.85 132.06 46.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.32 132.6 69.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.512 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.468 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.4 t-80 -83.07 177.64 8.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 1.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 11.7 t70 -51.5 -44.47 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.06 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.569 ' HB2' ' ND2' ' A' ' 126' ' ' ASN . 1.0 OUTLIER -67.42 -33.65 75.61 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.308 -177.493 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.52 10.48 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.546 -0.752 . . . . 1.0 113.468 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.569 ' ND2' ' HB2' ' A' ' 124' ' ' ASN . 0.5 OUTLIER -86.45 147.77 25.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.606 0.224 . . . . 1.0 111.606 177.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.3 mm -74.14 119.77 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.796 0.685 . . . . 1.0 109.57 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.724 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.8 mt -94.94 -43.86 7.98 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.271 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.423 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.71 166.85 30.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.923 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -139.35 160.36 40.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.026 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.433 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 68.0 p -58.74 -38.49 78.52 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.34 -42.28 3.08 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -91.47 173.49 7.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.719 -0.74 . . . . 1.0 110.776 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.47 125.7 1.66 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.85 171.21 14.74 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 120.431 0.157 . . . . 1.0 110.609 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.24 9.54 28.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.0 p -121.53 129.57 52.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.538 0.685 . . . . 1.0 112.551 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -64.94 -42.84 94.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.893 . . . . 1.0 111.173 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 62.2 tt0 -55.15 -45.0 75.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.459 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.557 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -56.98 -42.77 80.83 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.81 76.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.016 0.436 . . . . 1.0 110.402 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.496 ' HG2' HG21 ' A' ' 108' ' ' VAL . 45.3 mtmt -62.98 -38.65 91.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -63.46 -26.28 68.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.72 -43.85 93.44 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.093 -1.203 . . . . 1.0 110.093 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.486 ' O ' HG12 ' A' ' 148' ' ' VAL . 59.7 mt -62.18 -45.09 99.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.564 0.697 . . . . 1.0 110.169 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -62.74 -39.9 95.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -67.87 -34.71 77.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.57 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -72.93 -40.38 59.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.264 -177.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.89 -12.57 59.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.132 0.491 . . . . 1.0 111.651 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -103.4 -2.53 26.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.475 -0.784 . . . . 1.0 111.154 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.422 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.58 -39.14 1.14 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.887 -177.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.64 -50.09 88.96 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.388 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.6 Cg_endo -64.44 -16.57 55.85 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.163 1.242 . . . . 1.0 113.095 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -106.84 -23.9 12.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.498 . . . . 1.0 111.33 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.28 135.55 55.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.452 -0.794 . . . . 1.0 112.874 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -96.56 148.75 22.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.558 -1.201 . . . . 1.0 111.792 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.574 HG22 HG21 ' B' ' 245' ' ' ILE . 40.1 t -85.27 131.38 34.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 1.0 112.061 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt -123.38 133.95 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -87.21 103.5 15.48 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.103 -0.951 . . . . 1.0 111.199 -177.166 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 48.7 ttp . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.81 0.338 . . . . 1.0 110.697 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.422 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 6.4 p-10 -125.37 177.23 6.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.705 0.764 . . . . 1.0 111.98 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 13.1 mmmm -142.27 99.67 3.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.068 -1.424 . . . . 1.0 107.592 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.36 169.94 4.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.124 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.499 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 50.2 p-80 -169.53 150.11 4.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.444 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.8 m-85 -87.72 150.33 23.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.336 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.52 118.01 10.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.383 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' B' ' 218' ' ' TRP . 94.0 t -95.42 133.42 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.84 175.57 9.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.2 t -100.66 135.97 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.283 0.563 . . . . 1.0 111.536 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -82.11 178.29 8.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.997 -1.001 . . . . 1.0 110.101 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.91 -10.62 59.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.185 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.93 19.69 17.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.357 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 70.17 36.1 1.96 Allowed 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.165 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.6 mttt -110.05 144.76 38.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.459 -176.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.63 111.72 23.41 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.972 -1.467 . . . . 1.0 109.345 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -128.74 175.37 8.66 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.569 ' HB3' HG22 ' B' ' 208' ' ' VAL . 53.5 p-90 -153.4 162.15 41.57 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.014 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -144.17 151.35 39.4 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.456 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.707 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -98.58 131.2 44.98 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 13.7 t -128.55 133.56 66.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.361 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -82.2 173.25 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 16.5 t70 -58.02 -27.42 63.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.196 0.522 . . . . 1.0 110.963 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -72.12 -33.28 67.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.514 0.673 . . . . 1.0 110.165 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.42 10.28 22.09 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.848 -1.069 . . . . 1.0 112.772 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -87.64 142.96 27.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.671 0.272 . . . . 1.0 111.566 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.4 mm -74.75 123.57 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.583 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.707 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -100.56 -42.96 6.35 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.045 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -147.71 167.38 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.801 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 231' ' ' SER . 15.2 t0 -141.81 153.24 44.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.034 -0.985 . . . . 1.0 108.459 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 55.0 p -58.35 -40.31 81.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 1.0 112.098 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.97 -41.12 3.03 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.21 177.25 6.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.185 -0.508 . . . . 1.0 110.667 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -167.86 114.59 0.58 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -142.37 166.04 25.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.564 0.221 . . . . 1.0 110.493 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.96 6.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.117 0.784 . . . . 1.0 113.117 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 13.2 p -112.12 127.36 55.9 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.694 0.759 . . . . 1.0 111.994 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -68.37 -40.77 81.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.112 -0.949 . . . . 1.0 110.952 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 62.8 tt0 -56.43 -46.12 80.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.297 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -42.95 85.57 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.296 0.372 . . . . 1.0 110.972 -178.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.39 70.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 1.0 110.646 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -63.3 -38.01 89.47 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.24 -0.891 . . . . 1.0 111.222 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.8 mm-40 -63.4 -28.03 69.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.76 -43.45 97.71 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.574 HG21 HG22 ' A' ' 157' ' ' VAL . 48.7 mt -63.48 -46.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.435 0.636 . . . . 1.0 110.698 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.36 -38.24 88.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.23 0.538 . . . . 1.0 110.213 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -35.25 78.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.572 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.2 -41.48 58.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.535 -177.163 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -65.85 -15.13 62.63 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 1.0 112.121 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -104.74 -2.34 25.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.866 0.365 . . . . 1.0 111.315 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -127.8 -37.44 1.94 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.415 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.11 -51.09 82.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.893 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.0 Cg_endo -66.43 -12.29 35.08 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.168 1.245 . . . . 1.0 113.462 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.15 -27.48 10.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.576 0.703 . . . . 1.0 111.577 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.38 136.87 57.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.977 1.103 . . . . 1.0 113.977 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.65 139.08 30.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -88.79 131.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.38 0.61 . . . . 1.0 111.816 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.57 144.44 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.873 -1.058 . . . . 1.0 109.004 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -88.59 102.32 14.83 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.115 -0.945 . . . . 1.0 111.236 -177.295 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.822 0.344 . . . . 1.0 110.121 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 9.9 p-10 -89.79 161.38 16.05 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.408 0.623 . . . . 1.0 112.007 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 100.59 6.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.014 -1.476 . . . . 1.0 107.014 172.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -172.3 165.42 5.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.455 -1.248 . . . . 1.0 108.163 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.53 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.4 p-80 -167.81 150.21 5.69 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.56 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 57.1 m-85 -86.38 148.53 25.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.734 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.6 121.97 14.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.868 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 118' ' ' TRP . 92.1 t -95.05 135.98 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.9 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.17 178.08 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.714 0.293 . . . . 1.0 110.543 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 2.9 t -101.22 133.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.343 0.592 . . . . 1.0 110.898 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.67 178.78 7.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.711 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -12.7 61.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.174 0.511 . . . . 1.0 110.929 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.39 18.75 19.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.346 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 71.1 35.2 1.67 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.794 0.838 . . . . 1.0 111.567 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.6 mttt -109.72 148.58 31.15 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.254 -175.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.32 112.21 24.07 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.329 -1.305 . . . . 1.0 109.383 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -132.95 178.31 6.98 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.401 -0.962 . . . . 1.0 108.401 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.565 ' HB3' HG22 ' A' ' 108' ' ' VAL . 53.3 p-90 -150.09 164.0 36.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.813 0.34 . . . . 1.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -146.83 147.22 30.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.127 -0.942 . . . . 1.0 109.805 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.689 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.7 tp -96.65 134.69 39.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.1 t -128.06 131.07 69.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.448 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.466 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.0 t-80 -79.59 173.87 12.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.85 -39.39 68.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.279 0.562 . . . . 1.0 110.455 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.4 -33.44 74.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.046 -0.979 . . . . 1.0 110.642 -177.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.34 9.75 23.14 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.837 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -87.45 144.69 26.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.689 0.255 . . . . 1.0 111.689 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.2 119.49 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.762 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.689 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.5 mt -94.93 -43.92 7.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.639 0.733 . . . . 1.0 109.9 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.39 166.74 28.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.635 -1.166 . . . . 1.0 111.367 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -141.17 153.5 45.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.951 -1.022 . . . . 1.0 108.464 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.501 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 15.8 p -53.37 -36.57 61.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.006 0.372 . . . . 1.0 112.006 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.69 -45.92 3.56 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.526 -0.63 . . . . 1.0 111.526 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -93.49 174.4 7.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.285 0.564 . . . . 1.0 111.507 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.53 136.92 8.68 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.94 165.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 117.627 0.714 . . . . 1.0 111.094 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.09 10.98 37.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.218 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 m -139.64 137.28 35.14 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.483 0.659 . . . . 1.0 111.543 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -63.22 -39.58 95.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.861 -1.063 . . . . 1.0 111.047 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 58.3 tt0 -58.31 -47.02 85.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.268 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.9 -44.57 86.87 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.61 0.569 . . . . 1.0 110.976 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.29 83.36 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.266 0.555 . . . . 1.0 110.612 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.539 ' HG2' HG21 ' A' ' 108' ' ' VAL . 44.5 mtmt -64.56 -35.32 80.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.383 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -64.78 -27.92 69.22 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.88 91.97 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 142' ' ' LYS . 63.5 mt -61.43 -43.04 96.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 1.0 110.338 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.83 -40.07 94.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.5 m -63.54 -36.36 83.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.599 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.53 -42.78 55.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 C-N-CA 119.826 -0.75 . . . . 1.0 109.529 -178.116 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.17 -11.77 51.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -102.54 -2.31 28.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 1.0 110.664 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.429 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 23.9 m-80 -135.52 -37.77 0.76 Allowed 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.787 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.504 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.49 -49.7 91.08 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 44.4 Cg_endo -67.0 -11.96 34.27 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.322 1.348 . . . . 1.0 112.855 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -110.64 -19.8 12.75 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.065 0.46 . . . . 1.0 111.408 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.533 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -70.83 134.71 47.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.896 0.855 . . . . 1.0 113.153 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -94.53 142.25 27.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.22 -1.355 . . . . 1.0 110.317 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -90.67 134.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.237 0.541 . . . . 1.0 112.088 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt -119.01 142.63 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 114.902 -1.045 . . . . 1.0 109.192 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.14 104.19 16.46 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.387 -0.816 . . . . 1.0 110.965 -177.757 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.704 0.288 . . . . 1.0 110.245 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.429 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 9.3 p-10 -121.04 160.84 22.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.475 0.655 . . . . 1.0 112.189 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' B' ' 223' ' ' ASP . 0.0 OUTLIER -126.17 101.16 6.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 172.532 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.17 159.3 3.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.136 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.533 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 44.9 p-80 -166.95 150.81 6.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.744 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.574 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.6 m-85 -86.34 150.19 24.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.693 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -142.49 118.21 10.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.615 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' B' ' 218' ' ' TRP . 97.2 t -95.09 132.8 38.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.127 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.74 177.66 8.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.2 t -100.03 136.36 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.483 0.659 . . . . 1.0 112.346 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.7 -179.78 7.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.802 -1.09 . . . . 1.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.515 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.45 20.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.917 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 71.13 34.67 1.77 Allowed 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.498 0.719 . . . . 1.0 110.901 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.9 mttt -108.64 147.94 31.12 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.56 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -94.17 109.11 20.92 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.409 -1.269 . . . . 1.0 109.822 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -122.02 176.13 5.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.575 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.1 p-90 -150.62 162.76 40.04 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.28 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -147.28 146.71 29.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.197 -0.91 . . . . 1.0 110.247 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.741 ' HG ' HD12 ' B' ' 228' ' ' LEU . 35.0 tp -99.31 132.58 44.54 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 4.2 t -126.64 133.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.077 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' HIS . . . . . 0.524 ' HB2' HD21 ' B' ' 228' ' ' LEU . 1.6 t-80 -86.09 176.55 7.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.389 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' B' ' 203' ' ' LYS . 43.2 t0 -52.61 -43.37 65.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.176 -0.92 . . . . 1.0 110.847 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -63.05 -33.6 75.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.617 -0.72 . . . . 1.0 110.47 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.45 12.34 19.63 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.493 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -86.43 144.84 27.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.59 0.218 . . . . 1.0 111.59 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.99 116.94 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.741 HD12 ' HG ' ' B' ' 220' ' ' LEU . 17.7 mt -89.19 -43.23 11.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.742 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.478 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.07 164.92 35.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 1.0 111.471 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -139.48 156.82 46.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.379 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.457 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 13.6 p -53.89 -35.08 61.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.78 -47.04 3.37 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -104.93 177.59 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.921 -0.64 . . . . 1.0 111.796 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -137.2 135.24 7.52 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.899 -1.28 . . . . 1.0 109.899 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -133.1 165.48 24.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.385 0.592 . . . . 1.0 111.78 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.62 10.9 26.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.9 m -138.48 135.83 35.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.46 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -64.14 -38.18 90.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.703 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 62.8 tt0 -59.84 -43.01 94.81 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.194 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -61.57 -40.64 95.46 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.793 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.33 87.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.307 0.575 . . . . 1.0 109.854 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' B' ' 245' ' ' ILE . 41.0 mtmt -64.79 -35.3 80.66 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.914 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.0 mm-40 -62.18 -29.05 70.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.705 -0.48 . . . . 1.0 109.705 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.95 -42.81 94.6 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' B' ' 242' ' ' LYS . 57.3 mt -63.67 -44.16 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.235 0.54 . . . . 1.0 110.186 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -62.27 -40.88 97.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.974 0.416 . . . . 1.0 110.295 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.55 -35.0 79.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.504 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.3 OUTLIER -74.13 -41.96 51.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.478 -177.007 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.62 -11.76 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.816 -0.552 . . . . 1.0 111.832 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -104.79 -5.71 20.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.24 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 10.1 m-80 -130.08 -39.4 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.026 0.38 . . . . 1.0 112.026 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.574 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.74 -50.04 89.35 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 28.7 Cg_endo -62.03 -16.74 51.99 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.336 1.357 . . . . 1.0 113.187 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.64 -29.36 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.272 0.558 . . . . 1.0 111.899 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -59.11 135.92 57.79 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.644 0.979 . . . . 1.0 113.644 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -93.7 141.08 28.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.802 -1.545 . . . . 1.0 110.252 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.532 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.56 133.41 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.498 0.666 . . . . 1.0 112.233 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -119.41 146.76 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.691 -1.14 . . . . 1.0 109.034 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.95 104.1 16.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.088 -0.958 . . . . 1.0 111.873 -176.348 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.6 ttt . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.936 0.398 . . . . 1.0 111.695 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 16.4 p-10 -88.94 168.75 12.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.373 0.606 . . . . 1.0 112.34 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -131.87 97.22 4.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.98 168.24 4.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.055 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.527 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 31.8 p-80 -171.45 151.21 2.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.301 -0.259 . . . . 1.0 110.301 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -88.5 150.38 23.14 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.062 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.83 119.64 12.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.26 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 118' ' ' TRP . 73.4 t -93.97 131.69 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.975 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.43 179.78 6.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.772 0.32 . . . . 1.0 110.823 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.7 t -102.21 137.83 28.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.239 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.54 -179.97 7.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.939 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.17 -12.36 61.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.429 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.22 20.03 16.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.767 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 71.33 35.18 1.59 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.562 0.745 . . . . 1.0 111.249 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 9.5 mmtt -108.71 153.31 23.63 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.203 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -96.6 118.3 32.8 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.643 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.0 mtm105 -133.51 -179.99 5.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.516 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.7 p-90 -150.09 170.58 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.377 0.608 . . . . 1.0 112.366 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -148.41 141.88 25.33 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.448 -1.251 . . . . 1.0 110.63 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.737 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.6 tp -102.15 129.8 48.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 174.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.52 134.65 61.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 121.08 -0.248 . . . . 1.0 110.726 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -83.04 172.25 12.93 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -57.14 -30.55 64.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.958 0.409 . . . . 1.0 111.843 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.26 -33.6 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.3 0.571 . . . . 1.0 110.037 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.76 11.76 16.09 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.069 -0.969 . . . . 1.0 112.347 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -88.94 142.02 27.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.841 -0.18 . . . . 1.0 111.086 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.6 mm -77.58 118.19 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.921 0.763 . . . . 1.0 109.711 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.737 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.2 mt -89.83 -40.06 12.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.413 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.16 164.52 37.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.781 -1.1 . . . . 1.0 111.917 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.53 154.27 49.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.826 -1.079 . . . . 1.0 108.723 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 118' ' ' TRP . 77.6 p -55.59 -41.47 73.44 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.13 -35.52 2.77 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.441 -0.664 . . . . 1.0 111.441 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 49.4 mt-10 -94.71 174.92 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.19 0.519 . . . . 1.0 111.132 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.54 124.12 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.739 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -146.03 179.44 7.48 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.56 9.42 41.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.768 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.6 m -117.59 128.86 55.35 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.675 0.75 . . . . 1.0 111.664 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -69.52 -32.07 70.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.573 -1.194 . . . . 1.0 110.214 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 51.9 tt0 -63.06 -44.83 94.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.112 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 133' ' ' GLU . 27.5 tptp -60.87 -37.07 80.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.681 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.83 75.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.194 0.521 . . . . 1.0 109.962 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.458 ' HA ' HD12 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.97 -36.96 86.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.3 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.6 mm-40 -61.65 -27.44 68.68 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.14 -43.62 89.46 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.07 -1.212 . . . . 1.0 110.07 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.524 HG21 HG22 ' B' ' 257' ' ' VAL . 54.4 mt -63.29 -44.48 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.318 0.58 . . . . 1.0 109.97 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.09 -43.78 98.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.354 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.0 m -64.09 -34.93 79.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.745 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -73.5 -43.25 55.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 C-N-CA 119.897 -0.721 . . . . 1.0 109.653 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -67.6 -11.92 59.22 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.042 -0.411 . . . . 1.0 111.729 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -104.11 -2.35 25.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.807 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.428 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.1 m-80 -137.04 -37.2 0.65 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.89 -50.14 87.85 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -64.89 -11.12 28.0 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.329 1.353 . . . . 1.0 113.226 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.88 -22.42 11.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.065 0.459 . . . . 1.0 111.394 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -67.84 137.77 55.58 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.269 0.84 . . . . 1.0 113.269 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -100.11 154.21 18.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.3 -1.318 . . . . 1.0 111.489 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.516 HG22 HG21 ' B' ' 245' ' ' ILE . 36.1 t -87.61 133.45 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.995 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt -131.65 145.75 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -83.23 118.61 23.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.543 -0.742 . . . . 1.0 110.95 -179.694 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.305 0.097 . . . . 1.0 111.12 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.428 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.5 p-10 -143.6 -174.87 4.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.685 0.755 . . . . 1.0 112.878 -174.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -135.75 97.76 3.74 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.571 -1.649 . . . . 1.0 106.971 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.31 167.46 4.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.322 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.469 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 30.1 p80 -169.32 149.63 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.738 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -85.9 151.17 23.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -140.93 120.68 13.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.568 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' B' ' 218' ' ' TRP . 81.0 t -94.33 133.35 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.654 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -140.18 -178.79 5.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.101 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.9 t -108.36 138.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.333 0.494 . . . . 1.0 112.333 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.8 178.57 8.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.748 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.23 -18.86 65.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.735 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.89 23.09 14.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.112 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 62.64 40.87 9.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.854 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.2 mmtt -102.1 158.66 16.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -102.47 118.48 36.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -132.03 179.08 6.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.52 ' HB3' HG22 ' B' ' 208' ' ' VAL . 52.5 p-90 -149.0 171.05 16.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.588 0.709 . . . . 1.0 112.317 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -147.43 142.49 27.07 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.205 -1.361 . . . . 1.0 110.649 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.696 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.0 tp -100.46 129.39 46.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.56 135.0 61.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.363 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -81.73 168.59 17.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.46 -17.73 55.78 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.947 0.403 . . . . 1.0 111.419 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -74.25 -33.9 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.546 0.689 . . . . 1.0 109.488 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.59 10.91 15.89 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 114.41 -1.268 . . . . 1.0 112.596 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -90.54 143.26 26.92 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.265 0.226 . . . . 1.0 111.481 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.81 127.01 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 123.675 0.609 . . . . 1.0 109.513 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.696 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -103.81 -40.75 6.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.231 0.539 . . . . 1.0 109.99 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.86 164.86 36.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.908 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' B' ' 231' ' ' SER . 10.2 t0 -139.22 151.88 46.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.829 -1.078 . . . . 1.0 108.186 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 11.9 p -51.51 -36.47 44.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.864 0.32 . . . . 1.0 111.864 176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.62 -45.32 3.34 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.355 -0.698 . . . . 1.0 111.355 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' GLU . . . . . 0.553 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 89.0 mt-10 -113.26 171.26 7.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.559 . . . . 1.0 111.011 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.99 141.3 9.55 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.05 174.27 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.603 0.24 . . . . 1.0 110.458 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -86.17 10.83 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 -176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.3 m -128.61 131.17 48.1 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 121.74 -0.6 . . . . 1.0 111.336 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' B' ' 242' ' ' LYS . 20.3 ptmt -66.51 -34.87 78.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.627 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 58.2 tt0 -57.16 -43.99 83.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.905 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.4 OUTLIER -60.49 -40.88 92.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.22 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.25 78.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.217 0.532 . . . . 1.0 110.376 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' B' ' 238' ' ' LYS . 44.9 mtmt -63.0 -41.11 99.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.91 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.5 mm-40 -64.79 -26.22 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.134 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.27 -42.56 96.15 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.029 -1.228 . . . . 1.0 110.029 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.516 HG21 HG22 ' A' ' 157' ' ' VAL . 57.5 mt -62.23 -46.16 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 1.0 110.161 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.41 -40.3 96.06 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.201 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.02 -34.18 77.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.662 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.01 -43.03 52.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.888 -177.579 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -65.95 -12.01 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 1.0 111.848 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -102.63 -3.09 27.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.786 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 13.5 m-80 -135.65 -36.36 0.78 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -176.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.16 -50.41 87.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.538 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.4 Cg_endo -63.47 -14.12 40.4 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.444 1.43 . . . . 1.0 113.254 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.45 -21.49 12.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.88 0.371 . . . . 1.0 111.906 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.51 138.18 57.9 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.131 0.789 . . . . 1.0 113.131 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -97.05 150.38 20.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.328 -1.305 . . . . 1.0 112.053 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 145' ' ' ILE . 36.2 t -85.53 133.93 28.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.258 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.44 143.95 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.78 102.4 13.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.595 -0.717 . . . . 1.0 110.892 -178.14 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.459 0.647 . . . . 1.0 110.792 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.432 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 17.7 p-10 -69.99 167.52 17.35 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.659 -1.155 . . . . 1.0 112.744 -176.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.5 mptt -121.63 97.4 5.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.03 167.48 4.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.451 -1.249 . . . . 1.0 108.426 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.469 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 52.3 p-80 -168.88 148.37 4.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.929 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.563 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.9 m-85 -86.27 149.09 25.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.868 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -142.56 121.43 12.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.759 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.5 t -97.09 136.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -147.25 -179.26 6.71 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.245 0.341 . . . . 1.0 110.593 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -105.82 138.5 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.394 0.616 . . . . 1.0 112.082 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.23 178.54 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.744 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.21 63.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.046 0.45 . . . . 1.0 111.162 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.71 22.22 16.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.444 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 70.62 33.18 2.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.687 0.795 . . . . 1.0 111.236 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.4 mttt -107.42 146.56 31.53 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.517 0.675 . . . . 1.0 111.941 -175.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -92.9 115.76 28.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.198 -1.364 . . . . 1.0 109.802 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -128.99 179.36 5.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.203 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.587 ' HB3' HG22 ' A' ' 108' ' ' VAL . 54.9 p-90 -154.5 165.49 36.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.1 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 16.4 mtt180 -149.09 150.63 33.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 124.016 0.823 . . . . 1.0 110.497 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.712 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.0 tp -99.83 132.02 45.44 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.86 129.72 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.554 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -78.23 172.62 13.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 177.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.03 -32.39 66.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.15 0.5 . . . . 1.0 110.959 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.29 -33.73 76.67 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.203 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.66 14.22 16.39 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.078 -0.965 . . . . 1.0 112.384 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -90.34 143.6 26.6 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mm -74.96 118.64 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 123.926 0.766 . . . . 1.0 109.566 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.712 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.3 mt -93.87 -43.41 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.384 0.612 . . . . 1.0 109.799 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.479 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.21 163.74 37.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.367 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -139.07 156.86 46.86 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.8 p -53.74 -31.5 48.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.931 0.396 . . . . 1.0 111.401 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.06 -38.26 2.98 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.502 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 49.9 mt-10 -118.3 171.39 8.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.048 -0.576 . . . . 1.0 110.951 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.42 138.66 10.49 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -133.43 169.43 16.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.32 0.56 . . . . 1.0 111.982 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.01 10.72 30.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -142.5 139.22 31.42 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.815 -0.553 . . . . 1.0 111.9 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.64 -37.48 87.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.461 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.449 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 50.0 tt0 -59.03 -46.67 87.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.544 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -59.12 -41.59 88.55 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.614 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.11 75.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.09 0.471 . . . . 1.0 109.861 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 145' ' ' ILE . 43.9 mtmt -64.21 -34.73 78.76 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.344 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.0 mm-40 -63.69 -27.13 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.76 -42.38 87.02 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 142' ' ' LYS . 66.5 mt -62.2 -44.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.414 0.626 . . . . 1.0 109.637 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -61.52 -44.77 96.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.239 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.8 m -63.56 -34.83 78.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.751 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -74.55 -41.61 48.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 C-N-CA 119.878 -0.729 . . . . 1.0 109.684 -177.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.36 -12.1 54.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.753 0.311 . . . . 1.0 111.657 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -104.63 -2.8 24.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.591 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -132.02 -40.58 1.04 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.835 0.35 . . . . 1.0 111.502 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.15 -51.48 79.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.617 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -63.54 -9.0 16.52 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.508 1.472 . . . . 1.0 113.98 -177.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.58 -22.19 7.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.918 0.39 . . . . 1.0 111.939 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 136.52 57.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.777 0.799 . . . . 1.0 113.038 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.93 138.78 31.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.438 -1.255 . . . . 1.0 110.581 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.567 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.69 130.65 38.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.711 . . . . 1.0 112.699 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.8 mt -115.47 140.22 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.369 -1.287 . . . . 1.0 108.568 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -92.61 102.05 14.48 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.059 -0.973 . . . . 1.0 111.148 -177.064 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -109.7 171.37 7.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.022 0.439 . . . . 1.0 110.787 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 73.3 mmtt -137.73 95.77 3.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.609 -1.256 . . . . 1.0 107.609 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.91 173.03 2.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.094 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.496 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.6 p-80 -170.7 147.59 2.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.583 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.567 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 57.6 m-85 -85.16 147.61 26.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.654 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.37 119.55 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.08 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' B' ' 218' ' ' TRP . 75.4 t -92.14 133.93 31.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.151 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -145.66 -176.43 5.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.619 0.247 . . . . 1.0 110.4 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.8 t -101.99 139.42 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.909 0.707 . . . . 1.0 112.909 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -81.22 -178.65 7.01 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.309 -0.86 . . . . 1.0 109.548 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.82 -16.96 62.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.154 0.502 . . . . 1.0 110.673 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.37 19.33 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.712 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.67 39.99 1.44 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.425 0.69 . . . . 1.0 110.956 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -113.76 151.86 31.38 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.791 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -91.99 118.87 31.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.158 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.433 ' HG2' ' HA2' ' B' ' 234' ' ' GLY . 62.1 mtp180 -130.69 -178.67 4.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.808 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.507 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.8 p-90 -155.43 164.44 38.71 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.345 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -149.66 148.31 29.13 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.216 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.695 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -97.15 130.16 44.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.28 130.59 71.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.252 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -78.94 169.31 18.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 29.0 t70 -58.36 -26.47 63.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.266 0.555 . . . . 1.0 110.954 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.4 -33.07 70.95 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.941 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.48 11.52 19.44 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.125 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -89.55 144.21 26.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.807 -0.231 . . . . 1.0 111.385 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.9 mm -78.24 116.72 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 1.0 109.472 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.695 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -90.25 -42.58 10.92 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.547 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.483 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -150.35 164.27 36.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.608 -1.178 . . . . 1.0 111.374 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.34 155.33 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 65.6 p -54.72 -33.26 60.84 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.066 0.46 . . . . 1.0 111.55 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.69 3.51 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.53 -0.628 . . . . 1.0 111.53 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -122.72 166.94 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.175 0.512 . . . . 1.0 111.572 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' B' ' 217' ' ' ARG . . . -118.73 139.78 14.72 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.651 -1.38 . . . . 1.0 109.651 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -127.47 171.02 11.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.623 0.711 . . . . 1.0 111.545 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -100.73 9.69 42.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 1.0 112.28 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.7 m -143.78 137.21 27.9 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.68 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -62.88 -38.42 90.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.78 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 50.8 tt0 -60.98 -40.71 94.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.211 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -61.05 -41.51 96.74 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.647 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.28 89.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.973 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.572 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.0 mtmt -64.91 -34.99 79.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.228 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.3 mm-40 -62.62 -30.98 71.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.15 -41.28 95.03 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.048 -1.221 . . . . 1.0 110.048 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' B' ' 242' ' ' LYS . 66.6 mt -63.36 -43.08 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.976 -0.612 . . . . 1.0 110.582 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -63.99 -41.3 97.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.04 0.448 . . . . 1.0 110.232 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -64.03 -37.08 86.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.522 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -74.06 -41.46 52.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 C-N-CA 120.22 -0.592 . . . . 1.0 110.755 -176.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.53 -16.35 63.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -105.82 -3.23 22.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 1.0 111.353 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 15.2 m-80 -123.32 -38.88 2.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.986 0.422 . . . . 1.0 111.082 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.51 -50.87 85.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.495 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.5 Cg_endo -63.59 -12.75 32.66 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.53 1.486 . . . . 1.0 113.528 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.56 -19.47 10.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -64.57 136.77 57.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.866 0.841 . . . . 1.0 112.593 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -91.83 135.76 33.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.022 -1.445 . . . . 1.0 110.573 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.563 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -88.54 129.85 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.601 0.715 . . . . 1.0 112.298 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.9 mt -115.1 140.59 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.406 -1.27 . . . . 1.0 109.27 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -90.31 106.55 18.57 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.674 -0.862 . . . . 1.0 108.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.337 -0.839 . . . . 1.0 111.213 -177.399 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 53.3 ttp . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.372 0.606 . . . . 1.0 110.697 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 21.4 p-10 -92.63 173.99 7.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.421 -0.809 . . . . 1.0 112.066 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -134.37 96.64 3.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.55 171.13 3.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.856 -1.065 . . . . 1.0 109.401 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.5 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 48.4 p-80 -170.53 148.36 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.1 m-85 -84.83 149.94 25.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.38 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.35 118.73 12.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.559 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 118' ' ' TRP . 68.2 t -90.95 133.39 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.878 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -142.6 177.43 8.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.412 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.4 t -102.36 137.47 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.334 0.587 . . . . 1.0 111.969 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.57 177.76 8.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.96 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.87 -12.25 61.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.237 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.97 24.28 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.669 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 69.35 35.19 2.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 1.0 111.674 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.7 mttt -110.68 147.53 34.15 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.457 0.646 . . . . 1.0 111.4 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.6 120.98 32.13 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.431 -1.259 . . . . 1.0 110.467 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -136.32 -179.7 5.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.572 -1.194 . . . . 1.0 108.675 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.535 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.3 p-90 -151.7 162.9 40.24 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.683 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.531 HH11 HG21 ' A' ' 127' ' ' ILE . 21.6 mmt180 -143.48 142.82 31.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.298 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.719 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.5 tp -99.97 129.99 46.1 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -127.79 132.36 68.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.483 -0.192 . . . . 1.0 110.483 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.439 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.0 t-80 -83.34 174.35 10.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.4 -39.18 67.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.0 111.476 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -60.32 -33.96 73.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.513 0.673 . . . . 1.0 110.26 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.54 12.17 21.8 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.873 -1.058 . . . . 1.0 112.096 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -86.77 142.57 28.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.63 0.252 . . . . 1.0 111.376 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.531 HG21 HH11 ' A' ' 119' ' ' ARG . 50.9 mm -76.26 116.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.194 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.719 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.1 mt -88.38 -42.74 11.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.634 0.731 . . . . 1.0 109.917 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.65 166.43 30.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.756 -1.111 . . . . 1.0 111.237 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -140.34 155.41 46.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.87 -1.059 . . . . 1.0 110.13 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.447 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 18.9 p -54.5 -36.03 63.75 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.601 0.563 . . . . 1.0 111.605 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.38 -50.67 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.65 178.61 4.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.709 -0.746 . . . . 1.0 111.618 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -145.67 140.62 9.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -141.37 167.47 22.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.531 0.165 . . . . 1.0 110.66 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.4 9.9 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 p -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.601 0.715 . . . . 1.0 111.862 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -64.94 -41.52 95.44 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.595 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -59.83 -37.78 80.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.621 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -62.0 -43.35 99.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.241 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.95 83.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.26 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.587 ' HA ' HD12 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.66 -34.43 78.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.169 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -62.99 -30.29 71.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.34 -40.35 94.57 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.42 -1.072 . . . . 1.0 110.42 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 142' ' ' LYS . 58.3 mt -62.73 -42.26 95.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.085 0.469 . . . . 1.0 110.081 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.09 -43.75 97.63 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.155 0.502 . . . . 1.0 109.885 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -61.25 -36.16 79.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -75.22 -42.4 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 119.536 -0.866 . . . . 1.0 110.169 -177.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.6 mtpt -66.86 -15.65 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 1.0 112.399 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -105.43 -2.26 23.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.366 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.62 -37.53 1.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.693 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.603 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.34 -51.35 82.33 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.499 0.555 . . . . 1.0 112.499 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 57.8 Cg_endo -66.56 -4.81 11.55 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.261 1.308 . . . . 1.0 113.208 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.18 -23.41 6.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.593 0.59 . . . . 1.0 112.593 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -66.69 139.12 57.83 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.472 0.916 . . . . 1.0 113.472 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.78 135.42 33.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.488 -1.233 . . . . 1.0 111.189 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -88.04 131.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.335 0.588 . . . . 1.0 112.075 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.6 mt -123.84 145.94 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.93 -1.032 . . . . 1.0 108.92 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -88.63 113.44 24.2 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.118 -1.068 . . . . 1.0 108.118 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.126 -0.94 . . . . 1.0 111.271 -177.112 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 53.2 ttp . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.304 0.573 . . . . 1.0 111.075 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.434 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 14.4 p-10 -81.72 163.74 22.24 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.453 -0.794 . . . . 1.0 112.588 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 12.0 mptt -127.78 96.46 4.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 174.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.95 171.4 3.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.417 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.555 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.6 p-80 -169.32 147.26 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.213 -0.195 . . . . 1.0 110.59 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 52.1 m-85 -86.67 146.72 26.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.144 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -141.75 122.0 13.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.752 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.0 t -93.24 135.68 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.09 -178.62 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.355 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.1 t -106.15 139.65 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.22 179.12 7.8 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.47 -0.787 . . . . 1.0 109.51 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.38 -17.58 64.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.893 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.8 19.16 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.118 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 69.78 35.37 2.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.041 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.1 mmtt -108.57 149.16 29.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.407 -175.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.38 119.67 32.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.53 -1.214 . . . . 1.0 110.254 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -132.32 -178.1 4.76 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.706 -1.134 . . . . 1.0 108.972 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.517 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.0 p-90 -155.7 168.22 27.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.742 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 16.6 mtt180 -150.44 154.13 37.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.849 -1.069 . . . . 1.0 110.613 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.693 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -104.36 132.62 50.41 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.3 t -126.25 132.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.259 -0.275 . . . . 1.0 110.259 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' HIS . . . . . 0.485 ' HB2' HD21 ' B' ' 228' ' ' LEU . 0.6 OUTLIER -85.26 174.49 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.256 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 26.8 t70 -52.5 -33.88 46.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.833 -0.621 . . . . 1.0 112.249 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -70.81 -33.29 70.55 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.322 0.582 . . . . 1.0 110.179 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.92 10.34 21.09 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.074 -0.967 . . . . 1.0 112.38 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -85.69 144.51 27.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.35 118.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 O-C-N 123.926 0.766 . . . . 1.0 109.38 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.693 HD12 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -93.42 -43.52 8.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.608 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.67 40.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.195 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -136.85 155.11 50.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.458 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.3 p -51.86 -37.03 50.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.905 0.383 . . . . 1.0 111.817 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.18 -46.44 3.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' GLU . . . . . 0.462 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 7.8 mm-40 -98.15 -179.75 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.127 -0.537 . . . . 1.0 111.399 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -150.0 133.86 4.57 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -138.85 170.01 16.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.089 0.444 . . . . 1.0 110.962 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -92.27 9.46 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 6.5 p -126.96 129.05 47.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.594 0.711 . . . . 1.0 112.1 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.21 -41.17 94.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 53.5 tt0 -58.4 -41.14 84.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.342 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -60.59 -41.95 95.76 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.918 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.18 79.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.43 0.633 . . . . 1.0 109.511 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.515 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.2 mtmt -65.78 -33.68 76.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.265 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.1 mm-40 -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -68.15 -39.64 88.36 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.9 mt -61.58 -52.43 61.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.519 0.676 . . . . 1.0 110.59 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -61.87 -35.57 78.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.02 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.2 m -67.95 -36.29 79.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.846 177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.514 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.5 OUTLIER -71.54 -37.16 62.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -177.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -66.41 -15.46 63.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.938 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 41.2 ttt85 -105.04 -2.9 23.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.074 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 251' ' ' ASN . . . . . 0.44 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 16.1 m-80 -127.08 -41.17 1.8 Allowed 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.639 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.82 -50.51 87.64 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.768 -0.651 . . . . 1.0 112.431 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.6 Cg_endo -62.84 -15.15 45.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 121.162 1.241 . . . . 1.0 113.712 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.5 -18.3 11.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.823 0.344 . . . . 1.0 111.923 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.6 135.25 52.61 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.641 0.734 . . . . 1.0 112.791 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -93.56 140.28 29.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.213 -1.358 . . . . 1.0 110.592 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -87.27 136.36 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.369 0.604 . . . . 1.0 112.205 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.8 mt -124.58 148.72 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.658 -1.156 . . . . 1.0 109.761 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.9 106.37 17.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.577 -0.725 . . . . 1.0 111.296 -177.858 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.406 ' C ' ' SD ' ' A' ' 101' ' ' MET . 1.5 tmt? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.704 0.287 . . . . 1.0 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' C ' ' HD2' ' A' ' 103' ' ' LYS . 10.7 p-10 -85.79 159.58 19.7 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.351 0.595 . . . . 1.0 112.151 -176.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.2 mptt -122.71 97.91 5.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.72 169.34 4.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.685 -1.143 . . . . 1.0 108.954 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.509 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.9 p-80 -169.14 148.94 4.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.576 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.59 146.9 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.66 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.36 116.8 11.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.939 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 118' ' ' TRP . 70.2 t -90.97 132.12 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.526 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -140.5 -179.08 5.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.383 -0.228 . . . . 1.0 110.383 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.2 t -103.53 136.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.586 . . . . 1.0 112.388 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.11 177.55 8.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 1.0 108.957 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.29 62.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 1.0 111.006 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.55 19.16 20.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.102 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.6 39.99 1.96 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.672 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 13.2 mmtt -111.76 152.45 27.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.283 -176.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.44 118.63 31.55 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.727 -1.124 . . . . 1.0 110.067 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -132.06 -179.26 5.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.527 ' HB3' HG22 ' A' ' 108' ' ' VAL . 60.5 p-90 -155.77 167.41 30.48 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.082 0.468 . . . . 1.0 111.926 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -151.64 149.87 29.62 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.334 -1.303 . . . . 1.0 110.63 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.704 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.4 tp -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 t -126.59 131.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.561 -0.291 . . . . 1.0 110.549 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -81.65 172.08 13.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 26.3 t70 -57.84 -27.36 63.13 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.323 0.582 . . . . 1.0 110.792 177.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.1 -33.64 73.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.955 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.12 11.7 23.53 Favored Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.109 -0.95 . . . . 1.0 112.318 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -90.09 144.68 25.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.101 0.408 . . . . 1.0 112.101 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 50.6 mm -76.41 117.4 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.944 0.777 . . . . 1.0 109.137 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.704 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.0 mt -90.57 -43.96 9.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.6 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.51 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.48 158.48 44.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.692 -1.14 . . . . 1.0 111.02 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.64 154.99 51.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.421 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 16.3 p -52.9 -33.16 49.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.406 0.442 . . . . 1.0 112.159 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.35 -48.04 3.73 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -104.07 -175.38 2.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.913 -0.644 . . . . 1.0 111.406 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -149.25 137.77 6.48 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -144.34 168.47 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.96 0.38 . . . . 1.0 111.06 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.06 10.29 32.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.226 0.824 . . . . 1.0 113.226 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -125.83 132.53 52.21 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 111.076 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -64.77 -38.55 91.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.879 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 64.5 tt0 -61.17 -41.23 96.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.988 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.64 -41.21 94.47 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.555 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.985 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 145' ' ' ILE . 48.3 mtmt -63.63 -36.41 83.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.632 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.0 mm-40 -65.1 -25.49 67.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.2 -40.95 92.48 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 142' ' ' LYS . 67.7 mt -62.43 -44.53 99.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.8 -0.7 . . . . 1.0 109.766 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.55 -40.16 95.95 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.809 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -63.17 -35.39 80.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.007 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -73.68 -40.86 54.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 119.581 -0.848 . . . . 1.0 109.371 -178.286 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -68.06 -11.92 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.251 0.548 . . . . 1.0 110.768 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -97.73 -6.87 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.259 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -138.91 -37.51 0.52 Allowed 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -53.84 -50.68 82.47 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 56.8 Cg_endo -67.36 -6.21 15.82 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 121.307 1.338 . . . . 1.0 113.473 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.88 -26.96 5.9 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.247 0.546 . . . . 1.0 111.684 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -64.98 136.44 56.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.424 -0.807 . . . . 1.0 112.502 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.35 139.4 34.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.566 -1.197 . . . . 1.0 110.975 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.518 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -86.72 139.92 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.542 0.686 . . . . 1.0 112.584 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.7 mt -123.82 142.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.013 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -88.9 101.48 14.1 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.562 -0.732 . . . . 1.0 111.294 -177.582 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.515 0.198 . . . . 1.0 110.608 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -112.89 171.19 7.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.52 0.676 . . . . 1.0 112.252 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -144.94 97.12 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.17 -1.418 . . . . 1.0 107.17 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.98 177.41 1.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.958 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.476 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.8 p-80 -169.2 148.12 3.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.831 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 60.8 m-85 -86.16 150.12 24.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.836 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.16 117.59 10.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' B' ' 218' ' ' TRP . 88.9 t -93.5 134.53 30.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.958 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -145.75 179.76 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.312 . . . . 1.0 110.968 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.467 HG13 ' HA ' ' B' ' 214' ' ' ASP . 1.3 t -97.44 135.94 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.37 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.53 -179.11 7.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.055 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.05 -6.91 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.972 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.79 18.42 11.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.531 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.467 ' HA ' HG13 ' B' ' 210' ' ' VAL . 35.1 t70 69.83 43.69 0.92 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.47 1.128 . . . . 1.0 110.359 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.7 mmtt -113.51 150.23 33.21 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.749 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.06 116.32 28.71 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.799 -1.091 . . . . 1.0 109.988 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -134.03 178.29 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.528 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.1 p-90 -151.27 164.01 37.59 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.742 -0.383 . . . . 1.0 111.391 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' B' ' 219' ' ' ARG . 4.5 mtp-105 -146.63 145.76 30.17 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.913 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.699 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.5 tp -96.61 130.66 43.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 t -126.13 130.77 72.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.027 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' HIS . . . . . 0.434 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.1 t-80 -81.83 175.47 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.62 -36.81 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.414 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.13 -34.58 77.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.563 0.697 . . . . 1.0 110.503 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.63 12.33 17.02 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 114.97 -1.014 . . . . 1.0 112.203 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -87.06 143.33 27.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.056 0.391 . . . . 1.0 112.056 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.17 120.15 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 124.053 0.845 . . . . 1.0 109.911 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.699 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.9 mt -96.49 -43.96 7.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.703 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -150.46 162.3 40.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.489 -1.232 . . . . 1.0 111.135 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -137.65 152.93 49.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.972 -1.013 . . . . 1.0 108.442 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 79.8 p -55.25 -36.43 66.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.013 0.435 . . . . 1.0 111.416 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.25 -48.1 3.57 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 233' ' ' GLU . . . . . 0.417 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 14.9 mm-40 -98.01 171.76 8.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.78 -0.71 . . . . 1.0 111.563 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.11 135.82 6.23 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.349 -1.101 . . . . 1.0 110.349 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -141.86 178.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.066 0.433 . . . . 1.0 110.405 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -99.27 9.8 42.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.192 0.812 . . . . 1.0 113.192 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -125.86 131.83 52.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.2 0.524 . . . . 1.0 111.544 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.58 -39.13 93.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.164 -0.926 . . . . 1.0 110.448 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 53.8 tt0 -60.29 -43.82 95.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.224 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -59.52 -41.43 89.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.618 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.49 -51.08 71.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.064 0.459 . . . . 1.0 110.318 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.497 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.7 mtmt -63.59 -33.37 75.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.3 mm-40 -65.55 -30.38 71.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.425 -0.51 . . . . 1.0 109.72 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.14 96.42 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.509 ' O ' HG12 ' B' ' 248' ' ' VAL . 75.6 mt -61.62 -53.42 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.588 0.709 . . . . 1.0 110.535 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -61.37 -34.8 75.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.591 -0.731 . . . . 1.0 111.034 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.5 m -66.82 -37.64 84.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.389 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -70.72 -40.59 77.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.984 -0.687 . . . . 1.0 109.247 -177.637 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.72 -17.26 62.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 250' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 250' ' ' ARG . 8.4 ttt180 -104.07 -2.77 25.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.967 0.413 . . . . 1.0 111.033 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.82 -41.77 1.63 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.608 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.514 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.87 -50.68 85.81 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.503 -0.771 . . . . 1.0 112.852 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.3 Cg_endo -63.14 -15.14 46.16 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.232 1.288 . . . . 1.0 113.379 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.52 -19.94 11.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.925 0.393 . . . . 1.0 111.906 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.84 136.23 53.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.786 0.803 . . . . 1.0 112.507 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.81 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.125 -1.398 . . . . 1.0 110.988 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.576 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.0 OUTLIER -88.86 130.07 38.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.613 0.721 . . . . 1.0 112.621 179.084 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.3 mt -116.41 142.58 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.468 -1.242 . . . . 1.0 108.864 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -90.17 101.91 14.63 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.869 -0.586 . . . . 1.0 111.21 -177.137 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 48.0 ttp . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 121.166 0.508 . . . . 1.0 110.758 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -103.73 -178.38 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.494 -0.775 . . . . 1.0 112.033 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 46.8 mmtm -137.58 98.43 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.136 -1.393 . . . . 1.0 107.319 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.17 172.8 3.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.425 -0.807 . . . . 1.0 109.392 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.439 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 31.6 p-80 -172.02 149.41 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.154 0.283 . . . . 1.0 110.238 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 66.1 m-85 -86.11 153.63 21.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.483 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -141.66 117.68 10.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 118' ' ' TRP . 79.4 t -93.84 129.54 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -143.63 179.3 7.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.804 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -98.82 134.8 36.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.809 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.13 178.54 8.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.173 -0.922 . . . . 1.0 109.53 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.35 -16.83 64.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.165 0.507 . . . . 1.0 110.629 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.05 20.25 18.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.738 -0.664 . . . . 1.0 111.708 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 71.3 35.53 1.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.453 0.701 . . . . 1.0 111.398 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.2 mttt -109.61 150.27 28.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.159 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.06 109.38 20.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.006 -0.997 . . . . 1.0 109.264 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -126.15 176.91 6.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.526 ' HB3' HG22 ' A' ' 108' ' ' VAL . 49.8 p-90 -147.3 162.45 38.93 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.365 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.504 HH21 HG13 ' A' ' 127' ' ' ILE . 14.7 mmm-85 -144.5 142.18 30.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.157 -0.929 . . . . 1.0 109.635 -177.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.736 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.9 tp -98.79 131.61 44.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.238 -1.023 . . . . 1.0 108.238 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -130.78 132.97 63.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.542 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -81.81 174.71 11.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.7 t70 -56.11 -36.58 68.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.285 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -64.88 -33.45 76.04 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.551 0.691 . . . . 1.0 109.699 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 11.57 21.35 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 114.688 -1.142 . . . . 1.0 112.398 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -85.97 141.31 29.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.721 0.296 . . . . 1.0 111.587 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.504 HG13 HH21 ' A' ' 119' ' ' ARG . 47.6 mm -74.66 122.1 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.299 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.736 HD12 ' HG ' ' A' ' 120' ' ' LEU . 13.9 mt -98.17 -41.42 7.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.881 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.516 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.19 169.24 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.26 -0.882 . . . . 1.0 111.935 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -141.97 153.49 44.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.698 -1.137 . . . . 1.0 108.325 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.434 ' HA ' ' CE2' ' A' ' 118' ' ' TRP . 77.3 p -53.49 -34.49 58.25 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.005 0.431 . . . . 1.0 111.597 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.88 -40.45 3.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.652 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 93.9 mt-10 -110.82 174.85 5.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.307 -0.446 . . . . 1.0 110.78 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.85 136.67 6.74 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.311 -0.715 . . . . 1.0 111.311 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -144.54 177.53 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.733 0.266 . . . . 1.0 110.968 -177.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.36 9.67 42.32 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.773 0.657 . . . . 1.0 112.773 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 m -122.03 131.34 53.94 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.561 0.696 . . . . 1.0 111.451 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.96 -36.23 83.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.835 -1.075 . . . . 1.0 110.82 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 63.1 tt0 -63.31 -42.19 98.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.146 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -57.99 -41.26 82.64 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.689 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.2 70.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.194 0.521 . . . . 1.0 110.089 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.51 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.5 -36.77 85.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.682 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -64.0 -28.07 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.64 -41.91 95.73 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 142' ' ' LYS . 62.3 mt -63.48 -45.68 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.837 -0.682 . . . . 1.0 110.466 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.63 -40.43 94.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.871 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.4 m -66.8 -33.73 76.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.817 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.69 -40.39 54.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.037 -0.665 . . . . 1.0 109.948 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -68.17 -11.8 59.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 111.153 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.39 -8.61 26.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.289 -0.868 . . . . 1.0 109.691 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -134.39 -39.14 0.83 Allowed 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 113.482 0.919 . . . . 1.0 113.482 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.31 -49.18 91.92 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.837 0.68 . . . . 1.0 112.837 -177.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 53.7 Cg_endo -66.69 -7.06 17.01 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.32 1.347 . . . . 1.0 113.153 -177.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -122.44 -13.6 8.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.473 0.545 . . . . 1.0 112.473 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.27 135.21 44.43 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.748 0.785 . . . . 1.0 112.869 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -93.57 138.73 31.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.352 -1.295 . . . . 1.0 110.36 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.1 p -88.01 133.89 29.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 112.348 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.1 mt -119.84 143.81 30.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.275 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -87.71 107.14 18.49 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.227 -0.892 . . . . 1.0 110.883 -177.792 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 52.4 ttp . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.18 0.514 . . . . 1.0 110.697 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -102.09 177.19 4.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.642 -0.708 . . . . 1.0 112.319 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -133.47 98.92 4.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.392 -1.336 . . . . 1.0 107.392 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.4 170.23 3.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.75 -1.114 . . . . 1.0 108.694 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.454 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 47.7 p-80 -170.96 149.94 3.04 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.08 0.237 . . . . 1.0 110.497 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 54.9 m-85 -85.73 149.38 25.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.8 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -140.48 120.29 13.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.5 t -95.5 135.07 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.204 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -146.04 175.78 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 1.0 110.734 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 5.3 t -99.9 133.45 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 1.0 111.965 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.65 179.79 7.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.81 -1.086 . . . . 1.0 109.5 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.02 -17.96 64.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.95 0.405 . . . . 1.0 111.325 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.55 21.8 16.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.909 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 70.46 36.15 1.79 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 111.121 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -109.91 143.93 39.12 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.794 . . . . 1.0 111.185 -176.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.77 106.09 18.12 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.222 -1.354 . . . . 1.0 109.567 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -118.3 178.04 4.59 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.537 ' HB3' HG22 ' B' ' 208' ' ' VAL . 52.4 p-90 -147.8 167.33 25.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.459 0.647 . . . . 1.0 111.979 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -146.25 146.5 30.78 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.422 -1.263 . . . . 1.0 110.432 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.75 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.7 tp -105.53 130.69 53.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 174.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.06 132.96 66.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.919 -175.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -82.93 173.76 11.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.292 -0.632 . . . . 1.0 109.292 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.87 -36.87 68.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.08 0.467 . . . . 1.0 110.698 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.2 -32.96 74.49 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.296 -178.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.22 11.22 24.36 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 114.769 -1.105 . . . . 1.0 112.45 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -86.57 143.2 27.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.789 -0.206 . . . . 1.0 111.359 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.462 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.37 116.39 22.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.53 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.75 HD12 ' HG ' ' B' ' 220' ' ' LEU . 17.0 mt -88.73 -42.8 11.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.019 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -149.52 168.31 23.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.054 -0.975 . . . . 1.0 111.625 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -141.67 156.3 45.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.09 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 66.0 p -54.37 -35.14 62.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.0 0.37 . . . . 1.0 112.0 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.74 -33.68 3.47 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.045 -0.598 . . . . 1.0 111.761 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -122.89 178.57 4.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 1.0 111.174 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -143.01 137.43 7.67 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.337 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -140.01 166.71 23.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.814 -0.439 . . . . 1.0 109.814 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.02 29.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.8 m -126.26 131.84 51.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.325 0.583 . . . . 1.0 111.347 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.17 -35.93 81.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.034 -0.985 . . . . 1.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 61.5 tt0 -57.86 -47.22 83.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.251 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -59.9 -40.43 88.76 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.124 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.52 74.57 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.587 0.708 . . . . 1.0 109.533 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.499 ' HA ' HD12 ' B' ' 245' ' ' ILE . 49.3 mtmt -64.38 -35.54 81.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.528 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.2 mm-40 -64.22 -31.24 72.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.79 -41.11 95.86 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' B' ' 242' ' ' LYS . 65.6 mt -62.4 -43.86 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.064 -0.568 . . . . 1.0 110.278 177.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.9 -41.58 99.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.193 0.52 . . . . 1.0 110.141 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.7 m -64.38 -34.36 77.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.981 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.48 -41.33 49.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.968 -177.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -66.89 -11.86 57.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.035 0.445 . . . . 1.0 111.798 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -2.92 31.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.905 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -135.36 -42.74 0.7 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.77 0.656 . . . . 1.0 112.77 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -53.64 -48.34 93.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.1 Cg_endo -64.23 -10.6 24.18 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.036 1.158 . . . . 1.0 113.079 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.49 -22.12 7.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.373 0.508 . . . . 1.0 112.373 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.95 134.88 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.654 0.74 . . . . 1.0 112.736 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.47 142.08 29.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.423 -1.262 . . . . 1.0 110.691 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -89.13 134.18 29.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.8 mt -112.23 139.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.662 -1.154 . . . . 1.0 108.695 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.0 100.24 12.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.311 -0.852 . . . . 1.0 110.984 -177.783 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.8 ppp? . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 112.187 0.44 . . . . 1.0 112.187 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -107.54 170.55 7.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.223 0.535 . . . . 1.0 111.905 -176.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 2.5 mptp? -123.34 95.11 4.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 173.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.76 174.86 2.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.03 -0.987 . . . . 1.0 108.979 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -170.29 147.88 3.15 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.573 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 58.3 m-85 -86.15 150.18 24.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.258 177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -141.46 121.46 13.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.413 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.3 t -93.67 133.87 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.068 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.77 178.49 7.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.633 0.254 . . . . 1.0 110.414 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -100.53 136.79 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.772 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.03 -178.97 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.31 -13.01 62.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.651 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.14 19.58 17.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.962 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 71.0 38.25 1.14 Allowed 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.275 -0.875 . . . . 1.0 111.182 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 3.1 mmtp -108.91 153.29 23.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.804 -1.089 . . . . 1.0 111.219 -175.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -95.01 118.14 31.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.232 -0.895 . . . . 1.0 109.666 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -133.59 -179.03 5.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.107 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.504 ' HB3' HG22 ' A' ' 108' ' ' VAL . 58.7 p-90 -151.31 162.1 41.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.884 0.373 . . . . 1.0 111.455 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.45 HH21 HG13 ' A' ' 127' ' ' ILE . 36.3 mmm-85 -144.37 139.91 28.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.725 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.4 tp -96.94 131.44 43.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 176.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.0 t -131.07 132.34 63.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.054 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -78.31 172.9 12.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 30.3 t70 -57.95 -30.93 66.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.207 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.513 ' HB2' ' ND2' ' A' ' 126' ' ' ASN . 0.5 OUTLIER -72.14 -33.68 67.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.94 -177.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.03 13.84 10.59 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.244 -0.889 . . . . 1.0 113.836 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 124' ' ' ASN . 0.7 OUTLIER -87.85 143.68 27.0 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.075 0.15 . . . . 1.0 110.717 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.45 HG13 HH21 ' A' ' 119' ' ' ARG . 44.6 mm -76.36 115.13 17.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.722 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.1 mt -88.4 -42.25 12.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.789 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.504 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.05 170.53 20.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.283 -0.871 . . . . 1.0 111.582 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.962 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -53.52 -36.43 61.77 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.416 0.447 . . . . 1.0 111.896 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.76 -43.54 3.25 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.529 -0.628 . . . . 1.0 111.529 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 89.2 mt-10 -108.88 179.93 4.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.293 -0.454 . . . . 1.0 110.826 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.86 134.54 4.51 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -142.88 170.94 14.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 117.077 0.439 . . . . 1.0 110.637 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.06 24.65 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 m -118.63 131.11 56.18 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.362 0.601 . . . . 1.0 111.478 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -65.87 -33.67 76.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.803 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 61.7 tt0 -61.33 -48.48 81.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.971 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -56.82 -40.49 76.13 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.982 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.18 -53.38 58.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.239 0.543 . . . . 1.0 110.217 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 145' ' ' ILE . 41.7 mtmt -63.82 -36.72 84.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.238 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.8 mm-40 -63.79 -28.8 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 1.0 110.021 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.51 96.74 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.551 HG21 HG22 ' B' ' 257' ' ' VAL . 40.4 mt -64.11 -44.6 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.208 0.528 . . . . 1.0 110.133 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -60.34 -43.99 95.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.401 . . . . 1.0 110.149 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.4 m -64.37 -33.82 76.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.724 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' B' ' 229' ' ' ALA . 0.3 OUTLIER -74.43 -41.86 49.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.151 -0.62 . . . . 1.0 109.822 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -68.74 -11.57 60.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.085 0.469 . . . . 1.0 111.588 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -101.25 -3.14 29.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.928 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' B' ' 204' ' ' ALA . 23.0 m-80 -138.07 -38.63 0.56 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -176.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.42 -49.92 89.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 54.3 Cg_endo -67.57 -9.52 25.67 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 120.906 1.071 . . . . 1.0 112.95 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -109.8 -28.68 8.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.445 0.641 . . . . 1.0 110.927 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.08 135.8 57.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.873 -1.058 . . . . 1.0 113.671 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -96.59 140.65 30.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.064 -1.426 . . . . 1.0 110.716 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.557 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.58 133.11 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.352 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.3 mt -118.21 139.24 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 114.766 -1.106 . . . . 1.0 108.933 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -88.16 106.04 17.92 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.533 -0.746 . . . . 1.0 111.164 -177.349 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.1 ppp? . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 111.602 0.223 . . . . 1.0 111.602 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -94.64 167.24 11.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.339 0.59 . . . . 1.0 111.512 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 32.4 mmtp -136.98 97.88 3.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 204' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . . . -174.31 169.19 3.87 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.86 -1.064 . . . . 1.0 109.183 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.479 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 55.8 p-80 -171.34 149.1 2.7 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 61.8 m-85 -85.34 148.06 26.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.299 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -139.57 118.83 12.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.482 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' B' ' 218' ' ' TRP . 82.3 t -93.92 133.23 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.677 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -145.36 -178.4 6.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.648 0.261 . . . . 1.0 110.555 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.8 t -99.8 137.43 27.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.623 . . . . 1.0 112.238 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.07 179.78 7.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.565 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.31 -16.36 63.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.473 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.49 19.84 18.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.182 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 214' ' ' ASP . . . . . 0.404 ' HA ' HG13 ' B' ' 210' ' ' VAL . 24.4 m-20 69.28 41.26 1.37 Allowed 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.857 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 3.2 mmtp -110.95 156.51 21.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.266 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -99.82 117.03 33.27 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.854 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 20.6 mtp-105 -132.42 179.11 6.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.527 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.7 p-90 -151.72 163.66 38.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.079 0.466 . . . . 1.0 111.649 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -147.29 145.96 29.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.05 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.725 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.0 tp -96.28 131.85 42.36 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.19 133.79 62.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.738 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -79.77 171.31 15.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 36.6 t70 -62.54 -22.18 66.12 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.152 0.501 . . . . 1.0 110.851 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.34 -33.21 67.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.521 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.85 11.26 19.4 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 114.791 -1.095 . . . . 1.0 112.86 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.27 142.92 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.655 0.264 . . . . 1.0 111.572 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.477 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.55 116.81 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.491 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.725 HD12 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -89.58 -42.53 11.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.734 . . . . 1.0 109.638 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.18 164.97 35.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.845 -1.071 . . . . 1.0 111.597 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -140.67 153.37 45.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.238 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.443 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.6 p -52.88 -36.9 59.87 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.03 -47.31 3.51 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -96.74 -172.86 2.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.265 -0.468 . . . . 1.0 111.25 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -159.05 133.86 3.55 Favored Glycine 0 N--CA 1.454 -0.16 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -145.07 169.85 17.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.93 0.365 . . . . 1.0 110.338 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.38 9.11 41.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.708 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 m -116.0 129.53 56.41 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.425 0.631 . . . . 1.0 110.928 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -66.97 -34.5 77.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.951 -1.022 . . . . 1.0 110.364 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 61.8 tt0 -61.12 -46.12 91.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.255 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.66 -40.55 83.82 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.788 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.11 70.62 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.482 0.658 . . . . 1.0 110.127 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.509 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.4 mtmt -64.6 -37.0 86.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.91 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -64.05 -29.58 70.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -64.97 -41.37 97.37 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.462 -1.055 . . . . 1.0 110.462 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' B' ' 242' ' ' LYS . 56.8 mt -62.48 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 1.0 110.193 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -63.06 -40.11 96.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.3 m -65.62 -35.39 80.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.633 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -75.3 -39.96 42.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.069 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 63.8 mtpt -66.79 -12.51 59.14 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.987 0.365 . . . . 1.0 111.987 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -100.27 -12.12 19.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.843 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -120.97 -40.14 2.65 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.103 -0.499 . . . . 1.0 112.18 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.0 -48.94 94.78 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.5 Cg_endo -66.87 -11.69 33.09 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.276 1.317 . . . . 1.0 113.399 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -116.0 -16.76 11.05 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' ALA . . . . . . . . . . . . . . . -69.22 139.05 54.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.805 0.669 . . . . 1.0 112.805 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -94.88 147.41 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.666 -1.152 . . . . 1.0 111.99 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 145' ' ' ILE . 40.9 t -84.39 130.45 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.438 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.2 mt -128.85 142.47 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.541 -0.541 . . . . 1.0 109.541 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.9 113.17 22.46 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.203 -0.903 . . . . 1.0 110.843 -177.838 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.1 tmt? . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.06 -0.019 . . . . 1.0 110.968 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 101' ' ' MET . 12.6 p-10 171.03 168.65 0.08 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.117 0.886 . . . . 1.0 109.942 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 38.7 mmtm -145.28 96.36 2.82 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 173.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.13 176.44 1.73 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.01 -0.996 . . . . 1.0 109.533 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.504 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.9 p-80 -170.23 145.42 2.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.439 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.1 m-85 -85.51 147.61 26.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.146 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.68 119.97 13.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.592 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 118' ' ' TRP . 86.1 t -95.21 132.27 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.164 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -143.14 178.08 7.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.1 t -97.82 134.18 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.215 0.531 . . . . 1.0 111.562 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.22 -180.0 7.06 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 1.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.51 -15.3 63.49 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.942 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.63 21.47 16.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.713 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 69.75 35.85 2.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.626 0.77 . . . . 1.0 111.506 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -110.84 149.55 30.42 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.881 -176.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -91.63 112.0 23.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.801 -1.09 . . . . 1.0 109.537 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.481 HH12 ' CG ' ' A' ' 130' ' ' ASP . 19.2 mtm105 -126.8 179.92 5.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.541 ' HB3' HG22 ' A' ' 108' ' ' VAL . 55.8 p-90 -152.1 162.11 41.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.187 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 42.6 mtp180 -148.23 143.66 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.146 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.662 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.7 tp -93.62 134.39 35.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.3 131.02 71.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.896 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.473 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.9 t-80 -78.97 171.74 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 12.0 t70 -56.0 -33.59 65.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.003 0.43 . . . . 1.0 111.216 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -34.34 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.13 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.36 10.92 14.2 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.124 -0.944 . . . . 1.0 113.09 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -90.22 145.84 24.71 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.52 0.192 . . . . 1.0 111.52 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.5 123.55 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 123.778 0.674 . . . . 1.0 109.926 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.662 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.1 mt -98.07 -43.47 7.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.067 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -147.7 164.58 33.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.983 -1.008 . . . . 1.0 111.336 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.481 ' CG ' HH12 ' A' ' 117' ' ' ARG . 6.8 t70 -139.7 152.82 46.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.246 -0.888 . . . . 1.0 108.86 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.7 p -56.32 -38.41 71.26 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.31 0.485 . . . . 1.0 112.31 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.43 -42.66 3.17 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -94.52 172.14 8.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.152 -0.524 . . . . 1.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.63 124.67 1.52 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -142.05 171.05 14.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.714 0.257 . . . . 1.0 110.742 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.43 10.24 20.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.265 0.839 . . . . 1.0 113.265 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 m -120.0 130.71 54.86 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.529 0.68 . . . . 1.0 111.636 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.52 -35.41 80.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.485 -1.234 . . . . 1.0 110.333 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 51.2 tt0 -62.02 -45.96 91.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.484 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -59.9 -39.15 84.4 Favored 'General case' 0 CA--C 1.521 -0.163 0 O-C-N 123.2 0.313 . . . . 1.0 110.883 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.48 69.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.604 0.716 . . . . 1.0 109.786 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.0 mtmt -64.91 -33.77 76.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.561 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -65.64 -32.36 73.88 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 1.0 110.03 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.5 -39.87 97.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.552 HG21 HG22 ' B' ' 257' ' ' VAL . 67.4 mt -60.24 -51.49 72.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.529 0.681 . . . . 1.0 110.758 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.83 -33.03 75.04 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.5 m -66.03 -37.64 86.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.535 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' B' ' 229' ' ' ALA . 1.1 p -74.42 -40.0 48.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 120.399 -0.521 . . . . 1.0 109.846 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.61 -15.77 61.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.958 0.408 . . . . 1.0 111.871 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -100.1 -2.48 34.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.916 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 11.8 m-80 -133.74 -37.08 0.93 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.903 -177.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.85 -50.47 86.97 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.365 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.7 Cg_endo -64.44 -12.07 31.44 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 121.29 1.327 . . . . 1.0 113.419 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.13 -18.58 9.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.179 0.437 . . . . 1.0 112.179 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -66.03 135.71 55.04 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.484 0.659 . . . . 1.0 112.337 -177.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.78 132.39 34.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.585 -1.189 . . . . 1.0 110.919 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.41 130.79 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.462 0.648 . . . . 1.0 111.698 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt -120.32 145.84 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.474 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -89.39 102.39 15.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.606 -0.712 . . . . 1.0 110.549 -177.535 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 29.3 ttp . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.29 -0.263 . . . . 1.0 110.29 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 202' ' ' ASN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 21.1 p-10 -178.69 171.85 1.45 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.515 0.674 . . . . 1.0 112.323 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -138.92 96.32 3.1 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.093 -1.817 . . . . 1.0 106.093 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.81 175.69 2.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.638 -1.165 . . . . 1.0 108.612 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.47 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.5 p-80 -170.04 146.99 3.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.054 -0.259 . . . . 1.0 110.575 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.538 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 46.8 m-85 -87.11 146.69 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.479 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.65 121.4 13.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.856 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' B' ' 218' ' ' TRP . 96.3 t -94.27 133.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.767 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -144.48 -179.55 6.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.572 0.225 . . . . 1.0 110.582 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.7 t -96.14 133.48 37.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.138 -0.483 . . . . 1.0 112.232 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -81.74 178.34 8.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.928 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.37 -6.92 38.89 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.314 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.28 17.91 16.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.995 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 69.57 39.19 1.6 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.94 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 13.2 mmtt -111.04 156.88 20.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.121 -0.945 . . . . 1.0 111.217 -175.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.464 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 70.6 m-85 -98.74 102.53 14.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.799 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.581 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 14.9 mmm180 -121.5 179.82 4.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.518 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.5 p-90 -150.94 160.48 43.89 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.802 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -145.95 146.35 31.01 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.091 -0.959 . . . . 1.0 109.666 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.705 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.1 tp -95.78 132.63 40.81 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 t -127.41 130.12 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.354 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' HIS . . . . . 0.433 ' HB2' HD21 ' B' ' 228' ' ' LEU . 1.9 t-80 -82.51 173.66 11.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.26 -36.34 63.51 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.38 0.425 . . . . 1.0 111.913 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -65.08 -31.12 72.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.22 0.533 . . . . 1.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.31 13.86 21.77 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.375 -0.829 . . . . 1.0 112.41 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -89.41 142.08 27.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 111.789 0.292 . . . . 1.0 111.789 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.53 121.73 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.882 0.739 . . . . 1.0 109.564 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.705 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.5 mt -96.92 -43.8 7.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.228 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -150.83 163.88 37.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.419 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.38 160.07 40.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.383 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.468 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 83.6 p -60.24 -40.71 91.22 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.52 -48.38 2.59 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.285 -0.483 . . . . 1.0 112.669 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -94.75 -169.78 2.09 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.231 0.612 . . . . 1.0 110.936 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.581 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -156.75 136.43 4.95 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.715 -0.755 . . . . 1.0 113.289 176.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -143.92 168.66 19.43 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.396 -0.594 . . . . 1.0 109.396 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.49 11.43 36.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -127.0 135.02 50.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.207 -0.597 . . . . 1.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.14 -39.6 93.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.148 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 50.5 tt0 -57.65 -45.72 85.15 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.287 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -60.94 -39.53 89.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.787 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 241' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' B' ' 216' ' ' TYR . . . -58.2 -49.7 76.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.472 0.653 . . . . 1.0 110.231 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.565 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -64.81 -32.8 74.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.112 -0.949 . . . . 1.0 111.47 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.8 mm-40 -63.6 -33.02 74.69 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.588 -0.445 . . . . 1.0 109.916 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.78 95.31 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' B' ' 242' ' ' LYS . 75.9 mt -60.73 -52.36 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.664 0.745 . . . . 1.0 110.258 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.29 -33.97 77.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.264 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.4 m -67.61 -35.9 79.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.511 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -72.49 -40.47 63.53 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.373 -177.676 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.59 -15.45 61.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.121 -0.49 . . . . 1.0 112.187 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -103.35 -2.75 26.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.866 0.365 . . . . 1.0 111.3 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 28.6 m-80 -130.46 -38.37 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 111.452 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.548 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.86 -50.49 86.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.681 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.5 Cg_endo -63.24 -10.98 23.1 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.273 1.315 . . . . 1.0 113.663 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.11 -15.92 9.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.963 0.411 . . . . 1.0 111.938 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.22 138.65 57.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.68 0.752 . . . . 1.0 112.633 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -89.21 141.68 28.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.938 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 145' ' ' ILE . 60.6 t -83.74 128.66 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.432 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 12.3 mt -121.71 138.14 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -91.74 100.87 13.5 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.303 -0.856 . . . . 1.0 111.675 -176.699 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 28.9 ttp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.904 0.383 . . . . 1.0 111.455 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -92.94 -174.42 3.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.321 1.058 . . . . 1.0 113.579 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 28.8 mmtp -138.25 98.19 3.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.987 -1.915 . . . . 1.0 107.461 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.1 169.89 3.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.466 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.6 p-80 -168.22 150.34 5.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.233 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 63.7 m-85 -86.73 148.95 25.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.906 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.27 123.83 14.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.785 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 118' ' ' TRP . 91.1 t -94.75 134.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 O-C-N 123.585 0.553 . . . . 1.0 110.475 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -142.78 178.61 7.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.608 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -100.67 140.24 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.478 0.656 . . . . 1.0 112.689 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.83 177.87 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.416 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.57 -14.36 62.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.362 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.01 17.89 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.11 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 70.82 34.77 1.91 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.377 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -109.7 152.99 24.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.507 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.72 112.11 23.9 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.016 -0.993 . . . . 1.0 110.612 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -123.18 179.28 4.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.524 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.6 p-90 -153.02 168.47 25.74 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.366 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 22.6 mtt180 -150.76 152.28 33.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.508 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.681 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.9 tp -99.84 131.23 45.94 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -126.54 130.48 71.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.289 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -79.67 172.35 13.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 32.2 t70 -57.22 -30.98 65.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 1.0 111.342 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -33.37 74.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.504 0.669 . . . . 1.0 110.07 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.38 11.74 19.06 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 114.982 -1.008 . . . . 1.0 112.789 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -88.59 143.51 26.9 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.67 119.07 22.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.802 0.689 . . . . 1.0 109.744 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.681 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.0 mt -94.41 -43.31 8.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.63 0.729 . . . . 1.0 109.608 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.73 166.61 27.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.641 -1.163 . . . . 1.0 111.201 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -140.14 158.19 44.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 53.9 p -57.44 -35.23 69.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.448 . . . . 1.0 111.452 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.7 -48.62 3.54 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -102.87 171.8 7.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.374 -0.913 . . . . 1.0 111.648 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.04 139.06 9.29 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.236 -1.145 . . . . 1.0 110.236 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -141.53 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.175 0.488 . . . . 1.0 110.852 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.57 9.98 27.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -125.82 130.53 51.59 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.727 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 21.2 ptmt -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.104 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 64.1 tt0 -59.41 -42.14 91.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.962 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.4 OUTLIER -62.62 -39.78 94.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.005 -179.053 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.33 87.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.962 0.411 . . . . 1.0 109.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' A' ' 145' ' ' ILE . 7.3 mtmp? -63.86 -43.19 96.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.117 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 13.7 mm100 -60.01 -27.05 66.56 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.69 -46.32 90.22 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 148' ' ' VAL . 61.1 mt -62.51 -48.82 86.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.946 0.879 . . . . 1.0 109.938 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.53 -40.04 90.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.287 -0.869 . . . . 1.0 110.857 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -69.93 -34.55 73.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.213 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -70.5 -39.13 75.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 C-N-CA 120.08 -0.648 . . . . 1.0 110.033 -176.788 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.79 -12.98 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.975 -0.453 . . . . 1.0 111.516 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -104.69 -3.1 24.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.656 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -129.87 -42.76 1.25 Allowed 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.305 -0.407 . . . . 1.0 112.068 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.06 -50.94 83.58 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.9 Cg_endo -64.48 -13.15 36.9 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.129 1.219 . . . . 1.0 112.952 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.2 -27.56 9.5 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.324 0.583 . . . . 1.0 111.23 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 134.83 55.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.071 -0.968 . . . . 1.0 113.207 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.25 141.02 31.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.982 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -86.99 135.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.679 . . . . 1.0 112.344 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt -124.19 148.87 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.7 -1.136 . . . . 1.0 109.241 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.09 110.67 20.82 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.942 -0.762 . . . . 1.0 108.942 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.321 -0.847 . . . . 1.0 111.357 -177.191 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.933 0.396 . . . . 1.0 111.497 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -95.62 178.78 5.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.931 0.872 . . . . 1.0 112.805 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 22.7 mmtp -141.74 97.6 3.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.68 -1.6 . . . . 1.0 108.142 173.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.65 170.75 3.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.147 -0.933 . . . . 1.0 109.679 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.423 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 55.1 p-80 -170.01 147.79 3.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.0 m-85 -85.62 150.71 24.44 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.332 0.395 . . . . 1.0 110.383 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -143.09 124.3 14.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.862 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.2 t -95.08 133.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.937 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.8 -178.21 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.663 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -110.89 137.72 42.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.358 0.503 . . . . 1.0 112.358 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 25.4 t70 -83.25 -178.77 7.2 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.583 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 212' ' ' ALA . . . . . 0.41 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.63 -17.92 64.2 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.954 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.85 25.62 11.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 62.07 38.96 13.57 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.859 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -97.44 155.53 16.88 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.469 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 73.4 m-85 -109.05 102.92 11.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.311 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.568 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -122.54 -178.56 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -176.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.488 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.8 p-90 -151.29 162.83 40.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.768 0.318 . . . . 1.0 111.384 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -147.56 146.71 29.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.677 ' HG ' HD12 ' B' ' 228' ' ' LEU . 35.2 tp -93.86 132.68 38.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.92 129.88 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.66 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' HIS . . . . . 0.4 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.4 t-80 -80.04 174.54 11.49 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 223' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 26.7 t70 -55.93 -34.34 65.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.018 0.437 . . . . 1.0 111.46 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -65.96 -33.65 76.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.646 0.736 . . . . 1.0 110.324 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.01 10.7 22.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.967 -1.015 . . . . 1.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -87.02 143.49 27.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.593 0.235 . . . . 1.0 111.626 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -76.29 119.81 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.665 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.677 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.5 mt -94.19 -44.14 8.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.987 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -147.79 160.78 42.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.711 -1.131 . . . . 1.0 111.02 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.07 158.83 43.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.471 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 71.7 p -57.63 -37.37 73.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.49 0.552 . . . . 1.0 112.49 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.51 -50.56 3.55 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 121.184 0.325 . . . . 1.0 112.691 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -89.86 -168.67 2.2 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.409 0.684 . . . . 1.0 110.863 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.568 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -158.98 134.4 3.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.55 -0.833 . . . . 1.0 113.4 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.46 173.73 11.37 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.56 12.31 35.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.2 m -131.03 135.69 47.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.934 -0.706 . . . . 1.0 111.842 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.84 -39.65 95.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.032 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 55.4 tt0 -56.52 -44.01 80.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.494 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.32 -39.22 86.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.72 87.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.527 ' HA ' HD12 ' B' ' 245' ' ' ILE . 6.9 mtmp? -64.98 -37.78 88.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.765 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.46 -41.2 77.99 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.475 -0.869 . . . . 1.0 111.006 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.6 mt -60.19 -48.59 87.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.9 0.857 . . . . 1.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.49 -35.95 82.14 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.756 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.9 m -67.07 -37.1 83.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.402 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -72.55 -41.66 63.63 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.593 -177.747 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.24 -13.63 60.66 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.125 -0.359 . . . . 1.0 111.585 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -103.73 -2.64 26.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.839 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -130.85 -40.46 1.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.993 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.34 -50.53 86.16 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.6 Cg_endo -64.92 -16.6 56.21 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.208 1.272 . . . . 1.0 112.905 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.69 -29.8 11.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.588 0.709 . . . . 1.0 111.146 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -63.92 141.05 58.91 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.201 1.186 . . . . 1.0 114.201 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -103.47 146.38 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.096 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.4 p -93.27 132.05 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -120.64 150.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.187 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -85.02 108.16 17.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.328 -177.715 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.5 tmt? . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.504 0.192 . . . . 1.0 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -70.64 165.87 21.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.165 0.507 . . . . 1.0 111.877 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 47.5 mmtm -134.49 95.98 3.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -176.39 179.19 1.23 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.107 -0.952 . . . . 1.0 109.085 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.464 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 24.7 p-80 -171.69 147.9 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.383 0.427 . . . . 1.0 110.066 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 59.1 m-85 -85.47 152.05 23.49 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.832 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -140.62 120.22 13.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 118' ' ' TRP . 99.0 t -97.6 134.67 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.516 0.51 . . . . 1.0 109.738 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.37 178.28 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 110.611 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -99.39 134.12 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.455 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.55 179.85 7.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.02 62.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.478 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.76 19.2 18.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 70.91 36.42 1.49 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.742 0.651 . . . . 1.0 110.739 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.1 mmtt -109.3 150.51 27.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.289 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.07 111.72 23.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.369 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 mtm105 -128.76 179.13 5.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.537 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.6 p-90 -150.63 166.5 30.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 1.0 111.977 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -146.82 149.24 32.93 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.868 -1.06 . . . . 1.0 110.213 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.681 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.1 tp -100.56 133.17 45.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.58 130.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.048 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.424 ' HB2' HD21 ' A' ' 128' ' ' LEU . 3.3 t-80 -76.47 170.45 16.36 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.1 t70 -60.55 -24.18 65.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.116 0.484 . . . . 1.0 110.663 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -34.3 69.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.783 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 8.97 17.34 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.036 -0.983 . . . . 1.0 113.386 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -89.62 143.36 26.87 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.1 0.408 . . . . 1.0 112.1 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.6 mm -73.83 118.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.811 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.681 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.4 mt -94.13 -44.12 8.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.491 0.662 . . . . 1.0 109.818 -178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.56 165.1 34.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.285 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.6 154.4 47.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 20.7 p -51.86 -40.75 61.09 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.389 0.514 . . . . 1.0 112.389 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 -46.46 3.01 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -93.97 -178.84 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 1.0 110.597 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.74 127.63 2.14 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.253 -1.139 . . . . 1.0 110.253 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -139.8 173.23 11.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.311 0.556 . . . . 1.0 110.075 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.87 9.53 42.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.23 131.33 56.38 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.198 -0.601 . . . . 1.0 110.949 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.11 -38.4 90.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.819 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 52.2 tt0 -63.33 -42.81 99.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.149 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.523 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -58.07 -42.77 86.26 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.985 -177.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.11 75.24 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.17 0.509 . . . . 1.0 110.524 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.2 mtmt -63.8 -35.22 79.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.736 -0.666 . . . . 1.0 111.165 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.0 mm-40 -65.09 -26.83 68.39 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.19 97.13 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.04 -1.224 . . . . 1.0 110.04 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.509 HG21 HG22 ' B' ' 257' ' ' VAL . 55.8 mt -63.11 -45.15 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.194 0.521 . . . . 1.0 109.99 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.12 -38.28 88.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.093 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.8 m -65.3 -36.17 83.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.565 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.88 -42.37 46.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.474 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.99 -15.32 62.91 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.287 0.477 . . . . 1.0 112.287 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -103.61 -2.04 27.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.536 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -131.87 -40.07 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.574 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.51 -50.41 87.9 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.89 -0.596 . . . . 1.0 112.606 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 33.7 Cg_endo -63.4 -12.8 32.43 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.096 1.198 . . . . 1.0 113.162 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.97 -26.26 8.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.999 0.428 . . . . 1.0 111.574 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.4 137.99 58.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.698 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -94.75 149.48 21.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.186 -1.37 . . . . 1.0 111.976 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.551 HG22 HG21 ' B' ' 245' ' ' ILE . 43.9 t -86.17 131.67 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.537 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt -128.48 138.21 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -88.94 109.04 19.9 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.194 -0.907 . . . . 1.0 112.028 -176.44 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.674 0.273 . . . . 1.0 110.416 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -79.3 169.39 18.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 1.0 111.525 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -138.43 97.03 3.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.06 171.58 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.522 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 205' ' ' HIS . . . . . 0.539 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.9 p-80 -170.21 148.54 3.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.91 177.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.8 m-85 -87.05 148.82 25.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -141.72 122.38 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.788 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 208' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' B' ' 218' ' ' TRP . 97.7 t -96.6 133.96 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.623 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -145.15 -178.66 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.0 110.749 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.6 t -100.33 135.74 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.064 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -83.02 178.02 8.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.444 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.56 -9.98 52.91 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.256 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.85 20.14 15.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.503 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 69.59 38.13 1.79 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.115 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.9 mmtt -108.16 151.67 25.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.539 -176.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 216' ' ' TYR . . . . . 0.445 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 81.9 m-85 -98.25 102.7 14.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.162 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.588 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -120.26 179.37 4.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.365 0.415 . . . . 1.0 109.975 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 218' ' ' TRP . . . . . 0.531 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.0 p-90 -151.12 163.24 39.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.696 0.284 . . . . 1.0 111.62 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 36.3 mtp85 -148.25 145.0 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.99 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 220' ' ' LEU . . . . . 0.69 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.7 tp -97.62 135.01 40.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' HIS . . . . . 0.483 ' HB2' HD21 ' B' ' 228' ' ' LEU . 2.3 t-80 -84.78 177.23 8.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.645 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.01 -38.01 67.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.342 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.63 -33.12 74.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.572 0.701 . . . . 1.0 109.941 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 107.98 12.61 21.84 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.279 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -86.15 142.76 28.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.524 0.202 . . . . 1.0 111.334 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.5 mm -74.6 117.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 228' ' ' LEU . . . . . 0.69 HD12 ' HG ' ' B' ' 220' ' ' LEU . 21.3 mt -89.38 -43.16 11.1 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.076 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 229' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.63 159.51 44.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.533 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -134.66 155.49 50.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 231' ' ' SER . . . . . 0.493 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 79.5 p -55.79 -40.53 72.79 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.731 0.641 . . . . 1.0 112.731 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.68 -52.52 3.0 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.269 -0.491 . . . . 1.0 112.692 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.01 -169.31 2.52 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.347 0.659 . . . . 1.0 110.707 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.588 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -160.06 132.24 2.91 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.926 -0.654 . . . . 1.0 112.675 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.36 170.6 15.39 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 116.72 0.26 . . . . 1.0 110.423 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.73 10.48 38.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.673 0.99 . . . . 1.0 113.673 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.5 m -122.07 132.08 54.31 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.035 -0.666 . . . . 1.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.37 -35.82 82.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.372 -0.831 . . . . 1.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 239' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 52.7 tt0 -60.08 -47.23 86.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.739 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -61.52 -36.02 79.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.03 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.74 -49.87 75.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.406 0.622 . . . . 1.0 109.602 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' LYS . . . . . 0.499 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -65.47 -35.85 82.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.925 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 243' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.5 mm-40 -63.51 -29.65 70.88 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.67 96.77 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 157' ' ' VAL . 53.1 mt -63.13 -45.61 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.054 -0.573 . . . . 1.0 109.925 177.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.81 -39.07 90.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.183 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 m -66.39 -34.86 78.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.677 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -74.95 -43.21 45.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 120.27 -0.572 . . . . 1.0 110.289 -177.46 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -66.08 -11.96 52.22 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.104 -0.373 . . . . 1.0 111.946 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -100.72 -3.25 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -135.9 -36.97 0.74 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.828 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -54.52 -49.87 88.56 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.833 -0.622 . . . . 1.0 112.659 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 253' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.1 Cg_endo -63.81 -11.52 27.2 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.691 1.594 . . . . 1.0 113.8 -177.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.93 -14.48 8.46 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -68.04 137.16 54.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.444 0.64 . . . . 1.0 112.266 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -93.81 147.85 22.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.864 -1.062 . . . . 1.0 111.942 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 145' ' ' ILE . 40.8 t -84.61 132.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.281 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.1 134.22 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -87.13 100.48 12.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.466 -0.778 . . . . 1.0 110.97 -177.294 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 . . . . . 0 CA--C 1.517 -0.318 0 CA-C-O 121.216 0.531 . . . . 1.0 110.915 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 33.5 mmtp -140.13 98.31 3.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.65 172.33 3.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.627 -0.715 . . . . 1.0 109.904 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.503 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 52.3 p-80 -169.48 146.5 3.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.01 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.2 m-85 -85.0 145.57 27.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.592 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.98 124.26 20.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.346 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' A' ' 118' ' ' TRP . 62.6 t -96.48 133.78 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.449 -0.342 . . . . 1.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -142.95 179.72 6.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.027 0.205 . . . . 1.0 110.776 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.6 t -101.75 138.05 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.426 0.632 . . . . 1.0 112.485 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.71 178.15 8.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.379 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.51 -15.32 63.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 1.0 111.209 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.77 19.21 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.593 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 71.27 36.12 1.42 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.93 0.769 . . . . 1.0 110.927 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 10.5 mmtt -110.88 150.53 29.04 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.261 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -93.95 119.28 32.63 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.915 -1.038 . . . . 1.0 110.499 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -132.05 -179.95 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.49 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.2 p-90 -152.84 162.48 41.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.354 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -146.54 143.25 28.77 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.171 0.919 . . . . 1.0 109.882 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.726 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.1 tp -95.08 130.57 41.73 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.79 131.61 70.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.266 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.617 ' CB ' HD21 ' A' ' 126' ' ' ASN . 5.2 t-80 -81.4 172.93 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 23.8 t70 -58.5 -27.46 64.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.27 0.557 . . . . 1.0 110.873 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.62 -32.85 70.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.772 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.88 12.76 21.71 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.9 -1.045 . . . . 1.0 112.626 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.617 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.42 146.98 24.29 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 51.1 mm -79.42 114.53 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.726 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.6 mt -87.94 -43.24 11.91 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.415 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -152.27 162.98 40.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.952 -1.022 . . . . 1.0 111.051 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -135.94 155.41 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.047 -1.094 . . . . 1.0 108.047 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 53.3 p -55.88 -38.74 70.55 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.332 0.395 . . . . 1.0 111.968 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.19 -33.96 2.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 131' ' ' SER . 47.2 mt-10 -87.97 -178.68 6.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.934 -0.633 . . . . 1.0 111.118 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.65 114.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.094 -1.203 . . . . 1.0 110.094 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.49 169.68 17.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.616 0.208 . . . . 1.0 110.45 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.54 10.03 14.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.9 m -122.41 131.33 53.83 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.631 0.729 . . . . 1.0 112.234 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -67.39 -32.25 73.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.527 -1.215 . . . . 1.0 109.734 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.7 tt0 -60.93 -46.79 89.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.229 -0.896 . . . . 1.0 109.915 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.29 -38.74 80.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.462 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.245 0.545 . . . . 1.0 109.918 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.8 mtmt -64.82 -33.36 75.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -64.86 -32.29 73.92 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.444 -0.502 . . . . 1.0 109.974 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -40.84 94.41 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.732 -0.747 . . . . 1.0 111.257 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 142' ' ' LYS . 71.9 mt -59.83 -51.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 1.0 110.613 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.19 -35.66 81.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.806 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.5 m -66.74 -34.99 79.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.003 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.71 -35.17 43.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.712 -177.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -68.92 -15.44 63.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.742 0.782 . . . . 1.0 110.238 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -99.39 -2.72 35.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.431 -1.259 . . . . 1.0 112.591 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -136.91 -39.12 0.62 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.944 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.16 -51.6 80.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 55.7 Cg_endo -66.41 -7.77 18.68 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.243 1.296 . . . . 1.0 113.229 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -116.56 -24.62 7.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.056 0.455 . . . . 1.0 111.644 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.05 136.88 57.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.946 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -92.07 137.84 32.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 1.0 110.724 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.57 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -88.99 131.51 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.378 0.609 . . . . 1.0 112.587 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 114.832 -1.076 . . . . 1.0 108.46 177.405 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 . . . . . 0 N--CA 1.452 -0.365 0 CA-C-O 121.449 0.642 . . . . 1.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 72.8 mmtt -136.89 97.39 3.51 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.906 -1.516 . . . . 1.0 106.906 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.96 174.23 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.614 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.531 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 41.0 p-80 -170.95 148.16 2.77 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.273 0.358 . . . . 1.0 110.519 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.57 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 50.2 m-85 -85.61 149.56 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.734 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -141.99 118.39 10.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.721 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' B' ' 218' ' ' TRP . 75.9 t -93.48 132.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -143.16 -177.88 5.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.3 t -102.64 137.46 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 1.0 112.284 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.32 179.4 6.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.552 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.33 -14.61 62.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.049 0.452 . . . . 1.0 110.575 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.12 15.88 24.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.503 -0.772 . . . . 1.0 111.758 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' B' ' 210' ' ' VAL . 26.5 m-20 70.42 41.71 0.97 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.482 0.713 . . . . 1.0 110.611 177.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 9.2 mmtt -115.13 152.03 33.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.71 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.97 118.76 31.07 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.391 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -134.68 179.37 6.34 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.119 -0.946 . . . . 1.0 109.046 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.511 ' HB3' HG22 ' B' ' 208' ' ' VAL . 50.6 p-90 -154.28 161.46 41.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.516 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' B' ' 219' ' ' ARG . 9.2 mtp180 -147.31 142.85 27.59 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.885 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.703 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.8 tp -94.16 131.98 39.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 t -128.68 131.43 68.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.268 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.545 ' CB ' HD21 ' B' ' 226' ' ' ASN . 9.5 t-80 -78.01 170.7 16.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 20.8 t70 -57.19 -27.7 62.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.373 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.81 -33.77 62.27 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.19 13.33 10.93 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 114.999 -1.0 . . . . 1.0 113.459 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.545 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.2 OUTLIER -87.96 144.57 26.47 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.904 -0.174 . . . . 1.0 111.256 178.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.36 123.36 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.815 0.697 . . . . 1.0 109.262 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.703 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.0 mt -99.35 -42.11 7.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.322 0.582 . . . . 1.0 109.796 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -153.01 164.3 38.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.895 -1.048 . . . . 1.0 111.625 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -139.61 153.49 47.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 1.0 108.897 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.419 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 11.9 p -51.58 -35.43 41.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.49 -46.6 3.51 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.119 -0.792 . . . . 1.0 111.119 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.7 mt-10 -107.43 173.99 6.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.955 -0.623 . . . . 1.0 111.73 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -133.65 145.62 17.65 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.965 -1.254 . . . . 1.0 109.965 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -142.48 171.95 13.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.359 0.579 . . . . 1.0 110.788 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.69 10.28 41.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.306 0.484 . . . . 1.0 112.306 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 9.5 m -136.69 134.8 37.61 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.357 0.598 . . . . 1.0 111.484 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -63.98 -35.41 80.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.3 tt0 -57.74 -48.32 79.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.607 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -61.88 -38.14 87.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.351 0.407 . . . . 1.0 110.847 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.46 -49.56 76.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 1.0 109.698 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' B' ' 245' ' ' ILE . 43.9 mtmt -64.8 -33.81 76.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.369 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.9 mm-40 -63.42 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.32 -0.552 . . . . 1.0 109.744 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.26 89.44 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' B' ' 242' ' ' LYS . 73.9 mt -60.88 -50.5 80.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.697 0.76 . . . . 1.0 110.374 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.36 -33.83 76.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.652 -0.704 . . . . 1.0 111.23 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 m -65.05 -38.69 91.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.175 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' B' ' 252' ' ' ALA . 1.1 p -73.92 -40.61 52.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.094 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.09 -15.25 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.177 0.513 . . . . 1.0 111.907 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -101.31 -1.47 33.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.825 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -135.82 -37.39 0.74 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.84 0.352 . . . . 1.0 111.942 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.47 -50.67 85.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 112.898 0.703 . . . . 1.0 112.898 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.6 Cg_endo -65.46 -10.4 26.07 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 120.764 0.976 . . . . 1.0 113.503 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.07 -20.39 8.71 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -66.02 135.34 54.53 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.86 -0.609 . . . . 1.0 112.27 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.89 139.52 30.67 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.764 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -91.7 128.31 43.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . 0.449 HD11 ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -124.4 146.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.283 -1.326 . . . . 1.0 110.174 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -91.26 114.66 27.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.926 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.077 -0.963 . . . . 1.0 111.19 -178.123 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 121.253 0.549 . . . . 1.0 111.5 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 45.1 mmtm -136.98 97.7 3.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.055 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.44 171.14 3.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.076 -0.965 . . . . 1.0 109.504 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 44.2 p-80 -169.22 148.32 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.5 m-85 -85.32 147.74 26.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.388 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.59 116.92 11.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 118' ' ' TRP . 97.0 t -92.47 133.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.579 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -142.71 179.25 7.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 1.0 110.707 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.3 t -103.36 134.41 44.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.939 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.7 -179.95 7.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.762 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.09 -12.97 62.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.776 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -115.24 26.88 9.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.257 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 65.58 30.48 10.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.404 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 71.9 mmtt -95.66 156.24 16.41 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.9 117.2 33.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.3 mtm105 -132.91 178.0 7.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.53 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.9 p-90 -150.53 163.27 38.86 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.931 0.396 . . . . 1.0 111.417 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.417 HH21 HG13 ' A' ' 127' ' ' ILE . 39.7 mtp180 -147.73 143.37 27.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.826 -1.079 . . . . 1.0 109.304 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.768 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.7 tp -91.61 131.66 36.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.6 t -128.29 130.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.43 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.619 ' CB ' HD21 ' A' ' 126' ' ' ASN . 1.9 t-80 -79.08 170.95 15.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 11.7 t70 -55.73 -31.8 62.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.884 0.373 . . . . 1.0 111.187 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.3 -34.16 77.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.478 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.41 9.36 19.73 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.907 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.619 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.47 142.74 27.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.425 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 48.0 mm -77.09 118.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.634 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.768 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.2 mt -92.19 -42.42 9.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.217 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -152.0 164.77 36.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.654 -1.157 . . . . 1.0 111.255 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -137.32 154.02 50.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.844 . . . . 1.0 108.862 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 p -53.32 -35.01 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 1.0 112.343 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.0 -42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.566 -0.614 . . . . 1.0 111.566 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -102.79 -177.52 3.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.204 0.526 . . . . 1.0 111.556 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.9 126.31 1.8 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.4 173.1 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.136 0.468 . . . . 1.0 111.121 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.99 9.79 31.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.585 0.957 . . . . 1.0 113.585 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -122.64 130.55 53.1 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.427 0.632 . . . . 1.0 111.341 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.84 -38.31 88.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.5 tt0 -61.42 -41.39 97.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.081 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -60.06 -42.75 95.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.897 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.94 81.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.259 0.552 . . . . 1.0 110.196 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.24 -33.8 76.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.388 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -65.22 -31.45 72.62 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.921 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.98 -38.85 95.97 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.626 HG21 HG22 ' B' ' 257' ' ' VAL . 64.5 mt -61.28 -51.06 77.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.365 0.602 . . . . 1.0 110.304 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -63.41 -32.89 74.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.989 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -64.2 -39.68 94.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.336 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 152' ' ' ALA . 1.6 p -75.04 -38.28 42.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 C-N-CA 119.906 -0.718 . . . . 1.0 109.887 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -64.6 -13.83 55.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.145 0.498 . . . . 1.0 111.211 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -4.58 40.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.721 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 22.1 m-80 -137.03 -37.93 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.757 0.651 . . . . 1.0 112.757 -174.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -53.69 -50.01 85.82 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.1 Cg_endo -65.88 -14.12 43.09 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 120.882 1.055 . . . . 1.0 113.633 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.48 -27.46 8.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.546 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -61.32 135.51 57.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.555 0.946 . . . . 1.0 113.555 -176.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -90.98 139.21 30.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.06 -1.427 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.22 133.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.214 0.531 . . . . 1.0 111.983 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--N 1.332 -0.18 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.356 178.83 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 12.8 p-10 . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.848 0.832 . . . . 1.0 112.622 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -143.74 98.94 3.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.899 -1.5 . . . . 1.0 107.447 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.33 173.58 2.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.789 -1.096 . . . . 1.0 109.223 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.546 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 54.1 p-80 -169.5 148.78 3.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.512 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 49.5 m-85 -85.42 145.41 27.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.143 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -139.0 120.73 15.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.511 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' B' ' 218' ' ' TRP . 72.4 t -92.48 132.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.889 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.402 ' CE2' ' HD3' ' B' ' 219' ' ' ARG . 11.3 p90 -140.39 -176.02 4.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.078 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' B' ' 214' ' ' ASP . 4.8 t -107.33 139.69 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 1.0 112.579 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -81.85 -179.75 7.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.144 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.9 0.381 . . . . 1.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.24 24.05 13.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.497 ' HA ' HG13 ' B' ' 210' ' ' VAL . 4.9 m-20 63.17 41.36 8.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.344 0.592 . . . . 1.0 111.09 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.4 mmtt -103.61 155.82 18.26 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.447 -0.797 . . . . 1.0 108.901 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.49 123.01 41.19 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.043 0.449 . . . . 1.0 110.308 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -137.51 -178.83 5.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.058 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.525 ' HB3' HG22 ' B' ' 208' ' ' VAL . 58.2 p-90 -155.37 162.59 40.77 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.413 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' B' ' 219' ' ' ARG . 13.5 mtp180 -146.63 146.78 30.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.041 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.722 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.9 tp -97.03 130.2 44.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.73 130.18 71.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.444 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.535 ' CB ' HD21 ' B' ' 226' ' ' ASN . 1.9 t-80 -81.37 175.3 10.68 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.75 -35.56 63.88 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.347 0.404 . . . . 1.0 111.859 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -67.91 -33.26 74.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.285 0.564 . . . . 1.0 110.298 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.49 10.93 20.84 Favored Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 114.894 -1.048 . . . . 1.0 112.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.535 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.11 143.25 28.14 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 1.0 112.057 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.78 120.35 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.263 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.722 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.3 mt -97.39 -42.61 7.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.519 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -153.7 165.42 36.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.363 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.69 159.72 41.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 57.4 p -55.75 -33.81 64.64 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.151 0.5 . . . . 1.0 111.427 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.63 -51.19 3.58 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 57.4 mm-40 -100.99 177.79 4.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.979 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.95 139.5 9.67 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -137.49 172.46 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.544 0.672 . . . . 1.0 111.489 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.15 10.9 36.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.0 113.129 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 7.0 m -136.7 135.93 38.58 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.079 0.466 . . . . 1.0 110.926 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -64.53 -38.18 90.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.6 tt0 -57.24 -45.14 84.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.838 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -62.78 -40.75 98.29 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.906 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.63 79.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.558 0.694 . . . . 1.0 109.772 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.0 mtmt -65.02 -35.36 80.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.532 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.0 mm-40 -63.37 -28.02 69.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 176.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.75 -42.08 95.42 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' B' ' 242' ' ' LYS . 62.1 mt -61.83 -44.93 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.931 -0.634 . . . . 1.0 110.021 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.06 -39.74 93.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.208 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -67.68 -34.08 76.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.957 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.59 -39.27 53.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.03 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -68.43 -12.25 60.9 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.306 0.574 . . . . 1.0 111.078 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -101.22 -3.12 29.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 1.0 111.09 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -136.42 -40.09 0.65 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.35 -49.67 91.12 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 46.7 Cg_endo -66.48 -9.12 22.96 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 120.916 1.077 . . . . 1.0 113.456 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.61 -13.91 8.27 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -69.27 137.74 53.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.464 0.649 . . . . 1.0 112.13 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -91.14 144.01 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.997 -1.001 . . . . 1.0 111.495 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 145' ' ' ILE . 43.7 t -85.76 123.49 39.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.226 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.7 mt -115.53 138.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -89.65 100.51 13.3 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.492 -0.766 . . . . 1.0 110.965 -176.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 CA--C 1.515 -0.366 0 CA-C-O 121.42 0.629 . . . . 1.0 111.806 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 35.2 mmtp -142.37 96.39 2.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.24 174.67 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.164 -177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 53.3 p-80 -168.94 147.3 3.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.694 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.566 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 47.1 m-85 -85.04 148.82 25.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.71 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.06 120.44 13.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.766 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 118' ' ' TRP . 83.6 t -94.76 137.95 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.937 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.39 -178.63 6.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.437 -0.208 . . . . 1.0 110.437 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 8.2 t -103.98 136.75 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.186 0.517 . . . . 1.0 112.363 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.24 -179.68 7.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.086 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.48 -15.19 63.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.075 0.398 . . . . 1.0 112.075 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.81 22.59 15.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.677 0.275 . . . . 1.0 111.396 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.87 40.3 1.32 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.695 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 2.5 mmtp -111.79 149.88 31.1 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.286 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -94.19 120.67 34.78 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.62 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -133.91 -179.4 5.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.818 -1.083 . . . . 1.0 108.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.556 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.5 p-90 -153.25 162.94 40.75 Favored 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 120.55 -0.46 . . . . 1.0 111.428 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.509 HH21 HG13 ' A' ' 127' ' ' ILE . 41.9 mtp180 -148.23 141.17 24.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.397 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.659 ' HG ' HD12 ' A' ' 128' ' ' LEU . 36.0 tp -90.97 135.15 33.93 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.09 130.25 69.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.084 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.578 ' CB ' HD21 ' A' ' 126' ' ' ASN . 3.5 t-80 -77.49 171.84 14.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.6 t70 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.247 0.546 . . . . 1.0 110.356 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -33.57 75.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.169 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.89 8.18 24.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.289 -0.869 . . . . 1.0 112.884 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.578 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.83 145.26 26.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.715 0.265 . . . . 1.0 111.715 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.509 HG13 HH21 ' A' ' 119' ' ' ARG . 51.0 mm -76.81 119.74 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.809 0.693 . . . . 1.0 110.017 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.659 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -94.86 -43.75 8.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.104 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -148.01 168.91 21.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.663 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -143.83 155.86 44.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.272 -0.876 . . . . 1.0 108.671 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.3 p -58.16 -32.96 68.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.189 0.519 . . . . 1.0 111.191 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.89 -47.24 3.52 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -109.25 170.66 7.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.734 -0.733 . . . . 1.0 111.549 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.34 16.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.267 -0.878 . . . . 1.0 110.934 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -141.46 165.92 26.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.848 0.324 . . . . 1.0 110.45 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.43 10.27 30.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 p -127.38 129.23 47.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.453 0.644 . . . . 1.0 112.188 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -66.84 -37.05 83.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.456 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 10.0 tt0 -58.81 -43.17 90.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.135 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tppt? -60.07 -41.89 93.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.785 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.16 -50.29 69.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.293 0.568 . . . . 1.0 109.906 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.514 ' HA ' HD12 ' A' ' 145' ' ' ILE . 49.1 mtmt -65.45 -33.08 75.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.563 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.3 mm-40 -66.73 -31.02 71.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.128 176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.66 -38.26 93.08 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 142' ' ' LYS . 71.7 mt -61.47 -50.32 80.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.307 0.575 . . . . 1.0 110.652 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -62.8 -33.79 75.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.181 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 52.5 m -65.28 -37.45 87.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.753 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.604 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -74.49 -33.88 34.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 120.411 -0.516 . . . . 1.0 109.866 -177.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -69.35 -13.21 62.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.657 0.741 . . . . 1.0 110.634 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -101.21 -2.92 30.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.764 -1.107 . . . . 1.0 112.325 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.19 -39.5 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.745 0.307 . . . . 1.0 111.737 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.13 -51.32 82.57 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 32.0 Cg_endo -60.71 -12.26 20.86 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.364 1.376 . . . . 1.0 113.515 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -123.79 -7.46 7.9 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.48 134.3 43.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.704 0.764 . . . . 1.0 112.23 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.03 135.82 33.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.621 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -88.05 134.13 28.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.445 0.641 . . . . 1.0 112.124 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 11.0 mt . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 114.711 -1.131 . . . . 1.0 109.327 178.281 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 CA--C 1.513 -0.479 0 CA-C-O 121.838 0.828 . . . . 1.0 112.592 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 23.6 mmtp -140.14 97.26 3.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.926 -1.488 . . . . 1.0 107.699 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.63 172.2 3.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.899 . . . . 1.0 109.831 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.474 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 45.3 p-80 -169.22 148.09 3.89 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.781 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 53.2 m-85 -85.35 148.55 25.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.921 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -140.33 117.01 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.43 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.8 t -92.95 129.79 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.91 -0.586 . . . . 1.0 109.662 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -141.34 -179.19 5.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.788 0.328 . . . . 1.0 110.589 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.9 t -102.23 136.34 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 1.0 112.149 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -78.72 179.92 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.013 -0.994 . . . . 1.0 109.752 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.9 -18.01 64.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.238 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.54 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.236 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.447 ' HA ' HG13 ' B' ' 210' ' ' VAL . 11.7 m-20 63.53 39.37 9.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.431 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 31.7 mmtp -103.48 156.34 17.84 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.71 118.5 34.39 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.405 ' HG2' ' HA2' ' B' ' 234' ' ' GLY . 69.4 mtp180 -134.29 179.57 6.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.308 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.529 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.1 p-90 -154.0 161.37 42.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.945 0.402 . . . . 1.0 111.172 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 38.0 mtp180 -147.07 141.11 26.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.047 -0.979 . . . . 1.0 109.89 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.694 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -91.39 131.1 37.1 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.01 130.93 71.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.174 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.517 ' CB ' HD21 ' B' ' 226' ' ' ASN . 6.3 t-80 -77.16 173.19 12.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.598 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.0 t70 -56.56 -34.39 67.05 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.368 0.418 . . . . 1.0 111.063 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . 0.418 ' HB2' ' OD1' ' B' ' 226' ' ' ASN . 1.4 m-20 -68.65 -34.62 76.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.019 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.79 13.93 9.87 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.378 -0.828 . . . . 1.0 113.514 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.517 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.2 OUTLIER -87.63 147.33 25.32 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.98 -0.129 . . . . 1.0 111.112 178.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.53 119.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.588 0.555 . . . . 1.0 110.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.694 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -93.69 -43.35 8.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.555 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.451 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.42 165.07 35.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.297 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.0 157.16 46.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.053 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 12.9 p -54.67 -32.99 60.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.8 -43.77 3.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.87 170.02 8.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.17 0.51 . . . . 1.0 111.553 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' B' ' 217' ' ' ARG . . . -122.87 124.78 5.77 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.338 -1.505 . . . . 1.0 109.338 176.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -110.8 172.45 6.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.993 0.396 . . . . 1.0 111.372 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -105.54 10.85 32.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.874 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 3.3 p -143.94 130.88 20.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.629 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.03 -44.41 97.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.087 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.2 tt0 -54.04 -40.49 67.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.261 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.597 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.3 OUTLIER -61.62 -42.8 99.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.323 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.29 92.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.305 0.574 . . . . 1.0 109.817 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.3 mtmt -64.04 -35.52 80.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.13 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.2 mm-40 -65.4 -31.39 72.47 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.045 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.48 94.7 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.511 -0.852 . . . . 1.0 110.979 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.506 ' O ' HG12 ' B' ' 248' ' ' VAL . 70.6 mt -61.16 -52.3 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.365 0.602 . . . . 1.0 110.606 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -63.35 -34.85 78.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.646 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.7 m -66.15 -35.85 81.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.754 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.565 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -73.33 -41.06 57.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -65.06 -13.48 58.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.801 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -102.74 -2.92 27.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.261 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 17.8 m-80 -137.01 -38.31 0.63 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.223 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.565 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.58 -50.77 85.06 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.696 0.628 . . . . 1.0 112.696 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.9 Cg_endo -63.92 -10.65 23.61 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.037 1.158 . . . . 1.0 113.266 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.99 -17.04 11.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.978 0.418 . . . . 1.0 111.464 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -69.73 136.92 51.54 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.18 0.807 . . . . 1.0 113.18 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -90.25 137.58 32.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.966 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.566 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -88.72 132.27 34.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.253 0.549 . . . . 1.0 112.416 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -121.58 142.72 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.526 -1.215 . . . . 1.0 108.407 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -93.51 106.9 18.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.825 -176.633 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 . . . . . 0 CA--C 1.517 -0.326 0 CA-C-O 122.108 0.956 . . . . 1.0 113.081 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 72.3 mmtt -135.02 97.61 3.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.387 -1.733 . . . . 1.0 107.183 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.49 170.81 3.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.528 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 45.0 p-80 -170.75 150.78 3.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.413 -0.217 . . . . 1.0 110.413 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.452 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 69.7 m-85 -88.57 150.85 22.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.267 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -143.19 123.35 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.717 . . . . 1.0 110.636 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.7 t -96.96 134.06 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.909 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -146.32 -177.55 5.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 1.0 110.869 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -96.82 138.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.362 0.601 . . . . 1.0 112.552 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.12 179.67 7.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.772 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.61 62.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.289 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.82 26.33 10.44 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.871 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.42 ' HA ' HG13 ' A' ' 110' ' ' VAL . 13.3 m-20 59.54 43.61 15.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.402 0.62 . . . . 1.0 111.004 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.8 mmtp -101.72 178.32 4.66 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -118.57 103.37 9.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.584 ' HD3' ' HA2' ' A' ' 134' ' ' GLY . 12.7 mmm180 -122.28 178.63 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.52 ' HB3' HG22 ' A' ' 108' ' ' VAL . 60.2 p-90 -151.6 163.81 38.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.735 0.302 . . . . 1.0 111.355 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 39.0 mtp180 -148.4 149.64 32.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.658 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.699 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.7 tp -96.94 133.29 41.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 177.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -131.31 131.43 63.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.141 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.635 ' CB ' HD21 ' A' ' 126' ' ' ASN . 4.1 t-80 -76.89 168.2 20.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.413 -1.329 . . . . 1.0 107.413 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.502 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 22.8 t70 -61.36 -22.39 64.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.852 0.358 . . . . 1.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -35.04 72.12 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.511 0.672 . . . . 1.0 109.513 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.9 11.39 11.17 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 114.8 -1.091 . . . . 1.0 113.199 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.635 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -91.01 143.93 26.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.718 -0.283 . . . . 1.0 111.673 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.32 126.58 36.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 O-C-N 123.96 0.787 . . . . 1.0 110.133 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.699 HD12 ' HG ' ' A' ' 120' ' ' LEU . 13.4 mt -105.12 -39.62 6.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 1.0 110.071 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.451 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.03 166.81 31.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.775 -1.102 . . . . 1.0 111.277 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -139.6 156.0 47.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.341 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.498 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 83.1 p -56.64 -42.74 79.39 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.99 -41.88 3.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.903 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.529 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 35.7 mt-10 -83.95 -168.48 2.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.118 0.485 . . . . 1.0 110.17 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.584 ' HA2' ' HD3' ' A' ' 117' ' ' ARG . . . -168.65 119.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 1.0 111.706 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -141.3 169.01 18.42 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.76 35.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -116.62 131.85 56.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.409 0.624 . . . . 1.0 111.456 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -65.12 -36.11 83.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.792 -1.095 . . . . 1.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.8 tt0 -61.24 -45.59 93.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.394 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.6 -38.14 80.44 Favored 'General case' 0 CA--C 1.52 -0.176 0 O-C-N 123.208 0.317 . . . . 1.0 110.638 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.59 -52.33 65.85 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.538 0.685 . . . . 1.0 109.649 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.429 ' HA ' HD12 ' A' ' 145' ' ' ILE . 48.3 mtmt -64.12 -36.23 83.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.623 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.5 mm-40 -65.47 -27.03 68.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -41.75 94.05 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.552 HG21 HG22 ' B' ' 257' ' ' VAL . 47.8 mt -63.4 -40.96 91.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.186 -0.507 . . . . 1.0 110.162 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.76 -43.01 99.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.073 0.463 . . . . 1.0 110.075 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 m -63.27 -35.58 80.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.641 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -74.63 -42.55 48.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 119.832 -0.747 . . . . 1.0 110.239 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -67.19 -14.08 62.57 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.958 -0.464 . . . . 1.0 111.775 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -104.32 -1.88 26.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.016 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.7 m-80 -133.04 -39.33 0.95 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.908 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.613 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.32 -50.26 88.61 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 52.8 Cg_endo -67.24 -7.83 20.12 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.181 1.254 . . . . 1.0 113.344 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.21 -29.97 6.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.248 0.547 . . . . 1.0 111.727 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.41 136.81 58.08 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.238 -0.892 . . . . 1.0 113.361 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -96.89 141.92 29.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.149 -1.387 . . . . 1.0 111.024 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.31 135.26 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.986 0.736 . . . . 1.0 112.986 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.0 mt . . . . . 0 N--CA 1.45 -0.458 0 CA-C-N 114.88 -1.054 . . . . 1.0 109.272 176.958 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.427 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.7 p-10 . . . . . 0 CA--C 1.512 -0.497 0 CA-C-O 121.831 0.824 . . . . 1.0 112.905 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -140.04 96.87 3.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.436 -1.69 . . . . 1.0 106.436 173.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.41 174.02 2.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.238 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.46 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 40.4 p-80 -168.83 149.22 4.42 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.143 0.277 . . . . 1.0 110.607 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.542 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.7 m-85 -85.75 152.89 22.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.69 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -141.27 117.05 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.535 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' B' ' 218' ' ' TRP . 82.7 t -95.01 130.92 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.87 178.86 7.22 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.188 0.305 . . . . 1.0 110.39 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.1 t -101.58 136.77 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.256 0.55 . . . . 1.0 112.067 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -82.91 178.61 8.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.466 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.7 64.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.114 0.483 . . . . 1.0 110.956 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.22 21.54 16.95 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.563 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.431 ' HA ' HG13 ' B' ' 210' ' ' VAL . 18.5 m-20 64.23 36.28 9.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.414 -0.812 . . . . 1.0 111.187 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 32.2 mmtp -99.21 157.48 16.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.21 112.86 26.06 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.1 mtm105 -127.44 176.8 7.18 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.529 ' HB3' HG22 ' B' ' 208' ' ' VAL . 49.4 p-90 -149.12 161.84 41.16 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.735 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 219' ' ' ARG . 9.2 mtp180 -145.72 143.47 29.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.163 -0.926 . . . . 1.0 109.649 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.682 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.3 tp -93.54 134.09 36.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.17 133.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.505 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.58 ' CB ' HD21 ' B' ' 226' ' ' ASN . 4.4 t-80 -80.35 172.36 13.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.56 -31.77 66.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 1.0 111.1 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -32.86 74.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.897 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.5 10.65 21.3 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.722 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.58 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.57 145.1 25.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -73.42 130.17 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.789 0.681 . . . . 1.0 109.199 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.682 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.8 mt -107.44 -41.9 4.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.347 0.594 . . . . 1.0 110.033 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.84 166.61 30.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.962 -1.017 . . . . 1.0 111.376 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -139.23 154.29 47.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.851 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.472 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 24.8 p -54.22 -39.61 66.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 78.65 -26.92 2.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 1.0 111.149 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' B' ' 231' ' ' SER . 48.8 mt-10 -87.2 -175.84 5.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.59 0.71 . . . . 1.0 111.502 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -170.09 102.17 0.18 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -129.71 169.75 14.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.356 -0.238 . . . . 1.0 110.356 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.07 37.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -121.81 131.17 53.91 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.615 0.721 . . . . 1.0 111.365 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -65.2 -34.67 78.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.583 -1.189 . . . . 1.0 110.421 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.4 tt0 -58.57 -46.45 86.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.461 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -60.01 -40.29 88.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.52 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.81 68.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.015 0.436 . . . . 1.0 110.3 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.502 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.23 -35.88 82.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.676 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.4 mm-40 -65.7 -31.02 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.536 -0.466 . . . . 1.0 109.995 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.35 95.04 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.509 ' O ' HG12 ' B' ' 248' ' ' VAL . 73.5 mt -60.8 -53.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 1.0 110.687 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.11 -32.79 74.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.645 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -67.19 -38.11 84.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.635 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' B' ' 252' ' ' ALA . 1.4 p -73.05 -36.03 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 119.843 -0.743 . . . . 1.0 109.08 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.24 -12.62 57.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.98 0.419 . . . . 1.0 111.304 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -104.44 -2.25 25.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.723 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -131.32 -37.5 1.24 Allowed 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 111.944 0.35 . . . . 1.0 111.944 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.542 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.65 -51.5 80.77 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 112.504 0.557 . . . . 1.0 112.504 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 50.6 Cg_endo -66.66 -12.51 36.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.268 1.312 . . . . 1.0 113.2 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.35 -29.6 9.18 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.205 0.526 . . . . 1.0 111.437 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -63.24 137.89 58.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.16 -0.927 . . . . 1.0 112.939 -176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -97.72 149.41 22.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.148 -1.387 . . . . 1.0 111.557 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 145' ' ' ILE . 46.1 t -86.62 131.58 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.029 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.13 138.31 54.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -90.67 101.55 14.3 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.499 -0.763 . . . . 1.0 111.387 -176.886 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 . . . . . 0 CA--C 1.517 -0.31 0 CA-C-O 121.784 0.802 . . . . 1.0 112.439 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 14.2 mmtp -134.53 96.92 3.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.965 -1.471 . . . . 1.0 107.656 173.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.06 166.62 3.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.408 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.3 p-80 -168.83 146.87 3.93 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.025 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.23 147.98 26.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.543 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -139.46 117.11 11.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.464 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' A' ' 118' ' ' TRP . 93.9 t -94.61 134.27 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.942 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -146.29 -179.17 6.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.594 0.235 . . . . 1.0 110.639 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.1 t -101.39 134.97 40.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.175 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.58 178.94 8.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.4 52.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.829 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.1 21.64 13.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.856 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.05 33.36 1.63 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.807 0.843 . . . . 1.0 111.306 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.5 mttt -108.68 150.78 27.08 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.583 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -94.56 116.05 28.31 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.833 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.471 HH12 ' CG ' ' A' ' 130' ' ' ASP . 16.7 mtm105 -133.55 177.73 7.48 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.568 ' HB3' HG22 ' A' ' 108' ' ' VAL . 53.9 p-90 -150.19 161.09 43.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.782 0.325 . . . . 1.0 111.108 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 20.2 mtp180 -145.95 142.19 28.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.096 -0.956 . . . . 1.0 109.543 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.713 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.9 tp -91.88 132.69 36.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.38 132.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.533 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.533 ' CB ' HD21 ' A' ' 126' ' ' ASN . 1.7 t-80 -81.06 173.03 12.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.57 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 13.2 t70 -58.62 -31.99 68.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 1.0 110.691 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -63.68 -34.42 77.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.832 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 9.37 25.47 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.664 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.533 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.23 143.34 27.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.185 . . . . 1.0 111.496 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.81 123.73 31.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.895 0.747 . . . . 1.0 109.353 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.713 HD12 ' HG ' ' A' ' 120' ' ' LEU . 14.8 mt -98.37 -41.88 7.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.354 0.597 . . . . 1.0 109.91 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.73 169.09 22.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.677 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CG ' HH12 ' A' ' 117' ' ' ARG . 7.6 t70 -142.4 154.36 44.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.867 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.6 p -57.09 -35.07 68.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.903 0.382 . . . . 1.0 111.679 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.69 -44.96 3.38 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -94.66 177.54 5.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 1.0 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -150.45 127.04 2.28 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.858 -1.065 . . . . 1.0 110.454 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -141.97 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.792 0.296 . . . . 1.0 110.46 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.05 10.22 27.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.501 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -124.06 130.56 52.76 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.633 0.73 . . . . 1.0 111.715 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -65.95 -34.38 77.98 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.919 -1.037 . . . . 1.0 110.297 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.6 tt0 -58.37 -46.64 85.94 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.453 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -59.52 -38.63 81.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.422 -0.214 . . . . 1.0 110.422 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -52.94 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.225 0.536 . . . . 1.0 110.135 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 145' ' ' ILE . 46.5 mtmt -64.99 -35.97 82.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.033 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.2 mm-40 -65.32 -30.7 71.57 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.468 -0.493 . . . . 1.0 109.787 177.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.86 -38.73 94.59 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 142' ' ' LYS . 75.4 mt -60.52 -53.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.402 0.62 . . . . 1.0 110.531 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -62.53 -33.27 74.58 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.5 m -67.36 -38.17 84.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.636 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -73.17 -33.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.247 -0.581 . . . . 1.0 109.61 -177.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.58 -14.62 62.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.539 0.685 . . . . 1.0 110.396 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -100.49 -1.89 34.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.723 -1.126 . . . . 1.0 112.037 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -134.34 -40.89 0.81 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.263 0.468 . . . . 1.0 112.263 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.33 -52.06 77.08 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 113.041 0.756 . . . . 1.0 113.041 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 47.8 Cg_endo -64.9 -12.75 35.91 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 120.883 1.055 . . . . 1.0 113.294 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.47 -29.4 8.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.07 0.462 . . . . 1.0 111.149 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.14 136.45 57.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.949 -1.023 . . . . 1.0 113.347 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -99.12 144.06 28.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.131 -1.395 . . . . 1.0 110.534 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.05 137.16 21.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.668 177.377 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 . . . . . 0 CA--C 1.518 -0.285 0 CA-C-O 121.758 0.79 . . . . 1.0 111.991 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.583 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 18.1 mmtp -138.97 96.49 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.117 -1.401 . . . . 1.0 108.087 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.16 170.84 3.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.589 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.508 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 34.2 p-80 -170.26 148.08 3.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.391 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.509 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.5 m-85 -84.63 152.59 23.72 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.131 0.269 . . . . 1.0 110.696 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -141.52 120.45 12.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.419 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' B' ' 218' ' ' TRP . 89.1 t -96.29 135.17 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.061 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.82 178.66 8.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.136 0.273 . . . . 1.0 110.779 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -98.39 135.49 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.671 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.3 177.87 8.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.911 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.2 -13.73 62.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.967 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.73 19.02 19.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.619 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 69.4 38.84 1.73 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.511 -0.768 . . . . 1.0 111.008 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.8 mmtt -109.13 155.9 20.47 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.397 -0.819 . . . . 1.0 110.261 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.43 ' O ' ' HB2' ' B' ' 241' ' ' ALA . 81.0 m-85 -99.28 102.65 14.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.845 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.577 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 12.1 mmm180 -122.52 177.43 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.171 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.523 ' HB3' HG22 ' B' ' 208' ' ' VAL . 55.7 p-90 -150.7 161.12 43.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.768 0.318 . . . . 1.0 111.486 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 28.3 mtp180 -147.49 145.87 29.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.469 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.688 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.4 tp -94.22 134.95 36.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.14 132.94 64.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.792 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.566 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.1 t-80 -81.93 173.85 11.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.5 t70 -55.02 -32.18 61.64 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.353 0.408 . . . . 1.0 111.887 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -71.21 -34.29 70.71 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.419 0.628 . . . . 1.0 110.335 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.49 13.19 11.96 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.162 -0.926 . . . . 1.0 112.655 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.566 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.99 143.49 26.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 178.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.21 121.66 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.903 0.752 . . . . 1.0 109.717 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.688 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -96.88 -40.67 8.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.545 -0.752 . . . . 1.0 109.629 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -152.68 164.54 37.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.771 -1.104 . . . . 1.0 111.425 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -137.54 156.99 47.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.984 -1.007 . . . . 1.0 109.262 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.501 ' HB2' HH21 ' B' ' 217' ' ' ARG . 79.3 p -58.06 -45.99 86.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.73 2.89 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.806 -0.712 . . . . 1.0 112.989 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . 0.504 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 42.0 mt-10 -84.97 -168.9 2.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.072 0.463 . . . . 1.0 110.294 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.577 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -170.17 124.55 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.871 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -146.73 170.06 17.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.35 9.97 39.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.416 0.447 . . . . 1.0 112.007 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.0 m -111.94 130.21 55.92 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.393 0.616 . . . . 1.0 111.312 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' B' ' 216' ' ' TYR . 8.4 ptpp? -66.17 -35.95 81.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.175 -0.92 . . . . 1.0 110.89 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.3 tt0 -59.59 -46.84 87.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.459 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -59.91 -38.33 81.98 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.584 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 216' ' ' TYR . . . -58.73 -53.11 62.08 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.563 0.697 . . . . 1.0 110.319 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.488 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.9 mtmt -64.46 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.4 mm-40 -66.04 -30.26 70.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.16 95.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.425 -0.893 . . . . 1.0 110.971 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.506 ' O ' HG12 ' B' ' 248' ' ' VAL . 69.7 mt -60.47 -52.86 56.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 1.0 110.562 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.66 -35.96 81.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.253 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.3 m -66.94 -35.62 80.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.905 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -72.61 -38.79 59.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.565 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -65.56 -17.88 64.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.766 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' B' ' 250' ' ' ARG . 30.9 ttp-105 -100.9 -1.66 34.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.607 -0.724 . . . . 1.0 111.123 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -132.71 -40.58 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.557 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -57.17 -49.69 92.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 112.902 0.705 . . . . 1.0 112.902 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 55.9 Cg_endo -66.36 -5.75 13.38 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.029 1.153 . . . . 1.0 113.423 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.79 -11.06 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 1.0 111.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -71.95 137.02 47.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.213 0.53 . . . . 1.0 112.05 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.3 140.34 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.228 -0.896 . . . . 1.0 110.25 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -91.53 129.87 41.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.632 0.729 . . . . 1.0 112.468 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.04 140.2 37.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.54 -1.209 . . . . 1.0 109.054 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -89.06 102.66 15.31 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.458 -0.782 . . . . 1.0 111.447 -177.24 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 13.6 p-10 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.689 0.757 . . . . 1.0 112.514 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 23.9 mmtp -138.7 98.36 3.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.738 -1.574 . . . . 1.0 108.273 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.47 167.35 3.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.116 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.554 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.6 p-80 -167.87 147.11 4.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.547 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 52.2 m-85 -87.17 148.21 25.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.078 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -143.02 120.67 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.72 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.606 HG22 ' HB3' ' A' ' 118' ' ' TRP . 92.2 t -96.02 130.94 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.716 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.09 179.3 6.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.69 0.281 . . . . 1.0 110.644 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -103.28 136.81 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.191 0.519 . . . . 1.0 111.99 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.49 -175.28 5.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.286 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.2 -10.24 56.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.04 33.18 5.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.718 0.294 . . . . 1.0 111.523 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.5 35.13 17.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 mmtp -96.86 154.28 17.39 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.94 114.95 29.47 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.961 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 mtm105 -131.67 175.41 9.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.269 -0.878 . . . . 1.0 108.853 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.606 ' HB3' HG22 ' A' ' 108' ' ' VAL . 55.1 p-90 -151.07 162.45 40.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.656 0.265 . . . . 1.0 111.361 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -147.54 144.91 28.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.252 -0.885 . . . . 1.0 110.068 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.691 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.0 tp -97.29 134.15 40.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 t -127.31 132.56 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 1.0 110.736 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.521 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.6 t-80 -84.56 177.39 8.1 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.818 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 17.9 t70 -52.04 -43.98 64.01 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.805 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -63.13 -33.45 75.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.407 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.79 11.66 22.41 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.312 -0.858 . . . . 1.0 112.331 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.521 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.13 144.19 27.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.78 -0.21 . . . . 1.0 111.371 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.487 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 50.2 mm -74.46 120.43 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.691 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.6 mt -93.06 -42.76 9.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.067 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.66 166.33 29.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.655 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.37 155.72 45.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.041 -0.981 . . . . 1.0 108.558 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 13.6 p -53.33 -31.78 45.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.994 0.426 . . . . 1.0 111.698 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.55 -41.36 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' HG2' ' HB ' ' B' ' 227' ' ' ILE . 50.2 mm-40 -114.53 173.44 6.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.466 0.651 . . . . 1.0 111.933 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.7 132.71 8.82 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 109.947 -1.261 . . . . 1.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.28 167.21 13.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.114 0.457 . . . . 1.0 110.241 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -102.57 9.77 39.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.47 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -139.11 133.61 31.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.5 -38.43 91.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 1.0 110.401 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.4 tt0 -58.46 -43.04 88.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.897 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.89 -41.06 95.28 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.116 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.014 0.435 . . . . 1.0 110.029 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.493 ' HG2' HG21 ' A' ' 108' ' ' VAL . 42.6 mtmt -64.48 -37.04 86.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.2 mm-40 -63.58 -26.57 68.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.488 -0.56 . . . . 1.0 109.488 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.94 -41.74 93.14 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 142' ' ' LYS . 67.9 mt -60.98 -41.38 88.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.469 0.652 . . . . 1.0 109.771 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.95 -43.05 93.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.237 0.541 . . . . 1.0 110.166 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 m -63.49 -35.4 80.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.514 -0.767 . . . . 1.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.606 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.84 -41.86 53.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 120.165 -0.614 . . . . 1.0 109.841 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -66.72 -12.22 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.15 -0.344 . . . . 1.0 111.49 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -104.76 -2.78 24.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.205 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.2 m-80 -132.94 -39.58 0.95 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.923 0.392 . . . . 1.0 111.884 -177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.606 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.38 -50.33 87.36 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.692 -0.685 . . . . 1.0 112.456 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.6 Cg_endo -65.13 -9.34 21.41 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.387 1.391 . . . . 1.0 113.241 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -115.03 -23.34 9.1 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.284 0.475 . . . . 1.0 112.284 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.563 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -67.83 138.26 55.96 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -93.18 151.25 19.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.683 -1.144 . . . . 1.0 111.761 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.499 HG22 HG21 ' B' ' 245' ' ' ILE . 44.0 t -86.48 132.27 32.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.799 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 CA--C 1.515 -0.367 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 175.405 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.407 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 14.5 p-10 . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.66 0.743 . . . . 1.0 112.412 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 30.2 mmtp -138.55 98.5 3.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.174 -1.376 . . . . 1.0 107.659 172.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.47 168.12 3.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.592 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.563 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 46.7 p-80 -167.94 149.11 5.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.198 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -85.83 148.22 25.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.985 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -139.2 119.83 14.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.568 HG21 ' HG2' ' B' ' 242' ' ' LYS . 90.3 t -92.83 132.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.787 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -142.62 -178.37 5.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' B' ' 214' ' ' ASP . 3.3 t -104.6 139.77 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -81.85 -178.45 6.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.042 -0.981 . . . . 1.0 110.208 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.62 -20.15 64.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.043 0.449 . . . . 1.0 111.351 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.85 24.23 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.703 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' B' ' 210' ' ' VAL . 12.5 m-20 60.95 40.15 15.79 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.901 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -100.25 156.48 17.2 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' B' ' 238' ' ' LYS . 89.6 m-85 -98.48 115.86 29.47 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.702 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -133.91 178.57 6.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.511 ' HB3' HG22 ' B' ' 208' ' ' VAL . 53.4 p-90 -151.3 163.68 38.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.908 -0.317 . . . . 1.0 111.508 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -146.06 146.41 30.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.887 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.686 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -96.13 133.16 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.46 130.96 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.544 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.603 ' CB ' HD21 ' B' ' 226' ' ' ASN . 1.9 t-80 -80.75 172.64 13.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 19.4 t70 -54.94 -36.81 65.67 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.191 0.307 . . . . 1.0 111.63 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.02 -34.64 78.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.269 0.557 . . . . 1.0 110.396 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 111.75 15.08 10.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.423 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.603 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -90.99 142.33 27.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 133' ' ' GLU . 50.7 mm -75.83 119.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.933 0.771 . . . . 1.0 109.981 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.686 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -94.87 -43.38 8.22 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.468 -0.787 . . . . 1.0 109.739 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -149.72 170.03 19.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.494 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.72 157.31 44.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.981 -1.009 . . . . 1.0 108.538 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 77.4 p -59.09 -37.15 76.45 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.187 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.55 -45.7 3.48 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . 0.487 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 33.3 mm-40 -94.88 166.41 11.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.418 0.628 . . . . 1.0 111.502 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.19 126.86 4.94 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.08 166.62 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.873 0.337 . . . . 1.0 111.453 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.4 10.26 40.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.502 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.1 m -141.32 135.15 30.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.908 0.385 . . . . 1.0 110.663 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' B' ' 216' ' ' TYR . 16.6 ptpt -61.91 -41.95 98.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.4 tt0 -55.9 -45.22 78.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.565 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -62.42 -41.72 98.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.039 -177.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.06 87.46 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.356 0.598 . . . . 1.0 110.378 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.568 ' HG2' HG21 ' B' ' 208' ' ' VAL . 49.6 mtmt -63.12 -35.61 80.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.142 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.8 mm-40 -65.92 -26.82 67.77 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.74 96.02 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.499 HG21 HG22 ' A' ' 157' ' ' VAL . 58.5 mt -59.72 -45.51 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 121.409 0.623 . . . . 1.0 110.034 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.51 -39.43 93.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.126 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.9 m -66.34 -35.57 80.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.671 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -72.93 -40.48 59.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.599 -177.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -65.86 -12.41 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.436 . . . . 1.0 111.331 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -104.94 -3.14 23.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.696 -0.684 . . . . 1.0 111.004 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 17.6 m-80 -130.83 -40.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.99 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.6 -51.22 81.89 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.616 -0.72 . . . . 1.0 112.516 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.5 Cg_endo -65.91 -11.84 32.69 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 120.987 1.125 . . . . 1.0 113.219 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -113.01 -15.49 12.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.954 0.407 . . . . 1.0 112.04 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -74.95 137.88 41.93 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.022 0.749 . . . . 1.0 113.022 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.66 138.29 31.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.647 -1.161 . . . . 1.0 110.722 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.23 129.87 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.622 0.725 . . . . 1.0 112.339 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -116.1 142.21 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.033 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.93 104.87 17.39 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.607 -0.711 . . . . 1.0 110.819 -178.412 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 14.9 p-10 . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.77 0.795 . . . . 1.0 112.55 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 123' ' ' ASP . 28.2 mmtt -141.9 94.53 2.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 1.0 107.82 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.48 174.39 1.92 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.237 -177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.535 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 40.1 p-80 -170.56 148.79 3.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.388 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 67.1 m-85 -86.84 150.17 24.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.587 0.232 . . . . 1.0 110.681 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.51 120.12 12.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.788 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 118' ' ' TRP . 86.8 t -94.67 132.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.532 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -142.91 179.06 7.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.047 0.217 . . . . 1.0 110.576 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -99.87 133.24 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.98 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.83 178.78 8.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.866 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.25 -7.64 43.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.514 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.09 20.01 14.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.172 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 71.11 36.18 1.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.625 0.77 . . . . 1.0 111.062 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.4 mttt -110.92 151.19 28.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.624 -175.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.12 112.95 25.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.716 -1.129 . . . . 1.0 109.53 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -130.8 179.25 6.08 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.535 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.0 p-90 -150.68 163.7 37.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.714 -0.395 . . . . 1.0 111.522 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 25.5 mtp180 -147.91 146.3 28.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.78 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.686 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.1 tp -96.31 130.65 43.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.17 131.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.967 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.575 ' CB ' HD21 ' A' ' 126' ' ' ASN . 3.0 t-80 -78.0 172.17 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' A' ' 103' ' ' LYS . 11.5 t70 -57.89 -31.45 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.14 0.495 . . . . 1.0 110.637 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.31 -33.62 75.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.028 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.23 9.86 21.24 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.073 -0.967 . . . . 1.0 112.978 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.575 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.49 144.94 26.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.642 0.258 . . . . 1.0 111.467 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.8 mm -75.39 122.08 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.028 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.686 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -97.92 -42.53 7.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 1.0 109.374 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.05 165.71 32.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.156 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -141.39 155.09 45.94 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 71.2 p -55.79 -32.83 63.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.03 0.443 . . . . 1.0 111.471 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.18 -41.39 3.03 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.928 -0.636 . . . . 1.0 112.084 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -133.03 147.77 19.08 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -141.79 174.29 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.415 0.607 . . . . 1.0 110.99 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.27 10.16 41.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.616 0.599 . . . . 1.0 112.616 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -133.16 131.56 40.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.746 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -64.03 -36.15 83.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.355 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.8 tt0 -58.33 -45.21 88.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.762 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -59.91 -40.83 90.17 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.957 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.97 79.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 1.0 109.901 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.526 ' HA ' HD12 ' A' ' 145' ' ' ILE . 43.2 mtmt -64.29 -37.11 86.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.659 -0.701 . . . . 1.0 111.032 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.9 mm-40 -63.87 -29.68 70.84 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.41 97.98 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 142' ' ' LYS . 57.0 mt -63.98 -45.55 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.887 -0.657 . . . . 1.0 110.298 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.25 -38.28 88.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.137 0.494 . . . . 1.0 110.055 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.4 m -65.9 -36.27 82.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.638 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.1 -42.21 51.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.343 -177.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -66.22 -11.89 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 112.018 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -104.46 -2.84 24.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.079 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' B' ' 204' ' ' ALA . 11.1 m-80 -133.45 -37.88 0.94 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.997 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.21 -50.01 90.62 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.2 Cg_endo -63.48 -15.24 47.32 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.254 1.303 . . . . 1.0 113.185 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -109.93 -26.37 9.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.281 0.562 . . . . 1.0 111.362 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.26 136.43 57.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.008 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -96.61 141.68 29.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.18 -1.373 . . . . 1.0 111.117 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.522 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -89.84 135.01 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.333 0.587 . . . . 1.0 112.478 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.0 mt . . . . . 0 N--CA 1.453 -0.323 0 CA-C-N 114.937 -1.029 . . . . 1.0 109.266 177.758 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 121.526 0.679 . . . . 1.0 112.219 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 70.9 mmtt -136.59 95.52 3.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . . . -175.92 171.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.19 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.504 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.2 p-80 -170.92 148.61 2.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.159 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.2 m-85 -86.41 149.67 24.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.721 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -142.07 119.03 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.332 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.2 t -94.31 132.88 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -145.68 -178.68 6.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.126 0.266 . . . . 1.0 110.647 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -100.89 138.29 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.309 0.576 . . . . 1.0 112.129 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.46 179.7 7.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.098 -0.956 . . . . 1.0 109.664 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.13 -9.3 58.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.181 0.515 . . . . 1.0 111.004 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.69 20.43 15.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.462 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 70.04 36.84 1.83 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.634 0.774 . . . . 1.0 111.534 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.0 mttt -112.74 149.69 32.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.289 0.566 . . . . 1.0 111.332 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -89.97 119.6 30.47 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.715 -1.129 . . . . 1.0 109.978 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.29 -179.0 5.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.977 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.531 ' HB3' HG22 ' B' ' 208' ' ' VAL . 57.1 p-90 -154.31 161.55 41.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.257 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 27.6 mtp180 -146.79 141.86 27.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.813 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.729 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -93.46 130.77 39.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.59 131.48 70.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.044 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.564 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.6 t-80 -81.2 173.0 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 10.8 t70 -54.67 -36.98 65.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.035 0.445 . . . . 1.0 111.222 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.21 -33.78 76.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.219 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.84 12.13 19.24 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 115.087 -0.961 . . . . 1.0 112.659 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.564 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.32 144.06 26.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.819 0.303 . . . . 1.0 111.819 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.5 mm -75.97 116.63 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.007 0.817 . . . . 1.0 109.69 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.729 HD12 ' HG ' ' B' ' 220' ' ' LEU . 18.3 mt -90.57 -44.7 9.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.405 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.47 160.75 43.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.301 -1.318 . . . . 1.0 111.027 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.8 156.34 49.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 16.7 p -52.27 -35.63 50.64 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.378 0.424 . . . . 1.0 111.977 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.58 -46.09 3.53 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -99.32 179.51 4.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.915 -0.643 . . . . 1.0 110.792 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -146.0 137.78 7.12 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.83 171.28 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.68 0.74 . . . . 1.0 111.795 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.36 10.07 39.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.387 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 12.2 m -135.75 134.41 39.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.55 0.69 . . . . 1.0 111.276 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -64.51 -35.66 81.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.915 -1.039 . . . . 1.0 110.462 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.7 tt0 -56.12 -47.64 77.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.292 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -61.42 -40.48 94.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.804 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.54 80.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 1.0 109.768 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.492 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.14 -35.62 81.36 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.411 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.6 mm-40 -64.85 -29.09 70.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.48 -40.95 96.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.954 -1.258 . . . . 1.0 109.954 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' B' ' 242' ' ' LYS . 59.8 mt -62.78 -43.29 98.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.15 -0.525 . . . . 1.0 110.231 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.61 -43.56 98.5 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.648 -0.421 . . . . 1.0 109.921 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.6 m -63.63 -35.21 79.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.83 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -75.06 -41.8 45.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 119.697 -0.801 . . . . 1.0 109.49 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -67.2 -11.62 57.86 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.051 -0.406 . . . . 1.0 111.352 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -103.12 -3.12 26.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.319 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 10.7 m-80 -135.48 -37.45 0.76 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.968 0.358 . . . . 1.0 111.968 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.22 -49.87 90.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 1.0 112.478 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.4 Cg_endo -63.69 -9.53 18.82 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.642 1.562 . . . . 1.0 113.904 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -123.24 -11.57 7.95 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -70.61 138.93 51.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.27 0.557 . . . . 1.0 111.841 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.01 148.65 22.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.012 -0.994 . . . . 1.0 112.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.521 HG22 HG21 ' A' ' 145' ' ' ILE . 44.1 t -84.45 131.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.619 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.1 mt -124.26 139.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -87.66 101.89 14.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.265 -0.874 . . . . 1.0 111.349 -177.157 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 . . . . . 0 CA--C 1.512 -0.486 0 CA-C-O 121.054 0.454 . . . . 1.0 110.478 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -143.05 95.35 2.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.21 -1.404 . . . . 1.0 107.21 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.64 178.96 1.49 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.327 -0.851 . . . . 1.0 109.735 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.426 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.8 p-80 -169.52 147.72 3.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.808 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 48.7 m-85 -87.44 147.95 25.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.848 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -140.64 118.95 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.77 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 118' ' ' TRP . 81.7 t -94.23 135.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.549 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -144.86 -179.6 6.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.469 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -104.28 138.83 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.287 0.565 . . . . 1.0 111.989 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 179.85 7.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.947 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.12 46.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.577 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.23 24.37 10.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.486 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.25 33.17 2.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.654 0.782 . . . . 1.0 111.613 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.2 mttt -107.48 147.17 30.83 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.426 0.631 . . . . 1.0 111.123 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -93.46 118.89 31.88 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.028 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -131.87 179.79 5.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.162 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.562 ' HB3' HG22 ' A' ' 108' ' ' VAL . 58.2 p-90 -154.52 162.24 41.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.212 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.439 HH21 HG13 ' A' ' 127' ' ' ILE . 50.5 mtp180 -147.18 142.45 27.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.515 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.67 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.5 tp -91.48 133.21 35.69 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.67 128.57 69.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.103 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.589 ' CB ' HD21 ' A' ' 126' ' ' ASN . 3.0 t-80 -77.31 172.91 12.55 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.37 -28.17 58.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.598 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.02 -34.67 66.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.71 . . . . 1.0 109.898 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.39 10.1 15.95 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.579 -1.191 . . . . 1.0 112.709 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.589 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.53 142.84 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.748 0.277 . . . . 1.0 111.748 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.439 HG13 HH21 ' A' ' 119' ' ' ARG . 50.6 mm -74.45 119.79 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.92 0.763 . . . . 1.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.67 HD12 ' HG ' ' A' ' 120' ' ' LEU . 14.1 mt -96.88 -43.65 7.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.96 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.45 168.57 23.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.061 -0.972 . . . . 1.0 111.593 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.77 157.99 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.1 p -57.61 -32.26 67.04 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.296 0.57 . . . . 1.0 111.292 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.17 -50.05 3.83 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.493 ' HG2' ' HB ' ' B' ' 227' ' ' ILE . 69.4 mm-40 -100.81 178.96 4.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.446 -0.877 . . . . 1.0 111.424 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.06 137.53 7.97 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.49 166.47 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.096 0.448 . . . . 1.0 111.378 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.95 11.19 25.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.864 0.691 . . . . 1.0 112.864 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -127.97 131.06 49.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.399 0.618 . . . . 1.0 111.044 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.18 -38.23 90.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.882 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.5 tt0 -63.28 -43.16 98.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 1.0 110.027 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.603 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -57.77 -41.34 81.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.895 -178.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.13 74.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.369 0.604 . . . . 1.0 110.318 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.516 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.4 mtmt -64.16 -34.15 77.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.392 -0.822 . . . . 1.0 111.205 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.9 mm-40 -64.8 -30.96 71.99 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.121 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.79 -39.15 93.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.557 -0.83 . . . . 1.0 111.136 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 148' ' ' VAL . 76.8 mt -59.34 -51.47 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.635 0.731 . . . . 1.0 110.49 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -64.6 -35.05 79.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.016 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -66.37 -37.97 86.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.711 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.561 HG22 ' HB2' ' A' ' 152' ' ' ALA . 1.4 p -73.08 -37.46 53.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.132 -0.627 . . . . 1.0 109.618 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.13 -16.33 61.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.538 0.57 . . . . 1.0 112.538 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -104.46 -5.84 21.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.929 0.395 . . . . 1.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -121.69 -37.66 2.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.8 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.561 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.11 -51.03 83.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.829 -0.623 . . . . 1.0 112.602 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 56.0 Cg_endo -68.07 -7.82 20.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.154 1.236 . . . . 1.0 113.385 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.81 -21.14 10.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.157 0.504 . . . . 1.0 111.425 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -70.01 138.69 52.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.649 0.738 . . . . 1.0 112.952 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.37 136.73 36.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.265 -1.334 . . . . 1.0 110.801 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.53 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.82 135.29 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 112.45 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' B' ' 207' ' ' GLU . 6.4 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 114.796 -1.093 . . . . 1.0 109.799 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 121.404 0.621 . . . . 1.0 111.795 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.17 95.62 2.83 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.38 175.37 2.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.138 -0.937 . . . . 1.0 109.526 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.458 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.3 p-80 -170.27 146.38 2.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.101 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.53 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 55.0 m-85 -85.61 147.62 26.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.653 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 158' ' ' ILE . 40.1 mt-10 -141.3 121.9 14.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.546 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.4 t -93.36 131.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -140.99 -179.88 6.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.213 0.321 . . . . 1.0 110.808 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' B' ' 214' ' ' ASP . 1.4 t -102.08 139.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.334 0.588 . . . . 1.0 111.694 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.64 -176.47 5.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.637 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.94 63.7 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.976 -0.453 . . . . 1.0 110.874 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.06 17.08 22.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.603 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.565 ' HA ' HG13 ' B' ' 210' ' ' VAL . 30.1 t70 68.64 44.02 1.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.481 1.134 . . . . 1.0 110.374 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.1 mmtt -112.97 150.86 31.29 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.323 -177.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -91.12 117.82 29.92 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.843 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -133.8 179.18 6.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.631 -1.168 . . . . 1.0 108.368 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.507 ' HB3' HG22 ' B' ' 208' ' ' VAL . 55.3 p-90 -153.33 161.39 42.4 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.702 0.287 . . . . 1.0 111.052 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . 0.427 HH21 HG13 ' B' ' 227' ' ' ILE . 28.3 mtp180 -147.28 143.26 27.96 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.897 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.69 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -93.5 132.55 37.67 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 177.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.86 129.9 72.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.415 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.581 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.0 t-80 -80.77 172.85 13.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.15 -29.53 63.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 1.0 111.587 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -68.11 -33.51 74.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.511 0.672 . . . . 1.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.99 10.56 22.38 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.799 -1.091 . . . . 1.0 112.145 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.581 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.97 142.73 27.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.651 0.241 . . . . 1.0 111.651 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.493 ' HB ' ' HG2' ' A' ' 133' ' ' GLU . 51.2 mm -76.25 118.85 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 123.783 0.677 . . . . 1.0 109.495 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.69 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -93.18 -43.28 8.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.205 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -148.33 164.76 33.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.389 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -141.52 159.03 43.07 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.635 0.774 . . . . 1.0 109.278 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 58.5 p -57.64 -33.62 68.47 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.942 0.401 . . . . 1.0 111.666 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.4 -47.21 3.05 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -104.7 171.87 7.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.615 -0.792 . . . . 1.0 111.205 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -135.4 138.29 9.86 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.94 172.44 12.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.012 0.406 . . . . 1.0 110.883 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.83 10.53 38.66 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.7 m -131.68 131.42 43.11 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.455 0.645 . . . . 1.0 111.608 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -65.07 -35.23 80.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.191 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.0 tt0 -56.61 -46.48 80.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.819 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.96 -42.05 97.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.536 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.9 79.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.441 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.0 mtmt -64.05 -36.69 84.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.426 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 30.0 mm-40 -63.87 -32.93 74.62 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.763 -0.375 . . . . 1.0 109.99 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.88 94.13 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.532 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.7 mt -60.31 -51.57 71.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.542 0.686 . . . . 1.0 110.498 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.97 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.9 m -65.72 -37.6 86.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.366 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.572 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -72.9 -40.1 59.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.648 -177.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -64.03 -15.17 58.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -101.32 -10.45 20.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.042 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.68 -37.57 2.47 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.572 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.12 -51.9 75.7 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 43.0 Cg_endo -65.4 -10.64 26.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.19 1.26 . . . . 1.0 113.56 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.19 -13.9 11.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.702 0.287 . . . . 1.0 111.766 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.426 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -72.95 138.68 46.27 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.62 134.05 34.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.557 -1.201 . . . . 1.0 111.188 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -87.24 131.46 35.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.354 0.597 . . . . 1.0 111.977 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.9 mt -118.74 143.76 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.934 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -90.28 104.21 16.81 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.183 -177.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 . . . . . 0 CA--C 1.515 -0.372 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -138.22 93.46 2.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.91 179.69 1.02 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.567 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.42 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 47.8 p-80 -170.1 144.54 2.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 1.0 109.963 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.583 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.1 m-85 -84.71 149.3 25.88 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.161 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.69 118.77 11.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 118' ' ' TRP . 79.3 t -94.57 133.17 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.711 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -142.99 179.64 6.91 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.393 0.433 . . . . 1.0 110.603 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -101.68 135.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.736 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.26 179.46 7.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.353 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.57 39.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.622 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -117.7 20.19 13.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.134 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 69.46 37.13 2.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.203 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.8 mmtt -109.2 150.73 27.48 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.071 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 93.1 m-85 -93.05 112.39 24.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.65 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -129.33 178.62 6.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.558 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.8 p-90 -151.73 163.38 39.27 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 120.854 -0.338 . . . . 1.0 111.437 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 49.4 mtp180 -148.4 141.62 25.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.5 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.684 ' HG ' HD12 ' A' ' 128' ' ' LEU . 35.4 tp -93.75 134.45 36.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.73 131.03 68.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.628 ' CB ' HD21 ' A' ' 126' ' ' ASN . 6.0 t-80 -77.23 171.2 15.22 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -18.08 52.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.146 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -34.11 35.22 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.635 0.731 . . . . 1.0 109.638 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.32 9.29 15.45 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.871 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.628 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.55 145.15 25.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.338 0.113 . . . . 1.0 110.944 178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.4 mm -79.33 118.96 27.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.684 HD12 ' HG ' ' A' ' 120' ' ' LEU . 16.3 mt -90.78 -42.2 10.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.555 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.31 163.31 39.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.973 -1.012 . . . . 1.0 111.883 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.78 152.83 49.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.192 -0.913 . . . . 1.0 108.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 85.7 p -55.54 -34.04 64.36 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.982 0.42 . . . . 1.0 111.486 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.3 -45.92 3.45 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 47.1 mt-10 -109.27 168.59 9.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.799 -0.7 . . . . 1.0 111.562 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.24 145.84 16.34 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.174 -1.17 . . . . 1.0 110.174 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.56 165.59 25.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.245 0.522 . . . . 1.0 111.046 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.26 9.85 32.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.59 -0.732 . . . . 1.0 112.51 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 m -136.38 133.73 37.07 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.076 0.465 . . . . 1.0 110.775 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 6.8 ptpp? -63.87 -36.53 84.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.6 tt0 -56.89 -46.05 82.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.673 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.05 -39.19 91.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.8 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.29 72.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.313 0.578 . . . . 1.0 109.898 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.5 mtmt -65.28 -33.28 75.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.308 -0.86 . . . . 1.0 111.072 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.1 mm-40 -65.44 -31.84 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.178 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.98 95.15 Favored Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 142' ' ' LYS . 73.2 mt -60.66 -51.28 74.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.813 -0.694 . . . . 1.0 110.428 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.83 -33.03 74.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.468 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.6 m -68.06 -35.69 78.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.786 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' B' ' 229' ' ' ALA . 0.4 OUTLIER -72.61 -39.7 61.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -178.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.65 -16.12 63.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.326 0.584 . . . . 1.0 111.148 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -99.68 -1.43 37.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.799 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -137.24 -42.42 0.56 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.711 0.634 . . . . 1.0 112.711 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.69 -50.7 84.2 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 113.356 0.873 . . . . 1.0 113.356 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 42.5 Cg_endo -64.69 -9.41 20.74 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.248 1.299 . . . . 1.0 113.061 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.5 -12.22 8.59 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.861 0.362 . . . . 1.0 111.831 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.34 136.04 44.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.065 0.459 . . . . 1.0 111.443 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -96.44 145.12 25.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.511 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -90.88 129.5 41.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.84 0.828 . . . . 1.0 112.514 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.3 mt . . . . . 0 C--N 1.32 -0.702 0 CA-C-N 114.282 -1.326 . . . . 1.0 109.888 -179.899 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 121.373 0.606 . . . . 1.0 112.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -132.83 97.81 4.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.18 166.99 4.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.109 -1.405 . . . . 1.0 108.402 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.498 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 40.5 p-80 -168.69 149.52 4.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.512 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.5 m-85 -85.28 149.93 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.393 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -141.83 120.14 12.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.211 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' B' ' 218' ' ' TRP . 55.3 t -92.88 135.75 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.439 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -149.49 179.55 7.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.658 0.266 . . . . 1.0 110.724 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -101.77 140.13 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 16.1 t70 -83.47 -178.8 7.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.018 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . 0.413 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -71.01 -11.52 61.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.352 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.15 26.08 10.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.038 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 62.84 39.48 10.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.058 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 71.8 mmtt -103.8 156.03 18.14 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.33 117.96 32.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -134.16 -179.23 5.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.78 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.489 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.4 p-90 -154.08 162.43 41.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.503 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 40.4 mtp180 -147.41 141.67 26.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.2 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.707 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.2 tp -93.75 131.2 39.33 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.33 132.17 65.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.412 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.618 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.2 t-80 -80.89 170.34 16.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.77 -27.1 64.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.069 0.462 . . . . 1.0 110.895 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -66.97 -33.24 75.13 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.503 0.668 . . . . 1.0 109.977 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.99 9.84 25.47 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.695 -1.139 . . . . 1.0 112.261 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.618 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.99 143.81 27.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.395 0.141 . . . . 1.0 111.02 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.447 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.5 mm -80.27 117.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.707 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.8 mt -89.7 -41.25 12.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.746 . . . . 1.0 109.276 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -154.26 164.7 38.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.585 -1.189 . . . . 1.0 111.743 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -138.6 159.11 42.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.858 -1.064 . . . . 1.0 108.328 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 63.2 p -55.55 -30.78 61.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.149 0.5 . . . . 1.0 111.185 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.99 -40.12 3.04 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . 0.504 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.1 mt-10 -116.42 169.45 9.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.118 -0.541 . . . . 1.0 111.107 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -128.86 132.82 7.36 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.38 172.78 9.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.94 0.37 . . . . 1.0 111.808 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.63 9.8 41.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -136.02 131.95 35.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.957 0.408 . . . . 1.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -63.81 -36.47 84.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.694 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.449 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.6 tt0 -57.57 -42.59 83.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.281 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.68 -40.69 95.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.469 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.41 86.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.315 0.578 . . . . 1.0 109.975 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.492 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.7 mtmt -64.05 -35.25 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.264 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.8 mm-40 -65.27 -34.3 78.01 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.67 98.02 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.519 ' O ' HG12 ' B' ' 248' ' ' VAL . 65.9 mt -60.75 -52.24 63.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.39 0.614 . . . . 1.0 110.706 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.19 -36.66 84.78 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.167 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.2 m -64.16 -36.52 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.881 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -73.4 -40.18 55.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 -178.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.99 -15.59 62.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.739 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -100.54 -2.95 31.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.918 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 17.4 m-80 -135.66 -37.73 0.75 Allowed 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.575 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.18 -50.21 87.86 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 54.0 Cg_endo -65.96 -8.9 21.29 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.026 1.15 . . . . 1.0 113.797 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.53 -19.21 8.88 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -66.48 136.99 56.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.447 0.641 . . . . 1.0 112.619 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -92.88 135.9 33.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.819 -1.082 . . . . 1.0 111.286 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.583 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -85.23 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.635 0.731 . . . . 1.0 112.185 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.6 mt -116.38 140.7 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.489 -1.232 . . . . 1.0 109.366 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -86.62 107.34 18.12 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.285 -0.864 . . . . 1.0 111.182 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 . . . . . 0 CA--C 1.509 -0.597 0 CA-C-O 121.398 0.618 . . . . 1.0 111.76 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -125.9 99.35 5.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 172.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.41 163.7 3.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.511 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.0 p-80 -167.25 148.89 5.8 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.919 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.6 m-85 -87.93 148.47 24.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.719 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -141.21 119.27 11.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.387 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 118' ' ' TRP . 77.2 t -89.89 131.45 37.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -140.33 -179.65 6.12 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.059 0.224 . . . . 1.0 110.537 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.6 t -102.28 137.9 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.245 0.545 . . . . 1.0 112.341 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.84 179.8 7.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.193 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 -19.65 65.33 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.919 0.39 . . . . 1.0 110.765 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.02 21.08 17.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.72 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.441 ' HA ' HG13 ' A' ' 110' ' ' VAL . 3.6 m-20 69.83 37.13 1.87 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.66 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.0 mttt -110.72 150.54 28.92 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.981 -176.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -93.04 121.06 34.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.835 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 55.7 mtp180 -134.27 -176.78 4.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.661 -1.154 . . . . 1.0 108.109 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.521 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.8 p-90 -151.89 165.6 34.05 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.912 -0.715 . . . . 1.0 112.337 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -144.48 140.38 28.88 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.423 -1.262 . . . . 1.0 111.234 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.724 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.9 tp -100.85 132.06 46.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.32 132.6 69.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.512 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.468 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.4 t-80 -83.07 177.64 8.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 1.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 11.7 t70 -51.5 -44.47 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.06 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.407 ' HB2' ' OD1' ' A' ' 126' ' ' ASN . 1.2 m-20 -67.42 -33.65 75.61 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.308 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.52 10.48 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.546 -0.752 . . . . 1.0 113.468 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -86.45 147.77 25.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.606 0.224 . . . . 1.0 111.606 177.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.3 mm -74.14 119.77 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.796 0.685 . . . . 1.0 109.57 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.724 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.8 mt -94.94 -43.86 7.98 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.271 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.423 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.71 166.85 30.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.923 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -139.35 160.36 40.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.026 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.433 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 68.0 p -58.74 -38.49 78.52 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.34 -42.28 3.08 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -91.47 173.49 7.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.719 -0.74 . . . . 1.0 110.776 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.47 125.7 1.66 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.85 171.21 14.74 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 120.431 0.157 . . . . 1.0 110.609 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.24 9.54 28.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.0 p -121.53 129.57 52.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.538 0.685 . . . . 1.0 112.551 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -64.94 -42.84 94.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.893 . . . . 1.0 111.173 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.1 tt0 -55.15 -45.0 75.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.459 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.557 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -56.98 -42.77 80.83 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.81 76.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.016 0.436 . . . . 1.0 110.402 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.496 ' HG2' HG21 ' A' ' 108' ' ' VAL . 45.3 mtmt -62.98 -38.65 91.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -63.46 -26.28 68.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.72 -43.85 93.44 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.093 -1.203 . . . . 1.0 110.093 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.486 ' O ' HG12 ' A' ' 148' ' ' VAL . 59.7 mt -62.18 -45.09 99.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.564 0.697 . . . . 1.0 110.169 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -62.74 -39.9 95.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -67.87 -34.71 77.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.57 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -72.93 -40.38 59.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.264 -177.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.89 -12.57 59.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.132 0.491 . . . . 1.0 111.651 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -103.4 -2.53 26.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.475 -0.784 . . . . 1.0 111.154 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.422 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.58 -39.14 1.14 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.887 -177.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.64 -50.09 88.96 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.388 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.6 Cg_endo -64.44 -16.57 55.85 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.163 1.242 . . . . 1.0 113.095 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -106.84 -23.9 12.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.498 . . . . 1.0 111.33 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.28 135.55 55.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.452 -0.794 . . . . 1.0 112.874 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -96.56 148.75 22.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.558 -1.201 . . . . 1.0 111.792 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.574 HG22 HG21 ' B' ' 245' ' ' ILE . 40.1 t -85.27 131.38 34.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 1.0 112.061 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 175.667 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.422 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 6.4 p-10 . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.705 0.764 . . . . 1.0 111.98 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 13.1 mmmm -142.27 99.67 3.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.068 -1.424 . . . . 1.0 107.592 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.36 169.94 4.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.124 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.499 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 50.2 p-80 -169.53 150.11 4.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.444 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.8 m-85 -87.72 150.33 23.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.336 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.52 118.01 10.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.383 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' B' ' 218' ' ' TRP . 94.0 t -95.42 133.42 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.84 175.57 9.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.2 t -100.66 135.97 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.283 0.563 . . . . 1.0 111.536 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -82.11 178.29 8.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.997 -1.001 . . . . 1.0 110.101 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.91 -10.62 59.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.185 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.93 19.69 17.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.357 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 70.17 36.1 1.96 Allowed 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.165 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.6 mttt -110.05 144.76 38.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.459 -176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.63 111.72 23.41 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.972 -1.467 . . . . 1.0 109.345 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -128.74 175.37 8.66 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.569 ' HB3' HG22 ' B' ' 208' ' ' VAL . 53.5 p-90 -153.4 162.15 41.57 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.014 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -144.17 151.35 39.4 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.456 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.707 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -98.58 131.2 44.98 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 13.7 t -128.55 133.56 66.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.361 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.571 ' CB ' HD21 ' B' ' 226' ' ' ASN . 3.0 t-80 -82.2 173.25 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 16.5 t70 -58.02 -27.42 63.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.196 0.522 . . . . 1.0 110.963 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.12 -33.28 67.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.514 0.673 . . . . 1.0 110.165 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.42 10.28 22.09 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.848 -1.069 . . . . 1.0 112.772 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.571 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.64 142.96 27.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.671 0.272 . . . . 1.0 111.566 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.4 mm -74.75 123.57 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.583 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.707 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -100.56 -42.96 6.35 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.045 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -147.71 167.38 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.801 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 231' ' ' SER . 15.2 t0 -141.81 153.24 44.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.034 -0.985 . . . . 1.0 108.459 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 55.0 p -58.35 -40.31 81.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 1.0 112.098 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.97 -41.12 3.03 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.21 177.25 6.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.185 -0.508 . . . . 1.0 110.667 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -167.86 114.59 0.58 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -142.37 166.04 25.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.564 0.221 . . . . 1.0 110.493 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.96 6.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.117 0.784 . . . . 1.0 113.117 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 13.2 p -112.12 127.36 55.9 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.694 0.759 . . . . 1.0 111.994 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -68.37 -40.77 81.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.112 -0.949 . . . . 1.0 110.952 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.2 tt0 -56.43 -46.12 80.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.297 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -42.95 85.57 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.296 0.372 . . . . 1.0 110.972 -178.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.39 70.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 1.0 110.646 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -63.3 -38.01 89.47 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.24 -0.891 . . . . 1.0 111.222 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.8 mm-40 -63.4 -28.03 69.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.76 -43.45 97.71 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.574 HG21 HG22 ' A' ' 157' ' ' VAL . 48.7 mt -63.48 -46.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.435 0.636 . . . . 1.0 110.698 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.36 -38.24 88.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.23 0.538 . . . . 1.0 110.213 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -35.25 78.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.572 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.2 -41.48 58.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.535 -177.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -65.85 -15.13 62.63 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 1.0 112.121 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -104.74 -2.34 25.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.866 0.365 . . . . 1.0 111.315 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -127.8 -37.44 1.94 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.415 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.11 -51.09 82.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.893 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.0 Cg_endo -66.43 -12.29 35.08 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.168 1.245 . . . . 1.0 113.462 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.15 -27.48 10.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.576 0.703 . . . . 1.0 111.577 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.38 136.87 57.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.977 1.103 . . . . 1.0 113.977 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.65 139.08 30.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -88.79 131.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.38 0.61 . . . . 1.0 111.816 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.57 144.44 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.873 -1.058 . . . . 1.0 109.004 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -88.59 102.32 14.83 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.115 -0.945 . . . . 1.0 111.236 -177.295 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 9.9 p-10 . . . . . 0 CA--C 1.509 -0.611 0 CA-C-O 121.408 0.623 . . . . 1.0 112.007 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 100.59 6.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.014 -1.476 . . . . 1.0 107.014 172.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -172.3 165.42 5.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.455 -1.248 . . . . 1.0 108.163 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.53 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.4 p-80 -167.81 150.21 5.69 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.56 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 57.1 m-85 -86.38 148.53 25.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.734 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.6 121.97 14.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.868 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 118' ' ' TRP . 92.1 t -95.05 135.98 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.9 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.17 178.08 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.714 0.293 . . . . 1.0 110.543 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 2.9 t -101.22 133.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.343 0.592 . . . . 1.0 110.898 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.67 178.78 7.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.711 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -12.7 61.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.174 0.511 . . . . 1.0 110.929 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.39 18.75 19.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.346 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 71.1 35.2 1.67 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.794 0.838 . . . . 1.0 111.567 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.6 mttt -109.72 148.58 31.15 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.254 -175.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.32 112.21 24.07 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.329 -1.305 . . . . 1.0 109.383 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -132.95 178.31 6.98 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.401 -0.962 . . . . 1.0 108.401 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.565 ' HB3' HG22 ' A' ' 108' ' ' VAL . 53.3 p-90 -150.09 164.0 36.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.813 0.34 . . . . 1.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -146.83 147.22 30.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.127 -0.942 . . . . 1.0 109.805 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.689 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.7 tp -96.65 134.69 39.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.1 t -128.06 131.07 69.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.448 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.579 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.0 t-80 -79.59 173.87 12.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.85 -39.39 68.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.279 0.562 . . . . 1.0 110.455 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -33.44 74.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.046 -0.979 . . . . 1.0 110.642 -177.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.34 9.75 23.14 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.837 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.579 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.45 144.69 26.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.689 0.255 . . . . 1.0 111.689 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.2 119.49 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.762 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.689 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.5 mt -94.93 -43.92 7.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.639 0.733 . . . . 1.0 109.9 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.39 166.74 28.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.635 -1.166 . . . . 1.0 111.367 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -141.17 153.5 45.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.951 -1.022 . . . . 1.0 108.464 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.501 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 15.8 p -53.37 -36.57 61.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.006 0.372 . . . . 1.0 112.006 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.69 -45.92 3.56 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.526 -0.63 . . . . 1.0 111.526 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -93.49 174.4 7.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.285 0.564 . . . . 1.0 111.507 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.53 136.92 8.68 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.94 165.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 117.627 0.714 . . . . 1.0 111.094 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.09 10.98 37.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.218 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 m -139.64 137.28 35.14 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.483 0.659 . . . . 1.0 111.543 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -63.22 -39.58 95.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.861 -1.063 . . . . 1.0 111.047 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.3 tt0 -58.31 -47.02 85.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.268 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.9 -44.57 86.87 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.61 0.569 . . . . 1.0 110.976 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.29 83.36 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.266 0.555 . . . . 1.0 110.612 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.539 ' HG2' HG21 ' A' ' 108' ' ' VAL . 44.5 mtmt -64.56 -35.32 80.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.383 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -64.78 -27.92 69.22 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.88 91.97 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 142' ' ' LYS . 63.5 mt -61.43 -43.04 96.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 1.0 110.338 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.83 -40.07 94.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.5 m -63.54 -36.36 83.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.599 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.53 -42.78 55.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 C-N-CA 119.826 -0.75 . . . . 1.0 109.529 -178.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.17 -11.77 51.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -102.54 -2.31 28.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 1.0 110.664 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.429 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 23.9 m-80 -135.52 -37.77 0.76 Allowed 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.787 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.504 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.49 -49.7 91.08 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 44.4 Cg_endo -67.0 -11.96 34.27 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.322 1.348 . . . . 1.0 112.855 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -110.64 -19.8 12.75 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.065 0.46 . . . . 1.0 111.408 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.533 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -70.83 134.71 47.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.896 0.855 . . . . 1.0 113.153 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -94.53 142.25 27.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.22 -1.355 . . . . 1.0 110.317 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -90.67 134.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.237 0.541 . . . . 1.0 112.088 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt . . . . . 0 N--CA 1.45 -0.443 0 CA-C-N 114.902 -1.045 . . . . 1.0 109.192 177.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.429 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 9.3 p-10 . . . . . 0 CA--C 1.515 -0.374 0 CA-C-O 121.475 0.655 . . . . 1.0 112.189 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' B' ' 223' ' ' ASP . 0.0 OUTLIER -126.17 101.16 6.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 172.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.17 159.3 3.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.136 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.533 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 44.9 p-80 -166.95 150.81 6.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.744 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.574 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.6 m-85 -86.34 150.19 24.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.693 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -142.49 118.21 10.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.615 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' B' ' 218' ' ' TRP . 97.2 t -95.09 132.8 38.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.127 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.74 177.66 8.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.2 t -100.03 136.36 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.483 0.659 . . . . 1.0 112.346 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.7 -179.78 7.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.802 -1.09 . . . . 1.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.515 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.45 20.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.917 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 71.13 34.67 1.77 Allowed 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.498 0.719 . . . . 1.0 110.901 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.9 mttt -108.64 147.94 31.12 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.56 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -94.17 109.11 20.92 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.409 -1.269 . . . . 1.0 109.822 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -122.02 176.13 5.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.575 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.1 p-90 -150.62 162.76 40.04 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.28 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -147.28 146.71 29.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.197 -0.91 . . . . 1.0 110.247 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.741 ' HG ' HD12 ' B' ' 228' ' ' LEU . 35.0 tp -99.31 132.58 44.54 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 4.2 t -126.64 133.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.077 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.524 ' HB2' HD21 ' B' ' 228' ' ' LEU . 1.6 t-80 -86.09 176.55 7.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.389 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' B' ' 203' ' ' LYS . 43.2 t0 -52.61 -43.37 65.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.176 -0.92 . . . . 1.0 110.847 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.05 -33.6 75.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.617 -0.72 . . . . 1.0 110.47 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.45 12.34 19.63 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.493 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.512 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.43 144.84 27.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.59 0.218 . . . . 1.0 111.59 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.99 116.94 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.741 HD12 ' HG ' ' B' ' 220' ' ' LEU . 17.7 mt -89.19 -43.23 11.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.742 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.478 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.07 164.92 35.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 1.0 111.471 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -139.48 156.82 46.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.379 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.457 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 13.6 p -53.89 -35.08 61.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.78 -47.04 3.37 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -104.93 177.59 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.921 -0.64 . . . . 1.0 111.796 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -137.2 135.24 7.52 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.899 -1.28 . . . . 1.0 109.899 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -133.1 165.48 24.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.385 0.592 . . . . 1.0 111.78 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.62 10.9 26.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.9 m -138.48 135.83 35.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.46 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -64.14 -38.18 90.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.703 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.4 tt0 -59.84 -43.01 94.81 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.194 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -61.57 -40.64 95.46 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.793 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.33 87.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.307 0.575 . . . . 1.0 109.854 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' B' ' 245' ' ' ILE . 41.0 mtmt -64.79 -35.3 80.66 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.914 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.0 mm-40 -62.18 -29.05 70.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.705 -0.48 . . . . 1.0 109.705 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.95 -42.81 94.6 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' B' ' 242' ' ' LYS . 57.3 mt -63.67 -44.16 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.235 0.54 . . . . 1.0 110.186 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -62.27 -40.88 97.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.974 0.416 . . . . 1.0 110.295 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.55 -35.0 79.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.504 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.3 OUTLIER -74.13 -41.96 51.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.478 -177.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.62 -11.76 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.816 -0.552 . . . . 1.0 111.832 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -104.79 -5.71 20.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.24 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 10.1 m-80 -130.08 -39.4 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.026 0.38 . . . . 1.0 112.026 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.574 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.74 -50.04 89.35 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 28.7 Cg_endo -62.03 -16.74 51.99 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.336 1.357 . . . . 1.0 113.187 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.64 -29.36 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.272 0.558 . . . . 1.0 111.899 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -59.11 135.92 57.79 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.644 0.979 . . . . 1.0 113.644 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -93.7 141.08 28.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.802 -1.545 . . . . 1.0 110.252 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.532 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.56 133.41 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.498 0.666 . . . . 1.0 112.233 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -119.41 146.76 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.691 -1.14 . . . . 1.0 109.034 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.95 104.1 16.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.088 -0.958 . . . . 1.0 111.873 -176.348 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 16.4 p-10 . . . . . 0 CA--C 1.519 -0.224 0 CA-C-O 121.373 0.606 . . . . 1.0 112.34 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -131.87 97.22 4.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.98 168.24 4.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.055 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.527 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 31.8 p-80 -171.45 151.21 2.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.301 -0.259 . . . . 1.0 110.301 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -88.5 150.38 23.14 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.062 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.83 119.64 12.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.26 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 118' ' ' TRP . 73.4 t -93.97 131.69 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.975 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.43 179.78 6.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.772 0.32 . . . . 1.0 110.823 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.7 t -102.21 137.83 28.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.239 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.54 -179.97 7.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.939 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.17 -12.36 61.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.429 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.22 20.03 16.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.767 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 71.33 35.18 1.59 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.562 0.745 . . . . 1.0 111.249 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 9.5 mmtt -108.71 153.31 23.63 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.203 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -96.6 118.3 32.8 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.643 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.0 mtm105 -133.51 -179.99 5.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.516 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.7 p-90 -150.09 170.58 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.377 0.608 . . . . 1.0 112.366 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -148.41 141.88 25.33 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.448 -1.251 . . . . 1.0 110.63 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.737 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.6 tp -102.15 129.8 48.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 174.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.52 134.65 61.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 121.08 -0.248 . . . . 1.0 110.726 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.609 ' CB ' HD21 ' A' ' 126' ' ' ASN . 1.7 t-80 -83.04 172.25 12.93 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 177.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -57.14 -30.55 64.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.958 0.409 . . . . 1.0 111.843 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -68.26 -33.6 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.3 0.571 . . . . 1.0 110.037 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.76 11.76 16.09 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.069 -0.969 . . . . 1.0 112.347 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.609 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.94 142.02 27.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.841 -0.18 . . . . 1.0 111.086 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.6 mm -77.58 118.19 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.921 0.763 . . . . 1.0 109.711 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.737 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.2 mt -89.83 -40.06 12.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.413 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.16 164.52 37.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.781 -1.1 . . . . 1.0 111.917 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.53 154.27 49.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.826 -1.079 . . . . 1.0 108.723 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 118' ' ' TRP . 77.6 p -55.59 -41.47 73.44 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.13 -35.52 2.77 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.441 -0.664 . . . . 1.0 111.441 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 49.4 mt-10 -94.71 174.92 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.19 0.519 . . . . 1.0 111.132 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.54 124.12 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.739 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -146.03 179.44 7.48 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.56 9.42 41.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.768 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.6 m -117.59 128.86 55.35 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.675 0.75 . . . . 1.0 111.664 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -69.52 -32.07 70.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.573 -1.194 . . . . 1.0 110.214 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.3 tt0 -63.06 -44.83 94.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.112 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 133' ' ' GLU . 27.5 tptp -60.87 -37.07 80.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.681 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.83 75.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.194 0.521 . . . . 1.0 109.962 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.458 ' HA ' HD12 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.97 -36.96 86.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.3 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.6 mm-40 -61.65 -27.44 68.68 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.14 -43.62 89.46 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.07 -1.212 . . . . 1.0 110.07 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.524 HG21 HG22 ' B' ' 257' ' ' VAL . 54.4 mt -63.29 -44.48 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.318 0.58 . . . . 1.0 109.97 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.09 -43.78 98.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.354 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.0 m -64.09 -34.93 79.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.745 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -73.5 -43.25 55.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 C-N-CA 119.897 -0.721 . . . . 1.0 109.653 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -67.6 -11.92 59.22 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.042 -0.411 . . . . 1.0 111.729 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -104.11 -2.35 25.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.807 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.428 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.1 m-80 -137.04 -37.2 0.65 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.89 -50.14 87.85 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -64.89 -11.12 28.0 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.329 1.353 . . . . 1.0 113.226 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.88 -22.42 11.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.065 0.459 . . . . 1.0 111.394 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -67.84 137.77 55.58 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.269 0.84 . . . . 1.0 113.269 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -100.11 154.21 18.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.3 -1.318 . . . . 1.0 111.489 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.516 HG22 HG21 ' B' ' 245' ' ' ILE . 36.1 t -87.61 133.45 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.995 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 176.54 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.428 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.5 p-10 . . . . . 0 CA--C 1.514 -0.427 0 CA-C-O 121.685 0.755 . . . . 1.0 112.878 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -135.75 97.76 3.74 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.571 -1.649 . . . . 1.0 106.971 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.31 167.46 4.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.322 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.469 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 44.3 p-80 -169.32 149.63 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.738 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -85.9 151.17 23.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -140.93 120.68 13.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.568 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' B' ' 218' ' ' TRP . 81.0 t -94.33 133.35 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.654 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -140.18 -178.79 5.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.101 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.9 t -108.36 138.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.333 0.494 . . . . 1.0 112.333 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.8 178.57 8.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.748 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.23 -18.86 65.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.735 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.89 23.09 14.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.112 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 62.64 40.87 9.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.854 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.2 mmtt -102.1 158.66 16.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -102.47 118.48 36.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -132.03 179.08 6.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.52 ' HB3' HG22 ' B' ' 208' ' ' VAL . 52.5 p-90 -149.0 171.05 16.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.588 0.709 . . . . 1.0 112.317 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -147.43 142.49 27.07 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.205 -1.361 . . . . 1.0 110.649 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.696 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.0 tp -100.46 129.39 46.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.56 135.0 61.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.363 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.62 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.5 t-80 -81.73 168.59 17.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.46 -17.73 55.78 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.947 0.403 . . . . 1.0 111.419 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -74.25 -33.9 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.546 0.689 . . . . 1.0 109.488 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.59 10.91 15.89 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 114.41 -1.268 . . . . 1.0 112.596 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.62 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -90.54 143.26 26.92 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.265 0.226 . . . . 1.0 111.481 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.81 127.01 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 123.675 0.609 . . . . 1.0 109.513 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.696 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -103.81 -40.75 6.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.231 0.539 . . . . 1.0 109.99 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.86 164.86 36.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.908 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' B' ' 231' ' ' SER . 10.2 t0 -139.22 151.88 46.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.829 -1.078 . . . . 1.0 108.186 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 11.9 p -51.51 -36.47 44.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.864 0.32 . . . . 1.0 111.864 176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.62 -45.32 3.34 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.355 -0.698 . . . . 1.0 111.355 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . 0.553 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 89.0 mt-10 -113.26 171.26 7.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.559 . . . . 1.0 111.011 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.99 141.3 9.55 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.05 174.27 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.603 0.24 . . . . 1.0 110.458 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -86.17 10.83 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 -176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.3 m -128.61 131.17 48.1 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 121.74 -0.6 . . . . 1.0 111.336 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' B' ' 242' ' ' LYS . 20.3 ptmt -66.51 -34.87 78.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.627 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.8 tt0 -57.16 -43.99 83.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.905 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.4 OUTLIER -60.49 -40.88 92.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.22 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.25 78.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.217 0.532 . . . . 1.0 110.376 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' B' ' 238' ' ' LYS . 44.9 mtmt -63.0 -41.11 99.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.91 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.5 mm-40 -64.79 -26.22 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.134 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.27 -42.56 96.15 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.029 -1.228 . . . . 1.0 110.029 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.516 HG21 HG22 ' A' ' 157' ' ' VAL . 57.5 mt -62.23 -46.16 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 1.0 110.161 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.41 -40.3 96.06 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.201 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.02 -34.18 77.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.662 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.01 -43.03 52.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.888 -177.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -65.95 -12.01 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 1.0 111.848 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -102.63 -3.09 27.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.786 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 13.5 m-80 -135.65 -36.36 0.78 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -176.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.16 -50.41 87.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.538 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.4 Cg_endo -63.47 -14.12 40.4 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.444 1.43 . . . . 1.0 113.254 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.45 -21.49 12.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.88 0.371 . . . . 1.0 111.906 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.51 138.18 57.9 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.131 0.789 . . . . 1.0 113.131 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -97.05 150.38 20.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.328 -1.305 . . . . 1.0 112.053 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 145' ' ' ILE . 36.2 t -85.53 133.93 28.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.258 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.44 143.95 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.78 102.4 13.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.595 -0.717 . . . . 1.0 110.892 -178.14 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.432 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 17.7 p-10 . . . . . 0 CA--C 1.511 -0.535 0 CA-C-O 121.468 0.651 . . . . 1.0 112.744 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.5 mptt -121.63 97.4 5.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.03 167.48 4.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.451 -1.249 . . . . 1.0 108.426 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.469 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 52.3 p-80 -168.88 148.37 4.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.929 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.563 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.9 m-85 -86.27 149.09 25.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.868 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -142.56 121.43 12.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.759 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.5 t -97.09 136.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -147.25 -179.26 6.71 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.245 0.341 . . . . 1.0 110.593 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -105.82 138.5 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.394 0.616 . . . . 1.0 112.082 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.23 178.54 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.744 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.21 63.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.046 0.45 . . . . 1.0 111.162 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.71 22.22 16.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.444 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 70.62 33.18 2.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.687 0.795 . . . . 1.0 111.236 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.4 mttt -107.42 146.56 31.53 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.517 0.675 . . . . 1.0 111.941 -175.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -92.9 115.76 28.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.198 -1.364 . . . . 1.0 109.802 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -128.99 179.36 5.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.203 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.587 ' HB3' HG22 ' A' ' 108' ' ' VAL . 54.9 p-90 -154.5 165.49 36.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.1 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 16.4 mtt180 -149.09 150.63 33.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 124.016 0.823 . . . . 1.0 110.497 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.712 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.0 tp -99.83 132.02 45.44 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.86 129.72 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.554 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.62 ' CB ' HD21 ' A' ' 126' ' ' ASN . 3.0 t-80 -78.23 172.62 13.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.03 -32.39 66.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.15 0.5 . . . . 1.0 110.959 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -65.29 -33.73 76.67 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.203 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.66 14.22 16.39 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.078 -0.965 . . . . 1.0 112.384 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.62 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.34 143.6 26.6 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 178.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mm -74.96 118.64 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 123.926 0.766 . . . . 1.0 109.566 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.712 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.3 mt -93.87 -43.41 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.384 0.612 . . . . 1.0 109.799 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.479 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.21 163.74 37.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.367 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -139.07 156.86 46.86 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.8 p -53.74 -31.5 48.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.931 0.396 . . . . 1.0 111.401 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.06 -38.26 2.98 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.502 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 49.9 mt-10 -118.3 171.39 8.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.048 -0.576 . . . . 1.0 110.951 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.42 138.66 10.49 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -133.43 169.43 16.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.32 0.56 . . . . 1.0 111.982 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.01 10.72 30.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -142.5 139.22 31.42 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.815 -0.553 . . . . 1.0 111.9 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.64 -37.48 87.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.461 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.449 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.9 tt0 -59.03 -46.67 87.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.544 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -59.12 -41.59 88.55 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.614 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.11 75.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.09 0.471 . . . . 1.0 109.861 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 145' ' ' ILE . 43.9 mtmt -64.21 -34.73 78.76 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.344 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.0 mm-40 -63.69 -27.13 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.76 -42.38 87.02 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 142' ' ' LYS . 66.5 mt -62.2 -44.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.414 0.626 . . . . 1.0 109.637 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -61.52 -44.77 96.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.239 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.8 m -63.56 -34.83 78.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.751 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -74.55 -41.61 48.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 C-N-CA 119.878 -0.729 . . . . 1.0 109.684 -177.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.36 -12.1 54.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.753 0.311 . . . . 1.0 111.657 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -104.63 -2.8 24.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.591 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -132.02 -40.58 1.04 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.835 0.35 . . . . 1.0 111.502 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.15 -51.48 79.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.617 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -63.54 -9.0 16.52 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.508 1.472 . . . . 1.0 113.98 -177.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.58 -22.19 7.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.918 0.39 . . . . 1.0 111.939 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 136.52 57.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.777 0.799 . . . . 1.0 113.038 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.93 138.78 31.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.438 -1.255 . . . . 1.0 110.581 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.567 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.69 130.65 38.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.711 . . . . 1.0 112.699 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.8 mt . . . . . 0 N--CA 1.446 -0.649 0 CA-C-N 114.369 -1.287 . . . . 1.0 108.568 177.496 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 CA--C 1.514 -0.423 0 CA-C-O 121.022 0.439 . . . . 1.0 110.787 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 73.3 mmtt -137.73 95.77 3.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.609 -1.256 . . . . 1.0 107.609 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.91 173.03 2.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.094 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.496 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.6 p-80 -170.7 147.59 2.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.583 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.567 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 57.6 m-85 -85.16 147.61 26.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.654 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.37 119.55 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.08 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' B' ' 218' ' ' TRP . 75.4 t -92.14 133.93 31.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.151 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -145.66 -176.43 5.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.619 0.247 . . . . 1.0 110.4 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.8 t -101.99 139.42 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.909 0.707 . . . . 1.0 112.909 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -81.22 -178.65 7.01 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.309 -0.86 . . . . 1.0 109.548 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.82 -16.96 62.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.154 0.502 . . . . 1.0 110.673 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.37 19.33 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.712 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.67 39.99 1.44 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.425 0.69 . . . . 1.0 110.956 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -113.76 151.86 31.38 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.791 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -91.99 118.87 31.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.158 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.433 ' HG2' ' HA2' ' B' ' 234' ' ' GLY . 62.1 mtp180 -130.69 -178.67 4.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.808 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.507 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.8 p-90 -155.43 164.44 38.71 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.345 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -149.66 148.31 29.13 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.216 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.695 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -97.15 130.16 44.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.28 130.59 71.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.252 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.614 ' CB ' HD21 ' B' ' 226' ' ' ASN . 3.8 t-80 -78.94 169.31 18.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 29.0 t70 -58.36 -26.47 63.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.266 0.555 . . . . 1.0 110.954 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.4 -33.07 70.95 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.941 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.48 11.52 19.44 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.125 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.614 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.55 144.21 26.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.807 -0.231 . . . . 1.0 111.385 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.9 mm -78.24 116.72 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 1.0 109.472 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.695 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -90.25 -42.58 10.92 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.547 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.483 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -150.35 164.27 36.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.608 -1.178 . . . . 1.0 111.374 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.34 155.33 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 65.6 p -54.72 -33.26 60.84 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.066 0.46 . . . . 1.0 111.55 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.69 3.51 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.53 -0.628 . . . . 1.0 111.53 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -122.72 166.94 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.175 0.512 . . . . 1.0 111.572 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' B' ' 217' ' ' ARG . . . -118.73 139.78 14.72 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.651 -1.38 . . . . 1.0 109.651 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -127.47 171.02 11.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.623 0.711 . . . . 1.0 111.545 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -100.73 9.69 42.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 1.0 112.28 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.7 m -143.78 137.21 27.9 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.68 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -62.88 -38.42 90.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.78 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.3 tt0 -60.98 -40.71 94.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.211 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -61.05 -41.51 96.74 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.647 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.28 89.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.973 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.572 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.0 mtmt -64.91 -34.99 79.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.228 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.3 mm-40 -62.62 -30.98 71.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.15 -41.28 95.03 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.048 -1.221 . . . . 1.0 110.048 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' B' ' 242' ' ' LYS . 66.6 mt -63.36 -43.08 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.976 -0.612 . . . . 1.0 110.582 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -63.99 -41.3 97.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.04 0.448 . . . . 1.0 110.232 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -64.03 -37.08 86.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.522 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -74.06 -41.46 52.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 C-N-CA 120.22 -0.592 . . . . 1.0 110.755 -176.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.53 -16.35 63.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -105.82 -3.23 22.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 1.0 111.353 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 15.2 m-80 -123.32 -38.88 2.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.986 0.422 . . . . 1.0 111.082 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.51 -50.87 85.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.495 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.5 Cg_endo -63.59 -12.75 32.66 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.53 1.486 . . . . 1.0 113.528 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.56 -19.47 10.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -64.57 136.77 57.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.866 0.841 . . . . 1.0 112.593 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -91.83 135.76 33.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.022 -1.445 . . . . 1.0 110.573 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.563 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -88.54 129.85 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.601 0.715 . . . . 1.0 112.298 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.9 mt -115.1 140.59 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.406 -1.27 . . . . 1.0 109.27 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -90.31 106.55 18.57 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.674 -0.862 . . . . 1.0 108.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.337 -0.839 . . . . 1.0 111.213 -177.399 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 21.4 p-10 . . . . . 0 N--CA 1.453 -0.293 0 CA-C-O 121.333 0.587 . . . . 1.0 112.066 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -134.37 96.64 3.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.55 171.13 3.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.856 -1.065 . . . . 1.0 109.401 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.5 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 48.4 p-80 -170.53 148.36 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.1 m-85 -84.83 149.94 25.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.38 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.35 118.73 12.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.559 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 118' ' ' TRP . 68.2 t -90.95 133.39 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.878 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -142.6 177.43 8.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.412 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.4 t -102.36 137.47 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.334 0.587 . . . . 1.0 111.969 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.57 177.76 8.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.96 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.87 -12.25 61.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.237 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.97 24.28 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.669 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 69.35 35.19 2.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 1.0 111.674 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.7 mttt -110.68 147.53 34.15 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.457 0.646 . . . . 1.0 111.4 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.6 120.98 32.13 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.431 -1.259 . . . . 1.0 110.467 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -136.32 -179.7 5.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.572 -1.194 . . . . 1.0 108.675 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.535 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.3 p-90 -151.7 162.9 40.24 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.683 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.531 HH11 HG21 ' A' ' 127' ' ' ILE . 21.6 mmt180 -143.48 142.82 31.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.298 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.719 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.5 tp -99.97 129.99 46.1 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -127.79 132.36 68.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.483 -0.192 . . . . 1.0 110.483 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.571 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.0 t-80 -83.34 174.35 10.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.4 -39.18 67.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.0 111.476 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -60.32 -33.96 73.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.513 0.673 . . . . 1.0 110.26 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.54 12.17 21.8 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.873 -1.058 . . . . 1.0 112.096 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.571 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.77 142.57 28.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.63 0.252 . . . . 1.0 111.376 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.531 HG21 HH11 ' A' ' 119' ' ' ARG . 50.9 mm -76.26 116.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.194 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.719 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.1 mt -88.38 -42.74 11.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.634 0.731 . . . . 1.0 109.917 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.65 166.43 30.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.756 -1.111 . . . . 1.0 111.237 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -140.34 155.41 46.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.87 -1.059 . . . . 1.0 110.13 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.447 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 18.9 p -54.5 -36.03 63.75 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.601 0.563 . . . . 1.0 111.605 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.38 -50.67 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.65 178.61 4.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.709 -0.746 . . . . 1.0 111.618 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -145.67 140.62 9.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -141.37 167.47 22.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.531 0.165 . . . . 1.0 110.66 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.4 9.9 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 p -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.601 0.715 . . . . 1.0 111.862 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -64.94 -41.52 95.44 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.595 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -59.83 -37.78 80.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.621 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -62.0 -43.35 99.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.241 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.95 83.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.26 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.587 ' HA ' HD12 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.66 -34.43 78.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.169 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -62.99 -30.29 71.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.34 -40.35 94.57 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.42 -1.072 . . . . 1.0 110.42 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 142' ' ' LYS . 58.3 mt -62.73 -42.26 95.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.085 0.469 . . . . 1.0 110.081 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.09 -43.75 97.63 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.155 0.502 . . . . 1.0 109.885 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -61.25 -36.16 79.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -75.22 -42.4 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 119.536 -0.866 . . . . 1.0 110.169 -177.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.6 mtpt -66.86 -15.65 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 1.0 112.399 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -105.43 -2.26 23.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.366 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.62 -37.53 1.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.693 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.603 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.34 -51.35 82.33 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.499 0.555 . . . . 1.0 112.499 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 57.8 Cg_endo -66.56 -4.81 11.55 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.261 1.308 . . . . 1.0 113.208 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.18 -23.41 6.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.593 0.59 . . . . 1.0 112.593 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -66.69 139.12 57.83 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.472 0.916 . . . . 1.0 113.472 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.78 135.42 33.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.488 -1.233 . . . . 1.0 111.189 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -88.04 131.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.335 0.588 . . . . 1.0 112.075 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.6 mt . . . . . 0 N--CA 1.449 -0.476 0 CA-C-N 114.93 -1.032 . . . . 1.0 108.92 178.204 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.434 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 14.4 p-10 . . . . . 0 CA--C 1.512 -0.507 0 CA-C-O 121.363 0.601 . . . . 1.0 112.588 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 12.0 mptt -127.78 96.46 4.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 174.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.95 171.4 3.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.417 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.555 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.6 p-80 -169.32 147.26 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.213 -0.195 . . . . 1.0 110.59 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 52.1 m-85 -86.67 146.72 26.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.144 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -141.75 122.0 13.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.752 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.0 t -93.24 135.68 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.09 -178.62 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.355 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.1 t -106.15 139.65 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.22 179.12 7.8 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.47 -0.787 . . . . 1.0 109.51 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.38 -17.58 64.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.893 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.8 19.16 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.118 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 69.78 35.37 2.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.041 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.1 mmtt -108.57 149.16 29.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.407 -175.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.38 119.67 32.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.53 -1.214 . . . . 1.0 110.254 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -132.32 -178.1 4.76 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.706 -1.134 . . . . 1.0 108.972 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.517 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.0 p-90 -155.7 168.22 27.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.742 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 16.6 mtt180 -150.44 154.13 37.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.849 -1.069 . . . . 1.0 110.613 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.693 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -104.36 132.62 50.41 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.3 t -126.25 132.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.259 -0.275 . . . . 1.0 110.259 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.522 ' CB ' HD21 ' B' ' 226' ' ' ASN . 0.6 OUTLIER -85.26 174.49 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.256 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 26.8 t70 -52.5 -33.88 46.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.833 -0.621 . . . . 1.0 112.249 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -70.81 -33.29 70.55 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.322 0.582 . . . . 1.0 110.179 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.92 10.34 21.09 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.074 -0.967 . . . . 1.0 112.38 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.522 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -85.69 144.51 27.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.35 118.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 O-C-N 123.926 0.766 . . . . 1.0 109.38 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.693 HD12 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -93.42 -43.52 8.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.608 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.67 40.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.195 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -136.85 155.11 50.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.458 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.3 p -51.86 -37.03 50.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.905 0.383 . . . . 1.0 111.817 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.18 -46.44 3.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . 0.462 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 7.8 mm-40 -98.15 -179.75 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.127 -0.537 . . . . 1.0 111.399 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -150.0 133.86 4.57 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -138.85 170.01 16.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.089 0.444 . . . . 1.0 110.962 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -92.27 9.46 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 6.5 p -126.96 129.05 47.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.594 0.711 . . . . 1.0 112.1 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.21 -41.17 94.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.8 tt0 -58.4 -41.14 84.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.342 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -60.59 -41.95 95.76 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.918 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.18 79.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.43 0.633 . . . . 1.0 109.511 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.515 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.2 mtmt -65.78 -33.68 76.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.265 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.1 mm-40 -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -68.15 -39.64 88.36 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.9 mt -61.58 -52.43 61.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.519 0.676 . . . . 1.0 110.59 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -61.87 -35.57 78.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.02 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.2 m -67.95 -36.29 79.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.846 177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.514 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.5 OUTLIER -71.54 -37.16 62.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -177.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -66.41 -15.46 63.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.938 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 41.2 ttt85 -105.04 -2.9 23.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.074 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . 0.44 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 16.1 m-80 -127.08 -41.17 1.8 Allowed 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.639 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.82 -50.51 87.64 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.768 -0.651 . . . . 1.0 112.431 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.6 Cg_endo -62.84 -15.15 45.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 121.162 1.241 . . . . 1.0 113.712 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.5 -18.3 11.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.823 0.344 . . . . 1.0 111.923 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.6 135.25 52.61 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.641 0.734 . . . . 1.0 112.791 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -93.56 140.28 29.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.213 -1.358 . . . . 1.0 110.592 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -87.27 136.36 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.369 0.604 . . . . 1.0 112.205 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.8 mt -124.58 148.72 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.658 -1.156 . . . . 1.0 109.761 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.9 106.37 17.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.577 -0.725 . . . . 1.0 111.296 -177.858 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.434 ' C ' ' HD2' ' A' ' 103' ' ' LYS . 10.7 p-10 . . . . . 0 CA--C 1.508 -0.664 0 CA-C-O 121.351 0.595 . . . . 1.0 112.151 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.2 mptt -122.71 97.91 5.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.72 169.34 4.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.685 -1.143 . . . . 1.0 108.954 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.509 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.9 p-80 -169.14 148.94 4.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.576 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.59 146.9 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.66 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.36 116.8 11.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.939 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 118' ' ' TRP . 70.2 t -90.97 132.12 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.526 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -140.5 -179.08 5.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.383 -0.228 . . . . 1.0 110.383 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.2 t -103.53 136.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.586 . . . . 1.0 112.388 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.11 177.55 8.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 1.0 108.957 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.29 62.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 1.0 111.006 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.55 19.16 20.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.102 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.6 39.99 1.96 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.672 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 13.2 mmtt -111.76 152.45 27.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.283 -176.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.44 118.63 31.55 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.727 -1.124 . . . . 1.0 110.067 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -132.06 -179.26 5.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.527 ' HB3' HG22 ' A' ' 108' ' ' VAL . 60.5 p-90 -155.77 167.41 30.48 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.082 0.468 . . . . 1.0 111.926 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -151.64 149.87 29.62 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.334 -1.303 . . . . 1.0 110.63 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.704 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.4 tp -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 t -126.59 131.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.561 -0.291 . . . . 1.0 110.549 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.597 ' CB ' HD21 ' A' ' 126' ' ' ASN . 1.9 t-80 -81.65 172.08 13.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 26.3 t70 -57.84 -27.36 63.13 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.323 0.582 . . . . 1.0 110.792 177.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -33.64 73.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.955 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.12 11.7 23.53 Favored Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.109 -0.95 . . . . 1.0 112.318 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.597 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.09 144.68 25.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.101 0.408 . . . . 1.0 112.101 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 50.6 mm -76.41 117.4 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.944 0.777 . . . . 1.0 109.137 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.704 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.0 mt -90.57 -43.96 9.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.6 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.51 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.48 158.48 44.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.692 -1.14 . . . . 1.0 111.02 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.64 154.99 51.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.421 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 16.3 p -52.9 -33.16 49.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.406 0.442 . . . . 1.0 112.159 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.35 -48.04 3.73 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -104.07 -175.38 2.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.913 -0.644 . . . . 1.0 111.406 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -149.25 137.77 6.48 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -144.34 168.47 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.96 0.38 . . . . 1.0 111.06 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.06 10.29 32.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.226 0.824 . . . . 1.0 113.226 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -125.83 132.53 52.21 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 111.076 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -64.77 -38.55 91.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.879 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.9 tt0 -61.17 -41.23 96.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.988 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.64 -41.21 94.47 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.555 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.985 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 145' ' ' ILE . 48.3 mtmt -63.63 -36.41 83.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.632 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.0 mm-40 -65.1 -25.49 67.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.2 -40.95 92.48 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 142' ' ' LYS . 67.7 mt -62.43 -44.53 99.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.8 -0.7 . . . . 1.0 109.766 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.55 -40.16 95.95 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.809 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -63.17 -35.39 80.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.007 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -73.68 -40.86 54.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 119.581 -0.848 . . . . 1.0 109.371 -178.286 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -68.06 -11.92 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.251 0.548 . . . . 1.0 110.768 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -97.73 -6.87 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.259 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -138.91 -37.51 0.52 Allowed 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -53.84 -50.68 82.47 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 56.8 Cg_endo -67.36 -6.21 15.82 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 121.307 1.338 . . . . 1.0 113.473 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.88 -26.96 5.9 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.247 0.546 . . . . 1.0 111.684 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -64.98 136.44 56.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.424 -0.807 . . . . 1.0 112.502 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.35 139.4 34.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.566 -1.197 . . . . 1.0 110.975 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.518 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -86.72 139.92 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.542 0.686 . . . . 1.0 112.584 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.7 mt . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.013 177.291 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 CA--C 1.517 -0.296 0 CA-C-O 121.52 0.676 . . . . 1.0 112.252 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -144.94 97.12 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.17 -1.418 . . . . 1.0 107.17 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.98 177.41 1.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.958 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.476 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.8 p-80 -169.2 148.12 3.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.831 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 60.8 m-85 -86.16 150.12 24.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.836 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.16 117.59 10.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' B' ' 218' ' ' TRP . 88.9 t -93.5 134.53 30.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.958 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -145.75 179.76 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.312 . . . . 1.0 110.968 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.467 HG13 ' HA ' ' B' ' 214' ' ' ASP . 1.3 t -97.44 135.94 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.37 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.53 -179.11 7.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.055 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.05 -6.91 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.972 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.79 18.42 11.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.531 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.467 ' HA ' HG13 ' B' ' 210' ' ' VAL . 35.1 t70 69.83 43.69 0.92 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.47 1.128 . . . . 1.0 110.359 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.7 mmtt -113.51 150.23 33.21 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.749 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.06 116.32 28.71 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.799 -1.091 . . . . 1.0 109.988 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -134.03 178.29 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.528 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.1 p-90 -151.27 164.01 37.59 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.742 -0.383 . . . . 1.0 111.391 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' B' ' 219' ' ' ARG . 4.5 mtp-105 -146.63 145.76 30.17 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.913 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.699 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.5 tp -96.61 130.66 43.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 t -126.13 130.77 72.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.027 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.481 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.1 t-80 -81.83 175.47 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.62 -36.81 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.414 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -67.13 -34.58 77.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.563 0.697 . . . . 1.0 110.503 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.63 12.33 17.02 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 114.97 -1.014 . . . . 1.0 112.203 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.481 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.06 143.33 27.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.056 0.391 . . . . 1.0 112.056 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.17 120.15 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 124.053 0.845 . . . . 1.0 109.911 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.699 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.9 mt -96.49 -43.96 7.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.703 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -150.46 162.3 40.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.489 -1.232 . . . . 1.0 111.135 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -137.65 152.93 49.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.972 -1.013 . . . . 1.0 108.442 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 79.8 p -55.25 -36.43 66.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.013 0.435 . . . . 1.0 111.416 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.25 -48.1 3.57 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . 0.417 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 14.9 mm-40 -98.01 171.76 8.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.78 -0.71 . . . . 1.0 111.563 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.11 135.82 6.23 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.349 -1.101 . . . . 1.0 110.349 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -141.86 178.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.066 0.433 . . . . 1.0 110.405 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -99.27 9.8 42.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.192 0.812 . . . . 1.0 113.192 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -125.86 131.83 52.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.2 0.524 . . . . 1.0 111.544 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.58 -39.13 93.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.164 -0.926 . . . . 1.0 110.448 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.5 tt0 -60.29 -43.82 95.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.224 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -59.52 -41.43 89.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.618 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.49 -51.08 71.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.064 0.459 . . . . 1.0 110.318 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.497 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.7 mtmt -63.59 -33.37 75.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.3 mm-40 -65.55 -30.38 71.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.425 -0.51 . . . . 1.0 109.72 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.14 96.42 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.509 ' O ' HG12 ' B' ' 248' ' ' VAL . 75.6 mt -61.62 -53.42 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.588 0.709 . . . . 1.0 110.535 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -61.37 -34.8 75.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.591 -0.731 . . . . 1.0 111.034 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.5 m -66.82 -37.64 84.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.389 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -70.72 -40.59 77.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.984 -0.687 . . . . 1.0 109.247 -177.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.72 -17.26 62.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 250' ' ' ARG . 8.4 ttt180 -104.07 -2.77 25.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.967 0.413 . . . . 1.0 111.033 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.82 -41.77 1.63 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.608 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.514 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.87 -50.68 85.81 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.503 -0.771 . . . . 1.0 112.852 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.3 Cg_endo -63.14 -15.14 46.16 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.232 1.288 . . . . 1.0 113.379 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.52 -19.94 11.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.925 0.393 . . . . 1.0 111.906 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.84 136.23 53.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.786 0.803 . . . . 1.0 112.507 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.81 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.125 -1.398 . . . . 1.0 110.988 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.576 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.0 OUTLIER -88.86 130.07 38.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.613 0.721 . . . . 1.0 112.621 179.084 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.3 mt -116.41 142.58 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.468 -1.242 . . . . 1.0 108.864 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -90.17 101.91 14.63 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.869 -0.586 . . . . 1.0 111.21 -177.137 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 121.711 0.767 . . . . 1.0 112.033 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 46.8 mmtm -137.58 98.43 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.136 -1.393 . . . . 1.0 107.319 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.17 172.8 3.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.425 -0.807 . . . . 1.0 109.392 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.439 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 31.6 p-80 -172.02 149.41 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.154 0.283 . . . . 1.0 110.238 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 66.1 m-85 -86.11 153.63 21.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.483 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -141.66 117.68 10.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 118' ' ' TRP . 79.4 t -93.84 129.54 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -143.63 179.3 7.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.804 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -98.82 134.8 36.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.809 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.13 178.54 8.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.173 -0.922 . . . . 1.0 109.53 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.35 -16.83 64.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.165 0.507 . . . . 1.0 110.629 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.05 20.25 18.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.738 -0.664 . . . . 1.0 111.708 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 71.3 35.53 1.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.453 0.701 . . . . 1.0 111.398 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.2 mttt -109.61 150.27 28.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.159 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.06 109.38 20.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.006 -0.997 . . . . 1.0 109.264 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -126.15 176.91 6.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.526 ' HB3' HG22 ' A' ' 108' ' ' VAL . 49.8 p-90 -147.3 162.45 38.93 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.365 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.504 HH21 HG13 ' A' ' 127' ' ' ILE . 14.7 mmm-85 -144.5 142.18 30.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.157 -0.929 . . . . 1.0 109.635 -177.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.736 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.9 tp -98.79 131.61 44.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.238 -1.023 . . . . 1.0 108.238 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -130.78 132.97 63.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.542 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.552 ' CB ' HD21 ' A' ' 126' ' ' ASN . 4.8 t-80 -81.81 174.71 11.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.7 t70 -56.11 -36.58 68.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.285 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -64.88 -33.45 76.04 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.551 0.691 . . . . 1.0 109.699 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 11.57 21.35 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 114.688 -1.142 . . . . 1.0 112.398 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.552 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -85.97 141.31 29.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.721 0.296 . . . . 1.0 111.587 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.504 HG13 HH21 ' A' ' 119' ' ' ARG . 47.6 mm -74.66 122.1 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.299 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.736 HD12 ' HG ' ' A' ' 120' ' ' LEU . 13.9 mt -98.17 -41.42 7.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.881 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.516 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.19 169.24 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.26 -0.882 . . . . 1.0 111.935 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -141.97 153.49 44.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.698 -1.137 . . . . 1.0 108.325 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.434 ' HA ' ' CE2' ' A' ' 118' ' ' TRP . 77.3 p -53.49 -34.49 58.25 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.005 0.431 . . . . 1.0 111.597 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.88 -40.45 3.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.652 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 93.9 mt-10 -110.82 174.85 5.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.307 -0.446 . . . . 1.0 110.78 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.85 136.67 6.74 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.311 -0.715 . . . . 1.0 111.311 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -144.54 177.53 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.733 0.266 . . . . 1.0 110.968 -177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.36 9.67 42.32 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.773 0.657 . . . . 1.0 112.773 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 m -122.03 131.34 53.94 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.561 0.696 . . . . 1.0 111.451 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.96 -36.23 83.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.835 -1.075 . . . . 1.0 110.82 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.9 tt0 -63.31 -42.19 98.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.146 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -57.99 -41.26 82.64 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.689 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.2 70.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.194 0.521 . . . . 1.0 110.089 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.51 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.5 -36.77 85.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.682 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -64.0 -28.07 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.64 -41.91 95.73 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 142' ' ' LYS . 62.3 mt -63.48 -45.68 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.837 -0.682 . . . . 1.0 110.466 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.63 -40.43 94.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.871 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.4 m -66.8 -33.73 76.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.817 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.69 -40.39 54.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.037 -0.665 . . . . 1.0 109.948 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -68.17 -11.8 59.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 111.153 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.39 -8.61 26.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.289 -0.868 . . . . 1.0 109.691 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -134.39 -39.14 0.83 Allowed 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 113.482 0.919 . . . . 1.0 113.482 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.31 -49.18 91.92 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.837 0.68 . . . . 1.0 112.837 -177.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 53.7 Cg_endo -66.69 -7.06 17.01 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.32 1.347 . . . . 1.0 113.153 -177.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -122.44 -13.6 8.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.473 0.545 . . . . 1.0 112.473 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.27 135.21 44.43 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.748 0.785 . . . . 1.0 112.869 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -93.57 138.73 31.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.352 -1.295 . . . . 1.0 110.36 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.1 p -88.01 133.89 29.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 112.348 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.275 177.907 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.454 0.645 . . . . 1.0 112.319 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -133.47 98.92 4.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.392 -1.336 . . . . 1.0 107.392 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.4 170.23 3.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.75 -1.114 . . . . 1.0 108.694 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.454 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 47.7 p-80 -170.96 149.94 3.04 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.08 0.237 . . . . 1.0 110.497 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 54.9 m-85 -85.73 149.38 25.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.8 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -140.48 120.29 13.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.5 t -95.5 135.07 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.204 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -146.04 175.78 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 1.0 110.734 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 5.3 t -99.9 133.45 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 1.0 111.965 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.65 179.79 7.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.81 -1.086 . . . . 1.0 109.5 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.02 -17.96 64.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.95 0.405 . . . . 1.0 111.325 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.55 21.8 16.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.909 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 70.46 36.15 1.79 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 111.121 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -109.91 143.93 39.12 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.794 . . . . 1.0 111.185 -176.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.77 106.09 18.12 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.222 -1.354 . . . . 1.0 109.567 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -118.3 178.04 4.59 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.537 ' HB3' HG22 ' B' ' 208' ' ' VAL . 52.4 p-90 -147.8 167.33 25.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.459 0.647 . . . . 1.0 111.979 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -146.25 146.5 30.78 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.422 -1.263 . . . . 1.0 110.432 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.75 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.7 tp -105.53 130.69 53.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 174.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.06 132.96 66.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.919 -175.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.565 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.5 t-80 -82.93 173.76 11.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.292 -0.632 . . . . 1.0 109.292 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.87 -36.87 68.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.08 0.467 . . . . 1.0 110.698 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -63.2 -32.96 74.49 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.296 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.22 11.22 24.36 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 114.769 -1.105 . . . . 1.0 112.45 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.565 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.57 143.2 27.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.789 -0.206 . . . . 1.0 111.359 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.462 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.37 116.39 22.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.53 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.75 HD12 ' HG ' ' B' ' 220' ' ' LEU . 17.0 mt -88.73 -42.8 11.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.019 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -149.52 168.31 23.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.054 -0.975 . . . . 1.0 111.625 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -141.67 156.3 45.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.09 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 66.0 p -54.37 -35.14 62.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.0 0.37 . . . . 1.0 112.0 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.74 -33.68 3.47 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.045 -0.598 . . . . 1.0 111.761 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -122.89 178.57 4.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 1.0 111.174 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -143.01 137.43 7.67 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.337 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -140.01 166.71 23.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.814 -0.439 . . . . 1.0 109.814 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.02 29.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.8 m -126.26 131.84 51.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.325 0.583 . . . . 1.0 111.347 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.17 -35.93 81.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.034 -0.985 . . . . 1.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.5 tt0 -57.86 -47.22 83.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.251 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -59.9 -40.43 88.76 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.124 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.52 74.57 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.587 0.708 . . . . 1.0 109.533 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.499 ' HA ' HD12 ' B' ' 245' ' ' ILE . 49.3 mtmt -64.38 -35.54 81.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.528 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.2 mm-40 -64.22 -31.24 72.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.79 -41.11 95.86 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' B' ' 242' ' ' LYS . 65.6 mt -62.4 -43.86 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.064 -0.568 . . . . 1.0 110.278 177.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.9 -41.58 99.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.193 0.52 . . . . 1.0 110.141 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.7 m -64.38 -34.36 77.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.981 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.48 -41.33 49.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.968 -177.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -66.89 -11.86 57.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.035 0.445 . . . . 1.0 111.798 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -2.92 31.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.905 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -135.36 -42.74 0.7 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.77 0.656 . . . . 1.0 112.77 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -53.64 -48.34 93.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.1 Cg_endo -64.23 -10.6 24.18 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.036 1.158 . . . . 1.0 113.079 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.49 -22.12 7.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.373 0.508 . . . . 1.0 112.373 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.95 134.88 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.654 0.74 . . . . 1.0 112.736 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.47 142.08 29.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.423 -1.262 . . . . 1.0 110.691 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -89.13 134.18 29.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.8 mt -112.23 139.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.662 -1.154 . . . . 1.0 108.695 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.0 100.24 12.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.311 -0.852 . . . . 1.0 110.984 -177.783 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 . . . . . 0 CA--C 1.511 -0.538 0 CA-C-O 121.223 0.535 . . . . 1.0 111.905 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 2.5 mptp? -123.34 95.11 4.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 173.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.76 174.86 2.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.03 -0.987 . . . . 1.0 108.979 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -170.29 147.88 3.15 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.573 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 58.3 m-85 -86.15 150.18 24.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.258 177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -141.46 121.46 13.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.413 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.3 t -93.67 133.87 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.068 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.77 178.49 7.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.633 0.254 . . . . 1.0 110.414 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -100.53 136.79 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.772 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.03 -178.97 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.31 -13.01 62.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.651 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.14 19.58 17.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.962 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 71.0 38.25 1.14 Allowed 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.275 -0.875 . . . . 1.0 111.182 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 3.1 mmtp -108.91 153.29 23.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.804 -1.089 . . . . 1.0 111.219 -175.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -95.01 118.14 31.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.232 -0.895 . . . . 1.0 109.666 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -133.59 -179.03 5.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.107 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.504 ' HB3' HG22 ' A' ' 108' ' ' VAL . 58.7 p-90 -151.31 162.1 41.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.884 0.373 . . . . 1.0 111.455 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.45 HH21 HG13 ' A' ' 127' ' ' ILE . 36.3 mmm-85 -144.37 139.91 28.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.725 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.4 tp -96.94 131.44 43.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 176.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.0 t -131.07 132.34 63.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.054 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.525 ' CB ' HD21 ' A' ' 126' ' ' ASN . 4.4 t-80 -78.31 172.9 12.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 30.3 t70 -57.95 -30.93 66.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.207 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -33.68 67.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.94 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.03 13.84 10.59 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.244 -0.889 . . . . 1.0 113.836 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.525 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -87.85 143.68 27.0 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.075 0.15 . . . . 1.0 110.717 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.45 HG13 HH21 ' A' ' 119' ' ' ARG . 44.6 mm -76.36 115.13 17.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.722 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.1 mt -88.4 -42.25 12.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.789 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.504 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.05 170.53 20.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.283 -0.871 . . . . 1.0 111.582 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.962 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -53.52 -36.43 61.77 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.416 0.447 . . . . 1.0 111.896 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.76 -43.54 3.25 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.529 -0.628 . . . . 1.0 111.529 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 89.2 mt-10 -108.88 179.93 4.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.293 -0.454 . . . . 1.0 110.826 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.86 134.54 4.51 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -142.88 170.94 14.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 117.077 0.439 . . . . 1.0 110.637 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.06 24.65 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 m -118.63 131.11 56.18 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.362 0.601 . . . . 1.0 111.478 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -65.87 -33.67 76.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.803 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.0 tt0 -61.33 -48.48 81.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.971 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -56.82 -40.49 76.13 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.982 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.18 -53.38 58.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.239 0.543 . . . . 1.0 110.217 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 145' ' ' ILE . 41.7 mtmt -63.82 -36.72 84.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.238 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.8 mm-40 -63.79 -28.8 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 1.0 110.021 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.51 96.74 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.551 HG21 HG22 ' B' ' 257' ' ' VAL . 40.4 mt -64.11 -44.6 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.208 0.528 . . . . 1.0 110.133 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -60.34 -43.99 95.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.401 . . . . 1.0 110.149 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.4 m -64.37 -33.82 76.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.724 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' B' ' 229' ' ' ALA . 0.3 OUTLIER -74.43 -41.86 49.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.151 -0.62 . . . . 1.0 109.822 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -68.74 -11.57 60.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.085 0.469 . . . . 1.0 111.588 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -101.25 -3.14 29.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.928 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' B' ' 204' ' ' ALA . 23.0 m-80 -138.07 -38.63 0.56 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -176.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.42 -49.92 89.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 54.3 Cg_endo -67.57 -9.52 25.67 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 120.906 1.071 . . . . 1.0 112.95 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -109.8 -28.68 8.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.445 0.641 . . . . 1.0 110.927 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.08 135.8 57.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.873 -1.058 . . . . 1.0 113.671 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -96.59 140.65 30.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.064 -1.426 . . . . 1.0 110.716 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.557 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.58 133.11 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.352 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.3 mt . . . . . 0 N--CA 1.45 -0.473 0 CA-C-N 114.766 -1.106 . . . . 1.0 108.933 177.071 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.339 0.59 . . . . 1.0 111.512 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 32.4 mmtp -136.98 97.88 3.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . . . -174.31 169.19 3.87 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.86 -1.064 . . . . 1.0 109.183 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.479 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 55.8 p-80 -171.34 149.1 2.7 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 61.8 m-85 -85.34 148.06 26.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.299 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -139.57 118.83 12.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.482 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' B' ' 218' ' ' TRP . 82.3 t -93.92 133.23 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.677 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -145.36 -178.4 6.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.648 0.261 . . . . 1.0 110.555 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.8 t -99.8 137.43 27.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.623 . . . . 1.0 112.238 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.07 179.78 7.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.565 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.31 -16.36 63.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.473 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.49 19.84 18.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.182 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . 0.404 ' HA ' HG13 ' B' ' 210' ' ' VAL . 24.4 m-20 69.28 41.26 1.37 Allowed 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.857 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 3.2 mmtp -110.95 156.51 21.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.266 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -99.82 117.03 33.27 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.854 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 20.6 mtp-105 -132.42 179.11 6.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.527 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.7 p-90 -151.72 163.66 38.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.079 0.466 . . . . 1.0 111.649 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -147.29 145.96 29.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.05 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.725 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.0 tp -96.28 131.85 42.36 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.19 133.79 62.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.738 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.596 ' CB ' HD21 ' B' ' 226' ' ' ASN . 5.5 t-80 -79.77 171.31 15.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 36.6 t70 -62.54 -22.18 66.12 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.152 0.501 . . . . 1.0 110.851 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.34 -33.21 67.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.521 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.85 11.26 19.4 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 114.791 -1.095 . . . . 1.0 112.86 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.596 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.27 142.92 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.655 0.264 . . . . 1.0 111.572 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.477 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.55 116.81 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.491 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.725 HD12 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -89.58 -42.53 11.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.734 . . . . 1.0 109.638 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.18 164.97 35.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.845 -1.071 . . . . 1.0 111.597 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -140.67 153.37 45.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.238 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.443 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.6 p -52.88 -36.9 59.87 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.03 -47.31 3.51 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -96.74 -172.86 2.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.265 -0.468 . . . . 1.0 111.25 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -159.05 133.86 3.55 Favored Glycine 0 N--CA 1.454 -0.16 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -145.07 169.85 17.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.93 0.365 . . . . 1.0 110.338 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.38 9.11 41.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.708 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 m -116.0 129.53 56.41 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.425 0.631 . . . . 1.0 110.928 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -66.97 -34.5 77.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.951 -1.022 . . . . 1.0 110.364 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.3 tt0 -61.12 -46.12 91.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.255 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.66 -40.55 83.82 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.788 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.11 70.62 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.482 0.658 . . . . 1.0 110.127 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.509 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.4 mtmt -64.6 -37.0 86.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.91 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -64.05 -29.58 70.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -64.97 -41.37 97.37 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.462 -1.055 . . . . 1.0 110.462 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' B' ' 242' ' ' LYS . 56.8 mt -62.48 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 1.0 110.193 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -63.06 -40.11 96.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.3 m -65.62 -35.39 80.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.633 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -75.3 -39.96 42.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.069 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 63.8 mtpt -66.79 -12.51 59.14 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.987 0.365 . . . . 1.0 111.987 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -100.27 -12.12 19.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.843 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -120.97 -40.14 2.65 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.103 -0.499 . . . . 1.0 112.18 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.0 -48.94 94.78 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.5 Cg_endo -66.87 -11.69 33.09 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.276 1.317 . . . . 1.0 113.399 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -116.0 -16.76 11.05 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . . . . . . . . . . . -69.22 139.05 54.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.805 0.669 . . . . 1.0 112.805 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -94.88 147.41 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.666 -1.152 . . . . 1.0 111.99 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 145' ' ' ILE . 40.9 t -84.39 130.45 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.438 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.2 mt -128.85 142.47 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.541 -0.541 . . . . 1.0 109.541 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.9 113.17 22.46 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.203 -0.903 . . . . 1.0 110.843 -177.838 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 CA--C 1.519 -0.246 0 CA-C-O 120.973 0.416 . . . . 1.0 109.942 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 38.7 mmtm -145.28 96.36 2.82 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 173.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.13 176.44 1.73 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.01 -0.996 . . . . 1.0 109.533 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.504 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.9 p-80 -170.23 145.42 2.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.439 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.1 m-85 -85.51 147.61 26.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.146 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.68 119.97 13.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.592 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 118' ' ' TRP . 86.1 t -95.21 132.27 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.164 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -143.14 178.08 7.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.1 t -97.82 134.18 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.215 0.531 . . . . 1.0 111.562 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.22 -180.0 7.06 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 1.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.51 -15.3 63.49 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.942 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.63 21.47 16.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.713 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 69.75 35.85 2.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.626 0.77 . . . . 1.0 111.506 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -110.84 149.55 30.42 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.881 -176.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -91.63 112.0 23.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.801 -1.09 . . . . 1.0 109.537 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.481 HH12 ' CG ' ' A' ' 130' ' ' ASP . 19.2 mtm105 -126.8 179.92 5.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.541 ' HB3' HG22 ' A' ' 108' ' ' VAL . 55.8 p-90 -152.1 162.11 41.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.187 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 42.6 mtp180 -148.23 143.66 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.146 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.662 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.7 tp -93.62 134.39 35.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.3 131.02 71.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.896 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.592 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.9 t-80 -78.97 171.74 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 12.0 t70 -56.0 -33.59 65.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.003 0.43 . . . . 1.0 111.216 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -34.34 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.13 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.36 10.92 14.2 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.124 -0.944 . . . . 1.0 113.09 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.592 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.22 145.84 24.71 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.52 0.192 . . . . 1.0 111.52 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.5 123.55 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 123.778 0.674 . . . . 1.0 109.926 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.662 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.1 mt -98.07 -43.47 7.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.067 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -147.7 164.58 33.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.983 -1.008 . . . . 1.0 111.336 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.481 ' CG ' HH12 ' A' ' 117' ' ' ARG . 6.8 t70 -139.7 152.82 46.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.246 -0.888 . . . . 1.0 108.86 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.7 p -56.32 -38.41 71.26 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.31 0.485 . . . . 1.0 112.31 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.43 -42.66 3.17 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -94.52 172.14 8.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.152 -0.524 . . . . 1.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.63 124.67 1.52 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -142.05 171.05 14.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.714 0.257 . . . . 1.0 110.742 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.43 10.24 20.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.265 0.839 . . . . 1.0 113.265 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 m -120.0 130.71 54.86 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.529 0.68 . . . . 1.0 111.636 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.52 -35.41 80.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.485 -1.234 . . . . 1.0 110.333 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.5 tt0 -62.02 -45.96 91.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.484 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -59.9 -39.15 84.4 Favored 'General case' 0 CA--C 1.521 -0.163 0 O-C-N 123.2 0.313 . . . . 1.0 110.883 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.48 69.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.604 0.716 . . . . 1.0 109.786 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.0 mtmt -64.91 -33.77 76.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.561 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -65.64 -32.36 73.88 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 1.0 110.03 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.5 -39.87 97.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.552 HG21 HG22 ' B' ' 257' ' ' VAL . 67.4 mt -60.24 -51.49 72.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.529 0.681 . . . . 1.0 110.758 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.83 -33.03 75.04 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.5 m -66.03 -37.64 86.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.535 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' B' ' 229' ' ' ALA . 1.1 p -74.42 -40.0 48.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 120.399 -0.521 . . . . 1.0 109.846 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.61 -15.77 61.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.958 0.408 . . . . 1.0 111.871 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -100.1 -2.48 34.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.916 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 11.8 m-80 -133.74 -37.08 0.93 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.903 -177.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.85 -50.47 86.97 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.365 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.7 Cg_endo -64.44 -12.07 31.44 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 121.29 1.327 . . . . 1.0 113.419 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.13 -18.58 9.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.179 0.437 . . . . 1.0 112.179 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -66.03 135.71 55.04 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.484 0.659 . . . . 1.0 112.337 -177.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.78 132.39 34.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.585 -1.189 . . . . 1.0 110.919 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.41 130.79 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.462 0.648 . . . . 1.0 111.698 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.474 179.837 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 21.1 p-10 . . . . . 0 CA--C 1.516 -0.362 0 CA-C-O 121.515 0.674 . . . . 1.0 112.323 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -138.92 96.32 3.1 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.093 -1.817 . . . . 1.0 106.093 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.81 175.69 2.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.638 -1.165 . . . . 1.0 108.612 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.47 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.5 p-80 -170.04 146.99 3.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.054 -0.259 . . . . 1.0 110.575 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.538 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 46.8 m-85 -87.11 146.69 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.479 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.65 121.4 13.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.856 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' B' ' 218' ' ' TRP . 96.3 t -94.27 133.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.767 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -144.48 -179.55 6.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.572 0.225 . . . . 1.0 110.582 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.7 t -96.14 133.48 37.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.138 -0.483 . . . . 1.0 112.232 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -81.74 178.34 8.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.928 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.37 -6.92 38.89 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.314 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.28 17.91 16.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.995 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 69.57 39.19 1.6 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.94 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 13.2 mmtt -111.04 156.88 20.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.121 -0.945 . . . . 1.0 111.217 -175.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.464 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 70.6 m-85 -98.74 102.53 14.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.799 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.581 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 14.9 mmm180 -121.5 179.82 4.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.518 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.5 p-90 -150.94 160.48 43.89 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.802 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -145.95 146.35 31.01 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.091 -0.959 . . . . 1.0 109.666 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.705 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.1 tp -95.78 132.63 40.81 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 t -127.41 130.12 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.354 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.524 ' CB ' HD21 ' B' ' 226' ' ' ASN . 1.9 t-80 -82.51 173.66 11.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.26 -36.34 63.51 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.38 0.425 . . . . 1.0 111.913 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -65.08 -31.12 72.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.22 0.533 . . . . 1.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.31 13.86 21.77 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.375 -0.829 . . . . 1.0 112.41 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.524 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.41 142.08 27.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 111.789 0.292 . . . . 1.0 111.789 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.53 121.73 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.882 0.739 . . . . 1.0 109.564 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.705 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.5 mt -96.92 -43.8 7.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.228 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -150.83 163.88 37.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.419 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.38 160.07 40.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.383 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.468 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 83.6 p -60.24 -40.71 91.22 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.52 -48.38 2.59 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.285 -0.483 . . . . 1.0 112.669 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -94.75 -169.78 2.09 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.231 0.612 . . . . 1.0 110.936 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.581 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -156.75 136.43 4.95 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.715 -0.755 . . . . 1.0 113.289 176.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -143.92 168.66 19.43 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.396 -0.594 . . . . 1.0 109.396 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.49 11.43 36.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -127.0 135.02 50.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.207 -0.597 . . . . 1.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.14 -39.6 93.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.148 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.0 tt0 -57.65 -45.72 85.15 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.287 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -60.94 -39.53 89.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.787 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' B' ' 216' ' ' TYR . . . -58.2 -49.7 76.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.472 0.653 . . . . 1.0 110.231 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.565 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -64.81 -32.8 74.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.112 -0.949 . . . . 1.0 111.47 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.8 mm-40 -63.6 -33.02 74.69 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.588 -0.445 . . . . 1.0 109.916 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.78 95.31 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' B' ' 242' ' ' LYS . 75.9 mt -60.73 -52.36 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.664 0.745 . . . . 1.0 110.258 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.29 -33.97 77.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.264 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.4 m -67.61 -35.9 79.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.511 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -72.49 -40.47 63.53 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.373 -177.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.59 -15.45 61.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.121 -0.49 . . . . 1.0 112.187 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -103.35 -2.75 26.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.866 0.365 . . . . 1.0 111.3 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 28.6 m-80 -130.46 -38.37 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 111.452 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.548 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.86 -50.49 86.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.681 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.5 Cg_endo -63.24 -10.98 23.1 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.273 1.315 . . . . 1.0 113.663 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.11 -15.92 9.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.963 0.411 . . . . 1.0 111.938 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.22 138.65 57.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.68 0.752 . . . . 1.0 112.633 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -89.21 141.68 28.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.938 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 145' ' ' ILE . 60.6 t -83.74 128.66 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.432 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 12.3 mt -121.71 138.14 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -91.74 100.87 13.5 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.303 -0.856 . . . . 1.0 111.675 -176.699 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 122.321 1.058 . . . . 1.0 113.579 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 28.8 mmtp -138.25 98.19 3.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.987 -1.915 . . . . 1.0 107.461 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.1 169.89 3.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.466 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.6 p-80 -168.22 150.34 5.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.233 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 63.7 m-85 -86.73 148.95 25.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.906 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.27 123.83 14.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.785 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 118' ' ' TRP . 91.1 t -94.75 134.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 O-C-N 123.585 0.553 . . . . 1.0 110.475 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -142.78 178.61 7.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.608 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -100.67 140.24 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.478 0.656 . . . . 1.0 112.689 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.83 177.87 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.416 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.57 -14.36 62.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.362 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.01 17.89 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.11 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 70.82 34.77 1.91 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.377 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -109.7 152.99 24.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.507 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.72 112.11 23.9 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.016 -0.993 . . . . 1.0 110.612 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -123.18 179.28 4.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.524 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.6 p-90 -153.02 168.47 25.74 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.366 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 22.6 mtt180 -150.76 152.28 33.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.508 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.681 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.9 tp -99.84 131.23 45.94 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -126.54 130.48 71.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.289 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.599 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.4 t-80 -79.67 172.35 13.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 32.2 t70 -57.22 -30.98 65.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 1.0 111.342 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.66 -33.37 74.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.504 0.669 . . . . 1.0 110.07 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.38 11.74 19.06 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 114.982 -1.008 . . . . 1.0 112.789 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.599 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.59 143.51 26.9 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.67 119.07 22.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.802 0.689 . . . . 1.0 109.744 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.681 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.0 mt -94.41 -43.31 8.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.63 0.729 . . . . 1.0 109.608 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.73 166.61 27.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.641 -1.163 . . . . 1.0 111.201 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -140.14 158.19 44.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 53.9 p -57.44 -35.23 69.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.448 . . . . 1.0 111.452 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.7 -48.62 3.54 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -102.87 171.8 7.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.374 -0.913 . . . . 1.0 111.648 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.04 139.06 9.29 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.236 -1.145 . . . . 1.0 110.236 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -141.53 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.175 0.488 . . . . 1.0 110.852 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.57 9.98 27.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -125.82 130.53 51.59 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.727 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 21.2 ptmt -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.104 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 10.0 tt0 -59.41 -42.14 91.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.962 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.4 OUTLIER -62.62 -39.78 94.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.005 -179.053 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.33 87.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.962 0.411 . . . . 1.0 109.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' A' ' 145' ' ' ILE . 7.3 mtmp? -63.86 -43.19 96.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.117 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 32.8 mm-40 -60.01 -27.05 66.56 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.69 -46.32 90.22 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 148' ' ' VAL . 61.1 mt -62.51 -48.82 86.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.946 0.879 . . . . 1.0 109.938 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.53 -40.04 90.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.287 -0.869 . . . . 1.0 110.857 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -69.93 -34.55 73.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.213 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -70.5 -39.13 75.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 C-N-CA 120.08 -0.648 . . . . 1.0 110.033 -176.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.79 -12.98 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.975 -0.453 . . . . 1.0 111.516 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -104.69 -3.1 24.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.656 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -129.87 -42.76 1.25 Allowed 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.305 -0.407 . . . . 1.0 112.068 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.06 -50.94 83.58 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.9 Cg_endo -64.48 -13.15 36.9 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.129 1.219 . . . . 1.0 112.952 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.2 -27.56 9.5 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.324 0.583 . . . . 1.0 111.23 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 134.83 55.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.071 -0.968 . . . . 1.0 113.207 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.25 141.02 31.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.982 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -86.99 135.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.679 . . . . 1.0 112.344 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 114.7 -1.136 . . . . 1.0 109.241 178.777 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 . . . . . 0 CA--C 1.518 -0.261 0 CA-C-O 121.931 0.872 . . . . 1.0 112.805 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 22.7 mmtp -141.74 97.6 3.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.68 -1.6 . . . . 1.0 108.142 173.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.65 170.75 3.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.147 -0.933 . . . . 1.0 109.679 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.423 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 55.1 p-80 -170.01 147.79 3.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.0 m-85 -85.62 150.71 24.44 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.332 0.395 . . . . 1.0 110.383 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -143.09 124.3 14.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.862 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.2 t -95.08 133.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.937 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.8 -178.21 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.663 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -110.89 137.72 42.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.358 0.503 . . . . 1.0 112.358 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 25.4 t70 -83.25 -178.77 7.2 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.583 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . 0.41 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.63 -17.92 64.2 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.954 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.85 25.62 11.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 62.07 38.96 13.57 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.859 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -97.44 155.53 16.88 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.469 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 73.4 m-85 -109.05 102.92 11.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.311 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.568 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -122.54 -178.56 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -176.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.488 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.8 p-90 -151.29 162.83 40.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.768 0.318 . . . . 1.0 111.384 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -147.56 146.71 29.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.677 ' HG ' HD12 ' B' ' 228' ' ' LEU . 35.2 tp -93.86 132.68 38.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.92 129.88 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.66 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.576 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.4 t-80 -80.04 174.54 11.49 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 26.7 t70 -55.93 -34.34 65.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.018 0.437 . . . . 1.0 111.46 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.96 -33.65 76.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.646 0.736 . . . . 1.0 110.324 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.01 10.7 22.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.967 -1.015 . . . . 1.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.576 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.02 143.49 27.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.593 0.235 . . . . 1.0 111.626 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -76.29 119.81 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.665 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.677 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.5 mt -94.19 -44.14 8.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.987 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -147.79 160.78 42.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.711 -1.131 . . . . 1.0 111.02 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.07 158.83 43.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.471 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 71.7 p -57.63 -37.37 73.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.49 0.552 . . . . 1.0 112.49 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.51 -50.56 3.55 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 121.184 0.325 . . . . 1.0 112.691 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -89.86 -168.67 2.2 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.409 0.684 . . . . 1.0 110.863 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.568 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -158.98 134.4 3.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.55 -0.833 . . . . 1.0 113.4 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.46 173.73 11.37 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.56 12.31 35.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.2 m -131.03 135.69 47.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.934 -0.706 . . . . 1.0 111.842 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.84 -39.65 95.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.032 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.6 tt0 -56.52 -44.01 80.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.494 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.32 -39.22 86.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.72 87.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.527 ' HA ' HD12 ' B' ' 245' ' ' ILE . 6.9 mtmp? -64.98 -37.78 88.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.765 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.46 -41.2 77.99 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.475 -0.869 . . . . 1.0 111.006 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.6 mt -60.19 -48.59 87.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.9 0.857 . . . . 1.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.49 -35.95 82.14 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.756 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.9 m -67.07 -37.1 83.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.402 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -72.55 -41.66 63.63 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.593 -177.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.24 -13.63 60.66 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.125 -0.359 . . . . 1.0 111.585 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -103.73 -2.64 26.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.839 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -130.85 -40.46 1.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.993 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.34 -50.53 86.16 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.6 Cg_endo -64.92 -16.6 56.21 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.208 1.272 . . . . 1.0 112.905 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.69 -29.8 11.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.588 0.709 . . . . 1.0 111.146 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -63.92 141.05 58.91 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.201 1.186 . . . . 1.0 114.201 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -103.47 146.38 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.096 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.4 p -93.27 132.05 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -120.64 150.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.187 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -85.02 108.16 17.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.328 -177.715 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.165 0.507 . . . . 1.0 111.877 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 47.5 mmtm -134.49 95.98 3.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -176.39 179.19 1.23 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.107 -0.952 . . . . 1.0 109.085 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.464 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 24.7 p-80 -171.69 147.9 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.383 0.427 . . . . 1.0 110.066 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 59.1 m-85 -85.47 152.05 23.49 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.832 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -140.62 120.22 13.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 118' ' ' TRP . 99.0 t -97.6 134.67 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.516 0.51 . . . . 1.0 109.738 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.37 178.28 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 110.611 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -99.39 134.12 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.455 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.55 179.85 7.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.02 62.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.478 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.76 19.2 18.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 70.91 36.42 1.49 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.742 0.651 . . . . 1.0 110.739 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.1 mmtt -109.3 150.51 27.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.289 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.07 111.72 23.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.369 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 mtm105 -128.76 179.13 5.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.537 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.6 p-90 -150.63 166.5 30.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 1.0 111.977 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -146.82 149.24 32.93 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.868 -1.06 . . . . 1.0 110.213 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.681 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.1 tp -100.56 133.17 45.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.58 130.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.048 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.562 ' CB ' HD21 ' A' ' 126' ' ' ASN . 3.3 t-80 -76.47 170.45 16.36 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.1 t70 -60.55 -24.18 65.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.116 0.484 . . . . 1.0 110.663 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -34.3 69.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.783 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 8.97 17.34 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.036 -0.983 . . . . 1.0 113.386 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.562 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.62 143.36 26.87 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.1 0.408 . . . . 1.0 112.1 -179.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.6 mm -73.83 118.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.811 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.681 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.4 mt -94.13 -44.12 8.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.491 0.662 . . . . 1.0 109.818 -178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.56 165.1 34.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.285 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.6 154.4 47.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 20.7 p -51.86 -40.75 61.09 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.389 0.514 . . . . 1.0 112.389 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 -46.46 3.01 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -93.97 -178.84 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 1.0 110.597 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.74 127.63 2.14 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.253 -1.139 . . . . 1.0 110.253 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -139.8 173.23 11.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.311 0.556 . . . . 1.0 110.075 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.87 9.53 42.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.23 131.33 56.38 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.198 -0.601 . . . . 1.0 110.949 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.11 -38.4 90.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.819 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.4 tt0 -63.33 -42.81 99.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.149 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.523 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -58.07 -42.77 86.26 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.985 -177.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.11 75.24 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.17 0.509 . . . . 1.0 110.524 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.2 mtmt -63.8 -35.22 79.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.736 -0.666 . . . . 1.0 111.165 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.0 mm-40 -65.09 -26.83 68.39 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.19 97.13 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.04 -1.224 . . . . 1.0 110.04 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.509 HG21 HG22 ' B' ' 257' ' ' VAL . 55.8 mt -63.11 -45.15 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.194 0.521 . . . . 1.0 109.99 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.12 -38.28 88.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.093 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.8 m -65.3 -36.17 83.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.565 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.88 -42.37 46.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.474 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.99 -15.32 62.91 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.287 0.477 . . . . 1.0 112.287 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -103.61 -2.04 27.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.536 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -131.87 -40.07 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.574 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.51 -50.41 87.9 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.89 -0.596 . . . . 1.0 112.606 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 33.7 Cg_endo -63.4 -12.8 32.43 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.096 1.198 . . . . 1.0 113.162 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.97 -26.26 8.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.999 0.428 . . . . 1.0 111.574 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.4 137.99 58.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.698 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -94.75 149.48 21.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.186 -1.37 . . . . 1.0 111.976 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.551 HG22 HG21 ' B' ' 245' ' ' ILE . 43.9 t -86.17 131.67 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.537 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--N 1.329 -0.324 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 176.108 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 121.266 0.555 . . . . 1.0 111.525 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -138.43 97.03 3.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.06 171.58 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.522 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' HIS . . . . . 0.539 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.9 p-80 -170.21 148.54 3.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.91 177.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.8 m-85 -87.05 148.82 25.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -141.72 122.38 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.788 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' B' ' 218' ' ' TRP . 97.7 t -96.6 133.96 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.623 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -145.15 -178.66 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.0 110.749 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.6 t -100.33 135.74 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.064 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -83.02 178.02 8.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.444 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.56 -9.98 52.91 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.256 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.85 20.14 15.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.503 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 69.59 38.13 1.79 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.115 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.9 mmtt -108.16 151.67 25.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.539 -176.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' TYR . . . . . 0.445 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 81.9 m-85 -98.25 102.7 14.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.162 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' ARG . . . . . 0.588 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -120.26 179.37 4.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.365 0.415 . . . . 1.0 109.975 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' TRP . . . . . 0.531 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.0 p-90 -151.12 163.24 39.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.696 0.284 . . . . 1.0 111.62 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 36.3 mtp85 -148.25 145.0 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.99 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' LEU . . . . . 0.69 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.7 tp -97.62 135.01 40.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' HIS . . . . . 0.5 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.3 t-80 -84.78 177.23 8.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.645 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.01 -38.01 67.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.342 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -66.63 -33.12 74.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.572 0.701 . . . . 1.0 109.941 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 107.98 12.61 21.84 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.279 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.5 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.15 142.76 28.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.524 0.202 . . . . 1.0 111.334 179.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.5 mm -74.6 117.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' LEU . . . . . 0.69 HD12 ' HG ' ' B' ' 220' ' ' LEU . 21.3 mt -89.38 -43.16 11.1 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.076 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.63 159.51 44.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.533 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -134.66 155.49 50.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' SER . . . . . 0.493 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 79.5 p -55.79 -40.53 72.79 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.731 0.641 . . . . 1.0 112.731 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.68 -52.52 3.0 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.269 -0.491 . . . . 1.0 112.692 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.01 -169.31 2.52 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.347 0.659 . . . . 1.0 110.707 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.588 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -160.06 132.24 2.91 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.926 -0.654 . . . . 1.0 112.675 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.36 170.6 15.39 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 116.72 0.26 . . . . 1.0 110.423 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.73 10.48 38.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.673 0.99 . . . . 1.0 113.673 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.5 m -122.07 132.08 54.31 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.035 -0.666 . . . . 1.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.37 -35.82 82.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.372 -0.831 . . . . 1.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.1 tt0 -60.08 -47.23 86.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.739 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -61.52 -36.02 79.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.03 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.74 -49.87 75.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.406 0.622 . . . . 1.0 109.602 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' LYS . . . . . 0.499 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -65.47 -35.85 82.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.925 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.5 mm-40 -63.51 -29.65 70.88 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.67 96.77 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 157' ' ' VAL . 53.1 mt -63.13 -45.61 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.054 -0.573 . . . . 1.0 109.925 177.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.81 -39.07 90.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.183 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 m -66.39 -34.86 78.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.677 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -74.95 -43.21 45.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 120.27 -0.572 . . . . 1.0 110.289 -177.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -66.08 -11.96 52.22 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.104 -0.373 . . . . 1.0 111.946 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -100.72 -3.25 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -135.9 -36.97 0.74 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.828 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -54.52 -49.87 88.56 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.833 -0.622 . . . . 1.0 112.659 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 253' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.1 Cg_endo -63.81 -11.52 27.2 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.691 1.594 . . . . 1.0 113.8 -177.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.93 -14.48 8.46 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 255' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -68.04 137.16 54.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.444 0.64 . . . . 1.0 112.266 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -93.81 147.85 22.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.864 -1.062 . . . . 1.0 111.942 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 145' ' ' ILE . 40.8 t -84.61 132.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.281 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.1 134.22 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -87.13 100.48 12.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.466 -0.778 . . . . 1.0 110.97 -177.294 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.835 0.35 . . . . 1.0 110.566 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -123.88 174.33 7.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.216 0.531 . . . . 1.0 110.915 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 33.5 mmtp -140.13 98.31 3.42 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.919 -1.141 . . . . 1.0 107.919 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.65 172.33 3.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.627 -0.715 . . . . 1.0 109.904 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.503 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 52.3 p-80 -169.48 146.5 3.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.01 177.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.2 m-85 -85.0 145.57 27.64 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.592 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.98 124.26 20.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.346 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.49 HG22 ' HB3' ' A' ' 118' ' ' TRP . 62.6 t -96.48 133.78 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.449 -0.342 . . . . 1.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -142.95 179.72 6.86 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.027 0.205 . . . . 1.0 110.776 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.6 t -101.75 138.05 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-O 121.426 0.632 . . . . 1.0 112.485 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -83.71 178.15 8.07 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.35 -0.841 . . . . 1.0 109.379 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.51 -15.32 63.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.991 0.424 . . . . 1.0 111.209 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.77 19.21 19.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.593 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 71.27 36.12 1.42 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.93 0.769 . . . . 1.0 110.927 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 10.5 mmtt -110.88 150.53 29.04 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.261 -175.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -93.95 119.28 32.63 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.915 -1.038 . . . . 1.0 110.499 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -132.05 -179.95 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.779 -1.193 . . . . 1.0 107.779 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.49 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.2 p-90 -152.84 162.48 41.23 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 120.732 -0.387 . . . . 1.0 111.354 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -146.54 143.25 28.77 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.171 0.919 . . . . 1.0 109.882 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.726 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.1 tp -95.08 130.57 41.73 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.17 -1.048 . . . . 1.0 108.17 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.79 131.61 70.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.266 -176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.617 ' CB ' HD21 ' A' ' 126' ' ' ASN . 5.2 t-80 -81.4 172.93 12.95 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 177.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 23.8 t70 -58.5 -27.46 64.49 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.27 0.557 . . . . 1.0 110.873 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -70.62 -32.85 70.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 1.0 109.772 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 107.88 12.76 21.71 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 114.9 -1.045 . . . . 1.0 112.626 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.617 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.42 146.98 24.29 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.912 0.338 . . . . 1.0 111.912 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 51.1 mm -79.42 114.53 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.726 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.6 mt -87.94 -43.24 11.91 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.415 -178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -152.27 162.98 40.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.952 -1.022 . . . . 1.0 111.051 177.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -135.94 155.41 50.31 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.047 -1.094 . . . . 1.0 108.047 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 53.3 p -55.88 -38.74 70.55 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 123.332 0.395 . . . . 1.0 111.968 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.19 -33.96 2.66 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.492 -1.043 . . . . 1.0 110.492 -176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.429 ' H ' ' C ' ' A' ' 131' ' ' SER . 47.2 mt-10 -87.97 -178.68 6.06 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.934 -0.633 . . . . 1.0 111.118 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -168.65 114.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.094 -1.203 . . . . 1.0 110.094 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.49 169.68 17.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.616 0.208 . . . . 1.0 110.45 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -85.54 10.03 14.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 114.015 1.117 . . . . 1.0 114.015 -176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.9 m -122.41 131.33 53.83 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.631 0.729 . . . . 1.0 112.234 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -67.39 -32.25 73.02 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.527 -1.215 . . . . 1.0 109.734 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.7 tt0 -60.93 -46.79 89.28 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.229 -0.896 . . . . 1.0 109.915 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -59.29 -38.74 80.94 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.462 -177.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.54 -51.65 69.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.245 0.545 . . . . 1.0 109.918 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.8 mtmt -64.82 -33.36 75.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.41 -0.814 . . . . 1.0 111.875 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -64.86 -32.29 73.92 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.444 -0.502 . . . . 1.0 109.974 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -40.84 94.41 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.732 -0.747 . . . . 1.0 111.257 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 142' ' ' LYS . 71.9 mt -59.83 -51.85 67.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.32 0.581 . . . . 1.0 110.613 177.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.19 -35.66 81.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.806 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.5 m -66.74 -34.99 79.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.322 -0.399 . . . . 1.0 111.003 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.579 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.71 -35.17 43.09 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 C-N-CA 120.428 -0.509 . . . . 1.0 109.712 -177.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -68.92 -15.44 63.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.742 0.782 . . . . 1.0 110.238 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -99.39 -2.72 35.51 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.431 -1.259 . . . . 1.0 112.591 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -136.91 -39.12 0.62 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.255 -0.43 . . . . 1.0 111.944 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.579 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.16 -51.6 80.47 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 112.985 0.735 . . . . 1.0 112.985 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 55.7 Cg_endo -66.41 -7.77 18.68 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 121.243 1.296 . . . . 1.0 113.229 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -116.56 -24.62 7.73 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.056 0.455 . . . . 1.0 111.644 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.531 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.05 136.88 57.28 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.425 -0.807 . . . . 1.0 112.946 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -92.07 137.84 32.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.096 -1.411 . . . . 1.0 110.724 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.57 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -88.99 131.51 36.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.378 0.609 . . . . 1.0 112.587 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.4 mt -114.29 137.95 45.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 114.832 -1.076 . . . . 1.0 108.46 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -91.54 101.56 14.21 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.539 -0.744 . . . . 1.0 110.866 -177.829 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.87 0.367 . . . . 1.0 110.538 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -92.87 172.21 8.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.449 0.642 . . . . 1.0 111.163 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 72.8 mmtt -136.89 97.39 3.51 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 106.906 -1.516 . . . . 1.0 106.906 174.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.96 174.23 2.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.422 -0.808 . . . . 1.0 109.614 -177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.531 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 41.0 p-80 -170.95 148.16 2.77 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.273 0.358 . . . . 1.0 110.519 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.57 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 50.2 m-85 -85.61 149.56 25.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.734 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -141.99 118.39 10.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.721 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' B' ' 218' ' ' TRP . 75.9 t -93.48 132.07 38.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -143.16 -177.88 5.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.3 t -102.64 137.46 30.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.158 0.504 . . . . 1.0 112.284 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -78.32 179.4 6.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.335 -0.848 . . . . 1.0 109.552 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.33 -14.61 62.65 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.049 0.452 . . . . 1.0 110.575 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.12 15.88 24.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.503 -0.772 . . . . 1.0 111.758 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' B' ' 210' ' ' VAL . 26.5 m-20 70.42 41.71 0.97 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.482 0.713 . . . . 1.0 110.611 177.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 9.2 mmtt -115.13 152.03 33.3 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.71 -177.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -91.97 118.76 31.07 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.029 -0.987 . . . . 1.0 110.391 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 70.3 mtp180 -134.68 179.37 6.34 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 115.119 -0.946 . . . . 1.0 109.046 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.511 ' HB3' HG22 ' B' ' 208' ' ' VAL . 50.6 p-90 -154.28 161.46 41.77 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.516 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' B' ' 219' ' ' ARG . 9.2 mtp180 -147.31 142.85 27.59 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 115.086 -0.961 . . . . 1.0 109.885 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.703 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.8 tp -94.16 131.98 39.16 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 177.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.2 t -128.68 131.43 68.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.268 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.545 ' CB ' HD21 ' B' ' 226' ' ' ASN . 9.5 t-80 -78.01 170.7 16.17 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.235 -0.654 . . . . 1.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 20.8 t70 -57.19 -27.7 62.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.575 -0.739 . . . . 1.0 111.373 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.81 -33.77 62.27 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.19 13.33 10.93 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 114.999 -1.0 . . . . 1.0 113.459 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.545 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.2 OUTLIER -87.96 144.57 26.47 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 122.904 -0.174 . . . . 1.0 111.256 178.514 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -74.36 123.36 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 123.815 0.697 . . . . 1.0 109.262 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.703 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.0 mt -99.35 -42.11 7.13 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.322 0.582 . . . . 1.0 109.796 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -153.01 164.3 38.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.895 -1.048 . . . . 1.0 111.625 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -139.61 153.49 47.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.266 -0.879 . . . . 1.0 108.897 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.419 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 11.9 p -51.58 -35.43 41.32 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.49 -46.6 3.51 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.119 -0.792 . . . . 1.0 111.119 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . 0.446 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.7 mt-10 -107.43 173.99 6.08 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.955 -0.623 . . . . 1.0 111.73 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -133.65 145.62 17.65 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 109.965 -1.254 . . . . 1.0 109.965 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -142.48 171.95 13.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.359 0.579 . . . . 1.0 110.788 -176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.69 10.28 41.47 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.306 0.484 . . . . 1.0 112.306 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 9.5 m -136.69 134.8 37.61 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.357 0.598 . . . . 1.0 111.484 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -63.98 -35.41 80.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.472 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.3 tt0 -57.74 -48.32 79.96 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.672 -0.695 . . . . 1.0 110.607 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -61.88 -38.14 87.19 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 123.351 0.407 . . . . 1.0 110.847 -177.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.46 -49.56 76.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.219 0.533 . . . . 1.0 109.698 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.535 ' HA ' HD12 ' B' ' 245' ' ' ILE . 43.9 mtmt -64.8 -33.81 76.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.369 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.9 mm-40 -63.42 -30.61 71.71 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.32 -0.552 . . . . 1.0 109.744 176.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -67.86 -40.26 89.44 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' B' ' 242' ' ' LYS . 73.9 mt -60.88 -50.5 80.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.697 0.76 . . . . 1.0 110.374 177.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -65.36 -33.83 76.88 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.652 -0.704 . . . . 1.0 111.23 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 67.8 m -65.05 -38.69 91.68 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.175 177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' B' ' 252' ' ' ALA . 1.1 p -73.92 -40.61 52.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.713 0 C-N-CA 119.962 -0.695 . . . . 1.0 110.094 -177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -64.09 -15.25 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.177 0.513 . . . . 1.0 111.907 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 19.8 ttt85 -101.31 -1.47 33.45 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.44 -0.8 . . . . 1.0 110.825 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -135.82 -37.39 0.74 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.84 0.352 . . . . 1.0 111.942 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.638 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.47 -50.67 85.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 112.898 0.703 . . . . 1.0 112.898 -178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.6 Cg_endo -65.46 -10.4 26.07 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 120.764 0.976 . . . . 1.0 113.503 -177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -118.07 -20.39 8.71 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.291 0.478 . . . . 1.0 112.291 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.503 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -66.02 135.34 54.53 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.86 -0.609 . . . . 1.0 112.27 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -90.89 139.52 30.67 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.049 -0.978 . . . . 1.0 110.764 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.501 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -91.7 128.31 43.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.589 -0.732 . . . . 1.0 112.363 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . 0.449 HD11 ' CD2' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -124.4 146.9 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-N 114.283 -1.326 . . . . 1.0 110.174 176.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -91.26 114.66 27.24 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.926 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.077 -0.963 . . . . 1.0 111.19 -178.123 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.014 0.435 . . . . 1.0 109.925 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -116.6 176.24 5.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.253 0.549 . . . . 1.0 111.5 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 45.1 mmtm -136.98 97.7 3.58 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.672 -1.149 . . . . 1.0 108.055 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.44 171.14 3.43 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.076 -0.965 . . . . 1.0 109.504 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 44.2 p-80 -169.22 148.32 3.93 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.893 -0.41 . . . . 1.0 109.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.5 m-85 -85.32 147.74 26.39 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.388 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.59 116.92 11.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.218 -0.447 . . . . 1.0 110.81 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 118' ' ' TRP . 97.0 t -92.47 133.98 32.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.452 -0.795 . . . . 1.0 109.579 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -142.71 179.25 7.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 1.0 110.707 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.3 t -103.36 134.41 44.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.939 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -80.7 -179.95 7.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.762 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.09 -12.97 62.15 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.418 -0.356 . . . . 1.0 111.776 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -115.24 26.88 9.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.257 -178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 65.58 30.48 10.53 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.404 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 71.9 mmtt -95.66 156.24 16.41 Favored 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 108.732 -0.84 . . . . 1.0 108.732 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -104.9 117.2 33.43 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.243 -0.651 . . . . 1.0 109.243 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 10.3 mtm105 -132.91 178.0 7.21 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.661 -0.866 . . . . 1.0 108.661 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.53 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.9 p-90 -150.53 163.27 38.86 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.931 0.396 . . . . 1.0 111.417 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.417 HH21 HG13 ' A' ' 127' ' ' ILE . 39.7 mtp180 -147.73 143.37 27.53 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 114.826 -1.079 . . . . 1.0 109.304 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.768 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.7 tp -91.61 131.66 36.86 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 17.6 t -128.29 130.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.43 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.619 ' CB ' HD21 ' A' ' 126' ' ' ASN . 1.9 t-80 -79.08 170.95 15.89 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.874 -1.158 . . . . 1.0 107.874 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.411 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 11.7 t70 -55.73 -31.8 62.82 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.884 0.373 . . . . 1.0 111.187 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.3 -34.16 77.37 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.478 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 112.41 9.36 19.73 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.907 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.619 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.47 142.74 27.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 111.743 0.275 . . . . 1.0 111.743 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.425 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 48.0 mm -77.09 118.78 24.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.526 -0.761 . . . . 1.0 109.634 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.768 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.2 mt -92.19 -42.42 9.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.217 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.42 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -152.0 164.77 36.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.654 -1.157 . . . . 1.0 111.255 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -137.32 154.02 50.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.844 . . . . 1.0 108.862 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 20.5 p -53.32 -35.01 59.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.343 0.497 . . . . 1.0 112.343 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.0 -42.51 3.1 Favored Glycine 0 N--CA 1.452 -0.29 0 N-CA-C 111.566 -0.614 . . . . 1.0 111.566 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -102.79 -177.52 3.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.204 0.526 . . . . 1.0 111.556 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.9 126.31 1.8 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.05 -1.22 . . . . 1.0 110.05 177.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -136.4 173.1 12.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.136 0.468 . . . . 1.0 111.121 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.99 9.79 31.7 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.585 0.957 . . . . 1.0 113.585 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.3 m -122.64 130.55 53.1 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.427 0.632 . . . . 1.0 111.341 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.84 -38.31 88.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.553 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.5 tt0 -61.42 -41.39 97.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.081 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -60.06 -42.75 95.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.897 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.94 81.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.259 0.552 . . . . 1.0 110.196 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.509 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.24 -33.8 76.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.563 -0.744 . . . . 1.0 111.388 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -65.22 -31.45 72.62 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.564 -0.455 . . . . 1.0 109.921 176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.98 -38.85 95.97 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.089 -0.804 . . . . 1.0 111.089 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.626 HG21 HG22 ' B' ' 257' ' ' VAL . 64.5 mt -61.28 -51.06 77.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.365 0.602 . . . . 1.0 110.304 177.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -63.41 -32.89 74.46 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.989 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -64.2 -39.68 94.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.336 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.596 HG22 ' HB2' ' A' ' 152' ' ' ALA . 1.6 p -75.04 -38.28 42.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 C-N-CA 119.906 -0.718 . . . . 1.0 109.887 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -64.6 -13.83 55.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.145 0.498 . . . . 1.0 111.211 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -4.58 40.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.612 -0.722 . . . . 1.0 110.721 -178.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.425 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 22.1 m-80 -137.03 -37.93 0.64 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.757 0.651 . . . . 1.0 112.757 -174.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.596 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -53.69 -50.01 85.82 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.1 Cg_endo -65.88 -14.12 43.09 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 120.882 1.055 . . . . 1.0 113.633 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.48 -27.46 8.59 Favored 'General case' 0 CA--C 1.514 -0.425 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.546 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -61.32 135.51 57.74 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 113.555 0.946 . . . . 1.0 113.555 -176.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -90.98 139.21 30.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.06 -1.427 . . . . 1.0 110.54 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.22 133.28 31.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.214 0.531 . . . . 1.0 111.983 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt -124.57 146.61 29.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.356 178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -88.78 107.78 19.15 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.266 -0.873 . . . . 1.0 111.063 -177.623 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' B' ' 201' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.668 0.27 . . . . 1.0 110.653 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.425 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 12.8 p-10 -107.45 178.98 4.38 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.848 0.832 . . . . 1.0 112.622 -175.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -143.74 98.94 3.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.899 -1.5 . . . . 1.0 107.447 173.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.33 173.58 2.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.789 -1.096 . . . . 1.0 109.223 -177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.546 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 54.1 p-80 -169.5 148.78 3.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.904 -0.406 . . . . 1.0 109.904 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.512 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 49.5 m-85 -85.42 145.41 27.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.143 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -139.0 120.73 15.29 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.511 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' B' ' 218' ' ' TRP . 72.4 t -92.48 132.27 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.89 -0.595 . . . . 1.0 109.889 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.402 ' CE2' ' HD3' ' B' ' 219' ' ' ARG . 11.3 p90 -140.39 -176.02 4.47 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.078 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.497 HG13 ' HA ' ' B' ' 214' ' ' ASP . 4.8 t -107.33 139.69 28.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 1.0 112.579 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -81.85 -179.75 7.51 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.513 -0.767 . . . . 1.0 109.144 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.9 0.381 . . . . 1.0 111.834 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.24 24.05 13.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.44 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.497 ' HA ' HG13 ' B' ' 210' ' ' VAL . 4.9 m-20 63.17 41.36 8.07 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.344 0.592 . . . . 1.0 111.09 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.4 mmtt -103.61 155.82 18.26 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.447 -0.797 . . . . 1.0 108.901 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -97.49 123.01 41.19 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.043 0.449 . . . . 1.0 110.308 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -137.51 -178.83 5.4 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.381 -0.827 . . . . 1.0 109.058 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.525 ' HB3' HG22 ' B' ' 208' ' ' VAL . 58.2 p-90 -155.37 162.59 40.77 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.007 -0.277 . . . . 1.0 111.413 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' B' ' 219' ' ' ARG . 13.5 mtp180 -146.63 146.78 30.53 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.041 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.722 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.9 tp -97.03 130.2 44.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.193 -1.04 . . . . 1.0 108.193 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 6.9 t -126.73 130.18 71.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.444 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.535 ' CB ' HD21 ' B' ' 226' ' ' ASN . 1.9 t-80 -81.37 175.3 10.68 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -54.75 -35.56 63.88 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.347 0.404 . . . . 1.0 111.859 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -67.91 -33.26 74.36 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.285 0.564 . . . . 1.0 110.298 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.49 10.93 20.84 Favored Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 114.894 -1.048 . . . . 1.0 112.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.535 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.11 143.25 28.14 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.057 0.391 . . . . 1.0 112.057 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.6 mm -73.78 120.35 22.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.263 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.722 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.3 mt -97.39 -42.61 7.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.519 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -153.7 165.42 36.04 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.363 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -139.69 159.72 41.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 1.0 109.069 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 57.4 p -55.75 -33.81 64.64 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.151 0.5 . . . . 1.0 111.427 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.63 -51.19 3.58 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.232 -1.147 . . . . 1.0 110.232 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . 0.425 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 57.4 mm-40 -100.99 177.79 4.85 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.979 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -140.95 139.5 9.67 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 110.235 -1.146 . . . . 1.0 110.235 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -137.49 172.46 12.94 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.544 0.672 . . . . 1.0 111.489 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.15 10.9 36.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.129 0.789 . . . . 1.0 113.129 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 7.0 m -136.7 135.93 38.58 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.079 0.466 . . . . 1.0 110.926 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -64.53 -38.18 90.12 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.262 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.6 tt0 -57.24 -45.14 84.22 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.677 -0.692 . . . . 1.0 109.838 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -62.78 -40.75 98.29 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.906 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.63 79.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.558 0.694 . . . . 1.0 109.772 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.0 mtmt -65.02 -35.36 80.93 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.532 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.0 mm-40 -63.37 -28.02 69.71 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 176.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.75 -42.08 95.42 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' B' ' 242' ' ' LYS . 62.1 mt -61.83 -44.93 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.931 -0.634 . . . . 1.0 110.021 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.06 -39.74 93.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.208 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -67.68 -34.08 76.19 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.758 -0.655 . . . . 1.0 110.957 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.566 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.59 -39.27 53.59 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 C-N-CA 120.07 -0.652 . . . . 1.0 110.03 -177.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -68.43 -12.25 60.9 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.306 0.574 . . . . 1.0 111.078 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -101.22 -3.12 29.62 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.365 -0.834 . . . . 1.0 111.09 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -136.42 -40.09 0.65 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.566 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.35 -49.67 91.12 Favored Pre-proline 0 C--N 1.316 -0.882 0 N-CA-C 112.867 0.692 . . . . 1.0 112.867 -177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 46.7 Cg_endo -66.48 -9.12 22.96 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 120.916 1.077 . . . . 1.0 113.456 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -121.61 -13.91 8.27 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.685 0.624 . . . . 1.0 112.685 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -69.27 137.74 53.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.464 0.649 . . . . 1.0 112.13 -177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -91.14 144.01 26.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.997 -1.001 . . . . 1.0 111.495 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.626 HG22 HG21 ' A' ' 145' ' ' ILE . 43.7 t -85.76 123.49 39.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.226 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.7 mt -115.53 138.27 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -89.65 100.51 13.3 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.508 -0.923 . . . . 1.0 108.508 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.492 -0.766 . . . . 1.0 110.965 -176.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 112.239 0.459 . . . . 1.0 112.239 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.0 p-10 -90.64 168.21 11.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.42 0.629 . . . . 1.0 111.806 -176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 35.2 mmtp -142.37 96.39 2.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.808 -1.182 . . . . 1.0 107.808 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.24 174.67 1.97 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.164 -177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 53.3 p-80 -168.94 147.3 3.93 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.694 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.566 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 47.1 m-85 -85.04 148.82 25.97 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.71 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -141.06 120.44 13.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.766 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 118' ' ' TRP . 83.6 t -94.76 137.95 21.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.937 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -145.39 -178.63 6.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.437 -0.208 . . . . 1.0 110.437 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 8.2 t -103.98 136.75 35.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.186 0.517 . . . . 1.0 112.363 -179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.24 -179.68 7.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 1.0 109.086 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.48 -15.19 63.46 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.075 0.398 . . . . 1.0 112.075 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.81 22.59 15.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.677 0.275 . . . . 1.0 111.396 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.87 40.3 1.32 Allowed 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.434 -0.803 . . . . 1.0 110.695 177.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 2.5 mmtp -111.79 149.88 31.1 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.288 -0.869 . . . . 1.0 111.286 -176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -94.19 120.67 34.78 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.62 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -133.91 -179.4 5.52 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.818 -1.083 . . . . 1.0 108.444 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.556 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.5 p-90 -153.25 162.94 40.75 Favored 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 120.55 -0.46 . . . . 1.0 111.428 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.509 HH21 HG13 ' A' ' 127' ' ' ILE . 41.9 mtp180 -148.23 141.17 24.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.397 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.659 ' HG ' HD12 ' A' ' 128' ' ' LEU . 36.0 tp -90.97 135.15 33.93 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.09 130.25 69.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.084 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.578 ' CB ' HD21 ' A' ' 126' ' ' ASN . 3.5 t-80 -77.49 171.84 14.27 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.526 -0.916 . . . . 1.0 108.526 177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.6 t70 -58.86 -29.62 67.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.247 0.546 . . . . 1.0 110.356 177.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.68 -33.57 75.93 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.169 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.89 8.18 24.45 Favored Glycine 0 C--O 1.228 -0.267 0 CA-C-N 115.289 -0.869 . . . . 1.0 112.884 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.578 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.83 145.26 26.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 111.715 0.265 . . . . 1.0 111.715 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.509 HG13 HH21 ' A' ' 119' ' ' ARG . 51.0 mm -76.81 119.74 25.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.809 0.693 . . . . 1.0 110.017 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.659 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -94.86 -43.75 8.06 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.104 -178.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -148.01 168.91 21.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.115 -0.948 . . . . 1.0 111.663 178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -143.83 155.86 44.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.272 -0.876 . . . . 1.0 108.671 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 69.3 p -58.16 -32.96 68.7 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.189 0.519 . . . . 1.0 111.191 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.89 -47.24 3.52 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.803 -0.919 . . . . 1.0 110.803 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -109.25 170.66 7.91 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.734 -0.733 . . . . 1.0 111.549 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -130.83 145.34 16.78 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.267 -0.878 . . . . 1.0 110.934 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -141.46 165.92 26.18 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.848 0.324 . . . . 1.0 110.45 -176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.43 10.27 30.74 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 112.24 0.459 . . . . 1.0 112.24 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 p -127.38 129.23 47.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.453 0.644 . . . . 1.0 112.188 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -66.84 -37.05 83.73 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 115.348 -0.842 . . . . 1.0 110.456 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 10.0 tt0 -58.81 -43.17 90.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.745 -0.662 . . . . 1.0 110.135 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tppt? -60.07 -41.89 93.36 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.785 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.16 -50.29 69.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.293 0.568 . . . . 1.0 109.906 177.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.514 ' HA ' HD12 ' A' ' 145' ' ' ILE . 49.1 mtmt -65.45 -33.08 75.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.756 -0.656 . . . . 1.0 111.563 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.3 mm-40 -66.73 -31.02 71.4 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.588 -0.445 . . . . 1.0 110.128 176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.66 -38.26 93.08 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 111.086 -0.805 . . . . 1.0 111.086 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 142' ' ' LYS . 71.7 mt -61.47 -50.32 80.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.307 0.575 . . . . 1.0 110.652 177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -62.8 -33.79 75.92 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.211 -0.45 . . . . 1.0 111.181 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 52.5 m -65.28 -37.45 87.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.753 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.604 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -74.49 -33.88 34.14 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.551 0 C-N-CA 120.411 -0.516 . . . . 1.0 109.866 -177.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -69.35 -13.21 62.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.657 0.741 . . . . 1.0 110.634 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -101.21 -2.92 30.06 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.764 -1.107 . . . . 1.0 112.325 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -135.19 -39.5 0.75 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.745 0.307 . . . . 1.0 111.737 -175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.13 -51.32 82.57 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 32.0 Cg_endo -60.71 -12.26 20.86 Favored 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 121.364 1.376 . . . . 1.0 113.515 -176.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -123.79 -7.46 7.9 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.396 0.517 . . . . 1.0 112.396 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.48 134.3 43.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.704 0.764 . . . . 1.0 112.23 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.03 135.82 33.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.327 -1.306 . . . . 1.0 110.621 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -88.05 134.13 28.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.445 0.641 . . . . 1.0 112.124 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 11.0 mt -119.05 143.91 28.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 114.711 -1.131 . . . . 1.0 109.327 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -89.18 105.15 17.6 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.61 -0.709 . . . . 1.0 110.514 -178.371 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 14.4 ptm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 111.475 0.176 . . . . 1.0 111.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -128.35 171.92 11.57 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.838 0.828 . . . . 1.0 112.592 -176.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.598 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 23.6 mmtp -140.14 97.26 3.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.926 -1.488 . . . . 1.0 107.699 173.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.63 172.2 3.1 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.899 . . . . 1.0 109.831 -178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.474 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 45.3 p-80 -169.22 148.09 3.89 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.781 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 53.2 m-85 -85.35 148.55 25.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.921 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -140.33 117.01 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.43 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.8 t -92.95 129.79 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.91 -0.586 . . . . 1.0 109.662 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -141.34 -179.19 5.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.788 0.328 . . . . 1.0 110.589 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.9 t -102.23 136.34 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 1.0 112.149 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -78.72 179.92 6.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.013 -0.994 . . . . 1.0 109.752 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.9 -18.01 64.65 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.238 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -111.5 26.54 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.308 -0.405 . . . . 1.0 111.236 -177.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.447 ' HA ' HG13 ' B' ' 210' ' ' VAL . 11.7 m-20 63.53 39.37 9.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.768 -0.651 . . . . 1.0 111.431 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 31.7 mmtp -103.48 156.34 17.84 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -97.71 118.5 34.39 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.643 -0.503 . . . . 1.0 109.643 177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.405 ' HG2' ' HA2' ' B' ' 234' ' ' GLY . 69.4 mtp180 -134.29 179.57 6.19 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.735 . . . . 1.0 109.308 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.529 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.1 p-90 -154.0 161.37 42.01 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.945 0.402 . . . . 1.0 111.172 177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 38.0 mtp180 -147.07 141.11 26.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.047 -0.979 . . . . 1.0 109.89 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.694 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -91.39 131.1 37.1 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.01 130.93 71.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.174 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.517 ' CB ' HD21 ' B' ' 226' ' ' ASN . 6.3 t-80 -77.16 173.19 12.13 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 177.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.598 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.0 t70 -56.56 -34.39 67.05 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 123.368 0.418 . . . . 1.0 111.063 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . 0.418 ' HB2' ' OD1' ' B' ' 226' ' ' ASN . 1.4 m-20 -68.65 -34.62 76.03 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.019 -178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 113.79 13.93 9.87 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.378 -0.828 . . . . 1.0 113.514 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.517 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.2 OUTLIER -87.63 147.33 25.32 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 122.98 -0.129 . . . . 1.0 111.112 178.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -79.53 119.4 28.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 123.588 0.555 . . . . 1.0 110.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.694 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -93.69 -43.35 8.69 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.563 -0.744 . . . . 1.0 109.555 -178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.451 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.42 165.07 35.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.297 177.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -139.0 157.16 46.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.34 -0.845 . . . . 1.0 109.053 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 12.9 p -54.67 -32.99 60.12 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.278 0.473 . . . . 1.0 112.278 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.8 -43.77 3.19 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.236 -0.745 . . . . 1.0 111.236 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.87 170.02 8.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.17 0.51 . . . . 1.0 111.553 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' B' ' 217' ' ' ARG . . . -122.87 124.78 5.77 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 109.338 -1.505 . . . . 1.0 109.338 176.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -110.8 172.45 6.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.993 0.396 . . . . 1.0 111.372 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -105.54 10.85 32.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.874 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 3.3 p -143.94 130.88 20.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.629 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -61.03 -44.41 97.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.087 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.2 tt0 -54.04 -40.49 67.13 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.261 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.597 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.3 OUTLIER -61.62 -42.8 99.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.323 -178.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.61 -45.29 92.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.305 0.574 . . . . 1.0 109.817 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.469 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.3 mtmt -64.04 -35.52 80.98 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.13 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.2 mm-40 -65.4 -31.39 72.47 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.045 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.48 94.7 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 120.511 -0.852 . . . . 1.0 110.979 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.506 ' O ' HG12 ' B' ' 248' ' ' VAL . 70.6 mt -61.16 -52.3 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.365 0.602 . . . . 1.0 110.606 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -63.35 -34.85 78.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.646 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 61.7 m -66.15 -35.85 81.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.754 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.565 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -73.33 -41.06 57.45 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 -177.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -65.06 -13.48 58.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.801 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -102.74 -2.92 27.25 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.758 -0.656 . . . . 1.0 111.261 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . 0.473 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 17.8 m-80 -137.01 -38.31 0.63 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.036 -0.529 . . . . 1.0 112.223 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.565 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.58 -50.77 85.06 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 112.696 0.628 . . . . 1.0 112.696 -177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.9 Cg_endo -63.92 -10.65 23.61 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 121.037 1.158 . . . . 1.0 113.266 -177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -115.99 -17.04 11.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.978 0.418 . . . . 1.0 111.464 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -69.73 136.92 51.54 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.18 0.807 . . . . 1.0 113.18 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -90.25 137.58 32.23 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.595 -1.184 . . . . 1.0 110.966 177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.566 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.2 p -88.72 132.27 34.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.253 0.549 . . . . 1.0 112.416 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -121.58 142.72 36.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.526 -1.215 . . . . 1.0 108.407 177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -93.51 106.9 18.83 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.825 -176.633 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 54.7 ttp . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.869 0.366 . . . . 1.0 111.233 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -137.87 -174.17 3.71 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.108 0.956 . . . . 1.0 113.081 -174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 72.3 mmtt -135.02 97.61 3.78 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 113.387 -1.733 . . . . 1.0 107.183 173.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.49 170.81 3.47 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 -177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.528 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 45.0 p-80 -170.75 150.78 3.33 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.413 -0.217 . . . . 1.0 110.413 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.452 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 69.7 m-85 -88.57 150.85 22.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.267 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -143.19 123.35 13.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.624 -0.717 . . . . 1.0 110.636 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.7 t -96.96 134.06 36.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.576 -0.738 . . . . 1.0 109.909 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -146.32 -177.55 5.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.886 0.374 . . . . 1.0 110.869 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -96.82 138.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.362 0.601 . . . . 1.0 112.552 -179.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -82.12 179.67 7.72 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.214 -0.903 . . . . 1.0 109.772 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.61 62.29 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.843 -0.617 . . . . 1.0 111.289 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.82 26.33 10.44 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.943 -0.572 . . . . 1.0 110.871 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.42 ' HA ' HG13 ' A' ' 110' ' ' VAL . 13.3 m-20 59.54 43.61 15.81 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.402 0.62 . . . . 1.0 111.004 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.8 mmtp -101.72 178.32 4.66 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.268 -1.012 . . . . 1.0 108.268 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -118.57 103.37 9.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.584 ' HD3' ' HA2' ' A' ' 134' ' ' GLY . 12.7 mmm180 -122.28 178.63 4.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.52 ' HB3' HG22 ' A' ' 108' ' ' VAL . 60.2 p-90 -151.6 163.81 38.25 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 120.735 0.302 . . . . 1.0 111.355 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 39.0 mtp180 -148.4 149.64 32.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.234 -0.894 . . . . 1.0 109.658 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.699 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.7 tp -96.94 133.29 41.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.999 -0.741 . . . . 1.0 108.999 177.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.8 t -131.31 131.43 63.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.141 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.635 ' CB ' HD21 ' A' ' 126' ' ' ASN . 4.1 t-80 -76.89 168.2 20.51 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.413 -1.329 . . . . 1.0 107.413 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.502 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 22.8 t70 -61.36 -22.39 64.89 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 120.852 0.358 . . . . 1.0 111.008 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.91 -35.04 72.12 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.511 0.672 . . . . 1.0 109.513 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.9 11.39 11.17 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 114.8 -1.091 . . . . 1.0 113.199 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.635 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -91.01 143.93 26.19 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 122.718 -0.283 . . . . 1.0 111.673 179.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.32 126.58 36.26 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 O-C-N 123.96 0.787 . . . . 1.0 110.133 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.699 HD12 ' HG ' ' A' ' 120' ' ' LEU . 13.4 mt -105.12 -39.62 6.15 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.289 0.566 . . . . 1.0 110.071 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.451 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.03 166.81 31.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.775 -1.102 . . . . 1.0 111.277 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -139.6 156.0 47.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.863 -1.062 . . . . 1.0 108.341 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.498 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 83.1 p -56.64 -42.74 79.39 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.732 0.641 . . . . 1.0 112.732 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.99 -41.88 3.09 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.96 -0.638 . . . . 1.0 112.903 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.529 ' HB2' ' NH2' ' A' ' 117' ' ' ARG . 35.7 mt-10 -83.95 -168.48 2.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.118 0.485 . . . . 1.0 110.17 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.584 ' HA2' ' HD3' ' A' ' 117' ' ' ARG . . . -168.65 119.06 0.81 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.502 -0.772 . . . . 1.0 111.706 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -141.3 169.01 18.42 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.76 35.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.603 0.594 . . . . 1.0 112.603 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -116.62 131.85 56.84 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.409 0.624 . . . . 1.0 111.456 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -65.12 -36.11 83.25 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.792 -1.095 . . . . 1.0 110.692 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.8 tt0 -61.24 -45.59 93.91 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.394 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -59.6 -38.14 80.44 Favored 'General case' 0 CA--C 1.52 -0.176 0 O-C-N 123.208 0.317 . . . . 1.0 110.638 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.59 -52.33 65.85 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.538 0.685 . . . . 1.0 109.649 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.429 ' HA ' HD12 ' A' ' 145' ' ' ILE . 48.3 mtmt -64.12 -36.23 83.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.623 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.5 mm-40 -65.47 -27.03 68.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.5 -41.75 94.05 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.225 -1.15 . . . . 1.0 110.225 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.552 HG21 HG22 ' B' ' 257' ' ' VAL . 47.8 mt -63.4 -40.96 91.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.186 -0.507 . . . . 1.0 110.162 177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -62.76 -43.01 99.92 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.073 0.463 . . . . 1.0 110.075 178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.6 m -63.27 -35.58 80.83 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.391 -0.822 . . . . 1.0 110.641 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -74.63 -42.55 48.29 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 C-N-CA 119.832 -0.747 . . . . 1.0 110.239 -177.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -67.19 -14.08 62.57 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.958 -0.464 . . . . 1.0 111.775 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -104.32 -1.88 26.33 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.016 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.427 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.7 m-80 -133.04 -39.33 0.95 Allowed 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.376 -0.375 . . . . 1.0 111.908 -177.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.613 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.32 -50.26 88.61 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 52.8 Cg_endo -67.24 -7.83 20.12 Favored 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 121.181 1.254 . . . . 1.0 113.344 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.21 -29.97 6.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.248 0.547 . . . . 1.0 111.727 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.41 136.81 58.08 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.238 -0.892 . . . . 1.0 113.361 -176.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -96.89 141.92 29.5 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.149 -1.387 . . . . 1.0 111.024 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.3 p -89.31 135.26 26.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 112.986 0.736 . . . . 1.0 112.986 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.0 mt -115.61 139.88 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 114.88 -1.054 . . . . 1.0 109.272 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -87.4 103.47 15.53 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.502 -0.761 . . . . 1.0 110.971 -178.729 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 50.9 ttp . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.733 0.301 . . . . 1.0 110.958 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.427 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.7 p-10 -128.38 -175.55 3.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.831 0.824 . . . . 1.0 112.905 -174.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -140.04 96.87 3.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.436 -1.69 . . . . 1.0 106.436 173.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.41 174.02 2.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.238 -177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.46 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 40.4 p-80 -168.83 149.22 4.42 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 123.143 0.277 . . . . 1.0 110.607 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.542 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.7 m-85 -85.75 152.89 22.69 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.69 177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -141.27 117.05 10.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.42 -0.354 . . . . 1.0 110.535 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' B' ' 218' ' ' TRP . 82.7 t -95.01 130.92 43.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -141.87 178.86 7.22 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.188 0.305 . . . . 1.0 110.39 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.1 t -101.58 136.77 31.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.256 0.55 . . . . 1.0 112.067 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -82.91 178.61 8.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.15 -0.932 . . . . 1.0 109.466 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.14 -18.7 64.7 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.114 0.483 . . . . 1.0 110.956 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -105.22 21.54 16.95 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.563 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.431 ' HA ' HG13 ' B' ' 210' ' ' VAL . 18.5 m-20 64.23 36.28 9.5 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.414 -0.812 . . . . 1.0 111.187 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 32.2 mmtp -99.21 157.48 16.34 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 108.592 -0.892 . . . . 1.0 108.592 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -104.21 112.86 26.06 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 11.1 mtm105 -127.44 176.8 7.18 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.529 ' HB3' HG22 ' B' ' 208' ' ' VAL . 49.4 p-90 -149.12 161.84 41.16 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.735 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' B' ' 219' ' ' ARG . 9.2 mtp180 -145.72 143.47 29.78 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.163 -0.926 . . . . 1.0 109.649 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.682 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.3 tp -93.54 134.09 36.17 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -130.17 133.24 64.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.505 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.58 ' CB ' HD21 ' B' ' 226' ' ' ASN . 4.4 t-80 -80.35 172.36 13.86 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -57.56 -31.77 66.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 1.0 111.1 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.85 -32.86 74.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.897 -178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.5 10.65 21.3 Favored Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.006 -0.997 . . . . 1.0 112.722 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.58 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.57 145.1 25.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 111.74 0.274 . . . . 1.0 111.74 179.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.0 mm -73.42 130.17 35.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.789 0.681 . . . . 1.0 109.199 177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.682 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.8 mt -107.44 -41.9 4.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.347 0.594 . . . . 1.0 110.033 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.84 166.61 30.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.962 -1.017 . . . . 1.0 111.376 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -139.23 154.29 47.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.291 -0.868 . . . . 1.0 108.851 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.472 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 24.8 p -54.22 -39.61 66.89 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.735 0.642 . . . . 1.0 112.735 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 78.65 -26.92 2.25 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.554 -0.832 . . . . 1.0 111.149 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' B' ' 231' ' ' SER . 48.8 mt-10 -87.2 -175.84 5.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.59 0.71 . . . . 1.0 111.502 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -170.09 102.17 0.18 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.158 -1.177 . . . . 1.0 110.158 177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -129.71 169.75 14.7 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.356 -0.238 . . . . 1.0 110.356 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.35 10.07 37.61 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.207 0.447 . . . . 1.0 112.207 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -121.81 131.17 53.91 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.615 0.721 . . . . 1.0 111.365 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -65.2 -34.67 78.93 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.583 -1.189 . . . . 1.0 110.421 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.4 tt0 -58.57 -46.45 86.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.461 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -60.01 -40.29 88.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.52 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.22 -51.81 68.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.015 0.436 . . . . 1.0 110.3 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.502 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.23 -35.88 82.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.676 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.4 mm-40 -65.7 -31.02 71.78 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.536 -0.466 . . . . 1.0 109.995 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.23 -38.35 95.04 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.509 ' O ' HG12 ' B' ' 248' ' ' VAL . 73.5 mt -60.8 -53.26 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.259 0.552 . . . . 1.0 110.687 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -63.11 -32.79 74.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.645 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.0 m -67.19 -38.11 84.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.635 177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.542 HG22 ' HB2' ' B' ' 252' ' ' ALA . 1.4 p -73.05 -36.03 49.79 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 C-N-CA 119.843 -0.743 . . . . 1.0 109.08 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -66.24 -12.62 57.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.98 0.419 . . . . 1.0 111.304 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -104.44 -2.25 25.62 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.768 -0.651 . . . . 1.0 110.723 -178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -131.32 -37.5 1.24 Allowed 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 111.944 0.35 . . . . 1.0 111.944 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.542 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.65 -51.5 80.77 Favored Pre-proline 0 C--N 1.318 -0.772 0 N-CA-C 112.504 0.557 . . . . 1.0 112.504 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 50.6 Cg_endo -66.66 -12.51 36.16 Favored 'Trans proline' 0 C--N 1.358 1.031 0 C-N-CA 121.268 1.312 . . . . 1.0 113.2 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.35 -29.6 9.18 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.205 0.526 . . . . 1.0 111.437 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -63.24 137.89 58.36 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.16 -0.927 . . . . 1.0 112.939 -176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -97.72 149.41 22.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.148 -1.387 . . . . 1.0 111.557 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 145' ' ' ILE . 46.1 t -86.62 131.58 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.029 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -124.13 138.31 54.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -90.67 101.55 14.3 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.499 -0.763 . . . . 1.0 111.387 -176.886 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 112.033 0.383 . . . . 1.0 112.033 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -133.83 175.83 9.11 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.784 0.802 . . . . 1.0 112.439 -175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.57 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 14.2 mmtp -134.53 96.92 3.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.965 -1.471 . . . . 1.0 107.656 173.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.06 166.62 3.51 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.938 -1.028 . . . . 1.0 109.408 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.49 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.3 p-80 -168.83 146.87 3.93 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.025 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.23 147.98 26.31 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.543 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -139.46 117.11 11.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.464 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' A' ' 118' ' ' TRP . 93.9 t -94.61 134.27 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.942 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -146.29 -179.17 6.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.594 0.235 . . . . 1.0 110.639 -177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.1 t -101.39 134.97 40.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.175 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -81.58 178.94 8.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.05 -9.4 52.39 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.025 -0.534 . . . . 1.0 111.829 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.1 21.64 13.56 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.856 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 72.05 33.36 1.63 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.807 0.843 . . . . 1.0 111.306 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.5 mttt -108.68 150.78 27.08 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.71 -0.677 . . . . 1.0 111.583 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -94.56 116.05 28.31 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.833 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.471 HH12 ' CG ' ' A' ' 130' ' ' ASP . 16.7 mtm105 -133.55 177.73 7.48 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.535 -0.913 . . . . 1.0 108.535 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.568 ' HB3' HG22 ' A' ' 108' ' ' VAL . 53.9 p-90 -150.19 161.09 43.08 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.782 0.325 . . . . 1.0 111.108 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 20.2 mtp180 -145.95 142.19 28.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.096 -0.956 . . . . 1.0 109.543 178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.713 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.9 tp -91.88 132.69 36.29 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.38 132.56 68.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.533 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.533 ' CB ' HD21 ' A' ' 126' ' ' ASN . 1.7 t-80 -81.06 173.03 12.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.841 -0.8 . . . . 1.0 108.841 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.57 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 13.2 t70 -58.62 -31.99 68.59 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.123 0.487 . . . . 1.0 110.691 177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -63.68 -34.42 77.83 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.832 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 9.37 25.47 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.664 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.533 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.23 143.34 27.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.829 -0.185 . . . . 1.0 111.496 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.81 123.73 31.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.895 0.747 . . . . 1.0 109.353 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.713 HD12 ' HG ' ' A' ' 120' ' ' LEU . 14.8 mt -98.37 -41.88 7.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.354 0.597 . . . . 1.0 109.91 -178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.73 169.09 22.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.677 177.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.471 ' CG ' HH12 ' A' ' 117' ' ' ARG . 7.6 t70 -142.4 154.36 44.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.133 -0.94 . . . . 1.0 108.867 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.6 p -57.09 -35.07 68.96 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.903 0.382 . . . . 1.0 111.679 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.69 -44.96 3.38 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.226 -0.75 . . . . 1.0 111.226 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -94.66 177.54 5.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.315 0.579 . . . . 1.0 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -150.45 127.04 2.28 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 114.858 -1.065 . . . . 1.0 110.454 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -141.97 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.792 0.296 . . . . 1.0 110.46 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.05 10.22 27.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.821 -0.627 . . . . 1.0 112.501 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.1 m -124.06 130.56 52.76 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.633 0.73 . . . . 1.0 111.715 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -65.95 -34.38 77.98 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.919 -1.037 . . . . 1.0 110.297 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.6 tt0 -58.37 -46.64 85.94 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.453 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -59.52 -38.63 81.47 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 110.422 -0.214 . . . . 1.0 110.422 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.42 -52.94 63.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.225 0.536 . . . . 1.0 110.135 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 145' ' ' ILE . 46.5 mtmt -64.99 -35.97 82.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.033 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.2 mm-40 -65.32 -30.7 71.57 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.468 -0.493 . . . . 1.0 109.787 177.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.86 -38.73 94.59 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 142' ' ' LYS . 75.4 mt -60.52 -53.18 52.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.402 0.62 . . . . 1.0 110.531 177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -62.53 -33.27 74.58 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.773 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 58.5 m -67.36 -38.17 84.36 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.636 177.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.9 OUTLIER -73.17 -33.01 40.67 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.48 0 C-N-CA 120.247 -0.581 . . . . 1.0 109.61 -177.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -69.58 -14.62 62.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.539 0.685 . . . . 1.0 110.396 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.7 mtp180 -100.49 -1.89 34.55 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.723 -1.126 . . . . 1.0 112.037 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -134.34 -40.89 0.81 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.263 0.468 . . . . 1.0 112.263 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.33 -52.06 77.08 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 113.041 0.756 . . . . 1.0 113.041 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 47.8 Cg_endo -64.9 -12.75 35.91 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 120.883 1.055 . . . . 1.0 113.294 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -109.47 -29.4 8.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.07 0.462 . . . . 1.0 111.149 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.14 136.45 57.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.949 -1.023 . . . . 1.0 113.347 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -99.12 144.06 28.68 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.131 -1.395 . . . . 1.0 110.534 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.05 137.16 21.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 113.061 0.763 . . . . 1.0 113.061 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.1 mt -119.69 144.89 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.668 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -89.08 105.02 17.51 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.065 -0.717 . . . . 1.0 109.065 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.614 -0.708 . . . . 1.0 111.292 -177.736 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.708 0.29 . . . . 1.0 111.3 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -111.88 179.35 4.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.758 0.79 . . . . 1.0 111.991 -176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.583 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 18.1 mmtp -138.97 96.49 3.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.117 -1.401 . . . . 1.0 108.087 174.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.16 170.84 3.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.589 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.508 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 34.2 p-80 -170.26 148.08 3.2 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.705 -0.68 . . . . 1.0 109.391 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.509 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.5 m-85 -84.63 152.59 23.72 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.131 0.269 . . . . 1.0 110.696 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -141.52 120.45 12.77 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.419 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.523 HG22 ' HB3' ' B' ' 218' ' ' TRP . 89.1 t -96.29 135.17 31.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.061 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -146.82 178.66 8.16 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 123.136 0.273 . . . . 1.0 110.779 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -98.39 135.49 32.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.671 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.3 177.87 8.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.911 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.2 -13.73 62.45 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.967 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -110.73 19.02 19.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.619 -178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 69.4 38.84 1.73 Allowed 'General case' 0 CA--C 1.505 -0.758 0 CA-C-N 115.511 -0.768 . . . . 1.0 111.008 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.8 mmtt -109.13 155.9 20.47 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.397 -0.819 . . . . 1.0 110.261 -176.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.43 ' O ' ' HB2' ' B' ' 241' ' ' ALA . 81.0 m-85 -99.28 102.65 14.35 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.845 -177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.577 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 12.1 mmm180 -122.52 177.43 5.42 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.171 -177.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.523 ' HB3' HG22 ' B' ' 208' ' ' VAL . 55.7 p-90 -150.7 161.12 43.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.768 0.318 . . . . 1.0 111.486 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 28.3 mtp180 -147.49 145.87 29.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.281 -0.872 . . . . 1.0 109.469 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.688 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.4 tp -94.22 134.95 36.14 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.972 -0.751 . . . . 1.0 108.972 178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 16.9 t -130.14 132.94 64.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.792 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.566 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.1 t-80 -81.93 173.85 11.83 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.058 -0.719 . . . . 1.0 109.058 177.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 13.5 t70 -55.02 -32.18 61.64 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.353 0.408 . . . . 1.0 111.887 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -71.21 -34.29 70.71 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.419 0.628 . . . . 1.0 110.335 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.49 13.19 11.96 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.162 -0.926 . . . . 1.0 112.655 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.566 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.99 143.49 26.82 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 178.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.6 mm -76.21 121.66 28.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 123.903 0.752 . . . . 1.0 109.717 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.688 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -96.88 -40.67 8.8 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.545 -0.752 . . . . 1.0 109.629 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -152.68 164.54 37.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.771 -1.104 . . . . 1.0 111.425 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -137.54 156.99 47.48 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.984 -1.007 . . . . 1.0 109.262 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.501 ' HB2' HH21 ' B' ' 217' ' ' ARG . 79.3 p -58.06 -45.99 86.15 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.76 -40.73 2.89 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.806 -0.712 . . . . 1.0 112.989 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . 0.504 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 42.0 mt-10 -84.97 -168.9 2.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.072 0.463 . . . . 1.0 110.294 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.577 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -170.17 124.55 1.15 Allowed Glycine 0 C--N 1.333 0.368 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.871 173.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -146.73 170.06 17.77 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.35 9.97 39.53 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.416 0.447 . . . . 1.0 112.007 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.0 m -111.94 130.21 55.92 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.393 0.616 . . . . 1.0 111.312 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . 0.411 ' HB3' ' CE2' ' B' ' 216' ' ' TYR . 8.4 ptpp? -66.17 -35.95 81.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.175 -0.92 . . . . 1.0 110.89 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.3 tt0 -59.59 -46.84 87.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.459 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -59.91 -38.33 81.98 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.584 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' B' ' 216' ' ' TYR . . . -58.73 -53.11 62.08 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.563 0.697 . . . . 1.0 110.319 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.488 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.9 mtmt -64.46 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.411 -178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.4 mm-40 -66.04 -30.26 70.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.06 -40.16 95.02 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.425 -0.893 . . . . 1.0 110.971 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.506 ' O ' HG12 ' B' ' 248' ' ' VAL . 69.7 mt -60.47 -52.86 56.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 1.0 110.562 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -62.66 -35.96 81.32 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.865 -0.607 . . . . 1.0 111.253 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.3 m -66.94 -35.62 80.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.905 178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.557 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -72.61 -38.79 59.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.594 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.565 -177.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -65.56 -17.88 64.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.766 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' B' ' 250' ' ' ARG . 30.9 ttp-105 -100.9 -1.66 34.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.607 -0.724 . . . . 1.0 111.123 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -132.71 -40.58 0.96 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.411 0.523 . . . . 1.0 112.411 -177.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.557 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -57.17 -49.69 92.5 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 112.902 0.705 . . . . 1.0 112.902 -178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 55.9 Cg_endo -66.36 -5.75 13.38 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.029 1.153 . . . . 1.0 113.423 -177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -123.79 -11.06 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.838 0.352 . . . . 1.0 111.789 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -71.95 137.02 47.03 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.213 0.53 . . . . 1.0 112.05 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -93.3 140.34 29.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.228 -0.896 . . . . 1.0 110.25 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -91.53 129.87 41.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.632 0.729 . . . . 1.0 112.468 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.04 140.2 37.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.54 -1.209 . . . . 1.0 109.054 177.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -89.06 102.66 15.31 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.896 -0.779 . . . . 1.0 108.896 177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.458 -0.782 . . . . 1.0 111.447 -177.24 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 58.0 ttp . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 121.246 0.546 . . . . 1.0 110.86 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 13.6 p-10 -102.3 -177.56 3.44 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.432 -0.804 . . . . 1.0 112.514 -175.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 23.9 mmtp -138.7 98.36 3.55 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.738 -1.574 . . . . 1.0 108.273 174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.47 167.35 3.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.116 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.554 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.6 p-80 -167.87 147.11 4.79 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.31 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.547 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 52.2 m-85 -87.17 148.21 25.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.078 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -143.02 120.67 11.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.72 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.606 HG22 ' HB3' ' A' ' 118' ' ' TRP . 92.2 t -96.02 130.94 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.716 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.09 179.3 6.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.69 0.281 . . . . 1.0 110.644 -177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -103.28 136.81 34.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.191 0.519 . . . . 1.0 111.99 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -84.49 -175.28 5.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.286 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.2 -10.24 56.8 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.589 0.589 . . . . 1.0 112.589 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -124.04 33.18 5.35 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.718 0.294 . . . . 1.0 111.523 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.5 35.13 17.66 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.192 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 32.4 mmtp -96.86 154.28 17.39 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 109.104 -0.702 . . . . 1.0 109.104 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -104.94 114.95 29.47 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.792 -0.64 . . . . 1.0 109.961 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 mtm105 -131.67 175.41 9.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.269 -0.878 . . . . 1.0 108.853 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.606 ' HB3' HG22 ' A' ' 108' ' ' VAL . 55.1 p-90 -151.07 162.45 40.83 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 120.656 0.265 . . . . 1.0 111.361 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -147.54 144.91 28.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.252 -0.885 . . . . 1.0 110.068 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.691 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.0 tp -97.29 134.15 40.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 t -127.31 132.56 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.656 -0.247 . . . . 1.0 110.736 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.521 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.6 t-80 -84.56 177.39 8.1 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.818 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.527 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 17.9 t70 -52.04 -43.98 64.01 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.257 -0.883 . . . . 1.0 110.805 176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -63.13 -33.45 75.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.407 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.79 11.66 22.41 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.312 -0.858 . . . . 1.0 112.331 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.521 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.13 144.19 27.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.78 -0.21 . . . . 1.0 111.371 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.487 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 50.2 mm -74.46 120.43 23.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.996 -0.742 . . . . 1.0 108.996 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.691 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.6 mt -93.06 -42.76 9.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.067 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.513 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.66 166.33 29.66 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.739 -1.118 . . . . 1.0 111.655 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.37 155.72 45.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.041 -0.981 . . . . 1.0 108.558 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.438 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 13.6 p -53.33 -31.78 45.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.994 0.426 . . . . 1.0 111.698 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.55 -41.36 3.08 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' HG2' ' HB ' ' B' ' 227' ' ' ILE . 50.2 mm-40 -114.53 173.44 6.46 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.466 0.651 . . . . 1.0 111.933 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -122.7 132.71 8.82 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 109.947 -1.261 . . . . 1.0 109.947 177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -122.28 167.21 13.52 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 117.114 0.457 . . . . 1.0 110.241 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -102.57 9.77 39.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.47 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.0 m -139.11 133.61 31.76 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.88 -0.415 . . . . 1.0 109.88 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.5 -38.43 91.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 1.0 110.401 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.4 tt0 -58.46 -43.04 88.74 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.897 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.89 -41.06 95.28 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.116 -179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.2 -48.7 80.64 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.014 0.435 . . . . 1.0 110.029 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.493 ' HG2' HG21 ' A' ' 108' ' ' VAL . 42.6 mtmt -64.48 -37.04 86.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.804 -0.635 . . . . 1.0 111.112 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.2 mm-40 -63.58 -26.57 68.75 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.488 -0.56 . . . . 1.0 109.488 176.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.94 -41.74 93.14 Favored Glycine 0 C--N 1.338 0.67 0 N-CA-C 109.931 -1.268 . . . . 1.0 109.931 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' A' ' 142' ' ' LYS . 67.9 mt -60.98 -41.38 88.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.469 0.652 . . . . 1.0 109.771 177.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.95 -43.05 93.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.237 0.541 . . . . 1.0 110.166 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 37.1 m -63.49 -35.4 80.32 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.514 -0.767 . . . . 1.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.606 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.84 -41.86 53.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.567 0 C-N-CA 120.165 -0.614 . . . . 1.0 109.841 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.5 mtpt -66.72 -12.22 57.63 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 122.15 -0.344 . . . . 1.0 111.49 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 25.3 ttt180 -104.76 -2.78 24.41 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.932 -0.576 . . . . 1.0 111.205 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.2 m-80 -132.94 -39.58 0.95 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.923 0.392 . . . . 1.0 111.884 -177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.606 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.38 -50.33 87.36 Favored Pre-proline 0 C--N 1.317 -0.82 0 CA-C-N 115.692 -0.685 . . . . 1.0 112.456 -178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 38.6 Cg_endo -65.13 -9.34 21.41 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 121.387 1.391 . . . . 1.0 113.241 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -115.03 -23.34 9.1 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.284 0.475 . . . . 1.0 112.284 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.563 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -67.83 138.26 55.96 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 113.136 0.791 . . . . 1.0 113.136 -176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -93.18 151.25 19.95 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 114.683 -1.144 . . . . 1.0 111.761 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.499 HG22 HG21 ' B' ' 245' ' ' ILE . 44.0 t -86.48 132.27 32.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.799 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.6 mt -127.97 140.19 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 108.947 -0.76 . . . . 1.0 108.947 175.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -87.8 108.37 19.11 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.595 -0.717 . . . . 1.0 111.228 -177.427 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 60.8 ttp . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 120.962 0.411 . . . . 1.0 110.954 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.407 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 14.5 p-10 -102.3 179.74 4.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.66 0.743 . . . . 1.0 112.412 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 30.2 mmtp -138.55 98.5 3.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.174 -1.376 . . . . 1.0 107.659 172.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.47 168.12 3.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 1.0 109.592 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.563 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 46.7 p-80 -167.94 149.11 5.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.198 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -85.83 148.22 25.92 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.985 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -139.2 119.83 14.1 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.702 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.568 HG21 ' HG2' ' B' ' 242' ' ' LYS . 90.3 t -92.83 132.29 37.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.787 178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -142.62 -178.37 5.75 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 -177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' B' ' 214' ' ' ASP . 3.3 t -104.6 139.77 24.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -81.85 -178.45 6.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.042 -0.981 . . . . 1.0 110.208 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.62 -20.15 64.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.043 0.449 . . . . 1.0 111.351 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.85 24.23 13.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.815 -0.63 . . . . 1.0 110.703 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' B' ' 210' ' ' VAL . 12.5 m-20 60.95 40.15 15.79 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.751 -0.659 . . . . 1.0 110.901 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -100.25 156.48 17.2 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' B' ' 238' ' ' LYS . 89.6 m-85 -98.48 115.86 29.47 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.702 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 23.9 mtm105 -133.91 178.57 6.84 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.511 ' HB3' HG22 ' B' ' 208' ' ' VAL . 53.4 p-90 -151.3 163.68 38.35 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.908 -0.317 . . . . 1.0 111.508 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -146.06 146.41 30.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.295 -0.866 . . . . 1.0 109.887 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.686 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -96.13 133.16 40.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.6 t -128.46 130.96 69.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.544 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.603 ' CB ' HD21 ' B' ' 226' ' ' ASN . 1.9 t-80 -80.75 172.64 13.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 19.4 t70 -54.94 -36.81 65.67 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.191 0.307 . . . . 1.0 111.63 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.02 -34.64 78.0 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.269 0.557 . . . . 1.0 110.396 -178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 111.75 15.08 10.48 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.212 -0.904 . . . . 1.0 112.423 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.603 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -90.99 142.33 27.89 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.927 0.343 . . . . 1.0 111.927 179.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 133' ' ' GLU . 50.7 mm -75.83 119.19 23.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 123.933 0.771 . . . . 1.0 109.981 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.686 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -94.87 -43.38 8.22 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.468 -0.787 . . . . 1.0 109.739 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -149.72 170.03 19.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.053 -0.976 . . . . 1.0 111.494 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.72 157.31 44.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.981 -1.009 . . . . 1.0 108.538 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.441 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 77.4 p -59.09 -37.15 76.45 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.21 0.529 . . . . 1.0 111.187 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.55 -45.7 3.48 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.801 -0.92 . . . . 1.0 110.801 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . 0.487 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 33.3 mm-40 -94.88 166.41 11.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.418 0.628 . . . . 1.0 111.502 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.19 126.86 4.94 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.08 166.62 13.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.873 0.337 . . . . 1.0 111.453 -176.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.4 10.26 40.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.502 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.1 m -141.32 135.15 30.25 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.908 0.385 . . . . 1.0 110.663 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' B' ' 216' ' ' TYR . 16.6 ptpt -61.91 -41.95 98.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.4 tt0 -55.9 -45.22 78.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.557 -0.747 . . . . 1.0 110.565 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -62.42 -41.72 98.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.207 -0.452 . . . . 1.0 111.039 -177.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.1 -47.06 87.46 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.356 0.598 . . . . 1.0 110.378 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.568 ' HG2' HG21 ' B' ' 208' ' ' VAL . 49.6 mtmt -63.12 -35.61 80.85 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.247 -0.888 . . . . 1.0 111.142 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.8 mm-40 -65.92 -26.82 67.77 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.74 96.02 Favored Glycine 0 C--N 1.342 0.896 0 N-CA-C 110.547 -1.021 . . . . 1.0 110.547 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.499 HG21 HG22 ' A' ' 157' ' ' VAL . 58.5 mt -59.72 -45.51 94.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 121.409 0.623 . . . . 1.0 110.034 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -62.51 -39.43 93.52 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.911 -0.586 . . . . 1.0 110.126 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.9 m -66.34 -35.57 80.69 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.671 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -72.93 -40.48 59.72 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 C-N-CA 120.08 -0.648 . . . . 1.0 109.599 -177.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -65.86 -12.41 54.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.017 0.436 . . . . 1.0 111.331 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -104.94 -3.14 23.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.696 -0.684 . . . . 1.0 111.004 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 17.6 m-80 -130.83 -40.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.99 -177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.6 -51.22 81.89 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 115.616 -0.72 . . . . 1.0 112.516 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.5 Cg_endo -65.91 -11.84 32.69 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 120.987 1.125 . . . . 1.0 113.219 -177.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -113.01 -15.49 12.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.954 0.407 . . . . 1.0 112.04 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -74.95 137.88 41.93 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 113.022 0.749 . . . . 1.0 113.022 -177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -92.66 138.29 31.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.647 -1.161 . . . . 1.0 110.722 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.547 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.23 129.87 38.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.622 0.725 . . . . 1.0 112.339 178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -116.1 142.21 30.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 114.766 -1.106 . . . . 1.0 109.033 178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -89.93 104.87 17.39 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.607 -0.711 . . . . 1.0 110.819 -178.412 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 52.8 ttp . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.876 0.37 . . . . 1.0 111.302 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 14.9 p-10 -100.95 173.96 6.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.77 0.795 . . . . 1.0 112.55 -175.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 123' ' ' ASP . 28.2 mmtt -141.9 94.53 2.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.33 -1.305 . . . . 1.0 107.82 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.48 174.39 1.92 Allowed 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.237 -177.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.535 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 40.1 p-80 -170.56 148.79 3.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.388 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 67.1 m-85 -86.84 150.17 24.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.587 0.232 . . . . 1.0 110.681 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.51 120.12 12.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.788 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 118' ' ' TRP . 86.8 t -94.67 132.8 37.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.778 -0.646 . . . . 1.0 109.532 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -142.91 179.06 7.25 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.047 0.217 . . . . 1.0 110.576 -177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.0 t -99.87 133.24 43.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.98 178.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -80.83 178.78 8.17 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.453 -0.794 . . . . 1.0 109.866 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.25 -7.64 43.85 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.514 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -116.09 20.01 14.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.034 -0.53 . . . . 1.0 111.172 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 71.11 36.18 1.46 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.625 0.77 . . . . 1.0 111.062 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.4 mttt -110.92 151.19 28.19 Favored 'General case' 0 CA--C 1.497 -1.066 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.624 -175.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.12 112.95 25.06 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.716 -1.129 . . . . 1.0 109.53 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -130.8 179.25 6.08 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.535 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.0 p-90 -150.68 163.7 37.91 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.714 -0.395 . . . . 1.0 111.522 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 25.5 mtp180 -147.91 146.3 28.97 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.221 -0.9 . . . . 1.0 109.78 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.686 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.1 tp -96.31 130.65 43.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 t -128.17 131.31 69.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.333 -0.394 . . . . 1.0 109.967 -176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.575 ' CB ' HD21 ' A' ' 126' ' ' ASN . 3.0 t-80 -78.0 172.17 13.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.261 -1.014 . . . . 1.0 108.261 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' ' HD2' ' A' ' 103' ' ' LYS . 11.5 t70 -57.89 -31.45 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.14 0.495 . . . . 1.0 110.637 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.31 -33.62 75.64 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.028 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.23 9.86 21.24 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.073 -0.967 . . . . 1.0 112.978 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.575 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.49 144.94 26.03 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.642 0.258 . . . . 1.0 111.467 179.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.8 mm -75.39 122.08 28.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.028 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.686 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.3 mt -97.92 -42.53 7.5 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.575 -0.739 . . . . 1.0 109.374 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.05 165.71 32.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.156 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -141.39 155.09 45.94 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.395 -0.965 . . . . 1.0 108.395 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.41 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 71.2 p -55.79 -32.83 63.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.03 0.443 . . . . 1.0 111.471 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.18 -41.39 3.03 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -115.43 174.14 6.16 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.928 -0.636 . . . . 1.0 112.084 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -133.03 147.77 19.08 Favored Glycine 0 N--CA 1.449 -0.479 0 N-CA-C 110.54 -1.024 . . . . 1.0 110.54 177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -141.79 174.29 10.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 117.415 0.607 . . . . 1.0 110.99 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.27 10.16 41.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.616 0.599 . . . . 1.0 112.616 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -133.16 131.56 40.58 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.746 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -64.03 -36.15 83.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.355 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.8 tt0 -58.33 -45.21 88.54 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.644 -0.707 . . . . 1.0 109.762 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -59.91 -40.83 90.17 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.957 -178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.97 79.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.234 0.54 . . . . 1.0 109.901 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.526 ' HA ' HD12 ' A' ' 145' ' ' ILE . 43.2 mtmt -64.29 -37.11 86.34 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.659 -0.701 . . . . 1.0 111.032 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.9 mm-40 -63.87 -29.68 70.84 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.48 -41.41 97.98 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 109.968 -1.253 . . . . 1.0 109.968 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 142' ' ' LYS . 57.0 mt -63.98 -45.55 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 114.887 -0.657 . . . . 1.0 110.298 177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -62.25 -38.28 88.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.137 0.494 . . . . 1.0 110.055 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.4 m -65.9 -36.27 82.93 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.638 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.534 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.1 -42.21 51.96 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 C-N-CA 120.358 -0.537 . . . . 1.0 110.343 -177.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -66.22 -11.89 52.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.912 0.387 . . . . 1.0 112.018 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -104.46 -2.84 24.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.079 -177.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' B' ' 204' ' ' ALA . 11.1 m-80 -133.45 -37.88 0.94 Allowed 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.997 -176.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.21 -50.01 90.62 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 112.784 0.661 . . . . 1.0 112.784 -178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.2 Cg_endo -63.48 -15.24 47.32 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.254 1.303 . . . . 1.0 113.185 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -109.93 -26.37 9.79 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.281 0.562 . . . . 1.0 111.362 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.26 136.43 57.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.31 -0.859 . . . . 1.0 113.008 -177.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -96.61 141.68 29.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.18 -1.373 . . . . 1.0 111.117 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.522 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -89.84 135.01 27.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.333 0.587 . . . . 1.0 112.478 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.0 mt -119.69 143.2 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 114.937 -1.029 . . . . 1.0 109.266 177.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -88.57 107.1 18.72 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.227 -0.657 . . . . 1.0 109.227 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 119.177 -0.44 . . . . 1.0 110.461 -179.466 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 43.2 ttp . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 121.042 0.448 . . . . 1.0 110.63 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -63.51 171.91 2.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.555 -0.748 . . . . 1.0 112.219 -176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 70.9 mmtt -136.59 95.52 3.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.99 -1.115 . . . . 1.0 107.99 175.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . 0.42 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . . . -175.92 171.09 2.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.19 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.504 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.2 p-80 -170.92 148.61 2.86 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.159 177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.522 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.2 m-85 -86.41 149.67 24.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.721 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 77.1 mt-10 -142.07 119.03 11.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.332 -179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.2 t -94.31 132.88 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -145.68 -178.68 6.22 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 123.126 0.266 . . . . 1.0 110.647 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -100.89 138.29 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.309 0.576 . . . . 1.0 112.129 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -80.46 179.7 7.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.098 -0.956 . . . . 1.0 109.664 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -72.13 -9.3 58.23 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.181 0.515 . . . . 1.0 111.004 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.69 20.43 15.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.681 . . . . 1.0 111.462 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 70.04 36.84 1.83 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.634 0.774 . . . . 1.0 111.534 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.0 mttt -112.74 149.69 32.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.289 0.566 . . . . 1.0 111.332 -176.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -89.97 119.6 30.47 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 114.715 -1.129 . . . . 1.0 109.978 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 74.1 mtp180 -134.29 -179.0 5.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.053 -0.976 . . . . 1.0 108.977 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.531 ' HB3' HG22 ' B' ' 208' ' ' VAL . 57.1 p-90 -154.31 161.55 41.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.257 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 27.6 mtp180 -146.79 141.86 27.13 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.813 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.729 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -93.46 130.77 39.17 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.282 -1.007 . . . . 1.0 108.282 177.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 10.4 t -127.59 131.48 70.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.044 -176.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.564 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.6 t-80 -81.2 173.0 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 178.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 10.8 t70 -54.67 -36.98 65.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.035 0.445 . . . . 1.0 111.222 177.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.21 -33.78 76.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.649 -0.705 . . . . 1.0 110.219 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.84 12.13 19.24 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 115.087 -0.961 . . . . 1.0 112.659 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.564 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -88.32 144.06 26.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 111.819 0.303 . . . . 1.0 111.819 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.5 mm -75.97 116.63 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.007 0.817 . . . . 1.0 109.69 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.729 HD12 ' HG ' ' B' ' 220' ' ' LEU . 18.3 mt -90.57 -44.7 9.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.401 -0.818 . . . . 1.0 109.405 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.519 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.47 160.75 43.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.301 -1.318 . . . . 1.0 111.027 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -134.8 156.34 49.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.468 -0.938 . . . . 1.0 108.468 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.424 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 16.7 p -52.27 -35.63 50.64 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.378 0.424 . . . . 1.0 111.977 178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 86.58 -46.09 3.53 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -99.32 179.51 4.56 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.915 -0.643 . . . . 1.0 110.792 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -146.0 137.78 7.12 Favored Glycine 0 N--CA 1.452 -0.238 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -139.83 171.28 14.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.68 0.74 . . . . 1.0 111.795 -176.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.36 10.07 39.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.841 -0.618 . . . . 1.0 112.387 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 12.2 m -135.75 134.41 39.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.55 0.69 . . . . 1.0 111.276 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -64.51 -35.66 81.69 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.915 -1.039 . . . . 1.0 110.462 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.434 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 7.7 tt0 -56.12 -47.64 77.74 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.292 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -61.42 -40.48 94.58 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.798 -0.637 . . . . 1.0 110.804 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.44 -48.54 80.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.258 0.551 . . . . 1.0 109.768 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.492 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.0 mtmt -64.14 -35.62 81.36 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.508 -0.769 . . . . 1.0 111.411 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.6 mm-40 -64.85 -29.09 70.03 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.48 -40.95 96.5 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 109.954 -1.258 . . . . 1.0 109.954 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.492 HD12 ' HA ' ' B' ' 242' ' ' LYS . 59.8 mt -62.78 -43.29 98.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.15 -0.525 . . . . 1.0 110.231 177.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -62.61 -43.56 98.5 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.648 -0.421 . . . . 1.0 109.921 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.6 m -63.63 -35.21 79.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.83 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.547 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -75.06 -41.8 45.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 C-N-CA 119.697 -0.801 . . . . 1.0 109.49 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -67.2 -11.62 57.86 Favored 'General case' 0 C--N 1.332 -0.161 0 O-C-N 122.051 -0.406 . . . . 1.0 111.352 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -103.12 -3.12 26.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.163 -0.472 . . . . 1.0 111.319 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . 0.47 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 10.7 m-80 -135.48 -37.45 0.76 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 111.968 0.358 . . . . 1.0 111.968 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.547 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.22 -49.87 90.79 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.909 -0.587 . . . . 1.0 112.478 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.4 Cg_endo -63.69 -9.53 18.82 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 121.642 1.562 . . . . 1.0 113.904 -177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -123.24 -11.57 7.95 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.612 0.597 . . . . 1.0 112.612 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.535 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -70.61 138.93 51.22 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.27 0.557 . . . . 1.0 111.841 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -95.01 148.65 22.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.012 -0.994 . . . . 1.0 112.111 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.521 HG22 HG21 ' A' ' 145' ' ' ILE . 44.1 t -84.45 131.92 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.578 -0.737 . . . . 1.0 111.619 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.1 mt -124.26 139.4 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -87.66 101.89 14.1 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.265 -0.874 . . . . 1.0 111.349 -177.157 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.439 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.2 tmt? . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 119.847 -0.121 . . . . 1.0 110.876 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 101' ' ' MET . 14.9 p-10 172.07 172.27 0.1 Allowed 'General case' 0 CA--C 1.512 -0.486 0 O-C-N 124.082 0.864 . . . . 1.0 110.478 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -143.05 95.35 2.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.21 -1.404 . . . . 1.0 107.21 172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.64 178.96 1.49 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.327 -0.851 . . . . 1.0 109.735 -177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.426 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.8 p-80 -169.52 147.72 3.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.808 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.562 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 48.7 m-85 -87.44 147.95 25.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.848 178.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -140.64 118.95 12.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.77 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.562 HG22 ' HB3' ' A' ' 118' ' ' TRP . 81.7 t -94.23 135.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.549 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -144.86 -179.6 6.7 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.469 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -104.28 138.83 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 121.287 0.565 . . . . 1.0 111.989 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -82.52 179.85 7.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.203 -0.908 . . . . 1.0 109.947 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.93 -7.12 46.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.577 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -120.23 24.37 10.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.486 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.25 33.17 2.67 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.654 0.782 . . . . 1.0 111.613 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.2 mttt -107.48 147.17 30.83 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.426 0.631 . . . . 1.0 111.123 -175.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -93.46 118.89 31.88 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 114.708 -1.133 . . . . 1.0 110.028 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.3 mtp180 -131.87 179.79 5.86 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.162 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.562 ' HB3' HG22 ' A' ' 108' ' ' VAL . 58.2 p-90 -154.52 162.24 41.24 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.212 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.439 HH21 HG13 ' A' ' 127' ' ' ILE . 50.5 mtp180 -147.18 142.45 27.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.515 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.67 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.5 tp -91.48 133.21 35.69 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.67 128.57 69.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.103 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.589 ' CB ' HD21 ' A' ' 126' ' ' ASN . 3.0 t-80 -77.31 172.91 12.55 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.37 -28.17 58.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.598 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -73.02 -34.67 66.51 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.59 0.71 . . . . 1.0 109.898 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.39 10.1 15.95 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 114.579 -1.191 . . . . 1.0 112.709 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.589 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.53 142.84 28.04 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 111.748 0.277 . . . . 1.0 111.748 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.439 HG13 HH21 ' A' ' 119' ' ' ARG . 50.6 mm -74.45 119.79 22.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 O-C-N 123.92 0.763 . . . . 1.0 110.01 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.67 HD12 ' HG ' ' A' ' 120' ' ' LEU . 14.1 mt -96.88 -43.65 7.39 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.658 -0.701 . . . . 1.0 109.96 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.435 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.45 168.57 23.08 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.061 -0.972 . . . . 1.0 111.593 178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -142.77 157.99 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.571 -0.9 . . . . 1.0 108.571 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 34.1 p -57.61 -32.26 67.04 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.296 0.57 . . . . 1.0 111.292 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.17 -50.05 3.83 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.626 -0.99 . . . . 1.0 110.626 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.493 ' HG2' ' HB ' ' B' ' 227' ' ' ILE . 69.4 mm-40 -100.81 178.96 4.54 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.446 -0.877 . . . . 1.0 111.424 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -142.06 137.53 7.97 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 109.94 -1.264 . . . . 1.0 109.94 177.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.49 166.47 23.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.096 0.448 . . . . 1.0 111.378 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -91.95 11.19 25.91 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.864 0.691 . . . . 1.0 112.864 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -127.97 131.06 49.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.399 0.618 . . . . 1.0 111.044 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.18 -38.23 90.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.882 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.451 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.5 tt0 -63.28 -43.16 98.7 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.408 -0.815 . . . . 1.0 110.027 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.603 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -57.77 -41.34 81.79 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.895 -178.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.51 -50.13 74.87 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.369 0.604 . . . . 1.0 110.318 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.516 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.4 mtmt -64.16 -34.15 77.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.392 -0.822 . . . . 1.0 111.205 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.9 mm-40 -64.8 -30.96 71.99 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.776 -0.37 . . . . 1.0 110.121 176.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.79 -39.15 93.47 Favored Glycine 0 C--N 1.34 0.794 0 C-N-CA 120.557 -0.83 . . . . 1.0 111.136 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 148' ' ' VAL . 76.8 mt -59.34 -51.47 72.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.635 0.731 . . . . 1.0 110.49 177.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -64.6 -35.05 79.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.661 -0.7 . . . . 1.0 111.016 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -66.37 -37.97 86.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.711 178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.561 HG22 ' HB2' ' A' ' 152' ' ' ALA . 1.4 p -73.08 -37.46 53.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.612 0 C-N-CA 120.132 -0.627 . . . . 1.0 109.618 -177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -64.13 -16.33 61.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.538 0.57 . . . . 1.0 112.538 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -104.46 -5.84 21.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.929 0.395 . . . . 1.0 111.253 -177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -121.69 -37.66 2.85 Favored 'General case' 0 C--O 1.218 -0.568 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.8 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.561 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.11 -51.03 83.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.829 -0.623 . . . . 1.0 112.602 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 56.0 Cg_endo -68.07 -7.82 20.93 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 121.154 1.236 . . . . 1.0 113.385 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.81 -21.14 10.3 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.157 0.504 . . . . 1.0 111.425 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -70.01 138.69 52.4 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.649 0.738 . . . . 1.0 112.952 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -96.37 136.73 36.46 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.265 -1.334 . . . . 1.0 110.801 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.53 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.82 135.29 25.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.382 0.61 . . . . 1.0 112.45 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' B' ' 207' ' ' GLU . 6.4 mt -130.47 153.28 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 114.796 -1.093 . . . . 1.0 109.799 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -84.33 117.71 23.76 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.211 -0.663 . . . . 1.0 109.211 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' B' ' 207' ' ' GLU . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.448 -0.787 . . . . 1.0 111.106 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ttp . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -173.79 172.85 3.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.404 0.621 . . . . 1.0 111.795 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -142.17 95.62 2.83 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 173.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.38 175.37 2.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.138 -0.937 . . . . 1.0 109.526 -176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.458 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.3 p-80 -170.27 146.38 2.91 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.101 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.53 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 55.0 m-85 -85.61 147.62 26.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.653 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 160' ' ' ALA . 40.1 mt-10 -141.3 121.9 14.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.546 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.4 t -93.36 131.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.497 -0.556 . . . . 1.0 109.497 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -140.99 -179.88 6.33 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.213 0.321 . . . . 1.0 110.808 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.565 HG13 ' HA ' ' B' ' 214' ' ' ASP . 1.4 t -102.08 139.43 23.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.334 0.588 . . . . 1.0 111.694 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.64 -176.47 5.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.09 -0.959 . . . . 1.0 109.637 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.25 -16.94 63.7 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 121.976 -0.453 . . . . 1.0 110.874 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.06 17.08 22.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.603 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.565 ' HA ' HG13 ' B' ' 210' ' ' VAL . 30.1 t70 68.64 44.02 1.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.481 1.134 . . . . 1.0 110.374 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.1 mmtt -112.97 150.86 31.29 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.43 -1.259 . . . . 1.0 110.323 -177.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -91.12 117.82 29.92 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.843 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 61.6 mtp180 -133.8 179.18 6.4 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.631 -1.168 . . . . 1.0 108.368 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.507 ' HB3' HG22 ' B' ' 208' ' ' VAL . 55.3 p-90 -153.33 161.39 42.4 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.702 0.287 . . . . 1.0 111.052 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.427 HH21 HG13 ' B' ' 227' ' ' ILE . 28.3 mtp180 -147.28 143.26 27.96 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.897 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.69 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -93.5 132.55 37.67 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 177.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.86 129.9 72.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.415 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.581 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.0 t-80 -80.77 172.85 13.22 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 178.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.15 -29.53 63.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.939 0.4 . . . . 1.0 111.587 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -68.11 -33.51 74.65 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.511 0.672 . . . . 1.0 109.701 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.99 10.56 22.38 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 114.799 -1.091 . . . . 1.0 112.145 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.581 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.97 142.73 27.75 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.651 0.241 . . . . 1.0 111.651 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.493 ' HB ' ' HG2' ' A' ' 133' ' ' GLU . 51.2 mm -76.25 118.85 23.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 123.783 0.677 . . . . 1.0 109.495 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.69 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.4 mt -93.18 -43.28 8.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.286 -0.87 . . . . 1.0 110.205 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -148.33 164.76 33.09 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.799 -1.091 . . . . 1.0 111.389 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -141.52 159.03 43.07 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.635 0.774 . . . . 1.0 109.278 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 58.5 p -57.64 -33.62 68.47 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.942 0.401 . . . . 1.0 111.666 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 90.4 -47.21 3.05 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.016 -0.834 . . . . 1.0 111.016 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -104.7 171.87 7.1 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.615 -0.792 . . . . 1.0 111.205 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -135.4 138.29 9.86 Favored Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -140.94 172.44 12.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.012 0.406 . . . . 1.0 110.883 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.83 10.53 38.66 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.901 0.704 . . . . 1.0 112.901 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.7 m -131.68 131.42 43.11 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.455 0.645 . . . . 1.0 111.608 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -65.07 -35.23 80.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.994 -1.003 . . . . 1.0 110.191 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.461 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.0 tt0 -56.61 -46.48 80.86 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.225 -0.898 . . . . 1.0 109.819 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.96 -42.05 97.55 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.536 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.48 -48.9 79.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.441 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' B' ' 245' ' ' ILE . 44.0 mtmt -64.05 -36.69 84.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.073 -0.512 . . . . 1.0 111.426 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 30.0 mm-40 -63.87 -32.93 74.62 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.763 -0.375 . . . . 1.0 109.99 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.88 94.13 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.559 -0.829 . . . . 1.0 111.532 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.496 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.7 mt -60.31 -51.57 71.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.542 0.686 . . . . 1.0 110.498 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -65.2 -33.56 76.28 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.97 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.9 m -65.72 -37.6 86.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.916 -0.584 . . . . 1.0 110.366 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.572 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -72.9 -40.1 59.46 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.648 -177.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -64.03 -15.17 58.83 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.821 0.304 . . . . 1.0 111.821 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -101.32 -10.45 20.28 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.042 -177.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -124.68 -37.57 2.47 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 111.945 0.35 . . . . 1.0 111.945 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.572 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.12 -51.9 75.7 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 112.922 0.712 . . . . 1.0 112.922 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 43.0 Cg_endo -65.4 -10.64 26.87 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.19 1.26 . . . . 1.0 113.56 -177.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.19 -13.9 11.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.702 0.287 . . . . 1.0 111.766 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.426 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -72.95 138.68 46.27 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.561 0.949 . . . . 1.0 113.561 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -90.62 134.05 34.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.557 -1.201 . . . . 1.0 111.188 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.562 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -87.24 131.46 35.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.354 0.597 . . . . 1.0 111.977 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.9 mt -118.74 143.76 28.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.934 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -90.28 104.21 16.81 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.075 -0.713 . . . . 1.0 109.075 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.644 -0.693 . . . . 1.0 111.183 -177.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.419 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 111.372 0.138 . . . . 1.0 111.372 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 101' ' ' MET . 23.6 p-10 170.47 171.71 0.06 Allowed 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 124.451 1.094 . . . . 1.0 109.744 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -138.22 93.46 2.75 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.845 -1.168 . . . . 1.0 107.845 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.91 179.69 1.02 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.567 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.42 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 47.8 p-80 -170.1 144.54 2.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.191 -0.458 . . . . 1.0 109.963 176.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.583 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.1 m-85 -84.71 149.3 25.88 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.161 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -140.69 118.77 11.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.327 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 118' ' ' TRP . 79.3 t -94.57 133.17 36.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.711 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -142.99 179.64 6.91 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.393 0.433 . . . . 1.0 110.603 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -101.68 135.1 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.736 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.26 179.46 7.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.353 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.61 -7.57 39.95 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.178 -0.464 . . . . 1.0 111.622 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -117.7 20.19 13.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.134 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 69.46 37.13 2.06 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.369 -0.832 . . . . 1.0 111.203 177.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.8 mmtt -109.2 150.73 27.48 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 115.136 -0.938 . . . . 1.0 111.071 -176.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 138' ' ' LYS . 93.1 m-85 -93.05 112.39 24.33 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.48 -1.236 . . . . 1.0 109.65 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.1 mtm105 -129.33 178.62 6.31 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.879 -0.786 . . . . 1.0 108.879 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.558 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.8 p-90 -151.73 163.38 39.27 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 120.854 -0.338 . . . . 1.0 111.437 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 49.4 mtp180 -148.4 141.62 25.09 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.294 -0.866 . . . . 1.0 109.5 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.684 ' HG ' HD12 ' A' ' 128' ' ' LEU . 35.4 tp -93.75 134.45 36.07 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.589 -0.893 . . . . 1.0 108.589 177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 15.5 t -128.73 131.03 68.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.628 ' CB ' HD21 ' A' ' 126' ' ' ASN . 6.0 t-80 -77.23 171.2 15.22 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.106 -0.701 . . . . 1.0 109.106 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.71 -18.08 52.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.146 177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -34.11 35.22 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.635 0.731 . . . . 1.0 109.638 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.32 9.29 15.45 Favored Glycine 0 C--O 1.226 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.0 112.871 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.628 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.55 145.15 25.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.338 0.113 . . . . 1.0 110.944 178.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.504 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.4 mm -79.33 118.96 27.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.289 -0.634 . . . . 1.0 109.289 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.684 HD12 ' HG ' ' A' ' 120' ' ' LEU . 16.3 mt -90.78 -42.2 10.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.555 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.508 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.31 163.31 39.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.973 -1.012 . . . . 1.0 111.883 177.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -137.78 152.83 49.56 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.192 -0.913 . . . . 1.0 108.592 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 85.7 p -55.54 -34.04 64.36 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.982 0.42 . . . . 1.0 111.486 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.3 -45.92 3.45 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.985 -0.846 . . . . 1.0 110.985 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.447 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 47.1 mt-10 -109.27 168.59 9.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.799 -0.7 . . . . 1.0 111.562 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.24 145.84 16.34 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.174 -1.17 . . . . 1.0 110.174 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -137.56 165.59 25.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.245 0.522 . . . . 1.0 111.046 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.26 9.85 32.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.59 -0.732 . . . . 1.0 112.51 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 m -136.38 133.73 37.07 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.076 0.465 . . . . 1.0 110.775 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.455 ' HB3' ' CE2' ' A' ' 116' ' ' TYR . 6.8 ptpp? -63.87 -36.53 84.23 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.466 -0.788 . . . . 1.0 110.618 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.6 tt0 -56.89 -46.05 82.14 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.673 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -62.05 -39.19 91.51 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.8 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.87 -50.29 72.91 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.313 0.578 . . . . 1.0 109.898 177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.5 mtmt -65.28 -33.28 75.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.308 -0.86 . . . . 1.0 111.072 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.1 mm-40 -65.44 -31.84 73.15 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.178 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.94 -39.98 95.15 Favored Glycine 0 CA--C 1.505 -0.561 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 142' ' ' LYS . 73.2 mt -60.66 -51.28 74.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.813 -0.694 . . . . 1.0 110.428 177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -62.83 -33.03 74.38 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.468 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.6 m -68.06 -35.69 78.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.786 177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' B' ' 229' ' ' ALA . 0.4 OUTLIER -72.61 -39.7 61.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 109.115 -0.698 . . . . 1.0 109.115 -178.365 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -65.65 -16.12 63.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.326 0.584 . . . . 1.0 111.148 178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 50.0 ttt85 -99.68 -1.43 37.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.193 -0.912 . . . . 1.0 110.799 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -137.24 -42.42 0.56 Allowed 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 112.711 0.634 . . . . 1.0 112.711 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.505 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.69 -50.7 84.2 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 113.356 0.873 . . . . 1.0 113.356 -177.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 42.5 Cg_endo -64.69 -9.41 20.74 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.248 1.299 . . . . 1.0 113.061 -177.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -121.5 -12.22 8.59 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.861 0.362 . . . . 1.0 111.831 -178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.34 136.04 44.39 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.065 0.459 . . . . 1.0 111.443 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -96.44 145.12 25.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.295 -0.866 . . . . 1.0 110.511 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.512 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -90.88 129.5 41.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.84 0.828 . . . . 1.0 112.514 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.3 mt -116.47 149.46 18.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.282 -1.326 . . . . 1.0 109.888 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -85.41 111.72 20.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.59 -0.892 . . . . 1.0 108.59 176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.72 -0.657 . . . . 1.0 110.783 -178.766 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.987 0.423 . . . . 1.0 109.978 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -122.85 171.63 9.06 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.373 0.606 . . . . 1.0 112.029 -176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -132.83 97.81 4.14 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.036 -1.098 . . . . 1.0 108.036 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.18 166.99 4.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.109 -1.405 . . . . 1.0 108.402 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.498 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 40.5 p-80 -168.69 149.52 4.63 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.512 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.5 m-85 -85.28 149.93 25.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.393 179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -141.83 120.14 12.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.211 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.489 HG22 ' HB3' ' B' ' 218' ' ' TRP . 55.3 t -92.88 135.75 26.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.439 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -149.49 179.55 7.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.658 0.266 . . . . 1.0 110.724 -177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.8 t -101.77 140.13 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 CA-C-N 116.042 -0.526 . . . . 1.0 111.686 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 16.1 t70 -83.47 -178.8 7.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.449 -0.796 . . . . 1.0 111.018 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . 0.413 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -71.01 -11.52 61.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.352 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -117.15 26.08 10.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 1.0 111.038 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 62.84 39.48 10.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.058 178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 71.8 mmtt -103.8 156.03 18.14 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -97.33 117.96 32.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -134.16 -179.23 5.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.625 -0.716 . . . . 1.0 109.78 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.489 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.4 p-90 -154.08 162.43 41.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.503 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 40.4 mtp180 -147.41 141.67 26.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.621 -0.718 . . . . 1.0 110.2 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.707 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.2 tp -93.75 131.2 39.33 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.33 132.17 65.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.412 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.618 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.2 t-80 -80.89 170.34 16.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -58.77 -27.1 64.67 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.069 0.462 . . . . 1.0 110.895 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -66.97 -33.24 75.13 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.503 0.668 . . . . 1.0 109.977 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.99 9.84 25.47 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 114.695 -1.139 . . . . 1.0 112.261 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.618 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.99 143.81 27.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.395 0.141 . . . . 1.0 111.02 179.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.447 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.5 mm -80.27 117.28 25.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.707 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.8 mt -89.7 -41.25 12.02 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.558 -0.746 . . . . 1.0 109.276 -177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -154.26 164.7 38.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.585 -1.189 . . . . 1.0 111.743 176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -138.6 159.11 42.9 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.858 -1.064 . . . . 1.0 108.328 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 63.2 p -55.55 -30.78 61.37 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.149 0.5 . . . . 1.0 111.185 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.99 -40.12 3.04 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.204 -0.758 . . . . 1.0 111.204 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . 0.504 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 46.1 mt-10 -116.42 169.45 9.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.118 -0.541 . . . . 1.0 111.107 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -128.86 132.82 7.36 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -126.38 172.78 9.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.94 0.37 . . . . 1.0 111.808 -176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.63 9.8 41.58 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.99 0.737 . . . . 1.0 112.99 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -136.02 131.95 35.63 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.957 0.408 . . . . 1.0 110.565 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -63.81 -36.47 84.02 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.694 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.449 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.6 tt0 -57.57 -42.59 83.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.281 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.68 -40.69 95.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.469 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 -46.41 86.54 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.315 0.578 . . . . 1.0 109.975 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.492 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.7 mtmt -64.05 -35.25 80.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.264 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 31.8 mm-40 -65.27 -34.3 78.01 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.4 -39.67 98.02 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.519 ' O ' HG12 ' B' ' 248' ' ' VAL . 65.9 mt -60.75 -52.24 63.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.39 0.614 . . . . 1.0 110.706 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -64.19 -36.66 84.78 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.059 -0.519 . . . . 1.0 111.167 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 57.2 m -64.16 -36.52 84.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.881 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.575 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -73.4 -40.18 55.95 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.686 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 -178.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -64.99 -15.59 62.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.288 -0.415 . . . . 1.0 111.739 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -100.54 -2.95 31.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.918 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 17.4 m-80 -135.66 -37.73 0.75 Allowed 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -177.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.575 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.18 -50.21 87.86 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 54.0 Cg_endo -65.96 -8.9 21.29 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.026 1.15 . . . . 1.0 113.797 -177.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.53 -19.21 8.88 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.121 0.415 . . . . 1.0 112.121 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.42 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -66.48 136.99 56.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.447 0.641 . . . . 1.0 112.619 -177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -92.88 135.9 33.73 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.819 -1.082 . . . . 1.0 111.286 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.583 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -85.23 130.58 35.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.635 0.731 . . . . 1.0 112.185 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.6 mt -116.38 140.7 37.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.489 -1.232 . . . . 1.0 109.366 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -86.62 107.34 18.12 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.285 -0.864 . . . . 1.0 111.182 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.038 0.447 . . . . 1.0 111.511 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -103.42 -179.8 4.05 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.631 -0.713 . . . . 1.0 111.76 -176.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -125.9 99.35 5.91 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.597 -1.261 . . . . 1.0 107.597 172.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.41 163.7 3.73 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.511 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.0 p-80 -167.25 148.89 5.8 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.919 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.543 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 53.6 m-85 -87.93 148.47 24.57 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.506 -0.77 . . . . 1.0 110.719 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -141.21 119.27 11.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.728 -0.669 . . . . 1.0 110.387 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.521 HG22 ' HB3' ' A' ' 118' ' ' TRP . 77.2 t -89.89 131.45 37.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -140.33 -179.65 6.12 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 123.059 0.224 . . . . 1.0 110.537 -176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.6 t -102.28 137.9 28.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.245 0.545 . . . . 1.0 112.341 -178.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -80.84 179.8 7.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.266 -0.879 . . . . 1.0 109.193 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.52 -19.65 65.33 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.919 0.39 . . . . 1.0 110.765 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.02 21.08 17.92 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.72 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.441 ' HA ' HG13 ' A' ' 110' ' ' VAL . 3.6 m-20 69.83 37.13 1.87 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.66 177.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.0 mttt -110.72 150.54 28.92 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.981 -176.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -93.04 121.06 34.0 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.109 -0.951 . . . . 1.0 110.835 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 108' ' ' VAL . 55.7 mtp180 -134.27 -176.78 4.31 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.661 -1.154 . . . . 1.0 108.109 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.521 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.8 p-90 -151.89 165.6 34.05 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 119.912 -0.715 . . . . 1.0 112.337 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -144.48 140.38 28.88 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.423 -1.262 . . . . 1.0 111.234 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.724 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.9 tp -100.85 132.06 46.43 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 175.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.32 132.6 69.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.475 -0.33 . . . . 1.0 110.512 -176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.468 ' HB2' HD21 ' A' ' 128' ' ' LEU . 2.4 t-80 -83.07 177.64 8.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.773 0.32 . . . . 1.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 103' ' ' LYS . 11.7 t70 -51.5 -44.47 62.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.989 -1.005 . . . . 1.0 111.06 176.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.407 ' HB2' ' OD1' ' A' ' 126' ' ' ASN . 1.2 m-20 -67.42 -33.65 75.61 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.308 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.25 15.52 10.48 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.546 -0.752 . . . . 1.0 113.468 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 124' ' ' ASN . 0.2 OUTLIER -86.45 147.77 25.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 111.606 0.224 . . . . 1.0 111.606 177.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.3 mm -74.14 119.77 22.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.796 0.685 . . . . 1.0 109.57 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.724 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.8 mt -94.94 -43.86 7.98 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.271 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.423 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.71 166.85 30.02 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.923 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -139.35 160.36 40.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.829 -1.078 . . . . 1.0 109.026 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.433 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 68.0 p -58.74 -38.49 78.52 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.325 0.491 . . . . 1.0 112.325 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.34 -42.28 3.08 Favored Glycine 0 N--CA 1.452 -0.28 0 N-CA-C 110.707 -0.957 . . . . 1.0 110.707 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -91.47 173.49 7.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.719 -0.74 . . . . 1.0 110.776 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -156.47 125.7 1.66 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.796 -0.921 . . . . 1.0 110.796 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -144.85 171.21 14.74 Favored 'General case' 0 C--O 1.219 -0.516 0 CA-C-O 120.431 0.157 . . . . 1.0 110.609 -176.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.24 9.54 28.21 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.085 0.772 . . . . 1.0 113.085 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.0 p -121.53 129.57 52.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.538 0.685 . . . . 1.0 112.551 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -64.94 -42.84 94.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.235 -0.893 . . . . 1.0 111.173 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.1 tt0 -55.15 -45.0 75.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.459 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.557 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -56.98 -42.77 80.83 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.495 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -59.92 -49.81 76.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.016 0.436 . . . . 1.0 110.402 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.496 ' HG2' HG21 ' A' ' 108' ' ' VAL . 45.3 mtmt -62.98 -38.65 91.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.742 -0.663 . . . . 1.0 111.61 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.5 mm-40 -63.46 -26.28 68.65 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.509 -0.552 . . . . 1.0 109.509 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.72 -43.85 93.44 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.093 -1.203 . . . . 1.0 110.093 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.486 ' O ' HG12 ' A' ' 148' ' ' VAL . 59.7 mt -62.18 -45.09 99.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.564 0.697 . . . . 1.0 110.169 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -62.74 -39.9 95.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -67.87 -34.71 77.2 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.57 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -72.93 -40.38 59.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 C-N-CA 120.017 -0.673 . . . . 1.0 110.264 -177.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -66.89 -12.57 59.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.132 0.491 . . . . 1.0 111.651 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -103.4 -2.53 26.81 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.475 -0.784 . . . . 1.0 111.154 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.422 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.58 -39.14 1.14 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.887 -177.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.545 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.64 -50.09 88.96 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.664 -0.698 . . . . 1.0 112.388 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.6 Cg_endo -64.44 -16.57 55.85 Favored 'Trans proline' 0 C--N 1.359 1.125 0 C-N-CA 121.163 1.242 . . . . 1.0 113.095 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -106.84 -23.9 12.23 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.147 0.498 . . . . 1.0 111.33 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -65.28 135.55 55.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.452 -0.794 . . . . 1.0 112.874 -177.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -96.56 148.75 22.51 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.558 -1.201 . . . . 1.0 111.792 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.574 HG22 HG21 ' B' ' 245' ' ' ILE . 40.1 t -85.27 131.38 34.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 1.0 112.061 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt -123.38 133.95 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 108.932 -0.766 . . . . 1.0 108.932 175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -87.21 103.5 15.48 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.103 -0.951 . . . . 1.0 111.199 -177.166 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 48.7 ttp . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.81 0.338 . . . . 1.0 110.697 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.422 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 6.4 p-10 -125.37 177.23 6.28 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.705 0.764 . . . . 1.0 111.98 -176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 13.1 mmmm -142.27 99.67 3.55 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.068 -1.424 . . . . 1.0 107.592 174.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.36 169.94 4.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.447 -0.797 . . . . 1.0 109.124 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.499 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 50.2 p-80 -169.53 150.11 4.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.444 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.8 m-85 -87.72 150.33 23.67 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.291 -0.413 . . . . 1.0 111.336 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -142.52 118.01 10.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.383 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.569 HG22 ' HB3' ' B' ' 218' ' ' TRP . 94.0 t -95.42 133.42 36.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.84 175.57 9.51 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.2 t -100.66 135.97 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.283 0.563 . . . . 1.0 111.536 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -82.11 178.29 8.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.997 -1.001 . . . . 1.0 110.101 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -69.91 -10.62 59.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.598 -0.728 . . . . 1.0 111.185 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -112.93 19.69 17.07 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.636 -0.711 . . . . 1.0 111.357 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 70.17 36.1 1.96 Allowed 'General case' 0 CA--C 1.503 -0.831 0 CA-C-N 115.248 -0.887 . . . . 1.0 111.165 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.6 mttt -110.05 144.76 38.15 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.479 -0.782 . . . . 1.0 111.459 -176.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.63 111.72 23.41 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 113.972 -1.467 . . . . 1.0 109.345 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -128.74 175.37 8.66 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.569 ' HB3' HG22 ' B' ' 208' ' ' VAL . 53.5 p-90 -153.4 162.15 41.57 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.014 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -144.17 151.35 39.4 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.082 -0.963 . . . . 1.0 109.456 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.707 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.6 tp -98.58 131.2 44.98 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 13.7 t -128.55 133.56 66.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.361 -176.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.571 ' CB ' HD21 ' B' ' 226' ' ' ASN . 3.0 t-80 -82.2 173.25 12.28 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 16.5 t70 -58.02 -27.42 63.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.196 0.522 . . . . 1.0 110.963 178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -72.12 -33.28 67.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.514 0.673 . . . . 1.0 110.165 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.42 10.28 22.09 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 114.848 -1.069 . . . . 1.0 112.772 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.571 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.64 142.96 27.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.671 0.272 . . . . 1.0 111.566 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.4 mm -74.75 123.57 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.51 -0.768 . . . . 1.0 109.583 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.707 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -100.56 -42.96 6.35 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.045 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -147.71 167.38 24.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.013 -0.994 . . . . 1.0 111.801 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' B' ' 231' ' ' SER . 15.2 t0 -141.81 153.24 44.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.034 -0.985 . . . . 1.0 108.459 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.418 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 55.0 p -58.35 -40.31 81.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 1.0 112.098 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 84.97 -41.12 3.03 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 -177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -90.21 177.25 6.48 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.185 -0.508 . . . . 1.0 110.667 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -167.86 114.59 0.58 Allowed Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.502 -0.639 . . . . 1.0 111.502 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -142.37 166.04 25.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.564 0.221 . . . . 1.0 110.493 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -81.4 9.96 6.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.117 0.784 . . . . 1.0 113.117 -177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 13.2 p -112.12 127.36 55.9 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.694 0.759 . . . . 1.0 111.994 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt -68.37 -40.77 81.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.112 -0.949 . . . . 1.0 110.952 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.2 tt0 -56.43 -46.12 80.42 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.297 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.86 -42.95 85.57 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 123.296 0.372 . . . . 1.0 110.972 -178.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.76 -51.39 70.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.419 0.628 . . . . 1.0 110.646 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.401 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -63.3 -38.01 89.47 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.24 -0.891 . . . . 1.0 111.222 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.8 mm-40 -63.4 -28.03 69.7 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.808 -0.441 . . . . 1.0 109.808 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -63.76 -43.45 97.71 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.574 HG21 HG22 ' A' ' 157' ' ' VAL . 48.7 mt -63.48 -46.23 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-O 121.435 0.636 . . . . 1.0 110.698 177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -62.36 -38.24 88.8 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.23 0.538 . . . . 1.0 110.213 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.6 m -67.83 -35.25 78.28 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.737 -0.665 . . . . 1.0 110.572 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -73.2 -41.48 58.37 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.613 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.535 -177.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt -65.85 -15.13 62.63 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.86 -0.525 . . . . 1.0 112.121 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -104.74 -2.34 25.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.866 0.365 . . . . 1.0 111.315 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -127.8 -37.44 1.94 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.415 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.11 -51.09 82.49 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 115.841 -0.618 . . . . 1.0 111.893 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.0 Cg_endo -66.43 -12.29 35.08 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.168 1.245 . . . . 1.0 113.462 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -108.15 -27.48 10.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.576 0.703 . . . . 1.0 111.577 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.511 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.38 136.87 57.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.977 1.103 . . . . 1.0 113.977 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -92.65 139.08 30.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.271 -1.331 . . . . 1.0 110.651 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.543 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 0.7 OUTLIER -88.79 131.3 36.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.38 0.61 . . . . 1.0 111.816 177.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.0 mt -118.57 144.44 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.873 -1.058 . . . . 1.0 109.004 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -88.59 102.32 14.83 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.378 -0.601 . . . . 1.0 109.378 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.115 -0.945 . . . . 1.0 111.236 -177.295 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.822 0.344 . . . . 1.0 110.121 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 9.9 p-10 -89.79 161.38 16.05 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-O 121.408 0.623 . . . . 1.0 112.007 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.87 100.59 6.68 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.014 -1.476 . . . . 1.0 107.014 172.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -172.3 165.42 5.9 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.455 -1.248 . . . . 1.0 108.163 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.53 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 50.4 p-80 -167.81 150.21 5.69 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.56 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.532 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 57.1 m-85 -86.38 148.53 25.54 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.734 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.6 121.97 14.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.868 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 118' ' ' TRP . 92.1 t -95.05 135.98 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.9 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.17 178.08 8.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.714 0.293 . . . . 1.0 110.543 -177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 2.9 t -101.22 133.1 45.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.343 0.592 . . . . 1.0 110.898 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -78.67 178.78 7.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.204 -0.907 . . . . 1.0 109.711 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.37 -12.7 61.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.174 0.511 . . . . 1.0 110.929 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.39 18.75 19.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.523 -0.762 . . . . 1.0 111.346 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 71.1 35.2 1.67 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.794 0.838 . . . . 1.0 111.567 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.6 mttt -109.72 148.58 31.15 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.254 -175.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -93.32 112.21 24.07 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 114.329 -1.305 . . . . 1.0 109.383 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.0 mtm105 -132.95 178.31 6.98 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.401 -0.962 . . . . 1.0 108.401 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.565 ' HB3' HG22 ' A' ' 108' ' ' VAL . 53.3 p-90 -150.09 164.0 36.71 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.813 0.34 . . . . 1.0 111.689 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -146.83 147.22 30.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.127 -0.942 . . . . 1.0 109.805 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.689 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.7 tp -96.65 134.69 39.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.1 t -128.06 131.07 69.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.448 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.579 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.0 t-80 -79.59 173.87 12.15 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.85 -39.39 68.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.279 0.562 . . . . 1.0 110.455 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.4 -33.44 74.78 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.046 -0.979 . . . . 1.0 110.642 -177.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.34 9.75 23.14 Favored Glycine 0 CA--C 1.518 0.272 0 CA-C-N 115.614 -0.721 . . . . 1.0 112.837 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.579 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -87.45 144.69 26.61 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.689 0.255 . . . . 1.0 111.689 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.6 mm -74.2 119.49 21.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.497 -0.774 . . . . 1.0 109.762 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.689 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.5 mt -94.93 -43.92 7.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.639 0.733 . . . . 1.0 109.9 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.39 166.74 28.13 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.635 -1.166 . . . . 1.0 111.367 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -141.17 153.5 45.37 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.951 -1.022 . . . . 1.0 108.464 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.501 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 15.8 p -53.37 -36.57 61.55 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.006 0.372 . . . . 1.0 112.006 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.69 -45.92 3.56 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.526 -0.63 . . . . 1.0 111.526 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -93.49 174.4 7.21 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.285 0.564 . . . . 1.0 111.507 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -136.53 136.92 8.68 Favored Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -136.94 165.76 25.24 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 117.627 0.714 . . . . 1.0 111.094 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.09 10.98 37.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 1.0 112.218 -177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 8.6 m -139.64 137.28 35.14 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.483 0.659 . . . . 1.0 111.543 -178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -63.22 -39.58 95.03 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.861 -1.063 . . . . 1.0 111.047 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.3 tt0 -58.31 -47.02 85.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.268 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.9 -44.57 86.87 Favored 'General case' 0 C--N 1.333 -0.125 0 O-C-N 123.61 0.569 . . . . 1.0 110.976 -177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.95 -47.29 83.36 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.266 0.555 . . . . 1.0 110.612 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.539 ' HG2' HG21 ' A' ' 108' ' ' VAL . 44.5 mtmt -64.56 -35.32 80.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.383 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.1 mm-40 -64.78 -27.92 69.22 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.27 -38.88 91.97 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.674 -0.971 . . . . 1.0 110.674 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.531 HD12 ' HA ' ' A' ' 142' ' ' LYS . 63.5 mt -61.43 -43.04 96.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.248 0.547 . . . . 1.0 110.338 177.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.83 -40.07 94.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.5 m -63.54 -36.36 83.52 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 115.37 -0.832 . . . . 1.0 110.599 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.504 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -73.53 -42.78 55.91 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 C-N-CA 119.826 -0.75 . . . . 1.0 109.529 -178.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -66.17 -11.77 51.63 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.143 0.423 . . . . 1.0 112.143 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -102.54 -2.31 28.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.1 0.476 . . . . 1.0 110.664 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.429 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 23.9 m-80 -135.52 -37.77 0.76 Allowed 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.787 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.504 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.49 -49.7 91.08 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.637 0.606 . . . . 1.0 112.637 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 44.4 Cg_endo -67.0 -11.96 34.27 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.322 1.348 . . . . 1.0 112.855 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -110.64 -19.8 12.75 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.065 0.46 . . . . 1.0 111.408 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.533 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -70.83 134.71 47.56 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.896 0.855 . . . . 1.0 113.153 -177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -94.53 142.25 27.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.22 -1.355 . . . . 1.0 110.317 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -90.67 134.36 29.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.237 0.541 . . . . 1.0 112.088 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt -119.01 142.63 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 114.902 -1.045 . . . . 1.0 109.192 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -88.14 104.19 16.46 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.773 -0.825 . . . . 1.0 108.773 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.387 -0.816 . . . . 1.0 110.965 -177.757 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.704 0.288 . . . . 1.0 110.245 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.429 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 9.3 p-10 -121.04 160.84 22.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.475 0.655 . . . . 1.0 112.189 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.495 ' HB2' ' HB2' ' B' ' 223' ' ' ASP . 0.0 OUTLIER -126.17 101.16 6.63 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.683 -1.599 . . . . 1.0 106.683 172.532 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -173.17 159.3 3.84 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.172 -0.922 . . . . 1.0 109.136 -177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.533 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 44.9 p-80 -166.95 150.81 6.82 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.76 -0.376 . . . . 1.0 110.744 -177.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.574 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 62.6 m-85 -86.34 150.19 24.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.681 -0.69 . . . . 1.0 110.693 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -142.49 118.21 10.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.615 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' B' ' 218' ' ' TRP . 97.2 t -95.09 132.8 38.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.127 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -143.74 177.66 8.36 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.2 t -100.03 136.36 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.483 0.659 . . . . 1.0 112.346 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.7 -179.78 7.54 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 114.802 -1.09 . . . . 1.0 109.608 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.515 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.45 20.82 17.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.917 -177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 71.13 34.67 1.77 Allowed 'General case' 0 CA--C 1.505 -0.766 0 C-N-CA 123.498 0.719 . . . . 1.0 110.901 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.9 mttt -108.64 147.94 31.12 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.56 -175.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -94.17 109.11 20.92 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.409 -1.269 . . . . 1.0 109.822 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -122.02 176.13 5.96 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.408 -0.96 . . . . 1.0 108.408 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.575 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.1 p-90 -150.62 162.76 40.04 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.28 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -147.28 146.71 29.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.197 -0.91 . . . . 1.0 110.247 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.741 ' HG ' HD12 ' B' ' 228' ' ' LEU . 35.0 tp -99.31 132.58 44.54 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 4.2 t -126.64 133.64 68.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.077 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.524 ' HB2' HD21 ' B' ' 228' ' ' LEU . 1.6 t-80 -86.09 176.55 7.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.389 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.495 ' HB2' ' HB2' ' B' ' 203' ' ' LYS . 43.2 t0 -52.61 -43.37 65.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.176 -0.92 . . . . 1.0 110.847 176.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -63.05 -33.6 75.78 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.617 -0.72 . . . . 1.0 110.47 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 109.45 12.34 19.63 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.294 -0.866 . . . . 1.0 112.493 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.512 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.43 144.84 27.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 111.59 0.218 . . . . 1.0 111.59 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.0 mm -75.99 116.94 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.188 -0.671 . . . . 1.0 109.188 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.741 HD12 ' HG ' ' B' ' 220' ' ' LEU . 17.7 mt -89.19 -43.23 11.16 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.604 -0.726 . . . . 1.0 109.742 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.478 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.07 164.92 35.35 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.656 -1.157 . . . . 1.0 111.471 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -139.48 156.82 46.69 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.908 -1.042 . . . . 1.0 108.379 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.457 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 13.6 p -53.89 -35.08 61.22 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.264 0.468 . . . . 1.0 112.264 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.78 -47.04 3.37 Favored Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -104.93 177.59 4.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.921 -0.64 . . . . 1.0 111.796 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -137.2 135.24 7.52 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 109.899 -1.28 . . . . 1.0 109.899 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -133.1 165.48 24.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 117.385 0.592 . . . . 1.0 111.78 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.62 10.9 26.2 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.938 0.718 . . . . 1.0 112.938 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.9 m -138.48 135.83 35.54 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.288 -0.565 . . . . 1.0 111.46 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -64.14 -38.18 90.14 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.703 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.4 tt0 -59.84 -43.01 94.81 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.591 -0.732 . . . . 1.0 110.194 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -61.57 -40.64 95.46 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.793 -178.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.69 -46.33 87.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.307 0.575 . . . . 1.0 109.854 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' B' ' 245' ' ' ILE . 41.0 mtmt -64.79 -35.3 80.66 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.914 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.0 mm-40 -62.18 -29.05 70.09 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.705 -0.48 . . . . 1.0 109.705 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.95 -42.81 94.6 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.91 -1.276 . . . . 1.0 109.91 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' B' ' 242' ' ' LYS . 57.3 mt -63.67 -44.16 98.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.235 0.54 . . . . 1.0 110.186 177.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -62.27 -40.88 97.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.974 0.416 . . . . 1.0 110.295 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.55 -35.0 79.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.504 178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.574 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.3 OUTLIER -74.13 -41.96 51.76 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.478 -177.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -68.62 -11.76 60.47 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.816 -0.552 . . . . 1.0 111.832 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -104.79 -5.71 20.96 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.24 -178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . 0.436 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 10.1 m-80 -130.08 -39.4 1.37 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.026 0.38 . . . . 1.0 112.026 -176.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.574 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.74 -50.04 89.35 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 112.564 0.579 . . . . 1.0 112.564 -178.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 28.7 Cg_endo -62.03 -16.74 51.99 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.336 1.357 . . . . 1.0 113.187 -178.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.64 -29.36 9.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.272 0.558 . . . . 1.0 111.899 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.53 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -59.11 135.92 57.79 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 113.644 0.979 . . . . 1.0 113.644 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -93.7 141.08 28.9 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.802 -1.545 . . . . 1.0 110.252 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.532 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.1 p -88.56 133.41 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.498 0.666 . . . . 1.0 112.233 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 9.8 mt -119.41 146.76 23.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.691 -1.14 . . . . 1.0 109.034 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.95 104.1 16.65 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.128 -0.693 . . . . 1.0 109.128 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.088 -0.958 . . . . 1.0 111.873 -176.348 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 19.6 ttt . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.936 0.398 . . . . 1.0 111.695 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.433 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 16.4 p-10 -88.94 168.75 12.13 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.373 0.606 . . . . 1.0 112.34 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -131.87 97.22 4.12 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.152 -1.425 . . . . 1.0 107.152 173.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.98 168.24 4.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.833 -1.076 . . . . 1.0 109.055 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.527 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 31.8 p-80 -171.45 151.21 2.98 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 110.301 -0.259 . . . . 1.0 110.301 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -88.5 150.38 23.14 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.062 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.83 119.64 12.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.26 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 118' ' ' TRP . 73.4 t -93.97 131.69 40.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 1.0 109.975 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -141.43 179.78 6.59 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.772 0.32 . . . . 1.0 110.823 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.7 t -102.21 137.83 28.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.843 -0.617 . . . . 1.0 112.239 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -82.54 -179.97 7.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.347 -0.842 . . . . 1.0 109.939 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.17 -12.36 61.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.429 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.22 20.03 16.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.767 -178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 71.33 35.18 1.59 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.562 0.745 . . . . 1.0 111.249 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 9.5 mmtt -108.71 153.31 23.63 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.204 -0.907 . . . . 1.0 111.203 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -96.6 118.3 32.8 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.643 -177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 18.0 mtm105 -133.51 -179.99 5.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.657 -0.868 . . . . 1.0 108.657 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.516 ' HB3' HG22 ' A' ' 108' ' ' VAL . 51.7 p-90 -150.09 170.58 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.377 0.608 . . . . 1.0 112.366 178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -148.41 141.88 25.33 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 114.448 -1.251 . . . . 1.0 110.63 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.737 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.6 tp -102.15 129.8 48.61 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.421 -1.326 . . . . 1.0 107.421 174.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 t -130.52 134.65 61.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 121.08 -0.248 . . . . 1.0 110.726 -175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.609 ' CB ' HD21 ' A' ' 126' ' ' ASN . 1.7 t-80 -83.04 172.25 12.93 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 177.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -57.14 -30.55 64.53 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.958 0.409 . . . . 1.0 111.843 178.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -68.26 -33.6 74.66 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.3 0.571 . . . . 1.0 110.037 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 111.76 11.76 16.09 Favored Glycine 0 N--CA 1.453 -0.22 0 CA-C-N 115.069 -0.969 . . . . 1.0 112.347 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.609 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.94 142.02 27.99 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.841 -0.18 . . . . 1.0 111.086 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' B' ' 233' ' ' GLU . 49.6 mm -77.58 118.19 24.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 123.921 0.763 . . . . 1.0 109.711 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.737 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.2 mt -89.83 -40.06 12.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.183 -0.917 . . . . 1.0 109.413 -178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.473 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.16 164.52 37.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.781 -1.1 . . . . 1.0 111.917 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -137.53 154.27 49.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.826 -1.079 . . . . 1.0 108.723 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 118' ' ' TRP . 77.6 p -55.59 -41.47 73.44 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.664 0.616 . . . . 1.0 112.664 -178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.13 -35.52 2.77 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.441 -0.664 . . . . 1.0 111.441 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.403 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 49.4 mt-10 -94.71 174.92 6.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.19 0.519 . . . . 1.0 111.132 178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -160.54 124.12 1.3 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.083 -0.962 . . . . 1.0 110.739 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -146.03 179.44 7.48 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 109.783 -0.451 . . . . 1.0 109.783 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -96.56 9.42 41.53 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.077 -0.511 . . . . 1.0 111.768 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.6 m -117.59 128.86 55.35 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.675 0.75 . . . . 1.0 111.664 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -69.52 -32.07 70.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.573 -1.194 . . . . 1.0 110.214 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.3 tt0 -63.06 -44.83 94.71 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.663 -0.699 . . . . 1.0 110.112 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.403 ' NZ ' ' OE1' ' A' ' 133' ' ' GLU . 27.5 tptp -60.87 -37.07 80.88 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.681 -178.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.83 75.05 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.194 0.521 . . . . 1.0 109.962 176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.458 ' HA ' HD12 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.97 -36.96 86.08 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.65 -0.704 . . . . 1.0 111.3 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.6 mm-40 -61.65 -27.44 68.68 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.14 -43.62 89.46 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.07 -1.212 . . . . 1.0 110.07 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.524 HG21 HG22 ' B' ' 257' ' ' VAL . 54.4 mt -63.29 -44.48 99.16 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-O 121.318 0.58 . . . . 1.0 109.97 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.09 -43.78 98.37 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.02 -0.537 . . . . 1.0 110.354 178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.0 m -64.09 -34.93 79.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.745 178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -73.5 -43.25 55.7 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 C-N-CA 119.897 -0.721 . . . . 1.0 109.653 -177.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -67.6 -11.92 59.22 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.042 -0.411 . . . . 1.0 111.729 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -104.11 -2.35 25.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.807 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.428 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 16.1 m-80 -137.04 -37.2 0.65 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.402 0.519 . . . . 1.0 112.402 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.53 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.89 -50.14 87.85 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -64.89 -11.12 28.0 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 121.329 1.353 . . . . 1.0 113.226 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.88 -22.42 11.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.065 0.459 . . . . 1.0 111.394 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -67.84 137.77 55.58 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 113.269 0.84 . . . . 1.0 113.269 -176.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -100.11 154.21 18.61 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.3 -1.318 . . . . 1.0 111.489 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.516 HG22 HG21 ' B' ' 245' ' ' ILE . 36.1 t -87.61 133.45 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.874 -0.603 . . . . 1.0 111.995 -178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.7 mt -131.65 145.75 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.398 -0.593 . . . . 1.0 109.398 176.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -83.23 118.61 23.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.543 -0.742 . . . . 1.0 110.95 -179.694 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 120.305 0.097 . . . . 1.0 111.12 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.428 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 22.5 p-10 -143.6 -174.87 4.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.685 0.755 . . . . 1.0 112.878 -174.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -135.75 97.76 3.74 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 113.571 -1.649 . . . . 1.0 106.971 173.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.31 167.46 4.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.589 -0.732 . . . . 1.0 109.322 -177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.469 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 44.3 p-80 -169.32 149.63 4.13 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.877 -0.329 . . . . 1.0 110.738 -177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -85.9 151.17 23.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.771 -0.65 . . . . 1.0 110.766 179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -140.93 120.68 13.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.872 -0.603 . . . . 1.0 110.568 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' B' ' 218' ' ' TRP . 81.0 t -94.33 133.35 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.654 -179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -140.18 -178.79 5.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.101 -177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 2.9 t -108.36 138.28 35.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.333 0.494 . . . . 1.0 112.333 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.8 178.57 8.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.469 -0.787 . . . . 1.0 109.748 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -67.23 -18.86 65.41 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.735 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -106.89 23.09 14.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.984 -0.553 . . . . 1.0 111.112 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 62.64 40.87 9.9 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.854 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 72.2 mmtt -102.1 158.66 16.0 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 177.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -102.47 118.48 36.95 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.894 -0.41 . . . . 1.0 109.894 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 28.0 mtm105 -132.03 179.08 6.3 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.959 -0.756 . . . . 1.0 108.959 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.52 ' HB3' HG22 ' B' ' 208' ' ' VAL . 52.5 p-90 -149.0 171.05 16.99 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.588 0.709 . . . . 1.0 112.317 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -147.43 142.49 27.07 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 114.205 -1.361 . . . . 1.0 110.649 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.696 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.0 tp -100.46 129.39 46.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.656 -1.239 . . . . 1.0 107.656 174.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 15.9 t -130.56 135.0 61.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 116.604 -0.271 . . . . 1.0 110.363 -176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.62 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.5 t-80 -81.73 168.59 17.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 107.962 -1.125 . . . . 1.0 107.962 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -61.46 -17.73 55.78 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.947 0.403 . . . . 1.0 111.419 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -74.25 -33.9 63.45 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.546 0.689 . . . . 1.0 109.488 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.59 10.91 15.89 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 114.41 -1.268 . . . . 1.0 112.596 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.62 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -90.54 143.26 26.92 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.265 0.226 . . . . 1.0 111.481 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 51.1 mm -74.81 127.01 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 O-C-N 123.675 0.609 . . . . 1.0 109.513 177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.696 HD12 ' HG ' ' B' ' 220' ' ' LEU . 13.5 mt -103.81 -40.75 6.13 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.231 0.539 . . . . 1.0 109.99 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.86 164.86 36.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.956 -1.02 . . . . 1.0 111.908 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' B' ' 231' ' ' SER . 10.2 t0 -139.22 151.88 46.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.829 -1.078 . . . . 1.0 108.186 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 11.9 p -51.51 -36.47 44.84 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 111.864 0.32 . . . . 1.0 111.864 176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.62 -45.32 3.34 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.355 -0.698 . . . . 1.0 111.355 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . 0.553 ' HG3' ' HB ' ' A' ' 127' ' ' ILE . 89.0 mt-10 -113.26 171.26 7.66 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.082 -0.559 . . . . 1.0 111.011 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.99 141.3 9.55 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -141.05 174.27 10.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.603 0.24 . . . . 1.0 110.458 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -86.17 10.83 13.38 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.824 1.046 . . . . 1.0 113.824 -176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.3 m -128.61 131.17 48.1 Favored 'General case' 0 C--O 1.239 0.51 0 O-C-N 121.74 -0.6 . . . . 1.0 111.336 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' B' ' 242' ' ' LYS . 20.3 ptmt -66.51 -34.87 78.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.627 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.8 tt0 -57.16 -43.99 83.06 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.648 -0.706 . . . . 1.0 109.905 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 0.4 OUTLIER -60.49 -40.88 92.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.22 -179.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.82 -49.25 78.42 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.217 0.532 . . . . 1.0 110.376 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' B' ' 238' ' ' LYS . 44.9 mtmt -63.0 -41.11 99.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.91 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.5 mm-40 -64.79 -26.22 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.134 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.27 -42.56 96.15 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.029 -1.228 . . . . 1.0 110.029 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.516 HG21 HG22 ' A' ' 157' ' ' VAL . 57.5 mt -62.23 -46.16 97.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.481 0.658 . . . . 1.0 110.161 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -62.41 -40.3 96.06 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.057 -0.519 . . . . 1.0 110.201 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 48.8 m -65.02 -34.18 77.82 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.662 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.01 -43.03 52.56 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.888 -177.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -65.95 -12.01 51.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.849 0.357 . . . . 1.0 111.848 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -102.63 -3.09 27.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.786 -177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 13.5 m-80 -135.65 -36.36 0.78 Allowed 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.224 0.453 . . . . 1.0 112.224 -176.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.16 -50.41 87.63 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.752 -0.658 . . . . 1.0 112.538 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.4 Cg_endo -63.47 -14.12 40.4 Favored 'Trans proline' 0 C--N 1.361 1.19 0 C-N-CA 121.444 1.43 . . . . 1.0 113.254 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.45 -21.49 12.15 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.88 0.371 . . . . 1.0 111.906 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.51 138.18 57.9 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.131 0.789 . . . . 1.0 113.131 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -97.05 150.38 20.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.328 -1.305 . . . . 1.0 112.053 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 145' ' ' ILE . 36.2 t -85.53 133.93 28.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.72 -0.673 . . . . 1.0 111.258 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 10.0 mt -124.44 143.95 36.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 177.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -85.78 102.4 13.63 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.595 -0.717 . . . . 1.0 110.892 -178.14 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.459 0.647 . . . . 1.0 110.792 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.432 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 17.7 p-10 -69.99 167.52 17.35 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 114.659 -1.155 . . . . 1.0 112.744 -176.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.5 mptt -121.63 97.4 5.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.647 -1.242 . . . . 1.0 107.647 174.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.03 167.48 4.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.451 -1.249 . . . . 1.0 108.426 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.469 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 52.3 p-80 -168.88 148.37 4.2 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 120.702 -0.399 . . . . 1.0 110.929 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.563 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.9 m-85 -86.27 149.09 25.31 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.561 -0.745 . . . . 1.0 110.868 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -142.56 121.43 12.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.759 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.5 t -97.09 136.4 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.728 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -147.25 -179.26 6.71 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.245 0.341 . . . . 1.0 110.593 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -105.82 138.5 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 121.394 0.616 . . . . 1.0 112.082 179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -82.23 178.54 8.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.744 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.8 -15.21 63.44 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.046 0.45 . . . . 1.0 111.162 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.71 22.22 16.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.444 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 70.62 33.18 2.41 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.687 0.795 . . . . 1.0 111.236 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.4 mttt -107.42 146.56 31.53 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 121.517 0.675 . . . . 1.0 111.941 -175.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -92.9 115.76 28.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.198 -1.364 . . . . 1.0 109.802 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -128.99 179.36 5.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.966 -1.016 . . . . 1.0 109.203 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.587 ' HB3' HG22 ' A' ' 108' ' ' VAL . 54.9 p-90 -154.5 165.49 36.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.1 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 16.4 mtt180 -149.09 150.63 33.05 Favored 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 124.016 0.823 . . . . 1.0 110.497 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.712 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.0 tp -99.83 132.02 45.44 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.151 -1.055 . . . . 1.0 108.151 176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -128.86 129.72 68.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.554 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.62 ' CB ' HD21 ' A' ' 126' ' ' ASN . 3.0 t-80 -78.23 172.62 13.3 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.03 -32.39 66.11 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.15 0.5 . . . . 1.0 110.959 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -65.29 -33.73 76.67 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.203 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.66 14.22 16.39 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.078 -0.965 . . . . 1.0 112.384 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.62 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.34 143.6 26.6 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 111.583 0.216 . . . . 1.0 111.583 178.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 49.8 mm -74.96 118.64 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 123.926 0.766 . . . . 1.0 109.566 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.712 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.3 mt -93.87 -43.41 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.384 0.612 . . . . 1.0 109.799 -179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.479 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.21 163.74 37.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.627 -1.17 . . . . 1.0 111.367 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -139.07 156.86 46.86 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.658 -0.867 . . . . 1.0 108.658 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 58.8 p -53.74 -31.5 48.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.931 0.396 . . . . 1.0 111.401 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.06 -38.26 2.98 Favored Glycine 0 N--CA 1.453 -0.223 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.502 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 49.9 mt-10 -118.3 171.39 8.17 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.048 -0.576 . . . . 1.0 110.951 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -128.42 138.66 10.49 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -133.43 169.43 16.95 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 117.32 0.56 . . . . 1.0 111.982 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.01 10.72 30.19 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.559 0.948 . . . . 1.0 113.559 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 13.9 m -142.5 139.22 31.42 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.815 -0.553 . . . . 1.0 111.9 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.64 -37.48 87.71 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.341 -0.845 . . . . 1.0 110.461 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.449 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 7.9 tt0 -59.03 -46.67 87.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.887 -0.597 . . . . 1.0 109.544 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -59.12 -41.59 88.55 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.564 -0.744 . . . . 1.0 110.614 -179.019 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.98 -50.11 75.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.09 0.471 . . . . 1.0 109.861 177.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.529 ' HA ' HD12 ' A' ' 145' ' ' ILE . 43.9 mtmt -64.21 -34.73 78.76 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.758 -0.655 . . . . 1.0 111.344 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 27.0 mm-40 -63.69 -27.13 69.01 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 176.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.76 -42.38 87.02 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 142' ' ' LYS . 66.5 mt -62.2 -44.35 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.414 0.626 . . . . 1.0 109.637 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -61.52 -44.77 96.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.239 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.8 m -63.56 -34.83 78.67 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.68 -0.691 . . . . 1.0 110.751 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.539 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -74.55 -41.61 48.89 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 C-N-CA 119.878 -0.729 . . . . 1.0 109.684 -177.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -66.36 -12.1 54.89 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.753 0.311 . . . . 1.0 111.657 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.6 ttt85 -104.63 -2.8 24.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.237 -0.438 . . . . 1.0 111.591 -177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -132.02 -40.58 1.04 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.835 0.35 . . . . 1.0 111.502 -177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.539 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.15 -51.48 79.29 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.633 -0.712 . . . . 1.0 112.617 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.9 Cg_endo -63.54 -9.0 16.52 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.508 1.472 . . . . 1.0 113.98 -177.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.58 -22.19 7.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.918 0.39 . . . . 1.0 111.939 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 136.52 57.43 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.777 0.799 . . . . 1.0 113.038 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.93 138.78 31.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.438 -1.255 . . . . 1.0 110.581 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.567 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -89.69 130.65 38.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.592 0.711 . . . . 1.0 112.699 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.8 mt -115.47 140.22 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.369 -1.287 . . . . 1.0 108.568 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -92.61 102.05 14.48 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.236 -0.653 . . . . 1.0 109.236 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.96 0 CA-C-N 115.059 -0.973 . . . . 1.0 111.148 -177.064 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -109.7 171.37 7.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.022 0.439 . . . . 1.0 110.787 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 73.3 mmtt -137.73 95.77 3.11 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.609 -1.256 . . . . 1.0 107.609 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.91 173.03 2.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.094 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.496 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 53.6 p-80 -170.7 147.59 2.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.583 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.567 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 57.6 m-85 -85.16 147.61 26.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.654 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -140.37 119.55 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.08 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.507 HG22 ' HB3' ' B' ' 218' ' ' TRP . 75.4 t -92.14 133.93 31.96 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 CA-C-N 115.888 -0.597 . . . . 1.0 110.151 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -145.66 -176.43 5.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.619 0.247 . . . . 1.0 110.4 -176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.8 t -101.99 139.42 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.909 0.707 . . . . 1.0 112.909 -178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -81.22 -178.65 7.01 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-N 115.309 -0.86 . . . . 1.0 109.548 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.82 -16.96 62.76 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.154 0.502 . . . . 1.0 110.673 178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.37 19.33 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.712 -177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 69.67 39.99 1.44 Allowed 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 123.425 0.69 . . . . 1.0 110.956 177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -113.76 151.86 31.38 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.515 -0.766 . . . . 1.0 110.791 -176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -91.99 118.87 31.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.024 -0.989 . . . . 1.0 110.158 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.433 ' HG2' ' HA2' ' B' ' 234' ' ' GLY . 62.1 mtp180 -130.69 -178.67 4.89 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-N 114.821 -1.081 . . . . 1.0 108.808 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.507 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.8 p-90 -155.43 164.44 38.71 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.345 177.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -149.66 148.31 29.13 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 114.935 -1.03 . . . . 1.0 110.216 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.695 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -97.15 130.16 44.44 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.694 -1.225 . . . . 1.0 107.694 176.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 12.5 t -126.28 130.59 71.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.252 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.614 ' CB ' HD21 ' B' ' 226' ' ' ASN . 3.8 t-80 -78.94 169.31 18.42 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 29.0 t70 -58.36 -26.47 63.18 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.266 0.555 . . . . 1.0 110.954 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.4 -33.07 70.95 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.941 -179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.48 11.52 19.44 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 114.846 -1.07 . . . . 1.0 113.125 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.614 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.55 144.21 26.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 122.807 -0.231 . . . . 1.0 111.385 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 49.9 mm -78.24 116.72 22.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.837 -0.619 . . . . 1.0 109.472 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.695 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.4 mt -90.25 -42.58 10.92 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.541 -0.754 . . . . 1.0 109.547 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.483 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -150.35 164.27 36.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.608 -1.178 . . . . 1.0 111.374 177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.34 155.33 47.75 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.771 -0.825 . . . . 1.0 108.771 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.412 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 65.6 p -54.72 -33.26 60.84 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.066 0.46 . . . . 1.0 111.55 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.95 -33.69 3.51 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.53 -0.628 . . . . 1.0 111.53 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -122.72 166.94 14.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.175 0.512 . . . . 1.0 111.572 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.433 ' HA2' ' HG2' ' B' ' 217' ' ' ARG . . . -118.73 139.78 14.72 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 109.651 -1.38 . . . . 1.0 109.651 177.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -127.47 171.02 11.95 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.623 0.711 . . . . 1.0 111.545 -175.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -100.73 9.69 42.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.114 -0.494 . . . . 1.0 112.28 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.7 m -143.78 137.21 27.9 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.68 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 11.6 ptmm? -62.88 -38.42 90.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.78 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.3 tt0 -60.98 -40.71 94.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.211 177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -61.05 -41.51 96.74 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.647 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.57 -44.28 89.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.874 -0.603 . . . . 1.0 109.973 178.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.572 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.0 mtmt -64.91 -34.99 79.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 1.0 111.228 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 26.3 mm-40 -62.62 -30.98 71.75 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.15 -41.28 95.03 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.048 -1.221 . . . . 1.0 110.048 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' B' ' 242' ' ' LYS . 66.6 mt -63.36 -43.08 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.976 -0.612 . . . . 1.0 110.582 177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -63.99 -41.3 97.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.04 0.448 . . . . 1.0 110.232 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.5 m -64.03 -37.08 86.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.523 -0.762 . . . . 1.0 110.522 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.516 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -74.06 -41.46 52.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 C-N-CA 120.22 -0.592 . . . . 1.0 110.755 -176.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -65.53 -16.35 63.59 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 112.643 0.609 . . . . 1.0 112.643 -177.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -105.82 -3.23 22.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 1.0 111.353 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . 0.432 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 15.2 m-80 -123.32 -38.88 2.51 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.986 0.422 . . . . 1.0 111.082 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.516 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.51 -50.87 85.27 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.522 -0.763 . . . . 1.0 112.495 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.5 Cg_endo -63.59 -12.75 32.66 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 121.53 1.486 . . . . 1.0 113.528 -177.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -116.56 -19.47 10.02 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.525 0.565 . . . . 1.0 112.525 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -64.57 136.77 57.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.866 0.841 . . . . 1.0 112.593 -177.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -91.83 135.76 33.67 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.022 -1.445 . . . . 1.0 110.573 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.563 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -88.54 129.85 39.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.601 0.715 . . . . 1.0 112.298 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.9 mt -115.1 140.59 35.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 114.406 -1.27 . . . . 1.0 109.27 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -90.31 106.55 18.57 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.674 -0.862 . . . . 1.0 108.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.337 -0.839 . . . . 1.0 111.213 -177.399 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 53.3 ttp . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.372 0.606 . . . . 1.0 110.697 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' OD1' ' B' ' 251' ' ' ASN . 21.4 p-10 -92.63 173.99 7.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.421 -0.809 . . . . 1.0 112.066 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -134.37 96.64 3.64 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.247 -1.39 . . . . 1.0 107.247 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.55 171.13 3.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.856 -1.065 . . . . 1.0 109.401 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.5 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 48.4 p-80 -170.53 148.36 3.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 54.1 m-85 -84.83 149.94 25.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.38 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -140.35 118.73 12.14 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.559 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.535 HG22 ' HB3' ' A' ' 118' ' ' TRP . 68.2 t -90.95 133.39 32.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.246 -0.434 . . . . 1.0 109.878 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -142.6 177.43 8.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.412 -177.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.4 t -102.36 137.47 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.334 0.587 . . . . 1.0 111.969 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -79.57 177.76 8.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.33 -0.85 . . . . 1.0 109.96 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.87 -12.25 61.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.237 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -114.97 24.28 11.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.819 -0.628 . . . . 1.0 111.669 -177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 69.35 35.19 2.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.545 0.738 . . . . 1.0 111.674 176.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.7 mttt -110.68 147.53 34.15 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.457 0.646 . . . . 1.0 111.4 -176.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -90.6 120.98 32.13 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.431 -1.259 . . . . 1.0 110.467 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -136.32 -179.7 5.84 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.572 -1.194 . . . . 1.0 108.675 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.535 ' HB3' HG22 ' A' ' 108' ' ' VAL . 56.3 p-90 -151.7 162.9 40.24 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.623 -0.431 . . . . 1.0 111.683 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.531 HH11 HG21 ' A' ' 127' ' ' ILE . 21.6 mmt180 -143.48 142.82 31.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.298 -177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.719 ' HG ' HD12 ' A' ' 128' ' ' LEU . 31.5 tp -99.97 129.99 46.1 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.651 -1.24 . . . . 1.0 107.651 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 t -127.79 132.36 68.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 N-CA-C 110.483 -0.192 . . . . 1.0 110.483 -176.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.571 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.0 t-80 -83.34 174.35 10.77 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.117 -0.697 . . . . 1.0 109.117 177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.4 -39.18 67.03 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.855 0.36 . . . . 1.0 111.476 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -60.32 -33.96 73.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.513 0.673 . . . . 1.0 110.26 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.54 12.17 21.8 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 114.873 -1.058 . . . . 1.0 112.096 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.571 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -86.77 142.57 28.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.63 0.252 . . . . 1.0 111.376 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.531 HG21 HH11 ' A' ' 119' ' ' ARG . 50.9 mm -76.26 116.06 18.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.194 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.719 HD12 ' HG ' ' A' ' 120' ' ' LEU . 18.1 mt -88.38 -42.74 11.99 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.634 0.731 . . . . 1.0 109.917 -178.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.507 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.65 166.43 30.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.756 -1.111 . . . . 1.0 111.237 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -140.34 155.41 46.81 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.87 -1.059 . . . . 1.0 110.13 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.447 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 18.9 p -54.5 -36.03 63.75 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.601 0.563 . . . . 1.0 111.605 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.38 -50.67 4.1 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -100.65 178.61 4.66 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.709 -0.746 . . . . 1.0 111.618 -178.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -145.67 140.62 9.09 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -141.37 167.47 22.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.531 0.165 . . . . 1.0 110.66 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.4 9.9 32.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.4 p -129.41 129.89 45.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.601 0.715 . . . . 1.0 111.862 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.8 ptmm? -64.94 -41.52 95.44 Favored 'General case' 0 C--O 1.23 0.053 0 CA-C-N 115.401 -0.818 . . . . 1.0 111.595 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -59.83 -37.78 80.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.621 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -62.0 -43.35 99.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.898 -0.592 . . . . 1.0 110.241 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.95 83.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.26 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.587 ' HA ' HD12 ' A' ' 145' ' ' ILE . 39.6 mtmt -64.66 -34.43 78.28 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.169 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -62.99 -30.29 71.48 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.354 -0.609 . . . . 1.0 109.354 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -66.34 -40.35 94.57 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.42 -1.072 . . . . 1.0 110.42 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 142' ' ' LYS . 58.3 mt -62.73 -42.26 95.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.085 0.469 . . . . 1.0 110.081 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -63.09 -43.75 97.63 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.155 0.502 . . . . 1.0 109.885 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 56.8 m -61.25 -36.16 79.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.235 -0.893 . . . . 1.0 110.924 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -75.22 -42.4 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 119.536 -0.866 . . . . 1.0 110.169 -177.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 64.6 mtpt -66.86 -15.65 63.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.399 0.518 . . . . 1.0 112.399 -177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -105.43 -2.26 23.98 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.366 -177.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 17.4 m-80 -131.62 -37.53 1.19 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.531 -0.304 . . . . 1.0 111.693 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.603 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -57.34 -51.35 82.33 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 112.499 0.555 . . . . 1.0 112.499 -178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 57.8 Cg_endo -66.56 -4.81 11.55 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.261 1.308 . . . . 1.0 113.208 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -119.18 -23.41 6.79 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.593 0.59 . . . . 1.0 112.593 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.555 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -66.69 139.12 57.83 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.472 0.916 . . . . 1.0 113.472 -176.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -90.78 135.42 33.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.488 -1.233 . . . . 1.0 111.189 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.2 p -88.04 131.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.335 0.588 . . . . 1.0 112.075 178.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.6 mt -123.84 145.94 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 114.93 -1.032 . . . . 1.0 108.92 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -88.63 113.44 24.2 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.118 -1.068 . . . . 1.0 108.118 176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.126 -0.94 . . . . 1.0 111.271 -177.112 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 53.2 ttp . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.304 0.573 . . . . 1.0 111.075 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.434 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 14.4 p-10 -81.72 163.74 22.24 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.453 -0.794 . . . . 1.0 112.588 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.423 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 12.0 mptt -127.78 96.46 4.52 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.546 -1.65 . . . . 1.0 106.546 174.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.95 171.4 3.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.417 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.555 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.6 p-80 -169.32 147.26 3.66 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 121.213 -0.195 . . . . 1.0 110.59 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 52.1 m-85 -86.67 146.72 26.19 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.909 -0.587 . . . . 1.0 111.144 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -141.75 122.0 13.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.752 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.0 t -93.24 135.68 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.533 -0.758 . . . . 1.0 110.515 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -144.09 -178.62 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.355 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 4.1 t -106.15 139.65 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -83.22 179.12 7.8 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 115.47 -0.787 . . . . 1.0 109.51 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.38 -17.58 64.27 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.893 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -104.8 19.16 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.6 -0.727 . . . . 1.0 111.118 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 69.78 35.37 2.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 115.623 -0.717 . . . . 1.0 111.041 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.1 mmtt -108.57 149.16 29.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.407 -175.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -92.38 119.67 32.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.53 -1.214 . . . . 1.0 110.254 -177.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -132.32 -178.1 4.76 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.706 -1.134 . . . . 1.0 108.972 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.517 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.0 p-90 -155.7 168.22 27.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.742 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 16.6 mtt180 -150.44 154.13 37.16 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 114.849 -1.069 . . . . 1.0 110.613 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.693 ' HG ' HD12 ' B' ' 228' ' ' LEU . 31.9 tp -104.36 132.62 50.41 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.323 -0.992 . . . . 1.0 108.323 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.3 t -126.25 132.25 70.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.259 -0.275 . . . . 1.0 110.259 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.522 ' CB ' HD21 ' B' ' 226' ' ' ASN . 0.6 OUTLIER -85.26 174.49 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.256 179.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 26.8 t70 -52.5 -33.88 46.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.833 -0.621 . . . . 1.0 112.249 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -70.81 -33.29 70.55 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.322 0.582 . . . . 1.0 110.179 -178.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.92 10.34 21.09 Favored Glycine 0 C--O 1.228 -0.249 0 CA-C-N 115.074 -0.967 . . . . 1.0 112.38 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.522 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -85.69 144.51 27.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.6 mm -74.35 118.71 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 O-C-N 123.926 0.766 . . . . 1.0 109.38 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.693 HD12 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -93.42 -43.52 8.71 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.583 -0.735 . . . . 1.0 109.608 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -151.06 162.67 40.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.195 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -136.85 155.11 50.21 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.653 -0.869 . . . . 1.0 108.653 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.458 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.3 p -51.86 -37.03 50.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.905 0.383 . . . . 1.0 111.817 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 87.18 -46.44 3.53 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . 0.462 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 7.8 mm-40 -98.15 -179.75 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.127 -0.537 . . . . 1.0 111.399 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -150.0 133.86 4.57 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.185 -1.166 . . . . 1.0 110.185 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -138.85 170.01 16.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.089 0.444 . . . . 1.0 110.962 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -92.27 9.46 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 6.5 p -126.96 129.05 47.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.594 0.711 . . . . 1.0 112.1 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -65.21 -41.17 94.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 115.116 -0.947 . . . . 1.0 110.98 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.44 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.8 tt0 -58.4 -41.14 84.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.342 178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -60.59 -41.95 95.76 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.918 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.38 -47.18 79.46 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.43 0.633 . . . . 1.0 109.511 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.515 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.2 mtmt -65.78 -33.68 76.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.208 -0.905 . . . . 1.0 111.265 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 27.1 mm-40 -66.51 -28.88 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -68.15 -39.64 88.36 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.751 -0.94 . . . . 1.0 110.751 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.9 mt -61.58 -52.43 61.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.519 0.676 . . . . 1.0 110.59 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -61.87 -35.57 78.68 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.891 -0.595 . . . . 1.0 111.02 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 68.2 m -67.95 -36.29 79.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.846 177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.514 HG12 ' O ' ' B' ' 245' ' ' ILE . 0.5 OUTLIER -71.54 -37.16 62.91 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -177.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -66.41 -15.46 63.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.938 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 41.2 ttt85 -105.04 -2.9 23.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.074 -178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . 0.44 ' OD1' ' HB2' ' A' ' 102' ' ' ASN . 16.1 m-80 -127.08 -41.17 1.8 Allowed 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.639 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.512 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -56.82 -50.51 87.64 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-N 115.768 -0.651 . . . . 1.0 112.431 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.6 Cg_endo -62.84 -15.15 45.28 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 121.162 1.241 . . . . 1.0 113.712 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.5 -18.3 11.52 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.823 0.344 . . . . 1.0 111.923 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.6 135.25 52.61 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.641 0.734 . . . . 1.0 112.791 -177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -93.56 140.28 29.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.213 -1.358 . . . . 1.0 110.592 178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.3 p -87.27 136.36 23.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.369 0.604 . . . . 1.0 112.205 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.8 mt -124.58 148.72 28.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 114.658 -1.156 . . . . 1.0 109.761 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.9 106.37 17.05 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 CA-C-O 118.577 -0.725 . . . . 1.0 111.296 -177.858 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.406 ' C ' ' SD ' ' A' ' 101' ' ' MET . 1.5 tmt? . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.704 0.287 . . . . 1.0 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.434 ' C ' ' HD2' ' A' ' 103' ' ' LYS . 10.7 p-10 -85.79 159.58 19.7 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.351 0.595 . . . . 1.0 112.151 -176.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.434 ' HD2' ' C ' ' A' ' 102' ' ' ASN . 12.2 mptt -122.71 97.91 5.67 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.514 -1.291 . . . . 1.0 107.514 175.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -173.72 169.34 4.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.685 -1.143 . . . . 1.0 108.954 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.509 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.9 p-80 -169.14 148.94 4.11 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.576 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.6 m-85 -85.59 146.9 26.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.66 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -139.36 116.8 11.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.939 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 118' ' ' TRP . 70.2 t -90.97 132.12 36.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.526 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -140.5 -179.08 5.81 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 110.383 -0.228 . . . . 1.0 110.383 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 5.2 t -103.53 136.16 37.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.91 -0.586 . . . . 1.0 112.388 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.11 177.55 8.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.503 -0.771 . . . . 1.0 108.957 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.68 -14.29 62.92 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.028 0.442 . . . . 1.0 111.006 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -106.55 19.16 20.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.993 -0.549 . . . . 1.0 111.102 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 68.6 39.99 1.96 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.452 -0.795 . . . . 1.0 110.672 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 13.2 mmtt -111.76 152.45 27.8 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.283 -176.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -93.44 118.63 31.55 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.727 -1.124 . . . . 1.0 110.067 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -132.06 -179.26 5.31 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.527 ' HB3' HG22 ' A' ' 108' ' ' VAL . 60.5 p-90 -155.77 167.41 30.48 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.082 0.468 . . . . 1.0 111.926 178.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -151.64 149.87 29.62 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.334 -1.303 . . . . 1.0 110.63 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.704 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.4 tp -100.03 130.92 46.24 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 t -126.59 131.38 71.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 116.561 -0.291 . . . . 1.0 110.549 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.597 ' CB ' HD21 ' A' ' 126' ' ' ASN . 1.9 t-80 -81.65 172.08 13.84 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.266 -0.642 . . . . 1.0 109.266 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 26.3 t70 -57.84 -27.36 63.13 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.323 0.582 . . . . 1.0 110.792 177.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.1 -33.64 73.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.61 -0.723 . . . . 1.0 109.955 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 108.12 11.7 23.53 Favored Glycine 0 CA--C 1.518 0.238 0 CA-C-N 115.109 -0.95 . . . . 1.0 112.318 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.597 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.09 144.68 25.68 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.101 0.408 . . . . 1.0 112.101 179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.417 ' HB ' ' HG2' ' B' ' 233' ' ' GLU . 50.6 mm -76.41 117.4 21.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 O-C-N 123.944 0.777 . . . . 1.0 109.137 177.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.704 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.0 mt -90.57 -43.96 9.86 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.655 -0.702 . . . . 1.0 109.6 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.51 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -149.48 158.48 44.21 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.692 -1.14 . . . . 1.0 111.02 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -134.64 154.99 51.26 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.421 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 16.3 p -52.9 -33.16 49.06 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.406 0.442 . . . . 1.0 112.159 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 87.35 -48.04 3.73 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -104.07 -175.38 2.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.913 -0.644 . . . . 1.0 111.406 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -149.25 137.77 6.48 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.76 -0.936 . . . . 1.0 110.76 178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -144.34 168.47 20.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.96 0.38 . . . . 1.0 111.06 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.06 10.29 32.17 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 113.226 0.824 . . . . 1.0 113.226 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.2 m -125.83 132.53 52.21 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.201 0.524 . . . . 1.0 111.076 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -64.77 -38.55 91.38 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.879 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.9 tt0 -61.17 -41.23 96.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.988 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -60.64 -41.21 94.47 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.555 -178.013 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.56 -51.28 70.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.978 -0.556 . . . . 1.0 109.985 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.53 ' HA ' HD12 ' A' ' 145' ' ' ILE . 48.3 mtmt -63.63 -36.41 83.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.416 -0.811 . . . . 1.0 111.632 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 28.0 mm-40 -65.1 -25.49 67.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -67.2 -40.95 92.48 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.53 HD12 ' HA ' ' A' ' 142' ' ' LYS . 67.7 mt -62.43 -44.53 99.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.8 -0.7 . . . . 1.0 109.766 176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -62.55 -40.16 95.95 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.809 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.6 m -63.17 -35.39 80.13 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.798 -0.637 . . . . 1.0 111.007 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -73.68 -40.86 54.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 119.581 -0.848 . . . . 1.0 109.371 -178.286 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -68.06 -11.92 59.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.251 0.548 . . . . 1.0 110.768 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -97.73 -6.87 31.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.174 -0.921 . . . . 1.0 111.259 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -138.91 -37.51 0.52 Allowed 'General case' 0 C--O 1.22 -0.494 0 N-CA-C 112.804 0.668 . . . . 1.0 112.804 -174.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -53.84 -50.68 82.47 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 112.6 0.593 . . . . 1.0 112.6 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 56.8 Cg_endo -67.36 -6.21 15.82 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 121.307 1.338 . . . . 1.0 113.473 -177.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.88 -26.96 5.9 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.247 0.546 . . . . 1.0 111.684 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -64.98 136.44 56.81 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.424 -0.807 . . . . 1.0 112.502 -177.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -98.35 139.4 34.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.566 -1.197 . . . . 1.0 110.975 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.518 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.5 p -86.72 139.92 16.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.542 0.686 . . . . 1.0 112.584 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.7 mt -123.82 142.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.491 -1.231 . . . . 1.0 109.013 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -88.9 101.48 14.1 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.562 -0.732 . . . . 1.0 111.294 -177.582 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.515 0.198 . . . . 1.0 110.608 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -112.89 171.19 7.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.52 0.676 . . . . 1.0 112.252 -176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -144.94 97.12 2.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.17 -1.418 . . . . 1.0 107.17 173.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.98 177.41 1.97 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.602 -0.726 . . . . 1.0 109.958 -177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.476 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.8 p-80 -169.2 148.12 3.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.831 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 60.8 m-85 -86.16 150.12 24.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.836 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -141.16 117.59 10.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.904 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' B' ' 218' ' ' TRP . 88.9 t -93.5 134.53 30.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.808 -0.633 . . . . 1.0 109.958 179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -145.75 179.76 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.756 0.312 . . . . 1.0 110.968 -177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.467 HG13 ' HA ' ' B' ' 214' ' ' ASP . 1.3 t -97.44 135.94 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.509 -0.769 . . . . 1.0 111.37 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.53 -179.11 7.08 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.457 -0.792 . . . . 1.0 110.055 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.05 -6.91 25.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.972 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -120.79 18.42 11.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.531 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.467 ' HA ' HG13 ' B' ' 210' ' ' VAL . 35.1 t70 69.83 43.69 0.92 Allowed 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 122.47 1.128 . . . . 1.0 110.359 177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.7 mmtt -113.51 150.23 33.21 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.749 -177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -91.06 116.32 28.71 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.799 -1.091 . . . . 1.0 109.988 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 13.0 mtm105 -134.03 178.29 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.147 -1.057 . . . . 1.0 108.147 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.528 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.1 p-90 -151.27 164.01 37.59 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.742 -0.383 . . . . 1.0 111.391 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' B' ' 219' ' ' ARG . 4.5 mtp-105 -146.63 145.76 30.17 Favored 'General case' 0 CA--C 1.511 -0.519 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.913 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.699 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.5 tp -96.61 130.66 43.77 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 176.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 t -126.13 130.77 72.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.027 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.481 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.1 t-80 -81.83 175.47 10.4 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.62 -36.81 62.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.965 -0.561 . . . . 1.0 111.414 177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -67.13 -34.58 77.91 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.563 0.697 . . . . 1.0 110.503 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.63 12.33 17.02 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 114.97 -1.014 . . . . 1.0 112.203 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.481 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.06 143.33 27.37 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.056 0.391 . . . . 1.0 112.056 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.17 120.15 22.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 O-C-N 124.053 0.845 . . . . 1.0 109.911 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.699 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.9 mt -96.49 -43.96 7.39 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.703 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . . . . . . . . . . . -150.46 162.3 40.85 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.489 -1.232 . . . . 1.0 111.135 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -137.65 152.93 49.84 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.972 -1.013 . . . . 1.0 108.442 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 79.8 p -55.25 -36.43 66.04 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.013 0.435 . . . . 1.0 111.416 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.25 -48.1 3.57 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . 0.417 ' HG2' ' HB ' ' A' ' 127' ' ' ILE . 14.9 mm-40 -98.01 171.76 8.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.78 -0.71 . . . . 1.0 111.563 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.11 135.82 6.23 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.349 -1.101 . . . . 1.0 110.349 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -141.86 178.82 7.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.066 0.433 . . . . 1.0 110.405 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -99.27 9.8 42.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.192 0.812 . . . . 1.0 113.192 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -125.86 131.83 52.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.2 0.524 . . . . 1.0 111.544 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.58 -39.13 93.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.164 -0.926 . . . . 1.0 110.448 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.5 tt0 -60.29 -43.82 95.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.224 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.531 ' HE2' ' HA ' ' B' ' 240' ' ' LYS . 0.6 OUTLIER -59.52 -41.43 89.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.618 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.49 -51.08 71.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.064 0.459 . . . . 1.0 110.318 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.497 ' HA ' HD12 ' B' ' 245' ' ' ILE . 46.7 mtmt -63.59 -33.37 75.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.322 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 25.3 mm-40 -65.55 -30.38 71.12 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.425 -0.51 . . . . 1.0 109.72 176.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.28 -40.14 96.42 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.509 ' O ' HG12 ' B' ' 248' ' ' VAL . 75.6 mt -61.62 -53.42 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.588 0.709 . . . . 1.0 110.535 177.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -61.37 -34.8 75.91 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.591 -0.731 . . . . 1.0 111.034 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 51.5 m -66.82 -37.64 84.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.389 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.4 OUTLIER -70.72 -40.59 77.07 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.708 0 C-N-CA 119.984 -0.687 . . . . 1.0 109.247 -177.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -63.72 -17.26 62.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.146 -0.479 . . . . 1.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' B' ' 250' ' ' ARG . 8.4 ttt180 -104.07 -2.77 25.45 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.967 0.413 . . . . 1.0 111.033 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.82 -41.77 1.63 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.608 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.514 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.87 -50.68 85.81 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.503 -0.771 . . . . 1.0 112.852 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.3 Cg_endo -63.14 -15.14 46.16 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 121.232 1.288 . . . . 1.0 113.379 -177.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -112.52 -19.94 11.93 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.925 0.393 . . . . 1.0 111.906 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.84 136.23 53.78 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.786 0.803 . . . . 1.0 112.507 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -92.81 138.86 31.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.125 -1.398 . . . . 1.0 110.988 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.576 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.0 OUTLIER -88.86 130.07 38.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.613 0.721 . . . . 1.0 112.621 179.084 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 8.3 mt -116.41 142.58 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 114.468 -1.242 . . . . 1.0 108.864 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -90.17 101.91 14.63 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.869 -0.586 . . . . 1.0 111.21 -177.137 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 48.0 ttp . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 121.166 0.508 . . . . 1.0 110.758 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -103.73 -178.38 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.494 -0.775 . . . . 1.0 112.033 -176.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 46.8 mmtm -137.58 98.43 3.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.136 -1.393 . . . . 1.0 107.319 173.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.17 172.8 3.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.425 -0.807 . . . . 1.0 109.392 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.439 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 31.6 p-80 -172.02 149.41 2.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.154 0.283 . . . . 1.0 110.238 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 66.1 m-85 -86.11 153.63 21.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.483 178.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -141.66 117.68 10.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.488 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 118' ' ' TRP . 79.4 t -93.84 129.54 44.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -143.63 179.3 7.22 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.804 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.5 t -98.82 134.8 36.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.809 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -80.13 178.54 8.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.173 -0.922 . . . . 1.0 109.53 179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.35 -16.83 64.08 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.165 0.507 . . . . 1.0 110.629 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -108.05 20.25 18.95 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.738 -0.664 . . . . 1.0 111.708 -177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 71.3 35.53 1.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.453 0.701 . . . . 1.0 111.398 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.2 mttt -109.61 150.27 28.47 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.948 -0.569 . . . . 1.0 111.159 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -93.06 109.38 20.85 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.006 -0.997 . . . . 1.0 109.264 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.5 mtm105 -126.15 176.91 6.72 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.265 -1.013 . . . . 1.0 108.265 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.526 ' HB3' HG22 ' A' ' 108' ' ' VAL . 49.8 p-90 -147.3 162.45 38.93 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 120.555 -0.458 . . . . 1.0 111.365 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.504 HH21 HG13 ' A' ' 127' ' ' ILE . 14.7 mmm-85 -144.5 142.18 30.06 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.157 -0.929 . . . . 1.0 109.635 -177.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.736 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.9 tp -98.79 131.61 44.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.238 -1.023 . . . . 1.0 108.238 176.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.8 t -130.78 132.97 63.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.542 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.552 ' CB ' HD21 ' A' ' 126' ' ' ASN . 4.8 t-80 -81.81 174.71 11.06 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.7 t70 -56.11 -36.58 68.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.285 177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -64.88 -33.45 76.04 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.551 0.691 . . . . 1.0 109.699 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 109.44 11.57 21.35 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 114.688 -1.142 . . . . 1.0 112.398 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.552 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -85.97 141.31 29.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.721 0.296 . . . . 1.0 111.587 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.504 HG13 HH21 ' A' ' 119' ' ' ARG . 47.6 mm -74.66 122.1 27.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.0 110.299 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.736 HD12 ' HG ' ' A' ' 120' ' ' LEU . 13.9 mt -98.17 -41.42 7.91 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 114.981 -1.009 . . . . 1.0 109.881 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.516 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -151.19 169.24 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.26 -0.882 . . . . 1.0 111.935 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -141.97 153.49 44.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.698 -1.137 . . . . 1.0 108.325 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.434 ' HA ' ' CE2' ' A' ' 118' ' ' TRP . 77.3 p -53.49 -34.49 58.25 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.005 0.431 . . . . 1.0 111.597 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.88 -40.45 3.04 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.804 -0.634 . . . . 1.0 111.652 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.462 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 93.9 mt-10 -110.82 174.85 5.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.307 -0.446 . . . . 1.0 110.78 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.85 136.67 6.74 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.311 -0.715 . . . . 1.0 111.311 179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -144.54 177.53 8.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.733 0.266 . . . . 1.0 110.968 -177.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.36 9.67 42.32 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.773 0.657 . . . . 1.0 112.773 -176.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.2 m -122.03 131.34 53.94 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.561 0.696 . . . . 1.0 111.451 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -64.96 -36.23 83.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.835 -1.075 . . . . 1.0 110.82 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.9 tt0 -63.31 -42.19 98.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.146 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -57.99 -41.26 82.64 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.689 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.86 -51.2 70.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.194 0.521 . . . . 1.0 110.089 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.51 ' HA ' HD12 ' A' ' 145' ' ' ILE . 44.6 mtmt -64.5 -36.77 85.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.712 -0.676 . . . . 1.0 111.682 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -64.0 -28.07 69.55 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.64 -41.91 95.73 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 109.95 -1.26 . . . . 1.0 109.95 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 142' ' ' LYS . 62.3 mt -63.48 -45.68 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 114.837 -0.682 . . . . 1.0 110.466 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -61.63 -40.43 94.86 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.228 -0.442 . . . . 1.0 109.871 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.4 m -66.8 -33.73 76.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.817 177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.535 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.5 OUTLIER -73.69 -40.39 54.2 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 C-N-CA 120.037 -0.665 . . . . 1.0 109.948 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -68.17 -11.8 59.82 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 111.153 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.39 -8.61 26.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.289 -0.868 . . . . 1.0 109.691 -177.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -134.39 -39.14 0.83 Allowed 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 113.482 0.919 . . . . 1.0 113.482 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.535 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -54.31 -49.18 91.92 Favored Pre-proline 0 C--N 1.318 -0.791 0 N-CA-C 112.837 0.68 . . . . 1.0 112.837 -177.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 53.7 Cg_endo -66.69 -7.06 17.01 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.32 1.347 . . . . 1.0 113.153 -177.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -122.44 -13.6 8.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.473 0.545 . . . . 1.0 112.473 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.454 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -73.27 135.21 44.43 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.748 0.785 . . . . 1.0 112.869 -177.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -93.57 138.73 31.54 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.352 -1.295 . . . . 1.0 110.36 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.514 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.1 p -88.01 133.89 29.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.167 0.508 . . . . 1.0 112.348 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.1 mt -119.84 143.81 30.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 114.955 -1.02 . . . . 1.0 109.275 177.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -87.71 107.14 18.49 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.882 -0.785 . . . . 1.0 108.882 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.191 0 CA-C-O 118.227 -0.892 . . . . 1.0 110.883 -177.792 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 52.4 ttp . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 121.18 0.514 . . . . 1.0 110.697 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -102.09 177.19 4.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.642 -0.708 . . . . 1.0 112.319 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -133.47 98.92 4.35 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.392 -1.336 . . . . 1.0 107.392 173.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.4 170.23 3.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.75 -1.114 . . . . 1.0 108.694 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.454 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 47.7 p-80 -170.96 149.94 3.04 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 123.08 0.237 . . . . 1.0 110.497 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 54.9 m-85 -85.73 149.38 25.33 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.8 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -140.48 120.29 13.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.59 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' B' ' 218' ' ' TRP . 71.5 t -95.5 135.07 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.204 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 17.3 p90 -146.04 175.78 10.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.676 0.274 . . . . 1.0 110.734 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 5.3 t -99.9 133.45 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.598 0.713 . . . . 1.0 111.965 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.65 179.79 7.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 114.81 -1.086 . . . . 1.0 109.5 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.02 -17.96 64.57 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.95 0.405 . . . . 1.0 111.325 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -107.55 21.8 16.93 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.909 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 70.46 36.15 1.79 Allowed 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 111.121 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 11.5 mttt -109.91 143.93 39.12 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.452 -0.794 . . . . 1.0 111.185 -176.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.77 106.09 18.12 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-N 114.222 -1.354 . . . . 1.0 109.567 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 18.6 mtm105 -118.3 178.04 4.59 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.027 -0.988 . . . . 1.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.537 ' HB3' HG22 ' B' ' 208' ' ' VAL . 52.4 p-90 -147.8 167.33 25.01 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.459 0.647 . . . . 1.0 111.979 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -146.25 146.5 30.78 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.422 -1.263 . . . . 1.0 110.432 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.75 ' HG ' HD12 ' B' ' 228' ' ' LEU . 33.7 tp -105.53 130.69 53.54 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.581 -1.266 . . . . 1.0 107.581 174.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.5 t -129.06 132.96 66.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.919 -175.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.565 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.5 t-80 -82.93 173.76 11.52 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.292 -0.632 . . . . 1.0 109.292 177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -55.87 -36.87 68.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.08 0.467 . . . . 1.0 110.698 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -63.2 -32.96 74.49 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.296 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 108.22 11.22 24.36 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 114.769 -1.105 . . . . 1.0 112.45 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.565 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.57 143.2 27.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.789 -0.206 . . . . 1.0 111.359 179.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.462 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.37 116.39 22.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.825 -0.625 . . . . 1.0 109.53 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.75 HD12 ' HG ' ' B' ' 220' ' ' LEU . 17.0 mt -88.73 -42.8 11.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.019 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -149.52 168.31 23.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.054 -0.975 . . . . 1.0 111.625 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -141.67 156.3 45.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.671 -1.15 . . . . 1.0 109.09 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . . . . . . . . . 66.0 p -54.37 -35.14 62.48 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.0 0.37 . . . . 1.0 112.0 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 85.74 -33.68 3.47 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.045 -0.598 . . . . 1.0 111.761 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -122.89 178.57 4.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.027 0.441 . . . . 1.0 111.174 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -143.01 137.43 7.67 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.337 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -140.01 166.71 23.91 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.814 -0.439 . . . . 1.0 109.814 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -91.3 10.02 29.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.88 0.696 . . . . 1.0 112.88 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.8 m -126.26 131.84 51.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.325 0.583 . . . . 1.0 111.347 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -63.17 -35.93 81.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.034 -0.985 . . . . 1.0 110.246 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.495 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.5 tt0 -57.86 -47.22 83.35 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.263 -0.88 . . . . 1.0 110.251 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -59.9 -40.43 88.76 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.124 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.52 74.57 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.587 0.708 . . . . 1.0 109.533 177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.499 ' HA ' HD12 ' B' ' 245' ' ' ILE . 49.3 mtmt -64.38 -35.54 81.24 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.941 -1.027 . . . . 1.0 111.528 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.495 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.2 mm-40 -64.22 -31.24 72.37 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.79 -41.11 95.86 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.499 HD12 ' HA ' ' B' ' 242' ' ' LYS . 65.6 mt -62.4 -43.86 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.064 -0.568 . . . . 1.0 110.278 177.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -62.9 -41.58 99.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.193 0.52 . . . . 1.0 110.141 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 47.7 m -64.38 -34.36 77.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.52 -0.763 . . . . 1.0 110.981 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.5 OUTLIER -74.48 -41.33 49.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.968 -177.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.6 mtpt -66.89 -11.86 57.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.035 0.445 . . . . 1.0 111.798 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.53 -2.92 31.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.905 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -135.36 -42.74 0.7 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 112.77 0.656 . . . . 1.0 112.77 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.552 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -53.64 -48.34 93.51 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -177.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 36.1 Cg_endo -64.23 -10.6 24.18 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.036 1.158 . . . . 1.0 113.079 -177.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -118.49 -22.12 7.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.373 0.508 . . . . 1.0 112.373 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -65.95 134.88 53.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 121.654 0.74 . . . . 1.0 112.736 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.47 142.08 29.75 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.423 -1.262 . . . . 1.0 110.691 178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.54 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.5 p -89.13 134.18 29.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 112.785 0.661 . . . . 1.0 112.785 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.8 mt -112.23 139.74 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 114.662 -1.154 . . . . 1.0 108.695 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.0 100.24 12.77 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.311 -0.852 . . . . 1.0 110.984 -177.783 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.8 ppp? . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 112.187 0.44 . . . . 1.0 112.187 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -107.54 170.55 7.9 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.223 0.535 . . . . 1.0 111.905 -176.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 2.5 mptp? -123.34 95.11 4.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 107.166 -1.42 . . . . 1.0 107.166 173.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.76 174.86 2.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.03 -0.987 . . . . 1.0 108.979 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -170.29 147.88 3.15 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.573 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 58.3 m-85 -86.15 150.18 24.59 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.258 177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -141.46 121.46 13.69 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.413 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 118' ' ' TRP . 85.3 t -93.67 133.87 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.716 -0.674 . . . . 1.0 110.068 -179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -144.77 178.49 7.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.633 0.254 . . . . 1.0 110.414 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -100.53 136.79 30.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.772 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -83.03 -178.97 7.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.583 -0.735 . . . . 1.0 110.326 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.31 -13.01 62.15 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.651 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -113.14 19.58 17.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.962 -177.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 71.0 38.25 1.14 Allowed 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.275 -0.875 . . . . 1.0 111.182 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 3.1 mmtp -108.91 153.29 23.76 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.804 -1.089 . . . . 1.0 111.219 -175.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -95.01 118.14 31.33 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.232 -0.895 . . . . 1.0 109.666 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 74.8 mtp180 -133.59 -179.03 5.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.107 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.504 ' HB3' HG22 ' A' ' 108' ' ' VAL . 58.7 p-90 -151.31 162.1 41.52 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.884 0.373 . . . . 1.0 111.455 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.45 HH21 HG13 ' A' ' 127' ' ' ILE . 36.3 mmm-85 -144.37 139.91 28.74 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.573 -0.74 . . . . 1.0 109.725 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.722 ' HG ' HD12 ' A' ' 128' ' ' LEU . 33.4 tp -96.94 131.44 43.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.209 -1.034 . . . . 1.0 108.209 176.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.0 t -131.07 132.34 63.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.054 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' CB ' HD21 ' A' ' 126' ' ' ASN . 4.4 t-80 -78.31 172.9 12.92 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 178.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 30.3 t70 -57.95 -30.93 66.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.207 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.14 -33.68 67.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.812 -0.631 . . . . 1.0 109.94 -177.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.03 13.84 10.59 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.244 -0.889 . . . . 1.0 113.836 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.525 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.2 OUTLIER -87.85 143.68 27.0 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 122.075 0.15 . . . . 1.0 110.717 177.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.45 HG13 HH21 ' A' ' 119' ' ' ARG . 44.6 mm -76.36 115.13 17.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.646 -0.501 . . . . 1.0 109.646 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.722 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.1 mt -88.4 -42.25 12.29 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.789 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.504 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -153.05 170.53 20.23 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.283 -0.871 . . . . 1.0 111.582 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -143.22 156.7 44.81 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.962 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 13.3 p -53.52 -36.43 61.77 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 123.416 0.447 . . . . 1.0 111.896 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.76 -43.54 3.25 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.529 -0.628 . . . . 1.0 111.529 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.477 ' HG3' ' HB ' ' B' ' 227' ' ' ILE . 89.2 mt-10 -108.88 179.93 4.04 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.293 -0.454 . . . . 1.0 110.826 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -152.86 134.54 4.51 Favored Glycine 0 N--CA 1.451 -0.329 0 N-CA-C 111.283 -0.727 . . . . 1.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -142.88 170.94 14.76 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 117.077 0.439 . . . . 1.0 110.637 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.66 10.06 24.65 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.7 m -118.63 131.11 56.18 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.362 0.601 . . . . 1.0 111.478 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -65.87 -33.67 76.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.997 -1.002 . . . . 1.0 109.803 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 9.0 tt0 -61.33 -48.48 81.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.125 -0.943 . . . . 1.0 109.971 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -56.82 -40.49 76.13 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.982 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.18 -53.38 58.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.239 0.543 . . . . 1.0 110.217 177.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 145' ' ' ILE . 41.7 mtmt -63.82 -36.72 84.84 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.672 -0.695 . . . . 1.0 111.238 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 24.8 mm-40 -63.79 -28.8 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.021 -0.363 . . . . 1.0 110.021 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.51 96.74 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.551 HG21 HG22 ' B' ' 257' ' ' VAL . 40.4 mt -64.11 -44.6 97.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.208 0.528 . . . . 1.0 110.133 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -60.34 -43.99 95.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.941 0.401 . . . . 1.0 110.149 178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 47.4 m -64.37 -33.82 76.74 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.719 -0.673 . . . . 1.0 110.724 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' B' ' 229' ' ' ALA . 0.3 OUTLIER -74.43 -41.86 49.72 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 C-N-CA 120.151 -0.62 . . . . 1.0 109.822 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -68.74 -11.57 60.46 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.085 0.469 . . . . 1.0 111.588 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -101.25 -3.14 29.54 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.928 -177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' B' ' 204' ' ' ALA . 23.0 m-80 -138.07 -38.63 0.56 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -176.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.42 -49.92 89.73 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -176.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 54.3 Cg_endo -67.57 -9.52 25.67 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 120.906 1.071 . . . . 1.0 112.95 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -109.8 -28.68 8.67 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.445 0.641 . . . . 1.0 110.927 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.08 135.8 57.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.873 -1.058 . . . . 1.0 113.671 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -96.59 140.65 30.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.064 -1.426 . . . . 1.0 110.716 177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.557 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.58 133.11 31.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.352 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.3 mt -118.21 139.24 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 114.766 -1.106 . . . . 1.0 108.933 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -88.16 106.04 17.92 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.533 -0.746 . . . . 1.0 111.164 -177.349 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.1 ppp? . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 111.602 0.223 . . . . 1.0 111.602 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -94.64 167.24 11.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.339 0.59 . . . . 1.0 111.512 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.494 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 32.4 mmtp -136.98 97.88 3.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.002 -1.11 . . . . 1.0 108.002 174.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 151' ' ' ASN . . . -174.31 169.19 3.87 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 114.86 -1.064 . . . . 1.0 109.183 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.479 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 55.8 p-80 -171.34 149.1 2.7 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.557 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 61.8 m-85 -85.34 148.06 26.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.299 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -139.57 118.83 12.78 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.482 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' B' ' 218' ' ' TRP . 82.3 t -93.92 133.23 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.7 -0.682 . . . . 1.0 109.677 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -145.36 -178.4 6.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.648 0.261 . . . . 1.0 110.555 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.8 t -99.8 137.43 27.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.828 -0.623 . . . . 1.0 112.238 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -83.07 179.78 7.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 1.0 109.565 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.31 -16.36 63.92 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.473 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -109.49 19.84 18.85 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.182 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . 0.404 ' HA ' HG13 ' B' ' 210' ' ' VAL . 24.4 m-20 69.28 41.26 1.37 Allowed 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.256 -0.884 . . . . 1.0 110.857 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 3.2 mmtp -110.95 156.51 21.1 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.653 -1.158 . . . . 1.0 110.266 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -99.82 117.03 33.27 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.854 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 20.6 mtp-105 -132.42 179.11 6.32 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.301 -1.0 . . . . 1.0 108.301 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.527 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.7 p-90 -151.72 163.66 38.66 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.079 0.466 . . . . 1.0 111.649 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -147.29 145.96 29.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.05 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.725 ' HG ' HD12 ' B' ' 228' ' ' LEU . 34.0 tp -96.28 131.85 42.36 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.553 -1.277 . . . . 1.0 107.553 175.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 11.1 t -131.19 133.79 62.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 116.734 -0.212 . . . . 1.0 110.738 -176.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.596 ' CB ' HD21 ' B' ' 226' ' ' ASN . 5.5 t-80 -79.77 171.31 15.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.485 -0.931 . . . . 1.0 108.485 177.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.494 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 36.6 t70 -62.54 -22.18 66.12 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.152 0.501 . . . . 1.0 110.851 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.34 -33.21 67.14 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.521 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.85 11.26 19.4 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 114.791 -1.095 . . . . 1.0 112.86 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.596 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.27 142.92 27.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.655 0.264 . . . . 1.0 111.572 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.477 ' HB ' ' HG3' ' A' ' 133' ' ' GLU . 51.2 mm -78.55 116.81 22.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.84 -0.618 . . . . 1.0 109.491 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.725 HD12 ' HG ' ' B' ' 220' ' ' LEU . 16.0 mt -89.58 -42.53 11.36 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.584 -0.734 . . . . 1.0 109.638 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.521 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.18 164.97 35.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.845 -1.071 . . . . 1.0 111.597 177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -140.67 153.37 45.96 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.083 -0.962 . . . . 1.0 109.238 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.443 ' HB3' ' CD1' ' B' ' 218' ' ' TRP . 18.6 p -52.88 -36.9 59.87 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.315 0.487 . . . . 1.0 112.315 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 88.03 -47.31 3.51 Favored Glycine 0 N--CA 1.452 -0.247 0 N-CA-C 111.534 -0.626 . . . . 1.0 111.534 -178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -96.74 -172.86 2.57 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.265 -0.468 . . . . 1.0 111.25 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . . . . . . . . . . . -159.05 133.86 3.55 Favored Glycine 0 N--CA 1.454 -0.16 0 N-CA-C 111.13 -0.788 . . . . 1.0 111.13 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -145.07 169.85 17.34 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 116.93 0.365 . . . . 1.0 110.338 -176.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -95.38 9.11 41.13 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.708 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 m -116.0 129.53 56.41 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.425 0.631 . . . . 1.0 110.928 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -66.97 -34.5 77.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.951 -1.022 . . . . 1.0 110.364 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 9.3 tt0 -61.12 -46.12 91.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.694 -0.685 . . . . 1.0 110.255 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.66 -40.55 83.82 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.788 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.18 -51.11 70.62 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.482 0.658 . . . . 1.0 110.127 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.509 ' HA ' HD12 ' B' ' 245' ' ' ILE . 47.4 mtmt -64.6 -37.0 86.07 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.299 -0.864 . . . . 1.0 111.91 -179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -64.05 -29.58 70.71 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -64.97 -41.37 97.37 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.462 -1.055 . . . . 1.0 110.462 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.509 HD12 ' HA ' ' B' ' 242' ' ' LYS . 56.8 mt -62.48 -45.27 99.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.491 0.662 . . . . 1.0 110.193 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -63.06 -40.11 96.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.028 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 49.3 m -65.62 -35.39 80.67 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.633 178.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.555 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -75.3 -39.96 42.58 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 C-N-CA 120.338 -0.545 . . . . 1.0 111.069 -176.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 63.8 mtpt -66.79 -12.51 59.14 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 111.987 0.365 . . . . 1.0 111.987 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 54.8 ttt85 -100.27 -12.12 19.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.843 -179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -120.97 -40.14 2.65 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 116.103 -0.499 . . . . 1.0 112.18 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.0 -48.94 94.78 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 112.7 0.63 . . . . 1.0 112.7 -177.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 41.5 Cg_endo -66.87 -11.69 33.09 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.276 1.317 . . . . 1.0 113.399 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -116.0 -16.76 11.05 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.228 0.455 . . . . 1.0 112.228 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . . . . . . . . . . . -69.22 139.05 54.49 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 112.805 0.669 . . . . 1.0 112.805 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -94.88 147.41 23.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.666 -1.152 . . . . 1.0 111.99 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 145' ' ' ILE . 40.9 t -84.39 130.45 35.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.438 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.2 mt -128.85 142.47 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.541 -0.541 . . . . 1.0 109.541 176.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -86.9 113.17 22.46 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.989 -0.745 . . . . 1.0 108.989 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.203 -0.903 . . . . 1.0 110.843 -177.838 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.436 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.1 tmt? . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.06 -0.019 . . . . 1.0 110.968 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 101' ' ' MET . 12.6 p-10 171.03 168.65 0.08 Allowed 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 124.117 0.886 . . . . 1.0 109.942 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 38.7 mmtm -145.28 96.36 2.82 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.451 -0.944 . . . . 1.0 108.451 173.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' B' ' 251' ' ' ASN . . . -176.13 176.44 1.73 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.01 -0.996 . . . . 1.0 109.533 -179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.504 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 51.9 p-80 -170.23 145.42 2.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.913 -0.585 . . . . 1.0 109.439 177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 55.1 m-85 -85.51 147.61 26.36 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.998 -0.546 . . . . 1.0 111.146 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -139.68 119.97 13.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.592 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 118' ' ' TRP . 86.1 t -95.21 132.27 39.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.413 -0.812 . . . . 1.0 109.164 178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 11.2 p90 -143.14 178.08 7.95 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.186 -0.301 . . . . 1.0 110.186 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 4.1 t -97.82 134.18 37.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.215 0.531 . . . . 1.0 111.562 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.22 -180.0 7.06 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.228 -0.896 . . . . 1.0 109.529 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.51 -15.3 63.49 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.942 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.63 21.47 16.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 1.0 111.713 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 69.75 35.85 2.25 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.626 0.77 . . . . 1.0 111.506 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -110.84 149.55 30.42 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.757 -0.656 . . . . 1.0 110.881 -176.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -91.63 112.0 23.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.801 -1.09 . . . . 1.0 109.537 -179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.481 HH12 ' CG ' ' A' ' 130' ' ' ASP . 19.2 mtm105 -126.8 179.92 5.13 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.541 ' HB3' HG22 ' A' ' 108' ' ' VAL . 55.8 p-90 -152.1 162.11 41.61 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.187 178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 42.6 mtp180 -148.23 143.66 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.907 -1.042 . . . . 1.0 109.146 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.662 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.7 tp -93.62 134.39 35.98 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.3 131.02 71.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.896 -176.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.592 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.9 t-80 -78.97 171.74 14.78 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.757 -0.831 . . . . 1.0 108.757 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 12.0 t70 -56.0 -33.59 65.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.003 0.43 . . . . 1.0 111.216 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.31 -34.34 77.77 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.13 -177.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.36 10.92 14.2 Favored Glycine 0 N--CA 1.453 -0.218 0 CA-C-N 115.124 -0.944 . . . . 1.0 113.09 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.592 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -90.22 145.84 24.71 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.52 0.192 . . . . 1.0 111.52 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.5 123.55 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 123.778 0.674 . . . . 1.0 109.926 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.662 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.1 mt -98.07 -43.47 7.03 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.573 -0.74 . . . . 1.0 110.067 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.502 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -147.7 164.58 33.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.983 -1.008 . . . . 1.0 111.336 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.481 ' CG ' HH12 ' A' ' 117' ' ' ARG . 6.8 t70 -139.7 152.82 46.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.246 -0.888 . . . . 1.0 108.86 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.7 p -56.32 -38.41 71.26 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.31 0.485 . . . . 1.0 112.31 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 85.43 -42.66 3.17 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -94.52 172.14 8.37 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.152 -0.524 . . . . 1.0 111.461 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -155.63 124.67 1.52 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.747 -0.941 . . . . 1.0 110.747 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -142.05 171.05 14.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.714 0.257 . . . . 1.0 110.742 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -88.43 10.24 20.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.265 0.839 . . . . 1.0 113.265 -176.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 5.8 m -120.0 130.71 54.86 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.529 0.68 . . . . 1.0 111.636 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.52 -35.41 80.8 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.485 -1.234 . . . . 1.0 110.333 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.5 tt0 -62.02 -45.96 91.3 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.619 -0.719 . . . . 1.0 110.484 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -59.9 -39.15 84.4 Favored 'General case' 0 CA--C 1.521 -0.163 0 O-C-N 123.2 0.313 . . . . 1.0 110.883 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.7 -51.48 69.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.604 0.716 . . . . 1.0 109.786 176.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.538 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.0 mtmt -64.91 -33.77 76.82 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.22 -0.9 . . . . 1.0 111.561 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.444 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 25.7 mm-40 -65.64 -32.36 73.88 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.03 -0.359 . . . . 1.0 110.03 177.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.5 -39.87 97.2 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 111.126 -0.79 . . . . 1.0 111.126 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.552 HG21 HG22 ' B' ' 257' ' ' VAL . 67.4 mt -60.24 -51.49 72.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.529 0.681 . . . . 1.0 110.758 178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.83 -33.03 75.04 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.053 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 57.5 m -66.03 -37.64 86.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.535 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' B' ' 229' ' ' ALA . 1.1 p -74.42 -40.0 48.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 120.399 -0.521 . . . . 1.0 109.846 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -64.61 -15.77 61.67 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.958 0.408 . . . . 1.0 111.871 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -100.1 -2.48 34.13 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.897 -0.592 . . . . 1.0 110.916 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' B' ' 202' ' ' ASN . 11.8 m-80 -133.74 -37.08 0.93 Allowed 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 116.313 -0.403 . . . . 1.0 111.903 -177.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.529 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.85 -50.47 86.97 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.94 -0.573 . . . . 1.0 112.365 -178.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 37.7 Cg_endo -64.44 -12.07 31.44 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 121.29 1.327 . . . . 1.0 113.419 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.13 -18.58 9.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.179 0.437 . . . . 1.0 112.179 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.47 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -66.03 135.71 55.04 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.484 0.659 . . . . 1.0 112.337 -177.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -88.78 132.39 34.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.585 -1.189 . . . . 1.0 110.919 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.538 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -87.41 130.79 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.462 0.648 . . . . 1.0 111.698 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt -120.32 145.84 26.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.474 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -89.39 102.39 15.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.263 -0.643 . . . . 1.0 109.263 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.606 -0.712 . . . . 1.0 110.549 -177.535 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 29.3 ttp . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.29 -0.263 . . . . 1.0 110.29 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 151' ' ' ASN . 21.1 p-10 -178.69 171.85 1.45 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.515 0.674 . . . . 1.0 112.323 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -138.92 96.32 3.1 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.093 -1.817 . . . . 1.0 106.093 172.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.81 175.69 2.35 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.638 -1.165 . . . . 1.0 108.612 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.47 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.5 p-80 -170.04 146.99 3.16 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 121.054 -0.259 . . . . 1.0 110.575 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.538 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 46.8 m-85 -87.11 146.69 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.479 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -141.65 121.4 13.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.856 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' B' ' 218' ' ' TRP . 96.3 t -94.27 133.03 36.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.619 -0.719 . . . . 1.0 109.767 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -144.48 -179.55 6.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.572 0.225 . . . . 1.0 110.582 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.7 t -96.14 133.48 37.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.138 -0.483 . . . . 1.0 112.232 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -81.74 178.34 8.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.713 -0.676 . . . . 1.0 109.928 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -70.37 -6.92 38.89 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.314 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -115.28 17.91 16.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.995 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 69.57 39.19 1.6 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.338 -0.846 . . . . 1.0 110.94 177.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 13.2 mmtt -111.04 156.88 20.64 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.121 -0.945 . . . . 1.0 111.217 -175.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.464 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 70.6 m-85 -98.74 102.53 14.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.799 -177.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.581 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 14.9 mmm180 -121.5 179.82 4.33 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 109.54 -0.541 . . . . 1.0 109.54 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.518 ' HB3' HG22 ' B' ' 208' ' ' VAL . 51.5 p-90 -150.94 160.48 43.89 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.697 -0.401 . . . . 1.0 111.802 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 12.0 mtp180 -145.95 146.35 31.01 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.091 -0.959 . . . . 1.0 109.666 177.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.705 ' HG ' HD12 ' B' ' 228' ' ' LEU . 32.1 tp -95.78 132.63 40.81 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 t -127.41 130.12 70.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.354 -176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.524 ' CB ' HD21 ' B' ' 226' ' ' ASN . 1.9 t-80 -82.51 173.66 11.78 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 109.593 -0.521 . . . . 1.0 109.593 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -54.26 -36.34 63.51 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 123.38 0.425 . . . . 1.0 111.913 177.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -65.08 -31.12 72.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.22 0.533 . . . . 1.0 110.365 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 106.31 13.86 21.77 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.375 -0.829 . . . . 1.0 112.41 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.524 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -89.41 142.08 27.98 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 111.789 0.292 . . . . 1.0 111.789 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 50.1 mm -73.53 121.73 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 O-C-N 123.882 0.739 . . . . 1.0 109.564 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.705 HD12 ' HG ' ' B' ' 220' ' ' LEU . 14.5 mt -96.92 -43.8 7.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.709 -0.678 . . . . 1.0 110.228 -178.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.532 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -150.83 163.88 37.57 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.184 -0.916 . . . . 1.0 111.419 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -139.38 160.07 40.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.887 -1.052 . . . . 1.0 109.383 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.468 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 83.6 p -60.24 -40.71 91.22 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.904 0.705 . . . . 1.0 112.904 -179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 92.52 -48.38 2.59 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 121.285 -0.483 . . . . 1.0 112.669 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -94.75 -169.78 2.09 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 123.231 0.612 . . . . 1.0 110.936 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.581 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -156.75 136.43 4.95 Favored Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.715 -0.755 . . . . 1.0 113.289 176.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -143.92 168.66 19.43 Favored 'General case' 0 C--N 1.344 0.365 0 N-CA-C 109.396 -0.594 . . . . 1.0 109.396 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -97.49 11.43 36.81 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.268 0.84 . . . . 1.0 113.268 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.7 m -127.0 135.02 50.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 120.207 -0.597 . . . . 1.0 111.742 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -62.14 -39.6 93.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.268 -0.878 . . . . 1.0 111.148 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.47 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.0 tt0 -57.65 -45.72 85.15 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.287 -178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -60.94 -39.53 89.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.787 -178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' B' ' 216' ' ' TYR . . . -58.2 -49.7 76.12 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.472 0.653 . . . . 1.0 110.231 177.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.565 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -64.81 -32.8 74.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.112 -0.949 . . . . 1.0 111.47 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 28.8 mm-40 -63.6 -33.02 74.69 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.588 -0.445 . . . . 1.0 109.916 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -66.04 -40.78 95.31 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' B' ' 242' ' ' LYS . 75.9 mt -60.73 -52.36 62.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.664 0.745 . . . . 1.0 110.258 177.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -64.29 -33.97 77.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.264 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 63.4 m -67.61 -35.9 79.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.511 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.548 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.8 OUTLIER -72.49 -40.47 63.53 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.373 -177.676 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -64.59 -15.45 61.13 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.121 -0.49 . . . . 1.0 112.187 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -103.35 -2.75 26.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.866 0.365 . . . . 1.0 111.3 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 104' ' ' ALA . 28.6 m-80 -130.46 -38.37 1.35 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.906 0.384 . . . . 1.0 111.452 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.548 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.86 -50.49 86.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.462 -0.79 . . . . 1.0 112.681 -178.145 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 34.5 Cg_endo -63.24 -10.98 23.1 Favored 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.273 1.315 . . . . 1.0 113.663 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.11 -15.92 9.82 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.963 0.411 . . . . 1.0 111.938 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.504 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -67.22 138.65 57.1 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.68 0.752 . . . . 1.0 112.633 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -89.21 141.68 28.31 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 114.591 -1.186 . . . . 1.0 111.938 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 145' ' ' ILE . 60.6 t -83.74 128.66 38.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.477 -0.783 . . . . 1.0 111.432 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 12.3 mt -121.71 138.14 52.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 176.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -91.74 100.87 13.5 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.415 -0.957 . . . . 1.0 108.415 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.303 -0.856 . . . . 1.0 111.675 -176.699 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 28.9 ttp . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.904 0.383 . . . . 1.0 111.455 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -92.94 -174.42 3.58 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 122.321 1.058 . . . . 1.0 113.579 -174.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 28.8 mmtp -138.25 98.19 3.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.987 -1.915 . . . . 1.0 107.461 173.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -174.1 169.89 3.87 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.375 -0.83 . . . . 1.0 109.573 -178.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.466 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 56.6 p-80 -168.22 150.34 5.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.233 -178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.513 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 63.7 m-85 -86.73 148.95 25.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.906 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -142.27 123.83 14.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.785 177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 118' ' ' TRP . 91.1 t -94.75 134.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 O-C-N 123.585 0.553 . . . . 1.0 110.475 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -142.78 178.61 7.53 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.608 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.2 t -100.67 140.24 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 121.478 0.656 . . . . 1.0 112.689 -178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -81.83 177.87 8.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.126 -0.943 . . . . 1.0 109.416 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.57 -14.36 62.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.362 177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -107.01 17.89 22.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.438 -0.801 . . . . 1.0 111.11 -178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 70.82 34.77 1.91 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.389 -0.823 . . . . 1.0 111.377 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 11.1 mttt -109.7 152.99 24.91 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.938 -0.574 . . . . 1.0 111.507 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -91.72 112.11 23.9 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.016 -0.993 . . . . 1.0 110.612 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -123.18 179.28 4.75 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.102 -1.073 . . . . 1.0 108.102 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.524 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.6 p-90 -153.02 168.47 25.74 Favored 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.366 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 118' ' ' TRP . 22.6 mtt180 -150.76 152.28 33.61 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.079 -0.964 . . . . 1.0 110.508 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.681 ' HG ' HD12 ' A' ' 128' ' ' LEU . 32.9 tp -99.84 131.23 45.94 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.048 -1.093 . . . . 1.0 108.048 176.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.8 t -126.54 130.48 71.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.289 -176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.599 ' CB ' HD21 ' A' ' 126' ' ' ASN . 2.4 t-80 -79.67 172.35 13.91 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.707 -0.849 . . . . 1.0 108.707 177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 32.2 t70 -57.22 -30.98 65.03 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 1.0 111.342 177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -67.66 -33.37 74.8 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.504 0.669 . . . . 1.0 110.07 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.38 11.74 19.06 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 114.982 -1.008 . . . . 1.0 112.789 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.599 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -88.59 143.51 26.9 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.959 0.355 . . . . 1.0 111.959 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.67 119.07 22.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.802 0.689 . . . . 1.0 109.744 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.681 HD12 ' HG ' ' A' ' 120' ' ' LEU . 15.0 mt -94.41 -43.31 8.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.63 0.729 . . . . 1.0 109.608 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.73 166.61 27.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.641 -1.163 . . . . 1.0 111.201 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -140.14 158.19 44.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.405 -0.961 . . . . 1.0 108.405 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 53.9 p -57.44 -35.23 69.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.448 . . . . 1.0 111.452 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 88.7 -48.62 3.54 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.319 -1.112 . . . . 1.0 110.319 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -102.87 171.8 7.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.374 -0.913 . . . . 1.0 111.648 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -141.04 139.06 9.29 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 110.236 -1.145 . . . . 1.0 110.236 177.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -141.53 169.46 17.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.175 0.488 . . . . 1.0 110.852 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.57 9.98 27.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.93 0.715 . . . . 1.0 112.93 -176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.1 m -125.82 130.53 51.59 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.727 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 21.2 ptmt -65.88 -36.85 84.57 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.104 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.457 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 10.0 tt0 -59.41 -42.14 91.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.504 -0.771 . . . . 1.0 109.962 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.576 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.4 OUTLIER -62.62 -39.78 94.89 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.005 -179.053 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.83 -46.33 87.93 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.962 0.411 . . . . 1.0 109.957 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' A' ' 145' ' ' ILE . 7.3 mtmp? -63.86 -43.19 96.86 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.117 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 32.8 mm-40 -60.01 -27.05 66.56 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 109.59 -0.522 . . . . 1.0 109.59 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -64.69 -46.32 90.22 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.517 ' O ' HG12 ' A' ' 148' ' ' VAL . 61.1 mt -62.51 -48.82 86.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.946 0.879 . . . . 1.0 109.938 176.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.53 -40.04 90.06 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.287 -0.869 . . . . 1.0 110.857 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 49.5 m -69.93 -34.55 73.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.213 177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.582 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -70.5 -39.13 75.84 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.599 0 C-N-CA 120.08 -0.648 . . . . 1.0 110.033 -176.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -67.79 -12.98 61.71 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 121.975 -0.453 . . . . 1.0 111.516 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -104.69 -3.1 24.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.656 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -129.87 -42.76 1.25 Allowed 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.305 -0.407 . . . . 1.0 112.068 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.582 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -55.06 -50.94 83.58 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 112.769 0.655 . . . . 1.0 112.769 -177.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 36.9 Cg_endo -64.48 -13.15 36.9 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 121.129 1.219 . . . . 1.0 112.952 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.2 -27.56 9.5 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.324 0.583 . . . . 1.0 111.23 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -63.91 134.83 55.86 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.071 -0.968 . . . . 1.0 113.207 -176.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.25 141.02 31.68 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.982 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' B' ' 206' ' ' PHE . 1.4 p -86.99 135.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.527 0.679 . . . . 1.0 112.344 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 9.9 mt -124.19 148.87 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.7 -1.136 . . . . 1.0 109.241 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -88.09 110.67 20.82 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.942 -0.762 . . . . 1.0 108.942 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.321 -0.847 . . . . 1.0 111.357 -177.191 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.933 0.396 . . . . 1.0 111.497 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -95.62 178.78 5.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.931 0.872 . . . . 1.0 112.805 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . 0.529 ' HB3' ' HB2' ' B' ' 223' ' ' ASP . 22.7 mmtp -141.74 97.6 3.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.68 -1.6 . . . . 1.0 108.142 173.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -174.65 170.75 3.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.147 -0.933 . . . . 1.0 109.679 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.423 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 55.1 p-80 -170.01 147.79 3.32 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 63.0 m-85 -85.62 150.71 24.44 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 123.332 0.395 . . . . 1.0 110.383 178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -143.09 124.3 14.56 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.862 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.488 HG22 ' HB3' ' B' ' 218' ' ' TRP . 78.2 t -95.08 133.54 35.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.823 -0.626 . . . . 1.0 109.937 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -140.8 -178.21 5.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.561 -0.29 . . . . 1.0 110.663 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.5 t -110.89 137.72 42.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.358 0.503 . . . . 1.0 112.358 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' B' ' 212' ' ' ALA . 25.4 t70 -83.25 -178.77 7.2 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.47 -0.786 . . . . 1.0 109.583 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . 0.41 ' H ' ' CG ' ' B' ' 211' ' ' ASP . . . -68.63 -17.92 64.2 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.954 -179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -108.85 25.62 11.55 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.271 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 62.07 38.96 13.57 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.859 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 33.1 mmtp -97.44 155.53 16.88 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.469 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 73.4 m-85 -109.05 102.92 11.86 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.311 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.568 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -122.54 -178.56 3.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -176.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.488 ' HB3' HG22 ' B' ' 208' ' ' VAL . 54.8 p-90 -151.29 162.83 40.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.768 0.318 . . . . 1.0 111.384 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . . . . . . . . . 10.0 mtp180 -147.56 146.71 29.53 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.211 -0.904 . . . . 1.0 109.863 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.677 ' HG ' HD12 ' B' ' 228' ' ' LEU . 35.2 tp -93.86 132.68 38.05 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.232 -1.025 . . . . 1.0 108.232 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 17.5 t -126.92 129.88 71.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.66 -175.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.576 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.4 t-80 -80.04 174.54 11.49 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.9 -0.778 . . . . 1.0 108.9 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' B' ' 203' ' ' LYS . 26.7 t70 -55.93 -34.34 65.54 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.018 0.437 . . . . 1.0 111.46 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -65.96 -33.65 76.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.646 0.736 . . . . 1.0 110.324 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 110.01 10.7 22.1 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 114.967 -1.015 . . . . 1.0 112.469 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.576 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -87.02 143.49 27.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.593 0.235 . . . . 1.0 111.626 179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.7 mm -76.29 119.81 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.656 -0.702 . . . . 1.0 109.665 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.677 HD12 ' HG ' ' B' ' 220' ' ' LEU . 15.5 mt -94.19 -44.14 8.12 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.255 -0.884 . . . . 1.0 109.987 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -147.79 160.78 42.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.711 -1.131 . . . . 1.0 111.02 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -137.07 158.83 43.56 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.729 -0.841 . . . . 1.0 108.729 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.471 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 71.7 p -57.63 -37.37 73.19 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.49 0.552 . . . . 1.0 112.49 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 89.51 -50.56 3.55 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-O 121.184 0.325 . . . . 1.0 112.691 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -89.86 -168.67 2.2 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.409 0.684 . . . . 1.0 110.863 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.568 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -158.98 134.4 3.76 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.55 -0.833 . . . . 1.0 113.4 175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -143.46 173.73 11.37 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -98.56 12.31 35.61 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.287 1.217 . . . . 1.0 114.287 -175.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 5.2 m -131.03 135.69 47.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.934 -0.706 . . . . 1.0 111.842 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.84 -39.65 95.02 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.581 -0.736 . . . . 1.0 111.032 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.6 tt0 -56.52 -44.01 80.37 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.494 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . 0.584 ' HA ' ' HE3' ' B' ' 240' ' ' LYS . 1.3 tpmt? -60.32 -39.22 86.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.11 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.99 -46.72 87.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.531 177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.527 ' HA ' HD12 ' B' ' 245' ' ' ILE . 6.9 mtmp? -64.98 -37.78 88.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.765 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.428 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 29.7 mm-40 -63.37 -28.04 69.72 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.13 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -69.46 -41.2 77.99 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.475 -0.869 . . . . 1.0 111.006 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' B' ' 242' ' ' LYS . 72.6 mt -60.19 -48.59 87.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.9 0.857 . . . . 1.0 110.483 177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.49 -35.95 82.14 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.288 -0.869 . . . . 1.0 110.756 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 54.9 m -67.07 -37.1 83.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.402 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.543 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.6 OUTLIER -72.55 -41.66 63.63 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.706 0 C-N-CA 120.001 -0.68 . . . . 1.0 109.593 -177.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -66.24 -13.63 60.66 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 122.125 -0.359 . . . . 1.0 111.585 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 53.3 ttt180 -103.73 -2.64 26.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.839 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -130.85 -40.46 1.19 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.099 -0.5 . . . . 1.0 111.993 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.543 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -55.34 -50.53 86.16 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 113.164 0.801 . . . . 1.0 113.164 -176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 35.6 Cg_endo -64.92 -16.6 56.21 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.208 1.272 . . . . 1.0 112.905 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.69 -29.8 11.7 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.588 0.709 . . . . 1.0 111.146 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -63.92 141.05 58.91 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 114.201 1.186 . . . . 1.0 114.201 -175.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -103.47 146.38 28.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.096 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 106' ' ' PHE . 1.4 p -93.27 132.05 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 mt -120.64 150.6 23.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.187 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -85.02 108.16 17.48 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.66 -0.496 . . . . 1.0 109.66 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.439 -0.791 . . . . 1.0 111.328 -177.715 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 1.5 tmt? . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.504 0.192 . . . . 1.0 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -70.64 165.87 21.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.165 0.507 . . . . 1.0 111.877 -176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 123' ' ' ASP . 47.5 mmtm -134.49 95.98 3.49 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.478 -1.304 . . . . 1.0 107.478 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -176.39 179.19 1.23 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.107 -0.952 . . . . 1.0 109.085 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.464 ' HA ' ' HB1' ' B' ' 255' ' ' ALA . 24.7 p-80 -171.69 147.9 2.34 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 123.383 0.427 . . . . 1.0 110.066 177.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' B' ' 257' ' ' VAL . 59.1 m-85 -85.47 152.05 23.49 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.832 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -140.62 120.22 13.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.799 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 118' ' ' TRP . 99.0 t -97.6 134.67 34.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 O-C-N 123.516 0.51 . . . . 1.0 109.738 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -146.37 178.28 8.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 110.611 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 115' ' ' LYS . 3.8 t -99.39 134.12 39.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.145 -0.479 . . . . 1.0 111.455 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -81.55 179.85 7.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.769 -0.651 . . . . 1.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.58 -14.02 62.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.18 -0.464 . . . . 1.0 111.478 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -110.76 19.2 18.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.632 -177.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 70.91 36.42 1.49 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.742 0.651 . . . . 1.0 110.739 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 110' ' ' VAL . 12.1 mmtt -109.3 150.51 27.88 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.34 -0.846 . . . . 1.0 111.289 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -95.07 111.72 23.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.821 -1.081 . . . . 1.0 109.369 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.8 mtm105 -128.76 179.13 5.88 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.537 ' HB3' HG22 ' A' ' 108' ' ' VAL . 57.6 p-90 -150.63 166.5 30.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 1.0 111.977 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -146.82 149.24 32.93 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 114.868 -1.06 . . . . 1.0 110.213 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.681 ' HG ' HD12 ' A' ' 128' ' ' LEU . 34.1 tp -100.56 133.17 45.41 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.168 -1.049 . . . . 1.0 108.168 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 18.3 t -128.58 130.2 68.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.048 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.562 ' CB ' HD21 ' A' ' 126' ' ' ASN . 3.3 t-80 -76.47 170.45 16.36 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 103' ' ' LYS . 20.1 t70 -60.55 -24.18 65.19 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.116 0.484 . . . . 1.0 110.663 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -34.3 69.7 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.65 -0.705 . . . . 1.0 109.783 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 113.81 8.97 17.34 Favored Glycine 0 CA--C 1.519 0.292 0 CA-C-N 115.036 -0.983 . . . . 1.0 113.386 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.562 HD21 ' CB ' ' A' ' 122' ' ' HIS . 0.3 OUTLIER -89.62 143.36 26.87 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.1 0.408 . . . . 1.0 112.1 -179.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.6 mm -73.83 118.64 19.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.811 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.681 HD12 ' HG ' ' A' ' 120' ' ' LEU . 17.4 mt -94.13 -44.12 8.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.491 0.662 . . . . 1.0 109.818 -178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.443 ' HB2' HG21 ' B' ' 248' ' ' VAL . . . -150.56 165.1 34.33 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.737 -1.12 . . . . 1.0 111.285 179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.6 154.4 47.58 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.448 ' HB3' ' CD1' ' A' ' 118' ' ' TRP . 20.7 p -51.86 -40.75 61.09 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.389 0.514 . . . . 1.0 112.389 179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.39 -46.46 3.01 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -93.97 -178.84 4.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.091 0.472 . . . . 1.0 110.597 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -154.74 127.63 2.14 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 110.253 -1.139 . . . . 1.0 110.253 178.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -139.8 173.23 11.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.311 0.556 . . . . 1.0 110.075 -176.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -97.87 9.53 42.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.5 m -118.23 131.33 56.38 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.198 -0.601 . . . . 1.0 110.949 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -65.11 -38.4 90.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.379 -0.828 . . . . 1.0 110.819 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.413 ' O ' ' HG2' ' A' ' 143' ' ' GLN . 8.4 tt0 -63.33 -42.81 99.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.149 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.523 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.2 OUTLIER -58.07 -42.77 86.26 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.637 -0.71 . . . . 1.0 110.985 -177.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -58.9 -50.11 75.24 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.17 0.509 . . . . 1.0 110.524 177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.495 ' HA ' HD12 ' A' ' 145' ' ' ILE . 45.2 mtmt -63.8 -35.22 79.89 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.736 -0.666 . . . . 1.0 111.165 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.413 ' HG2' ' O ' ' A' ' 139' ' ' GLN . 29.0 mm-40 -65.09 -26.83 68.39 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.622 -0.51 . . . . 1.0 109.622 176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.14 -41.19 97.13 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.04 -1.224 . . . . 1.0 110.04 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.509 HG21 HG22 ' B' ' 257' ' ' VAL . 55.8 mt -63.11 -45.15 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 CA-C-O 121.194 0.521 . . . . 1.0 109.99 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -62.12 -38.28 88.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.093 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.8 m -65.3 -36.17 83.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.565 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.57 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.4 OUTLIER -74.88 -42.37 46.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 C-N-CA 120.313 -0.555 . . . . 1.0 110.474 -177.01 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -65.99 -15.32 62.91 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.287 0.477 . . . . 1.0 112.287 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -103.61 -2.04 27.27 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.536 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -131.87 -40.07 1.07 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.574 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB2' HG22 ' A' ' 148' ' ' VAL . . . -56.51 -50.41 87.9 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 115.89 -0.596 . . . . 1.0 112.606 -178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 152' ' ' ALA . 33.7 Cg_endo -63.4 -12.8 32.43 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 121.096 1.198 . . . . 1.0 113.162 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -111.97 -26.26 8.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.999 0.428 . . . . 1.0 111.574 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.539 ' HB1' ' HA ' ' B' ' 205' ' ' HIS . . . -62.4 137.99 58.36 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.0 112.698 -177.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -94.75 149.48 21.2 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.186 -1.37 . . . . 1.0 111.976 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.551 HG22 HG21 ' B' ' 245' ' ' ILE . 43.9 t -86.17 131.67 34.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.524 -0.762 . . . . 1.0 111.537 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 8.3 mt -128.48 138.21 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 176.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -88.94 109.04 19.9 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 177.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.194 -0.907 . . . . 1.0 112.028 -176.44 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.674 0.273 . . . . 1.0 110.416 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -79.3 169.39 18.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.266 0.555 . . . . 1.0 111.525 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -138.43 97.03 3.27 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.869 -1.16 . . . . 1.0 107.869 174.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' ALA . . . . . . . . . . . . . . . -175.06 171.58 2.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.522 -178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' HIS . . . . . 0.539 ' HA ' ' HB1' ' A' ' 155' ' ' ALA . 52.9 p-80 -170.21 148.54 3.32 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.162 -0.472 . . . . 1.0 109.91 177.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.465 ' HB2' ' HA ' ' A' ' 157' ' ' VAL . 65.8 m-85 -87.05 148.82 25.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.813 -0.63 . . . . 1.0 110.881 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -141.72 122.38 14.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.788 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' VAL . . . . . 0.531 HG22 ' HB3' ' B' ' 218' ' ' TRP . 97.7 t -96.6 133.96 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.662 -0.699 . . . . 1.0 110.623 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -145.15 -178.66 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.0 110.749 -177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' B' ' 215' ' ' LYS . 3.6 t -100.33 135.74 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.854 -0.612 . . . . 1.0 112.064 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -83.02 178.02 8.34 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 1.0 109.444 178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -68.56 -9.98 52.91 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.97 -0.559 . . . . 1.0 112.256 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' ALA . . . . . . . . . . . . . . . -114.85 20.14 15.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.503 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 69.59 38.13 1.79 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 115.431 -0.804 . . . . 1.0 111.115 177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' B' ' 210' ' ' VAL . 12.9 mmtt -108.16 151.67 25.59 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.539 -176.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' TYR . . . . . 0.445 ' C ' ' HD2' ' B' ' 217' ' ' ARG . 81.9 m-85 -98.25 102.7 14.52 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.134 -0.939 . . . . 1.0 110.162 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.588 ' HD3' ' HA2' ' B' ' 234' ' ' GLY . 15.3 mmm180 -120.26 179.37 4.31 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.365 0.415 . . . . 1.0 109.975 -177.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' TRP . . . . . 0.531 ' HB3' HG22 ' B' ' 208' ' ' VAL . 56.0 p-90 -151.12 163.24 39.26 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.696 0.284 . . . . 1.0 111.62 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' B' ' 218' ' ' TRP . 36.3 mtp85 -148.25 145.0 28.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.129 -0.942 . . . . 1.0 109.99 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' LEU . . . . . 0.69 ' HG ' HD12 ' B' ' 228' ' ' LEU . 36.7 tp -97.62 135.01 40.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.987 -0.746 . . . . 1.0 108.987 178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . . . . . . . . . 5.9 t -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 -176.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' HIS . . . . . 0.5 ' CB ' HD21 ' B' ' 226' ' ' ASN . 2.3 t-80 -84.78 177.23 8.08 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.645 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -55.01 -38.01 67.36 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.711 -0.677 . . . . 1.0 111.342 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -66.63 -33.12 74.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.572 0.701 . . . . 1.0 109.941 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . 107.98 12.61 21.84 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.279 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.5 HD21 ' CB ' ' B' ' 222' ' ' HIS . 0.3 OUTLIER -86.15 142.76 28.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.524 0.202 . . . . 1.0 111.334 179.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 49.5 mm -74.6 117.56 18.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' LEU . . . . . 0.69 HD12 ' HG ' ' B' ' 220' ' ' LEU . 21.3 mt -89.38 -43.16 11.1 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.285 -0.87 . . . . 1.0 110.076 -177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 148' ' ' VAL . . . -151.63 159.51 44.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.578 -1.192 . . . . 1.0 111.533 177.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -134.66 155.49 50.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' SER . . . . . 0.493 ' HB2' ' NH2' ' B' ' 217' ' ' ARG . 79.5 p -55.79 -40.53 72.79 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.731 0.641 . . . . 1.0 112.731 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' GLY . . . . . . . . . . . . . . . 91.68 -52.52 3.0 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.269 -0.491 . . . . 1.0 112.692 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.01 -169.31 2.52 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 123.347 0.659 . . . . 1.0 110.707 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.588 ' HA2' ' HD3' ' B' ' 217' ' ' ARG . . . -160.06 132.24 2.91 Favored Glycine 0 C--N 1.338 0.666 0 C-N-CA 120.926 -0.654 . . . . 1.0 112.675 176.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -142.36 170.6 15.39 Favored 'General case' 0 C--N 1.347 0.487 0 CA-C-N 116.72 0.26 . . . . 1.0 110.423 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' ALA . . . . . . . . . . . . . . . -96.73 10.48 38.61 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.673 0.99 . . . . 1.0 113.673 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 4.5 m -122.07 132.08 54.31 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 120.035 -0.666 . . . . 1.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -64.37 -35.82 82.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.372 -0.831 . . . . 1.0 110.366 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' B' ' 243' ' ' GLN . 8.1 tt0 -60.08 -47.23 86.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.739 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -61.52 -36.02 79.36 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.03 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.74 -49.87 75.11 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.406 0.622 . . . . 1.0 109.602 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' LYS . . . . . 0.499 ' HA ' HD12 ' B' ' 245' ' ' ILE . 45.2 mtmt -65.47 -35.85 82.12 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.94 -1.027 . . . . 1.0 110.925 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' B' ' 239' ' ' GLN . 24.5 mm-40 -63.51 -29.65 70.88 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.552 -0.536 . . . . 1.0 109.552 177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . -65.2 -41.67 96.77 Favored Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.223 -1.151 . . . . 1.0 110.223 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 157' ' ' VAL . 53.1 mt -63.13 -45.61 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.054 -0.573 . . . . 1.0 109.925 177.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -61.81 -39.07 90.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.183 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . . . . . . . . . 46.1 m -66.39 -34.86 78.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.677 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' B' ' 252' ' ' ALA . 0.7 OUTLIER -74.95 -43.21 45.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 C-N-CA 120.27 -0.572 . . . . 1.0 110.289 -177.46 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -66.08 -11.96 52.22 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.104 -0.373 . . . . 1.0 111.946 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -100.72 -3.25 30.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.976 -0.557 . . . . 1.0 110.887 -177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -135.9 -36.97 0.74 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.397 -0.365 . . . . 1.0 111.828 -177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' B' ' 248' ' ' VAL . . . -54.52 -49.87 88.56 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.833 -0.622 . . . . 1.0 112.659 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' B' ' 252' ' ' ALA . 37.1 Cg_endo -63.81 -11.52 27.2 Favored 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 121.691 1.594 . . . . 1.0 113.8 -177.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.93 -14.48 8.46 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.318 0.488 . . . . 1.0 112.318 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' ALA . . . . . 0.464 ' HB1' ' HA ' ' A' ' 105' ' ' HIS . . . -68.04 137.16 54.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.444 0.64 . . . . 1.0 112.266 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -93.81 147.85 22.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.864 -1.062 . . . . 1.0 111.942 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 145' ' ' ILE . 40.8 t -84.61 132.68 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.283 -0.871 . . . . 1.0 112.281 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.1 134.22 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.933 -0.766 . . . . 1.0 108.933 174.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -87.13 100.48 12.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.466 -0.778 . . . . 1.0 110.97 -177.294 . . . . . . . . 0 0 . 1 stop_ save_